<SEC-DOCUMENT>0001654954-22-008496.txt : 20220617
<SEC-HEADER>0001654954-22-008496.hdr.sgml : 20220617
<ACCEPTANCE-DATETIME>20220617171025
ACCESSION NUMBER:		0001654954-22-008496
CONFORMED SUBMISSION TYPE:	S-1
PUBLIC DOCUMENT COUNT:		70
FILED AS OF DATE:		20220617
DATE AS OF CHANGE:		20220617

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			374Water Inc.
		CENTRAL INDEX KEY:			0000933972
		STANDARD INDUSTRIAL CLASSIFICATION:	MOTORS & GENERATORS [3621]
		IRS NUMBER:				880271109
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-265712
		FILM NUMBER:		221024945

	BUSINESS ADDRESS:	
		STREET 1:		701 W. MAIN STREET
		STREET 2:		SUITE 410
		CITY:			DURHAM
		STATE:			NC
		ZIP:			27701
		BUSINESS PHONE:		919-888-8194

	MAIL ADDRESS:	
		STREET 1:		3710 SHANNON RD #51877
		STREET 2:		SUITE 410
		CITY:			DURHAM
		STATE:			NC
		ZIP:			27717

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	POWERVERDE, INC.
		DATE OF NAME CHANGE:	20080820

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	VYREX CORP
		DATE OF NAME CHANGE:	19951206
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1
<SEQUENCE>1
<FILENAME>scwo_s1.htm
<DESCRIPTION>FORM S-1
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?><html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:scwo="http://powerverdeinc.com/20220331"><head><title>scwo_s1.htm</title><!--Document Created by XBRLMaster--><meta http-equiv="Content-Type" content="text/html" /></head><body style="text-align:justify;font:10pt times new roman"><div style='display:none;text-align:justify;font:10pt times new roman;' id='XBRLDIV'><ix:header><ix:hidden><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="From2022-01-01to2022-03-31">0000933972</ix:nonNumeric><ix:nonNumeric name="dei:AmendmentFlag" contextRef="From2022-01-01to2022-03-31" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonFraction name="us-gaap:DeferredRevenue" contextRef="AsOf2021-12-31" unitRef="USD" decimals="0">0</ix:nonFraction><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2020-12-31" unitRef="Shares" decimals="0">1000000</ix:nonFraction><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2020-12-31" unitRef="USDPShares" decimals="INF">0.0001</ix:nonFraction><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2022-03-31" unitRef="Shares" decimals="0">0</ix:nonFraction><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2020-12-31" unitRef="Shares" decimals="0">0</ix:nonFraction><ix:nonFraction name="us-gaap:PreferredStockLiquidationPreferenceValue" contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">409005</ix:nonFraction><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2021-12-31" unitRef="Shares" decimals="0">27272</ix:nonFraction><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2020-12-31" unitRef="Shares" decimals="0">0</ix:nonFraction><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2022-03-31" unitRef="Shares" decimals="0">0</ix:nonFraction><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2020-12-31" unitRef="Shares" decimals="0">200000000</ix:nonFraction><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2020-12-31" unitRef="USDPShares" decimals="INF">0.001</ix:nonFraction><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-12-31" unitRef="Shares" decimals="0">125317746</ix:nonFraction><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2020-12-31" unitRef="Shares" decimals="0">62410452</ix:nonFraction><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">0</ix:nonFraction><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefits" contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">0</ix:nonFraction><ix:nonFraction name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">0</ix:nonFraction><ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">0</ix:nonFraction><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2021-09-30_us-gaap_SeriesDPreferredStockMember" unitRef="USDPShares" decimals="INF">.0001</ix:nonFraction><ix:nonFraction name="scwo:IntangibleAssetsAdditions" contextRef="AsOf2022-03-31_scwo_LicenseAgreementMember" unitRef="USD" decimals="0">0</ix:nonFraction><ix:nonFraction name="scwo:IntangibleAssetsAdditions" contextRef="AsOf2022-03-31_us-gaap_PatentsMember" unitRef="USD" decimals="0">0</ix:nonFraction><ix:nonNumeric name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" contextRef="From2022-01-01to2022-03-31_scwo_LicenseAgreementMember">P17Y</ix:nonNumeric><ix:nonNumeric name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" contextRef="From2022-01-01to2022-03-31_us-gaap_PatentsMember">P20Y</ix:nonNumeric><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-01-01to2021-12-31_scwo_OptionUnvestedMember" unitRef="Shares" decimals="0">2885000</ix:nonFraction><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" contextRef="From2022-01-01to2022-03-31_scwo_OptionsMember" unitRef="Shares" decimals="0">0</ix:nonFraction><ix:nonFraction name="scwo:Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice" contextRef="From2022-01-01to2022-03-31_scwo_OptionsMember" unitRef="USDPShares" decimals="INF">0</ix:nonFraction><ix:nonFraction name="scwo:Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice" contextRef="From2022-01-01to2022-03-31_scwo_OptionsMember" unitRef="USDPShares" decimals="INF">0</ix:nonFraction><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2022-01-01to2022-03-31" unitRef="Shares" decimals="0">0</ix:nonFraction><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2022-01-01to2022-03-31" unitRef="Shares" decimals="0">0</ix:nonFraction><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2022-01-01to2022-03-31" unitRef="USDPShares" decimals="INF">0</ix:nonFraction><ix:nonFraction name="scwo:WeightedAverageExercisePriceExercised" contextRef="From2022-01-01to2022-03-31" unitRef="USDPShares" decimals="INF">0</ix:nonFraction><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2019-12-31" unitRef="USDPShares" decimals="INF">0.11</ix:nonFraction><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-01-01to2021-12-31" unitRef="Shares" decimals="0">5033333</ix:nonFraction><ix:nonFraction name="scwo:WarrantsOutstandingSeriesOneShares" contextRef="AsOf2022-03-31" unitRef="Shares" decimals="0">1250000</ix:nonFraction><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-04-01to2021-04-16_us-gaap_SeriesDPreferredStockMember" unitRef="USD" decimals="0">6551691</ix:nonFraction><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-01-12_us-gaap_SeriesDPreferredStockMember" unitRef="Shares" decimals="0">27272</ix:nonFraction><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-09-29_us-gaap_SeriesDPreferredStockMember" unitRef="Shares" decimals="0">412853</ix:nonFraction><ix:nonFraction name="scwo:LiabilityForPreferredStockShares" contextRef="From2022-01-01to2022-03-31" unitRef="USD" decimals="0">50000</ix:nonFraction><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-12-31_scwo_ThreeSevenFourWaterMember" unitRef="Shares" decimals="0">125317746</ix:nonFraction><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-04-16_us-gaap_PatentsMember" unitRef="Shares" decimals="0">1602282</ix:nonFraction><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="From2021-01-01to2021-12-31_us-gaap_PatentsMember" unitRef="Shares" decimals="0">2500000</ix:nonFraction><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesOther" contextRef="From2021-01-01to2021-12-31_us-gaap_PatentsMember" unitRef="Shares" decimals="0">4958833</ix:nonFraction><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2021-12-31_us-gaap_SeriesDPreferredStockMember" unitRef="Shares" decimals="0">27272</ix:nonFraction><ix:nonFraction name="scwo:PreferredStockParValue" contextRef="AsOf2020-10-30_us-gaap_SeriesDPreferredStockMember" unitRef="USDPShares" decimals="INF">0.0001</ix:nonFraction><ix:nonFraction name="us-gaap:PreferredStockConvertibleSharesIssuable" contextRef="AsOf2021-09-29_us-gaap_SeriesDPreferredStockMember" unitRef="Shares" decimals="0">20642667</ix:nonFraction><ix:nonFraction name="us-gaap:PreferredStockConvertibleSharesIssuable" contextRef="AsOf2022-01-12_us-gaap_SeriesDPreferredStockMember" unitRef="Shares" decimals="0">1363149</ix:nonFraction><ix:nonFraction name="scwo:PreferredStockStatedValuePerShare" contextRef="AsOf2021-04-16_scwo_ThreeSevenFourWaterMember" unitRef="USDPShares" decimals="INF">15</ix:nonFraction></ix:hidden><ix:references><link:schemaRef xlink:type='simple' xlink:href='scwo-20220331.xsd'></link:schemaRef></ix:references><ix:resources><xbrli:context id="From2022-01-01to2022-03-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2022-04-13_us-gaap_SubsequentEventMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2020-01-01to2020-09-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2021-01-01to2021-03-31_scwo_ConsultantMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">scwo:ConsultantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2022-01-01to2022-03-31_scwo_ConsultantMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">scwo:ConsultantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2021-04-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2021-04-01to2021-04-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2020-01-01to2020-12-31_scwo_ConsultantMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">scwo:ConsultantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2021-01-01to2021-12-31_scwo_ConsultantMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">scwo:ConsultantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2021-01-01to2021-12-31_us-gaap_PatentsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2021-04-16_us-gaap_PatentsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2021-04-16_scwo_ThreeSeverFourWaterFormerStockholdersMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">scwo:ThreeSeverFourWaterFormerStockholdersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2021-04-16_scwo_ThreeSevenFourWaterMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">scwo:ThreeSevenFourWaterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2020-10-30_us-gaap_SeriesDPreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2021-09-29_us-gaap_SeriesDPreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2022-01-12_us-gaap_SeriesDPreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2021-04-01to2021-04-16_us-gaap_SeriesDPreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2019-01-01to2019-12-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2021-01-01to2021-12-31_scwo_WarrantsMember_scwo_MaximumsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">scwo:WarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">scwo:MaximumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2021-01-01to2021-12-31_scwo_WarrantsMember_scwo_MinimumsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">scwo:WarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">scwo:MinimumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2022-01-01to2022-03-31_scwo_OptionsMember_scwo_MaximumsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">scwo:OptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">scwo:MaximumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2022-01-01to2022-03-31_scwo_OptionsMember_scwo_MinimumsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">scwo:OptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">scwo:MinimumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2021-01-01to2021-12-31_scwo_OptionsMember_scwo_MaximumsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">scwo:OptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">scwo:MaximumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2021-01-01to2021-12-31_scwo_OptionsMember_scwo_MinimumsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">scwo:OptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">scwo:MinimumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2019-01-01to2019-12-31_scwo_OptionsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">scwo:OptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2022-03-31_scwo_OptionsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">scwo:OptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2021-01-01to2021-12-31_scwo_OptionsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">scwo:OptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2022-01-01to2022-03-31_scwo_OptionsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">scwo:OptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2020-01-01to2020-12-31_scwo_OptionsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">scwo:OptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2019-12-31_scwo_OptionsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">scwo:OptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2020-12-31_scwo_OptionsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">scwo:OptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2021-12-31_scwo_OptionsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">scwo:OptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2021-12-31_scwo_OptionUnvestedMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">scwo:OptionUnvestedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2021-01-01to2021-12-31_scwo_OptionUnvestedMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">scwo:OptionUnvestedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2020-12-31_us-gaap_PatentsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2020-12-31_scwo_LicenseAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">scwo:LicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2022-01-01to2022-03-31_us-gaap_PatentsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2022-01-01to2022-03-31_scwo_LicenseAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">scwo:LicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2021-12-31_us-gaap_PatentsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2021-12-31_scwo_LicenseAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">scwo:LicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2022-03-31_us-gaap_PatentsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2022-03-31_scwo_LicenseAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">scwo:LicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2021-01-01to2021-12-31_srt_ChiefExecutiveOfficerMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2021-01-01to2021-12-31_us-gaap_SeriesDPreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2021-12-31_us-gaap_SeriesDPreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2021-09-30_us-gaap_SeriesDPreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2021-01-01to2021-12-31_scwo_MrNagarMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">scwo:MrNagarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2022-03-31_us-gaap_SeriesDPreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2022-01-01to2022-03-31_us-gaap_SeriesDPreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2022-01-01to2022-03-31_srt_ChiefExecutiveOfficerMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2022-01-01to2022-03-31_scwo_MrNagarMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">scwo:MrNagarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2022-03-31_scwo_ThreeSevenFourWaterMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">scwo:ThreeSevenFourWaterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2021-12-31_scwo_ThreeSevenFourWaterMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">scwo:ThreeSevenFourWaterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2021-01-01to2021-06-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2020-01-01to2020-12-31_scwo_WarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">scwo:WarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2021-01-01to2021-12-31_scwo_WarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">scwo:WarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2021-04-01to2021-04-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2021-04-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-04-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2021-01-01to2021-12-31_us-gaap_StockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2022-01-01to2022-03-31_us-gaap_StockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2022-03-31_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2022-03-31_us-gaap_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2022-03-31_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2022-01-01to2022-03-31_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2022-01-01to2022-03-31_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2022-01-01to2022-03-31_us-gaap_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2022-01-01to2022-03-31_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2021-12-31_us-gaap_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2021-12-31_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2021-01-01to2021-12-31_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2021-01-01to2021-12-31_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2021-01-01to2021-12-31_us-gaap_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2021-01-01to2021-12-31_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2021-03-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2021-03-31_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2021-03-31_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2021-03-31_us-gaap_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2021-03-31_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2021-01-01to2021-03-31_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2021-01-01to2021-03-31_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2021-01-01to2021-03-31_us-gaap_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2021-01-01to2021-03-31_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2020-12-31_us-gaap_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2020-12-31_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2020-01-01to2020-12-31_us-gaap_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2020-01-01to2020-12-31_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2019-12-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2019-12-31_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2019-12-31_us-gaap_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2019-12-31_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2020-01-01to2020-12-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2021-01-01to2021-03-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2021-01-01to2021-12-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2020-12-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2021-12-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2022-03-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="Shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="USDPShares"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="Pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit></ix:resources></ix:header></div><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">As filed with the U.S. Securities and Exchange Commission on June&#160;17, 2022</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>Registration No.&#160;333-</strong></p><table style="font-size:1px;width:100%"><tbody><tr><td style="BORDER-BOTTOM: 5px solid;"></td></tr><tr><td style="BORDER-BOTTOM: 2px solid;"></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>UNITED STATES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>SECURITIES AND EXCHANGE COMMISSION</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Washington, D.C. 20549</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="font-size:18pt">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="From2022-01-01to2022-03-31">S-1</ix:nonNumeric></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>REGISTRATION STATEMENT</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>UNDER</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>THE SECURITIES ACT OF 1933</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:60%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><span style="font-size:18pt">&#160;<strong><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="From2022-01-01to2022-03-31">374Water Inc.</ix:nonNumeric></strong></span></p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>(Exact name of registrant as specified in its charter)</strong></p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:85%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:30%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="From2022-01-01to2022-03-31" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></strong></p></td><td style="width:5%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:30%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>3621</strong></p></td><td style="width:5%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:30%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="From2022-01-01to2022-03-31">88-0271109</ix:nonNumeric></strong></p></td></tr><tr style="height:15px"><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>(State or other jurisdiction of </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>incorporation or organization)</strong></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>(Primary Standard Industrial </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Classification Code Number</strong></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>(I.R.S. Employer </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Identification Number)</strong></p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="From2022-01-01to2022-03-31">701 W. Main Street</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="From2022-01-01to2022-03-31">Suite 410</ix:nonNumeric></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="From2022-01-01to2022-03-31">Durham</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="From2022-01-01to2022-03-31">NC</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="From2022-01-01to2022-03-31">27701</ix:nonNumeric> </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="text-decoration:underline">(<ix:nonNumeric name="dei:CityAreaCode" contextRef="From2022-01-01to2022-03-31">919</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="From2022-01-01to2022-03-31">888-8194</ix:nonNumeric></span></strong>&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>(Address, including zip code, and telephone number, including area code, of registrant&#8217;s principal executive offices)</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Yaacov Nagar</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>374Water&#160;Inc. </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Chief Executive Officer</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>701 W. Main Street, Suite 410</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Durham, NC 27701</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="text-decoration:underline">(919) 888-8194</span></strong>&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.75in; text-align:center;"><strong>(Name, address, including zip code, and telephone number, including area code, of agent for service)</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><em><strong>Copies to:</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:32%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Damian C. Georgino</strong></p></td><td style="width:33%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Jeffrey M. Quick,&#160;Esq.</strong></p></td><td style="width:32%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>M. Ali Panjwani&#160;Esq.</strong></p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>F. Reid Avett</strong></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Quick Law Group, P.C.</strong></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Pryor Cashman LLP</strong></p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Womble Bond Dickinson (US) LLP</strong></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>1035 Pearl Street, Suite&#160;403</strong>&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>7 Time Square</strong></p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>One Wells Fargo Center, Suite 3500</strong></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Boulder, CO 80302</strong></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>New York, New York 10036</strong></p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>301 South College Street</strong></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;<strong>(720) 259-3393</strong></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>(212) 421-4100&#160;</strong></p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Charlotte, NC 28202</strong></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>(704) 331-4900</strong></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Approximate date of commencement of proposed sale to the public:</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As soon as practicable after this registration statement is declared effective. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">If any of the securities being registered on this Form&#160;are to be offered on a delayed or continuous basis pursuant to Rule&#160;415 under the Securities Act, check the following box: &#9744;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">If this Form&#160;is filed to register additional securities for an offering pursuant to Rule&#160;462(b)&#160;under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">If this Form&#160;is a post-effective amendment filed pursuant to Rule&#160;462(c)&#160;under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">If this Form&#160;is a post-effective amendment filed pursuant to Rule&#160;462(d)&#160;under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act. (Check one):</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:85%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:30%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Large accelerated filer</p></td><td style="width:20%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#9744;</p></td><td style="width:30%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accelerated filer</p></td><td style="width:20%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#9744;</p></td></tr><tr style="height:15px"><td style="vertical-align:bottom;"><ix:nonNumeric name="dei:EntityFilerCategory" contextRef="From2022-01-01to2022-03-31" format="ixt-sec:entityfilercategoryen"><p style="font-size:10pt;font-family:times new roman;margin:0px">Non-accelerated filer</p></ix:nonNumeric></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#9746;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Smaller reporting company</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><ix:nonNumeric name="dei:EntitySmallBusiness" contextRef="From2022-01-01to2022-03-31" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Emerging growth company</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="From2022-01-01to2022-03-31" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided to Section&#160;7(a)(2)(B)&#160;of the Securities Act. <ix:nonNumeric name="dei:EntityExTransitionPeriod" contextRef="From2022-01-01to2022-03-31" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;"><strong>The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section&#160;8(a)&#160;of the Securities Act of 1933, as amended, or until the registration statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section&#160;8(a), may determine.</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="font-size:1px;width:100%"><tbody><tr><td style="BORDER-BOTTOM: 2px solid;"></td></tr><tr><td style="BORDER-BOTTOM: 5px solid;"></td></tr></tbody></table><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="TEXT-INDENT: 0px;"></td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td>&#160;</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="color:red">The information in this preliminary prospectus is not complete and may be changed. These securities may not be sold until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell nor does it seek an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:30%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong><span style="color:red">PRELIMINARY PROSPECTUS</span></strong></p></td><td style="width:31%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="color:red">SUBJECT TO COMPLETION</span></strong></p></td><td style="width:30%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong><span style="color:red">&#160;DATED&#160;JUNE 17, 2022</span></strong></p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares</strong> <strong>of Common Stock</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="scwo_s1img7.jpg" alt="scwo_s1img7.jpg" /></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>&#160;374Water</strong><strong>&#160;Inc.</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">We are offering shares of 374Water&#160;Inc. common stock, par value of $0.0001 in a firm commitment underwritten offering.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">On June 14, 2022, our common stock began trading on the Nasdaq Capital Market (&#8220;Nasdaq&#8221;) under the symbol &#8220;SCWO&#8221;. Prior to June 14, 2022, our common stock traded on the OTCQB Marketplace (the &#8220;OTCQB&#8221;) under the symbol &#8220;SCWO.&#8221; Only a limited public market exists for our common stock.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#160;&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">On , 2022, the last reported sale price of our common stock on Nasdaq was $ per share. We have assumed a public offering price of $ per share, the last reported sale price for our common stock as reported on Nasdaq on , 2022. The actual public offering price per share will be determined through negotiations between us and the underwriter at the time of pricing and may be at a discount to the current market price. Accordingly, the assumed public offering price used throughout this prospectus may not be indicative of the final offering price.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">We are an &#8220;emerging growth company&#8221; as defined in Section 2(a) of the Securities Act of 1933, as amended, and, as such, have elected to comply with certain reduced disclosure and regulatory requirements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;"><strong>Investing in our securities involves a high degree of risk. See the section of this prospectus entitled &#8220;Risk Factors&#8221; beginning on page 14 to read about factors you should consider before buying our securities.</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;"><strong>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus. Any representation to the contrary is a criminal offense.</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:67%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Per&#160;Share</strong></p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Total</strong></p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:67%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Public offering price </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">$</p></td><td style="width:9%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#160;</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">$</p></td><td style="width:9%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#160;</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:67%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Underwriting discounts and commissions<sup>(1)&#160;</sup></p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">$</p></td><td style="width:9%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#160;</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">$</p></td><td style="width:9%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#160;</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:67%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Proceeds to us, before expenses </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">$</p></td><td style="width:9%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#160;</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">$</p></td><td style="width:9%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#160;</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(1)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Does not include additional compensation payable to the underwriter. We have agreed to reimburse the underwriter for certain expenses incurred relating to this offering. In addition, we will issue to the underwriter a warrant to purchase the number of shares of our common stock equal to up to&#160;[&#160; ]&#160;percent ([&#160; ]%) of the number of shares issued in this offering. See &#8220;Underwriting&#8221; on page&#160;[&#160; ]&#160;of this prospectus for additional information</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">This offering is being underwritten on a firm commitment basis. The underwriter has the option to purchase up to an additional shares of common stock to purchase up to shares of common stock solely to cover overallotments, if any, at the public offering price, less underwriting discounts and commissions, within 45 days of the date of this prospectus.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">The underwriter expects to deliver the securities to purchasers in the offering on or about , 2022.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="font-size:18pt">Roth Capital Partners</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">The date of this prospectus is , 2022</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"></td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td>&#160;</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="toc">TABLE OF CONTENTS</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Prospectus</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:8%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;<strong>Page</strong></p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#industry">INDUSTRY AND MARKET DATA</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#pros">PROSPECTUS SUMMARY</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">3</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#riskfactors">RISK FACTORS</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">14</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#special">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">22</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#useofpro">USE OF PROCEEDS</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">23</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#dividend">DIVIDEND POLICY</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">24</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#market">MARKET FOR COMMON EQUITY</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">24</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#cap">CAPITALIZATION</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">25</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#dilution">DILUTION</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">26</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#mda">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF&#160;FINANCIAL CONDITION AND RESULTS OF OPERATIONS</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">28</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#business">BUSINESS</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">31</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#management">MANAGEMENT</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">40</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#exec">EXECUTIVE COMPENSATION</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">44</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#certain">CERTAIN RELATIONSHIPS AND RELATED-PARTY TRANSACTIONS</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">48</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#desofcap">DESCRIPTION OF CAPITAL STOCK</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">49</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#descofsec">DESCRIPTION OF SECURITIES WE ARE OFFERING</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">55</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#material">MATERIAL U.S. FEDERAL INCOME AND ESTATE TAX CONSIDERATIONS</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">55</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#underw">UNDERWRITING</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">60</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#legel">LEGAL MATTERS</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">68</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#experts">EXPERTS</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">68</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#where">WHERE YOU CAN FIND MORE INFORMATION</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">68</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">1</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Unless otherwise indicated or the context otherwise requires, financial data included in this prospectus reflects the business and operations of 374Water&#160;Inc. and its consolidated subsidiaries and all references herein to &#8220;374Water&#160;Inc.,&#8221; &#8220;374Water,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our&#8221; or &#8220;us&#8221; refer to 374Water&#160;Inc. and its consolidated subsidiaries.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;"><strong>Neither we nor the underwriter have authorized anyone to provide any information or to make any representations other than those contained in this prospectus or in any free writing prospectus we have prepared. We and the underwriter take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. We are offering to sell, and seeking offers to buy, our securities only under circumstances and in jurisdictions where it is lawful to do so. The information contained in this prospectus is accurate only as of the date of this prospectus, regardless of the time of delivery of this prospectus or of any sale of our securities.</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">For investors outside the United States: Neither we nor the underwriter have done anything that would permit this offering or the possession or distribution of this prospectus in any jurisdiction where action for those purposes is required, other than in the United States. Persons outside the United States who come into possession of this prospectus must inform themselves about, and observe any restrictions relating to, this offering and the distribution of this prospectus outside the United States.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">This prospectus includes some of our trademarks, including, among others, &#8220;374Water,&#8221; and &#8220;AirSCWO&#8482;&#8221;. Each one of these names is our registered trademark. This prospectus also includes additional trademarks, service marks and trade names of others, which are the property of their respective owners.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Solely for convenience, the references to our trademarks included in this prospectus are without the &#8482; symbol, but such references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights to our trademarks.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="industry">INDUSTRY AND MARKET DATA</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Market data, industry statistics, and forecasts included in this prospectus, other than those provided by third party experts, are based on the good faith estimates of management, which in turn are based upon management&#8217;s reviews of independent industry publications, reports by market research firms, and other independent and publicly available sources. Data regarding the industry in which we compete and our market position and market share within this industry are inherently imprecise and are subject to significant business, economic and competitive uncertainties beyond our control; however, we believe they generally indicate size, position and market share within this industry. Our own estimates are based on internally-derived metrics, as well as data from trade and business organizations and other contacts in the markets we operate.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">We are responsible for all of the disclosures included in this prospectus, and we believe these estimates to be accurate as of the date of this prospectus or such other date as stated in this prospectus. However, this information may prove to be inaccurate due to the method by which we obtained some of the data for the estimates or the fact that this information cannot always be verified with complete certainty due to limits on the availability and reliability of raw data, the voluntary nature of the data gathering process and other limitations and uncertainties. While we believe that each of the publications used throughout this prospectus are prepared by reputable sources, neither we nor the underwriter have independently verified market and industry data from third party sources. While we believe our internal company research and estimates are reliable, such research and estimates have not been verified by any independent source. In addition, assumptions and estimates of our and our industry&#8217;s future performance are necessarily subject to a high degree of uncertainty and risk due to a variety of factors, including those described in &#8220;Risk Factors&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in this prospectus.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">2</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="pros">PROSPECTUS SUMMARY</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>This summary highlights certain significant aspects of our business and this offering and is a summary of information contained elsewhere in this prospectus. This summary does not contain all the information that you should consider before deciding to invest in our securities. You should read the entire prospectus carefully, including &#8220;Risk Factors,&#8221; &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations,&#8221; &#8220;Business,&#8221; and our financial statements and related notes thereto included in this prospectus, before making an investment decision.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Overview</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">374Water offers a disruptive technology that transforms all wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into valuable, recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. We are pioneering a new era of waste management that supports a circular economy and enables organizations to achieve their Environment, Social, and Governance (ESG) goals. Our vision is a world without waste and our mission is to help create and preserve a clean and healthy environment that sustains life.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Our Technology</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We have developed proprietary treatment systems based on Supercritical Water Oxidation (SCWO). Our patented and proprietary AirSCWO&#8482; leverages the unique properties of water in its supercritical phase (above 374<sup>o</sup>C and 221 Bar), as described in Illustration 1 (below). The supercritical phase produces properties of both a gas and liquid to convert organic matter to energy in the form of recoverable heat and safe byproducts that can be recovered and put to economically productive use, as shown in Illustration 2 (below). We call our systems AirSCWO&#8482;, as it utilizes a combination of air and the SCWO process. Because our AirSCWO&#8482; destroys any organic material, the AirSCWO&#8482; systems are essentially waste stream agnostic with the capability of treating a variety of complex, hazardous and non-hazardous waste streams, thus opening up opportunities for multiple applications in diverse market verticals on an international scale, as described visually below. Most pertinently, the technology is shifting the landscape in addressing environmental challenges that, until now, have been considered insurmountable due to science/engineering and/or cost barriers. For example, we can treat PFAS (&#8220;per- and polyfluoroalkyl substances&#8221;) which essentially eliminates all traces of any &#8220;forever&#8221; chemicals. See below Table 1: Representative target markets. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Illustration 1: Water properties and how the supercritical phase is reached:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="scwo_s1img11.jpg" alt="scwo_s1img11.jpg" /></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Illustration 2: AirSCWO&#8482; technology</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="scwo_s1img12.jpg" alt="scwo_s1img12.jpg" /></p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">3</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Products and Services</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We believe, AirSCWO&#8482; systems have the ability to address environmental issues across multiple market verticals. We will initially target biosolids and PFAS-laden waste. Our revenue model includes both capital equipment sales and long-term service agreements. Our sales and market strategy is a combination of direct customer and channel partner sales routes, depending on the specific market and territory. In some cases, the AirSCWO&#8482; systems may be &#8220;white labeled&#8221; and sold directly to others who will integrate our equipment with other equipment as part of an integrated system and solution.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We sell AirSCWO&#8482; as a modular and containerized system. The units are compact and prefabricated so that they may be cost effectively shipped, installed, and operated within the footprint of an existing plant. We are currently offering a six (6) wet tons per day throughput capacity system and a thirty (30) wet tons per day throughput capacity system is anticipated to be commercialized in 2023. A two hundred (200) wet tons per day throughput capacity system is to be designed in 2024-25. Illustration 3 below highlights our product mix.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Illustration 3: AirSCWO&#8482; system models and capacity:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="scwo_s1img13.jpg" alt="scwo_s1img13.jpg" /></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We offer three purchase options for our AirSCWO&#8482; systems as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">1.</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Capital equipment purchase</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">a.</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Payment in full is received before title is transferred, in which the client owns the system outright.</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">b.</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Financing a system for a specified period, making even capital equipment and service fee payments until full payment is received and the client owns the system outright. </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2.</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Leasing</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">a.</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Capital lease &#8211; By making payments throughout the lease term, the client pays the entire cost of the system and owns it outright at the end of the term.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">b.</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Operating lease - An agreement to use a system over a specified period of time. At the end of the operating lease term, the client does not own the system, but instead has the option to purchase the system at the fair market value or return the system to us.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">3.</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Service Agreements (SAs) by which the client pays a fee for having their waste treated. Examples of these agreements can include, but are not limited to: Build-Own-Operate (BOO), Build-Operate-Transfer (BOT) or Build-Own-Operate-Transfer (BOOT) using a long term contract basis by which we own and service the equipment. In a BOO model, we are responsible for designing, building, operating and maintaining the system during the contracted period. The client will pay us a service fee for operating and maintaining the system, which does not include installation and commissioning fees. In a BOT model, we are responsible for designing, building, operating and maintaining (during the contracted period), and transferring a system to the client at the end of the contract term. The client will pay us a service fee for operating and maintaining the system (which does not include installation and commissioning fees). A BOOT model is a variation of the BOT model, except that the ownership of the system will rest with us during the period of the contract, and the client is contractually obligated to purchase the system on mutually agreed upon terms at the end of the defined term, after we recover our investment and reasonable return as per the contract.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">4</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We will also sell, as part of a broader solution package, ancillary equipment that is required to pre-treat the inlet waste stream and post-treat a product stream, depending on the application. For example, in some cases, to meet the AirSCWO&#8482;<sup> </sup>inlet requirements (i.e., water percentage, total dissolved solids, etc.), a pre-treatment &#8220;bolt-on&#8221; process is implemented to ensure our system performance or a post-treatment packaged system to enhance the system outputs value (i.e., carbon dioxide utilization or sequestration, minerals recovery and upgrade, and water purification). Those package and bolt-on solutions will be developed by the company or by its strategic partners to provide a complete solution and integrated train. In addition, the Company will offer after sales agreements for supply of parts, maintenance and repairs, as well as long term Service Agreements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Markets and Industries </strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The trends that are transforming the markets discussed below and dictating a more robust and sustainable approach to waste stream management, are derived from recognition by waste generators, waste operators, government and society that there are key social, environmental and economic benefits to be gained by moving waste up the waste management hierarchy, towards prevention, reuse, recycling and recovery. The drivers that are facilitating adoption of our technology include, but are not limited to: population growth and urbanization, increasing quantity/complexity of waste streams, climate change, carbon economics, resource scarcity, corporate sustainability targets, commodity prices, energy security and tightening regulations (Global Industrial Wastewater Systems Market Survey Report, December 2021). The AirSCWO&#8482; technology is prime to address those key market drivers due to the fact that the system provides a complete, compact, energy-efficient, and decentralized solution able to treat a broad range of waste.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The AirSCWO&#8482; technology can treat diverse waste streams across different industries and market segments. We believe our technology provides a unique value proposition that will support its adoption across various markets, including, but not limited to: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Generating value from waste by recovering clean energy (in the form of heat), water, and minerals;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Providing a highly energy efficient, compact and sustainable waste treatment option that we believe can deliver unprecedented elimination of many environmentally persistent pollutants, e.g., PFAS, 1,4 Dioxane, microplastics, pharmaceuticals and personal care products (PPCPs), and contaminants of emerging concern (CECs);</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Treating waste at the source thereby eliminating haulage and transportation needs and reducing greenhouse gas (GHG) emissions; and</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Offsetting methane emissions by offering a solution to waste that does not form methane as a byproduct.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">One of our key markets is sludge treatment, which includes both municipal and industrial wastes. Sludge is the semi-solid by-product obtained from the treatment of residential and commercial (i.e., municipal) or industrial wastewater. Municipal sludge is typically treated in large biological treatment processes that allow for the wastewater to reside for extended periods in an air or oxygen rich environment (aerobic digestion or anaerobic digestion) that promotes biological breakdown of organic solids. This process generates a final residue known as biosolids, as it mainly consists of biological bacteria. Sludge and biosolids management are a key part of any wastewater treatment process. Those high strength streams are prime for the AirSCWO&#8482; technology since they contain significate calorific content that can be treated effectively and self-propel the oxidation process. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The global demand for municipal and industrial sludge treatment is expected to generate revenue of above $9 billion by the end of 2026, growing at a Compound Annual Growth Rate (CAGR) of around 5.7% between 2020 and 2026 (<span style="text-decoration:underline">Research and Markets Report, August 2020</span>). Growing populations and economic advancement have resulted in increased volumes of sludge, which drives the market for municipal and industrial sludge treatment.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The municipal sludge market is expected to drive the near-term growth of the Company&#8217;s revenue because of increasing disposal costs, and future regulation on organic emerging contaminants of concern (i.e PFAS, Microplastics, Pharmaceuticals). We are also targeting additional high value markets that we expect will contribute to the Company&#8217;s revenue and thereby help fuel our growth plans. Table 1 below shows near-term target markets, their subsegments, and the relevant applications associated with those markets.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">5</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Table1: Representative target markets, their subsegments and applications</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Key Markets</strong></p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Subsegments</strong></p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Applications</strong></p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Industrial:</p><p style="font-size:10pt;font-family:times new roman;margin:0px">manufacturing</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Chemical, Pharmaceutical,</p><p style="font-size:10pt;font-family:times new roman;margin:0px">Semiconductor, Food &amp; Beverage</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Hazardous and non-hazardous wastes, recalcitrant(1) organics, microplastics, PPCPs(2), CECs(3) and PFAS.</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Municipal</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Utilities</p><p style="font-size:10pt;font-family:times new roman;margin:0px">Landfills</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Sludge and biosolids, Landfill leachate(4)</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Defense</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Military Bases</p><p style="font-size:10pt;font-family:times new roman;margin:0px">Government owned manufacturing facilities</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Fuel and oil residuals, rinsates(5), AFFF(6) (PFAS)</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Oil and Gas</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exploration, Extraction/Offshore &amp; Onshore</p><p style="font-size:10pt;font-family:times new roman;margin:0px">Petroleum refining</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Concentrated waste streams, rinsates(5), AFFF (6)(PFAS), petroleum refining by-products</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Agricultural</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Farms, Slaughterhouses, Poultry houses</p><p style="font-size:10pt;font-family:times new roman;margin:0px">Recycling Centers</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Manure, concentrated waste streams</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Waste Management</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Incinerators</p><p style="font-size:10pt;font-family:times new roman;margin:0px">Landfills</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Landfill leachate(4), food waste, waste oils; Fats, Oil &amp; Greases (FOG), hazardous and non-hazardous organic waste.</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Sanitation Projects in developing countries</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Regional centralized facilities, decentralized treatment facilities (villages, schools)</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Municipal sludge and biosolids, mixed wastes</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(1)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Resistant&#160;to&#160;chemical&#160;decomposition;&#160;decomposing&#160;extremely&#160;slowly</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(2)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Pharmaceuticals and Personal Care Products</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(3)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Contaminants of Emerging Concern</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(4)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Water that has percolated through a solid and leached out some of the constituents</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(5)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Containing low concentrations of contaminants, resulting from the cleaning of containers, etc.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(6)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Aqueous Film Forming Foam</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The markets shown represent multi billions in Total Addressable Market (TAM) value, with typical 5-year CAGRs of between 5%-8% (<span style="text-decoration:underline">Research and Markets Report, August 2020</span>).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Strategy</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The execution of our growth strategy includes a blend of opportunities:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Growth Initiatives</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">After over nine years of research and development (R&amp;D) and testing at Duke University, we have sold our first commercial unit to a public agency responsible for 2.6 million people in Southern California. The Nix6 system, expected to be installed in the 4th quarter of 2022, is capable of processing six (6) wet tons per day (WMT/d) of wastewater in a 40-foot modular standard shipping container. We expect to sell and deliver at least one additional system in 2022 and to receive several additional purchase orders for systems this year. Additionally, we are finalizing the design of larger capacity systems to process thirty (30) WMT/d (Nix30) and later on two hundred (200) WMT/d (Nix200), respectively. We anticipate initial sales of our thirty (30) ton system within the next twelve months.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The Company&#8217;s growth over the next two years will be predominantly driven by sales of AirSCWO&#8482; systems in the identified key markets, leading to customer base expansion, with the municipal market expected to generate a significant portion of the Company&#8217;s revenue. The initial geographical focus will be North America and EMEA (to include Europe, the Middle East and Africa). Our business model includes direct sales to end-users and indirect sales via channel partners. In some markets, revenue will be generated from a mix of capital equipment sales and a Service Agreement (SA), which is a paid service for waste treatment pursuant to long-term contracts. The latter will be offered through a separate financing division that we are targeting to establish in 2022 and will initially be deployed via direct end-user engagement. The financing systems to be sold via service agreements will lower barriers to entry in our key markets and facilitate more rapid expansion of our client base. Examples of models to be used can include, but are not limited to: Build-Operate-Transfer (BOT) and Build-Own-Operate-Transfer (BOOT), depending on clients&#8217; preferences and limitations. We envisage that in some cases, public private partnerships (PPPs) will be established, particularly when selling to public utilities and addressing projects in developing geographies.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">In addition, during the next two to three years, we are planning to conduct further product development and expand our product portfolio. which will facilitate entrance into new subsegments where particularly high strength waste streams require treatment. This is most relevant to some industrial manufacturing, defense, and waste management applications. Our intention is to maintain a Research and Development budget sufficient to attain this goal.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">6</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Third Party Growth Initiatives</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">As an early-stage growth company with, what we believe is, a highly differentiated technology platform, we expect to leverage strategic partnerships with larger companies that serve the environmental or our various target end markets. We are currently engaging with potential strategic partners in a variety of markets, including:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(1)</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Technology companies offering complimentary technologies that can enhance our product offering. More specifically, we are exploring technologies that are capable of recycling our end-products to achieve more efficient resource recovery (which has both environmental and cost impacts). We believe such relationships would also help accelerate our growth by providing us access to our partners&#8217; existing client bases. We are currently discussing options with a waste management company based in the EU.</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(2)</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Original Equipment Manufacturers (OEMs) offering &#8220;bolt-on&#8221; technologies as ancillary equipment. In some cases, such equipment may be required for integration of our systems into a wider waste treatment train.</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(3)</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Technology integrators, engineering consultancies, Engineering-Procurement and Construction (EPC) companies that design and install complete solution packages in which our technology will be a key component. These companies can serve as highly effective distribution channels to accelerate deployment within their existing client base, thereby facilitating our growth agenda.</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(4)</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">The Company currently leverages two strategic partnering arrangements with companies that serve the environmental or our targeted end markets. These relationships provide the Company with adequate facilities to ensure successful deployment of our AirSCWO&#8482; systems and also attain economies of scale:</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(4)(i)</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">North America. We have a partnering arrangement in place with Merrell Bros., Inc. Merrell Bros., Inc. is a nationwide biosolids management company helping municipalities, industries and agricultural operations successfully manage and recycle biosolids since 1982. We believe the company has the facilities and capability to rapidly ramp-up manufacturing volumes and also support system modifications and deployment as required per market and clients. We expect Merrell Bros., Inc. to be a valuable resource as an additional sales channel for our AirSCWO&#8482; systems which will continue to spur overall growth of the Company.</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(4)(ii)</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Western Asia. Environmental Services Company Ltd. (ESC), is an Israeli government-owned company that specializes with treating industrial and hazardous waste in Israel. ESC is expected to provide the Company with access to new markets in the Middle-East that are more closely focused toward hazardous material treatment.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(5)</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Mid-term growth strategies include licensing agreements and acquisition of technologies to increase functionality of our systems (such as implementation of IooT and AIML platforms for full process digitization) and to increase supply chain reliability and efficiency for ancillary process equipment that is required for full integration of systems (i.e., pumps, valves, filters, dewatering equipment etc.).</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">7</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Intellectual Property</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We have designed an offensive intellectual property strategy to ensure we maintain a competitive edge in this space. We have currently filed five (5) provisional patents that cover crucial process operational aspects and improve system efficiencies and performance, including a provisional patent to cover a next generation AirSCWO&#8482; system for high strength waste stream treatment. We are allocating R&amp;D resources to support data generation that will allow us to move to a full non-provisional patent application by November 2022, with the intention of filing Patent Cooperation Treaty (PCT) application.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Collaborations with Strategic Partners</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We have an exclusive manufacturing agreement in place with Merrell Bros., Inc., which is based in Kokomo, Indiana, and is a nationwide biosolids management company helping municipalities, industries and agricultural operations successfully manage and recycle biosolids. They also serve as a channel partner to facilitate our market penetration and expansion plans in the US by opening up their existing client base.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We have a Sponsored Partnership Agreement with Duke University that provides access to Duke&#8217;s world-class research capabilities, building on our own R&amp;D expertise and strengthening our core development activities when needed.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We have an exclusive partnership agreement with Environmental Services Company Ltd., which is based in Israel, to act as our channel partner for treating industrial waste streams in Israel. Environmental Services Company Ltd. is known for its unique knowledge, regulatory and physical infrastructure, and a variety of halogenated organic wastes required for the R&amp;D effort.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Marketing</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Our marketing approach is through information, education, and thought leadership. This approach is because business purchase decisions are based more on bottom-line revenue impact. Return on investment (ROI) is a primary focus for corporate decision makers. The AirSCWO&#8482; technology offer a waste treatment for the modern era and a versatile treatment tool that could address future regulation and improve resiliency.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We perform a business-to-business style of marketing for our products and services. We conduct marketing campaigns are aimed at any individual(s) with control or influence on purchasing decisions. This can encompass a wide variety of titles and functions, from entry-level end-users all the way up to the C-suite.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">We deploy conventional, yet highly creative, demand generation marketing tactics including the following:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Pull</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Website</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">White papers</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Product brochures and datasheets</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Case studies</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Videos and films</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;Industry, Trade Show, Client, and Partner Events</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Push</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Emails</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Newsletters</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Webinars</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Blogs</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Social media</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Public Relations (PR) and Investor Relations (IR) firms</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">8</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Client</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Our clients include channel partners (EPCs, technology integrators, waste service providers, operations service providers, NGOs) and end-users which include utilities (private and public), industrial manufacturing facilities (i.e., pharmaceutical, chemical, food &amp; beverage, semi-conductor etc.), waste management and environmental remediation companies (that own/operate waste disposal sites, landfills, incineration sites etc.), agricultural companies, and governmental entities (i.e., Ministry of Defense aka MODs, etc.).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Government Regulations</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Our operations and AirSCWO&#8482; units may be subject to various United States federal, state and local and, in the case of our Israel operations, Israeli laws and regulations and requirements governing the protection of the environment, public health and safety, and other matters. For example, the construction and operation of our AirSCWO&#8482; units may require obtaining air permits from various states or, alternatively, obtaining a formal determination from a state that a permit is not required. We may also be required to obtain state and local treatment works approval to install our AirSCWO&#8482; units if a unit is connected to a system which is permitted pursuant to the United States National Pollutant Discharge Elimination Systems Act (NPDES). In the event our AirSCWO&#8482; units are used to treat metals, the resulting mineral stream may constitute heavy metals under the United States Resource Conservation and Recovery Act (the &#8220;RCRA&#8221;) and require separation and regulated disposal if such heavy metals were deemed to be hazardous waste under the RCRA. If the operators of our AirSCWO&#8482; units are treating hazardous waste, they may be required to obtain special hazardous waste technician training. Additionally, we are currently evaluating whether our AirSCWO&#8482; units may be regulated pursuant to the United States Occupational Safety and Health Act and thereby be subject to inspections thereunder. We intend that our operations and AirSCWO&#8482; units will be in material compliance with, and in many cases surpass, minimum standards required by applicable laws and regulations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Implications of Being an Emerging Growth Company and a Smaller Reporting Company</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We qualify as an &#8220;emerging growth company,&#8221; as defined in the Jumpstart Our Business Startups Act (the &#8220;JOBS Act&#8221;) enacted in April 2012. An emerging growth company may take advantage of exemptions from some of the reporting requirements that are otherwise applicable to public companies. These exemptions include:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Being permitted to present only two years of audited financial statements and only two years of related Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations in this prospectus;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, as amended (the &#8220;Sarbanes-Oxley Act&#8221;);</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Reduced disclosure obligations regarding executive compensation in our periodic reports, proxy statements and registration statements; and</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exemptions from the requirements to hold a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We may take advantage of these provisions until the last day of the fiscal year following the fifth anniversary of the date of the first sale of our common equity securities pursuant to a registration statement declared effective by the Securities and Exchange Commission (the &#8220;SEC&#8221;). However, if certain events occur prior to the end of such five-year period, including if we become a &#8220;large accelerated filer,&#8221; our annual gross revenue exceeds $1.07 billion, or we issue more than $1.0 billion of non-convertible debt in any three-year period, we will cease to be an emerging growth company prior to the end of such five-year period.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">9</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">In addition, the JOBS Act provides that an emerging growth company can take advantage of an extended transition period for complying with new or revised accounting standards. We have elected not to take advantage of the benefits of this exemption and our election is irrevocable. Therefore, we will not be able to take advantage of this exemption at any time in the future.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Finally, we are a &#8220;smaller reporting company&#8221; (and may continue to qualify as such even after we no longer qualify as an emerging growth company) and, accordingly, may provide less public disclosure than larger public companies. As a result, the information that we provide to our stockholders may be different than you might receive from other public reporting companies in which you hold equity interests.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Corporate Information</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">374Water Inc. (the &#8220;Company&#8221;, &#8220;374Water&#8221;, &#8220;We&#8221;, or &#8220;Our&#8221;) is a Delaware corporation which was formed in September 2005. The Company was initially formed to develop, commercialize and market a series of unique electric generating power systems designed to produce electrical power with zero emissions or waste byproducts, based on a patented pressure-driven expander motor and related organic rankine cycle technology.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#160;On April 16, 2021, 374Water Inc. (f/k/a PowerVerde, Inc.) entered into an Agreement and Plan of Merger (the &#8220;Merger&#8221;) with 374Water Inc., a privately held company based in Durham, North Carolina, (&#8220;374Water Private Company&#8221;) and 374Water Acquisition Corp., a newly-formed wholly-owned subsidiary of PowerVerde. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Subsequent to the Merger, 374Water is focused on being a cleantech and social impact company providing a disruptive technology that addresses imminent environmental pollution challenges. We are focused on a new era of sustainable waste stream management that promotes circular economy initiatives and enables organizations to achieve sustainability goals and create green impact. Our vision is a world without waste and our mission is to preserve a clean and healthy environment that sustains life.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Our principal executive offices are located at 701 W. Main Street, Suite 410, Durham, North Carolina 27701, telephone number (919) 888-8194. Our website address is www.374water.com. Information accessed through our website is not incorporated into this prospectus and is not a part of this prospectus.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">10</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>The Offering</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:30%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Shares offered by us</strong></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:left;">shares of common stock.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Over-allotment option</strong></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We have granted the underwriter a 45-day option to purchase up to an additional shares of common stock at the public offering price, less underwriting discounts and commissions. Unless we indicate otherwise or the context otherwise requires, all information in this prospectus assumes no exercise of the underwriter&#8217;s overallotment option.</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Common stock outstanding immediately prior to this offering</strong></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">126,680,895 shares</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Common stock to be outstanding immediately after this offering</strong></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">shares. If the underwriter&#8217;s over-allotment option is exercised in full, the total number of shares of common stock outstanding immediately after this offering will be .</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Use of proceeds</strong></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We currently intend to use the net proceeds we receive from this offering for general corporate purposes, including sales, marketing and further development of our AirSCWO&#8482; systems. </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Lock-up</strong></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In connection with our offering, we, our directors, executive officers, and certain stockholders holding five percent (5%) or more of our common stock have agreed not to offer, issue, sell, contract to sell, encumber, grant any option for the sale of or otherwise dispose of any of our securities for a period of one hundred and eighty (180) days following the closing of this offering. See &#8220;Underwriting&#8221; for more information.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td colspan="2" style="width:30%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Representative warrant</strong></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Upon the closing of this offering, we have agreed to issue to the representative of the underwriters warrants exercisable for a period of five years from the commencement of sales in this offering entitling the underwriters to purchase up to [&#160; ]% of the number of shares of common stock issued in this offering at an exercise price equal to % of the public offering price. The warrants will not be exercisable for a period of six months from the date of effectiveness of the registration statement. For additional information regarding our arrangement with the underwriters, please see &#8220;Underwriting.&#8221;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Risk factors</strong></p></td><td colspan="2" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Investing in our securities involves a high degree of risk. You should carefully read and consider the information set forth under &#8220;Risk Factors&#8221; and all other information in this prospectus before investing in our securities.</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Trading symbol</strong></p></td><td colspan="2" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">Nasdaq: SCWO</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">11</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">In this prospectus, unless otherwise indicated, the number of shares of common stock is based on 126,680,895 outstanding shares of common stock as of&#160;, 2022. This number excludes:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">12,620,000 shares of common stock issuable upon the exercise of outstanding stock options at a weighted average exercise price of $0.44 per share;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">1,250,000 shares of common stock issuable upon the exercise of warrants at a weighted average exercise price of approximately $2.50; and</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">10,000,000 shares of common stock reserved for future issuance under the 374Water&#160;Inc. 2021 Equity Incentive Plan.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">In addition, except as otherwise indicated, the information above reflects and assumes:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="width:90%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">No exercise by the underwriter of its option to purchase additional shares of our common stock; </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">No exercise of the warrants to be issued to the underwriter in this offering; and</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The shares to be sold in this offering are sold at the initial public offering price of $ per share, the midpoint of the estimated price range shown on the cover of this prospectus.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">12</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Summary Consolidated Financial Information</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The following tables set forth our summary consolidated historical financial data for the periods presented below. The summary unaudited condensed consolidated financial data as of March 31, 2022 and 2021 and for the three-month periods ended March 31, 2022 and 2021 have been derived from our unaudited condensed consolidated financial statements and related notes included elsewhere in this prospectus. The summary consolidated financial data as of December 31, 2021 and 2020 and for each of the years in the two-year period ended December 31, 2020 have been derived from our audited consolidated financial statements and related notes included elsewhere in this prospectus.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;<strong>For the three months ended</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>(unaudited)</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Statements of Operations Data:&#160;</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">273,231</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cost of Goods Sold</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">247,986</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Gross Profit</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">25,245</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Operating Expenses:</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Research and development</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">185,653</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">29,185</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Compensation and related expenses </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">301,235</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><p style="font-size:10pt;font-family:times new roman;margin:0px">18,686</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Professional Fees</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">150,658</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">8,203</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">General and administrative</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">261,403</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">10,477</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total Operating Expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">898,950</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">66,551</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total Other Income (Expenses)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">847</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Provision for Income Taxes</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Net Loss</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>(872,858 </strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>(66,551)</strong></p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Balance Sheet Data (at end of period)</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Cash</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">11,243,795</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">30,052</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total Assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">12,462,310</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">46,634</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total Stockholders&#8217; Equity (Deficit)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">11,551,785</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(629,964</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Cash Flow Data:</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Cash (used in) provided by operating activities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">115,911</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(4,022</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net cash (used in) investing activities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(3,291</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net cash provided by financing activities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4,821</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;<strong>For the year ended</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2020</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Statements of Operations Data:&#160;</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">48,100</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">86,570</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cost of Revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">14,241</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">48,100</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">72,329</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Operating Expenses:</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Research and development</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">375,032</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">57,718</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Product development </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,399,833</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Professional Fees</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">343,862</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">8,791</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">General and administrative</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,095,381</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">17,483</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total Operating Expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">3,214,108</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">83,992</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total Other Income (Expenses)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,400</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">52,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Provision for Income Taxes</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Net Income (Loss)</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>(3,164,608 </strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>40,337</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Balance Sheet Data (at end of period)</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Cash</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">11,131,175</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">71,799</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total Assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">12,413,456</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">103,807</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total Stockholders&#8217; Equity</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">12,327,085</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><p style="font-size:10pt;font-family:times new roman;margin:0px">11,250</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Cash Flow Data:</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Cash (used in) provided by operating activities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(1,840,950 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">64,759</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net cash (used in) investing activities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">28,345</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(275 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net cash provided by financing activities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">12,871,981</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,052</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">13</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="riskfactors">RISK FACTORS</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;"><em>Investing in our securities involves a high degree of risk. You should carefully consider the following risk factors, as well as the other information in this prospectus, before deciding whether to invest in our securities. If any of the following risks actually occur, our business, results of operations and financial condition could be materially adversely affected. In this case, the trading price of our common stock would likely decline and you might lose part or all your investment in our common stock.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Risks Related to General Economic Conditions and Our Business</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>We may be unable to obtain required licenses from third parties for product development.</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We may be required to obtain licenses to patents or other proprietary rights from third parties. If we do not obtain required licenses, we could encounter delays in product development or find that the development, manufacture or sale of products requiring these licenses could be prevented in the U.S. or abroad.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>We have limited protection over our trade secrets and know-how.</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Although we have entered into confidentiality and invention agreements with our key personnel, there can be no assurance that these agreements will be honored or that we will be able to protect our rights to our non-patented trade secrets and know-how effectively. There can be no assurance that competitors will not independently develop equivalent or superior proprietary information and techniques or otherwise gain access to our trade secrets and know-how.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>We have a limited operating history with no material revenues.</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We have only a limited operating history. We have yet to generate material revenues from our business and we have not yet produced commercially viable systems. Currently, the only working version of our system is a demonstration unit that is owned by and has been operating on the campus of Duke University since 2015. Therefore, the commercial value of our systems is uncertain. There can be no assurance that we will ever be profitable. Further, we are subject to all the risks inherent in a new business including, but not limited to: intense competition; lack of sufficient capital; loss of protection of proprietary technology and trade secrets; difficulties in commercializing our products, managing growth and hiring and retaining key employees; adverse changes in costs and general business and economic conditions; and the need to achieve product acceptance, to enter and develop new markets and to develop and maintain successful relationships with customers, third party suppliers and contractors.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>We may have difficulty in protecting our intellectual property and may incur substantial costs to defend ourselves in patent infringement litigation.</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">At this time we rely primarily on a combination of trade secrets, copyright and trademark laws, and confidentiality procedures to protect our proprietary technology, which is our principal asset.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Our ability to compete effectively will depend to a large extent on our success in protecting our proprietary technology, both in the United States and abroad. There can be no assurance that (i) any patents that we apply for will be issued, (ii) we will ever obtain the rights to any patents covering the technology on which our current systems are based, (iii) any patents issued will not be challenged, invalidated, or circumvented, (iv) we will have the financial resources to enforce any such patents or (v) any patent rights granted will provide any competitive advantage. We could incur substantial costs in obtaining patent coverage and defending any patent infringement suits or in asserting our patent rights, including those granted by third parties, and we might not be able to afford such expenditures.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">14</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Our success is dependent on the services of our key management and personnel.</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Our success will depend in large part upon the skill and efforts of our key personnel hired or who may be hired, particularly our two founders, Yaacov (Kobe) Nagar and Professor Marc Deshusses. Loss of any such personnel, whether due to resignation, illness, death, disability or otherwise, could have a material adverse effect on our business. We are substantially dependent on the continued service of our existing personnel because of the complexity of our services and technologies. Following the April 2021 Merger with PowerVerde, Inc., Professor Deshusses has retained his position at Duke. We will need to hire and retain appropriate personnel in key management and technical roles for 374Water to be successful. There can be no assurance that we will be able to do so.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>We need to raise substantial additional capital to fund our business.</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We will need to promptly raise substantial additional funds. Without such additional funds, we may have to cease operations. We will require substantial additional funding for our contemplated research and development activities, commercialization of our products and ordinary operating expenses. Adequate funds for these purposes may not be available when needed or on terms acceptable to us. Insufficient funds may require us to delay or scale back our activities or to cease operations. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Our suppliers may fail to deliver materials and parts according to schedules, prices, quality and volumes that are acceptable to us, or we may be unable to manage these materials and parts effectively.</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Our products contain materials and parts purchased globally from hundreds of suppliers, including single-source direct suppliers, which exposes us to potential component shortages or delays. Unexpected changes in business conditions, materials pricing, labor issues, wars such as the current conflict in Ukraine, trade policies, natural disasters, health epidemics such as the global COVID-19 pandemic, trade and shipping disruptions, port congestions and other factors beyond our or our suppliers&#8217; control could also affect these suppliers&#8217; ability to deliver components to us or to remain solvent and operational. Additionally, if our suppliers do not accurately forecast and effectively allocate production or if they are not willing to allocate sufficient production to us, it may reduce our access to components and require us to search for new suppliers. The unavailability of any component or supplier could result in production delays, idle manufacturing facilities, product design changes and loss of access to important technology and tools for producing and supporting our products, as well as impact the capacity of our AirSCWO&#8482; systems. Product design changes by us may also require us to procure additional components in a short amount of time. Our suppliers may not be willing or able to sustainably meet our timelines or our cost, quality and volume needs, or to do so may cost us more, which may require us to replace them with other sources. While we believe that we will be able to secure additional or alternate sources for most of our components, there is no assurance that we will be able to do so quickly or at all. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">As we scale of production of our AirSCWO&#8482; systems, we will also need to accurately forecast, purchase, warehouse and transport components at high volumes to our manufacturing facilities. If we are unable to accurately match the timing and quantities of component purchases to our actual needs or successfully implement automation, inventory management and other systems to accommodate the increased complexity in our supply chain and parts management, we may incur unexpected production disruption, storage, transportation and write-off costs, which may harm our business and operating results.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Our financial results depend on successful project execution and may be adversely affected by cost overruns, failure to meet customer schedules or other execution issues.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">A portion of our revenue is derived from large projects that are technically complex and may occur over multiple years. These projects are subject to a number of significant risks, including project delays, cost overruns, changes in scope, unanticipated site conditions, design and engineering issues, incorrect cost assumptions, increases in the cost of materials and labor, safety hazards, third party performance issues, weather issues and changes in laws or permitting requirements. If we are unable to manage these risks, we may incur higher costs, liquidated damages and other liabilities to our customers, which may decrease our profitability and harm our reputation. Our continued growth will depend in part on executing a higher volume of large projects, which will require us to expand and retain our project management and execution personnel and resources.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">15</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>We face competition in our industry, and we may be unable to attract customers and maintain a viable business.</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Our principal direct competitors in the SCWO field are General Atomic (US) and SCFI (Ireland). Several other technologies are in competition with SCWO, depending on the market sector including: anaerobic digestion, landfilling, drying and incineration, lagoon and spray-fields, lime stabilization, and others. We believe that our systems will prove much more economical with higher treatment efficiency and lower operating costs; however, there can be no assurance that we will be able to successfully compete with General Atomics, SCFI or any other competitor. Our competitors may prove more successful in offering similar systems and/or may offer alternative systems which prove to be more popular with potential customers than our system. Our ability to commercialize our systems and grow and achieve profitability in accordance with our business plan will depend on our ability to satisfy our customers and withstand increasing competition by providing superior waste treatment at reasonable cost. There can be no assurance that we will be able to achieve or maintain a successful competitive position.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>374Water&#8217;s financial condition and results of operations may be negatively affected by public health crises such as the ongoing coronavirus pandemic.</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Severe financial market and economic disruptions may occur in response to public health epidemics, and the U.S. and global economies are suffering huge negative impacts as a result of the ongoing coronavirus pandemic. The rapid spread of the coronavirus, and the fear associated with this pandemic, along with the negative impact on economic growth and financial markets generally, may have a material adverse effect on the demand for our SCWO systems in the U.S. and abroad. If our customers and/or sources of financing are adversely affected by the pandemic and the accompanying economic crisis, our financial condition and results of operations could be materially adversely affected. Moreover, our operations and productivity could be negatively impacted if our key personnel and employees are continuously quarantined as the result of exposure to coronavirus or another contagious illness. The extent to which the coronavirus crisis affects us will depend on future developments, which are highly uncertain at this time and cannot be predicted, including new information, which may emerge concerning the severity of the coronavirus, its economic and social impact and the measures taken to contain or treat the coronavirus, among others.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>If we become subject to claims relating to handling, storage, release or disposal of hazardous materials, we could incur significant cost and time to comply.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Our business activities, including our manufacturing processes and waste recycling and treatment processes, currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes. These activities create a risk of significant environmental liabilities and reputational damage. Under applicable environmental laws and regulations, we could be strictly, jointly and severally liable for releases of regulated substances by us at our current or former properties or the properties of others or by other businesses that previously owned or used our current or former properties, including if such releases result in contamination of air, water or soil, or cause harm to individuals. We could also be liable or incur reputational damage if we merely generate hazardous materials or wastes, or arrange for their transportation, disposal or treatment, or we transport such materials, and they are subsequently released or cause harm.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">16</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Our business activities also create a risk of contamination or injury to our employees, customers or third parties, from the use, treatment, storage, transfer, handling and/or disposal of these materials.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">In the event that our business activities result in environmental liabilities, such as those described above, we could incur significant costs or reputational damage in connection with the investigation and remediation of environmental contamination, and we could be liable for any resulting damages including natural resource damages. Such liabilities could exceed our available cash or any applicable insurance coverage we may have. Additionally, we are subject to, on an ongoing basis, federal, state and local laws and regulations governing the use, storage, handling and disposal of these materials and specified waste products. The cost of compliance with these laws and regulations may become significant and could have a material adverse effect on our business, financial condition, results of operations or prospects.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Further, we may incur costs to defend our position even if we are not liable for consequences arising out of a release of or exposure to a hazardous substance or waste, or other environmental damage. Our insurance policies may not be sufficient to cover the costs of such claims.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Failure to effectively treat emerging contaminants could result in material liabilities.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">A number of emerging contaminants might be found in water that we treat, including PFAS, PFOA, selenium, micro-plastics, hazardous chemicals, or pathogens that may cause a number of illnesses, including cholera, typhoid fever, cancer, giardiasis, cryptosporidiosis, amoebiasis and free-living amoebic infections. Such contaminants or pathogens may be found in the environment, and, as a result, there is a risk that they could be present in water treated using our systems or products. In applications where treated water enters the human body, illness and death may result if contaminants or pathogens are not eliminated during the treatment process. In particular, contamination could result from failing to properly treat reusable products before they are distributed, or from actions taken by our customers or other third parties using our products, which could result in material liability. The potential impact of a contamination of water treated using our products, services or solutions is difficult to predict and could lead to an increased risk of exposure to product liability claims, increased scrutiny by federal and state regulatory agencies and negative publicity. Further, an outbreak of disease in any one of the municipal markets we serve could result in a widespread loss of customers across other such markets.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Wastewater operations entail significant risks that may impose significant costs.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Wastewater treatment involves various unique risks. If our treatment systems fail or do not operate properly, or if there is a spill, untreated or partially treated wastewater could discharge onto property or into nearby streams and rivers, causing various damages and injuries, including environmental damage. Liabilities resulting from such damages and injuries could materially adversely affect our business, financial condition, results of operations or prospects.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">These risks could be increased by the potential physical impacts of climate change on our operations. The physical impacts of climate change are highly uncertain and would vary depending on geographical location, but could include changing temperatures, water shortages, changes in weather and rainfall patterns and changing storm patterns and intensities. Many climate change predictions, if true, present several potential challenges to water and wastewater service providers, such as increased precipitation and flooding, potential degradation of water quality and changes in demand for water services.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>We may incur liabilities to customers as a result of warranty claims or failure to meet performance guarantees, which could reduce our profitability.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Our customers typically require product warranties as to the proper operation and conformance to specifications of the products we manufacture or install and performance guarantees as to any effluent produced by our equipment and services. Failure of our products to operate properly or to meet specifications of our customers or our failure to meet our performance guarantees may increase costs by requiring additional engineering resources and services, replacement of parts and equipment and frequent replacement of consumables or monetary reimbursement to a customer or could otherwise result in liability to our customers. There are significant uncertainties and judgments involved in estimating warranty and performance guarantee obligations, including changing product designs, differences in customer installation processes and failure to identify or disclaim certain variables in a customer&#8217;s influent. To the extent that we incur substantial warranty or performance guarantee claims in any period, our reputation, earnings and ability to obtain future business could be materially adversely affected. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">17</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Developments in, and compliance with, current and future environmental and climate change laws and regulations could impact our business, financial condition or results of operations.</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Our business, operations, and product and service offerings are subject to and affected by many federal, state, local and foreign environmental laws and regulations, including those enacted in response to climate change concerns.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Increasing public and governmental awareness and concern regarding the effects of climate change has led to significant legislative and regulatory efforts to limit greenhouse gas emissions and will likely result in further environmental and climate change laws and regulations. Compliance with existing laws and regulations currently requires, and compliance with future laws is expected to continue to require, increasing operating and capital expenditures, including with respect to the design or re-design of our products in order to conform to changing environmental standards and regulations, which could impact our business, financial condition and results of operations. Furthermore, environmental laws and regulations may authorize substantial fines and criminal sanctions as well as facility shutdowns to address violations, and may require the installation of costly pollution control equipment or operational changes to limit emissions or discharges. We also incur, and expect to continue to incur, costs to comply with current environmental laws and regulations. Developments such as the adoption of new environmental laws and regulations, stricter enforcement of existing laws and regulations, violations by us of such laws and regulations, discovery of previously unknown or more extensive contamination, litigation involving environmental impacts, our inability to recover costs associated with any such developments, or financial insolvency of other responsible parties could in the future have a material adverse effect on our financial condition and results of operations. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Our insurance may not provide adequate coverage.</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Although we maintain general and product liability, property and commercial insurance coverage, which we consider prudent, there can be no assurance that such insurance will prove adequate in the event of actual casualty losses or broader calamities such as terrorist attacks, earthquakes, financial crises, economic depressions or other catastrophic events, which are either uninsurable or not economically insurable. Any such losses could have a material adverse effect on the performance of our systems.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>We may be unable to obtain or maintain insurance for our commercial products.</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The design, development and manufacture of our products involve an inherent risk of product liability claims and associated adverse publicity. There can be no assurance we will be able to maintain insurance for any of our proposed commercial products. Such insurance is expensive, difficult to obtain and may not be available in the future on acceptable terms or at all. We are also exposed to product liability claims in the event the use of our proposed products result in injury.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">18</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Risks Relating to our Common Stock and Capital Structure</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>There is currently limited trading in our common stock and an active trading market may not develop or be sustained and our stock price may fluctuate significantly once we do trade.</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">There is currently a limited public market for our common stock. On June 14, 2022, our common stock began trading on the Nasdaq Capital Market (&#8220;Nasdaq&#8221;) under the symbol &#8220;SCWO&#8221;. Prior to June 14, 2022, our common stock traded on the OTCQB Marketplace (the &#8220;OTCQB&#8221;) under the symbol &#8220;SCWO.&#8221;&#160; . However, an active trading market for our common stock may not develop or may not be sustained in the future. The lack of an active market may make it more difficult for stockholders to sell our shares and could lead to our share price being depressed or volatile.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We cannot predict the prices at which our common stock may trade. The market price of our common stock may fluctuate widely, depending on many factors, some of which may be beyond our control, including:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Actual or anticipated fluctuations in our operating results due to factors related to our business;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Success or failure of our business strategies;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our quarterly or annual earnings, or those of other companies in our industry;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our ability to obtain financing as needed;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Announcements by us or our competitors of significant acquisitions or dispositions;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Changes in accounting standards, policies, guidance, interpretations or principles;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The failure of securities analysts to cover our common stock after we commence trading;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Changes in earnings estimates by securities analysts or our ability to meet those estimates;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The operating and stock price performance of other comparable companies;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Overall market fluctuations;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Results from any material litigation or government investigation;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Changes in laws and regulations (including tax laws and regulations) affecting our business;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Changes in capital gains taxes and taxes on dividends affecting stockholders; and</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">General economic conditions and other external factors.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Furthermore, our business profile and market capitalization may not fit the investment objectives of some of our stockholders in the future and, as a result, these stockholders may sell their shares of our common stock - regardless of whether we are able to list our common stock on The Nasdaq Capital Market. Substantial sales of our common stock could cause our stock price to decline. Low trading volume for our stock, which may occur if an active trading market does not develop, among other reasons, would amplify the effect of the above factors on our stock price volatility.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>We are an &#8220;emerging growth company&#8221; and the reduced disclosure requirements applicable to emerging growth companies may make our common stock less attractive to investors.</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The JOBS Act permits &#8220;emerging growth companies&#8221; like us to rely on some of the reduced disclosure requirements that are already available to smaller reporting companies. As long as we qualify as an emerging growth company or a smaller reporting company, we would be permitted to omit the auditor&#8217;s attestation on internal control over financial reporting that would otherwise be required by the Sarbanes-Oxley Act, as described above, and are also exempt from the requirement to submit &#8220;say-on-pay&#8221;, &#8220;say-on-pay frequency&#8221; and &#8220;say-on-parachute&#8221; votes to our stockholders and may avail ourselves of reduced executive compensation disclosure that is already available to smaller reporting companies.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We will cease to be an emerging growth company upon the earliest of (i) the last day of the fiscal year during which we had total annual gross revenues of $1.07 billion (as indexed for inflation); (ii) the last day of the fiscal year following the fifth anniversary of the date of the first sale of our common equity securities pursuant to a registration statement declared effective by the SEC; (iii) the date on which we have, during the previous 3-year period, issued more than $1 billion in non-convertible debt; or (iv) the date on which we are deemed to be a &#8216;large accelerated filer,&#8217; as defined by the SEC, which would generally occur upon our attaining a public float of at least $700 million.. Until such time, however, we cannot predict if investors will find our common stock less attractive because we may rely on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and our stock price may be more volatile and could cause our stock price to decline.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">19</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>We do not intend to pay dividends on our common stock for the foreseeable future, and our indebtedness may limit our ability to pay dividends on our common stock in the future.</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">We currently intend to retain our future earnings to finance the development and expansion of our business and, therefore, do not intend to pay cash dividends on our common stock for the foreseeable futures. The timing, declaration, amount and payment of future dividends to stockholders will fall within the discretion of our board of directors. Our board of directors&#8217; decisions regarding the payment of future dividends will depend on many factors, including our financial condition, earnings, capital requirements of our business and covenants associated with debt obligations, as well as legal requirements, regulatory constraints, industry practice and other factors that our board of directors deem relevant. There can be no assurance that we will pay a dividend in the future or continue to pay any dividend if we do commence paying dividends.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>The interests of our principal stockholders, officers and directors, who collectively beneficially own approximately&#160;56.13 % </strong><strong>of our stock, may not coincide with yours and such stockholders will have the ability to control decisions with which you may disagree</strong><em>.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">As of , 2022, our principal stockholders, officers and directors beneficially owned approximately 56.13% of our common stock and will own approximately % of our common stock if the offering contemplated by this prospectus is successful. As a result, our principal stockholders, officers and directors will have the ability to control matters requiring stockholder approval, including the election of directors and approval of significant corporate transactions. In addition, this concentration of ownership may delay or prevent a change in control of our company and make some future transactions more difficult or impossible without the support of our controlling stockholders. The interests of such stockholders may not coincide with your interests or the interests of other stockholders.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>You will experience immediate and substantial dilution.</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The initial public offering price will be substantially higher than the net tangible book value of each outstanding share of common stock immediately after this offering. If you purchase common stock in this offering, you will suffer immediate and substantial dilution. At an assumed initial public offering price of $ with net proceeds to us of $ million, after deducting estimated underwriting discounts and commissions and estimated offering expenses, investors who purchase shares in this offering will have contributed approximately % of the total amount of funding we have received to date, but will only hold approximately % of the total voting rights. The dilution will be $ per share in the net tangible book value of the common stock from the assumed initial public offering price. In addition, if outstanding options or warrants to purchase shares of our common stock are exercised, there could be further dilution. For more information refer to &#8220;Dilution&#8221;.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>If we fail to maintain an effective system of internal controls over financial reporting, we may not be able to accurately report our financial results or prevent fraud and our business may be harmed and our stock price may be adversely impacted.</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Effective internal controls over financial reporting are necessary for us to provide reliable financial reports and to effectively prevent fraud. Any inability to provide reliable financial reports or to prevent fraud could harm our business. The Sarbanes-Oxley Act requires management to evaluate and assess the effectiveness of our internal controls over financial reporting. In order to comply with the requirements of the Sarbanes-Oxley Act, we are required to continuously evaluate and, where appropriate, enhance our policies, procedures and internal controls. If we fail to maintain the adequacy of our internal controls over financial reporting, we could be subject to litigation or regulatory scrutiny and investors could lose confidence in the accuracy and completeness of our financial reports. We cannot assure you that in the future we will be able to fully comply with the requirements of the Sarbanes-Oxley Act or that management will conclude that our internal control over financial reporting is effective. If we fail to fully comply with the requirements of the Sarbanes-Oxley Act, our business may be harmed and our stock price may decline. Additionally, as long as we remain an &#8220;emerging growth company,&#8221; we will not be required to have our independent registered public accounting firm formally assess our internal controls over financial reporting.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">20</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>If securities or industry analysts do not publish research about our business, or publish negative reports about our business, our share price and trading volume could decline.</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">The trading market for our common stock, to some extent, may at some point depend on the research and reports that securities or industry analysts publish about our business. We do not have any control over these analysts. If one or more of the analysts elect to cover us and downgrade our shares or lower their opinion of our shares, our share price would likely decline. If one or more of these analysts elect to cover us and subsequently cease coverage of our company or fail to regularly publish reports on us, we could lose visibility in the financial markets, which could cause our share price or trading volume to decline.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>We have broad discretion in the use of the net proceeds from this offering and we might not use them effectively.</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We cannot specify with certainty the particular uses of the net proceeds we will receive from this offering. Our management will have broad discretion in the application of the net proceeds, including for any of the purposes described in &#8220;Use of Proceeds&#8221;. Accordingly, you will have to rely on the judgment of our management with respect to the use of the proceeds, with only limited information concerning management&#8217;s specific intentions. Our management might spend a portion or all of the net proceeds from this offering in ways that our shareholders do not desire or that might not yield a favorable return. The failure by our management to apply these funds effectively could harm our business. Pending their use, we might invest the net proceeds from this offering in a manner that does not produce income or that loses value.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Future sales or potential sales of our common stock in the public market could cause our share price to decline.</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">If the existing holders of our common stock, particularly our directors and officers, sell a large number of shares, they could adversely affect the market price for our common stock. Sales of substantial amounts of our common stock in the public market, or the perception that these sales could occur, could cause the market price of our common stock to decline.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>We incur costs as a result of operating as a public company, and our management will be required to devote substantial time to new compliance initiatives.</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">As a public reporting company, we incur significant legal, accounting and other expenses. The Sarbanes-Oxley Act and rules subsequently implemented by the SEC, have imposed various requirements on public companies, including establishment and maintenance of effective disclosure and financial controls and corporate governance practices. Our management and other personnel will need to devote a substantial amount of time to these compliance initiatives. Moreover, these rules and regulations will entail significant legal and financial compliance costs and will make some activities more time consuming and costly. For example, we expect that these rules and regulations may make it difficult and expensive for us to obtain director and officer liability insurance, and we may be required to accept low policy limits and coverage.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Provisions in our Amended and Restated Certificate of Incorporation and Bylaws and of Delaware law may prevent or delay an acquisition of our company, which could decrease the trading price of our common stock.</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Several provisions of our Amended and Restated Certificate of Incorporation, Amended and Restated Bylaws and Delaware law may discourage, delay or prevent a merger or acquisition that stockholders may consider favorable. These include provisions that:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Permit us to issue blank check preferred stock as more fully described under &#8220;Description of Our Capital Stock Anti-Takeover Effects of Various Provisions of Delaware Law and Our Amended and Restated Articles of Incorporation and Amended and Restated Bylaws&#8221;;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Require stockholders to follow certain advance notice and disclosure requirements in order to propose business or nominate directors at an annual or special meeting; and</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Limit our ability to enter into business combination transactions with certain stockholders.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">These and other provisions of our Amended and Restated Certificate of Incorporation, Amended and Restated Bylaws and Delaware law may discourage, delay or prevent certain types of transactions involving an actual or a threatened acquisition or change in control of us, including unsolicited takeover attempts, even though the transaction may offer our stockholders the opportunity to sell their shares of our common stock at a price above the prevailing market price. See &#8220;Description of Our Capital Stock Anti-Takeover Effects of Various Provisions of Delaware Law and Our Amended and Restated Articles of Incorporation and Amended and Restated Bylaws&#8221; for more information.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">21</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="special">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">This prospectus contains &#8220;forward-looking statements,&#8221; which include information relating to future events, future financial performance, strategies, expectations, competitive environment and regulation. Words such as &#8220;may,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;continue,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;future,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; and similar expressions, as well as statements in future tense, identify forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results and may not be accurate indications of when such performance or results will actually be achieved. Forward-looking statements are based on information we have when those statements are made or our management&#8217;s good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Important factors that could cause such differences include, but are not limited to:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Inadequate capital;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Inadequate or an inability to raise sufficient capital to execute our business plan;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Our ability to comply with current good manufacturing practices;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Loss or retirement of key executives;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Our plans to make significant additional outlays of working capital before we expect to generate significant revenues and the uncertainty regarding when we will begin to generate significant revenues, if we are able to do so;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Adverse economic conditions and/or intense competition;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Loss of a key customer or supplier;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Entry of new competitors;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Adverse federal, state and local government regulation;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Technological obsolescence of our manufacturing process and equipment;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Technical problems with our research and products;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Risks of mergers and acquisitions including the time and cost of implementing transactions and the potential failure to achieve expected gains, revenue growth or expense savings;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Price increases for supplies and components; and</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">The inability to carry out our business plans.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">For a discussion of these and other risks that relate to our business and investing in shares of our common stock, you should carefully review the risks and uncertainties described elsewhere in this prospectus. The forward-looking statements contained in this prospectus are expressly qualified in their entirety by this cautionary statement. We do not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any such statement is made or to reflect the occurrence of unanticipated events.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">There may be other factors that may cause our actual results to differ materially from the forward-looking statements, including factors disclosed under the section titled and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in this information statement. You should evaluate all forward-looking statements made in this information statement in the context of these risks and uncertainties.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">No assurance can be given that any goal or plan set forth in any forward-looking statement can or will be achieved, and readers are cautioned not to place undue reliance on such statements which speak only as of the date they are made. We do not undertake any obligation to update or release any revisions to any forward-looking statement or to report any events or circumstances after the date of this information statement or to reflect the occurrence of unanticipated events, except as required by law.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 30px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">22</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="useofpro">USE OF PROCEEDS</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We estimate that the net proceeds to us from the sale of the shares of common stock offered by us will be approximately $ million based on an assumed initial public offering price of $ per share, the midpoint of the price range set forth on the cover of this prospectus, and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. If the underwriters&#8217; option to purchase additional shares in this offering is exercised in full, we estimate that our net proceeds will be approximately $ million. A $ increase or decrease in the assumed initial public offering price of $ per share would increase or decrease the net proceeds to us from this offering by $ million, assuming the number of shares offered by us, as indicated on the cover page of this prospectus, remains the same and after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The principal purposes of this offering are to increase our financial flexibility and increase our visibility in the marketplace [as well as other general corporate purposes]. We intend to use the net proceeds we receive from this offering for general corporate purposes, which will include sales, marketing and further development of our AirSCWO&#8482; systems.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">As of the date of this prospectus, except as described above, we cannot specify with certainty all particular uses for the net proceeds from this offering. However, we expect to use the remaining net proceeds from this offering primarily for general corporate purposes, which may include financing our growth, developing new services, and funding capital expenditures, acquisitions, and investments.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Management&#8217;s plans for the remaining proceeds of this offering are subject to change due to unforeseen events and opportunities, and the amounts and timing of our actual expenditures depend on several factors. Accordingly, our management team will have broad discretion in using the remaining net proceeds from this offering. Pending the use of proceeds from this offering, we intend to invest the net proceeds in short-term, investment-grade, interest-bearing securities.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">23</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="dividend">DIVIDEND POLICY</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We have never declared or paid cash dividends on our capital stock. We currently intend to retain all available funds and any future earnings for use in the operation of our business and do not anticipate paying any cash dividends in the foreseeable future. Any decision to declare and pay dividends in the future will be made at the discretion of our board of directors and will depend on, among other things, our results of operations, cash requirements, financial condition, contractual restrictions, and other factors that our board of directors may deem relevant.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="market">MARKET FOR COMMON EQUITY</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">On June 14, 2022, our common stock began trading on the Nasdaq Capital Market (&#8220;Nasdaq&#8221;) under the symbol &#8220;SCWO&#8221;.&#160;&#160; Prior to June 14, 2022, our common stock traded on the OTCQB Marketplace (the &#8220;OTCQB&#8221;) under the symbol &#8220;SCWO.&#8221; The over-the-counter market quotations provided below reflect inter-dealer prices, without retail mark-ups, mark-down or commission and may not represent actual transactions. The following table sets forth the range of high and low sales prices on the OTCQB for the periods indicated.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Period Beginning</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Period Ending</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>High</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Low</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:23%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">January 1, 2020</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:23%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">March 31, 2020</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="width:23%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.25</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="width:23%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.08</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">April 1, 2020</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">June 30, 2020</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.37</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.11</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">July 1, 2020</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">September 30, 2020</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.68</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.25</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">October 1, 2020</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">December 31, 2020</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.95</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.36</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">January 1, 2021</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">March 3, 2021</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.89</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.16</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">April 1, 2021</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">June 30, 2021</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2.56</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.45</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">July 1, 2021</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">September 30, 2021</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2.44</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1.00</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">October 1, 2021</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">December 31, 2021</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2.85</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1.90</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">January 1, 2022</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">March 31, 2022</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">S</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">6.68</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2.67</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Dividends</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 22.5pt; text-align:justify;">We have never declared or paid any cash dividends on our common stock, nor do we intend to declare or pay any cash dividends on our common stock in the foreseeable future. Subject to the limitations described below, the holders of our common stock are entitled to receive only such dividends (cash or otherwise) as may (or may not) be declared by our board of directors.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Recent Sales of Unregistered Securities</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">All of 374Water&#8217;s sales of unregistered securities during the previous three fiscal years have been made pursuant to private offerings to accredited investors. The sales set forth below were made pursuant to an exemption from registration requirements under Regulation D and/or Section 4(a)(2) of the Securities Act of 1933, as amended. Except as otherwise noted below, no placement agent fees or commissions were paid on these offerings, and net proceeds were used for working capital.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">In connection with the Merger described in Prospectus Summary&#8212;Corporate Information, 374Water closed on a private placement of&#160;440,125&#160;shares of Series D Convertible Preferred Stock (the &#8220;Preferred Stock&#8221;) with a par value of $.0001, yielding gross proceeds of $6,551,745&#160;(the &#8220;Private Placement&#8221;) and the settlement of a $50,000&#160;liability for Preferred Stock shares. The Private Placement proceeds were raised for general corporate purposes, primarily for development, manufacture and commercialization of 374Water Inc.&#8217;s AirSCWO&#8482; systems. All of the Preferred Stock was converted to Common Stock as of January 31, 2022. All of the Preferred Stock was sold pursuant to an exemption from registration requirements under Regulation D and/or Section 4(a)(2) of the Securities Act of 1933, as amended.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">In December 2021, 374Water closed on a Series 1 private placement of 2,500,000 shares of Common Stock with a par value of $.0001 and a price of $2.00 per share, yielding gross proceeds of $5,000,000. Along with the issuance of the Common Stock, investors received a warrant for every two common shares purchased during the offering at an exercise price of $2.50 per share, for a total of 1,250,000 warrants. The private placement proceeds were raised to assist in the Company&#8217;s efforts towards meeting Nasdaq uplisting requirements. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">24</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Issuer Purchases of Equity Securities</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">As of December 31, 2021, the Company did not have any purchases of equity securities from stockholders. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Transfer Agent</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Our transfer agent is Direct Transfer, LLC, whose address One Glenwood Avenue, Suite 1001, Raleigh, North Carolina 27603 and telephone number is (919) 744-2722.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="cap">CAPITALIZATION</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The following table sets forth our cash and capitalization as of March 31, 2022, on:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">An actual basis;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">An as adjusted basis, giving effect to the sale and issuance of shares by us in this offering, based upon the assumed public offering price of $ per share after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 36pt; text-align:justify;">The information below is illustrative only, and our capitalization following the completion of this offering will be adjusted based on the actual public offering price and other terms of the offering determined at the pricing of this offering. You should read this table together with the section of this prospectus entitled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations,&#8221; &#8220;Use of Proceeds,&#8221; and our audited consolidated financial statements for the years ended December&#160;31, 2021 and 2020 and our unaudited consolidated financial statements for the periods ended March&#160;31, 2022 and 2021.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="5"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><em><strong>As of March 31, 2022</strong> </em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><em>(in thousands)</em></p></td><td style="width:1%;">&#160;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Actual</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>As </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Adjusted</strong></p></td><td>&#160;</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash and cash equivalents</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">11,243</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;">&#160;</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Stockholders&#8217; equity:</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;">&#160;</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Preferred Stock: 1,000,000 Convertible Series D preferred shares authorized; par value $0.0001 per share, none issued and outstanding at March 31, 2022; and as adjusted: shares issued and outstanding:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;">&#160;</td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;">&#160;</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Common stock, $0.0001 par value; 200,000,000 shares authorized; 126,680,895 shares issued and outstanding at March 31, 2022; and as adjusted: shares issued and outstanding:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">13</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;">&#160;</td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;">&#160;</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:12pt">Additional paid-in capital</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">15,572</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;">&#160;</td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;">&#160;</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:12pt">Accumulated deficit</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(4,033</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;">&#160;</td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;">&#160;</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30pt">Total stockholders&#8217; equity</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">11,552</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;">&#160;</td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;">&#160;</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total capitalization</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="BORDER-BOTTOM: 1px solid;"></td><td style="width:1%;">&#160;</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">25</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Each $1.00 increase or decrease in the assumed public offering price of $ per share would increase or decrease, as applicable, our cash, additional paid-in capital, total stockholders&#8217; equity and total capitalization by approximately $ million, assuming that the number of shares offered by us remains the same, and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. Each increase or decrease of 1,000,000 shares offered by us would increase or decrease the amount of our cash and total stockholders&#8217; equity by approximately $ million, assuming a public offering price of $ per share, after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160; &#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In this prospectus, unless otherwise indicated, the number of shares of common stock is based on 126,680,895 outstanding shares of common stock as of , 2022. This number excludes:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">12,620,000 shares of common stock issuable upon the exercise of outstanding stock options at a weighted average exercise price of $0.44 per share;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">1,250,000 shares of common stock issuable upon the exercise of warrants at a weighted average exercise price of approximately $2.50; and</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">10,000,000 shares of common stock reserved for future issuance under the 374Water&#160;Inc. 2021 Equity Incentive Plan.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">In addition, except as otherwise indicated, the information above reflects and assumes:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">No exercise by the underwriter of its option to purchase additional shares of our common stock;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">No exercise of the warrants to be issued to the underwriter in this offering; and</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The shares to be sold in this offering are sold at the initial public offering price of $ per share, the midpoint of the estimated price range shown on the cover of this prospectus.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="dilution">DILUTION</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">As of March 31, 2022, our historical net tangible book value was $10,539,459, or $0.83 per share of our common stock. Our historical net tangible book value is the amount of our total tangible assets less our liabilities. Historical net tangible book value per share is our historical net tangible book value divided by the number of shares of common stock outstanding as of March 31, 2022.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Our as adjusted net tangible book value as of March 31, 2022, which is our net tangible book value at that date, after giving effect to the sale of shares in this offering by us at an assumed public offering price of $ per share and after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us, would have been $ , or $ per share. This amount represents an immediate increase in net tangible book value of $ per share to our existing stockholders and an immediate dilution of $ per share to investors participating in this offering. Dilution per share to investors participating in this offering is determined by subtracting as adjusted net tangible book value per share after this offering from the assumed public offering price per share paid by investors in this offering.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The following table illustrates this dilution on a per share basis except as indicated below:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Assumed public offering price per share</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;"></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Historical net tangible book value (deficit) per share as of March 31, 2022 </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(<em>in thousands</em>)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">10,539</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 11.25pt; text-align:justify;">Increase in net tangible book value per share attributable to new investors purchasing shares in this offering</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"></td><td class="ffcell" style="width:9%;"></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As adjusted net tangible book value per share after giving effect to this offering</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;"></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Dilution per share to investors participating in this offering</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;"></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">26</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">The information discussed above is illustrative only, and will be adjusted based on the actual public offering price and other terms of this offering determined at pricing. Each $1.00 increase or decrease in the assumed public offering price of $ per share, would further increase or decrease the as adjusted net tangible book value per share after this offering by $ per share and the dilution per share to investors participating in this offering by $ per share, assuming that the number of shares offered by us, as set forth on the cover page&#160;of this prospectus, remains the same and after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">We may also increase or decrease the number of shares we are offering. An increase of 1,000,000 in the number of shares offered by us would increase or decrease our as adjusted net tangible book value per share by approximately $ , and the dilution per share to investors participating in this offering by $ , after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. The information discussed above is illustrative only and will be adjusted based on the actual offering price, the actual number of shares we offer in this offering, and other terms of this offering determined at pricing.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">If the underwriter exercises its option to purchase additional securities in full, the as adjusted net tangible book value will increase to $ per share, representing an immediate increase in as adjusted net tangible book value to existing stockholders of $ per share and immediate dilution of $ per share to investors participating in this offering.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">In this prospectus, unless otherwise indicated, the number of shares of common stock is based on 126,680,895 outstanding shares of common stock as of , 2022. This number excludes:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">12,620,000 shares of common stock issuable upon the exercise of outstanding stock options at a weighted average exercise price of $0.44 per share;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">1,250,000 shares of common stock issuable upon the exercise of warrants at a weighted average exercise price of approximately $2.50; and</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">10,000,000 shares of common stock reserved for future issuance under the 374Water Inc. 2021 Equity Incentive Plan.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">In addition, except as otherwise indicated, the information above reflects and assumes:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">No exercise by the underwriter of its option to purchase additional shares of our common stock;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">No exercise of the warrants to be issued to the underwriter in this offering; and</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The shares to be sold in this offering are sold at the initial public offering price of $ per share, the midpoint of the estimated price range shown on the cover of this prospectus.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">To the extent that any outstanding options or warrants are exercised, new options or restricted stock units are issued under our stock-based compensation plans or we issue additional shares of common stock or other equity or convertible debt securities in the future, there will be further dilution to investors participating in this offering.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">27</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="mda">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>FINANCIAL CONDITION AND RESULTS OF OPERATIONS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;"><em>The following discussion and analysis is intended to help prospective investors understand our business, financial condition, results of operations, liquidity and capital resources. You should read this discussion in conjunction with our financial statements and related notes thereto included elsewhere in this information statement.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;"><em>The statements in this discussion regarding industry outlook, expectations regarding our future performance, liquidity and capital resources and other non-historical statements are forward-looking statements. These forward-looking statements are subject to numerous risks and uncertainties, including, but not limited to, the risks and uncertainties described in &#8220;Special Note Regarding Forward-Looking Statements.&#8221; Actual results may differ materially from those contained in any forward-looking statements.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;"><em>The 374Water Financial Statements, discussed below, reflect the 374Water financial condition, results of operations, and cash flows. The financial information discussed below and included in this information statement, however, may not necessarily reflect what the 374Water financial condition, results of operations, or cash flows would have been had 374Water been operated as a separate, independent entity during the periods presented, or what the 374Water financial condition, results of operations, and cash flows may be in the future.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Critical Accounting Policies</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">The consolidated financial statements of 374Water Inc., formerly known as PowerVerde, Inc. (&#8220;374Water Inc.,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; or the &#8220;Company&#8221;) are prepared in conformity with generally accepted accounting principles in the United States of America (&#8220;GAAP&#8221;). The preparation of these consolidated financial statements requires our management to make estimates and assumptions about future events that effect the amounts reported in the financial statements and related notes. Future events and their effects cannot be determined with absolute certainty. Therefore, the determination of estimates requires the exercise of judgment. We believe the following critical accounting policies affect its more significant judgments and estimates used in the preparation of the consolidated financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Common Stock Purchase Warrants</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">The Company accounts for common stock purchase warrants in accordance with ASC Topic 815- 40, Derivatives and Hedging &#8211; Contracts in Entity&#8217;s Own Equity (&#8220;ASC 815-40&#8221;). Based on the provisions of ASC 815- 40, the Company classifies as equity any contracts that (i) require physical settlement or net-share settlement, or (ii) gives the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). The Company classifies as assets or liabilities any contracts that (i) require net-cash settlement including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company, or (ii) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). All outstanding warrants as of December 31, 2021 and 2020 were classified as equity. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">The Company utilizes the Black Scholes Model to complete valuation of warrants and uses the inputs for the Black Scholes Model including Risk Free Rate, Dividend yield, stock price, exercise price, term, and volatility. The Company uses other public company comparison for Volatility and pulls the risk-free rate from the federal treasury rates based on the term. The Company&#8217;s exercise price is pulled from the warrant agreement and the stock price is pulled from the market close on the day of issuance. The Company&#8217;s term for the warrants utilizes the simplified method for the calculation of the term.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Intellectual Property</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;The Company reviews intangible assets with finite lives for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company uses an estimate of the undiscounted cash flows over the remaining life of its long-lived assets, or related group of assets where applicable, in measuring whether the assets to be held and used will be realizable. In the event of impairment, the Company would discount the future cash flows using its then estimated incremental borrowing rate to estimate the amount of the impairment.<strong> </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">28</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Stock-based compensation</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">We account for stock-based compensation based on ASC Topic 718-Stock Compensation which requires expensing of stock options and other share-based payments based on the fair value of each stock option awarded. The fair value of each stock option is estimated on the date of grant using the Black-Scholes valuation model. This model requires management to estimate the expected volatility, expected dividends, and expected term as inputs to the valuation model.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Overview </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">374Water Inc. (the &#8220;Company&#8221;, &#8220;374Water&#8221;, &#8220;We&#8221;, or &#8220;Our&#8221;) is a Delaware corporation which was formed in September 2005. The Company was initially formed to develop, commercialize and market a series of unique electric generating power systems designed to produce electrical power with zero emissions or waste byproducts, based on a patented pressure-driven expander motor and related organic rankine cycle technology.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#160;On April 16, 2021, 374Water Inc. (f/k/a PowerVerde, Inc.) entered into an Agreement and Plan of Merger (the &#8220;Merger&#8221;) with 374Water Inc., a privately held company based in Durham, North Carolina, (&#8220;374Water Private Company&#8221;) and 374Water Acquisition Corp., a newly-formed wholly-owned subsidiary of PowerVerde. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">As a result of the Merger, the former 374Water Private Company shareholders own 65.8% of our issued and outstanding common stock and 53.8% of our issued and outstanding voting stock (which includes the preferred stock on an as converted basis).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Subsequent to the Merger, 374Water is focused on being a cleantech and social impact company providing a disruptive technology that addresses imminent environmental pollution challenges. We are focused on a new era of sustainable waste stream management that promotes circular economy initiatives and enables organizations to achieve sustainability goals and create green impact. Our vision is a world without waste and our mission is to preserve a clean and healthy environment that sustains life.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">We have developed proprietary waste stream treatment systems based on Supercritical Water Oxidation (SCWO). The term used for the process is AirSCWO&#8482;. SCWO leverages the unique properties of water in its supercritical phase (above 374 <sup>o</sup>C and 221 Bar) to convert organic matter to energy and safe products that can be recovered and used. Essentially, the AirSCWO&#8482; systems are waste stream agnostic and able to treat a variety of complex, hazardous and non-hazardous waste streams, opening up opportunities for multiple applications in diverse market verticals on an international scale. Most pertinently, the technology is shifting the landscape in addressing environmental challenges that, until now, have been considered insurmountable (due to science/engineering and/or cost barriers), one good example being the global PFAS crisis. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">We currently outsource manufacturing of our systems to our strategic partner in the US, Merrell Bros., Inc., that have the facilities and capability to rapidly ramp-up manufacturing volumes and also support system modifications and deployment as required per market and clients. We envision in the future applying an outsourced manufacturing model in a few territories and may consider establishing our own manufacturing capability in geographies where this is needed to adequately grow our market share.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">The systems are supplied to multiple market verticals, and our revenue model includes both capital equipment sales and long-term service agreements based on throughput and capacity (Service Agreements). Our market penetration strategy is a combination of direct client and channel partner sales routes, depending on the specific market and territory. In some cases, the AirSCWO&#8482; systems may be white labelled and sold as part of a broader solution package. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">29</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Results of Operations</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Three Months Ended March 31, 2022, as Compared to Three Months Ended March 31, 2021</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">Since inception, we have focused on the development, testing and commercialization of our clean energy electric power generation systems. Since the closing of the 374Water Merger, our business has been focused on development and commercialization of 374Water&#8217;s supercritical water oxidation (SCWO) systems. We generated $273,231 and $0 in revenue from the sale of our first AIRSCWO system, manufacturing assembly services and from consulting and advisory services during the years ended March 31, 2022, and 2021, respectively. Our general and administrative expenses were $261,403 during the period ended March 31, 2022, as compared to $10,477 in the same period of 2021, primarily because of increased insurance costs, payroll expenses due to hiring employees and stock-based compensation expenses. Our professional fees increased to $150,658 during the period ended March 31, 2022, as compared to $8,203 in the same period of 2021, primarily because of increased legal fees and accounting fees relating to the 374Water Merger and our status as a public company. Our research and development expenses were $185,653 during the period ended March 31, 2022, as compared to $29,185 in the same period of 2021, primarily because of the increase in engineering expenses following the 374Water Merger. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Year Ended December 31, 2021, as Compared to the Year Ended December 31, 2020</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Since inception, we have focused on the development, testing and commercialization of our clean energy electric power generation systems. Since the closing of the Merger, our business has been focused on development and commercialization of 374Water&#8217;s supercritical water oxidation (SCWO) systems. We generated $48,100 and $86,570 in revenue from manufacturing assembly services and from consulting and advisory services during the year ended December 31, 2021, and 2020, respectively. This year, we had substantial expenses due to our ongoing research and development activities and efforts to commercialize our systems, as well as substantial administrative expenses associated with our status as a public company. Our general and administrative expenses increased to $1,095,382 during the year ended December 31, 2021, as compared to $17,483 in the same period of 2020, primarily because of increased insurance costs, payroll expenses due to hiring employees and stock-based compensation expenses. Our professional fees increased to $343,862 during the year ended December 31, 2021, as compared to $8,791 in the same period of 2020, primarily because of increased legal fees and accounting fees relating to the Merger and our status as a public company. Our research and development expenses were $375,032 during the year ended December 31, 2021, as compared to $57,718 in the same period of 2020, primarily because of the increase in engineering expenses following the Merger. Our product development expenses were $1,399,833 during the year ended December 31, 2021, compared to no such expenses in the same period of 2020. This activity represents the issuance of stock warrants to a strategic partner in the second quarter of 2021 as part of compensation for the manufacturing, supply and service of AirSCWO&#8482; products. Substantial net losses are expected until we are able to successfully commercialize and market our 374Water systems, as to which there can be no assurance.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Liquidity and Capital Resources</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Three Months Ended March 31, 2022, as Compared to Three Months Ended March 31, 2021</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">In April 2021, in connection with the Merger, we raised approximately $6.6 million from the sale of Series D Preferred Stock and converted all of its convertible debt notes and accrued interest to shares of common stock. On December 17, 2021, the Company raised approximately $5 million from the sales of Common Stock.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">As of March 31, 2022, we had working capital of $10,501,137 compared to working capital of 11,263,270 at December 31, 2021.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">We believe that these funds will satisfy our working capital needs for the next twelve months. There can be no assurance that these funds will be sufficient to finance our plan of operations and commercialize our systems or that we will be able to raise any necessary additional funds on a commercially reasonable basis or at all.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">30</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Year Ended December 31, 2021, as Compared to the Year Ended December 31, 2020</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">In April 2021, in connection with the Merger, we raised approximately $6.6 million from the sale of Series D Preferred Stock and converted all of its convertible debt notes and accrued interest to shares of common stock. On December 17, 2021, the Company raised approximately $5 million from the sales of Common Stock.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">We have financed our operations since inception principally through the sale of debt and equity securities. As of December 31, 2021, we had working capital of $11,263,270 compared to working capital of $10,572 at December 31, 2020. This increase in working capital occurred in April 2021, and is due primarily to the gross proceeds of $6,551,745 from the sale of Series D Convertible Preferred Stock, the receipt of $1,134,999 of proceeds from the exercise of a warrant, and the gross proceeds of $4,999,975 from the private placement in December 2021 for the sale of Common Stock.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">We believe these funds will satisfy our working capital needs for the next twelve months. There can be no assurance that these funds will be sufficient to finance our plan of operations and commercialize our systems or that we will be able to raise any necessary additional funds on a commercially reasonable basis or at all. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="business">BUSINESS</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Overview</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">374Water offers a disruptive technology that transforms all wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into valuable, recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. We are pioneering a new era of waste management that supports a circular economy and enables organizations to achieve their Environment, Social, and Governance (ESG) goals. Our vision is a world without waste and our mission is to help create and preserve a clean and healthy environment that sustains life.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Our Technology</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We have developed proprietary treatment systems based on Supercritical Water Oxidation (SCWO). Our patented and proprietary AirSCWO&#8482; leverages the unique properties of water in its supercritical phase (above 374<sup>o</sup>C and 221 Bar), as described in Illustration 1 (below). The supercritical phase produces properties of both a gas and liquid to convert organic matter to energy in the form of recoverable heat and safe byproducts that can be recovered and put to economically productive use, as shown in Illustration 2 (below). We call our systems AirSCWO&#8482;, as it utilizes a combination of air and the SCWO process. Because our AirSCWO&#8482; converts any organic material and eliminates contamination of emerging concerns., the AirSCWO&#8482; systems are essentially waste stream agnostic with the capability of treating a variety of complex, hazardous and non-hazardous waste streams, thus opening up opportunities for multiple applications in diverse market verticals on an international scale, as described visually below. Most pertinently, the technology is shifting the landscape in addressing environmental challenges that, until now, have been considered insurmountable due to science/engineering and/or cost barriers. For example, we can treat PFAS (&#8220;per- and polyfluoroalkyl substances&#8221;) which essentially eliminates all traces of any &#8220;forever&#8221; chemicals. See below Table 1: Representative target markets. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">31</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Illustration 1: Water properties and how the supercritical phase is reached:&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="pwvi_s1img4.jpg" alt="pwvi_s1img4.jpg" /></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Illustration 2: AirSCWO&#8482; technology</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="pwvi_s1img5.jpg" alt="pwvi_s1img5.jpg" /></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Products and Services</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We believe, AirSCWO&#8482; systems have the ability to address environmental issues across multiple market verticals. We will initially target biosolids and PFAS-laden waste. Our revenue model includes both capital equipment sales and long-term service agreements. Our sales and market strategy is a combination of direct customer and channel partner sales routes, depending on the specific market and territory. In some cases, the AirSCWO&#8482; systems may be &#8220;white labeled&#8221; and sold directly to others who will integrate our equipment with other equipment as part of an integrated system and solution.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We sell AirSCWO&#8482; as a modular and containerized system. The units are compact and prefabricated so that they may be cost effectively shipped, installed, and operated within the footprint of an existing plant. We are currently offering a six (6) wet tons per day throughput capacity system and a thirty (30) wet tons per day throughput capacity system is anticipated to be commercialized in 2023. A two hundred (200) wet tons per day throughput capacity system is to be designed in 2024-25. Illustration 3 below highlights our product mix.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">32</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Illustration 3: AirSCWO&#8482; system models and capacity:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="pwvi_s1img6.jpg" alt="pwvi_s1img6.jpg" /></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We offer three purchase options for our AirSCWO&#8482; systems as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">1.</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Capital equipment purchase</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:3%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:5%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">a.</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Payment in full is received before title is transferred, in which the client owns the system outright.</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">b.</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Financing a system for a specified period, making even capital equipment and service fee payments until full payment is received and the client owns the system outright. </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2.</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Leasing</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:3%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:3%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">a.</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Capital lease &#8211; By making payments throughout the lease term, the client pays the entire cost of the system and owns it outright at the end of the term.</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">b.</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Operating lease - An agreement to use a system over a specified period of time. At the end of the operating lease term, the client does not own the system, but instead has the option to purchase the system at the fair market value or return the system to us.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">3.</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Service Agreements (SAs) by which the client pays a fee for having their waste treated. Examples of these agreements can include, but are not limited to: Build-Own-Operate (BOO), Build-Operate-Transfer (BOT) or Build-Own-Operate-Transfer (BOOT) using a long term contract basis by which we own and service the equipment. In a BOO model, we are responsible for designing, building, operating and maintaining the system during the contracted period. The client will pay us a service fee for operating and maintaining the system, which does not include installation and commissioning fees. In a BOT model, we are responsible for designing, building, operating and maintaining (during the contracted period), and transferring a system to the client at the end of the contract term. The client will pay us a service fee for operating and maintaining the system (which does not include installation and commissioning fees). A BOOT model is a variation of the BOT model, except that the ownership of the system will rest with us during the period of the contract, and the client is contractually obligated to purchase the system on mutually agreed upon terms at the end of the defined term, after we recover our investment and reasonable return as per the contract.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We will also sell, as part of a broader solution package, ancillary equipment that is required to pre-treat the inlet waste stream and post-treat a product stream, depending on the application. For example, in some cases, to meet the AirSCWO&#8482;<sup> </sup>inlet requirements (i.e., water percentage, total dissolved solids, etc.), a pre-treatment &#8220;bolt-on&#8221; process is implemented to ensure our system performance or a post-treatment packaged system to enhance the system outputs value (i.e., carbon dioxide utilization or sequestration, minerals recovery and upgrade, and water purification). Those package and bolt-on solutions will be developed by the company or by its strategic partners to provide a complete solution and integrated train. In addition, the Company will offer after sales agreements for supply of parts, maintenance and repairs, as well as long term Service Agreements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">33</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Human Capital and Culture</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">We currently employ eleven full-time employees and twelve consultants on a full or part-time basis. Our current projections are to increase the workforce to twelve full-time employees in 2022 and twenty full-time employees in 2023. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We recognize and value our people as our most important asset in achieving our strategic goals and growing a great company. We are working towards a human resources strategy that will help drive the right culture, leadership, talent management, performance, reward and recognition, personal development, and ways of working vital to ensure the Company achieves its strategic goals while our people benefit from an exceptional experience.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Our focus areas in creating a working environment that draws out the best in our employees and allows them to fulfil their potential and support the Company to attain its goals are as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">1)</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Attract, identify, develop and retain high-performing talent across all areas.</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2)</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Develop and support the growth of leadership.</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">3)</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Enable the development of a high-performance culture in which staff performance can be supported, rewarded, enhanced and managed effectively.</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">4)</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Foster a values-based culture focused on diversity, inclusivity, wellbeing, and positive staff engagement.</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">5)</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Develop a total reward approach which is valued by staff and facilitates organizational objectives.</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">6)</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Provide excellent core HR, professional development and health and safety services across all business areas to enable the effective operation of the organization.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Our recruitment strategy is based on identifying top talent, predominantly via existing networks and referrals, and offering competitive remuneration packages that combine salary, benefits, equity and a bonus scheme. As we move forward, our recruitment strategy will expand to wider platforms allowing outreach to a wider audience. In the immediate future, we will use an outsourced human resources firm, and as we grow, within 2022, embed a human resources function into the Company. We intend to apply a wide range of retention initiatives that include rewarding high-performance and opening opportunities for progression and career development. Identification of high-performing talent will be linked to succession planning and development of the future-workforce will be embedded in employee professional development schemes. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">We are setting clear standards with respect to generating an open and transparent working environment in which everyone has a voice. This will invoke effective personal development discussions and provide the opportunity to conduct performance reviews supported by transparent data and open conversation.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">We are dedicated to embedding Diversity and Inclusion (D&amp;I) as an important part of developing our culture through delivery of innovative initiatives and internal workshops, ensuring that D&amp;I policies touch on all aspects of the Company from recruitment practices to company behavior/operating frameworks. These policies will also be reviewed periodically as required and updated accordingly. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Moving forward we intend to deliver a total reward strategy which appropriately supports achievement of organizational aims and priorities, and will help position us as an employer of choice which employees value and understand. This will undergo periodical review to ensure we are able to attract and retain top talent in a financially sustainable way.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">All of our human resource initiatives will be supported by key performance indicators to monitor their effectiveness and gain insight into gaps that can be addressed quickly. This will ensure our overall human resource strategy is adapted as required and maintained to a high degree.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">34</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Markets and Industries </strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">The trends that are transforming the markets described below and dictating a more robust and sustainable approach to waste stream management, are derived from recognition by waste generators, waste operators, government and society that there are key social, environmental and economic benefits to be gained by moving waste up the waste management hierarchy, towards prevention, reuse, recycling and recovery. The drivers that are facilitating adoption of our technology include, but are not limited to: population growth and urbanization, increasing quantity/complexity of waste streams, climate change, carbon economics, resource scarcity, corporate sustainability targets, commodity prices, energy security and tightening regulations (Global Industrial Wastewater Systems Market Survey Report, December 2021). The AirSCWO&#8482; technology is prime to address those key market drivers due to the fact that the system provides a complete, compact, energy-efficient, and decentralized solution able to treat a broad range of waste. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">The AirSCWO&#8482; technology can treat diverse waste streams across different industries and market segments. We believe our technology provides a unique value proposition that will support its adoption across various markets, including, but not limited to: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Generating value from waste by recovering clean energy (in the form of heat), water, and minerals;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Providing a highly energy efficient, compact and sustainable waste treatment option that we believe can deliver unprecedented elimination of many environmentally persistent pollutants, e.g., PFAS, 1,4 Dioxane, microplastics, pharmaceuticals and personal care products (PPCPs), and contaminants of emerging concern (CECs);</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Treating waste at the source thereby eliminating haulage and transportation needs and reducing greenhouse gas (GHG) emissions; and</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Offsetting methane emissions by offering a solution to waste that does not form methane as a byproduct.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">One of our key markets is sludge treatment, which includes both municipal and industrial wastes. Sludge is the semi-solid by-product obtained from the treatment of residential and commercial (i.e., municipal) or industrial wastewater. Municipal sludge is typically treated in large biological treatment processes that allow for the wastewater to reside for extended periods in an air or oxygen rich environment (aerobic digestion or anaerobic digestion) that promotes biological breakdown of organic solids. This process generates a final residue known as biosolids, as it mainly consists of biological bacteria. Sludge and biosolids management are a key part of any wastewater treatment process. Those high strength streams are prime for the AirSCWO&#8482; technology since they contain significate calorific content that can be treated effectively and self-propel the oxidation process. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The global demand for municipal and industrial sludge treatment is expected to generate revenue of above $9 billion by the end of 2026, growing at a Compound Annual Growth Rate (CAGR) of around 5.7% between 2020 and 2026 (<span style="text-decoration:underline">Research and Markets Report, August 2020</span>). Growing populations and economic advancement have resulted in increased volumes of sludge, which drives the market for municipal and industrial sludge treatment.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The municipal sludge market is expected to drive the near-term growth of the Company&#8217;s revenue because of increasing disposal costs, and future regulation on organic emerging contaminants of concern (i.e PFAS, Microplastics, Pharmaceuticals). We are also targeting additional high value markets that we expect will contribute to the Company&#8217;s revenue and thereby help fuel our growth plans. Table 1 below shows near-term target markets, their subsegments, and the relevant applications associated with those markets.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">35</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Table1: Representative target markets, their subsegments and applications</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Key Markets</strong></p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Subsegments</strong></p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Applications</strong></p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">Industrial:</p><p style="font-size:10pt;font-family:times new roman;margin:0px">Manufacturing</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">Chemical, Pharmaceutical, Semiconductor, Food &amp; Beverage</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">Hazardous and non-hazardous wastes, recalcitrant(1) organics, microplastics, PPCPs(2), CECs(3) and PFAS.</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">Municipal</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">Utilities</p><p style="font-size:10pt;font-family:times new roman;margin:0px">Landfills</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">Sludge and biosolids, Landfill leachate(4)</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">Defense</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">Military Bases</p><p style="font-size:10pt;font-family:times new roman;margin:0px">Government owned manufacturing facilities</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">Fuel and oil residuals, rinsates(5), AFFF(6) (PFAS)</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">Oil and Gas</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">Exploration, Extraction/Offshore &amp; Onshore</p><p style="font-size:10pt;font-family:times new roman;margin:0px">Petroleum refining</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">Concentrated waste streams, rinsates(5), AFFF (PFAS), petroleum refining by-products</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">Agricultural</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">Farms, Slaughterhouses, Poultry houses</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">Manure, concentrated waste streams</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">Waste Management</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">Recycling Centers</p><p style="font-size:10pt;font-family:times new roman;margin:0px">Incinerators</p><p style="font-size:10pt;font-family:times new roman;margin:0px">Landfills</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">Landfill leachate(4), food waste, waste oils; Fats, Oil &amp; Greases (FOG), hazardous and non-hazardous organic waste.</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">Sanitation Projects in Developing Countries</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">Regional centralized facilities, decentralized treatment facilities (villages, schools)</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">Municipal sludge and biosolids, mixed wastes</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(1)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Resistant&#160;to&#160;chemical&#160;decomposition;&#160;decomposing&#160;extremely&#160;slowly</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(2)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Pharmaceuticals and Personal Care Products</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(3)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Contaminants of Emerging Concern</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(4)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Water that has percolated through a solid and leached out some of the constituent.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(5)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Containing low concentrations of contaminants, resulting from the cleaning of containers, etc.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(6)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Aqueous Film Forming Foam</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The markets shown represent multi billions in Total Addressable Market (TAM) value, with typical 5-year CAGRs of between 5%-8% (<span style="text-decoration:underline">Research and Markets Report, August 2020</span>).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Strategy</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The execution of our growth strategy includes a blend of organic and inorganic opportunities:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Growth Initiatives:</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">After over nine years of research and development (R&amp;D) and testing at Duke University, we have sold our first commercial unit to a public agency responsible for 2.6 million people in Southern California. The Nix6 system, expected to be installed in the 4th quarter of 2022, is capable of processing six (6) wet tons per day (WMT/d) of wastewater in a 40-foot modular standard shipping container. We expect to sell and deliver at least one additional system in 2022 and to receive several additional purchase orders for systems this year. Additionally, we are finalizing the design of larger capacity systems to process thirty (30) WMT/d (Nix30) and later on two hundred (200) WMT/d (Nix200), respectively. We anticipate initial sales of our thirty (30) ton system within the next twelve months.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The Company&#8217;s growth over the next two years will be predominantly driven by sales of AirSCWO&#8482; systems in the identified key markets, leading to customer base expansion, with the municipal market expected to generate a significant portion of the Company&#8217;s revenue. The initial geographical focus will be North America and EMEA (to include Europe, the Middle East and Africa). Our business model includes direct sales to end-users and indirect sales via channel partners. In some markets, revenue will be generated from a mix of capital equipment sales and a Service Agreement (SA), which is a paid service for waste treatment pursuant to long-term contracts. The latter will be offered through a separate financing division that we are targeting to establish in 2022 and will initially be deployed via direct end-user engagement. The financing systems to be sold via service agreements will lower barriers to entry in our key markets and facilitate more rapid expansion of our client base. Examples of models to be used can include, but are not limited to: Build-Operate-Transfer (BOT) and Build-Own-Operate-Transfer (BOOT), depending on clients&#8217; preferences and limitations. We envisage that in some cases, public private partnerships (PPPs) will be established, particularly when selling to public utilities and addressing projects in developing geographies.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">36</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">In addition, during the next two to three years, we are planning to conduct further product development and expand our product portfolio. which will facilitate entrance into new subsegments where particularly high strength waste streams require treatment. This is most relevant to some industrial manufacturing, defense, and waste management applications. Our intention is to maintain a Research and Development budget sufficient to attain this goal.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Third Party Growth Initiatives</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As an early-stage growth company with, what we believe is, a highly differentiated technology platform, we expect to leverage strategic partnerships with larger companies that serve the environmental or our various target end markets. We are currently engaging with potential strategic partners in a variety of markets, including:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(1)</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Technology companies offering complimentary technologies that can enhance our product offering. More specifically, we are exploring technologies that are capable of recycling our end-products to achieve more efficient resource recovery (which has both environmental and cost impacts). We believe such relationships would also help accelerate our growth by providing us access to our partners&#8217; existing client bases. We are currently discussing options with a waste management company based in the EU.</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(2)</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Original Equipment Manufacturers (OEMs) offering &#8220;bolt-on&#8221; technologies as ancillary equipment. In some cases, such equipment may be required for integration of our systems into a wider waste treatment train.</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(3)</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Technology integrators, engineering consultancies, Engineering-Procurement and Construction (EPC) companies that design and install complete solution packages in which our technology will be a key component. These companies can serve as highly effective distribution channels to accelerate deployment within their existing client base, thereby facilitating our growth agenda.</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(4)</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">The Company currently leverages two strategic partnering arrangements with companies that serve the environmental or our targeted end markets. These relationships provide the Company with adequate facilities to ensure successful deployment of our AirSCWO&#8482; systems and also attain economies of scale:</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(4)(i)</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">North America. We have a partnering arrangement in place with Merrell Bros., Inc. Merrell Bros., Inc. is a nationwide biosolids management company helping municipalities, industries and agricultural operations successfully manage and recycle biosolids since 1982. We believe the company has the facilities and capability to rapidly ramp-up manufacturing volumes and also support system modifications and deployment as required per market and clients. We expect Merrell Bros., Inc. to be a valuable resource as an additional sales channel for our AirSCWO&#8482; systems which will continue to spur overall growth of the Company.</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(4)(ii)</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Western Asia. Environmental Services Company Ltd. (ESC), is an Israeli government-owned company that specializes with treating industrial and hazardous waste in Israel. ESC is expected to provide the Company with access to new markets in the Middle-East that are more closely focused toward hazardous material treatment.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(5)</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Mid-term growth strategies include licensing agreements and acquisition of technologies to increase functionality of our systems (such as implementation of IIoT and AIML platforms for full process digitization) and to increase supply chain reliability and efficiency for ancillary process equipment that is required for full integration of systems (i.e., pumps, valves, filters, dewatering equipment etc.).</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">37</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Intellectual Property</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We have designed an offensive intellectual property strategy to ensure we maintain a competitive edge in this space. We have currently filed five (5) provisional patents that cover crucial process operational aspects and improve system efficiencies and performance, including a provisional patent to cover a next generation AirSCWO&#8482; system for high strength waste stream treatment. We are allocating R&amp;D resources to support data generation that will allow us to move to a full non-provisional patent application by November 2022, with the intention of filing Patent Cooperation Treaty (PCT) application.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Collaborations with Strategic Partners</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We have an exclusive manufacturing agreement in place with Merrell Bros., Inc., which is based in Kokomo, Indiana, and is a nationwide biosolids management company helping municipalities, industries and agricultural operations successfully manage and recycle biosolids. They also serve as a channel partner to facilitate our market penetration and expansion plans in the US by opening up their existing client base.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We have a Sponsored Partnership Agreement with Duke University that provides access to Duke&#8217;s world-class research capabilities, building on our own R&amp;D expertise and strengthening our core development activities when needed.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We have an exclusive partnership agreement with Environmental Services Company Ltd., which is based in Israel, to act as our channel partner for treating industrial waste streams in Israel. Environmental Services Company Ltd. is known for its unique knowledge, regulatory and physical infrastructure, and a variety of halogenated organic wastes required for the R&amp;D effort. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Marketing</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Our marketing approach is through information, education, and thought leadership. This approach is because business purchase decisions are based more on bottom-line revenue impact. Return on investment (ROI) is a primary focus for corporate decision makers. Our marketing approach is through information, education, and thought leadership. This approach is because business purchase decisions are based more on bottom-line revenue impact. Return on investment (ROI) is a primary focus for corporate decision makers. The AirSCWO&#8482; technology offer a waste treatment for the modern era and a versatile treatment tool that could address future regulation and improve resiliency.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">We perform a business-to-business style of marketing for our products and services. We conduct marketing campaigns are aimed at any individual(s) with control or influence on purchasing decisions. This can encompass a wide variety of titles and functions, from entry-level end-users all the way up to the C-suite.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We deploy conventional, yet highly creative, demand generation marketing tactics including the following:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Pull</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Website</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">White papers</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Product brochures and datasheets</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Case studies</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Videos and films</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Industry, Trade Show, Client, and Partner Events</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">38</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Push</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Emails</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Newsletters</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Webinars</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Blogs</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Social media</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Public Relations (PR) and Investor Relations (IR) firms</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Client</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Our clients include channel partners (EPCs, technology integrators, waste service providers, operations service providers, NGOs) and end-users which include utilities (private and public), industrial manufacturing facilities (i.e., pharmaceutical, chemical, food &amp; beverage, semi-conductor etc.), waste management and environmental remediation companies (that own/operate waste disposal sites, landfills, incineration sites etc.), agricultural companies, and governmental entities (i.e., Ministry of Defense aka MODs, etc.). </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Government Regulations</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Our operations and AirSCWO&#8482; units may be subject to various United States federal, state and local and, in the case of our Israel operations, Israeli laws and regulations and requirements governing the protection of the environment, public health and safety, and other matters. For example, the construction and operation of our AirSCWO&#8482; units may require obtaining air permits from various states or, alternatively, obtaining a formal determination from a state that a permit is not required. We may also be required to obtain state and local treatment works approval to install our AirSCWO&#8482; units if a unit is connected to a system which is permitted pursuant to the United States National Pollutant Discharge Elimination Systems Act (NPDES). In the event our AirSCWO&#8482; units are used to treat metals, the resulting mineral stream may constitute heavy metals under the United States Resource Conservation and Recovery Act (the &#8220;RCRA&#8221;) and require separation and regulated disposal if such heavy metals were deemed to be hazardous waste under the RCRA. If the operators of our AirSCWO&#8482; units are treating hazardous waste, they may be required to obtain special hazardous waste technician training. Additionally, we are currently evaluating whether our AirSCWO&#8482; units may be regulated pursuant to the United States Occupational Safety and Health Act (OSHA) and thereby be subject to inspections thereunder. We intend that our operations and AirSCWO&#8482; units will be in material compliance with, and in many cases surpass, minimum standards required by applicable laws and regulations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Properties</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We maintain a corporate office at 701 W. Main Street, Suite 410, Durham, North Carolina 27701.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Legal Proceedings</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties and an adverse result in these or other matters may arise from time to time that may harm our business. We are currently not aware of any such legal proceedings or claims.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">There are no material proceedings in which any of our directors, officers or affiliates or any registered or beneficial shareholder of more than five percent (5%) of our common stock is an adverse party or has a material interest adverse to our interest.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">39</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="management">MANAGEMENT</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Executive Officers and Directors</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The following table and biographies that follow sets forth the name, age, position and description of the business experience of individuals who serve as our executive officers and directors as of the date of this prospectus and brief statements of those aspects of our directors&#8217; backgrounds that led us to conclude that they should serve as directors. Prior to the consummation of this offering, we intend to appoint three additional non-employee directors to our board of directors.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The names of our officers and directors, as well as certain information about them are set forth below:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:15%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Name</strong></p></td><td style="width:2%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Age</strong></p></td><td style="width:2%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:47%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Position(s)</strong></p></td><td style="width:3%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:13%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Held Since </strong></p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Yaacov (Kobe) Nagar</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">43</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Chief Executive Officer, Chairman of the Board</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2021 </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Israel D. Abitbol</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">38</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Chief Financial Officer</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2022</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Marc Deshusses</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">56</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Head of Technology</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2021 </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Richard H. Davis</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">65</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Director</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2008 </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Terry Merrell</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">58</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Director</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2021</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Deanna Rene Estes</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">55</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Director</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2022</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Buddie Joe (BJ) Penn</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">84</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Director</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2022</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Yizhaq (Itzik) Polad</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">42</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Director</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2022</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">James M. Vanderhider</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">63</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Director</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2022</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;"><em>Yaacov (Kobe) Nagar. </em>Mr. Nagar is a co-founder of 374Water and patent inventor of the supercritical water oxidation AirSCWO&#8482; system. He has been the Chief Executive Officer of 374Water from inception in July 2018 and the Chairman of the Board since the Merger. Mr. Nagar holds degrees in chemical engineering from Ben Gurion University (2001) and material engineering from Tel-Aviv University (2007) and thereafter held positions in the defense industry and renewable energy sectors in Israel, where he worked on developing fuel cell, CO2&#160;sequestration and low energy chemicals technologies. He joined the Bill and Melinda Gates Foundation project at Duke University in 2017 to scale up and commercialize the SCWO technology.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;"><em>Israel D. Abitbol.</em> Mr. Abitbol became our Chief Financial Officer in February 2022. Mr. Abitbol has served as the Company&#8217;s Head of Finance since January 2019. Prior to serving as the Company&#8217;s Head of Finance, Mr. Abitbol was an Auditor at BDO USA, LLP from June 2013 until April 2019. Mr. Abitbol is a senior finance executive with years of finance responsibilities and a consistent record of managing key financial processes contributing to successful business management. Mr. Abitbol is a Certified Public Accountant with a B.S.in Business Administration from the University of North Carolina at Chapel Hill and a Master of Accounting from Kenan-Flagler Business School. Mr. Abitbol is a member of the North Carolina Association of CPAs, and a member of the American Institute of CPAs.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;"><em>Marc Deshusses</em>. Dr. Deshusses is a co-founder of 374Water and patent inventor of the supercritical water oxidation AirSCWO&#8482; system. He has served as the Chief Technology Officer of 374Water from inception in July 2018 and served as a member of our board of directors from April 16, 2021 to June 13, 2022. Dr. Deshusses holds a Ph.D. in chemical engineering from the Swiss Federal Institute of Technology, Zurich (1994) and a B.S. in chemical engineering from the Swiss Federal Institute of Technology, Lausanne (1990). He is a professor of civil and environmental engineering at Duke University since 2008. Previously, he was a professor of civil and environmental engineering and department chair at the University of California Riverside from 1994-2008. He is a world-renowned researcher in biofiltration, odor, and novel waste-to-energy technologies. Dr. Deshusses has been the principal investigator for the supercritical water oxidation development project at Duke University since 2013. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;"><em>Richard H. Davis</em>. Mr. Davis joined our board in February 2008, and served as the Chief Executive Officer from August 2011 to April 2021. He received a B.S degree in economics from Florida State University in 1982. He joined First Equity Corporation (&#8220;First Equity&#8221;) in Miami that same year. First Equity operated as a regional full-service brokerage and investment bank. Mr. Davis&#8217; duties included equity deal structure and brokerage-related activities. After First Equity was acquired in 2001, Mr. Davis joined the corporate finance department of William R. Hough &amp; Company (&#8220;Hough&#8221;), where he continued structuring equity finance and private acquisitions. Hough was acquired in 2004 by RBC Dain Rauscher (&#8220;Dain&#8221;), a global investment banking firm. Dain consolidated Hough&#8217;s corporate finance activities into its New York offices. Mr. Davis elected to remain in Miami and joined Martinez-Ayme Securities (&#8220;MAS&#8221;), assuming the newly-created position of managing director of corporate finance. In 2005, Mr. Davis resigned from MAS and ceased working as an investment banker.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">40</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;"><em>Terry Merrell</em>. Mr. Merrell is a co-founder of Merrell Bros., Inc. (&#8220;Merrell&#8221;), Kokomo, Indiana, where he has served as the Chief Financial Officer since inception in 1982. He also is the founder of Cross America, Inc. which is a non-profit organization where he has served as President since 2018. He also serves as Elder at Upper Deer Creek Church. He has developed several technologies related to the biosolids management and disposal industry and currently has a patent pending status on some of these technologies.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;"><em>Deanna Rene Estes</em>.&#160; Since September 2016, Ms. Estes has served as the Finance Manager of 10 Branch Management LLC, a private entity which governs the Jay and Renee Haladay Family Office, where she has established the mission, governance, policy, procedures, systems and reporting for the family offices which handles the investment and other affairs of five families.&#160; For more than fifteen years, Ms. Estes has partnered with investors, entrepreneurs, financiers, developers, and operators to achieve economic success for ventures in multiple industries and, at times, extreme market conditions. &#160;Ms. Estes received her BA in Business Administration with a Major in Finance from Washington State University.&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:45px"><em>Buddie Joe (BJ) Penn</em>.&#160; Since January 2013, Mr. Penn has served as the Chief Executive Officer of Genesis IV, an executive consulting firm and Penn Construction Group, both headquartered in the Washington D.C. Metro area.&#160; Mr. Penn was Acting Secretary of the US Navy from March to May 2009, having previously been Assistant Secretary of the US Navy (Installations and Environment) since 2005. He&#160;began his career as a Naval Aviator and was named EA-6B Pilot of the Year in 1972. Throughout his distinguished career, significant leadership assignments included: Executive Officer/Commanding Officer VAQ 33, Battalion Officer at the US Naval Academy, Air Officer in USS&#160;America, Special Assistant to the Chief of Naval Operations, Commanding Officer of NAS North Island, CA, and Deputy Director of the Navy Office of Technology Transfer &amp; Security Assistance.&#160;Mr. Penn left the Navy in 1995, joining Loral Corporation&#160;as Director of International Business. In 1996, Loral sold its defense electronics and system integration businesses to Lockheed Martin and Mr. Penn was assigned to Lockheed Martin&#8217;s Corporate Staff. Mr. Penn returned to the US Navy in 2001 as Director of Industrial Base Assessments.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">Mr. Penn received his BS in Industrial Technology from Purdue University and his MS in Human Resource Management &amp; Personnel Administration from The George Washington University. Mr. Penn serves on the Secretary of Defense Policy Board, as Trustee Emeritus at The George Washington University and the Boards of the National Trust for the Humanities, Naval Aviation Museum and Naval Historical Foundation. Mr. Penn also serves as the Chairman of the Board of Directors Spectra System Corporation, a London Stock Exchange listed company (SPSY) and on the Board of Directors of Healthcare Trust Inc., a Nasdaq listed company (HTIA).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;"><em>Yizhaq (Itzik) Polad</em>.&#160; Since August 2019, Mr. Polad has served as the Vice President of BI and Business Applications at&#160;Papaya Global, a private SaaS company headquartered in New York, New York,&#160;where he leads its business intelligence and data analytics products and the scaling of its data infrastructure.&#160; Mr. Polad previously held a number of positions in&#160;Hewlett Packard from September 2006 until January 2019 and assisted its Indigo division in its rapid growth by implementing information systems, business applications, data analytics and business intelligence. Mr. Polad holds a B.Sc degree in Industrial Engineering, Information Systems &amp; Management as well as an MBA degree, both from Ben-Gurion University located in Israel.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;"><em>James M. Vanderhider</em>.&#160; Since December 2018, Mr. Vanderhider has served as President of Aspen View GP, LLC. Previously, Mr. Vanderhider served as a Principal, Executive Vice President and Chief Financial Officer of EnerVest, Ltd. from 1996 until 2018.&#160; He was responsible for building EnerVest's private equity business and for the oversight of the institutional investments. During such tenure, he led initiatives for raising over $8 billion of private equity and over $12 billion of total institutional capital, securing over 150 institutional investors.&#160; Such investors included a diversified group of pension funds, endowments, foundations, family offices, insurance companies, fund of funds, international investors and other financial institutions.&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">Mr. Vanderhider currently serves as President of the Foundation of Goodwill Industries of Houston, along with serving on the Audit Committee of Goodwill Industries of Houston. During 2019, he joined the Advisory Board of Midway Companies, a privately owned, multi-billion dollar fully integrated real estate development and investment firm based in Houston, Texas. During January, 2022 he joined the Board of Directors of Scranton Holding Company, a private start-up venture in Hibbing, Minnesota, with a mission to become the only dedicated US producer of merchant pig iron and conducting operations leading to clean steel production through a carbon neutral, ESG-focused process. Mr. Vanderhider holds a BA of Business Administration degree in Accounting from Texas A&amp;M University and is a Certified Public Accountant.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Family Relationships</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">There are no family relationships among any of 374Water&#8217;s directors or executive officers.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Director Independence</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 36pt; text-align:justify;">Our common stock currently trades on The Nasdaq Capital Market under the symbol &#8220;SCWO&#8221;.&#160; Under the rules&#160;of Nasdaq, independent directors must comprise a majority of a listed company&#8217;s board of directors, subject to certain phase-in periods available to companies that do not yet have a class of common stock registered under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). In addition, Nasdaq rules&#160;require that, subject to specified exceptions, each member of a listed company&#8217;s audit, compensation and corporate governance and nominating committees be independent.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 36pt; text-align:justify;">Our board of directors has undertaken a review of the composition of our board of directors, our committees and the independence of each director. Based upon information requested from and provided by each director concerning their background, employment and affiliations, including family relationships, the board of directors has determined that Messrs.&#160;Penn, Polad and Vanderhider and Ms.&#160;Estes are &#8220;independent&#8221; as that term is defined under applicable Nasdaq rules.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 36pt; text-align:justify;">In making these determinations, the board of directors considered the current and prior relationships that Messrs.&#160;Penn, Polad and Vanderhider and Ms.&#160;Estes has with us and all other facts and circumstances the board of directors deemed relevant in determining his independence, including the beneficial ownership of capital stock by that Messrs.&#160;Penn, Polad and Vanderhider and Ms.&#160;Estes.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Committees of the Board of Directors</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 36pt; text-align:justify;">Our board of directors has established an audit committee, a compensation committee and a nominating and corporate governance committee, each of which has the composition and responsibilities described below.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Audit Committee</em></p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 36pt; text-align:justify;">Our audit committee is currently comprised of Messrs.&#160;Penn, Polad and Vanderhider, each of whom our board has determined is financially literate and qualifies as an independent director under Section 5605(a)(2) and Section 5605(c)(2) of the Nasdaq rules. Mr. Vanderhider is the chairman of our audit committee and Ms. Vanderhider qualifies as an audit committee financial expert, as defined in Item 407(d)(5)(ii) of Regulation S-K.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 36pt; text-align:justify;">Our audit committee has adopted a written audit committee charter, viewable at https://374water.com/corporategovernance.com, that provides that the functions of our audit committee include, among other things:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 36pt; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#9679;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">selecting a qualified firm to serve as the independent registered public accounting firm to audit our financial statements;</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">41</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#9679;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">helping to ensure the independence and performance of the independent registered public accounting firm;</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#9679;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">discussing the scope and results of the audit with the independent registered public accounting firm, and reviewing, with management and the independent accountants, our interim and year-end operating results;</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#9679;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">developing procedures for employees to submit concerns anonymously about questionable accounting or audit matters;</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#9679;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">reviewing our policies on risk assessment and risk management;</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#9679;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">reviewing and approving related party transactions;</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#9679;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">obtaining and reviewing a report by the independent registered public accounting firm, at least annually, that describes our internal quality-control procedures, any material issues with such procedures, and any steps taken to deal with such issues when required by applicable law; and</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#9679;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">approving (or, as permitted, pre-approving) all audit and all permissible non-audit services, other than de minimis non-audit services, to be performed by the independent registered public accounting firm.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Compensation Committee</em></p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 36pt; text-align:justify;">Our compensation committee is currently comprised of Messrs.&#160;Penn and Polad. Our board has determined that each of Messrs.&#160;Penn and Polad qualifies as an independent director under Section 5605(a)(2) of the Nasdaq rules and a &#8220;non-employee director&#8221; for purposes of Section 16b-3 under the Exchange Act and does not have a material relationship with us that would affect his ability to be independent from management in connection with the duties of a compensation committee member, as described in Section 5605(d)(2) of the Nasdaq rules. Mr. Polad is the chairman of our compensation committee.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 36pt; text-align:justify;">Our compensation committee has adopted a written compensation committee charter, viewable at https://374water.com/corporategovernance.com, that provides that the functions of our compensation committee include, among other things:</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#9679;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">reviewing and approving, or recommending to our board of directors for approval, the compensation of our executive officers and any compensatory arrangement with our executive officers;</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#9679;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">reviewing and recommending to our board of directors for approval the compensation of our directors and any changes to their compensation;</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;&#160; </p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td>&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">42</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#9679;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">reviewing and approving, or recommending to our board of directors for approval, and administering incentive compensation and equity incentive plans; and</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#9679;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">reviewing and establishing general policies relating to compensation and benefits of our employees and reviewing our overall compensation philosophy.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Nominating and Corporate Governance Committee</em></p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 36pt; text-align:justify;">Our nominating and corporate governance committee is currently comprised of Messrs.&#160;Penn and Polad. Our board has determined that each of Messrs.&#160;Penn and Polad qualifies as an independent director under Section 5605(a)(2) of the Nasdaq rules. Mr. Penn is the chairman of our nominating and corporate governance committee.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 36pt; text-align:justify;">Our nominating and corporate governance committee has adopted a written nominating and corporate governance committee charter, viewable at https://374water.com/corporategovernance.com, that provides that the functions of our nominating and corporate governance committee include, among other things:</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#9679;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">identifying, evaluating and selecting, or making recommendations to our board of directors regarding, nominees for election to our board of directors and its committees;</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#9679;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">overseeing the evaluation and the performance of our board of directors and of individual directors;</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#9679;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">considering and making recommendations to our board of directors regarding the composition of our board of directors and its committees;</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#9679;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">overseeing our corporate governance practices;</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#9679;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">contributing to succession planning; and</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#9679;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">developing and making recommendations to our board of directors regarding corporate governance guidelines and matters.</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Codes of Conduct</em></strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">We are committed to high standards of ethical conduct and professionalism. We have adopted a Code of Business Conduct that confirms our commitment to ethical behavior in the conduct of all our activities. The Code of Business Conduct applies to all our directors, all our officers (including our principal executive officer, principal financial officer and principal accounting officer) and employees and sets forth our policies and expectations on a number of topics including avoiding conflicts of interest, confidentiality, insider trading, protection of 374Water and customer property and providing a proper and professional work environment.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Advisory Board Members</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">In July 2021, our board of directors created an Advisory Board to advise and recommend, on a non-legally-binding basis, certain directions or actions deemed to be beneficial to the Company&#8217;s success. The Advisory Board&#8217;s members may be shareholders or non-shareholders; however, each member represents a specific industry or vocation complementary to the Company&#8217;s anticipated markets, customers and technical needs. It is anticipated that the Advisory Board will meet once a year in person and meet by conference call quarterly. The members of the Advisory Board are as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#9679;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><em>Steve Brock</em>. Mr. Brock is an experienced Strategic leader in National Security, Foreign Affairs, and Environment. He is a Senior Advisor for the Council on Strategic Risk at the Center for Climate and Security and was Chief of Staff for the Joint Staff, Chairman Joint Chiefs of Staff as well as Director for Asia Security Affairs for the White House. He received an MBA from Georgetown University.</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#9679;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><em>Howard Teicher</em>. Mr. Teicher is an experienced advisor for security technologies with experience in US Government National Security, a co-founder of Artificial Intelligence and Machine Learning software company and a focus on development and policy advocacy to governmental and international agencies and organizations. Mr. Teicher received a Master in International Affairs from John Hopkins University. </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#9679;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><em>Tatjana Vujic</em>. Mrs. Vujic is an experienced advisor on Environmental Sciences &amp; Policy and Clean energy. Mrs. Vujic received a BA from Yale University and a JD from George Washington University. </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">43</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="exec">EXECUTIVE COMPENSATION</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Summary</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The following table summarizes all compensation received by our named executive officer December&#160;31, 2021 and 2020:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Name and</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Principal</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Position</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Year</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Salary </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">($) </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(a)</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Bonus ($) </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(b)</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Stock Awards ($) </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(c)</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Option Awards ($) </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(d)</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Non-Equity </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Incentive </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Plan Compensation </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">($)</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(e)</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Nonqualified </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Deferred Compensation ($) </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(f)</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>All Other Compensation ($) </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(g)</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Total </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Earnings </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>($) </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>(h)</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Yaacov (Kobe) Nagar,</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">160,348</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">160,348</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">CEO </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2020</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Marc Deshusses, </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">40,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">40,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Head of Technology</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2020</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">John Hofmann,</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">396,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">10,820</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">406,820</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">CFO(1)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2020</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Richard H. Davis,</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">90,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">90,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Former CEO(2)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2020</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(a)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Salaries include those amounts paid and accrued as an expense on the books of the Company.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(c)(d)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Stock and Option Awards are calculated based on the face value of awards as of the date of grant.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(g)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">All Other Compensation is comprised of consulting fees.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(1)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On February 7, 2022, Israel D. Abitbol was promoted from his then current role as the Company&#8217;s Head of Finance to serve as the Company&#8217;s Chief Financial Officer. As of the same date, John L Hofmann, the Company&#8217;s then current Chief Financial Officer, assumed the role of the Company&#8217;s Senior Vice President. Mr. Abitbol receives an annual salary of $156,000.</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(2)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On April 16, 2021, Richard H. Davis was replaced in the CEO position 374Water Inc. (formerly known as PowerVerde) by Yaacov (Kobe) Nagar. Rick continued his employment at the Company. Mr. Davis continues to serve as a member of our board of directors.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">44</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Employment Agreements</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;"><strong><em>Yaacov (Kobe) Nagar, CEO</em>. </strong>Mr. Nagar signed his employment agreement with the Company on April 16, 2021. The term is three years, with potential extensions at the agreement of the parties. His base salary is $200,000 per year. If he is terminated for cause, as defined in the agreement, or he leaves the employment of the Company on his own volition, Mr. Nagar shall receive salary and benefits that have accrued up to the date of termination. If he is terminated without cause or following a material change, as defined in the agreement, Mr. Nagar will receive salary through the date of termination, all stock options shall vest immediately and salary and healthcare benefits will continue for 24 months. Mr. Nagar also agreed to a twelve month non-compete/non-solicitation, and signed a separate Proprietary Information and Inventions Agreement with his employment agreement which assigns to the Company any intellectual property developed by him during his employment.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">On January 26, 2022 the (&#8220;Effective Date&#8221;), the Company entered into a First Amendment to Employment Agreement (the &#8220;Nagar Amendment&#8221;) with Mr. Nagar to amend certain cash compensation provisions of the Employment Agreement the Company and Mr. Nagar entered into on April 16, 2021. Specifically, as of the Effective Date, the Nagar Amendment increased Mr. Nagar&#8217;s annual base salary from $200,000 to $250,000. Additionally, Mr. Nagar is now eligible to receive compensation as follows: (i) a one-time $33,000 bonus in the event the Company achieves net income for two consecutive fiscal calendar quarters for the period which is one year after the Initial Public Offering (the &#8220;Net Income Bonus&#8221;) and (ii) a one-time $67,000 cash bonus in the event the average closing price of the Company&#8217;s common stock over any consecutive three month period during the first year subsequent to the Initial Public Offering equals or exceeds one hundred and fifty percent (150%) the price per share at which the Company&#8217;s common stock is sold at the Initial Public Offering (the &#8220;Trading Price Bonus&#8221;). Both the Net Income Bonus and the Trading Price Bonus may be earned if both thresholds are achieved or either the Net Income Bonus or the Trading Price Bonus may be earned if only one of the thresholds is achieved. For the purposes of the Nagar Amendment, the &#8220;Initial Public Offering&#8221; means the date on which the Company&#8217;s common stock is initially listed for trading on any tier of the NASDAQ Stock Market, the New York Stock Exchange, the NYSE American, or any other national securities exchange.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;"><strong><em>Marc Deshusses, Head of Technology</em>. </strong>Mr. Deshusses signed his employment agreement with the Company on April 16, 2021. The term is three years, with potential extensions at the agreement of the parties. His base salary is $60,000 per year. If he is terminated for cause, as defined in the agreement, or he leaves the employment of the Company on his own volition, Mr. Deshusses shall receive salary and benefits that have accrued up to the date of termination. If he is terminated without cause or following a material change, as defined in the agreement, Mr. Deshusses will receive salary through the date of termination, all stock options shall vest immediately and salary and healthcare benefits will continue for 24 months. Mr. Deshusses also agreed to a twelve month non-compete/non-solicitation, and signed a separate Proprietary Information and Inventions Agreement with his employment agreement which assigns to the Company any intellectual property developed by him during his employment.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;"><strong><em>Israel D. Abitbol, Chief Financial Officer</em>.</strong> Mr. Abitbol currently does not have a written employment agreement. His current base salary is $156,000 per year.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Proprietary Information and Inventions Agreement</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">All officers, directors, and other key employees and consultants have signed a Proprietary Information and Invention Agreement (&#8220;PIIA&#8221;) with the Company that provides in material part the following:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#9679;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">All inventions and discoveries made by them during their employment or using Company resources shall be assigned to the Company.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#9679;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">They will not interfere in customer relationships during the term of employment plus twelve months after termination for any reason.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#9679;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">They will not solicit other employees of the Company during the term of employment plus twelve months after termination for any reason.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#9679;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">They will not compete with the business of the Company during the term of employment plus twelve months after termination for any reason.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">45</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Agreement with Merrell Bros.</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">On July 7, 2021, 374Water Systems Inc. (&#8220;374Water&#8221;), a subsidiary of 374Water Inc. (the &#8220;Company&#8221;) entered into a Manufacturing and Service Agreement (the &#8220;Manufacturing and Service Agreement&#8221;) with Merrell Bros. Fabrication, LLC (&#8220;Merrell Bros.&#8221;) pursuant to which Merrell Bros. will manufacture, supply and service AirSCWO supercritical water oxidation products for 374Water. Subject to certain termination rights, the Manufacturing and Service Agreement is for an initial period of three years and will renew for successive one-year periods thereafter. Under the Manufacturing and Service Agreement, Merrell Bros. will be 374Water&#8217;s exclusive supplier and service provider with respect to the products in the United States and Canada.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Director Compensation</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">During 2021, we did not provide any cash or equity compensation to our non-employee directors for their service on our board of directors. We have not yet determined a compensation plan for our directors. We intend to provide our directors with reasonable compensation for their services in cash, stock and/or options.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">On June 13, 2022, the Company appointed Messrs.&#160;Penn, Polad and Vanderhider and Ms.&#160;Estes to the Board of Directors and in consideration for each person&#8217;s appointment to the board of directors, the Company granted each of Messrs.&#160;Penn, Polad and Vanderhider and Ms.&#160;Estes an option to purchase up to 20,000 shares of common stock at a per share exercise price of $3.00, which was the closing price of the Company&#8217;s common stock on June 13, 2022, under the Company&#8217;s 2021 Equity Incentive Plan.&#160; The option grants vest in four equal quarterly share installments.&#160; &#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Indemnification of Directors and Officers</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Our Certificate of Incorporation allows us to indemnify our present and former officers and directors and other personnel against liabilities and expenses arising from their service to the fullest extent permitted by Delaware law. The persons indemnified include our (i) present or former directors or officers, (ii) any person who while serving in any of the capacities referred to in clause (i) who served at our request as a director, officer, partner, proprietor, trustee, employee, agent or similar functionary of another foreign or domestic corporation, partnership, joint venture, trust, employee benefit plan or other enterprise, and (iii) any person nominated or designated by (or pursuant to authority granted by) our board of directors or any committee thereof to serve in any of the capacities referred to in clauses (i) or (ii). See the section below entitled &#8220;Limitation on Liability and Indemnification of Directors and Executive Officers&#8221; for further information on our indemnification obligations to our present and former officers and directors.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">46</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160; &#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The following table sets forth information about beneficial ownership of our common stock as of , 2022, (unless otherwise noted) by (i)&#160;each stockholder that has indicated in public filings that the stockholder beneficially owns more than five percent (5%) of the common stock, (ii)&#160;each of the Company&#8217;s directors and named officers and (iii)&#160;all directors and officers as a group. Except as otherwise noted, each person listed below, either alone or together with members of the person&#8217;s family sharing the same household, had, to our knowledge, sole voting and investment power with respect to the shares listed next to the person&#8217;s name.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Name&#160;and&#160;address(1)</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number&#160;of&#160;shares </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>beneficially</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>owned</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Percentage </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>of</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>ownership</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>before </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>offering</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>(2)</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Percentage </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>of </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>ownership </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>after </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>offering&#160;</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>5% stockholders (other than directors and officers)</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">None</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">-</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">-</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">-</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">%</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Directors and officers</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Yaacov Nagar</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">37,700,752</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">29.76</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Marc Deshusses</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">22,620,451</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">17.86</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Terry Merrell (3)</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">7,118,333</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">5.62</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Richard H. Davis</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:9%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">3,982,898</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;(4)</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:9%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">3.05</p></td><td style="width:1%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#160;</p></td><td style="width:1%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">%</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Israel D. Abitbol</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">579,812</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;(5)</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.46</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">%</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Deanna Rene Estes</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">12,500</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.01</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">%</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Buddie Joe (BJ) Penn</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">-</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">-</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">%</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Yizhaq (Itzik) Polad</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">100,000</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.08</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">%</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">James M. Vanderhider (6)</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1,170,000</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.92</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">%</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(All directors and officers as a group 9 persons)</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">73,284,746</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;(7)</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">56.13</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">%</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">* </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Less than 1%</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160; </p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td colspan="2" style="width:3%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(1)</p></td><td colspan="3" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Except as indicated, the address of the person named in the table is c/o 374Water&#160;Inc., 701 W. Main Street, Suite 410. Durham North Carolina 27701.</p></td></tr><tr style="height:15px"><td colspan="2" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(2)</p></td><td colspan="3" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In computing the number of shares beneficially owned by a person and the percentage ownership of that person, shares of the common stock subject to options or warrants held by that person that are currently exercisable or will become exercisable within 60 days after , 2022, are deemed outstanding, while the shares are not deemed outstanding for purposes of computing percentage ownership of any other person. Except as otherwise indicated, and subject to applicable community property laws, the persons named in the table have sole voting and investment power with respect to all shares of the common stock held by them. Applicable percentage ownership is based on 126,680,895 shares of the common stock outstanding as of , 2022. The inclusion in the table above of any shares deemed beneficially owned does not constitute an admission of beneficial ownership of those shares.</p></td></tr><tr style="height:15px"><td colspan="2" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(3)</p></td><td colspan="3" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">All 7,118,333 shares are owned and held by MB Holdings Inc. Terry Merrell has sole voting and dispositive power over the securities held by MB Holdings Inc. Mr. Merrell is a member of our board of directors. </p></td></tr><tr style="height:15px"><td colspan="2" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(4)</p></td><td colspan="3" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Consists of 282,898 shares of common stock and options to purchase 3,700,000 shares of common stock that are either exercisable or will become exercisable within 60 days of , 2022</p></td></tr><tr style="height:15px"><td colspan="2" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(5)</p></td><td colspan="3" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Consists of 392,716 shares of common stock and options to&#160;purchase 187,096 shares of common stock that are either exercisable or will become exercisable within 60 days of , 2022.</p></td></tr><tr style="height:15px"><td colspan="2" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(6)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">All 1,170,000 shares are owned and held by Aspen View LP. James Vanderhider has sole voting and dispositive power over the securities held by Aspen View LP. Mr. Vanderhider is a member of our board of directors. </p></td></tr><tr style="height:15px"><td colspan="2" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(7)</p></td><td colspan="3" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Consists of 73,284,746 shares of common stock held by our current directors and executive officers, of which 3,887,096 consist of stock options to purchase shares of common stock which are either exercisable or will become exercisable within 60 days of , 2022.</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">47</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="certain">CERTAIN RELATIONSHIPS AND RELATED-PARTY TRANSACTIONS</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">In addition to the compensation arrangements with our directors and executive officers, including those discussed in the sections titled &#8220;Management&#8221; and &#8220;Executive Compensation,&#8221; the following is a description of each transaction since January&#160;1, 2019 and each currently proposed transaction in which:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We have been or are to be a participant;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The amount involved exceeded or exceeds the lesser of $120,000 or one percent (1%) of the average of our total assets at year-end for the last two completed fiscal years; and</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Any of our directors, executive officers or holders of more than five percent (5%) of our outstanding capital stock, or any immediate family member of, or person sharing the household with, any of these individuals or entities, had or will have a direct or indirect material interest.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">At December 31, , the Company was due $15,108 for advances received from stockholders of the Company for working capital. There is no formal agreement and these advances are non-interest bearing and due on demand. There were no advances due as of December 31, 2021. During the year ended December 31, 2020, stockholders advanced $2,053 for working capital needs. Advancements were fully paid in fiscal year 2021. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Our previous Chief Financial Officer, John L Hofmann, is a member of the accounting firm Kabat, Schertzer, De La Torre, Taraboulos &amp; Co, LLC (&#8220;KSDT&#8221;). The Company paid $43,205 to KSDT for its services in the year ended December 31, 2021 which was fully paid as of December 31, 2021. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Additionally, the Company entered into an agreement to fabricate and manufacture the units with Merrell Bros. Holding Company. As part of the agreement, the Company provided Terry Merrell a board of director position. As of December 31, 2021, Merrell Bros. own stock in excess of five percent (5%) of the outstanding common stock.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Related-Party Transaction Policy</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Prior to the consummation of this offering, we plan to adopt an audit committee charter that will give our audit committee the primary responsibility for reviewing and approving or disapproving &#8220;related-party transactions,&#8221; which are generally transactions between us and related persons in which the aggregate amount involved exceeds or may be expected to exceed $120,000 and in which a related person has or will have a direct or indirect material interest. The written charter of our audit committee will provide that our audit committee shall review and approve in advance any related-party transaction.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">In approving or rejecting any related party transactions, our audit committee will consider the relevant facts and circumstances available and deemed relevant to our audit committee, including whether the transaction is on terms no less favorable than terms generally available to an unaffiliated third party under the same or similar circumstances and the extent of the related person&#8217;s interest in the transaction.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Historically, our entire board of directors has been responsible for approving related-party transactions. The transactions described above were approved by our board of directors.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">48</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="desofcap">DESCRIPTION OF CAPITAL STOCK</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>DESCRIPTION OF SECURITIES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>General</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The following summarizes information concerning our capital stock, including material provisions of our Amended and Restated Certificate of Incorporation, our Amended and Restated Bylaws and certain provisions of Delaware law. You are encouraged to read our form of Amended and Restated Certificate of Incorporation and our form of Amended and Restated Bylaws.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Authorized Capital Stock</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">As of , 2022, our authorized capital stock consists of 200,000,000 shares of common stock, par value $0.0001 per share, and 1,000,000 shares of &#8220;blank check&#8221; preferred stock, par value $0.0001 per share.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Shares Outstanding</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">As of , 2022, 126,680,895 shares of our common stock were issued and outstanding and no shares of our preferred stock were issued or outstanding.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Common Stock</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Dividend Rights</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Subject to preferences that may be applicable to any then outstanding preferred stock, holders of our common stock are entitled to receive dividends, if any, as may be declared from time to time by our board of directors out of legally available funds.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Voting Rights</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Except as required by law or matters relating solely to the terms of preferred stock, each outstanding share of common stock will be entitled to one vote on all matters submitted to a vote of stockholders. Holders of shares of our common stock shall have no cumulative voting rights. Except in respect of matters relating to the election and removal of directors on our board of directors and as otherwise provided in our Amended and Restated Certificate of Incorporation or required by law, all matters to be voted on by our stockholders must be approved by a majority of the shares present in person or by proxy at the meeting and entitled to vote on the subject matter. In the case of election of directors, all matters to be voted on by our stockholders must be approved by a plurality of the voting power of the shares present in person or by proxy at the meeting and entitled to vote thereon.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Liquidation</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">In the event of the liquidation, dissolution or winding up of our company, holders of our common stock are entitled to share ratably in the net assets legally available for distribution to stockholders after the payment of all of our debts and other liabilities and the satisfaction of any liquidation preference granted to the holders of any then outstanding shares of preferred stock.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Rights and Preferences</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Holders of our common stock have no preemptive, conversion, subscription or other rights, and there is no redemption or sinking fund provisions applicable to our common stock. The rights, preferences and privileges of the holders of our common stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of our preferred stock that we may designate in the future.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">49</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Preferred Stock</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">The Amended and Restated Certificate of Incorporation authorizes the Company&#8217;s board of directors to establish one or more series of preferred stock. Unless required by law or by NASDAQ, the authorized shares of preferred stock will be available for issuance without further action by you. The Company&#8217;s board of directors is authorized to fix from time to time before issuance the number of preferred shares to be included in any such series and the designation, powers, preferences and relative participating, optional or other rights, if any, and the qualifications, limitations or restrictions thereof. The authority of the Company&#8217;s board of directors with respect to each such series will include, without limiting the generality of the foregoing, the determination of any or all of the following:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The number of shares of any series and the designation to distinguish the shares of such series from the shares of all other series;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The voting powers, if any, and whether such voting powers are full or limited in such series;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The redemption provisions, if any, applicable to such series, including the redemption price or prices to be paid;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Whether dividends, if any, will be cumulative or noncumulative, the dividend rate of such series, and the dates and preferences of dividends on such series;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The rights of such series upon the voluntary or involuntary dissolution of, or upon any distribution of the assets of, the Company;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The provisions, if any, pursuant to which the shares of such series are convertible into, or exchangeable for, shares of any other class or classes or of any other series of the same or any other class or classes of stock, or any other security, of the Company or any other corporation or other entity, and the rates or other determinants of conversion or exchange applicable thereto;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The right, if any, to subscribe for or to purchase any securities of the Company or any other corporation or other entity;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The provisions, if any, of a sinking fund applicable to such series; and</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Any other relative, participating, optional, or other special powers, preferences or rights and qualifications, limitations, or restrictions thereof;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">All as may be determined from time to time by the Company&#8217;s board of directors and stated or expressed in the resolution or resolutions providing for the issuance of such preferred stock.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The Company could issue a series of preferred stock that could, depending on the terms of the series, impede or discourage an acquisition attempt or other transaction that some, or a majority, of the holders of the Company&#8217;s common stock might believe to be in their best interests or in which the holders of the Company&#8217;s common stock might receive a premium for their Company common stock over its market price. Additionally, the issuance of preferred stock may adversely affect the rights of holders of the Company&#8217;s common stock by restricting dividends on the Company&#8217;s common stock, diluting the voting power of the Company&#8217;s common stock or subordinating the liquidation rights of the Company&#8217;s common stock. As a result of these or other factors, the issuance of preferred stock could have an adverse impact on the market price of the Company&#8217;s common stock. The Company has no current plans to issue any series of preferred stock. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">50</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Delaware Anti-Takeover Law and Provisions of our Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">The Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws contain and the DGCL contains provisions, which are summarized in the following paragraphs, that are intended to enhance the likelihood of continuity and stability in the composition of the Company&#8217;s board of directors. These provisions are intended to avoid costly takeover battles, reduce the Company&#8217;s vulnerability to a hostile change of control and enhance the ability of the Company&#8217;s board of directors to maximize stockholder value in connection with any unsolicited offer to acquire the Company. However, these provisions may have an anti-takeover effect and may delay, deter or prevent a merger or acquisition of the Company by means of a tender offer, a proxy contest or other takeover attempt that a stockholder might consider in its best interest, including those attempts that might result in a premium over the prevailing market price for the shares of the Company&#8217;s common stock held by stockholders.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Delaware Anti-Takeover Law</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We are subject to Section&#160;203 of the Delaware General Corporation Law (&#8220;DGCL&#8221;). Section&#160;203 generally prohibits a public Delaware corporation from engaging in a &#8220;business combination&#8221; with an &#8220;interested stockholder&#8221; for a period of three years after the date of the transaction in which the person became an interested stockholder, unless:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Prior to the date of the transaction, the board of directors of the corporation approved either the business combination or the transaction which resulted in the stockholder becoming an interested stockholder;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">The interested stockholder owned at least eighty five percent (85%) of the voting stock of the corporation outstanding at the time the transaction commenced, excluding for purposes of determining the number of shares outstanding (i) shares owned by persons who are directors and also officers and (ii) shares owned by employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">On or subsequent to the date of the transaction, the business combination is approved by the board and authorized at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 66 2&#8725;3% of the outstanding voting stock which is not owned by the interested stockholder.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">Section&#160;203 defines a business combination to include:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"></td><td colspan="2" style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td colspan="2" style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Any merger or consolidation involving the corporation and the interested stockholder;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="3"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td colspan="3" style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Any sale, transfer, pledge or other disposition involving the interested stockholder of ten percent (10%) or more of the assets of the corporation;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="3"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td colspan="3" style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Subject to exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="3"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td colspan="3" style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Subject to exceptions, any transaction involving the corporation or any direct or indirect majority-owned subsidiary of the corporation which has the effect, directly or indirectly, of increasing the proportionate share of the stock of any class or series, or securities convertible into the stock of any class or series, of the corporation or of any such subsidiary which is owned by the interested stockholder; or</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="3"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td colspan="3" style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">The receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits provided by or through the corporation.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">In general, Section&#160;203 defines an interested stockholder as any entity or person beneficially owning fifteen percent (15%) or more of the outstanding voting stock of the corporation or any entity or person affiliated with, or controlling, or controlled by, the entity or person. The term &#8220;owner&#8221; is broadly defined to include any person that, individually, with or through that person&#8217;s affiliates or associates, among other things, beneficially owns the stock, or has the right to acquire the stock, whether or not the right is immediately exercisable, under any agreement or understanding or upon the exercise of warrants or options or otherwise or has the right to vote the stock under any agreement or understanding, or has an agreement or understanding with the beneficial owner of the stock for the purpose of acquiring, holding, voting or disposing of the stock.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">51</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The restrictions in Section&#160;203 do not apply to corporations that have elected, in the manner provided in Section&#160;203, not to be subject to Section&#160;203 of the Delaware General Corporation Law or, with certain exceptions, which do not have a class of voting stock that is listed on a national securities exchange or authorized for quotation on the Nasdaq Stock Market or held of record by more than 2,000 stockholders. Our Amended and Restated Certificate of Incorporation and Bylaws do not opt out of Section&#160;203.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">Section&#160;203 could delay or prohibit mergers or other takeover or change in control attempts with respect to us and, accordingly, may discourage attempts to acquire us even though such a transaction may offer our stockholders the opportunity to sell their stock at a price above the prevailing market price.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Certificate of Incorporation and Bylaws</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Provisions of our Amended and Restated Certificate of Incorporation and Bylaws may delay or discourage transactions involving an actual or potential change in our control or change in our management, including transactions in which shareholders might otherwise receive a premium for their shares, or transactions that our shareholders might otherwise deem to be in their best interests. Therefore, these provisions could adversely affect the price of our common stock. Among other things, our Amended and Restated Certificate of Incorporation and Bylaws:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Permit our board of directors to issue up to 1,000,000 shares of preferred stock, without further action by the shareholders, with any rights, preferences and privileges as they may designate, including the right to approve an acquisition or other change in control;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Provide that the authorized number of directors may be changed only by resolution of a majority of the total number of authorized directors whether or not there exist any vacancies in the previously authorized directorships (the &#8220;Whole Board&#8221;);</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Provide that all vacancies, including newly created directorships, may, except as otherwise required by law, be filled by the affirmative vote of a majority of directors then in office, even if less than a quorum;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Do not provide for cumulative voting rights (therefore allowing the holders of a majority of the shares of common stock entitled to vote in any election of directors to elect all of the directors standing for election, if they should so choose);</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Provide that special meetings of our shareholders may be called only by the board of directors acting pursuant to a resolution adopted by a majority of the Whole Board or holders of a majority of the outstanding voting power of the shares of capital stock of the Company; and</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Set forth an advance notice procedure with regard to the nomination, other than by or at the direction of our board of directors, of candidates for election as directors and with regard to business to be brought before a meeting of shareholders.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Special Stockholder Meetings</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Subject to the rights of the holders of any future series of preferred stock, special meetings of stockholders may be called by the President or board of directors. At any annual meeting or special meeting of stockholders, only such business will be conducted or considered as has been brought before such meeting as shall have been properly brought before the meeting.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">52</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Consent of Stockholders in Lieu of Meeting</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Subject to the rights of the holders of any series of preferred stock, any action required or permitted to be taken by the stockholders may be taken only at a duly called annual meeting of stockholders.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Dissenters&#8217; Rights of Appraisal and Payment</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Under the DGCL, with certain exceptions, the Company&#8217;s stockholders will have appraisal rights in connection with a merger or consolidation of the Company. Pursuant to the DGCL, stockholders who properly request and perfect appraisal rights in connection with such merger or consolidation will have the right to receive payment of the fair value of their shares as determined by the Delaware Court of Chancery.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Stockholders&#8217; Derivative Actions</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Under the DGCL, any of the Company&#8217;s stockholders may bring an action in the Company&#8217;s name to procure a judgment in the Company&#8217;s favor, also known as a derivative action, provided that the stockholder bringing the action is a holder of the Company&#8217;s shares at the time of the transaction to which the action relates or such stockholder&#8217;s stock thereafter devolved by operation of law.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Limitation on Liability and Indemnification of Directors and Executive Officers</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Our Amended and Restated Certificate of Incorporation will limit our directors&#8217; liability to the fullest extent permitted under Delaware law. Delaware law provides that directors of a corporation will not be personally liable for monetary damages for breach of their fiduciary duties as directors, except for liability:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">For any breach of a director&#8217;s duty of loyalty to us and our stockholders;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">For any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Under Section 174 of the Delaware General Corporation Law (unlawful payment of dividends or redemption of shares); or</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">For any breach of a director&#8217;s duty of loyalty to us or our stockholders.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">If the Delaware General Corporation Law is amended to authorize corporate action further eliminating or limiting the personal liability of directors, then the liability of our directors shall be eliminated or limited to the fullest extent permitted by the Delaware General Corporation Law, as so amended.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Delaware law provides, and our Amended and Restated Bylaws will provide that we will, in certain situations, indemnify our directors and officers and may indemnify other employees and other agents, to the fullest extent permitted by law. Any indemnified person is also entitled, subject to certain limitations, to payment or reimbursement of reasonable expenses in advance of the final disposition of the proceeding.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We intend to maintain a directors&#8217; and officers&#8217; insurance policy pursuant to which our directors and officers are insured against liability for certain actions taken in their capacities as directors and officers. We believe that these provisions in our Amended and Restated Certificate of Incorporation and Bylaws and any such insurance policy are necessary to attract and retain qualified persons as directors and officers.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The limitation of liability, advancement and indemnification provisions in the Amended and Restated Certificate of Incorporation may discourage stockholders from bringing a lawsuit against directors for breach of their fiduciary duty. These provisions also may have the effect of reducing the likelihood of derivative litigation against directors and officers, even though such an action, if successful, might otherwise benefit the Company and its stockholders. In addition, your investment may be adversely affected to the extent the Company pays the costs of settlement and damage awards against directors and officers pursuant to these indemnification provisions.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">53</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Insofar as indemnification for liabilities arising under the Securities Act, may be permitted to directors, officers or control persons, in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Authorized but Unissued Shares</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Delaware law does not require stockholder approval for any issuance of authorized shares. However, the listing requirements of NASDAQ, which would apply if and so long as the Company&#8217;s common stock is listed on NASDAQ, require stockholder approval of certain issuances equal to or exceeding twenty percent (20%) of the then outstanding voting power or then outstanding number of shares of common stock. Additional shares that may be used in the future may be issued for a variety of corporate purposes, including future public offerings, to raise additional capital or as employee compensation. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">The Company&#8217;s board of directors may generally issue preferred shares on terms calculated to discourage, delay or prevent a change of control of the Company or the removal of the Company&#8217;s management. Moreover, the Company&#8217;s authorized but unissued shares of preferred stock will be available for future issuances without stockholder approval and could be utilized for a variety of corporate purposes, including future offerings to raise additional capital, to facilitate acquisitions and employee benefit plans.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">One of the effects of the existence of unissued and unreserved common stock or preferred stock may be to enable the Company&#8217;s board of directors to issue shares to persons friendly to current management, which issuance could render more difficult or discourage an attempt to obtain control of the Company by means of a merger, tender offer, proxy contest or otherwise, and thereby protect the continuity of the Company&#8217;s management and possibly deprive the Company&#8217;s stockholders of opportunities to sell their shares of the Company&#8217;s common stock at prices higher than prevailing market prices.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Transfer Agent and Registrar</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The transfer agent and registrar for our common stock is Direct Transfer, LLC.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Shares Eligible for Future Sale</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">There is currently no established public market for our common stock. Future sales of substantial amounts of our common stock in the public market, or the availability of such shares for sale in the public market, could adversely affect the market price of our common stock prevailing from time to time and could impair our ability to raise capital through sales of equity securities.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Rule&#160;144</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">In general, under Rule&#160;144, as currently in effect, a person (or persons whose shares are aggregated), including an affiliate, who beneficially owns &#8220;restricted securities&#8221; of a &#8220;reporting company&#8221; may not sell these securities until the person has beneficially owned them for at least six months. Thereafter, affiliates may not sell within any three-month period a number of shares in excess of the greater of: (i)&#160;one percent (1%) of the then outstanding shares of common stock as shown by the most recent report or statement published by the issuer; and (ii)&#160;the average weekly reported trading volume in such securities during the four preceding calendar weeks.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Sales under Rule&#160;144 by our affiliates will also be subject to restrictions relating to manner of sale, notice and the availability of current public information about us and may be affected only through unsolicited brokers&#8217; transactions.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Persons not deemed to be affiliates who have beneficially owned &#8220;restricted securities&#8221; for at least six months but for less than one year may sell these securities, provided that current public information about the Company is &#8220;available,&#8221; which means that, on the date of sale, we have been subject to the reporting requirements of the Exchange Act for at least 90 days and are current in our Exchange Act filings. After beneficially owning &#8220;restricted securities&#8221; for one year, our non-affiliates may engage in unlimited re-sales of such securities.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">54</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Shares received by our affiliates upon exercise of stock options or upon vesting of other equity-linked awards may be &#8220;controlled securities&#8221; rather than &#8220;restricted securities.&#8221; &#8220;Controlled securities&#8221; are subject to the same volume limitations as &#8220;restricted securities&#8221; but are not subject to holding period requirements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="descofsec">DESCRIPTION OF SECURITIES WE ARE OFFERING</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Common Stock</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We are offering shares of our common stock in this offering. The material terms and provisions of our common stock are described under the caption &#8220;Description of Capital Stock&#8221; in this prospectus.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Representative&#8217;s Warrants</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Please see &#8220;Underwriting&#8212;Representative&#8217;s Warrants&#8221; for a description of the warrants we have agreed to issue to the underwriter in this offering, subject to the completion of the offering. We expect to enter into a warrant agreement in respect of the representative&#8217;s warrants in connection with the closing of this offering.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Listing</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We have applied to list our shares of common stock offered hereby for trading on The Nasdaq Capital Market under the symbol &#8220;SCWO&#8221;. No assurance can be given that our listing application will be approved.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="material">MATERIAL U.S. FEDERAL INCOME AND ESTATE TAX CONSIDERATIONS</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The following is a summary of the material U.S. federal income tax considerations relating to the purchase, ownership and disposition of our common stock purchased in this offering but is for general information purposes only and does not purport to be a complete analysis of all the potential tax considerations relating thereto. This summary is based upon the provisions of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), existing and proposed Treasury regulations promulgated thereunder, administrative rulings and judicial decisions, all as of the date hereof. These authorities may be changed, possibly retroactively, so as to result in U.S. federal income and estate tax consequences different from those set forth below. There can be no assurance that the Internal Revenue Service (the &#8220;IRS&#8221;) will not challenge one or more of the tax consequences described herein, and we have not obtained, and do not intend to obtain, an opinion of counsel or ruling from the IRS with respect to the U.S. federal income tax considerations relating to the purchase, ownership or disposition of our common stock.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">This summary does not address any alternative minimum tax considerations, any considerations regarding the tax on net investment income, or the tax considerations arising under the laws of any state, local or non-U.S. jurisdiction, or under any non-income&#160;tax laws, including U.S. federal gift and estate tax laws, except to the limited extent set forth below. In addition, this summary does not address tax considerations applicable to an investor&#8217;s particular circumstances or to investors that may be subject to special tax rules, including, without limitation:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Banks, insurance companies or other financial institutions;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Tax-exempt organizations or governmental organizations;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Regulated investment companies and real estate investment trusts;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Controlled foreign corporations, passive foreign investment companies and corporations that accumulate earnings to avoid U.S. federal income tax;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">55</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Brokers or dealers in securities or currencies;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Traders in securities that elect to use a mark-to-market method of accounting for their securities holdings;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Persons that own, or are deemed to own, more than five percent (5%) of our capital stock (except to the extent specifically set forth below);</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Tax-qualified retirement plans;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Certain former citizens or long-term residents of the United States;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Partnerships or entities or arrangements classified as partnerships for U.S. federal income tax purposes and other pass-through entities (and investors therein);</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Persons who hold our common stock as a position in a hedging transaction, &#8220;straddle,&#8221; &#8220;conversion transaction&#8221; or other risk reduction transaction or integrated investment;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Persons who hold or receive our common stock pursuant to the exercise of any employee stock option or otherwise as compensation;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Persons who do not hold our common stock as a capital asset within the meaning of Section 1221 of the Code; or</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Persons deemed to sell our common stock under the constructive sale provisions of the Code.</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">&#160;In addition, if a partnership (or entity or arrangement classified as a partnership for U.S. federal income tax purposes) holds our common stock, the tax treatment of a partner generally will depend on the status of the partner and upon the activities of the partnership. Accordingly, partnerships that hold our common stock, and partners in such partnerships, should consult their tax advisors.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;"><strong>You are urged to consult your own tax advisors with respect to the application of the U.S. federal income tax laws to your particular situation, as well as any tax consequences of the purchase, ownership and disposition of our common stock arising under the U.S. federal estate or gift tax laws or under the laws of any state, local, non-U.S., or other taxing jurisdiction or under any applicable tax treaty.</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Consequences to U.S. Holders</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">The following is a summary of the U.S. federal income tax consequences that will apply to a U.S. holder of our common stock. For purposes of this discussion, you are a U.S. holder if, for U.S. federal income tax purposes, you are a beneficial owner of our common stock, other than a partnership, that is:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">An individual citizen or resident of the United States;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">A corporation or other entity taxable as a corporation created or organized in the United States or under the laws of the United States, any State thereof or the District of Columbia;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">An estate whose income is subject to U.S. federal income tax regardless of its source; or</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">A trust (x) whose administration is subject to the primary supervision of a U.S. court and which has one or more &#8220;United States persons&#8221; (within the meaning of Section 7701(a)(30) of the Code) who have the authority to control all substantial decisions of the trust or (y) which has made a valid election to be treated as a &#8220;United States person.&#8221;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">56</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Distributions</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">As described in the section titled &#8220;Dividend Policy,&#8221; we have never declared or paid cash dividends on our common stock and do not anticipate paying any dividends on our common stock in the foreseeable future. However, if we do make distributions on our common stock, those payments will constitute dividends for U.S. tax purposes to the extent paid from our current or accumulated earnings and profits, as determined under U.S. federal income tax principles. To the extent those distributions exceed both our current and our accumulated earnings and profits, the excess will constitute a return of capital and will first reduce your basis in our common stock, but not below zero, and then will be treated as gain from the sale of stock as described below under &#8220;&#8212;Sale, Exchange or Other Taxable Disposition of Common Stock.&#8221;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Dividend income may be taxed to an individual U.S. holder at rates applicable to long-term&#160;capital gains, provided that a minimum holding period and other limitations and requirements are satisfied. Any dividends that we pay to a U.S. holder that is a corporation will qualify for a deduction allowed to U.S. corporations in respect of dividends received from other U.S. corporations equal to a portion of any dividends received, subject to generally applicable limitations on that deduction. U.S. holders should consult their own tax advisors regarding the holding period and other requirements that must be satisfied in order to qualify for the reduced tax rate on dividends or the dividends-received&#160;deduction.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Sale, Exchange or Other Taxable Disposition of Common Stock</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">A U.S. holder will generally recognize capital gain or loss on the sale, exchange or other taxable disposition of our common stock. The amount of gain or loss will equal the difference between the amount realized on the sale and such U.S. holder&#8217;s tax basis in such common stock. The amount realized will include the amount of any cash and the fair market value of any other property received in exchange for such common stock. Gain or loss will be long-term&#160;capital gain or loss if the U.S. holder has held the common stock for more than one year. Long-term&#160;capital gains of non-corporate&#160;U.S. holders are generally taxed at preferential rates. The deductibility of capital losses is subject to certain limitations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Consequences to Non-U.S. Holders</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The following is a summary of the U.S. federal income tax consequences that will apply to a non-U.S. holder of our common stock. A &#8220;non-U.S. holder&#8221; is a beneficial owner of our common stock (other than a partnership or an entity or arrangement treated as a partnership for U.S. federal income tax purposes) that, for U.S. federal income tax purposes, is not a U.S. holder.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Distributions</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Any dividend paid to a non-U.S. holder generally will be subject to U.S. withholding tax either at a rate of thirty percent (30%) of the gross amount of the dividend or such lower rate as may be specified by an applicable income tax treaty. In order to receive a reduced treaty rate, a non-U.S. holder must provide us with an IRS Form&#160;W-8BEN,&#160;IRS Form&#160;W-8BEN-E&#160;or other applicable IRS Form&#160;W-8&#160;properly certifying qualification for the reduced rate. These forms must be updated periodically. A non-U.S. holder eligible for a reduced rate of U.S. withholding tax pursuant to an income tax treaty may obtain a refund of any excess amounts withheld by timely filing an appropriate claim for refund with the IRS. If a non-U.S. holder holds our common stock through a financial institution or other agent acting on the non-U.S. holder&#8217;s behalf, the non-U.S. holder will be required to provide appropriate documentation to the agent, which then may be required to provide certification to us or our paying agent, either directly or through other intermediaries.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">57</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">Dividends received by a non-U.S. holder that are effectively connected with its conduct of a U.S. trade or business (and, if required by an applicable income tax treaty, attributable to a permanent establishment or fixed base maintained by the non-U.S. holder in the United States) are generally exempt from such withholding tax if the non-U.S. holder satisfies certain certification and disclosure requirements. In order to obtain this exemption, the non-U.S. holder must provide us with an IRS Form&#160;W-8ECI&#160;or other applicable IRS Form&#160;W-8&#160;properly certifying such exemption. Such effectively connected dividends, although not subject to withholding tax, are taxed at the same graduated U.S. federal income tax rates applicable to U.S. holders, net of certain deductions and credits. In addition, dividends received by a corporate non-U.S. holder that are effectively connected with its conduct of a U.S. trade or business may also be subject to a branch profits tax at a rate of thirty percent (30%) or such lower rate as may be specified by an applicable income tax treaty. Non-U.S. holders should consult their own tax advisors regarding any applicable tax treaties that may provide for different rules.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Gain on Sale, Exchange or Other Taxable Disposition of Common Stock </strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Subject to the discussion below regarding backup withholding and foreign accounts, a non-U.S. holder generally will not be required to pay U.S. federal income tax on any gain realized upon the sale, exchange or other taxable disposition of our common stock unless:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">The gain is effectively connected with the non-U.S. holder&#8217;s conduct of a U.S. trade or business (and, if required by an applicable income tax treaty, the gain is attributable to a permanent establishment or fixed base maintained by the non-U.S. holder in the United States);</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">The non-U.S. holder is a non-resident alien individual who is present in the United States for a period or periods aggregating 183 days or more during the calendar year in which the sale or disposition occurs and certain other conditions are met; or</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Shares of our common stock, as applicable, constitute U.S. real property interests by reason of our status as a &#8220;United States real property holding corporation&#8221; (a &#8220;USRPHC&#8221;) for U.S. federal income tax purposes at any time within the shorter of the five-year period preceding the non-U.S. holder&#8217;s disposition of, or the non-U.S. holder&#8217;s holding period for, our common stock, as applicable.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We believe that we are not currently and will not become a USRPHC for U.S. federal income tax purposes, and the remainder of this discussion so assumes. However, because the determination of whether we are a USRPHC depends on the fair market value of our U.S. real property relative to the fair market value of our other business assets, there can be no assurance that we will not become a USRPHC in the future. Even if we become a USRPHC, however, if our common stock becomes regularly traded on an established securities market (as defined by applicable Treasury regulations), such common stock will be treated as U.S. real property interests only if the non-U.S. holder actually or constructively held more than five percent (5%) of such regularly traded common stock at any time during the shorter of the five-year&#160;period preceding the non-U.S. holder&#8217;s disposition of, or the non-U.S. holder&#8217;s holding period for, our common stock. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">If the non-U.S. holder is described in the first bullet above, it will be required to pay tax on the net gain derived from the sale, exchange or other taxable disposition under regular graduated U.S. federal income tax rates, and a corporate non-U.S. holder described in the first bullet above also may be subject to the branch profits tax at a rate of thirty percent (30%), or such lower rate as may be specified by an applicable income tax treaty. An individual non-U.S. holder described in the second bullet above will be required to pay a flat thirty percent (30%) tax (or such lower rate specified by an applicable income tax treaty) on the gain derived from the sale, exchange or other taxable disposition, which gain may be offset by U.S. source capital losses for the year (provided the non-U.S. holder has timely filed U.S. federal income tax returns with respect to such losses). Non-U.S. holders should consult their own tax advisors regarding any applicable income tax or other treaties that may provide for different rules.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Federal Estate Tax</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Common stock beneficially owned by an individual who is not a citizen or resident of the United States (as defined for U.S. federal estate tax purposes) at the time of their death will generally be includable in the decedent&#8217;s gross estate for U.S. federal estate tax purposes. Such securities, therefore, may be subject to U.S. federal estate tax, unless an applicable estate tax treaty provides otherwise.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">58</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Backup Withholding and Information Reporting</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Generally, we must report annually to the IRS the amount of dividends paid to you, your name and address and the amount of tax withheld, if any. A similar report will be sent to you. Pursuant to applicable income tax treaties or other agreements, the IRS may make these reports available to tax authorities in your country of residence if you reside outside of the United States.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Payments of dividends on or of proceeds from the disposition of our common stock made to you may be subject to information reporting and backup withholding. Backup withholding may apply at a current rate of twenty-four percent (24%) unless you (i)&#160;provide the payor with a correct taxpayer identification number and comply with applicable certification requirements, or (ii)&#160;establish an exemption, for example, by properly certifying your non-U.S. status on an IRS Form&#160;W-8BEN&#160;or IRS Form&#160;W-8BEN-E&#160;or other applicable IRS Form&#160;W-8. Notwithstanding the foregoing, backup withholding and information reporting may apply if either we or our paying agent has actual knowledge, or reason to know, that you are a U.S. person that is not an exempt recipient.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Backup withholding is not an additional tax; rather, the U.S. federal income tax liability of persons subject to backup withholding will be reduced by the amount of tax withheld. If withholding results in an overpayment of taxes, a refund or credit may generally be obtained from the IRS, provided that the required information is furnished to the IRS in a timely manner.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Foreign Account Tax Compliance</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The Foreign Account Tax Compliance Act (&#8220;FATCA&#8221;) generally imposes withholding tax at a rate of thirty percent (30%) on dividends on and gross proceeds from the sale or other disposition of our common stock paid to a &#8220;foreign financial institution&#8221; (as specially defined under these rules), unless such institution enters into an agreement with the U.S. government to, among other things, withhold on certain payments and to collect and provide to the U.S. tax authorities substantial information regarding the U.S. account holders of such institution (which includes certain equity and debt holders of such institution, as well as certain account holders that are foreign entities with U.S. owners) or otherwise establishes an exemption. FATCA also generally imposes a U.S. federal withholding tax of thirty percent (30%) on dividends on and gross proceeds from the sale or other disposition of our common stock paid to a &#8220;non-financial&#160;foreign entity&#8221; (as specially defined for purposes of these rules) unless such entity provides the withholding agent with a certification identifying certain substantial direct and indirect U.S. owners of the entity, certifies that there are none or otherwise establishes an exemption. The withholding provisions under FATCA generally apply to dividends paid by us. Under certain circumstances, a non-U.S. holder might be eligible for refunds or credits of such taxes. An intergovernmental agreement between the United States and an applicable foreign country may modify the requirements described in this paragraph. Non-U.S. holders should consult their own tax advisors regarding the possible implications of this legislation on their investment in our common stock.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;"><strong>Each prospective investor should consult its own tax advisor regarding the particular U.S. federal, state and local and non-U.S. tax consequences of purchasing, owning and disposing of our common stock, including the consequences of any proposed changes in applicable laws.</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">59</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="underw">UNDERWRITING</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">Roth Capital Partners, LLC is acting as the underwriter for this offering. We have entered into an underwriting agreement dated , 2022, with the underwriter. Subject to the terms and conditions of the underwriting agreement, we have agreed to sell to the underwriter, and the underwriter has agreed to purchase from us, at the public offering price per share less the underwriting discounts set forth on the cover page&#160;of this prospectus, the number of shares listed next to its name in the following table:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Underwriter</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Roth Capital Partners, LLC</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Total</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">All of the shares to be purchased by the underwriter will be purchased from us.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The underwriting agreement provides that the obligations of the underwriter to pay for and accept delivery of the shares offered by this prospectus are subject to various conditions and representations and warranties, including the approval of certain legal matters by their counsel and other conditions specified in the underwriting agreement. The shares are offered by the underwriter, subject to prior sale, when, as and if issued to and accepted by it. The underwriter reserves the right to withdraw, cancel or modify the offer to the public and to reject orders in whole or in part. The underwriter is obligated to take and pay for all of the shares offered by this prospectus if any such shares are taken, other than those shares of common stock and/or warrants covered by the over-allotment option described below.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Over-Allotment Option</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We have granted to the underwriter an option, exercisable no later than 45 calendar days after the closing of this offering, to purchase up to an additional shares of common stock to purchase up to shares of common stock, in any combination thereof, from us to cover over-allotments, if any. If the underwriter exercises all or any part of this option, it will purchase shares covered by the option at the public offering price per share, less the underwriting discount. If this option is exercised in full, the total offering price to the public will be $ and the total net proceeds, before expenses, to us will be $ .</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Discounts and Commissions</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The underwriter has advised us that it proposes to offer the shares to the public at the public offering price per share set forth on the cover page&#160;of this prospectus. The underwriter may offer shares to securities dealers at that price less a concession of not more than $ per share, of which up to $ per share may be re-allowed to other dealers. After the initial offering to the public, the public offering price and other selling terms may be changed by the underwriter.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The following table summarizes the public offering price, underwriting discounts and commissions and proceeds before expenses to us assuming both no exercise and full exercise by the underwriter of its over-allotment option:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Per Share</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Total Without </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Over-allotment</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Option</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Total With </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Over-allotment</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Option</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Public offering price</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;"></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;"></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;"></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Underwriting discounts and commissions (%)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;"></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;"></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;"></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Proceeds, before expenses, to us</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;"></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;"></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;"></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">60</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">In addition, we have also agreed to pay the following expenses of the underwriter up to an amount not to exceed $ in the aggregate relating to the offering including: (a)&#160;all fees, expenses and disbursements relating to background checks of our officers and directors and (b)&#160;the underwriter&#8217;s legal fees incurred in connection with this offering.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We estimate the expenses of this offering payable by us, not including underwriting discounts and commissions, will be approximately $ .</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Underwriter&#8217;s Warrants</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Upon closing of this offering, we have agreed to issue to the underwriter as compensation warrants to purchase a number of shares of common stock equal to % of the aggregate number of shares of common stock sold in this offering (including any shares sold as part of the over-allotment option). The underwriter&#8217;s warrants will be exercisable at a per share exercise price equal to % of the public offering price per share sold in this offering. The underwriter&#8217;s warrants are exercisable at any time and from time to time, in whole or in part, during the four and one-half year period commencing six months from the effective date of the registration statement related to this offering. We have registered the shares of our common stock issuable upon the exercise of the underwriter&#8217;s warrants in the registration statement of which this prospectus is a part.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The underwriter&#8217;s warrants have been deemed compensation by the Financial Industry Regulatory Authority,&#160;Inc. (&#8220;FINRA&#8221;) and are therefore subject to a 180-day lock-up pursuant to Rule&#160;5110(g)(1)&#160;of FINRA. The underwriter (or permitted assignees under Rule&#160;5110(g)(1)) will not sell, transfer, assign, pledge, or hypothecate these warrants or the securities underlying these warrants, nor will they engage in any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the warrants or the underlying securities for a period of 180 days from the effective date of the registration statement. In addition, the warrants provide for registration rights upon request, in certain cases. The demand registration right provided will not be greater than five years from the effective date of the offering in compliance with FINRA Rule&#160;5110(f)(2)(G)(iv). The piggyback registration right provided will not be greater than seven years from the effective date of the offering in compliance with FINRA Rule&#160;5110(f)(2)(G)(v). We will bear all fees and expenses attendant to registering the securities issuable on exercise of the warrants other than underwriting commissions incurred and payable by the holders. The exercise price and number of shares issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend or our recapitalization, reorganization, merger or consolidation. However, the warrant exercise price or underlying shares will not be adjusted for issuances of shares of common stock at a price below the warrant exercise price.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Determination of Public Offering Price</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The public offering price for the shares being sold in this offering will be determined by negotiations between us and the underwriter. Among the factors considered in determining the public offering price of the shares, in addition to prevailing market conditions, was the information set forth in this prospectus and otherwise available to the underwriter; our history and prospects and the history and prospects for the industry in which we compete; estimates of our business potential and earnings prospects; an assessment of our management; recent market prices of, and demand for, publicly traded common stock of generally comparable companies; and other factors deemed relevant by the underwriter and us.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Neither we nor the underwriter can assure investors that an active trading market for our securities will develop. It is also possible that, after the offering, the securities will not trade in the public market at or above the public offering price.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The underwriter has advised us that it proposes to offer the securities directly to the public at the public offering price set forth on the cover of this prospectus. After the offering to the public, the offering price and other selling terms may be changed by the underwriter without changing our proceeds from the underwriter&#8217;s purchase of the securities.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">61</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The underwriter and its affiliates may in the future provide various investment banking and other financial services for us, for which they may receive, in the future, customary fees.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Listing</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We have applied to list our shares of common stock offered hereby for trading on The Nasdaq Capital Market under the symbol &#8220;SCWO&#8221;. No assurance can be given that our listing application will be approved.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Lock-Up Agreements</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We have agreed, on behalf of the company and any successor entity, that, without the prior written consent of the underwriter, we will not, for a period of 180 days after the date of this prospectus (subject to limited exceptions), (i)&#160;offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of our capital stock or any securities convertible into or exercisable or exchangeable for shares of our capital stock; (ii)&#160;file or caused to be filed any registration statement with the SEC relating to the offering of any shares of our capital stock or any securities convertible into or exercisable or exchangeable for shares of our capital stock; (iii)&#160;complete any offering of debt securities, other than entering into a line of credit with a traditional bank or (iv)&#160;enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of our capital stock, whether any such transaction described in clause (i), (ii), (iii)&#160;or (iv)&#160;above is to be settled by delivery of shares of capital stock of the Company or such other securities, in cash or otherwise.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">&#160;Each of our directors and officers have agreed, for a period of 180 days after the date of this prospectus, and certain stockholders have agreed to various lock-up periods after the date of this prospectus, without the prior written consent of the underwriter, not to directly or indirectly (subject to limited exceptions):</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Offer, pledge, sell, contract to sell, grant lend or otherwise transfer or dispose of, directly or indirectly, any shares of our capital stock or any securities convertible into or exercisable or exchangeable for shares of our capital stock (the &#8220;Lock-Up Securities&#8221;), whether any such transaction is to be settled by delivery of Lock-Up Securities, in cash or otherwise;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of the Lock-Up Securities, whether any such transaction is to be settled by delivery of Lock-Up Securities, in cash or otherwise;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Make any demand for or exercise any right with respect to the registration of any Lock-Up Securities; or</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Publicly disclose the intention to make any offer, sale, pledge or disposition, or to enter into any transaction, swap, hedge or other arrangement relating to any Lock-Up Securities.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Price Stabilization, Short Positions and Penalty Bids</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">In connection with this offering, the underwriter may engage in transactions that stabilize, maintain or otherwise affect the price of our common stock. Specifically, the underwriter may over-allot in connection with this offering by selling more securities than are set forth on the cover page of this prospectus. This creates a short position in our securities for its own account. The short position may be either a covered short position or a naked short position. In a covered short position, the number of securities over-allotted by the underwriter is not greater than the number of securities that they may purchase in the over-allotment option. In a naked short position, the number of securities involved is greater than the number of securities in the over-allotment option. To close out a short position, the underwriter may elect to exercise all or part of the over-allotment option. The underwriter may also elect to stabilize the price of our securities or reduce any short position by bidding for, and purchasing, our securities in the open market.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">62</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The underwriter may also impose a penalty bid. This occurs when a particular underwriter or dealer repays selling concessions allowed to it for distributing our securities in this offering because the underwriter repurchases our securities in stabilizing or short covering transactions.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Finally, the underwriter may bid for, and purchase, securities in market making transactions, including &#8220;passive&#8221; market making transactions as described below.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">These activities may stabilize or maintain the market price of our securities at a price that is higher than the price that might otherwise exist in the absence of these activities. The underwriter is not required to engage in these activities, and may discontinue any of these activities at any time without notice. These transactions may be effected on the national securities exchange on which our shares of common stock are traded, in the over-the-counter market, or otherwise.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Indemnification</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We have agreed to indemnify the underwriter against liabilities relating to the offering arising under the Securities Act and the Exchange Act, liabilities arising from breaches of some or all of the representations and warranties contained in the underwriting agreement, and to contribute to payments that the underwriter may be required to make for these liabilities.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Electronic Distribution</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">A prospectus in electronic format may be made available on a website maintained by the underwriter, or selling group members, if any, participating in this offering. The underwriter may agree to allocate a number of shares to selling group members for sale to their online brokerage account holders. Internet distributions will be allocated by the underwriter to selling group members that may make internet distributions on the same basis as other allocations. In connection with the offering, the underwriter may distribute prospectuses electronically.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The underwriter has informed us that it does not intend to confirm sales to accounts over which it exercises discretionary authority in excess of five percent (5%) of the total number of shares of common stock offered by it.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Other than the prospectus in electronic format, the information on any underwriter&#8217;s website and any information contained in any other website maintained by an underwriter is not part of the prospectus or the registration statement of which this prospectus is a part, has not been approved and/or endorsed by us or any underwriter in its capacity as underwriter and should not be relied upon by investors.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Selling Restrictions</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">No action has been taken in any jurisdiction (except in the United States) that would permit a public offering of our securities, or the possession, circulation or distribution of this prospectus or any other material relating to us or our securities in any jurisdiction where action for that purpose is required. Accordingly, our securities may not be offered or sold, directly or indirectly, and none of this prospectus or any other offering material or advertisements in connection with our securities may be distributed or published, in or from any country or jurisdiction, except in compliance with any applicable rules and regulations of any such country or jurisdiction.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Australia</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">This prospectus is not a disclosure document under Chapter 6D of the Australian Corporations Act, has not been lodged with the Australian Securities and Investments Commission and does not purport to include the information required of a disclosure document under Chapter 6D of the Australian Corporations Act. Accordingly, (i) the offer of the securities under this prospectus is only made to persons to whom it is lawful to offer the securities without disclosure under Chapter 6D of the Australian Corporations Act under one or more exemptions set out in section 708 of the Australian Corporations Act, (ii) this prospectus is made available in Australia only to those persons as set forth in clause (i) above, and (iii) the offeree must be sent a notice stating in substance that by accepting this offer, the offeree represents that the offeree is such a person as set forth in clause (i) above, and, unless permitted under the Australian Corporations Act, agrees not to sell or offer for sale within Australia any of the securities sold to the offeree within twelve months after its transfer to the offeree under this prospectus.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">63</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Canada</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The Securities may be sold in Canada only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in National Instrument 45-106 Prospectus Exemptions or subsection 73.3(1) of the Securities Act (Ontario) and are permitted clients, as defined in National Instrument 31-103 Registration Requirements, Exemptions and Ongoing Registrant Obligations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Any resale of the securities must be made in accordance with applicable Canadian securities laws, which require resales to be made in accordance with an exemption from, or in a transaction not subject to, the prospectus requirements of applicable securities laws.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Securities legislation in certain provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if this prospectus (including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser within the time limit prescribed by the securities legislation of the purchaser&#8217;s province or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser&#8217;s province or territory for particulars of these rights or consult with a legal advisor.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Pursuant to section 3A.3 of National Instrument 33-105 <em>Underwriting Conflicts</em> (&#8220;NI 33-105&#8221;), the underwriter is not required to comply with the disclosure requirements of N133-105 regarding underwriter conflicts of interest in connection with this offering.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>China</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The information in this document does not constitute a public offer of the securities, whether by way of sale or subscription, in the People&#8217;s Republic of China (&#8220;PRC&#8221;) (excluding, for purposes of this paragraph, Hong Kong Special Administrative Region, Macau Special Administrative Region and Taiwan). The securities may not be offered or sold directly or indirectly in the PRC to legal or natural persons other than directly to &#8220;qualified domestic institutional investors.&#8221;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>European Economic Area &#8211; Belgium, Germany, Luxembourg and Netherlands</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The information in this document has been prepared on the basis that all offers of securities will be made pursuant to an exemption under the Directive 2003/71/EC (&#8220;Prospectus Directive&#8221;), as implemented in Member States of the European Economic Area (each, a &#8220;Relevant Member State&#8221;), from the requirement to produce a prospectus for offers of securities.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">An offer to the public of securities has not been made, and may not be made, in a Relevant Member State except pursuant to one of the following exemptions under the Prospectus Directive as implemented in that Relevant Member State:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">To legal entities that are authorized or regulated to operate in the financial markets or, if not so authorized or regulated, whose corporate purpose is solely to invest in securities;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">To any legal entity that has two or more of (i) an average of at least 250 employees during its last fiscal year; (ii) a total balance sheet of more than &#8364;43,000,000 (as shown on its last annual unconsolidated or consolidated financial statements) and (iii) an annual net turnover of more than &#8364;50,000,000 (as shown on its last annual unconsolidated or consolidated financial statements);</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">To fewer than 100 natural or legal persons (other than qualified investors within the meaning of Article 2(1)(e) of the Prospectus Directive) subject to obtaining our prior consent or any underwriter for any such offer; or</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In any other circumstances falling within Article 3(2) of the Prospectus Directive, provided that no such offer of securities shall require us to publish a prospectus pursuant to Article 3 of the Prospectus Directive.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">64</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>France</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">This document is not being distributed in the context of a public offering of financial securities (offre au public de titres financiers) in France within the meaning of Article L.411-1 of the French Monetary and Financial Code (Code mon&#233;taire et financier) and Articles 211-1 et seq. of the General Regulation of the French Autorit&#233; des march&#233;s financiers (&#8220;AMF&#8221;). The securities have not been offered or sold and will not be offered or sold, directly or indirectly, to the public in France.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">This document and any other offering material relating to the securities have not been, and will not be, submitted to the AMF for approval in France and, accordingly, may not be distributed or caused to distributed, directly or indirectly, to the public in France. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Such offers, sales and distributions have been and shall only be made in France to (i) qualified investors (investisseurs qualifi&#233;s) acting for their own account, as defined in and in accordance with Articles L.411-2-II-2 and D.411-1 to D.411-3, D. 744-1, D.754-1 and D.764-1 of the French Monetary and Financial Code and any implementing regulation and/or (ii) a restricted number of non-qualified investors (cercle restreint d&#8217;investisseurs) acting for their own account, as defined in and in accordance with Articles L.411-2-II-2&#176; and D.411-4, D.744-1, D.754-1 and D.764-1 of the French Monetary and Financial Code and any implementing regulation. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Pursuant to Article 211-3 of the General Regulation of the AMF, investors in France are informed that the securities cannot be distributed (directly or indirectly) to the public by the investors otherwise than in accordance with Articles L.411-1, L.411-2, L.412-1 and L.621-8 to L.621-8-3 of the French Monetary and Financial Code.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Ireland</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The information in this document does not constitute a prospectus under any Irish laws or regulations and this document has not been filed with or approved by any Irish regulatory authority as the information has not been prepared in the context of a public offering of securities in Ireland within the meaning of the Irish Prospectus (Directive 2003/71/EC) Regulations 2005 (the &#8220;Prospectus Regulations&#8221;). The securities have not been offered or sold, and will not be offered, sold or delivered directly or indirectly in Ireland by way of a public offering, except to (i) qualified investors as defined in Regulation 2(l) of the Prospectus Regulations and (ii) fewer than 100 natural or legal persons who are not qualified investors.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Israel</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The securities offered by this prospectus have not been approved or disapproved by the Israeli Securities Authority (the ISA), or ISA, nor have such securities been registered for sale in Israel. The shares may not be offered or sold, directly or indirectly, to the public in Israel, absent the publication of a prospectus. The ISA has not issued permits, approvals or licenses in connection with this offering or publishing the prospectus; nor has it authenticated the details included herein, confirmed their reliability or completeness, or rendered an opinion as to the quality of the securities being offered. Any resale in Israel, directly or indirectly, to the public of the securities offered by this prospectus is subject to restrictions on transferability and must be effected only in compliance with the Israeli securities laws and regulations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">65</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Italy</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The offering of the securities in the Republic of Italy has not been authorized by the Italian Securities and Exchange Commission (Commissione Nazionale per le Societ&#224; e la Borsa, &#8220;CONSOB&#8221; pursuant to the Italian securities legislation and, accordingly, no offering material relating to the securities may be distributed in Italy and such securities may not be offered or sold in Italy in a public offer within the meaning of Article 1.1(t) of Legislative Decree No. 58 of 24 February 1998 (&#8220;Decree No. 58&#8221;), other than:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">To Italian qualified investors, as defined in Article 100 of Decree no. 58 by reference to Article 34-ter of CONSOB Regulation no. 11971 of 14 May 1999 (&#8220;Regulation no. 1197l&#8221;) as amended (&#8220;Qualified Investors&#8221;); and</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In other circumstances that are exempt from the rules on public offer pursuant to Article 100 of Decree No. 58 and Article 34-ter of Regulation No. 11971 as amended.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Any offer, sale or delivery of the securities or distribution of any offer document relating to the securities in Italy (excluding placements where a Qualified Investor solicits an offer from the issuer) under the paragraphs above must be: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Made by investment firms, banks or financial intermediaries permitted to conduct such activities in Italy in accordance with Legislative Decree No. 385 of 1 September 1993 (as amended), Decree No. 58, CONSOB Regulation No. 16190 of 29 October 2007 and any other applicable laws; and</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In compliance with all relevant Italian securities, tax and exchange controls and any other applicable laws.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Any subsequent distribution of the securities in Italy must be made in compliance with the public offer and prospectus requirement rules provided under Decree No. 58 and the Regulation No. 11971 as amended, unless an exception from those rules applies. Failure to comply with such rules may result in the sale of such securities being declared null and void and in the liability of the entity transferring the securities for any damages suffered by the investors.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Japan</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The securities have not been and will not be registered under Article 4, paragraph 1 of the Financial Instruments and Exchange Law of Japan (Law No. 25 of 1948), as amended (the &#8220;FIEL&#8221;) pursuant to an exemption from the registration requirements applicable to a private placement of securities to Qualified Institutional Investors (as defined in and in accordance with Article 2, paragraph 3 of the FIEL and the regulations promulgated thereunder). Accordingly, the securities may not be offered or sold, directly or indirectly, in Japan or to, or for the benefit of, any resident of Japan other than Qualified Institutional Investors. Any Qualified Institutional Investor who acquires securities may not resell them to any person in Japan that is not a Qualified Institutional Investor, and acquisition by any such person of securities is conditional upon the execution of an agreement to that effect.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>New Zealand</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The shares of common stock offered hereby have not been offered or sold, and will not be offered or sold, directly or indirectly in New Zealand and no offering materials or advertisements have been or will be distributed in relation to any offer of shares in New Zealand, in each case other than:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">To persons whose principal business is the investment of money or who, in the course of and for the purposes of their business, habitually invest money;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">To persons who in all the circumstances can properly be regarded as having been selected otherwise than as members of the public;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">To persons who are each required to pay a minimum subscription price of at least NZ$500,000 for the shares before the allotment of those shares (disregarding any amounts payable, or paid, out of money lent by the issuer or any associated person of the issuer); or</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In other circumstances where there is no contravention of the Securities Act 1978 of New Zealand (or any statutory modification or reenactment of, or statutory substitution for, the Securities Act 1978 of New Zealand).</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">66</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Portugal</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">This document is not being distributed in the context of a public offer of financial securities (oferta p&#250;blica de valores mobili&#225;rios) in Portugal, within the meaning of Article 109 of the Portuguese Securities Code (C&#243;digo dos Valores Mobili&#225;rios). The securities have not been offered or sold and will not be offered or sold, directly or indirectly, to the public in Portugal. This document and any other offering material relating to the securities have not been, and will not be, submitted to the Portuguese Securities Market Commission (Comiss&#259;o do Mercado de Valores Mobili&#225;rios) for approval in Portugal and, accordingly, may not be distributed or caused to be distributed, directly or indirectly, to the public in Portugal, other than under circumstances that are deemed not to qualify as a public offer under the Portuguese Securities Code. Such offers, sales and distributions of securities in Portugal are limited to persons who are &#8220;qualified investors&#8221; (as defined in the Portuguese Securities Code). Only such investors may receive this document and they may not distribute it or the information contained in it to any other person.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Sweden</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">This document has not been, and will not be, registered with or approved by Finansinspektionen (the Swedish Financial Supervisory Authority). Accordingly, this document may not be made available, nor may the securities be offered for sale in Sweden, other than under circumstances that are deemed not to require a prospectus under the Swedish Financial Instruments Trading Act (1991:980) (Sw. lag (1991:980) om handel med finansiella instrument). Any offering of securities in Sweden is limited to persons who are &#8220;qualified investors&#8221; (as defined in the Financial Instruments Trading Act). Only such investors may receive this document and they may not distribute it or the information contained in it to any other person.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>Switzerland</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The securities may not be publicly offered in Switzerland and will not be listed on the SIX Swiss Exchange (&#8220;SIX&#8221;) or on any other stock exchange or regulated trading facility in Switzerland. This document has been prepared without regard to the disclosure standards for issuance prospectuses under art. 652a or art. 1156 of the Swiss Code of Obligations or the disclosure standards for listing prospectuses under art. 27 ff. of the SIX Listing Rules or the listing rules of any other stock exchange or regulated trading facility in Switzerland.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Neither this document nor any other offering material relating to the securities may be publicly distributed or otherwise made publicly available in Switzerland. Neither this document nor any other offering material relating to the securities have been or will be filed with or approved by any Swiss regulatory authority. In particular, this document will not be filed with, and the offer of securities will not be supervised by, the Swiss Financial Market Supervisory Authority (FINMA). </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">This document is personal to the recipient only and not for general circulation in Switzerland.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>United Arab Emirates</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Neither this document nor the securities have been approved, disapproved or passed on in any way by the Central Bank of the United Arab Emirates or any other governmental authority in the United Arab Emirates, nor have we received authorization or licensing from the Central Bank of the United Arab Emirates or any other governmental authority in the United Arab Emirates to market or sell the securities within the United Arab Emirates. This document does not constitute and may not be used for the purpose of an offer or invitation. We may not render services relating to the securities within the United Arab Emirates, including the receipt of applications and/or the allotment or redemption of such shares.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">No offer or invitation to subscribe for securities is valid or permitted in the Dubai International Financial Centre.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">67</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><strong>United Kingdom</strong></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">Neither the information in this document nor any other document relating to the offer has been delivered for approval to the Financial Services Authority in the United Kingdom and no prospectus (within the meaning of section 85 of the Financial Services and Markets Act 2000, as amended (&#8220;FSMA&#8221;)) has been published or is intended to be published in respect of the securities. This document is issued on a confidential basis to &#8220;qualified investors&#8221; (within the meaning of section 86(7) of FSMA) in the United Kingdom, and the securities may not be offered or sold in the United Kingdom by means of this document, any accompanying letter or any other document, except in circumstances which do not require the publication of a prospectus pursuant to section 86(1) FSMA. This document should not be distributed, published or reproduced, in whole or in part, nor may its contents be disclosed by recipients to any other person in the United Kingdom.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Any invitation or inducement to engage in investment activity (within the meaning of section 21 of FSMA) received in connection with the issue or sale of the securities has only been communicated or caused to be communicated and will only be communicated or caused to be communicated in the United Kingdom in circumstances in which section 21(1) of FSMA does not apply us.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">In the United Kingdom, this document is being distributed only to, and is directed at, persons (i) who have professional experience in matters relating to investments falling within Article 19(5) (investment professionals) of the Financial Services and Markets Act 2000 (Financial Promotions) Order 2005 (&#8220;FPO&#8221;), (ii) who fall within the categories of persons referred to in Article 49(2)(a) to (d) (high net worth companies, unincorporated associations, etc.) of the FPO or (iii) to whom it may otherwise be lawfully communicated (together &#8220;relevant persons&#8221;).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The investments to which this document relates are available only to, and any invitation, offer or agreement to purchase will be engaged in only with, relevant persons. Any person who is not a relevant person should not act or rely on this document or any of its contents.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="legel">LEGAL MATTERS</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">The validity of the securities offered hereby will be passed upon for us by Womble Bond Dickinson (US) LLP, Charlotte, North Carolina. Pryor Cashman LLP, New York, New York, is acting as counsel for the underwriter in connection with this offering.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="experts">EXPERTS</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">The consolidated financial statements of 374Water Inc. and subsidiaries as of December 31, 2021, and for the year ended December 31, 2021, included in this prospectus have been audited by Cherry Bekaert LLP, independent registered public accounting firm, as stated in its report appearing in the registration statement, and are included in reliance upon the report of such firm given upon its authority as experts in accounting and auditing.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Our financial statements as of December&#160;31, 2020 and for the year then ended included in this prospectus have been audited by D. Brooks and Associates CPAs, P.A., an independent registered public accounting firm, as stated in its report appearing in the registration statement, and are included in reliance upon the report of such firm given upon its authority as experts in accounting and auditing.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="where">WHERE YOU CAN FIND MORE INFORMATION</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We have filed with the SEC a registration statement on Form&#160;S-1 under the Securities Act with respect to the securities offered by this prospectus. This prospectus, which constitutes a part of the registration statement, does not contain all of the information set forth in the registration statement, some of which is contained in exhibits to the registration statement as permitted by the rules&#160;and regulations of the SEC. For further information with respect to us and our securities, we refer you to the registration statement, including the exhibits filed as a part of the registration statement. Statements contained in this prospectus concerning the contents of any contract or any other document are not necessarily complete. If a contract or document has been filed as an exhibit to the registration statement, please see the copy of the contract or document that has been filed. Each statement in this prospectus relating to a contract or document filed as an exhibit is qualified in all respects by the filed exhibit.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">You can read our SEC filings, including the registration statement, over the Internet at the SEC&#8217;s website at <em>http://www.sec.gov</em>. We are subject to the information reporting requirements of the Exchange Act, and file annual, quarterly and special reports, proxy statements and other information with the SEC. These reports, proxy statements and other information are available for inspection on the website of the SEC referred to above. We also maintain a website at <em>www.374Water.com</em>, at which you may access these materials free of charge as soon as reasonably practicable after they are electronically filed with, or furnished to, the SEC. The information contained in, or that can be accessed through, our website is not part of, and is not incorporated into, this prospectus.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">68</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#toc">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="TOCFS">374 WATER INC. AND SUBSIDIARIES</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>CONSOLIDATED FINANCIAL STATEMENTS - TABLE OF CONTENTS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:8%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Page(s)</strong></p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Annual Consolidated Financial Statements (Audited):</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#re">Reports of Independent Registered Public Accounting Firms</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">F-1</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="#BS">Consolidated Balance Sheets at December&#160;31, 2021 and 2020</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">F-3</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="#STO">Consolidated Statements of Operations for the years ended December&#160;31, 2021 and 2020</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">F-4</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="#EQT">Consolidated Statements of Stockholders&#8217; Equity for the years ended December&#160;31, 2021 and 2020</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">F-5</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="#CF">Consolidated Statements of Cash Flows for the years ended December&#160;31, 2021 and 2020</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">F-6</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><a href="#NOTS">Notes to Consolidated Financial Statements</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">F-7</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Interim Condensed Consolidated Financial Statements (Unaudited):</strong>&#160;&#160;&#160;&#160;&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><a href="#BS1">Condensed Consolidated Balance Sheets at March 31, 2022 and 2021</a></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:8%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">F-18</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><a href="#STO1">Condensed Consolidated Statements of Operations for the three months ended March 31, 2022 and 2021</a></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">F-19</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><a href="#EQT1">Condensed Consolidated Statements of Stockholders&#8217; Equity for the three months ended March 31, 2022 and 2021</a></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">F-20</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><a href="#CF1">Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2022 and 2021</a></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">F-21</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><a href="#NOTS1">Notes to Unaudited Condensed Consolidated Financial Statements</a></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">F-22</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">69</p></td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td>&#160;</td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="re">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">To the Board of Directors and Stockholders</p><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">374Water Inc. and subsidiaries</p><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Durham, North Carolina</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Opinion on the Financial Statements</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">We have audited the accompanying consolidated balance sheet of 374Water Inc. and subsidiaries (the &#8220;Company&#8221;) as of December 31, 2021, and the related consolidated statements of operations, changes in stockholders&#8217; equity, and cash flows for the year ended December 31, 2021, and the related notes (collectively, the &#8220;financial statements&#8221;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021, and the results of its operations and its cash flows for the year ended December 31, 2021, in conformity with accounting principles generally accepted in the United States of America.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Basis for Opinion</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provided a reasonable basis for our opinion.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td colspan="2" style="width:165%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">/s/ CHERRY BEKAERT LLP</p></td></tr><tr style="height:15px"><td style="width:135%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:30%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td colspan="2" style="width:165%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">We have served as the Company&#8217;s auditor since 2021.</p></td></tr><tr style="height:15px"><td style="width:135%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:30%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td colspan="2" style="width:165%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Raleigh, North Carolina</p></td></tr><tr style="height:15px"><td style="width:135%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">March&#160;1, 2022</p></td><td></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">F-1</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#TOCFS">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px"><img src="scwo_s1img9.jpg" alt="scwo_s1img9.jpg" /></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;<strong>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">To the Board of Directors of</p><p style="font-size:10pt;font-family:times new roman;margin:0px">374Water, Inc.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Opinion on the Financial Statements</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">We have audited the accompanying balance sheets of 374Water, Inc. (the Company) as of December 31, 2020, and the related statements of operations, stockholders&#8217; deficit, and cash flows for the year ended December 31, 2020, and the related notes to the financial statements (collectively referred to as the financial statements).</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2020, and the results of its operations and its cash flows&#160;for the years ended December 31, 2020, in conformity with accounting principles generally accepted in the United States of America.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Substantial Doubt Regarding Going Concern</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the financial statements, the Company has incurred operating losses, has incurred negative cash flows from operations and has an accumulated deficit. These and other factors raise substantial doubt about the Company&#8217;s ability to continue as a going concern. Management&#8217;s plan regarding these matters is also described in Note 2 to the financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Basis for Opinion</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">We conducted our audit in accordance with the standards of the PCAOB and in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Critical Audit Matters</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">Critical audit matters are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. We determined that there were no critical audit matters.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">D. Brooks and Associates&#160;CPAs, P.A.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px"><img src="scwo_s1img8.jpg" alt="scwo_s1img8.jpg" /></p><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">We have served as the Company&#8217;s auditor since 2020.</p><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Palm Beach Gardens, Florida</p><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">March 29, 2021</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="scwo_s1img10.jpg" alt="scwo_s1img10.jpg" /></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#160;&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">F-2</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#TOCFS">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="BS">374 Water Inc. and Subsidiaries</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Consolidated Balance Sheet</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>As of December 31, 2021 and December 31, 2020</strong>&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2020</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Assets</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Current Assets:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:15px">Cash</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_2" name="us-gaap:Cash" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">11,131,175</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_3" name="us-gaap:Cash" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">71,799</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:15px">Accounts receivable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_4" name="us-gaap:AccountsReceivableNet" contextRef="AsOf2021-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_5" name="us-gaap:AccountsReceivableNet" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">31,330</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:15px">Prepaid expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_6" name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">218,466</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_7" name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2020-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:15px">Total Current Assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_8" name="us-gaap:AssetsCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">11,349,641</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_9" name="us-gaap:AssetsCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">103,129</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Long-Term Assets:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:15px">Equipment, net</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_11" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">959</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_12" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">403</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:15px">Intangible asset, net</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_13" name="us-gaap:OtherIntangibleAssetsNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,028,114</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_14" name="us-gaap:OtherIntangibleAssetsNet" contextRef="AsOf2020-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:15px">Other assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_15" name="us-gaap:OtherAssets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">34,742</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_16" name="us-gaap:OtherAssets" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">275</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:15px">Total Long-Term Assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_17" name="us-gaap:AssetsNoncurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,063,815</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_18" name="us-gaap:AssetsNoncurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">678</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Total Assets</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_19" name="us-gaap:Assets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">12,413,456</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_20" name="us-gaap:Assets" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">103,807</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Liabilities and Stockholders&#8217; Equity</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Current Liabilities:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:15px">Accounts payable and accrued expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_23" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">62,981</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_24" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">76,249</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:15px">Advances from stockholders</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_25" name="scwo:AdvancesFromStockholders" contextRef="AsOf2021-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_26" name="scwo:AdvancesFromStockholders" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">15,108</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:15px">Other liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_27" name="us-gaap:OtherLiabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">23,390</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_28" name="us-gaap:OtherLiabilities" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,200</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:15px">Total Current Liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_29" name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">86,371</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_30" name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">92,557</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Total Liabilities</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_31" name="us-gaap:Liabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">86,371</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_32" name="us-gaap:Liabilities" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">92,557</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Commitments and contingencies (Note 8) </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Stockholders&#8217; Equity</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Preferred Stock: <ix:nonFraction id="fid_801" name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">1,000,000</ix:nonFraction> Convertible Series D preferred shares authorized; par value $<ix:nonFraction id="fid_803" name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">0.0001</ix:nonFraction> per share, <ix:nonFraction id="fid_806" name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">27,272</ix:nonFraction> issued and outstanding at December 31, 2021 and nil issued and outstanding at December 31, 2020 (Liquidation Preference of $<ix:nonFraction id="fid_827" name="us-gaap:PreferredStockLiquidationPreferenceValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">409,005</ix:nonFraction>)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_35" name="us-gaap:PreferredStockValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">3</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_36" name="us-gaap:PreferredStockValue" contextRef="AsOf2020-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Common stock: <ix:nonFraction id="fid_810" name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">200,000,000</ix:nonFraction> common shares authorized, par value $<ix:nonFraction id="fid_812" name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">0.0001</ix:nonFraction> per share, <ix:nonFraction id="fid_815" name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">125,317,746</ix:nonFraction> and <ix:nonFraction id="fid_822" name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">62,410,452</ix:nonFraction> shares outstanding at December 31, 2021 and December 31, 2020, respectively</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_37" name="us-gaap:CommonStockValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">12,531</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_38" name="us-gaap:CommonStockValue" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">6,241</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Additional paid-in capital</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_39" name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">15,474,566</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_40" name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">416</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accumulated (deficit) earnings</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_41" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">3,160,015</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_42" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">4,593</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Total Stockholders&#8217; Equity</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_43" name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">12,327,085</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_44" name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">11,250</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Total Liabilities and Stockholders&#8217; Equity</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_45" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">12,413,456</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_46" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">103,807</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><em>The accompanying notes are an integral part of these consolidated financial statements.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">F-3</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#TOCFS">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="STO">374 Water Inc. and Subsidiaries</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Consolidated Statement of Operations</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>For the years ended December 31, 2021 and December 31, 2020</strong>&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;<strong>For the year ended</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2020</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_64" name="us-gaap:Revenues" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">48,100</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_65" name="us-gaap:Revenues" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">86,570</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cost of revenues</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_66" name="us-gaap:CostOfRevenue" contextRef="From2021-01-01to2021-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><ix:nonFraction id="fid_96" name="us-gaap:CostOfRevenue" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">14,241</ix:nonFraction></p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_67" name="us-gaap:GrossProfit" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">48,100</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><ix:nonFraction id="fid_97" name="us-gaap:GrossProfit" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">72,329</ix:nonFraction></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Operating Expenses</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:15px">Research and development</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_69" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">375,032</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_70" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">57,718</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:15px">Product development </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_71" name="us-gaap:ProductionCosts" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,399,833</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_72" name="us-gaap:ProductionCosts" contextRef="From2020-01-01to2020-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:15px">Professional Fees</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_73" name="us-gaap:ProfessionalFees" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">343,862</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_74" name="us-gaap:ProfessionalFees" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">8,791</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:15px">General and administrative</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_75" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,095,381</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_76" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">17,483</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total Operating Expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_77" name="us-gaap:OperatingExpenses" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">3,214,108</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_78" name="us-gaap:OperatingExpenses" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">83,992</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Loss from Operations</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>(<ix:nonFraction id="fid_79" name="us-gaap:OperatingIncomeLoss" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">3,166,008</ix:nonFraction></strong></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>(<ix:nonFraction id="fid_80" name="us-gaap:OperatingIncomeLoss" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">11,663</ix:nonFraction></strong></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Other Income</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:15px">Award income</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_82" name="scwo:AwardIncome" contextRef="From2021-01-01to2021-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_83" name="scwo:AwardIncome" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">52,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:15px">Interest income</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_84" name="us-gaap:InterestIncomeOperating" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,066</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_85" name="us-gaap:InterestIncomeOperating" contextRef="From2020-01-01to2020-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:15px">Other income</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_94" name="us-gaap:OtherIncome" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">334</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_95" name="us-gaap:OtherIncome" contextRef="From2020-01-01to2020-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px;text-indent:15px">Total Other Income</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_86" name="us-gaap:NonoperatingIncomeExpense" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,400</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_87" name="us-gaap:NonoperatingIncomeExpense" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">52,000</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Net Income (Loss) before Income Taxes</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>(<ix:nonFraction id="fid_88" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">3,164,608</ix:nonFraction></strong></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_89" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">40,337</ix:nonFraction></strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>&#160;</strong></p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Provision for Income Taxes</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_90" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-01-01to2021-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_91" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2020-01-01to2020-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Net Income (Loss)</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>(<ix:nonFraction id="fid_92" name="us-gaap:NetIncomeLoss" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">3,164,608</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_93" name="us-gaap:NetIncomeLoss" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">40,337</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>&#160;</strong></p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Net Income (Loss) per Share - Basic and Diluted</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>(<ix:nonFraction id="fid_754" name="scwo:NetLossPerShareBasicAndDiluted" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF" sign="-">0.03</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_755" name="scwo:NetLossPerShareBasicAndDiluted" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">0.00</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>&#160;</strong></p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>&#160;</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Weighted Average Common Shares Outstanding - Basic and Diluted</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_756" name="scwo:WeightedAverageCommonSharesOutstandingBasicAndDiluted" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">94,002,888</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_757" name="scwo:WeightedAverageCommonSharesOutstandingBasicAndDiluted" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">62,410,452</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><em>The accompanying notes are an integral part of these consolidated financial statements.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">F-4</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#TOCFS">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="EQT">374 Water Inc. and Subsidiaries</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Consolidated Changes in Stockholders&#8217; Equity </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>For the years ended December 31, 2021 and December 31, 2020</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Preferred Stock</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Common Stock</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Additional </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Paid-in </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Accumulated </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Total Stockholders&#8217; </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;white-space: nowrap;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;<strong>Capital</strong></p></td><td></td><td></td><td style="BORDER-BOTTOM: #000000 1px solid;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Deficit</strong></p></td><td></td><td></td><td style="BORDER-BOTTOM: #000000 1px solid;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Deficit</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balances, December 31, 2019</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_103" name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31_us-gaap_PreferredStockMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_759" name="us-gaap:SharesIssued" contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">62,410,452</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_758" name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">6,241</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_104" name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">6,241</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_105" name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">35,744</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_106" name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">35,744</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Issuance of common stock for services</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#160;&#8212;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#160;<ix:nonFraction id="fid_762" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2020-01-01to2020-12-31_us-gaap_PreferredStockMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_107" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_108" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">6,329</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_109" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_110" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">6,329</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accretion of stock-based</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_111" name="scwo:AccretionOfStockBasedCompensation" contextRef="From2020-01-01to2020-12-31_us-gaap_PreferredStockMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_760" name="scwo:AccretionOfStockBasedCompensation" contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_112" name="scwo:AccretionOfStockBasedCompensation" contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">328</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_113" name="scwo:AccretionOfStockBasedCompensation" contextRef="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_114" name="scwo:AccretionOfStockBasedCompensation" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">328</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Income</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_115" name="us-gaap:ProfitLoss" contextRef="From2020-01-01to2020-12-31_us-gaap_PreferredStockMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_761" name="us-gaap:ProfitLoss" contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_116" name="us-gaap:ProfitLoss" contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_117" name="us-gaap:ProfitLoss" contextRef="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">40,337</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_118" name="us-gaap:ProfitLoss" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">40,337</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balances, December 31, 2020</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:6%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_120" name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_PreferredStockMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_559" name="us-gaap:SharesIssued" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">62,410,452</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_560" name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">6,241</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_121" name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">416</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_122" name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">4,593</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_123" name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">11,250</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accretion of stock-based</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_124" name="scwo:AccretionOfStockBasedCompensation" contextRef="From2021-01-01to2021-12-31_us-gaap_PreferredStockMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_763" name="scwo:AccretionOfStockBasedCompensation" contextRef="From2021-01-01to2021-12-31_us-gaap_CommonStockMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_125" name="scwo:AccretionOfStockBasedCompensation" contextRef="From2021-01-01to2021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">204,217</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_126" name="scwo:AccretionOfStockBasedCompensation" contextRef="From2021-01-01to2021-12-31_us-gaap_RetainedEarningsMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_127" name="scwo:AccretionOfStockBasedCompensation" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">204,217</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Issuance of stock warrants for development of product</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_128" name="scwo:IssuanceOfStockWarrantsForDevelopmentOfProduct" contextRef="From2021-01-01to2021-12-31_us-gaap_PreferredStockMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_764" name="scwo:IssuanceOfStockWarrantsForDevelopmentOfProduct" contextRef="From2021-01-01to2021-12-31_us-gaap_CommonStockMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_129" name="scwo:IssuanceOfStockWarrantsForDevelopmentOfProduct" contextRef="From2021-01-01to2021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,399,833</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_130" name="scwo:IssuanceOfStockWarrantsForDevelopmentOfProduct" contextRef="From2021-01-01to2021-12-31_us-gaap_RetainedEarningsMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_131" name="scwo:IssuanceOfStockWarrantsForDevelopmentOfProduct" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,399,833</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Recapitalization of the Company</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#160;&#8212;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#160;<ix:nonFraction id="fid_765" name="scwo:RecapitalizationOfTheCompanyAmount" contextRef="From2021-01-01to2021-12-31_us-gaap_PreferredStockMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_132" name="scwo:RecapitalizationOfTheCompanyShares" contextRef="From2021-01-01to2021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">33,203,512</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_133" name="scwo:RecapitalizationOfTheCompanyAmount" contextRef="From2021-01-01to2021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">3,320</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_134" name="scwo:RecapitalizationOfTheCompanyAmount" contextRef="From2021-01-01to2021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">87,545</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_135" name="scwo:RecapitalizationOfTheCompanyAmount" contextRef="From2021-01-01to2021-12-31_us-gaap_RetainedEarningsMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_136" name="scwo:RecapitalizationOfTheCompanyAmount" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">84,225</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series D Preferred Stock issued for cash</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_137" name="scwo:SeriesDPreferredStockIssuedForCashShares" contextRef="From2021-01-01to2021-12-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">440,125</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_138" name="scwo:SeriesDPreferredStockIssuedForCashAmount" contextRef="From2021-01-01to2021-12-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">44</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#160;&#8212;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#160;<ix:nonFraction id="fid_766" name="scwo:SeriesDPreferredStockIssuedForCashAmount" contextRef="From2021-01-01to2021-12-31_us-gaap_CommonStockMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_139" name="scwo:SeriesDPreferredStockIssuedForCashAmount" contextRef="From2021-01-01to2021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">6,601,701</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#160;<ix:nonFraction id="fid_772" name="scwo:SeriesDPreferredStockIssuedForCashAmount" contextRef="From2021-01-01to2021-12-31_us-gaap_RetainedEarningsMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_140" name="scwo:SeriesDPreferredStockIssuedForCashAmount" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">6,601,745</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercised. Option and Warrants</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#160;&#8212;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#160;<ix:nonFraction id="fid_767" name="scwo:ExercisedOptionAndWarrantsAmount" contextRef="From2021-01-01to2021-12-31_us-gaap_PreferredStockMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_141" name="scwo:ExercisedOptionAndWarrantsShares" contextRef="From2021-01-01to2021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">4,958,833</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_142" name="scwo:ExercisedOptionAndWarrantsAmount" contextRef="From2021-01-01to2021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">496</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_143" name="scwo:ExercisedOptionAndWarrantsAmount" contextRef="From2021-01-01to2021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,284,848</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_144" name="scwo:ExercisedOptionAndWarrantsAmount" contextRef="From2021-01-01to2021-12-31_us-gaap_RetainedEarningsMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_145" name="scwo:ExercisedOptionAndWarrantsAmount" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,285,344</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Issuance of common stock for license rights</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#160;&#8212;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#160;<ix:nonFraction id="fid_768" name="scwo:IssuanceOfCommonStockForLicenseRightsAmount" contextRef="From2021-01-01to2021-12-31_us-gaap_PreferredStockMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_146" name="scwo:IssuanceOfCommonStockForLicenseRightsShares" contextRef="From2021-01-01to2021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">1,602,282</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_147" name="scwo:IssuanceOfCommonStockForLicenseRightsAmount" contextRef="From2021-01-01to2021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">160</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_148" name="scwo:IssuanceOfCommonStockForLicenseRightsAmount" contextRef="From2021-01-01to2021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,073,369</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_149" name="scwo:IssuanceOfCommonStockForLicenseRightsAmount" contextRef="From2021-01-01to2021-12-31_us-gaap_RetainedEarningsMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_150" name="scwo:IssuanceOfCommonStockForLicenseRightsAmount" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,073,529</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Conversion of convertible preferred shares into common stock</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_151" name="scwo:ConversionOfConvertiblePreferredSharesIntoCommonStockShares" contextRef="From2021-01-01to2021-12-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0" sign="-">412,853</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_152" name="scwo:ConversionOfConvertiblePreferredSharesIntoCommonStockAmount" contextRef="From2021-01-01to2021-12-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">41</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_769" name="scwo:ConversionOfConvertiblePreferredSharesIntoCommonStockShares" contextRef="From2021-01-01to2021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">20,642,667</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_770" name="scwo:ConversionOfConvertiblePreferredSharesIntoCommonStockAmount" contextRef="From2021-01-01to2021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">2,064</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_153" name="scwo:ConversionOfConvertiblePreferredSharesIntoCommonStockAmount" contextRef="From2021-01-01to2021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">2,023</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#160;<ix:nonFraction id="fid_771" name="scwo:ConversionOfConvertiblePreferredSharesIntoCommonStockAmount" contextRef="From2021-01-01to2021-12-31_us-gaap_RetainedEarningsMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_154" name="scwo:ConversionOfConvertiblePreferredSharesIntoCommonStockAmount" contextRef="From2021-01-01to2021-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Issuance of common stock</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#160;&#8212;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#160;<ix:nonFraction id="fid_773" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-01-01to2021-12-31_us-gaap_PreferredStockMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_155" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-01-01to2021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">2,500,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_156" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-01-01to2021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">250</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_157" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-01-01to2021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">4,999,750</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#160;<ix:nonFraction id="fid_774" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-01-01to2021-12-31_us-gaap_RetainedEarningsMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_158" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">5,000,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Loss</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#160;&#8212;</p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#160;<ix:nonFraction id="fid_776" name="us-gaap:NetIncomeLoss" contextRef="From2021-01-01to2021-12-31_us-gaap_PreferredStockMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#160;&#8212;</p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#160;<ix:nonFraction id="fid_775" name="us-gaap:NetIncomeLoss" contextRef="From2021-01-01to2021-12-31_us-gaap_CommonStockMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#160;<ix:nonFraction id="fid_777" name="us-gaap:NetIncomeLoss" contextRef="From2021-01-01to2021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_159" name="us-gaap:NetIncomeLoss" contextRef="From2021-01-01to2021-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">3,164,608</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_160" name="us-gaap:NetIncomeLoss" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">3,164,608</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balances, December 31, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_161" name="us-gaap:SharesIssued" contextRef="AsOf2021-12-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">27,272</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_162" name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">3</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_778" name="us-gaap:SharesIssued" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">125,317,746</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_779" name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">12,531</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_163" name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">15,474,566</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:6%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_164" name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">3,160,015</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_165" name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">12,327,085</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><em>The accompanying notes are an integral part of these consolidated financial statements.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">F-5</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#TOCFS">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="CF">374 Water Inc. and Subsidiaries </span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Consolidated Statements of Cash Flows</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>For the years ended December 31, 2021 and 2020&#160;</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>For the years ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2020</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>CASH FLOWS FROM OPERATING ACTIVITIES</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:15px">Net Loss</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_167" name="us-gaap:NetIncomeLoss" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">3,164,608</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_168" name="us-gaap:NetIncomeLoss" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">40,337</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Adjustments to reconcile net loss to net cash provided by operations:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">Depreciation and amortization expense</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_170" name="us-gaap:DepreciationAndAmortization" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">46,050</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_171" name="us-gaap:DepreciationAndAmortization" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">911</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">Stock-based compensation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_172" name="us-gaap:ShareBasedCompensation" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">204,217</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_173" name="us-gaap:ShareBasedCompensation" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">328</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">Common stock issued for services</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_174" name="scwo:AdjustmentForCommonStockIssuedForServices" contextRef="From2021-01-01to2021-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_175" name="scwo:AdjustmentForCommonStockIssuedForServices" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">6,329</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">Warrant issued for product development agreement</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_176" name="scwo:WarrantIssuedForProductDevelopmentAgreement" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,399,833</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_177" name="scwo:WarrantIssuedForProductDevelopmentAgreement" contextRef="From2020-01-01to2020-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">Changes in operating assets and liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">Accounts receivable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_179" name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">32,330</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_180" name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">31,330</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">Accounts payable and accrued expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_181" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">142,512</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_182" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">47,488</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">Prepaid expense and other assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_183" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">238,450</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#160;<ix:nonFraction id="fid_241" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="From2020-01-01to2020-12-31" format="ixt:zerodash" unitRef="USD" decimals="0" sign="-">&#8212;</ix:nonFraction></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">Other liabilities </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_184" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">22,190</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_185" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">696</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"></td><td style="width:1%;white-space: nowrap;"></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net cash (used in) provided by operating activities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_188" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">1,840,950</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><ix:nonFraction id="fid_189" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">64,759</ix:nonFraction></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>CASH FLOWS FROM INVESTING ACTIVITIES</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px;text-indent:15px">Purchase of property and equipment</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_191" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,190</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_192" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2020-01-01to2020-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px;text-indent:15px">Proceeds from reverse acquisition</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_193" name="scwo:ProceedsFromReverseAcquisition" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">113,760</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_194" name="scwo:ProceedsFromReverseAcquisition" contextRef="From2020-01-01to2020-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px;text-indent:15px">Increase in other assets acquisition</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><ix:nonFraction id="fid_195" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" contextRef="From2021-01-01to2021-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_240" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">275</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">Recapitalization of the Company</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">(<ix:nonFraction id="fid_186" name="us-gaap:PaymentsOfCapitalDistribution" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">84,225</ix:nonFraction></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">)</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><ix:nonFraction id="fid_187" name="us-gaap:PaymentsOfCapitalDistribution" contextRef="From2020-01-01to2020-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net cash used in&#160;investing activities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_196" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">28,345</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_197" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">275</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>CASH FLOWS FROM FINANCING ACTIVITIES</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:15px">Advances from Stockholders</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_199" name="us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">15,108</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_200" name="us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">2,052</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:15px">Proceeds from Series D Preferred Shares</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_201" name="us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">6,601,745</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_202" name="us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" contextRef="From2020-01-01to2020-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:15px">Proceeds from Common Stock Offering</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_203" name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">5,000,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_204" name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2020-01-01to2020-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:15px">Proceeds from exercise of Options</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_205" name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">42,845</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><ix:nonFraction id="fid_206" name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2020-01-01to2020-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:15px">Proceeds from exercise of Warrants</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_238" name="us-gaap:ProceedsFromWarrantExercises" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,242,499</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_239" name="us-gaap:ProceedsFromWarrantExercises" contextRef="From2020-01-01to2020-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net cash provided by financing activities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_207" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">12,871,981</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_208" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">2,052</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">NET INCREASE IN CASH</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_209" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">11,059,376</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_210" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">66,536</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">CASH - Beginning of year</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_607" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">71,799</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_783" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">5,263</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">CASH - End of year</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_784" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">11,131,175</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_785" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">71,799</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>SUPPLEMENTAL CASH FLOW DISCLOSURES:</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash paid for interest</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_216" name="us-gaap:InterestPaidNet" contextRef="From2021-01-01to2021-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_217" name="us-gaap:InterestPaidNet" contextRef="From2020-01-01to2020-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash paid for taxes</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_218" name="us-gaap:RepaymentsOfDebt" contextRef="From2021-01-01to2021-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_219" name="us-gaap:RepaymentsOfDebt" contextRef="From2020-01-01to2020-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>NON-CASH INVESTING AND FINANCING ACTIVITIES:</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Issuance of common stock for license rights</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_221" name="scwo:IssuanceOfCommonStockForLicenseRights" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,073,529</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_222" name="scwo:IssuanceOfCommonStockForLicenseRights" contextRef="From2020-01-01to2020-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accounts payable settled with Series D Preferred Stock</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_223" name="scwo:AccountsPayableSettledWithStockOption" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">50,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_224" name="scwo:AccountsPayableSettledWithStockOption" contextRef="From2020-01-01to2020-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Liabilities Assumed in Reverse Acquisition:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 30px">Cash</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_226" name="scwo:NetLiabilitiesAssumedInReverseAcquisitioncash" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">29,536</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_227" name="scwo:NetLiabilitiesAssumedInReverseAcquisitioncash" contextRef="From2020-01-01to2020-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 30px">Prepaid expense</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_228" name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">14,483</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_229" name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2020-01-01to2020-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 30px">Accounts receivable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_230" name="us-gaap:AccountsReceivableSale" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_231" name="us-gaap:AccountsReceivableSale" contextRef="From2020-01-01to2020-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 30px">Accounts payable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_232" name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">46,150</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_233" name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2020-01-01to2020-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 30px">Accrued expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_234" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">83,094</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_235" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="From2020-01-01to2020-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 30px">Net liability assumed</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_236" name="scwo:NetLiabilityAssumed" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">84,225</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_237" name="scwo:NetLiabilityAssumed" contextRef="From2020-01-01to2020-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><em>The accompanying notes are an integral part of these consolidated financial statements. </em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><em>&#160;</em></p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">F-6</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#TOCFS">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="NOTS">374 Water Inc. and Subsidiaries </span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>For the Years Ended December 31, 2021 and 2020</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Notes to Consolidated Financial Statements</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><ix:nonNumeric id="fid_242" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" contextRef="From2021-01-01to2021-12-31" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong>Note 1 &#8211; Nature of Business</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">374Water, Inc., f/k/a PowerVerde, Inc. (the &#8220;Company&#8221;) is a Delaware corporation incorporated on September 8, 2005. The Company was formed to develop, commercialize, and market a series of unique electric generating power systems designed to produce electrical power with zero emissions or waste byproducts, based on a patented pressure-driven expander motor and related organic rankine cycle technology.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">On April 16, 2021, 374Water Inc. (f/k/a PowerVerde, Inc.) entered into an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;) with 374Water, Inc., a privately held company based in Durham, North Carolina, (&#8220;374Water&#8221;) and 374Water Acquisition Corp., a newly-formed wholly-owned subsidiary of PowerVerde (&#8220;Sub&#8221;). The parties entered into the Agreement pursuant to their Binding Letter of Intent dated September 20, 2020.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Pursuant to the merger contemplated by the Merger Agreement (the &#8220;Merger&#8221;), on April 16, 2021, Sub merged into 374Water, with 374Water as the surviving corporation. In connection with the Merger, all 374Water shares were cancelled and 374Water, Inc. issued to the former 374Water shareholders a total of <ix:nonFraction id="fid_275" name="scwo:SharesIssuedToFormerHolder" contextRef="AsOf2021-04-16" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">62,410,452</ix:nonFraction> shares of 374Water, Inc. common stock. <ix:nonNumeric id="fid_276" name="scwo:MergerEffectDescription" contextRef="From2021-04-01to2021-04-16">Immediately following the Merger, 374Water changed its name to 374Water Systems Inc and PowerVerde changed its name to 374Water, Inc. After the Merger, the former 374Water stockholders own 65.8% of 374Water Inc&#8217;s issued and outstanding common stock and 53.8% of 374Water Inc.&#8217;s issued and outstanding voting stock which includes the Preferred Stock.</ix:nonNumeric> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">With the Merger, 374Water Inc.&#8217;s current mission is to support a clean and healthy environment to sustain life. The Company plans to use what is believes to be cutting-edge science to recover resources from the waste our society generates and keep drinking water clean. The Company&#8217;s customers will include businesses and local governments that will make the sustainable development goals a reality. No material revenues from this planned principal operation have been generated since inception. Revenues to date have been from manufacturing assembly services and from testing, consulting, and advisory services procedures for multiple customers, which have been performed in collaboration with Duke University.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160; </p><ix:nonNumeric id="fid_243" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" contextRef="From2021-01-01to2021-12-31" escape="true" continuedAt="cont_b32d5b"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong>Note 2 &#8211; Summary of Significant Accounting Policies&#160; </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><span style="text-decoration:underline">Cash and Cash Equivalents</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><ix:nonNumeric id="fid_252" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" contextRef="From2021-01-01to2021-12-31" escape="true">The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. The Company held <ix:nonFraction id="fid_285" name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="AsOf2021-12-31" format="ixt-sec:numwordsen" unitRef="USD" decimals="0">no</ix:nonFraction> cash equivalents as of December 31, 2021 and 2020.</ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><span style="text-decoration:underline">Concentration of Credit Risk </span></p><ix:nonNumeric id="fid_253" name="us-gaap:ConcentrationRiskDisclosureTextBlock" contextRef="From2021-01-01to2021-12-31" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Financial instruments that potentially subject the Company to credit risk consist of cash and cash equivalents. Deposits with financial institutions are insured, up to certain limits, by the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;). The Company&#8217;s cash deposits often exceed the FDIC insurance limit; however, all deposits are maintained with high credit quality institutions and the Company has not experienced any losses in such accounts. The financial condition of financial institutions is periodically reassessed, and the Company believes the risk of any loss is minimal. The Company believes the risk of any loss on cash due to credit risk is minimal.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><span style="text-decoration:underline">Accounts Receivable </span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><ix:nonNumeric id="fid_254" name="us-gaap:ReceivablesPolicyTextBlock" contextRef="From2021-01-01to2021-12-31" escape="true">Accounts receivables consist of balances due from service revenues. The Company monitors accounts receivable and provides allowances when considered necessary. At December 31, 2021 and 2020, accounts receivable were considered to be fully collectible. Accordingly, <ix:nonFraction id="fid_277" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="AsOf2021-12-31" format="ixt-sec:numwordsen" unitRef="USD" decimals="0">no</ix:nonFraction> allowance for doubtful accounts was provided and there was no bad debt expense as of December 31, 2021 and 2020. </ix:nonNumeric></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">F-7</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#TOCFS">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:continuation id="cont_b32d5b" continuedAt="cont_1cc37c"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><span style="text-decoration:underline">Equipment</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><ix:nonNumeric id="fid_255" name="scwo:EquipmentPolicy" contextRef="From2021-01-01to2021-12-31" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Equipment is recorded at cost. Depreciation is computed using the straight-line method and an estimated useful life of three years. Expenses for maintenance and repairs are charged to expense as incurred.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><span style="text-decoration:underline">Intangible Assets</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><ix:nonNumeric id="fid_256" name="us-gaap:IntangibleAssetsFiniteLivedPolicy" contextRef="From2021-01-01to2021-12-31" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Intangible assets are subject to amortization, and any impairment is determined in accordance with ASC 360, &#8220;Property, Plant, and Equipment.&#8221; Intangible assets are stated at historical cost and amortized over their estimated useful lives. The Company uses a straight-line method of amortization, unless a method that better reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up can be reliably determined.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><span style="text-decoration:underline">Long-Lived Assets</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><ix:nonNumeric id="fid_257" name="scwo:LongLivedAssetsPolicy" contextRef="From2021-01-01to2021-12-31" escape="true">The Company reviews long-lived assets, including intangible assets with finite lives, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company uses an estimate of the undiscounted cash flows over the remaining life of its long-lived assets, or related group of assets where applicable, in measuring whether the assets to be held and used will be realizable. Recoverability of assets held and used is measured by a comparison of the carrying amount to the future undiscounted expected net cash flows to be generated by the asset. As of December 31, 2021 and 2020, there were <ix:nonFraction id="fid_278" name="us-gaap:GoodwillImpairmentLoss" contextRef="From2021-01-01to2021-12-31" format="ixt-sec:numwordsen" unitRef="USD" decimals="0">no</ix:nonFraction> impairments.</ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><span style="text-decoration:underline">Revenue Recognition and Concentration</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><ix:nonNumeric id="fid_258" name="scwo:RevenueRecognitionAndConcentrationPolicy" contextRef="From2021-01-01to2021-12-31" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">The Company follows the revenue standards of Financial Accounting Standards Board Update No. 2014-09: &#8220;Revenue from Contracts with Customers (Topic 606).&#8221; The core principle of this Topic is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Revenue is recognized in accordance with that core principle by applying the following five steps: 1) identify the contracts with a customer; 2) identify the performance obligations in the contract; 3) determine the transaction price; 4) allocate the transaction price to the performance obligations; and 5) recognize revenue when (or as) we satisfy a performance obligation.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">The Company&#8217;s performance obligations will be satisfied at the point in time when products are shipped or delivered to the customer, which is when the customer has title and the significant risks and rewards of ownership. Therefore, the Company&#8217;s contracts will have a single performance obligation (shipment or delivery of product). The Company will primarily receive fixed consideration for sales of product. Manufacturing assembly services are recognized as revenue when the assembled product is delivered to the customer and the Company has completed its performance obligations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Revenues for the year ended December 31, 2021 were generated from consulting and advisory service agreements, which were recognized when the Company completed its performance obligations under the relevant service agreements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">During the year ended December 31, 2020, 100% of the Company&#8217;s revenues were earned from consulting and advisory services, which were recognized when the Company performed the service pursuant to its agreement with its clients which was the point in time when the Company completed its performance obligations under the agreements. One customer accounted for approximately 88% of revenues in 2020 and 92% of accounts receivable at December 31, 2020. Revenues generated in 2020 were not from the Company&#8217;s planned operations. </p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><span style="text-decoration:underline">Stock-based Compensation</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><ix:nonNumeric id="fid_259" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" contextRef="From2021-01-01to2021-12-31" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">The Company has accounted for stock-based compensation under the provisions of Accounting Standards Codification (ASC) Topic 718 &#8211; &#8220;Stock Compensation&#8221; which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments (stock options and common stock purchase warrants). The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate. Expected volatilities are based on historical volatility of peer companies and other factors estimated over the expected term of the stock options. The expected term of options granted is derived using the &#8220;simplified method&#8221; which computes expected term as the average of the sum of the vesting term plus the contract term. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term.</p></ix:nonNumeric></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">F-8</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#TOCFS">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:continuation id="cont_1cc37c" continuedAt="cont_22bb2e"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><span style="text-decoration:underline">Accounting for Uncertainty in Income Taxes</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><ix:nonNumeric id="fid_260" name="us-gaap:IncomeTaxUncertaintiesPolicy" contextRef="From2021-01-01to2021-12-31" escape="true">The Company follows the provisions of ASC Topic 740-10, &#8220;Accounting for Uncertainty in Income Taxes&#8221; which clarifies the accounting for uncertainty in income taxes recognized in an enterprise&#8217;s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This topic also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. There were <ix:nonFraction id="fid_280" name="us-gaap:UnrecognizedTaxBenefits" contextRef="AsOf2021-12-31" format="ixt-sec:numwordsen" unitRef="USD" decimals="0">no</ix:nonFraction> uncertain tax positions as of December 31, 2021 and 2020.</ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><span style="text-decoration:underline">Income Tax Policy</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><span style="text-decoration:underline"></span>&#160;</p><ix:nonNumeric id="fid_261" name="us-gaap:IncomeTaxPolicyTextBlock" contextRef="From2021-01-01to2021-12-31" escape="true">The Company accounts for income taxes using the liability method prescribed by ASC 740 - Income Taxes. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets if, based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the period that includes the enactment date.</ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><span style="text-decoration:underline">Research and Development Costs</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><ix:nonNumeric id="fid_262" name="us-gaap:ResearchAndDevelopmentExpensePolicy" contextRef="From2021-01-01to2021-12-31" escape="true">The Company&#8217;s research and development costs are expensed in the period in which they are incurred. Such expenditures amounted to $<ix:nonFraction id="fid_281" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">375,032</ix:nonFraction> and $<ix:nonFraction id="fid_282" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2020-01-01to2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">57,718</ix:nonFraction> for the years ended December 31, 2021 and 2020, respectively. </ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><span style="text-decoration:underline">Earnings (Loss) Per Share</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><ix:nonNumeric id="fid_263" name="us-gaap:EarningsPerSharePolicyTextBlock" contextRef="From2021-01-01to2021-12-31" escape="true">Earnings (loss) per share is computed in accordance with FASB ASC Topic 260, &#8220;Earnings per Share&#8221;. Diluted earnings per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities outstanding during the period. Certain common stock equivalents were not included in the earnings (loss) per share calculation as their effect would be anti-dilutive. As of December 31, 2021, there were the following potentially dilutive securities that were excluded from diluted net loss per share because their effect would be antidilutive: options for <ix:nonFraction id="fid_283" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2021-01-01to2021-12-31_scwo_WarrantsMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">12,596,000</ix:nonFraction> shares of common stock and <ix:nonFraction id="fid_284" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2020-01-01to2020-12-31_scwo_WarrantsMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">1,363,350</ix:nonFraction> common stock shares issuable upon conversion of the Series D Preferred Stock. There were no dilutive shares as of December 31, 2020.</ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><span style="text-decoration:underline">Financial Instruments</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><ix:nonNumeric id="fid_264" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" contextRef="From2021-01-01to2021-12-31" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">The Company carries cash, accounts receivable, accounts payable and accrued expenses, at historical costs. The respective estimated fair values of these assets and liabilities approximate carrying values / useful lives of equipment and intangible assets due to their current nature.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><span style="text-decoration:underline">Use of Estimates</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><ix:nonNumeric id="fid_265" name="us-gaap:UseOfEstimates" contextRef="From2021-01-01to2021-12-31" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates in the accompanying financial statements include the fair value of equity-based compensation, fair value of intangible assets, useful lives of intangible assets, capital raise transactions, and valuation allowance against deferred tax assets.</p></ix:nonNumeric></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">F-9</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#TOCFS">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:continuation id="cont_22bb2e"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><span style="text-decoration:underline">Recent Accounting Pronouncements</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><ix:nonNumeric id="fid_266" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" contextRef="From2021-01-01to2021-12-31" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">In August 2020, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2020-06, Debt &#8212; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#8212; Contracts in Entity&#8217;s Own Equity (Subtopic 815-40) (&#8220;ASU 2020-06&#8221;) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity&#8217;s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity&#8217;s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company notes that there will be no effect on the current financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">There are several other new accounting pronouncements issued or proposed by the FASB. Each of these pronouncements, as applicable, has been or will be adopted by the Company. Management does not believe any of these accounting pronouncements has had or will have a material impact on the Company&#8217;s condensed consolidated financial position, operating results, or cash flows.&#160;</p></ix:nonNumeric></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_244" name="us-gaap:SubstantialDoubtAboutGoingConcernTextBlock" contextRef="From2021-01-01to2021-12-31" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong>Note 3 &#8211; Liquidity, Capital Resources</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">As of December 31, 2021, the Company had working capital of $<ix:nonFraction id="fid_289" name="scwo:WorkingCapital" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">11,263,270</ix:nonFraction> compared to working capital of $<ix:nonFraction id="fid_290" name="scwo:WorkingCapital" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">10,572</ix:nonFraction> at December 31, 2020. This significant increase in working capital is due primarily to the increase in cash over the twelve-month period is based on the Company&#8217;s sale and issuance of Series D Convertible Preferred Stock (&#8220;Preferred Stock&#8221;) and the proceeds for the exercise of warrants (see Note 4 and Note 6). During the second quarter of 2021, in connection with the Merger (described in Note 4 below), the Company received gross proceeds of $<ix:nonFraction id="fid_291" name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">6,551,745</ix:nonFraction> from the sale of Series D Convertible Preferred Stock. During the fourth quarter of 2021, the Company received gross proceeds of $<ix:nonFraction id="fid_292" name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" contextRef="From2021-01-01to2021-06-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">5,000,000</ix:nonFraction> from the sale of Common Stock (see Note 6). As of December 31, 2021, the Company has an accumulated deficit of $<ix:nonFraction id="fid_293" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">3,160,015</ix:nonFraction>. For the year ended December 31, 2021, the Company had a net loss of $<ix:nonFraction id="fid_797" name="us-gaap:NetIncomeLoss" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">3,164,608</ix:nonFraction> and $<ix:nonFraction id="fid_295" name="scwo:NetCashProvidedByUsedInOperatingActivity" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,840,950</ix:nonFraction> of net cash used in operations for the period.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">The Company believes that the capital raised from the sale of Common and Preferred Stock and proceeds from conversion of warrants will provide sufficient cash flow for the Company to meet its financial obligations as they come due for at least the next 12 months. </p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_245" name="us-gaap:BusinessCombinationDisclosureTextBlock" contextRef="From2021-01-01to2021-12-31" escape="true" continuedAt="cont_067a8f"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong>Note 4 &#8211; Acquisition of 374Water, Inc. f/k/a PowerVerde Inc. </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">In connection with the Merger,&#160;374Water&#160;closed on a private placement of <ix:nonFraction id="fid_308" name="us-gaap:PartnersCapitalAccountUnitsSoldInPrivatePlacement" contextRef="From2021-01-01to2021-12-31_us-gaap_SeriesDPreferredStockMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">436,783</ix:nonFraction> shares of Series D Convertible Preferred Stock (the &#8220;Preferred Stock&#8221;) with a par value of $<ix:nonFraction id="fid_306" name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2021-12-31_us-gaap_SeriesDPreferredStockMember" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">0.0001</ix:nonFraction>, yielding gross proceeds of $<ix:nonFraction id="fid_307" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-01-01to2021-12-31_us-gaap_SeriesDPreferredStockMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">6,551,745</ix:nonFraction> (the &#8220;Private Placement&#8221;) and the settlement of a $<ix:nonFraction id="fid_309" name="scwo:SettlementOfLiabilityForPreferredStockShares" contextRef="From2021-01-01to2021-12-31_us-gaap_SeriesDPreferredStockMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">50,000</ix:nonFraction> liability for Preferred Stock shares. The Private Placement proceeds will be used for working capital, primarily for development, manufacture and commercialization of 374Water Inc.&#8217;s Air SCWO Nix systems. The Preferred Stock has a stated value of $15 per share, is convertible into common stock at $.30 per share and has voting rights based on the underlying shares of common stock. Upon liquidation of the Company, the Preferred Stockholders have liquidation preference before any assets can be distributed to common stockholders. All of the Preferred Stock was sold pursuant to an exemption from registration requirements under Regulation D and/or Section 4(2) of the Securities Act of 1933, as amended.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">As a result of the Merger, the issuance of the Preferred Stock, <ix:nonNumeric id="fid_311" name="scwo:Description" contextRef="From2021-01-01to2021-12-31_us-gaap_SeriesDPreferredStockMember">the former 374Water shareholders own 65.8% of 374Water Inc&#8217;s issued and outstanding common stock and 53.8% of 374Water Inc.&#8217;s issued and outstanding voting stock</ix:nonNumeric> (which includes the Preferred Stock on an as converted basis).</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">F-10</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#TOCFS">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:continuation id="cont_067a8f"><p style="font-size:10pt;font-family:times new roman;margin:0px">Also as a result of the Merger, 374Water Inc. entered into two-year employment agreements with 374Water founders Yaacov (Kobe) Nagar and Marc Deshusses, Ph. D. Mr. Nagar will serve as the Company&#8217;s CEO, replacing Richard H. Davis, who resigned upon closing of the Merger. Mr. Nagar will receive an annual salary of $<ix:nonFraction id="fid_312" name="us-gaap:SalariesAndWages" contextRef="From2021-01-01to2021-12-31_scwo_MrNagarMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">200,000</ix:nonFraction>. Dr. Deshusses will serve as the Company&#8217;s Head of Technology on a part-time basis at a salary of $<ix:nonFraction id="fid_310" name="us-gaap:SalariesAndWages" contextRef="From2021-01-01to2021-12-31_srt_ChiefExecutiveOfficerMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">60,000</ix:nonFraction> per year. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Pursuant to the Merger, Messrs. Nagar and Deshusses were appointed to the Company&#8217;s Board of Directors, joining Mr. Davis, who remains as a Director.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">The patented technology underlying 374Water&#8217;s supercritical water oxidation (SCWO) units, which was developed principally through the efforts of Messrs. Nagar and Deshusses at the facilities of Duke University, Durham, North Carolina (&#8220;Duke&#8221;), where Dr. Deshusses is a professor, is licensed to 374Water pursuant to a worldwide license agreement with Duke executed on April 16, 2021 (the &#8220;License Agreement&#8221;) simultaneous with the merger. In connection with the License Agreement, 374Water also executed an equity transfer Agreement with Duke pursuant to which Duke received a small block of shares of common stock (see Note 5).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">As a result of the Merger Agreement, for financial statement reporting purposes, the business combination between 374Water Inc. and PowerVerde, Inc. was treated as a reverse acquisition and recapitalization for accounting purposes with 374Water, Inc. deemed the accounting acquirer and PowerVerde, Inc. deemed the accounting acquiree under the acquisition method of accounting in accordance with FASB Accounting Standards Codification (&#8220;ASC&#8221;) Section 805-10-55.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><span style="text-decoration:underline">The following assets and liabilities were assumed in the transaction:</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><ix:nonNumeric id="fid_267" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" contextRef="From2021-01-01to2021-12-31" escape="true"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_298" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" contextRef="AsOf2021-12-31_scwo_ThreeSevenFourWaterMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">29,536</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Prepaid expense</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_297" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" contextRef="AsOf2021-12-31_scwo_ThreeSevenFourWaterMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">14,483</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accounts Receivable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_299" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" contextRef="AsOf2021-12-31_scwo_ThreeSevenFourWaterMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,000</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total assets acquired</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_300" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" contextRef="AsOf2021-12-31_scwo_ThreeSevenFourWaterMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">45,019</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accounts payable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_301" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" contextRef="AsOf2021-12-31_scwo_ThreeSevenFourWaterMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">46,150</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accrued expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_302" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" contextRef="AsOf2021-12-31_scwo_ThreeSevenFourWaterMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">83,094</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total liabilities assumed</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_303" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" contextRef="AsOf2021-12-31_scwo_ThreeSevenFourWaterMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">129,244</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net liabilities assumed</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_304" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" contextRef="AsOf2021-12-31_scwo_ThreeSevenFourWaterMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">84,225</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr></tbody></table></ix:nonNumeric></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_246" name="us-gaap:IntangibleAssetsDisclosureTextBlock" contextRef="From2021-01-01to2021-12-31" escape="true" continuedAt="cont_e42cb0"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong>Note 5 &#8211; Intangible Assets</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Intangible assets are recorded at cost and consist of the license agreement with Duke University. The Company issued Duke University a small block of shares of common stock estimated to have a fair value of $<ix:nonFraction id="fid_331" name="us-gaap:CommonStockValue" contextRef="AsOf2021-12-31_scwo_LicenseAgreementMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,073,529</ix:nonFraction> as consideration for granting the Company the license based on the Company&#8217;s common stock market price on the date the license agreement was executed (see Note 8). Intangible assets are comprised of the following as of December 31, 2021 and 2020:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><ix:nonNumeric id="fid_268" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" contextRef="From2021-01-01to2021-12-31" escape="true"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Name</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Estimated Life</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Balance at</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, 2020</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Additions</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Amortization</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Balance at</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, 2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">License agreement</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">17 Years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_320" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2020-12-31_scwo_LicenseAgreementMember" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_313" name="scwo:IntangibleAssetsAdditions" contextRef="AsOf2021-12-31_scwo_LicenseAgreementMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,073,529</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_314" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2021-12-31_scwo_LicenseAgreementMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">45,415</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_316" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2021-12-31_scwo_LicenseAgreementMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,028,114</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Patents</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">20 Years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_321" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2020-12-31_us-gaap_PatentsMember" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_318" name="scwo:IntangibleAssetsAdditions" contextRef="AsOf2021-12-31_us-gaap_PatentsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">34,741</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_317" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2021-12-31_us-gaap_PatentsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">34,741</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Total</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,108,270</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_314-0f08b8" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">45,415</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_315" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,062,855</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table></ix:nonNumeric></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">F-11</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#TOCFS">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:continuation id="cont_e42cb0"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Amortization expense for the year ended December 31, 2021 was $<ix:nonFraction id="fid_332" name="us-gaap:AdjustmentForAmortization" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">45,415</ix:nonFraction>. There is no amortization expense associated with the patent expenses. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Estimated future amortization expense as of December 31, 2021:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><ix:nonNumeric id="fid_786" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" contextRef="From2021-01-01to2021-12-31" escape="true"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2022 </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_324" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">63,149</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_325" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">63,149</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_326" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">63,149</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2025</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_327" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">63,149</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2026</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_328" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">63,149</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Thereafter</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_329" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">712,369</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Intangible assets, Net</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_330" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,028,114</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table></ix:nonNumeric></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_247" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" contextRef="From2021-01-01to2021-12-31" escape="true" continuedAt="cont_614d17"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong>Note 6 &#8211; Stockholder&#8217; Equity</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">The Company is authorized to issue <ix:nonFraction id="fid_385" name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">1,000,000</ix:nonFraction> preferred stock shares and <ix:nonFraction id="fid_386" name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">200,000,000</ix:nonFraction> common stock shares both with a par value of $0.0001.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong>Preferred Stock</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">On October 30, 2020, the Company designated <ix:nonFraction id="fid_387" name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2020-10-30_us-gaap_SeriesDPreferredStockMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">1,000,000</ix:nonFraction> shares as Series D Convertible Preferred Stock with a par value of $<ix:nonFraction id="fid_427" name="scwo:Preferredstockparorstatedvaluepershare" contextRef="AsOf2020-10-30_us-gaap_SeriesDPreferredStockMember" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">0.0001</ix:nonFraction>.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">On April 16, 2021, the Company closed on a private placement of <ix:nonFraction id="fid_388" name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2021-04-16" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">436,782</ix:nonFraction> shares of Series D Convertible Preferred Stock (the &#8220;Preferred Stock&#8221;) with a par value of $.0001, yielding gross proceeds of $<ix:nonFraction id="fid_389" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">6,551,691</ix:nonFraction> (the &#8220;Private Placement&#8221;) and settlement of a $<ix:nonFraction id="fid_390" name="scwo:LiabilityForPreferredStockShares" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">50,000</ix:nonFraction> liability for Preferred Stock shares. The Private Placement proceeds will be used for working capital, primarily for the development, manufacturing and commercialization of 374Water&#8217;s Air SCWO Nix systems. The Preferred Stock has a stated value of $<ix:nonFraction id="fid_391" name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2021-04-16_scwo_ThreeSevenFourWaterMember" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">15</ix:nonFraction> per share, is convertible into common stock at $<ix:nonFraction id="fid_392" name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-04-16_scwo_ThreeSevenFourWaterMember" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">0.30</ix:nonFraction> per share and has voting rights based on the underlying shares of common stock. Upon liquidation of the Company, the Preferred Stockholders have a liquidation preference before any assets can be distributed to common stockholders. The current liquidation value is $<ix:nonFraction id="fid_393" name="us-gaap:PreferredStockLiquidationPreferenceValue" contextRef="AsOf2021-04-16_scwo_ThreeSevenFourWaterMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">409,005</ix:nonFraction>. All of the Preferred Stock were sold pursuant to an exemption from registration requirements under Regulation D and/or Section 4(2) of the Securities Act of 1933, as amended. On September 30, 2021, <ix:nonFraction id="fid_409" name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-09-30_us-gaap_SeriesDPreferredStockMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">412,853</ix:nonFraction> shares of Series D Preferred stock were converted into <ix:nonFraction id="fid_394" name="us-gaap:PreferredStockConvertibleSharesIssuable" contextRef="AsOf2021-09-30_us-gaap_SeriesDPreferredStockMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">20,642,667</ix:nonFraction> shares of common stock. As of December 31, 2021, there were <ix:nonFraction id="fid_408" name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2021-12-31_us-gaap_SeriesDPreferredStockMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">27,272</ix:nonFraction> shares of Series D Preferred stock issued and outstanding.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong>Common Stock</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">The holders of common stock are entitled to one vote per share on all matters submitted to a vote of shareholders, including the directors&#8217; election. There is no right to cumulate votes in the election of directors. The holders of common stock are entitled to any dividends that may be declared by the board of directors out of funds legally available for payment of dividends subject to the prior rights of holders of preferred stock and any contractual restrictions the Company has against the payment of dividends on common stock. In the event of our liquidation or dissolution, holders of common stock are entitled to share ratably in all assets remaining after payment of liabilities and the liquidation preferences of any outstanding shares of preferred stock. Holders of common stock have no preemptive rights and have no right to convert their common stock into any other securities. As of December 31, 2021, there were <ix:nonFraction id="fid_396" name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-12-31_scwo_ThreeSevenFourWaterMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">125,317,746</ix:nonFraction> shares of common stock issued and outstanding.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">On April 16, 2021, as a result of the closing of the Merger Agreement (see Note 4), the equity of the consolidated entity is the historical equity of 374Water, Inc (&#8220;374Water&#8221;) retroactively restated to reflect the number of shares issued by the Company in the reverse recapitalization.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">In connection with the Merger, <ix:nonFraction id="fid_397" name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-04-16" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">33,203,512</ix:nonFraction> shares of common stock were issued to 374Water, Inc. (f/k/a PowerVerde, Inc.) stockholders.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">F-12</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#TOCFS">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:continuation id="cont_614d17" continuedAt="cont_0c9f9c"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Pursuant to the Merger, all 374Water shares were cancelled and 374Water, Inc. issued to the former 374Water stockholders a total of <ix:nonFraction id="fid_398" name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-04-16_scwo_ThreeSeverFourWaterFormerStockholdersMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">62,410,452</ix:nonFraction> shares of 374Water, Inc. common stock. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">On April 16, 2021, the Company issued&#160;Common Stock estimated to have a fair value of $<ix:nonFraction id="fid_400" name="us-gaap:CommonStockValue" contextRef="AsOf2021-04-16_us-gaap_PatentsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,073,369</ix:nonFraction> as consideration for the grant of a license to the Company (see Notes 5 and 8).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">In December 2021, the Company raised $<ix:nonFraction id="fid_403" name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">5,000,000</ix:nonFraction> through a private placement and sale of <ix:nonFraction id="fid_404" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">2,500,000</ix:nonFraction> shares of Common Stock which were issued to investees as part of the capital raise. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">During the year ended December 31, 2021, the Company issued <ix:nonFraction id="fid_405" name="scwo:CommonStockSharesIssuesForCash" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">4,958,833</ix:nonFraction> shares of common stock, in connection with the exercise of warrants and options and received cash proceeds of $<ix:nonFraction id="fid_406" name="us-gaap:ShareBasedCompensation" contextRef="From2021-01-01to2021-12-31_scwo_WarrantsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,284,848</ix:nonFraction>.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><span style="text-decoration:underline">Stock-based compensation</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">During the year ended December 31, 2021 and 2020, the Company recorded stock-based compensation of $<ix:nonFraction id="fid_414" name="us-gaap:ShareBasedCompensation" contextRef="From2021-01-01to2021-12-31_scwo_ConsultantMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">204,217</ix:nonFraction> and $<ix:nonFraction id="fid_415" name="us-gaap:ShareBasedCompensation" contextRef="From2020-01-01to2020-12-31_scwo_ConsultantMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">6,657</ix:nonFraction>, respectively, related to common stock issued or vested options to employees and various consultants of the Company, of which $<ix:nonFraction id="fid_410" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2021-01-01to2021-12-31_scwo_ConsultantMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">190,136</ix:nonFraction> and $<ix:nonFraction id="fid_411" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2020-01-01to2020-12-31_scwo_ConsultantMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">328</ix:nonFraction> was charged as general and administrative expenses and $<ix:nonFraction id="fid_412" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2021-01-01to2021-12-31_scwo_ConsultantMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">14,081</ix:nonFraction> and $<ix:nonFraction id="fid_413" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2020-01-01to2020-12-31_scwo_ConsultantMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">6,329</ix:nonFraction> as research and development expenses in the accompanying consolidated statements of operations during the years ended December 31, 2021 and 2020, respectively</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong>Stock Options</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Stock option activity for the year ended December 31, 2021, is summarized as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><ix:nonNumeric id="fid_270" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" contextRef="From2021-01-01to2021-12-31" escape="true"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise Price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Aggregate</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Intrinsic Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Remaining</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Contractual</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Life (Years)</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Options outstanding at December 31, 2019</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_342" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-12-31_scwo_OptionsMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">12,180,500</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_350" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2020-12-31_scwo_OptionsMember" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">0.20</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_339" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2020-12-31_scwo_OptionsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">4,750,395</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonNumeric id="fid_347" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="From2019-01-01to2019-12-31_scwo_OptionsMember" format="ixt-sec:duryear">5.59</ix:nonNumeric></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Granted </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_853" name="scwo:Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice" contextRef="From2020-01-01to2020-12-31_scwo_OptionsMember" format="ixt:zerodash" unitRef="USDPShares" decimals="INF">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_854" name="scwo:Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice" contextRef="From2020-01-01to2020-12-31_scwo_OptionsMember" format="ixt:zerodash" unitRef="USDPShares" decimals="INF">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_855" name="scwo:Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice" contextRef="From2020-01-01to2020-12-31_scwo_OptionsMember" format="ixt:zerodash" unitRef="USDPShares" decimals="INF">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#8212;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#8212;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expired/forfeit</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#8212;</p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Options outstanding at December 31, 2020</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_344" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2019-12-31_scwo_OptionsMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">12,180,500</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_352" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2019-12-31_scwo_OptionsMember" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">0.20</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_348" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2019-12-31_scwo_OptionsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">4,750,395</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonNumeric id="fid_346" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="From2020-01-01to2020-12-31_scwo_OptionsMember" format="ixt-sec:duryear">4.59</ix:nonNumeric></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Granted </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_336" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-01-01to2021-12-31_scwo_OptionsMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">2,885,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_334" name="scwo:Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice" contextRef="From2021-01-01to2021-12-31_scwo_OptionsMember" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">1.20</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_337" name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2021-01-01to2021-12-31_scwo_OptionsMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0" sign="-">225,500</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_333" name="scwo:Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice" contextRef="From2021-01-01to2021-12-31_scwo_OptionsMember" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">0.19</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expired/forfeit</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_338" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" contextRef="From2021-01-01to2021-12-31_scwo_OptionsMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">2,540,000</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_335" name="scwo:Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice" contextRef="From2021-01-01to2021-12-31_scwo_OptionsMember" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">0.17</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Options outstanding at December 31, 2021</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_343" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-12-31_scwo_OptionsMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">12,300,000</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_351" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-12-31_scwo_OptionsMember" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">0.37</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_340" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2021-12-31_scwo_OptionsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">4,521,310</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonNumeric id="fid_341" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="From2021-01-01to2021-12-31_scwo_OptionsMember" format="ixt-sec:duryear">5.62</ix:nonNumeric></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Stock option unvested activity for the year ended December 31, 2021, is summarized as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><ix:nonNumeric id="fid_271" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" contextRef="From2021-01-01to2021-12-31" escape="true"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Options</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Options Unvested at December 31, 2019</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Granted </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Vested</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expired/forfeit</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Options Unvested at December 31, 2020</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Granted </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_336-1970bd" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-01-01to2021-12-31_scwo_OptionsMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">2,885,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Vested </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_851" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" contextRef="From2021-01-01to2021-12-31_scwo_OptionUnvestedMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">379,817</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expired/forfeit</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_852" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" contextRef="From2021-01-01to2021-12-31_scwo_OptionUnvestedMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">40,000</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Options Unvested at December 31, 2021</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_842" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-12-31_scwo_OptionUnvestedMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">2,465,183</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table></ix:nonNumeric></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">F-13</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#TOCFS">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:continuation id="cont_0c9f9c" continuedAt="cont_3c5c66"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Total unrecognized compensation associated with these unvested options is approximately $<ix:nonFraction id="fid_416" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" contextRef="AsOf2021-12-31_scwo_OptionsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,136,921</ix:nonFraction> which will be recognized over a period of four years. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">The fair value of these options granted were estimated on the date of grant, using the Black-Scholes option-pricing model with the following assumptions:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><ix:nonNumeric id="fid_272" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" contextRef="From2021-01-01to2021-12-31_us-gaap_StockOptionMember" escape="true" continuedAt="cont_63f0c2"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>For the years ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2020</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Dividend yield</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_354" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2021-01-01to2021-12-31_scwo_OptionsMember" unitRef="Pure" decimals="INF" scale="-2">0.00</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected life</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><ix:nonNumeric id="fid_355" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="From2021-01-01to2021-12-31_scwo_OptionsMember_scwo_MinimumsMember" format="ixt-sec:duryear">5.49</ix:nonNumeric> &#8211; <ix:nonNumeric id="fid_356" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="From2021-01-01to2021-12-31_scwo_OptionsMember_scwo_MaximumsMember" format="ixt-sec:duryear">6.25</ix:nonNumeric> Years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#8212;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected volatility</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><ix:nonFraction id="fid_357" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2021-01-01to2021-12-31_scwo_OptionsMember_scwo_MinimumsMember" unitRef="Pure" decimals="INF" scale="-2">38.39</ix:nonFraction>- <ix:nonFraction id="fid_358" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2021-01-01to2021-12-31_scwo_OptionsMember_scwo_MaximumsMember" unitRef="Pure" decimals="INF" scale="-2">38.67</ix:nonFraction></p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Risk-free interest rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><ix:nonFraction id="fid_359" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2021-01-01to2021-12-31_scwo_OptionsMember_scwo_MinimumsMember" unitRef="Pure" decimals="INF" scale="-2">0.87</ix:nonFraction>&#8211; <ix:nonFraction id="fid_360" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2021-01-01to2021-12-31_scwo_OptionsMember_scwo_MaximumsMember" unitRef="Pure" decimals="INF" scale="-2">1.07</ix:nonFraction></p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"></td></tr></tbody></table></ix:nonNumeric><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong>Stock Warrants</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">In April 2021, pursuant to the binding Memorandum of Understanding dated as of March 30, 2021, between 374Water and MB Holding Inc. (the &#8220;MOU&#8221;), a warrant for the purchase of <ix:nonFraction id="fid_417" name="scwo:NumberOfWarrantPurchase" contextRef="From2021-04-01to2021-04-30" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">3,783,333</ix:nonFraction> shares of common stock at an exercise price of $<ix:nonFraction id="fid_418" name="us-gaap:WarrantExercisePriceIncrease" contextRef="From2021-04-01to2021-04-30" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">0.30</ix:nonFraction> per share was issued to MB Holding Inc. as consideration for executing the MOU and was considered fully vested upon the execution of the MOU. These warrants expire in March 2022. Those warrants were estimated to have a grant-date fair value of $<ix:nonFraction id="fid_419" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2021-04-01to2021-04-30" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">0.37</ix:nonFraction> per warrant or aggregate fair value of $<ix:nonFraction id="fid_420" name="scwo:AggregateFairValueOfWarrant" contextRef="AsOf2021-04-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,399,833</ix:nonFraction> which has been presented as product development expense on the condensed statements of operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">During the year ended December 31, 2021, the warrants were exercised resulting in the issuance of <ix:nonFraction id="fid_736" name="scwo:StockIssuedUponWarrantExercised" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">3,783,333</ix:nonFraction> shares of common stock and proceeds of $<ix:nonFraction id="fid_737" name="scwo:ProceedsFromStockIssuedUponWarrantsExercisedAmount" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,134,499</ix:nonFraction>. As of December 31, 2021, there were <ix:nonFraction id="fid_423" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">1,250,000</ix:nonFraction> warrants outstanding which relate to the Series 1 offering executed in December 2021, where investors were offered a warrant for every two common shares purchased during the offering at an exercise price of $<ix:nonFraction id="fid_425" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">2.50</ix:nonFraction> per share. The intrinsic value of all outstanding warrants as of December 31, 2021 was $<ix:nonFraction id="fid_424" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">437,500</ix:nonFraction> based on the market price of our common stock of $<ix:nonFraction id="fid_426" name="us-gaap:CommonStockNoParValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">2.85</ix:nonFraction> per share.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">The fair value of those warrants granted were estimated on the date of grant, using the Black-Scholes option-pricing model with the following assumptions:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><ix:continuation id="cont_63f0c2" continuedAt="cont_389d4f"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>For the years ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2020</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Dividend yield</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_361" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2021-01-01to2021-12-31_scwo_WarrantsMember" unitRef="Pure" decimals="INF" scale="-2">0.00</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected life</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><ix:nonNumeric id="fid_362" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="From2021-01-01to2021-12-31_scwo_WarrantsMember_scwo_MinimumsMember" format="ixt-sec:duryear">1</ix:nonNumeric> - <ix:nonNumeric id="fid_363" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="From2021-01-01to2021-12-31_scwo_WarrantsMember_scwo_MaximumsMember" format="ixt-sec:duryear">3</ix:nonNumeric> Years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected volatility</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><ix:nonFraction id="fid_364" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2021-01-01to2021-12-31_scwo_WarrantsMember_scwo_MinimumsMember" unitRef="Pure" decimals="INF" scale="-2">42.39</ix:nonFraction>% - <ix:nonFraction id="fid_365" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2021-01-01to2021-12-31_scwo_WarrantsMember_scwo_MaximumsMember" unitRef="Pure" decimals="INF" scale="-2">45.24</ix:nonFraction>%</p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Risk-free interest rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><ix:nonFraction id="fid_366" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2021-01-01to2021-12-31_scwo_WarrantsMember_scwo_MinimumsMember" unitRef="Pure" decimals="INF" scale="-2">0.600</ix:nonFraction>% - <ix:nonFraction id="fid_367" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2021-01-01to2021-12-31_scwo_WarrantsMember_scwo_MaximumsMember" unitRef="Pure" decimals="INF" scale="-2">0.795</ix:nonFraction>%</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table></ix:continuation><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">F-14</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#TOCFS">Table of Contents</a></em></td></tr></tbody></table></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:continuation id="cont_3c5c66"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">A summary of warrant activity during the year ended December 31, 2021, is as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><ix:continuation id="cont_389d4f"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise Price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Aggregate</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Intrinsic Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Remaining</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Contractual</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Life (Years)</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance at December 31, 2019</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_368" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">950,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_371" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">0.11</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_377" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">690,500</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonNumeric id="fid_380" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="From2020-01-01to2020-12-31" format="ixt-sec:duryear">1.44</ix:nonNumeric></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Issued</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance at December 31, 2020</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_382" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">950,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_383" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">0.11</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_378" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">690,500</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonNumeric id="fid_381" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="From2019-01-01to2019-12-31" format="ixt-sec:duryear">0.44</ix:nonNumeric></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Issued</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,033,333</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_373" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">0.85</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#8212;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_370" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">4,733,333</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_374" name="scwo:WeightedAverageExercisePriceExercised" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">0.26</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance at December 31, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_375" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">1,250,000</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_372" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">2.50</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_376" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">437,500</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonNumeric id="fid_379" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="From2021-01-01to2021-12-31" format="ixt-sec:duryear">2.96</ix:nonNumeric></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table></ix:continuation></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_248" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" contextRef="From2021-01-01to2021-12-31" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong>Note 7 - Related Party Transactions</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At December 31, 2021 and 2020, the Company has due $<ix:nonFraction id="fid_431" name="scwo:AdvancesFromStockholders" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">0</ix:nonFraction> and <ix:nonFraction id="fid_432" name="scwo:AdvancesFromStockholders" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">15,108</ix:nonFraction>, respectively, of advances received from stockholders of the Company for working capital. There is no formal agreement, these advances are non-interest bearing and due on demand. During the years ended December 31, 2021 and 2020, stockholders advanced $0 and 2,053 respectively, for working capital needs. Advancements were fully paid in fiscal year 2021. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our previous CFO John L Hofmann is a member of the accounting firm Kabat, Schertzer, De La Torre, Taraboulos &amp; Co, LLC (&#8220;KSDT&#8221;). The Company paid $<ix:nonFraction id="fid_428" name="us-gaap:RelatedPartyCosts" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">43,205</ix:nonFraction> and $<ix:nonFraction id="fid_429" name="us-gaap:RelatedPartyCosts" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" unitRef="USD" decimals="0">0</ix:nonFraction> to KSDT for its services in the year ended December 31, 2021 and 2020, respectively, and $<ix:nonFraction id="fid_430" name="us-gaap:DueFromRelatedParties" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">0</ix:nonFraction> of services rendered remain unpaid as of December 31, 2021. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Additionally, the Company entered into an agreement to fabricate and manufacture the units with Merrell Bros. Holding Company. As part of the agreement, the Company provided Terry Merrell a board of director position. As of December 31, 2021, Merrell Bros. own stock in excess of 5% of the outstanding common stock.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_249" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" contextRef="From2021-01-01to2021-12-31" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong>Note 8 &#8211; Commitments and Contingencies </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">The patented technology underlying 374Water&#8217;s supercritical water oxidation (SCWO) units, which was developed principally through the efforts of Messrs. Nagar and Deshusses at the facilities of Duke University, Durham, North Carolina (&#8220;Duke&#8221;), where Dr. Deshusses is a professor, is licensed to 374Water pursuant to a worldwide license agreement with Duke executed on April 16, 2021 (the &#8220;License Agreement&#8221;). In connection with the License Agreement, 374Water also executed an equity transfer Agreement with Duke pursuant to which Duke received a small block of common stock in the Company (See Notes 4 and 6). Under the terms of the License Agreement, the Company is required to make royalty payments based on a percentage of licensed product sales, as defined in the License Agreement which is triggered by the sale of licensed products. Further, the Company is also required to pay royalties on a percentage of sublicensing fees. The Company will reimburse Duke for any ongoing patent expenses incurred. During the year ended December 31, 2021, the Company has incurred $19,075 in connection with this License Agreement. The Company may terminate the license agreement anytime by providing Duke 60 days&#8217; notice.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">F-15</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#TOCFS">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_250" name="us-gaap:IncomeTaxDisclosureTextBlock" contextRef="From2021-01-01to2021-12-31" escape="true" continuedAt="cont_e93d4f"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong>Note 9 &#8211; Income Taxes </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Deferred income taxes are provided based on the provisions of ASC Topic 740, &#8220;Accounting for Income Taxes&#8221;, to reflect the tax consequences in future years of differences between the tax basis of assets and liabilities and their financial reporting amounts based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><ix:nonNumeric id="fid_273" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" contextRef="From2021-01-01to2021-12-31" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Significant components of the Company&#8217;s net deferred income taxes are as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2020</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Deferred tax assets:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Goodwill </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_441" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">208,742</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_440" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" contextRef="AsOf2020-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Capitalized Start-Up Costs</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_439" name="scwo:DeferredTaxAssetsStartupCost" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">83,710</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_438" name="scwo:DeferredTaxAssetsStartupCost" contextRef="AsOf2020-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Other Intangibles</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_450" name="scwo:OtherIntangibles" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">10,339</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_452" name="scwo:OtherIntangibles" contextRef="AsOf2020-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Other Accruals</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_451" name="scwo:OtherAccruals" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,875</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_453" name="scwo:OtherAccruals" contextRef="AsOf2020-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Stock Compensation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_443" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">17,423</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_442" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,764</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Operating Loss</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_437" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">381,112</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Deferred tax assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_445" name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">703,211</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_444" name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,764</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Less valuation allowance</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_447" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">703,083</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_446" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,764</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net deferred tax assets after valuation allowance</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_449" name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">128</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_448" name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2020-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2020</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Deferred tax liabilities:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Depreciation </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_458" name="us-gaap:DeferredTaxLiabilitiesOther" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">128</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_459" name="us-gaap:DeferredTaxLiabilitiesOther" contextRef="AsOf2020-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Deferred tax liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_454" name="us-gaap:DeferredTaxLiabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">128</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_455" name="us-gaap:DeferredTaxLiabilities" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,764</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net deferred tax asset (liability) </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_456" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="AsOf2021-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_457" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="AsOf2020-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">A reconciliation of the U.S. statutory federal income tax rate to the effective income tax rate (benefit) follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong>Rate Reconciliation</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><ix:nonNumeric id="fid_274" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" contextRef="From2021-01-01to2021-12-31" escape="true"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2020</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Rate Reconciliation</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Federal income tax at statutory rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_460" name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-01to2020-12-31" unitRef="Pure" decimals="INF" scale="-2">21.00</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_461" name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2019-01-01to2019-12-31" unitRef="Pure" decimals="INF" scale="-2">21.00</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Change in State Tax</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_470" name="scwo:IncomeTaxRateReconciliationChangeInStateTax" contextRef="From2020-01-01to2020-12-31" unitRef="Pure" decimals="INF" scale="-2">0</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_471" name="scwo:IncomeTaxRateReconciliationChangeInStateTax" contextRef="From2019-01-01to2019-12-31" unitRef="Pure" decimals="INF" scale="-2">0</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Change in Valuation Allowance</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-<ix:nonFraction id="fid_468" name="scwo:IncomeTaxReconciliationChangeInValuationAllowance" contextRef="From2020-01-01to2020-12-31" unitRef="Pure" decimals="INF" sign="-" scale="-2">22.16</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_469" name="scwo:IncomeTaxReconciliationChangeInValuationAllowance" contextRef="From2019-01-01to2019-12-31" unitRef="Pure" decimals="INF" scale="-2">19.11</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Permanent Differences</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-<ix:nonFraction id="fid_464" name="scwo:IncomeTaxReconciliationPermanentDifferences" contextRef="From2020-01-01to2020-12-31" unitRef="Pure" decimals="INF" sign="-" scale="-2">12.26</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_465" name="scwo:IncomeTaxReconciliationPermanentDifferences" contextRef="From2019-01-01to2019-12-31" unitRef="Pure" decimals="INF" scale="-2">0</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">State Taxes </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_462" name="scwo:IncomeTaxReconciliationStateTaxes" contextRef="From2020-01-01to2020-12-31" unitRef="Pure" decimals="INF" scale="-2">1.98</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_463" name="scwo:IncomeTaxReconciliationStateTaxes" contextRef="From2019-01-01to2019-12-31" unitRef="Pure" decimals="INF" scale="-2">5.50</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Other</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_466" name="scwo:IncomeTaxReconciliationOther" contextRef="From2020-01-01to2020-12-31" unitRef="Pure" decimals="INF" scale="-2">11.44</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-<ix:nonFraction id="fid_467" name="scwo:IncomeTaxReconciliationOther" contextRef="From2019-01-01to2019-12-31" unitRef="Pure" decimals="INF" sign="-" scale="-2">45.61</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr></tbody></table></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">At December 31, 2021, the Company had U.S. federal net operating loss carryforwards of approximately $<ix:nonFraction id="fid_472" name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="-5" scale="6">1.7</ix:nonFraction> million, which will carry forward indefinitely.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">NOLs that were acquired with the acquisition of businesses are excluded from the amount of available NOLs to the extent their use is limited by the provisions of Section 382 of the Internal Revenue Code. Under the provisions of the Internal Revenue Code, certain substantial changes in the Company&#8217;s ownership may result in further limitation on the amount of net operating loss carryforwards which can be utilized in future years.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">F-16</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#TOCFS">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:continuation id="cont_e93d4f"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">In evaluating the amount of the valuation allowance against its deferred tax assets as of December 31, 2021 and 2020, the Company considered all available positive and negative evidence and concluded that it is more likely than not that a portion of its deferred tax assets would not be realized. Accordingly, the Company has recorded a valuation allowance against its net deferred tax assets due to the uncertainty surrounding the realization of such assets.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">The Company had no unrecognized tax benefits as of December 31, 2021 and 2020. The Company does not anticipate a significant change in total unrecognized tax benefits within the next 12 months. Tax years 2018-2020 remain open to examination by the major taxing jurisdictions to which the Company is subject.</p></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_251" name="us-gaap:SubsequentEventsTextBlock" contextRef="From2021-01-01to2021-12-31" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong>Note 10 &#8211; Subsequent Events </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">On Feb 17, 2022, the Company opened 374Water Sustainability Israel LTD in Israel as a subsidiary of the Company.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Effective February 7, 2022, Israel Abitbol was promoted to CFO of the Company and the prior CFO, John Hofmann, moved to a senior vice president role. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">On February 2, 2022, the Company signed a MOU with Environmental Services Company Ltd. An Israeli based company, in order to produce and sell the second AirSCWO unit. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">On February 1, 2022, the Company sold its first AirSCWO unit to the Orange County Sanitation District of Fountain Valley, California. </p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">F-17</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#TOCFS">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;&#160;&#160;&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Item 1. Condensed Consolidated Financial Statements</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><span class="atag" style="display: inline" id="BS1"><strong><span style="text-decoration:underline">374Water Inc. and Subsidiaries</span></strong> </span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="text-decoration:underline">Condensed Consolidated Balance Sheets</span></strong> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="text-decoration:underline">March 31, 2022 (Unaudited) and December 31, 2021 </span></strong>&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Assets</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Current Assets:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Cash</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_473" name="us-gaap:Cash" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">11,243,795</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_2-52a6fe" name="us-gaap:Cash" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">11,131,175</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Prepaid expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_474" name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">167,867</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_6-573195" name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">218,466</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Total Current Assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_475" name="us-gaap:AssetsCurrent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">11,411,662</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_8-4100c0" name="us-gaap:AssetsCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">11,349,641</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Long-Term Assets:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Equipment, net</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_476" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">4,015</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_11-782875" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">959</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Intangible asset, net</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_477" name="us-gaap:OtherIntangibleAssetsNet" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,012,327</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_13-9907dd" name="us-gaap:OtherIntangibleAssetsNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,028,114</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Other assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_478" name="us-gaap:OtherAssets" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">34,306</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_15-b2c315" name="us-gaap:OtherAssets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">34,742</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Total Long-Term Assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_479" name="us-gaap:AssetsNoncurrent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,050,648</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_17-cc0fd0" name="us-gaap:AssetsNoncurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,063,815</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Total Assets</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_480" name="us-gaap:Assets" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">12,462,310</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_19-bab962" name="us-gaap:Assets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">12,413,456</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Liabilities and Stockholders&#8217; Equity</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Current Liabilities:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Accounts payable and accrued expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_481" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">144,040</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_23-dc08a9" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">62,981</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Deferred revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_483" name="us-gaap:DeferredRevenue" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">763,333</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_4-f1132b" name="us-gaap:AccountsReceivableNet" contextRef="AsOf2021-12-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Other liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_484" name="us-gaap:OtherLiabilities" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">3,152</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_27-932f96" name="us-gaap:OtherLiabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">23,390</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="MARGIN: 0px 0px 0px 15px;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Total Current Liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_485" name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">910,525</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_29-8a6862" name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">86,371</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Total Liabilities</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_486" name="us-gaap:Liabilities" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">910,525</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_31-669953" name="us-gaap:Liabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">86,371</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Commitments and contingencies (Note 8)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Stockholders&#8217; Equity</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Preferred Stock: <ix:nonFraction id="fid_802" name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">1,000,000</ix:nonFraction> Convertible Series D preferred shares authorized; par value $<ix:nonFraction id="fid_804" name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">0.0001</ix:nonFraction> per share, nil issued and outstanding at March 31, 2022 and 27,272 issued and outstanding at December 31, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_487" name="us-gaap:PreferredStockValue" contextRef="AsOf2022-03-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_35-6c5647" name="us-gaap:PreferredStockValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">3</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Common stock: <ix:nonFraction id="fid_811" name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">200,000,000</ix:nonFraction> common shares authorized, par value $<ix:nonFraction id="fid_813" name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">0.0001</ix:nonFraction> per share, <ix:nonFraction id="fid_814" name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">126,680,895</ix:nonFraction> and 125,317,746 shares outstanding at March 31, 2022 and December 31, 2021, respectively</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_488" name="us-gaap:CommonStockValue" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">12,669</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_37-9c46a7" name="us-gaap:CommonStockValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">12,531</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Additional paid-in capital</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_489" name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">15,571,989</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_39-446a4f" name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">15,474,566</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Accumulated (deficit) earnings</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_490" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">4,032,873</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_41-57e764" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">3,160,015</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Total Stockholders&#8217; Equity</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_491" name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">11,551,785</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_43-71a9f2" name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">12,327,085</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Total Liabilities and Stockholders&#8217; Equity</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_492" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">12,462,310</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_45-5ce6af" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">12,413,456</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">F-18</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#TOCFS">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><span class="atag" style="display: inline" id="STO1"><strong><span style="text-decoration:underline">374Water, Inc. and Subsidiary</span></strong>&#160;</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong><span style="text-decoration:underline"><span id="op" class="atag" style="display:inline">Condensed Consolidated Statements of Operations </span></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong><span style="text-decoration:underline">For the three months ended March 31, 2022 and 2021</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong><span style="text-decoration:underline">(Unaudited)</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_501" name="us-gaap:Revenues" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">273,231</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_502" name="us-gaap:Revenues" contextRef="From2021-01-01to2021-03-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Cost of Goods Sold</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_503" name="us-gaap:CostOfRevenue" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">247,986</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_504" name="us-gaap:CostOfRevenue" contextRef="From2021-01-01to2021-03-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Gross Profit</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_752" name="us-gaap:GrossProfit" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">25,245</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_753" name="us-gaap:GrossProfit" contextRef="From2021-01-01to2021-03-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Operating Expenses</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Research and development</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_507" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">185,653</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_508" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2021-01-01to2021-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">29,185</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Compensation and related expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_533" name="us-gaap:LaborAndRelatedExpense" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">301,235</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_534" name="us-gaap:LaborAndRelatedExpense" contextRef="From2021-01-01to2021-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">18,686</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Professional Fees</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_509" name="us-gaap:ProfessionalFees" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">150,658</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_510" name="us-gaap:ProfessionalFees" contextRef="From2021-01-01to2021-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">8,203</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">General and administrative</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_511" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">261,403</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_512" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2021-01-01to2021-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">10,477</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total Operating Expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_513" name="us-gaap:OperatingExpenses" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">898,950</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_514" name="us-gaap:OperatingExpenses" contextRef="From2021-01-01to2021-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">66,551</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>&#160;Income (Loss) from Operations</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>(<ix:nonFraction id="fid_515" name="us-gaap:OperatingIncomeLoss" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">873,705</ix:nonFraction></strong></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>(<ix:nonFraction id="fid_516" name="us-gaap:OperatingIncomeLoss" contextRef="From2021-01-01to2021-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">66,551</ix:nonFraction></strong></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Other Income (Expense)</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Interest income</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_517" name="us-gaap:InterestIncomeOperating" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">840</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_518" name="us-gaap:InterestIncomeOperating" contextRef="From2021-01-01to2021-03-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Other income</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_519" name="us-gaap:OtherIncome" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">7</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_520" name="us-gaap:OtherIncome" contextRef="From2021-01-01to2021-03-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 30px">Total Other Income (Expense)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_521" name="us-gaap:NonoperatingIncomeExpense" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">847</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_522" name="us-gaap:NonoperatingIncomeExpense" contextRef="From2021-01-01to2021-03-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Net Loss before Income Taxes</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>(<ix:nonFraction id="fid_523" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">872,858</ix:nonFraction></strong></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>(<ix:nonFraction id="fid_524" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2021-01-01to2021-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">66,551</ix:nonFraction></strong></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Provision for Income Taxes</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_525" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-01-01to2022-03-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_526" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-01-01to2021-03-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Net Loss</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>(<ix:nonFraction id="fid_527" name="us-gaap:NetIncomeLoss" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">872,858</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>(<ix:nonFraction id="fid_528" name="us-gaap:NetIncomeLoss" contextRef="From2021-01-01to2021-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">66,551</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Net Loss per Share - Basic and Diluted</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>(<ix:nonFraction id="fid_529" name="scwo:NetLossPerShareBasicAndDiluted" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF" sign="-">0.01</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>(<ix:nonFraction id="fid_530" name="scwo:NetLossPerShareBasicAndDiluted" contextRef="From2021-01-01to2021-03-31" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF" sign="-">0.00</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Weighted Average Common Shares Outstanding - Basic and Diluted</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_531" name="scwo:WeightedAverageCommonSharesOutstandingBasicAndDiluted" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">126,499,142</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_532" name="scwo:WeightedAverageCommonSharesOutstandingBasicAndDiluted" contextRef="From2021-01-01to2021-03-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">62,410,452</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:center;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">F-19</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#TOCFS">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><span class="atag" style="display: inline" id="EQT1"><strong><span style="text-decoration:underline">374Water Inc. and Subsidiary</span></strong>&#160;</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong><span style="text-decoration:underline"><span id="eq" class="atag" style="display:inline">Condensed Consolidated Changes in Stockholders&#8217; Equity</span></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong><span style="text-decoration:underline">For the three months ended March 31, 2022 and 2021</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong><span style="text-decoration:underline">(Unaudited)</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>For the three months ended March 31, 2022</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Preferred Stock</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Common Stock</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Additional</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:6%;"></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:6%;"></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Number of</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:6%;"></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Number of</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:6%;"></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Paid in</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Accumulated</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Total Stockholders&#8217;</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Amount</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;"><strong>Amount</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Capital</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Deficit</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>&#160;&#160; Equity</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Balances, December 31, 2021</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_161-0d54c2" name="us-gaap:SharesIssued" contextRef="AsOf2021-12-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">27,272</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_162-42db7a" name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">3</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">125,317,746</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">12,531</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_163-e5b1ce" name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">15,474,566</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_164-ecbb44" name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">3,160,015</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_165-e328b2" name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">12,327,085</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Conversion of Preferred Shares to Common Shares</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_537" name="us-gaap:ConversionOfStockSharesIssued1" contextRef="From2022-01-01to2022-03-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0" sign="-">27,272</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_539" name="us-gaap:ConversionOfStockAmountIssued1" contextRef="From2022-01-01to2022-03-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">3</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_538" name="us-gaap:ConversionOfStockSharesIssued1" contextRef="From2022-01-01to2022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">1,363,149</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_578" name="us-gaap:ConversionOfStockAmountIssued1" contextRef="From2022-01-01to2022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">136</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_579" name="us-gaap:ConversionOfStockAmountIssued1" contextRef="From2022-01-01to2022-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">135</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_540" name="us-gaap:ConversionOfStockAmountIssued1" contextRef="From2022-01-01to2022-03-31_us-gaap_RetainedEarningsMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_541" name="us-gaap:ConversionOfStockAmountIssued1" contextRef="From2022-01-01to2022-03-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Accretion of stock-based compensation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_542" name="us-gaap:AccretionExpense" contextRef="From2022-01-01to2022-03-31_us-gaap_PreferredStockMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_543" name="us-gaap:AccretionExpense" contextRef="From2022-01-01to2022-03-31_us-gaap_CommonStockMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_544" name="us-gaap:AccretionExpense" contextRef="From2022-01-01to2022-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">97,558</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_545" name="us-gaap:AccretionExpense" contextRef="From2022-01-01to2022-03-31_us-gaap_RetainedEarningsMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_546" name="us-gaap:AccretionExpense" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">97,558</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Net loss</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_547" name="us-gaap:NetIncomeLoss" contextRef="From2022-01-01to2022-03-31_us-gaap_PreferredStockMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_548" name="us-gaap:NetIncomeLoss" contextRef="From2022-01-01to2022-03-31_us-gaap_CommonStockMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_549" name="us-gaap:NetIncomeLoss" contextRef="From2022-01-01to2022-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_550" name="us-gaap:NetIncomeLoss" contextRef="From2022-01-01to2022-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">872,858</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_551" name="us-gaap:NetIncomeLoss" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">872,858</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Balances, March 31, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_552" name="us-gaap:SharesIssued" contextRef="AsOf2022-03-31_us-gaap_PreferredStockMember" format="ixt:zerodash" unitRef="Shares" decimals="0">&#8212;</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_553" name="us-gaap:SharesIssued" contextRef="AsOf2022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">126,680,895</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_555" name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">12,667</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_556" name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">15,571,989</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>(<ix:nonFraction id="fid_557" name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">3,884,460</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_558" name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">11,551,785</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>For the three months ended March 31, 2021</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Preferred Stock</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Common Stock</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Additional</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:6%;"></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:6%;"></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Number of</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:6%;"></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Number of</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:6%;"></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Paid in</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Accumulated</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Total Stockholders&#8217;</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Amount</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;"><strong>Amount</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Capital</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Deficit</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>&#160;&#160; Equity</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Balances, December 31, 2020</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">62,410,452</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">6,241</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_121-64188c" name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">416</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_122-4ea4fb" name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">4,593</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_123-b05836" name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">11,250</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Accretion of stock-based compensation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_561" name="us-gaap:AccretionExpense" contextRef="From2021-01-01to2021-03-31_us-gaap_PreferredStockMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_562" name="us-gaap:AccretionExpense" contextRef="From2021-01-01to2021-03-31_us-gaap_CommonStockMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_563" name="us-gaap:AccretionExpense" contextRef="From2021-01-01to2021-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">10,433</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_564" name="us-gaap:AccretionExpense" contextRef="From2021-01-01to2021-03-31_us-gaap_RetainedEarningsMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_565" name="us-gaap:AccretionExpense" contextRef="From2021-01-01to2021-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">10,433</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Net loss</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_566" name="us-gaap:NetIncomeLoss" contextRef="From2021-01-01to2021-03-31_us-gaap_PreferredStockMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_567" name="us-gaap:NetIncomeLoss" contextRef="From2021-01-01to2021-03-31_us-gaap_CommonStockMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_568" name="us-gaap:NetIncomeLoss" contextRef="From2021-01-01to2021-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_569" name="us-gaap:NetIncomeLoss" contextRef="From2021-01-01to2021-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">66,551</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_570" name="us-gaap:NetIncomeLoss" contextRef="From2021-01-01to2021-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">66,551</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Balances, March 31, 2021 &#160; </strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_573" name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31_us-gaap_PreferredStockMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_572" name="us-gaap:SharesIssued" contextRef="AsOf2021-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">62,410,452</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_574" name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">6,241</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_575" name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">10,849</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_576" name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">61,958</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_577" name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">44,868</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">F-20</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#TOCFS">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="text-decoration:underline"><span id="CF1" class="atag" style="display:inline">374Water Inc. and Subsidiary</span></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="text-decoration:underline"><span id="cf" class="atag" style="display:inline">Condensed Consolidated Statements of Cash Flows</span></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="text-decoration:underline">For the three months ended March 31, 2022 and 2021</span></strong> <strong><span style="text-decoration:underline">(Unaudited)</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Cash Flows from Operating Activities</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Net income (loss)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_580" name="us-gaap:NetIncomeLoss" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">872,858</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_581" name="us-gaap:NetIncomeLoss" contextRef="From2021-01-01to2021-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">66,551</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Depreciation and amortization expense</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_582" name="us-gaap:DepreciationAndAmortization" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">16,458</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_583" name="us-gaap:DepreciationAndAmortization" contextRef="From2021-01-01to2021-03-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Stock based compensation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_584" name="us-gaap:ShareBasedCompensation" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">97,558</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_585" name="us-gaap:ShareBasedCompensation" contextRef="From2021-01-01to2021-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">10,433</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Changes in operating assets and liabilities:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Accounts receivable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_586" name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2022-01-01to2022-03-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_587" name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2021-01-01to2021-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">24,340</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Accounts payable and accrued expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_588" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">81,059</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_589" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2021-01-01to2021-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">28,966</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Deferred revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_612" name="us-gaap:IncreaseDecreaseInDeferredRevenue" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">763,333</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_613" name="us-gaap:IncreaseDecreaseInDeferredRevenue" contextRef="From2021-01-01to2021-03-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Prepaid expense</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_781" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">50,599</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_782" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="From2021-01-01to2021-03-31" format="ixt:zerodash" unitRef="USD" decimals="0" sign="-">&#8212;</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Other liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_592" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">20,238</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_593" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" contextRef="From2021-01-01to2021-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">1,200</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Cash Provided by (Used In) Operating Activities</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_594" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">115,911</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>(<ix:nonFraction id="fid_595" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2021-01-01to2021-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">4,022</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Cash Flows from Investing Activities</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Purchase of equipment</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_596" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">3,291</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_597" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2021-01-01to2021-03-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Cash Provided by (Used In) Investing Activities</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>(<ix:nonFraction id="fid_598" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">3,291</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_599" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2021-01-01to2021-03-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Cash Flow from Financing Activities</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Funding from exercise of capital stock</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_600" name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2022-01-01to2022-03-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_601" name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2021-01-01to2021-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">4,821</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Cash Provided by Financing Activities</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_602" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2022-01-01to2022-03-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_603" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2021-01-01to2021-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">4,821</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Net Increase in Cash</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_604" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">112,620</ix:nonFraction></strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_605" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2021-01-01to2021-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">799</ix:nonFraction></strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Cash, Beginning of the Period</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_606" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">11,131,175</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_607-61051f" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">71,799</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Cash, End of the Period</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_608" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">11,243,795</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_609" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2021-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">72,598</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">NON-CASH FINANCING ACTIVITIES</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Conversion of preferred stock to common stock</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_610" name="scwo:ConversionOfStockAmountIssued" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">133</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_611" name="scwo:ConversionOfStockAmountIssued" contextRef="From2021-01-01to2021-03-31" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">F-21</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#TOCFS">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><span class="atag" style="display: inline" id="NOTS1"><strong><span style="text-decoration:underline">374Water Inc. and Subsidiary</span></strong>&#160;</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Notes to Unaudited Condensed Consolidated Financial Statements</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><ix:nonNumeric id="fid_614" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" contextRef="From2022-01-01to2022-03-31" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><strong>Note 1 &#8211; Nature of Business and Presentation of Financial Statements</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><span style="text-decoration:underline">Description of the Company</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">374Water, Inc., f/k/a PowerVerde, Inc. (the &#8220;Company&#8221;) was a Delaware corporation formed in March 2007. The Company was formed to develop, commercialize, and market a series of unique electric generating power systems designed to produce electrical power with zero emissions or waste byproducts, based on a patented pressure-driven expander motor and related organic rankine cycle technology.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">On April 16, 2021, 374Water Inc. (f/k/a PowerVerde, Inc.) entered into an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;) with 374Water, Inc., a privately held company based in Durham, North Carolina, (&#8220;Private 374Water&#8221;) and 374Water Acquisition Corp., a newly-formed wholly-owned subsidiary of PowerVerde (&#8220;Sub&#8221;). The parties entered into the Agreement pursuant to their Binding Letter of Intent dated September 20, 2020.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">Pursuant to the merger contemplated by the Merger Agreement (the &#8220;Merger&#8221;), on April 16, 2021, Sub merged into Private 374Water, with Private 374Water as the surviving corporation. In connection with the Merger, all Private 374Water shares were cancelled and the Company issued to the former Private 374Water shareholders a total of 62,410,452 shares of the Company common stock. , 374 374 374, . , 374 64.2 53.8 . The Merger was accounted for as a reverse acquisition (See Note 4). On April 16, 2021, as a result of the closing of the Merger Agreement (see Note 4), the equity of the consolidated entity is the historical equity of 374Water, Inc (&#8220;374Water&#8221;) retroactively restated to reflect the number of shares issued by the Company in the reverse recapitalization.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><span style="text-decoration:underline">Nature of Business </span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">With the Merger, the Company&#8217;s current mission is to support a clean and healthy environment to sustain life. The Company plans to use what it believes to be cutting-edge science to recover resources from the waste our society generates and keep drinking water clean. The Company&#8217;s customers will include businesses and local governments that will make the sustainable development goals a reality. On February 1, 2022, the Company sold their first AIRSCWO&#160;system to Orange County Sanitation District of Fountain Valley, California.&#160; Revenues to date have been from sale of the first AIRSCWO system&#160;and from testing, consulting, and advisory services procedures for our customers, which have been performed in collaboration with Duke University.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><span style="text-decoration:underline">Presentation of Financial Statements</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules and regulations of the United States Securities and Exchange Commission (SEC) for interim financial information.&#160; It is management&#8217;s opinion that that the accompanying unaudited condensed consolidated financial statements are prepared in accordance with instructions for Form 10-Q and include all adjustments (consisting only of normal recurring accruals) which are necessary for a fair presentation of the results for the periods presented. Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these condensed consolidated financial statements be read in conjunction with the Annual Report on Form 10-K of 374Water Inc, formerly known as PowerVerde, Inc. (&#8220;374 Water," &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; or the &#8220;Company&#8221;) as of and for the year ended December 31, 2021 filed with the Securities and Exchange Commission (&#8220;SEC&#8221;) on March 1, 2022. The results of operations for the three months ended March 31, 2022, are not necessarily indicative of the results to be expected for the full year or for future periods. The condensed consolidated financial statements include the accounts of 374Water Inc, formerly known as PowerVerde, Inc. (the &#8220;Company&#8221;), and PowerVerde Systems, Inc., 374Water Systems Inc, and 374Water Sustainability Israel LTD,&#160;each a&#160;wholly-owned subsidiary of 374 Water. Intercompany balances and transactions have been eliminated in consolidation. These interim financial statements reflect the acquisition of the Company&#8217;s new wholly-owned subsidiary, 374Water Systems Inc., which was consummated on April 16, 2021, as more fully disclosed in Note 4.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">F-22</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#TOCFS">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_615" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" contextRef="From2022-01-01to2022-03-31" escape="true" continuedAt="cont_607c2d"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">&#160;<strong>Note 2 &#8211; Summary of Significant Accounting Policies</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><span style="text-decoration:underline">Cash and Cash Equivalents</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><ix:nonNumeric id="fid_624" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" contextRef="From2022-01-01to2022-03-31" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. The Company held no cash equivalents as of March 31, 2022, and December 31, 2021.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><span style="text-decoration:underline">Accounts Receivable </span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><ix:nonNumeric id="fid_625" name="us-gaap:ReceivablesPolicyTextBlock" contextRef="From2022-01-01to2022-03-31" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">Accounts receivables consist of balances due from service revenues. The Company monitors accounts receivable and provides allowances when considered necessary. At March 31, 2022 and December 31, 2021, there were no outstanding accounts receivable. Accordingly, no allowance for doubtful accounts was provided.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><span style="text-decoration:underline">Equipment</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><ix:nonNumeric id="fid_626" name="scwo:EquipmentPolicy" contextRef="From2022-01-01to2022-03-31" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">Equipment is recorded at cost. Depreciation is computed using the straight-line method and an estimated useful live of three years. Expenses for maintenance and repairs are charged to expense as incurred.&#160; The Company&#8217;s depreciation expense in the period is $<ix:nonFraction id="fid_647" name="us-gaap:Depreciation" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">235</ix:nonFraction>.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><span style="text-decoration:underline">Intangible Assets</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><ix:nonNumeric id="fid_748" name="us-gaap:IntangibleAssetsFiniteLivedPolicy" contextRef="From2022-01-01to2022-03-31" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">Intangible assets are subject to amortization, and any impairment is determined in accordance with ASC 360, &#8220;Property, Plant, and Equipment.&#8221; Intangible assets are stated at historical cost and amortized over their estimated useful lives. The Company uses a straight-line method of amortization, unless a method that better reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up can be reliably determined.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><span style="text-decoration:underline">Long-Lived Assets</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><ix:nonNumeric id="fid_628" name="scwo:LongLivedAssetsPolicy" contextRef="From2022-01-01to2022-03-31" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">The Company reviews long-lived assets, including intangible assets with finite lives, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company uses an estimate of the undiscounted cash flows over the remaining life of its long-lived assets, or related group of assets where applicable, in measuring whether the assets to be held and used will be realizable. Recoverability of assets held and used is measured by a comparison of the carrying amount to the future undiscounted expected net cash flows to be generated by the asset. As of March 31, 2022, and 2021, there were no events or changes in circumstances requiring an impairment analysis.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><span style="text-decoration:underline">Revenue Recognition and Concentration</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><ix:nonNumeric id="fid_629" name="scwo:RevenueRecognitionAndConcentrationPolicy" contextRef="From2022-01-01to2022-03-31" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">The Company follows the revenue standards of Financial Accounting Standards Board Update No. 2014-09: &#8220;Revenue from Contracts with Customers (Topic 606).&#8221; The core principle of this Topic is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Revenue is recognized in accordance with that core principle by applying the following five steps: 1) identify the contracts with a customer; 2) identify the performance obligations in the contract; 3) determine the transaction price; 4) allocate the transaction price to the performance obligations; and 5) recognize revenue when (or as) we satisfy a performance obligation.&#160; Deferred revenue primarily consists of billings or payments received in advance of revenue recognition from the completion of the equipment build for each customer as the outputs are measured against the cost to build the product.&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">The Company&#8217;s performance obligations will be satisfied overtime as the specialized equipment is built for the customer.&#160; Based on the Company&#8217;s contracts, the Company will have a single performance obligation (build and install of the product). The Company will primarily receive fixed consideration for sales of product. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">Revenues for the three months ended March 31, 2022 were generated from the sale of the first AIRSCWO system.&#160; &#160;For the three months ended March 31, 2021, the Company did not have any revenues.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">&#160;</p></ix:nonNumeric></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">F-23</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#TOCFS">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">&#160;</p><ix:continuation id="cont_607c2d" continuedAt="cont_de336b"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><span style="text-decoration:underline">Stock-based Compensation</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><ix:nonNumeric id="fid_749" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" contextRef="From2022-01-01to2022-03-31" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">The Company has accounted for stock-based compensation under the provisions of Accounting Standards Codification (ASC) Topic 718 &#8211; &#8220;Stock Compensation&#8221; which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments (stock options and common stock purchase warrants). The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate. Expected volatilities are based on historical volatility of peer companies and other factors estimated over the expected term of the stock options. The expected term of options granted is derived using the &#8220;simplified method&#8221; which computes expected term as the average of the sum of the vesting term plus the contract term. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><span style="text-decoration:underline">Accounting for Uncertainty in Income Taxes</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><ix:nonNumeric id="fid_631" name="us-gaap:IncomeTaxUncertaintiesPolicy" contextRef="From2022-01-01to2022-03-31" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">The Company&#160;follows the provisions of ASC Topic 740-10, &#8220;Accounting for Uncertainty in Income Taxes&#8221; which clarifies the accounting for uncertainty in income taxes recognized in an enterprise&#8217;s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This topic also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. There were no uncertain tax positions as of March 31, 2022, and December 31, 2021.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><span style="text-decoration:underline">Income Tax Policy</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><ix:nonNumeric id="fid_632" name="us-gaap:IncomeTaxPolicyTextBlock" contextRef="From2022-01-01to2022-03-31" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">The Company accounts for income taxes using the liability method prescribed by ASC 740 - Income Taxes. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets if, based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the period that includes the enactment date.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><span style="text-decoration:underline">Research and Development Costs</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><ix:nonNumeric id="fid_633" name="us-gaap:ResearchAndDevelopmentExpensePolicy" contextRef="From2022-01-01to2022-03-31" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">The Company&#8217;s research and development costs are expensed in the period in which they are incurred. Such expenditures amounted to $<ix:nonFraction id="fid_644" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">185,653</ix:nonFraction> and $<ix:nonFraction id="fid_645" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2021-01-01to2021-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">29,185</ix:nonFraction> for the three months ended March 31, 2022, and 2021, respectively.&#160; </p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><span style="text-decoration:underline">Earnings (Loss) Per Share</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><ix:nonNumeric id="fid_750" name="us-gaap:EarningsPerSharePolicyTextBlock" contextRef="From2022-01-01to2022-03-31" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">Earnings (loss) per share is computed in accordance with FASB ASC Topic 260, &#8220;Earnings per Share&#8221;. Diluted earnings per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities outstanding during the period. Certain common stock equivalents were not included in the earnings (loss) per share calculation as their effect would be anti-dilutive. As of March 31, 2022, there were the following potentially dilutive securities that were excluded from diluted net loss per share because their effect would be antidilutive: options for <ix:nonFraction id="fid_646" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">12,660,000</ix:nonFraction> shares of common stock.&#160; There were no dilutive shares as of March 31, 2022.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><span style="text-decoration:underline">Financial Instruments</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><ix:nonNumeric id="fid_635" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" contextRef="From2022-01-01to2022-03-31" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">The Company carries cash, accounts receivable, accounts payable and accrued expenses, at historical costs. The respective estimated fair values of these assets and liabilities approximate carrying values / useful lives of equipment and intangible assets due to their current nature.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">&#160;</p></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">F-24</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#TOCFS">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:continuation id="cont_de336b"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><span style="text-decoration:underline">Use of Estimates</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><ix:nonNumeric id="fid_636" name="us-gaap:UseOfEstimates" contextRef="From2022-01-01to2022-03-31" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates in the accompanying financial statements include the fair value of equity-based compensation, useful lives of intangible assets, and valuation allowance against deferred tax assets.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><span style="text-decoration:underline">Recent Accounting Pronouncements</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><ix:nonNumeric id="fid_751" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" contextRef="From2022-01-01to2022-03-31" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">All other newly issued but not yet effective accounting pronouncements have been deemed to be not applicable or immaterial to the Company.&#160;</p></ix:nonNumeric></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_616" name="us-gaap:SubstantialDoubtAboutGoingConcernTextBlock" contextRef="From2022-01-01to2022-03-31" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><strong>Note 3 &#8211; Liquidity, Capital Resources and Going Concern</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">As of March 31, 2022, the Company had working capital of $<ix:nonFraction id="fid_798" name="scwo:WorkingCapital" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">10,501,137</ix:nonFraction> compared to working capital of $11,263,270 at December 31, 2021.&#160; As of March 31, 2022, the Company has an accumulated deficit of $<ix:nonFraction id="fid_648" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">4032873</ix:nonFraction>. For the three months ended March 31, 2022, the Company had a net loss of (<ix:nonFraction id="fid_649" name="us-gaap:NetIncomeLoss" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">872,858</ix:nonFraction>) and $<ix:nonFraction id="fid_650" name="us-gaap:NetCashProvidedByUsedInContinuingOperations" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">115,911</ix:nonFraction> of net cash provided by operations for the period.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">The Company believes they have sufficient cash-on-hand&#160;for the Company to meet its financial obligations for at least the next 12 months from the date of the report as they come due. </p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_746" name="us-gaap:BusinessCombinationDisclosureTextBlock" contextRef="From2022-01-01to2022-03-31" escape="true" continuedAt="cont_294005"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><strong>Note 4 &#8211; Acquisition of 374Water, Inc. f/k/a PowerVerde Inc. </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><span style="text-decoration:underline">Agreement and Plan of Merger</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">In connection with the Merger,&#160;(see Note 1), the Company closed on a private placement of&#160;<ix:nonFraction id="fid_658" name="us-gaap:PartnersCapitalAccountUnitsSoldInPrivatePlacement" contextRef="From2022-01-01to2022-03-31_us-gaap_SeriesDPreferredStockMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">436,783</ix:nonFraction>&#160;shares of Series D Convertible Preferred Stock (the &#8220;Preferred Stock&#8221;) with a par value of $<ix:nonFraction id="fid_656" name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2022-03-31_us-gaap_SeriesDPreferredStockMember" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">0.0001</ix:nonFraction>, yielding gross proceeds of $<ix:nonFraction id="fid_657" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2022-01-01to2022-03-31_us-gaap_SeriesDPreferredStockMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">6,551,745</ix:nonFraction>&#160;(the &#8220;Private Placement&#8221;) and the settlement of a $<ix:nonFraction id="fid_659" name="scwo:SettlementOfLiabilityForPreferredStockShares" contextRef="From2022-01-01to2022-03-31_us-gaap_SeriesDPreferredStockMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">50,000</ix:nonFraction>&#160;liability for Preferred Stock shares. The Private Placement proceeds will be used for working capital, primarily for development, manufacture and commercialization of the Company&#8217;s Air SCWO systems. The Preferred Stock has a stated value of $15 per share, is convertible into common stock at $.30 per share and has voting rights based on the underlying shares of common stock. Upon liquidation of the Company, the Preferred Stockholders have liquidation preference before any assets can be distributed to common stockholders. All of the Preferred Stock was sold pursuant to an exemption from registration requirements under Regulation D and/or Section 4(2) of the Securities Act of 1933, as amended.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">As a result of the Merger, the issuance of the Preferred Stock, <ix:nonNumeric id="fid_655" name="scwo:Description" contextRef="From2022-01-01to2022-03-31_us-gaap_SeriesDPreferredStockMember">the former Private 374Water shareholders own 65.8% of the Company&#8217;s issued and outstanding common stock and 53.8% of the Company&#8217;s issued and outstanding voting stock</ix:nonNumeric> (which includes the Preferred Stock on an as converted basis).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">Also as a result of the Merger, the Company entered into two-year employment agreements with&#160;the Company &#160;founders Yaacov (Kobe) Nagar and Marc Deshusses, Ph. D. Mr. Nagar will serve as the Company&#8217;s CEO, replacing Richard H. Davis, who resigned as CEO upon closing of the Merger. Mr. Nagar&#160;initially receive an annual salary of $<ix:nonFraction id="fid_653" name="us-gaap:SalariesAndWages" contextRef="From2022-01-01to2022-03-31_scwo_MrNagarMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">200,000</ix:nonFraction>&#160;which was increased to $<ix:nonFraction id="fid_660" name="scwo:AnnaulSalaryIncreasedAmount" contextRef="From2022-01-01to2022-03-31_scwo_MrNagarMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">250,000</ix:nonFraction> effective January 26, 2022. Dr. Deshusses will serve as the Company&#8217;s Head of Technology on a part-time basis at a salary of $<ix:nonFraction id="fid_654" name="us-gaap:SalariesAndWages" contextRef="From2022-01-01to2022-03-31_srt_ChiefExecutiveOfficerMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">60,000</ix:nonFraction> per year.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">&#160;</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">F-25</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#TOCFS">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">&#160;</p><ix:continuation id="cont_294005"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">Pursuant to the Merger, Messrs. Nagar and Deshusses were appointed to the Company&#8217;s Board of Directors, joining Mr. Davis, who remains as a Director.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">The patented technology underlying 374Water&#8217;s supercritical water oxidation (SCWO) units, which was developed principally through the efforts of Messrs. Nagar and Deshusses at the facilities of Duke University, Durham, North Carolina (&#8220;Duke&#8221;), where Dr. Deshusses is a professor, is licensed to 374Water pursuant to a worldwide license agreement with Duke executed on April 16, 2021 (the &#8220;License Agreement&#8221;) simultaneous with the merger. In connection with the License Agreement, 374Water also executed an equity transfer Agreement with Duke pursuant to which Duke received a small block of shares of common stock (see Note 5).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">As a result of the Merger Agreement, for financial statement reporting purposes, the business combination between 374Water Inc. and 374Water was treated as a reverse acquisition and recapitalization for accounting purposes with 374Water deemed the accounting acquirer and 374Water Inc. deemed the accounting acquiree under the acquisition method of accounting in accordance with FASB Accounting Standards Codification (&#8220;ASC&#8221;) Section 805-10-55.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><span style="text-decoration:underline">The following assets and liabilities were assumed in the transaction:</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><ix:nonNumeric id="fid_638" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" contextRef="From2022-01-01to2022-03-31" escape="true"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Cash</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_788" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" contextRef="AsOf2022-03-31_scwo_ThreeSevenFourWaterMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">29,536</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Prepaid expense</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_789" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" contextRef="AsOf2022-03-31_scwo_ThreeSevenFourWaterMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">14,483</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Accounts Receivable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_790" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" contextRef="AsOf2022-03-31_scwo_ThreeSevenFourWaterMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,000</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Total assets acquired</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_791" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" contextRef="AsOf2022-03-31_scwo_ThreeSevenFourWaterMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">45,019</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Accounts payable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_792" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" contextRef="AsOf2022-03-31_scwo_ThreeSevenFourWaterMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">46,150</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Accrued expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_793" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" contextRef="AsOf2022-03-31_scwo_ThreeSevenFourWaterMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">83,094</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Total liabilities assumed</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_794" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" contextRef="AsOf2022-03-31_scwo_ThreeSevenFourWaterMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">129,244</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Net liabilities assumed</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_795" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" contextRef="AsOf2022-03-31_scwo_ThreeSevenFourWaterMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">84,225</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr></tbody></table></ix:nonNumeric></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;&#160;</p><ix:nonNumeric id="fid_747" name="us-gaap:IntangibleAssetsDisclosureTextBlock" contextRef="From2022-01-01to2022-03-31" escape="true" continuedAt="cont_f5d418"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><strong>Note 5 &#8211; Intangible Assets</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">Intangible assets are recorded at cost and consist of the license agreement with Duke University. The Company issued Duke University a small block of shares of common stock estimated to have a fair value of $<ix:nonFraction id="fid_680" name="us-gaap:CommonStockValue" contextRef="AsOf2022-03-31_scwo_LicenseAgreementMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,073,529</ix:nonFraction> as consideration for granting the Company the license based on the Company&#8217;s common stock market price on the date the license agreement was executed (see Note 8). Intangible assets are comprised of the following as of March 31, 2022 and December 31, 2021:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><ix:nonNumeric id="fid_640" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" contextRef="From2022-01-01to2022-03-31" escape="true"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Name</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Estimated Life</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Balance at December 31, 2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Additions</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Amortization</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Balance at March 31, 2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">License agreement</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">17 Years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_316-a7e9c3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2021-12-31_scwo_LicenseAgreementMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,028,114</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_319" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2021-12-31_us-gaap_PatentsMember" format="ixt:zerodash" unitRef="USD" decimals="0">&#8212;</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_664" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2022-03-31_scwo_LicenseAgreementMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">15,787</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_670" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2022-03-31_scwo_LicenseAgreementMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,012,327</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Patents</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">20 Years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_668" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2021-12-31_us-gaap_PatentsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">34,742</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_665" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2022-03-31_us-gaap_PatentsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">436</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_671" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2022-03-31_us-gaap_PatentsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">34,306</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Total</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_669" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2021-12-31_scwo_LicenseAgreementMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,062,856</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_796" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">16,223</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_663" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,046,633</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">Depreciation and Amortization expense for the three months ended March 31, 2022, was $<ix:nonFraction id="fid_679" name="us-gaap:AdjustmentForAmortization" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">16,458</ix:nonFraction>.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">&#160;</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">F-26</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#TOCFS">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:continuation id="cont_f5d418"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">Estimated future amortization expense as of March 31, 2022:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><ix:nonNumeric id="fid_639" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" contextRef="From2022-01-01to2022-03-31" escape="true"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">2022 (Remaining 9 months)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_672" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">48,663</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_673" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">64,884</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_674" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">64,884</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">2025</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_675" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">64,884</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">2026</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_676" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">64,884</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Thereafter</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_677" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">738,434</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Intangible assets, Net</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_678" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,046,633</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table></ix:nonNumeric></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_619" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" contextRef="From2022-01-01to2022-03-31" escape="true" continuedAt="cont_3a19ee"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><strong>Note 6 &#8211; Stockholder&#8217; Equity</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">The Company is authorized to issue <ix:nonFraction id="fid_710" name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">1,000,000</ix:nonFraction> preferred stock shares and <ix:nonFraction id="fid_800" name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">200,000,000</ix:nonFraction> common stock shares both with a par value of $<ix:nonFraction id="fid_721" name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">0.0001</ix:nonFraction>.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><strong>Preferred Stock</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">On October 30, 2020, the Company designated 1,000,000 shares as Series D Convertible Preferred Stock with a par value of $0.0001.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">On April 16, 2021, the Company closed on a private placement of 440,125 shares of Series D Convertible Preferred Stock (the &#8220;Preferred Stock&#8221;) with a par value of $0.0001, yielding gross proceeds of $6,551,691 (the &#8220;Private Placement&#8221;) and settlement of a $50,000 liability for Preferred Stock shares. The Private Placement proceeds will be used for working capital, primarily for the development, manufacturing and commercialization of 374Water&#8217;s Air SCWO systems. The Preferred Stock has a stated value of $15 per share, is convertible into common stock at $0.30 per share and has voting rights based on the underlying shares of common stock. Upon liquidation of the Company, the Preferred Stockholders have a liquidation preference before any assets can be distributed to common stockholders. All of the Preferred Stock were sold pursuant to an exemption from registration requirements under Regulation D and/or Section 4(2) of the Securities Act of 1933, as amended. On September 29, 2021, 412,853 shares of Series D Preferred stock were converted into 20,642,667 shares of common stock.&#160; On January 12, 2022, the Company converted the remaining 27,272 shares of Series D Preferred stock to 1,363,149 shares of common stock.&#160; As of March 31, 2022, there were no shares of Series D Preferred stock issued and outstanding.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><strong>Common Stock</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">The holders of common stock are entitled to one vote per share on all matters submitted to a vote of shareholders, including the directors&#8217; election. There is no right to cumulate votes in the election of directors. The holders of common stock are entitled to any dividends that may be declared by the board of directors out of funds legally available for payment of dividends subject to the prior rights of holders of preferred stock and any contractual restrictions the Company has against the payment of dividends on common stock. In the event of our liquidation or dissolution, holders of common stock are entitled to share ratably in all assets remaining after payment of liabilities and the liquidation preferences of any outstanding shares of preferred stock. Holders of common stock have no preemptive rights and have no right to convert their common stock into any other securities. As of March 31, 2022, there were <ix:nonFraction id="fid_724" name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">126,680,895</ix:nonFraction> shares of common stock issued and outstanding.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">F-27</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#TOCFS">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:continuation id="cont_3a19ee" continuedAt="cont_efbb3f"><p style="font-size:10pt;font-family:times new roman;margin:0px">On April 16, 2021, as a result of the closing of the Merger Agreement (see Note 4), the equity of the consolidated entity is the historical equity of 374Water, Inc (&#8220;Private 374Water&#8221;) retroactively restated to reflect the number of shares issued by the Company in the reverse recapitalization. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">Pursuant to the Merger, all Private 374Water shares were cancelled and&#160;the Company &#160;issued to the former Private 374Water stockholders a total of 62,410,452 shares of&#160;the Company&#8217;s common stock.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">On April 16, 2021, the Company issued a small block of shares of common stock estimated to have a fair value of $1,073,369 as consideration for the grant of a license to the Company (see Notes 5 and 8).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">During the three months ended March 31, 2022, the Company issued <ix:nonFraction id="fid_733" name="us-gaap:ConversionOfStockSharesIssued1" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">1,363,149</ix:nonFraction> shares of common stock from the conversion of <ix:nonFraction id="fid_734" name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">27,272</ix:nonFraction> Preferred Stock shares.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><span style="text-decoration:underline">Stock-based compensation</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">During the three months ended March 31, 2022, and 2021, the Company recorded stock-based compensation of $<ix:nonFraction id="fid_719" name="us-gaap:ShareBasedCompensation" contextRef="From2022-01-01to2022-03-31_scwo_ConsultantMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">97,558</ix:nonFraction> and $<ix:nonFraction id="fid_720" name="us-gaap:ShareBasedCompensation" contextRef="From2021-01-01to2021-03-31_scwo_ConsultantMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">10,433</ix:nonFraction>, respectively, related to common stock issued or vested options to employees and various consultants of the Company.&#160; For the three months ended March 31, 2022, $<ix:nonFraction id="fid_728" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2022-01-01to2022-03-31_scwo_ConsultantMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">93,868</ix:nonFraction> was charged as general and administrative expenses and $<ix:nonFraction id="fid_726" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2022-01-01to2022-03-31_scwo_ConsultantMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">3,690</ix:nonFraction> as research and development expenses in the accompanying condensed consolidated statements of operations.&#160; For the three months ended March 31, 2021, $<ix:nonFraction id="fid_729" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2021-01-01to2021-03-31_scwo_ConsultantMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">6,518</ix:nonFraction> was charged as general and administrative expenses and $<ix:nonFraction id="fid_727" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2021-01-01to2021-03-31_scwo_ConsultantMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">3,915</ix:nonFraction> as research and development expenses in the accompanying condensed consolidated statements of operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><strong>Stock Options</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">Stock option activity for the three months ended March 31, 2022, is summarized as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">&#160;</p><ix:nonNumeric id="fid_641" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" contextRef="From2022-01-01to2022-03-31" escape="true"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Weighted Average Exercise Price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Aggregate Intrinsic Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Weighted Average Remaining Contractual Life (Years)</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Options outstanding at December 31, 2021</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_343-ded48a" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-12-31_scwo_OptionsMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">12,300,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_351-c44ca4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-12-31_scwo_OptionsMember" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">0.37</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_340-482c35" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2021-12-31_scwo_OptionsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">4,521,310</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonNumeric id="fid_341-3d2fcb" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="From2021-01-01to2021-12-31_scwo_OptionsMember" format="ixt-sec:duryear">5.62</ix:nonNumeric></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Granted </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_681" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2022-01-01to2022-03-31_scwo_OptionsMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">360,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_685" name="scwo:Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice" contextRef="From2022-01-01to2022-03-31_scwo_OptionsMember" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">3.33</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Expired/forfeit</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Options outstanding at March 31, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_688" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-03-31_scwo_OptionsMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">12,660,000</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_689" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2022-03-31_scwo_OptionsMember" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">0.45</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_690" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2022-03-31_scwo_OptionsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">5,719,310</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonNumeric id="fid_684" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="From2022-01-01to2022-03-31_scwo_OptionsMember" format="ixt-sec:duryear">5.39</ix:nonNumeric></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">Total unrecognized compensation associated with these unvested options is approximately $<ix:nonFraction id="fid_725" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" contextRef="AsOf2022-03-31_scwo_OptionsMember" format="ixt:numdotdecimal" unitRef="USD" decimals="0">501,471</ix:nonFraction> which will be recognized over a period of four years.</p></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">F-28</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td><em><a href="#TOCFS">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:continuation id="cont_efbb3f"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">The fair value of these options granted were estimated on the date of grant, using the Black-Scholes option-pricing model with the following assumptions:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">&#160;</p><ix:nonNumeric id="fid_643" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" contextRef="From2022-01-01to2022-03-31_us-gaap_StockOptionMember" escape="true"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>March 31, 2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Dividend yield</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonFraction id="fid_691" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2022-01-01to2022-03-31_scwo_OptionsMember" unitRef="Pure" decimals="INF" scale="-2">0.00</ix:nonFraction>%</p></td><td style="width:1%;white-space: nowrap;"></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Expected life</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><ix:nonNumeric id="fid_692" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="From2022-01-01to2022-03-31_scwo_OptionsMember_scwo_MinimumsMember" format="ixt-sec:duryear">5.65</ix:nonNumeric> &#8211; <ix:nonNumeric id="fid_693" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="From2022-01-01to2022-03-31_scwo_OptionsMember_scwo_MaximumsMember" format="ixt-sec:duryear">5.75</ix:nonNumeric> Years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Expected volatility</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><ix:nonFraction id="fid_694" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2022-01-01to2022-03-31_scwo_OptionsMember_scwo_MinimumsMember" unitRef="Pure" decimals="INF" scale="-2">37.73</ix:nonFraction> &#8211; <ix:nonFraction id="fid_695" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2022-01-01to2022-03-31_scwo_OptionsMember_scwo_MaximumsMember" unitRef="Pure" decimals="INF" scale="-2">39.18</ix:nonFraction>%</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Risk-free interest rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><ix:nonFraction id="fid_696" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2022-01-01to2022-03-31_scwo_OptionsMember_scwo_MinimumsMember" unitRef="Pure" decimals="INF" scale="-2">1.44</ix:nonFraction> &#8211; <ix:nonFraction id="fid_697" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2022-01-01to2022-03-31_scwo_OptionsMember_scwo_MaximumsMember" unitRef="Pure" decimals="INF" scale="-2">2.12</ix:nonFraction>%</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><strong>Stock Warrants</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">In April 2021, pursuant to the binding Memorandum of Understanding dated as of March 30, 2021, between 374Water and MB Holding Inc. (the &#8220;MOU&#8221;), a warrant for the purchase of&#160;<ix:nonFraction id="fid_421" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">3,783,333</ix:nonFraction>&#160;shares of common stock at an exercise price of $0.30&#160;per share was issued to MB Holding Inc. as consideration for executing the MOU and was considered fully vested upon the execution of the MOU. These warrants were to expire in March 2022. Those warrants were estimated to have a grant-date fair value of $0.37&#160;per warrant or aggregate fair value of $1,399,833&#160;which has been presented as product development expense on the condensed statements of operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">During the year ended December 31, 2021, the warrants were exercised resulting in the issuance of 3,783,333 shares of common stock and proceeds of $1,134,499. Terry Merrell, a member of the Company&#8217;s Board of Directors, has sole voting and dispositive power over the securities held by MB Holdings Inc. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">As of March 31, 2022, there were&#160;1,250,000&#160;warrants outstanding which relate to the Series 1 offering executed in December 2021, where investors were offered a warrant for every two common shares purchased during the offering at an exercise price of $<ix:nonFraction id="fid_716" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">2.50</ix:nonFraction>&#160;per share. The intrinsic value of all outstanding warrants as of March 31, 2022 was $<ix:nonFraction id="fid_735" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">437,500</ix:nonFraction>&#160;based on the market price of our common stock of $<ix:nonFraction id="fid_715" name="us-gaap:CommonStockNoParValue" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">2.85</ix:nonFraction>&#160;per share.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">During the three months ended March 31, 2022, no warrants were issued or exercised. As of March 31, 2022, there are <ix:nonFraction id="fid_714" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">1,250,000</ix:nonFraction> outstanding warrants.&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">&#160;A summary of warrant activity during the three months ended March 31, 2022, is as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">&#160;</p><ix:nonNumeric id="fid_642" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" contextRef="From2022-01-01to2022-03-31" escape="true"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Shares</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Weighted Average Exercise Price</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Aggregate Intrinsic Value</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Weighted Average Remaining Contractual Life (Years)</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Balance at December 31, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_698" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">1,250,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_706" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">2.50</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_699" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">437,500</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonNumeric id="fid_709" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="From2021-01-01to2021-12-31" format="ixt-sec:duryear">2.96</ix:nonNumeric></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Issued</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">&#8212;&#8212;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Balance at March 31, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_705" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">1,250,000</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_707" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">2.50</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_708" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">437,500</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonNumeric id="fid_700" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="From2022-01-01to2022-03-31" format="ixt-sec:duryear">2.72</ix:nonNumeric></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table></ix:nonNumeric></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_620" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" contextRef="From2022-01-01to2022-03-31" escape="true"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Note 7 - Related Party Transactions</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">In 2021, the Company entered into an agreement to fabricate and manufacture the AIRSCWO systems&#160;with Merrell Bros. Holding Company. As part of the agreement, the Company&#160;appointed Terry Merrell to its board of directors. As of March 31, 2022, Merrell Bros. or their affiliates own stock in excess of <ix:nonFraction id="fid_741" name="scwo:StockInExcessPercentageOfOutstandingShare" contextRef="From2022-01-01to2022-03-31" unitRef="Pure" decimals="INF" scale="-2">5</ix:nonFraction>% of the outstanding common stock.&#160; As of March 31, 2022, the Company had $<ix:nonFraction id="fid_740" name="us-gaap:RelatedPartyCosts" contextRef="From2022-01-01to2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">50,000</ix:nonFraction> in related party expenses related to the manufacturing of the AIRSCWO systems.&#160;</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_621" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" contextRef="From2022-01-01to2022-03-31" escape="true"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Note 8 &#8211; Commitments and Contingencies </strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px">The patented technology underlying 374Water&#8217;s supercritical water oxidation (SCWO) units, which was developed principally through the efforts of Messrs. Nagar and Deshusses at the facilities of Duke University, Durham, North Carolina (&#8220;Duke&#8221;), where Dr. Deshusses is a professor, is licensed to 374Water pursuant to a worldwide license agreement with Duke executed on April 16, 2021 (the &#8220;License Agreement&#8221;). In connection with the License Agreement, 374Water also executed an equity transfer Agreement with Duke pursuant to which Duke received a small block of common stock in the Company (See Notes 4 and 6). Under the terms of the License Agreement, the Company is required to make royalty payments based on a percentage of licensed product sales, as defined in the License Agreement which is triggered by the sale of licensed products. Further, the Company is also required to pay royalties on a percentage of sublicensing fees. The Company will reimburse Duke for any ongoing patent expenses incurred. During the three month period ending March 31, 2022, the Company has not incurred any expenses in connection with this License Agreement. The Company may terminate the license agreement anytime by providing Duke 60 days&#8217; written notice.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_622" name="us-gaap:DeferredRevenueDisclosureTextBlock" contextRef="From2022-01-01to2022-03-31" escape="true"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Note 9 &#8211; Deferred Revenue</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">As of March&#160;31, 2022 and March 31, 2021, the Company had total deferred revenue of $<ix:nonFraction id="fid_742" name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">763,333</ix:nonFraction> and $<ix:nonFraction id="fid_743" name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2021-03-31" format="ixt:numdotdecimal" unitRef="USD" decimals="0">0</ix:nonFraction>, respectively. As of March&#160;31, 2022, the Company expects&#160;<ix:nonFraction id="fid_744" name="scwo:DeferredRevenuePercentage" contextRef="AsOf2022-03-31" unitRef="Pure" decimals="INF" scale="-2">100</ix:nonFraction>% of total deferred revenue to be realized in less than a year.&#160; </p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_623" name="us-gaap:SubsequentEventsTextBlock" contextRef="From2022-01-01to2022-03-31" escape="true"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Note 10 &#8211; Subsequent Events </strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">Effective April 13, 2022, in accordance with Section 228 of the Delaware Corporation Law, shareholders of the Company holding a majority of the voting power of the Company (the &#8220;Consenting Shareholders&#8221;) approved the adoption of the Company&#8217;s 2021 Equity Incentive Plan, reserving up to <ix:nonFraction id="fid_745" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="AsOf2022-04-13_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">10,000,000</ix:nonFraction> shares of Common Stock for issuance in connection with awards thereunder (the &#8220;Equity Plan Adoption&#8221;).&#160; </p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">F-29</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td>&#160;</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares of Common Stock</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>374Water,&#160;Inc.</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="font-size:18pt">Roth Capital Partners</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>, 2022</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"></td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td>&#160;</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>PART&#160;II</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>INFORMATION NOT REQUIRED IN PROSPECTUS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Item 13.</strong>&#160;<strong>Other Expenses of Issuance and Distribution</strong>&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">The following table sets forth the fees and expenses, other than underwriting discounts and commissions, payable by us in connection with the offering described in this registration statement. All amounts shown are estimates other than the registration fee, the FINRA filing fee and the listing fee.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">SEC registration fee</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2,318</p></td><td style="width:1%;white-space: nowrap;"></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">FINRA filing fee</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">*</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Nasdaq listing fee</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">*</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Printing fees and expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">*</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Legal fees and expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">*</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Registrar and transfer agent fees</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">*</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Blue sky fees and expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">*</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounting fees and expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">*</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Miscellaneous expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">*</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Total</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;"></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">*</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">*</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">To be completed by amendment.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Item 14.</strong>&#160;<strong>Indemnification of Directors and Officers</strong>&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Our Amended and Restated Certificate of Incorporation limit our directors&#8217; liability to the fullest extent permitted under Delaware law. Delaware law provides that directors of a corporation will not be personally liable for monetary damages for breach of their fiduciary duties as directors, except for liability:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">For any breach of a director&#8217;s duty of loyalty to us and our stockholders;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">For any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Under Section 174 of the Delaware General Corporation Law (unlawful payment of dividends or redemption of shares); or</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">For any breach of a director&#8217;s duty of loyalty to us or our stockholders.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">If the Delaware General Corporation Law is amended to authorize corporate action further eliminating or limiting the personal liability of directors, then the liability of our directors shall be eliminated or limited to the fullest extent permitted by the Delaware General Corporation Law, as so amended.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Delaware law provides, and our Amended and Restated Bylaws will provide that we will, in certain situations, indemnify our directors and officers and may indemnify other employees and other agents, to the fullest extent permitted by law. Any indemnified person is also entitled, subject to certain limitations, to payment or reimbursement of reasonable expenses in advance of the final disposition of the proceeding.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We intend to maintain a directors&#8217; and officers&#8217; insurance policy pursuant to which our directors and officers are insured against liability for certain actions taken in their capacities as directors and officers. We believe that these provisions in our Amended and Restated Certificate of Incorporation and Bylaws and any such insurance policy are necessary to attract and retain qualified persons as directors and officers.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">II-1</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td>&#160;</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or control persons, in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">There is no pending litigation or proceeding naming any of our directors or officers as to which indemnification is being sought, nor are we aware of any pending or threatened litigation that may result in claims for indemnification</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The underwriter is obligated, under certain circumstances, pursuant to the underwriting agreement to be filed as Exhibit&#160;1.1 hereto, to indemnify us, our officers and directors against liabilities under the Securities Act.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Item 15.</strong>&#160;<strong>Recent Sales of Unregistered Securities</strong>&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">All of 374Water&#8217;s sales of unregistered securities since inception have been made pursuant to private offerings to accredited investors. The sales set forth below were made pursuant to an exemption from registration requirements under Regulation D and/or Section 4(a)(2) of the Securities Act of 1933, as amended. Except as otherwise noted below, no placement agent fees or commissions were paid on these offerings, and net proceeds were used for working capital.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">In connection with the Merger with PowerVerde, 374Water closed on a private placement of&#160;440,125&#160;shares of Series D Convertible Preferred Stock (the &#8220;Preferred Stock&#8221;) with a par value of $.0001, yielding gross proceeds of $6,551,745&#160;(the &#8220;Private Placement&#8221;) and the settlement of a $50,000&#160;liability for Preferred Stock shares. The Private Placement proceeds were raised for general corporate purposes, primarily for development, manufacture and commercialization of 374Water Inc.&#8217;s AirSCWO&#8482; systems.&#160;The Preferred Stock has a stated value of $15 per share, is convertible into common stock at $.30 per share and has voting rights based on the underlying shares of common stock. All of shares of Preferred Stock were converted to shares of Common Stock as of January 31, 2022. The Preferred Stock was sold pursuant to an exemption from registration requirements under Regulation D and/or Section 4(a)(2) of the Securities Act of 1933, as amended.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">In December 2021, 374Water closed on a private placement of 2,500,000 shares of Common Stock with a par value of $.0001 and at an exercise price of $2.00 yielding $5,000,000. Along with the issuance of the Common Stock, investors received a warrant for every two common shares purchased during the offering at an exercise price of $2.50 per share, for a total of 1,250,000 warrants. The private placement proceeds were raised to assist in the Company&#8217;s efforts towards meeting Nasdaq uplisting requirements. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">II-2</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td>&#160;</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Item 16.</strong>&#160;<strong>Exhibits and Financial Statement Schedules</strong>&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(a)</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><em>Exhibits. </em>The following exhibits are included herein or incorporated herein by reference:</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:justify;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px;background-color:#cceeff"><td style="width:6%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">1.1** </p></td><td style="width:2%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;">Form of Underwriting Agreement.</td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="http://www.sec.gov/Archives/edgar/data/933972/000119312508180941/dex31.htm">3.1 </a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><a href="http://www.sec.gov/Archives/edgar/data/933972/000119312508180941/dex31.htm">Amended and Restated Certificate of Incorporation of Vyrex Corporation as filed with the Delaware Secretary of State on August 14, 2008 (previously filed on Form 10-Q for the quarter ended June 30, 2008, as filed with the SEC on August 19, 2008).</a></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="http://www.sec.gov/Archives/edgar/data/933972/000157570521000209/ex3_5.htm">3.2 </a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><a href="http://www.sec.gov/Archives/edgar/data/933972/000157570521000209/ex3_5.htm">Certificate of Designation of Preferences, Rights and Limitations of PowerVerde, Inc. Series D Convertible Preferred Stock dated as of October 30, 2020, and filed April 16, 2021, with the Secretary of State of Delaware (previously filed on Form 8-K with the SEC on April 22, 2021).</a></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="http://www.sec.gov/Archives/edgar/data/933972/000157570521000209/ex3_4.htm">3.4 </a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><a href="http://www.sec.gov/Archives/edgar/data/933972/000157570521000209/ex3_4.htm">Certificate of Merger of 374Water Acquisition Corp. into 374 Water Inc. filed April 16, 2021 with the Secretary of State of Delaware (previously filed on Form 8-K filed with the SEC on April 22, 2021).</a></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="http://www.sec.gov/Archives/edgar/data/933972/000119312505206052/dex3ii.htm">3.3 </a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><a href="http://www.sec.gov/Archives/edgar/data/933972/000119312505206052/dex3ii.htm">Bylaws of Vyrex Corporation, dated as of September 9, 2005 (previously filed on Form 8-K filed with the SEC on October 21, 2005).</a></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">4.1**</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">Form of Underwriter&#8217;s Warrant</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">5.1** </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;">Opinion of Womble Bond Dickinson (US) LLP.</td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="http://www.sec.gov/Archives/edgar/data/933972/000093639208000112/a37963exv10w1.htm">10.1 </a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><a href="http://www.sec.gov/Archives/edgar/data/933972/000093639208000112/a37963exv10w1.htm">Agreement and Plan of Merger dated as of February 11, 2008 by and among Vyrex Corporation, Vyrex Acquisition Corporation and PowerVerde, Inc (previously filed on Form 8-K with the SEC on February 12, 2008).</a></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="http://www.sec.gov/Archives/edgar/data/933972/000157570520000249/ex99_1.htm">10.2 </a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><a href="http://www.sec.gov/Archives/edgar/data/933972/000157570520000249/ex99_1.htm">Employment Agreement between PowerVerde Inc. and Daniel T. Bogar dated September 1, 2020 (previously filed on Form 10-Q for the quarter ended September 30, 2020, as filed with the SEC on November 16, 2020).</a></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="http://www.sec.gov/Archives/edgar/data/933972/000157570520000249/ex99_2.htm">10.3 </a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><a href="http://www.sec.gov/Archives/edgar/data/933972/000157570520000249/ex99_2.htm">Employment Agreement between PowerVerde Inc. and Richard H. Davis dated September 1, 2020 (previously filed on Form 10-Q for the quarter ended September 30, 2020, as filed with the SEC on November 16, 2020).</a></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="http://www.sec.gov/Archives/edgar/data/933972/000157570521000209/ex10_1.htm">10.4 </a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><a href="http://www.sec.gov/Archives/edgar/data/933972/000157570521000209/ex10_1.htm">Agreement and Plan of Merger dated as of April 16, 2021 among PowerVerde, Inc., 374Water Inc. and 374 Water Acquisition Corp. (previously filed on Form 8-K filed with the SEC on April 22, 2021).</a></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="http://www.sec.gov/Archives/edgar/data/933972/000157570521000209/ex10_2.htm">10.5 </a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><a href="http://www.sec.gov/Archives/edgar/data/933972/000157570521000209/ex10_2.htm">Employment Agreement dated as of April 16, 2021 between PowerVerde, Inc. and Yaacov Nagar (previously filed on Form 8-K filed with the SEC on April 22, 2021).</a></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="http://www.sec.gov/Archives/edgar/data/933972/000165495422000931/scwo_ex101.htm">10.6</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><a href="http://www.sec.gov/Archives/edgar/data/933972/000165495422000931/scwo_ex101.htm">First Amendment to Employment Agreement dated as of January 26, 2022 between 374 Water Inc. and Yaacov Nagar (previously filed on Form 8-K filed with the SEC on February 1, 2022).</a></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="http://www.sec.gov/Archives/edgar/data/933972/000157570521000209/ex10_3.htm">10.7 </a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><a href="http://www.sec.gov/Archives/edgar/data/933972/000157570521000209/ex10_3.htm">Employment Agreement dated as of April 16, 2021 between PowerVerde, Inc. and Marc Deshusses, Ph.D. (previously filed on Form 8-K filed with the SEC on April 22, 2021).</a></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="http://www.sec.gov/Archives/edgar/data/933972/000157570521000209/ex10_4.htm">10.8 </a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><a href="http://www.sec.gov/Archives/edgar/data/933972/000157570521000209/ex10_4.htm">License Agreement dated as of April 16, 2021 between 374Water Inc. and Duke University (previously filed on Form 8-K filed with the SEC on April 22, 2021).</a></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="http://www.sec.gov/Archives/edgar/data/933972/000157570521000209/ex10_5.htm">10.9 </a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><a href="http://www.sec.gov/Archives/edgar/data/933972/000157570521000209/ex10_5.htm">Equity Transfer Agreement dated as of April 16, 2021 between 374Water Inc. and Duke University (previously filed on Form 8-K filed with the SEC on April 22, 2021).</a></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">II-3</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td>&#160;</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:justify;font:10pt times new roman;margin-left:auto;margin-right:auto;width:100%" cellpadding="0"><tbody><tr style="height:15px;background-color:#cceeff"><td style="width:6%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="http://www.sec.gov/Archives/edgar/data/933972/000157570521000209/ex10_6.htm">10.10 </a></p></td><td style="width:2%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><a href="http://www.sec.gov/Archives/edgar/data/933972/000157570521000209/ex10_6.htm">Binding Memorandum of Understanding dated March 30, 2021 between 374Water Inc. and MB Holding Inc. (previously filed on Form 8-K filed with the SEC on April 22, 2021).</a></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="http://www.sec.gov/Archives/edgar/data/933972/000157570521000431/ex10_1.htm">10.11 </a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><a href="http://www.sec.gov/Archives/edgar/data/933972/000157570521000431/ex10_1.htm">Manufacturing and Service Agreement, dated as of July 7, 2021, by and between 374Water Systems Inc. and Merrell Bros. Fabrication, LLC (previously filed on Form 8-K filed with the SEC on July 13, 2021).</a></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="http://www.sec.gov/Archives/edgar/data/933972/000165495421013464/scwo_ex101.htm">10.12 </a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><a href="http://www.sec.gov/Archives/edgar/data/933972/000165495421013464/scwo_ex101.htm">Form of Accredited Investor Subscription Agreement (including the form of Warrant for the Purchase of Common Stock) for the December 17, 2021 private placement closing (previously filed on Form 8-K filed with the SEC on December 23, 2021).</a></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="http://www.sec.gov/Archives/edgar/data/933972/000165495422005446/scwo_def14c.htm">10.13</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="http://www.sec.gov/Archives/edgar/data/933972/000165495422005446/scwo_def14c.htm">2021 Equity Incentive Plan (previously filed as Annex A to Schedule 14C filed with the SEC on April 27, 2022)</a></p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="http://www.sec.gov/Archives/edgar/data/933972/000165495422008456/scwo_ex101.htm">10.14</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="http://www.sec.gov/Archives/edgar/data/933972/000165495422008456/scwo_ex101.htm">Form of Board of Directors Agreement (previously filed on Form 8-K filed with the SEC on June 16, 2022).</a></p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="scwo_ex231.htm">23.1* </a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><a href="scwo_ex231.htm">Consent of Cherry Bekaert LLP</a></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="scwo_ex232.htm">23.2* </a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><a href="scwo_ex232.htm">Consent of D. Brooks and Associates CPAs, P.A.</a></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">23.3** </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;">Consent of Womble Bond Dickinson (US) LLP (included in Exhibit 5.1).</td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">24.1*</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;">Power of Attorney (contained on the signature page to this registration statement).</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="scwo_ex107.htm">107*</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="scwo_ex107.htm">Calculation of Filing Fee Tables</a></p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">*</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Filed herewith.</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">**</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">To be filed by amendment.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">II-4</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td>&#160;</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:6%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Item 17.</strong></p></td><td style="width:84%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Undertakings</strong></p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">a.</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">The undersigned registrant hereby undertakes:</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">1. </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">i. </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">To include any prospectus required by section 10(a)(3) of the Securities Act of 1933;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">ii.</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than twenty percent (20%) change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement; and</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">iii.</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>provided, however</em>, that paragraphs (1)(i), (1)(ii) and (1)(iii) above do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934, as amended, or the&#160;Exchange Act, that are incorporated by reference in this Registration Statement or is contained in a form of prospectus filed pursuant to Rule 427(b) that is part of this Registration Statement.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">2.</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">3.</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">4.</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">i.</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">ii.</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">iii.</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">iv.</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">II-5</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td>&#160;</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">b.</p></td><td colspan="3"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant&#8217;s annual report pursuant to section 13(a) or section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan&#8217;s annual report pursuant to section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160; </p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">c.</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act of 1933 and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">d.</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The undersigned registrant hereby undertakes that:</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">1.</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For purposes of determining any liability under the Securities Act of 1933, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">2.</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For the purpose of determining any liability under the Securities Act of 1933, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">II-6</td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td>&#160;</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>SIGNATURES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Durham, State of North Carolina on June 17, 2022.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td colspan="2" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>374WATER&#160;INC.</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="width:50%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:3%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:35%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:12%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">By:</p></td><td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">/s/ Yaacov Nagar</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Yaacov Nagar</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Chief Executive Officer and President</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The undersigned directors and officers of 374Water&#160;Inc. hereby constitute and appoint Yaacov Nagar and Israel D. Abitbol, and each of them, any of whom may act without joinder of the other, as the individual&#8217;s true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for the person and in his or her name, place and stead, in any and all capacities, to sign this registration statement and any or all amendments, including post-effective amendments to the registration statement, including a prospectus or an amended prospectus therein and any registration statement for the same offering that is to be effective upon filing pursuant to Rule&#160;462(b)&#160;under the Securities Act, and all other documents in connection therewith to be filed with the SEC, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact as agents or any of them, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:35%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><em>Signature</em></strong></p></td><td style="width:3%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:12%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><em>Date</em></strong></p></td><td style="width:2%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><em>Title</em></strong></p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>/s/ Yaacov Nagar</em></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">June&#160;17, 2022</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Chairman of the Board, Chief Executive Officer and President (Principal Executive Officer)</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Yaacov Nagar</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><em>/s/ Israel D. Abitbol</em></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">June&#160;17, 2022</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Chief Financial Officer (Principal Accounting Officer)</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Israel D. Abitbol</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>/s/ Richard H. Davis</em></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">June 17, 2022</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Director</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Richard H. Davis</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>/s/ Terry Merrell</em></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">June&#160;17, 2022</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Director</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Terry Merrell</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><em><span style="text-decoration:underline">/s/ Deanna Rene Estes__________</span></em><span style="text-decoration:underline"></span></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">June&#160;17, 2022</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Director</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Deanna Rene Estes</em></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">/s/ Buddie Joe Penn___________</span></em></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">June&#160;17, 2022</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Director</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Buddie Joe Penn</em></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">/s/ Yizhaq Polad_____________</span></em></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">June&#160;17, 2022</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Director</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Yizhaq Polad</em></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">/s/James M. Vanderhider______</span></em></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">June&#160;17, 2022</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Director</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>James M. Vanderhider</em></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">II-7</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>2
<FILENAME>scwo_ex231.htm
<DESCRIPTION>CONSENT OF CHERRY BEKAERT LLP
<TEXT>
<html><head><title>scwo_ex231.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: left; FONT: 10pt times new roman"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>&nbsp; EXHIBIT 23.1</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Consent of Independent Registered Public Accounting Firm</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We hereby consent to the incorporation by reference in the Registration Statement on Form S-1 of 374Water Inc. and subsidiaries (the &#8220;Company&#8221;), of our report dated March 1, 2022, relating to the consolidated financial statements as of and for the year ended December 31, 2021, which appears in the Company&#8217;s Annual Report on Form 10&#8209;K and incorporated by reference herein. We also consent to the reference to our firm under the heading &#8220;Experts&#8221; in the prospectus. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px"><em>/s/ Cherry Bekaert LLP</em></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">Raleigh, North Carolina</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">June 17, 2022</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>3
<FILENAME>scwo_ex232.htm
<DESCRIPTION>CONSENT OF D. BROOKS AND ASSOCIATES CPAS, P.A.
<TEXT>
<html><head><title>scwo_ex232.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: left; FONT: 10pt times new roman"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>EXHIBIT 23.2</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&nbsp; </p> <p style="font-size:10pt;font-family:times new roman;margin:0px"><img src="scwo_ex232img2.jpg"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</strong></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">374Water, Inc. </p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">We hereby consent to the incorporation by reference in this Registration Statement of 374Water, Inc. on Form S-1 to be filed on or about June 17, 2022 of our report dated March 29, 2021 on our audit of 374Water, Inc.&#8217;s financial statements as of December 31, 2020 and for the year then ended. Our report includes an explanatory paragraph about the existence of the substantial doubt concerning the Company&#8217;s ability to continue as a going concern. </p> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><img src="scwo_ex232img1.jpg"> </p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">D. Brooks and Associates CPAs, P.A.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">Palm Beach Gardens, FL</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">June 17, 2022</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="scwo_ex232img3.jpg"></p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>scwo_ex107.htm
<DESCRIPTION>FILING FEES
<TEXT>
<html><head><title>scwo_ex107.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: justify; FONT: 10pt times new roman"><p style="MARGIN: 0px; text-align:right;"><strong>EXHIBIT 107</strong></p> <p style="MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Calculation of Filing Fee Tables</strong></p> <p style="MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Registration Statement on Form S-1</strong></p> <p style="MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>(Form Type)</strong></p> <p style="MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0in; text-align:center;">&nbsp;<strong>374WATER INC. &nbsp;</strong></p> <p style="MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>(Exact Name of Registrant as Specified in its Charter)</strong></p> <p style="MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>Table 1: Newly Registered and Carry Forward Securities </strong> <p style="MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>&nbsp; <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"></p></strong> <p style="MARGIN: 0px; text-align:justify;"> <p style="margin:0px"> <table style="border-spacing:0;font-size:10pt;border-right:#000000 1px solid;border-bottom:#000000 1px solid;text-align:justify;margin-left:auto;margin-right:auto;width:100%" cellpadding="2"> <tr style="height:15px"> <td style="border-top:#000000 1px solid;border-left:#000000 1px solid;padding:2px;width:9%;"> <p style="text-align:center;margin:0px">&nbsp;</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:7%;vertical-align:bottom;"> <p style="text-align:center;margin:0px 0px 0px 0in"><strong>Security Type</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:8%;vertical-align:bottom;"> <p style="text-align:center;margin:0px 0px 0px 0in"><strong>Security Class Title</strong><sup>(1)</sup></p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:7%;vertical-align:bottom;"> <p style="text-align:center;margin:0px 0px 0px 0in"><strong>Fee Calculation or Carry Forward Rule</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:7%;vertical-align:bottom;"> <p style="text-align:center;margin:0px 0px 0px 0in"><strong>Amount</strong></p> <p style="text-align:center;margin:0px 0px 0px 0in"><strong>Registered</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:7%;vertical-align:bottom;"> <p style="text-align:center;margin:0px 0px 0px 0in"><strong>Proposed Maximum Offering Price Per Unit</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:9%;vertical-align:bottom;"> <p style="text-align:center;margin:0px 0px 0px 0in"><strong>Maximum Aggregate Offering Price</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:7%;vertical-align:bottom;"> <p style="text-align:center;margin:0px 0px 0px 0in"><strong>Fee Rate</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:8%;vertical-align:bottom;"> <p style="text-align:center;margin:0px 0px 0px 0in"><strong>Amount of</strong></p> <p style="text-align:center;margin:0px 0px 0px 0in"><strong>Registration Fee</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:6%;vertical-align:bottom;"> <p style="text-align:center;margin:0px 0px 0px 0in"><strong>Carry</strong></p> <p style="text-align:center;margin:0px 0px 0px 0in"><strong>Forward</strong></p> <p style="text-align:center;margin:0px 0px 0px 0in"><strong>Form Type</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:6%;vertical-align:bottom;"> <p style="text-align:center;margin:0px 0px 0px 0in"><strong>Carry</strong></p> <p style="text-align:center;margin:0px 0px 0px 0in"><strong>Forward</strong></p> <p style="text-align:center;margin:0px 0px 0px 0in"><strong>File Number</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:6%;vertical-align:bottom;"> <p style="text-align:center;margin:0px 0px 0px 0in"><strong>Carry</strong></p> <p style="text-align:center;margin:0px 0px 0px 0in"><strong>Forward</strong></p> <p style="text-align:center;margin:0px 0px 0px 0in"><strong>Initial</strong></p> <p style="text-align:center;margin:0px 0px 0px 0in"><strong>Effective Date</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:9%;vertical-align:bottom;"> <p style="text-align:center;margin:0px 0px 0px 0in"><strong>Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward</strong></p></td></tr> <tr style="height:15px"> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:9%;vertical-align:top;"> <p style="margin:0px 0px 0px 0in">Fees to Be Paid</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:7%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">Equity</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:8%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">Common Stock, par value $0.0001 <sup>(3)</sup></p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:7%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">Rule 457(o)</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:7%;"></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:7%;"></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:9%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">$25,000,000 <sup>(2)</sup></p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:7%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">$92.70 per $1,000,000</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:8%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">$2,317.50</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:6%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:6%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:6%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:9%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td></tr> <tr style="height:15px"> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:9%;vertical-align:top;"> <p style="margin:0px 0px 0px 0in">Fees to Be Paid</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:7%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">Equity</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:8%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">Underwriter&#8217;s warrants <sup>(4)</sup></p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:7%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">Rule 457(g)</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:7%;"></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:7%;"></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:9%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:7%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:8%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:6%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:6%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:6%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:9%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td></tr> <tr style="height:15px"> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:9%;vertical-align:top;"> <p style="margin:0px 0px 0px 0in">Fees to Be Paid</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:7%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">Equity</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:8%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">Common stock issuable upon exercise of underwriter&#8217;s warrants <sup>(5)</sup></p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:7%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">Rule 457(g)</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:7%;"></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:7%;"></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:9%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:7%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:8%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:6%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:6%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:6%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:9%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td></tr> <tr style="height:15px"> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:9%;vertical-align:top;"> <p style="margin:0px 0px 0px 0in">Fees Previously Paid</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:7%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:8%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:7%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:7%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:7%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:9%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:7%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:8%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:6%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:6%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:6%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:9%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td></tr> <tr style="height:15px"> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:9%;vertical-align:top;"> <p style="text-align:left;margin:0px 0px 0px 0in">Carry Forward Securities</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:7%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:8%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:7%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:7%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:7%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:9%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:7%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:8%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:6%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:6%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:6%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:9%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td></tr> <tr style="height:15px"> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:9%;"> <p style="margin:0px">&nbsp;</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:30%;vertical-align:top;" colspan="4"> <p style="text-align:center;margin:0px 0px 0px 0in"><strong>Total Offering Amounts</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:7%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:9%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">$25,000,000</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:7%;"> <p style="text-align:center;margin:0px">&nbsp;</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:8%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">$2,317.50</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:6%;"> <p style="text-align:center;margin:0px">&nbsp;</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:6%;"> <p style="text-align:center;margin:0px">&nbsp;</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:6%;"> <p style="text-align:center;margin:0px">&nbsp;</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:9%;"> <p style="text-align:center;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:9%;"> <p style="margin:0px">&nbsp;</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:30%;vertical-align:top;" colspan="4"> <p style="text-align:center;margin:0px 0px 0px 0in"><strong>Total Fees Previously Paid</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:7%;"> <p style="text-align:center;margin:0px">&nbsp;</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:9%;"> <p style="text-align:center;margin:0px">&nbsp;</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:7%;"> <p style="text-align:center;margin:0px">&nbsp;</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:8%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:6%;"> <p style="text-align:center;margin:0px">&nbsp;</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:6%;"> <p style="text-align:center;margin:0px">&nbsp;</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:6%;"> <p style="text-align:center;margin:0px">&nbsp;</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:9%;"> <p style="text-align:center;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:9%;"> <p style="margin:0px">&nbsp;</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:30%;vertical-align:top;" colspan="4"> <p style="text-align:center;margin:0px 0px 0px 0in"><strong>Total Fee Offsets</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:7%;"> <p style="text-align:center;margin:0px">&nbsp;</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:9%;"> <p style="text-align:center;margin:0px">&nbsp;</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:7%;"> <p style="text-align:center;margin:0px">&nbsp;</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:8%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:6%;"> <p style="text-align:center;margin:0px">&nbsp;</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:6%;"> <p style="text-align:center;margin:0px">&nbsp;</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:6%;"> <p style="text-align:center;margin:0px">&nbsp;</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:9%;"> <p style="text-align:center;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:9%;"> <p style="margin:0px">&nbsp;</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:30%;vertical-align:top;" colspan="4"> <p style="text-align:center;margin:0px 0px 0px 0in"><strong>Net Fee Due</strong></p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:7%;"> <p style="text-align:center;margin:0px">&nbsp;</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:9%;"> <p style="text-align:center;margin:0px">&nbsp;</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:7%;"> <p style="text-align:center;margin:0px">&nbsp;</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:8%;vertical-align:top;"> <p style="text-align:center;margin:0px 0px 0px 0in">$2,317.50</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:6%;"> <p style="text-align:center;margin:0px">&nbsp;</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:6%;"> <p style="text-align:center;margin:0px">&nbsp;</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:6%;"> <p style="text-align:center;margin:0px">&nbsp;</p></td> <td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:9%;"> <p style="text-align:center;margin:0px">&nbsp;</p></td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; text-align:justify;"> <p style="margin:0px"> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="margin:0px 0px 0px 0in">(1)</p></td> <td style="width:95%;vertical-align:top;"> <p style="text-align:justify;margin:0px 0px 0px 0in">Pursuant to Rule 416 under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). The securities being registered hereunder include such indeterminate number of additional shares of common stock as may be issued after the date hereof as a result of stock splits, stock dividends or similar transactions</p></td></tr> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="margin:0px 0px 0px 0in">(2)</p></td> <td style="width:95%;vertical-align:top;"> <p style="text-align:justify;margin:0px 0px 0px 0in">Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(o) under the Securities Act.</p></td></tr> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="margin:0px 0px 0px 0in">(3)</p></td> <td style="width:95%;vertical-align:top;"> <p style="text-align:justify;margin:0px 0px 0px 0in">Includes shares of our common stock which may be issued upon exercise of the underwriter&#8217;s 45-day over-allotment option.</p></td></tr> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="margin:0px 0px 0px 0in">(4)</p></td> <td style="width:95%;vertical-align:top;"> <p style="text-align:justify;margin:0px 0px 0px 0in">We have agreed to issue to the underwriter warrants to purchase up to &#9744; percent (&#9744;%) in the aggregate of the shares of our common stock (the &#8220;Underwriter Warrants&#8221;) to be issued and sold in this offering. The Underwriter Warrants are exercisable for a price per share equal to &#9744; percent (&#9744;%) of the public offering price.</p></td></tr> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="margin:0px 0px 0px 0in">(5)</p></td> <td style="width:95%;vertical-align:top;"> <p style="text-align:justify;margin:0px 0px 0px 0in">Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(g) under the Securities Act. The warrants are exercisable at a per share exercise price equal to &#9744;% of the public offering price. As estimated solely for the purpose of recalculating the registration fee pursuant to Rule 457(g) under the Securities Act, the proposed maximum aggregate offering price of the Underwriter&#8217;s Warrants is $&#9744;, which is equal to &#9744;% of $ (&#9744;% of $&#9744;).</p></td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>scwo-20220331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 06/17/2022-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2022 I-NET Business Solutions, Inc. All Rights Reserved.-->
<schema xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:us-gaap-att="http://fasb.org/us-gaap/attributes" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:srt-roles="http://fasb.org/srt-roles/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:scwo="http://powerverdeinc.com/20220331" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://powerverdeinc.com/20220331">
  <annotation>
    <appinfo>
      <link:roleType roleURI="http://powerverdeinc.com/role/Cover" id="Cover">
        <link:definition>000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets" id="CondensedConsolidatedBalanceSheets">
        <link:definition>000002 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical" id="CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations" id="CondensedConsolidatedStatementsOfOperations">
        <link:definition>000004 - Statement - Condensed Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://powerverdeinc.com/role/CondensedConsolidatedChangesInStockholdersDeficit" id="CondensedConsolidatedChangesInStockholdersDeficit">
        <link:definition>000005 - Statement - Condensed Consolidated Changes in Stockholders' Deficit</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" id="CondensedConsolidatedStatementsOfCashFlowsUnaudited">
        <link:definition>000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://powerverdeinc.com/role/NatureOfBusinessAndPresentationOfFinancialStatements" id="NatureOfBusinessAndPresentationOfFinancialStatements">
        <link:definition>000007 - Disclosure - Nature of Business and Presentation of Financial Statements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://powerverdeinc.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
        <link:definition>000008 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://powerverdeinc.com/role/LiquidityCapitalResourcesAndGoingConcern" id="LiquidityCapitalResourcesAndGoingConcern">
        <link:definition>000009 - Disclosure - Liquidity Capital Resources and Going Concern</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeInc" id="AcquisitionOf374WaterIncFkaPowerverdeInc">
        <link:definition>000010 - Disclosure - Acquisition of 374Water Inc fka PowerVerde Inc</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://powerverdeinc.com/role/IntangibleAssets" id="IntangibleAssets">
        <link:definition>000011 - Disclosure - Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://powerverdeinc.com/role/StockholderEquity" id="StockholderEquity">
        <link:definition>000012 - Disclosure - Stockholder Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://powerverdeinc.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
        <link:definition>000013 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://powerverdeinc.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
        <link:definition>000014 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://powerverdeinc.com/role/IncomeTaxes" id="IncomeTaxes">
        <link:definition>000015 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://powerverdeinc.com/role/DeferredRevenue" id="DeferredRevenue">
        <link:definition>000016 - Disclosure - Deferred Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://powerverdeinc.com/role/SubsequentEvents" id="SubsequentEvents">
        <link:definition>000017 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>000018 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncTables" id="AcquisitionOf374WaterIncFkaPowerverdeIncTables">
        <link:definition>000019 - Disclosure - Acquisition of 374Water Inc fka PowerVerde Inc (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://powerverdeinc.com/role/IntangibleAssetsTables" id="IntangibleAssetsTables">
        <link:definition>000020 - Disclosure - Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://powerverdeinc.com/role/StockholderEquityTables" id="StockholderEquityTables">
        <link:definition>000021 - Disclosure - Stockholder Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://powerverdeinc.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
        <link:definition>000022 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://powerverdeinc.com/role/NatureOfBusinessAndPresentationOfFinancialStatementsDetailsNarrative" id="NatureOfBusinessAndPresentationOfFinancialStatementsDetailsNarrative">
        <link:definition>000023 - Disclosure - Nature of Business and Presentation of Financial Statements (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative">
        <link:definition>000024 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://powerverdeinc.com/role/LiquidityCapitalResourcesAndGoingConcernDetailsNarrative" id="LiquidityCapitalResourcesAndGoingConcernDetailsNarrative">
        <link:definition>000025 - Disclosure - Liquidity Capital Resources and Going Concern (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetails" id="AcquisitionOf374WaterIncFkaPowerverdeIncDetails">
        <link:definition>000026 - Disclosure - Acquisition of 374Water Inc fka PowerVerde Inc (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetailsNarrative" id="AcquisitionOf374WaterIncFkaPowerverdeIncDetailsNarrative">
        <link:definition>000027 - Disclosure - Acquisition of 374Water Inc fka PowerVerde Inc (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://powerverdeinc.com/role/IntangibleAssetsDetails" id="IntangibleAssetsDetails">
        <link:definition>000028 - Disclosure - Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://powerverdeinc.com/role/IntangibleAssetsDetails1" id="IntangibleAssetsDetails1">
        <link:definition>000029 - Disclosure - Intangible Assets (Details 1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://powerverdeinc.com/role/IntangibleAssetsDetailsNarrative" id="IntangibleAssetsDetailsNarrative">
        <link:definition>000030 - Disclosure - Intangible Assets (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://powerverdeinc.com/role/StockholderEquityDetails" id="StockholderEquityDetails">
        <link:definition>000031 - Disclosure - Stockholder Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://powerverdeinc.com/role/StockholderEquityDetails1" id="StockholderEquityDetails1">
        <link:definition>000032 - Disclosure - Stockholder Equity (Details 1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://powerverdeinc.com/role/StockholderEquityDetails2" id="StockholderEquityDetails2">
        <link:definition>000033 - Disclosure - Stockholder Equity (Details 2)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://powerverdeinc.com/role/StockholderEquityDetails3" id="StockholderEquityDetails3">
        <link:definition>000034 - Disclosure - Stockholder Equity (Details 3)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://powerverdeinc.com/role/StockholderEquityDetailsNarrative" id="StockholderEquityDetailsNarrative">
        <link:definition>000035 - Disclosure - Stockholder Equity (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://powerverdeinc.com/role/RelatedPartyTransactionsDetailsNarrative" id="RelatedPartyTransactionsDetailsNarrative">
        <link:definition>000036 - Disclosure - Related Party Transactions (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://powerverdeinc.com/role/IncomeTaxesDetails" id="IncomeTaxesDetails">
        <link:definition>000037 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://powerverdeinc.com/role/IncomeTaxesDetails1" id="IncomeTaxesDetails1">
        <link:definition>000038 - Disclosure - Income Taxes (Details 1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://powerverdeinc.com/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
        <link:definition>000039 - Disclosure - Income Taxes (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://powerverdeinc.com/role/DeferredRevenueDetailsNarrative" id="DeferredRevenueDetailsNarrative">
        <link:definition>000040 - Disclosure - Deferred Revenue (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://powerverdeinc.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
        <link:definition>000041 - Disclosure - Subsequent Events (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="scwo-20220331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="scwo-20220331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="scwo-20220331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="scwo-20220331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
    </appinfo>
  </annotation>
  <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
  <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
  <import namespace="http://xbrl.sec.gov/currency/2021" schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd" />
  <import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
  <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <import namespace="http://xbrl.sec.gov/exch/2021" schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd" />
  <import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <import namespace="http://xbrl.sec.gov/naics/2021" schemaLocation="https://xbrl.sec.gov/naics/2021/naics-2021.xsd" />
  <import namespace="http://xbrl.sec.gov/sic/2021" schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd" />
  <import namespace="http://fasb.org/srt-roles/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd" />
  <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
  <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
  <import namespace="http://xbrl.sec.gov/stpr/2021" schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" />
  <import namespace="http://fasb.org/us-roles/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd" />
  <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
  <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
  <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
  <element id="scwo_AdvancesFromStockholders" name="AdvancesFromStockholders" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_AwardIncome" name="AwardIncome" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_NetLossPerShareBasicAndDiluted" name="NetLossPerShareBasicAndDiluted" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_WeightedAverageCommonSharesOutstandingBasicAndDiluted" name="WeightedAverageCommonSharesOutstandingBasicAndDiluted" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_AccretionOfStockBasedCompensation" name="AccretionOfStockBasedCompensation" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_IssuanceOfStockWarrantsForDevelopmentOfProduct" name="IssuanceOfStockWarrantsForDevelopmentOfProduct" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_RecapitalizationOfTheCompanyShares" name="RecapitalizationOfTheCompanyShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_RecapitalizationOfTheCompanyAmount" name="RecapitalizationOfTheCompanyAmount" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_SeriesDPreferredStockIssuedForCashShares" name="SeriesDPreferredStockIssuedForCashShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_SeriesDPreferredStockIssuedForCashAmount" name="SeriesDPreferredStockIssuedForCashAmount" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_ExercisedOptionAndWarrantsShares" name="ExercisedOptionAndWarrantsShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_ExercisedOptionAndWarrantsAmount" name="ExercisedOptionAndWarrantsAmount" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_IssuanceOfCommonStockForLicenseRightsShares" name="IssuanceOfCommonStockForLicenseRightsShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_IssuanceOfCommonStockForLicenseRightsAmount" name="IssuanceOfCommonStockForLicenseRightsAmount" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_ConversionOfConvertiblePreferredSharesIntoCommonStockShares" name="ConversionOfConvertiblePreferredSharesIntoCommonStockShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_ConversionOfConvertiblePreferredSharesIntoCommonStockAmount" name="ConversionOfConvertiblePreferredSharesIntoCommonStockAmount" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_AdjustmentForCommonStockIssuedForServices" name="AdjustmentForCommonStockIssuedForServices" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_WarrantIssuedForProductDevelopmentAgreement" name="WarrantIssuedForProductDevelopmentAgreement" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_ProceedsFromReverseAcquisition" name="ProceedsFromReverseAcquisition" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_ConversionOfStockAmountIssued" name="ConversionOfStockAmountIssued" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_IssuanceOfCommonStockForLicenseRights" name="IssuanceOfCommonStockForLicenseRights" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_AccountsPayableSettledWithStockOption" name="AccountsPayableSettledWithStockOption" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_NetLiabilitiesAssumedInReverseAcquisitionAbstract" name="NetLiabilitiesAssumedInReverseAcquisitionAbstract" nillable="true" abstract="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_NetLiabilitiesAssumedInReverseAcquisitioncash" name="NetLiabilitiesAssumedInReverseAcquisitioncash" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_NetLiabilityAssumed" name="NetLiabilityAssumed" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_EquipmentPolicy" name="EquipmentPolicy" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_LongLivedAssetsPolicy" name="LongLivedAssetsPolicy" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_RevenueRecognitionAndConcentrationPolicy" name="RevenueRecognitionAndConcentrationPolicy" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_SharesIssuedToFormerHolder" name="SharesIssuedToFormerHolder" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_MergerEffectDescription" name="MergerEffectDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_WorkingCapital" name="WorkingCapital" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_NetCashProvidedByUsedInOperatingActivity" name="NetCashProvidedByUsedInOperatingActivity" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_AnnaulSalaryIncreasedAmount" name="AnnaulSalaryIncreasedAmount" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_Description" name="Description" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_SettlementOfLiabilityForPreferredStockShares" name="SettlementOfLiabilityForPreferredStockShares" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_IntangibleAssetsAdditions" name="IntangibleAssetsAdditions" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice" name="Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice" name="Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice" name="Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_WeightedAverageExercisePriceExercised" name="WeightedAverageExercisePriceExercised" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_StockIssuedUponWarrantExercised" name="StockIssuedUponWarrantExercised" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_ProceedsFromStockIssuedUponWarrantsExercisedAmount" name="ProceedsFromStockIssuedUponWarrantsExercisedAmount" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_WarrantsOutstandingSeriesOneShares" name="WarrantsOutstandingSeriesOneShares" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_LiabilityForPreferredStockShares" name="LiabilityForPreferredStockShares" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_CommonStockSharesIssuesForCash" name="CommonStockSharesIssuesForCash" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_NumberOfWarrantPurchase" name="NumberOfWarrantPurchase" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_AggregateFairValueOfWarrant" name="AggregateFairValueOfWarrant" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_Preferredstockparorstatedvaluepershare" name="Preferredstockparorstatedvaluepershare" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_PreferredStockParValue" name="PreferredStockParValue" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_PreferredStockStatedValuePerShare" name="PreferredStockStatedValuePerShare" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_StockInExcessPercentageOfOutstandingShare" name="StockInExcessPercentageOfOutstandingShare" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_DeferredTaxAssetsStartupCost" name="DeferredTaxAssetsStartupCost" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_OtherIntangibles" name="OtherIntangibles" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_OtherAccruals" name="OtherAccruals" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_IncomeTaxRateReconciliationChangeInStateTax" name="IncomeTaxRateReconciliationChangeInStateTax" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_IncomeTaxReconciliationChangeInValuationAllowance" name="IncomeTaxReconciliationChangeInValuationAllowance" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_IncomeTaxReconciliationPermanentDifferences" name="IncomeTaxReconciliationPermanentDifferences" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_IncomeTaxReconciliationStateTaxes" name="IncomeTaxReconciliationStateTaxes" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_IncomeTaxReconciliationOther" name="IncomeTaxReconciliationOther" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_DeferredRevenuePercentage" name="DeferredRevenuePercentage" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_IncomeTaxesAbstract" name="IncomeTaxesAbstract" nillable="true" abstract="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_DeferredIncomeTaxAssetAbstract" name="DeferredIncomeTaxAssetAbstract" nillable="true" abstract="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_RateReconciliationAbstract" name="RateReconciliationAbstract" nillable="true" abstract="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element name="WarrantsMember" id="scwo_WarrantsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="ThreeSevenFourWaterMember" id="scwo_ThreeSevenFourWaterMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="MrNagarMember" id="scwo_MrNagarMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="LicenseAgreementMember" id="scwo_LicenseAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="OptionsMember" id="scwo_OptionsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="MinimumsMember" id="scwo_MinimumsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="MaximumsMember" id="scwo_MaximumsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="ThreeSeverFourWaterFormerStockholdersMember" id="scwo_ThreeSeverFourWaterFormerStockholdersMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="ConsultantMember" id="scwo_ConsultantMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="OptionUnvestedMember" id="scwo_OptionUnvestedMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>scwo-20220331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 06/17/2022-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2022 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
  <link:roleRef xlink:type="simple" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address Address Line 1</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address Address Line 2</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address City Or Town</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address State Or Province</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl_1c7a96" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl_1c7a96" xml:lang="en-US">Condensed Consolidated Balance Sheets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl_79f030" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Cash_lbl_79f030" xml:lang="en-US">Cash</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNet" xlink:label="us-gaap_AccountsReceivableNet" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNet" xlink:to="us-gaap_AccountsReceivableNet_lbl_9d3dfb" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNet_lbl_9d3dfb" xml:lang="en-US">Accounts receivable</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl_d31b37" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl_d31b37" xml:lang="en-US">Prepaid Expenses</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl_315b36" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl_315b36" xml:lang="en-US">Total Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl_5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_lbl_5" xml:lang="en-US">[Assets, Current]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl_5849cb" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl_5849cb" xml:lang="en-US">Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsNet" xlink:label="us-gaap_OtherIntangibleAssetsNet" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIntangibleAssetsNet" xlink:to="us-gaap_OtherIntangibleAssetsNet_lbl_ca3767" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIntangibleAssetsNet_lbl_ca3767" xml:lang="en-US">Intangible Asset, Net</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssets" xlink:label="us-gaap_OtherAssets" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssets" xlink:to="us-gaap_OtherAssets_lbl_9f2ffb" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssets_lbl_9f2ffb" xml:lang="en-US">Other Assets</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_lbl_e792f2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsNoncurrent_lbl_e792f2" xml:lang="en-US">Total Long-term Assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="us-gaap_AssetsNoncurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_lbl_9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrent_lbl_9" xml:lang="en-US">[Assets, Noncurrent]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl_8558eb" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl_8558eb" xml:lang="en-US">Total Assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl_10" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_lbl_10" xml:lang="en-US">[Assets]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl_86827e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl_86827e" xml:lang="en-US">Current Assets:</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl_0ffada" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl_0ffada" xml:lang="en-US">Accounts Payable And Accrued Expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_AdvancesFromStockholders" xlink:label="scwo_AdvancesFromStockholders" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_AdvancesFromStockholders" xlink:to="scwo_AdvancesFromStockholders_lbl_a26782" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_AdvancesFromStockholders_lbl_a26782" xml:lang="en-US">Advances from stockholders</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenue" xlink:to="us-gaap_DeferredRevenue_lbl_2449ea" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredRevenue_lbl_2449ea" xml:lang="en-US">Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenue" xlink:to="us-gaap_DeferredRevenue_lbl_14" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenue_lbl_14" xml:lang="en-US">[Deferred Revenue]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilities" xlink:label="us-gaap_OtherLiabilities" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilities" xlink:to="us-gaap_OtherLiabilities_lbl_342179" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilities_lbl_342179" xml:lang="en-US">Other Liabilities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl_cc7e20" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl_cc7e20" xml:lang="en-US">Total Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl_16" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_lbl_16" xml:lang="en-US">[Liabilities, Current]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl_f77b26" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl_f77b26" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="us-gaap_AssetsNoncurrentAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract_lbl_857d25" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrentAbstract_lbl_857d25" xml:lang="en-US">Long-Term Assets:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl_bffc55" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl_bffc55" xml:lang="en-US">Total Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl_19" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_lbl_19" xml:lang="en-US">[Liabilities]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl_b2be86" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl_b2be86" xml:lang="en-US">Commitments and contingencies (Note 8)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl_2920fc" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl_2920fc" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl_affda7" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl_affda7" xml:lang="en-US">Preferred Stock: 1,000,000 Convertible Series D Preferred Shares Authorized; Par Value $0.0001 Per Share, Nil Issued And Outstanding At March 31, 2022 And 27,272 Issued And Outstanding At December 31, 2021</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl_8237d5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl_8237d5" xml:lang="en-US">Common Stock: 200,000,000 Common Shares Authorized, Par Value $0.0001 Per Share, 126,680,895 And 125,317,746 Shares Outstanding At March 31, 2022 And December 31, 2021, Respectively</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl_4e5b38" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl_4e5b38" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl_4ca574" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl_4ca574" xml:lang="en-US">Accumulated (deficit) Earnings</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl_a1460d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl_a1460d" xml:lang="en-US">Liabilities and Stockholders' Equity</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl_9f0efa" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl_9f0efa" xml:lang="en-US">Current Liabilities:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl_8f949b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl_8f949b" xml:lang="en-US">Total Stockholders' Equity</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl_28" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_lbl_28" xml:lang="en-US">[Stockholders' Equity Attributable to Parent]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl_5acc48" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl_5acc48" xml:lang="en-US">Total Liabilities And Stockholders' Equity</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl_29" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl_29" xml:lang="en-US">[Liabilities and Equity]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl_087cc8" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl_087cc8" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl_66b0d9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl_66b0d9" xml:lang="en-US">Preferred Stock Par Value</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl_4b0ff3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl_4b0ff3" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockLiquidationPreferenceValue" xlink:label="us-gaap_PreferredStockLiquidationPreferenceValue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockLiquidationPreferenceValue" xlink:to="us-gaap_PreferredStockLiquidationPreferenceValue_lbl_cbeb62" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockLiquidationPreferenceValue_lbl_cbeb62" xml:lang="en-US">Preferred Stock, Shares Liquidation</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl_d6572b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl_d6572b" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl_0df7b7" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl_0df7b7" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl_4c64ea" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl_4c64ea" xml:lang="en-US">Common Stock, Par Value</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl_c123c1" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl_c123c1" xml:lang="en-US">Common Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl_235e5c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl_235e5c" xml:lang="en-US">Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl_343c52" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl_343c52" xml:lang="en-US">Condensed Consolidated Statements of Operations</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl_d76644" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl_d76644" xml:lang="en-US">Revenue</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl_39a5e1" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfRevenue_lbl_39a5e1" xml:lang="en-US">Cost Of Goods Sold</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl_e19ff7" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl_e19ff7" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl_4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_lbl_4" xml:lang="en-US">[Gross Profit]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl_e4296a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl_e4296a" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl_da14ac" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl_da14ac" xml:lang="en-US">Research and development</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="us-gaap_LaborAndRelatedExpense" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LaborAndRelatedExpense" xlink:to="us-gaap_LaborAndRelatedExpense_lbl_3a0784" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LaborAndRelatedExpense_lbl_3a0784" xml:lang="en-US">Compensation And Related Expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductionCosts" xlink:label="us-gaap_ProductionCosts" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductionCosts" xlink:to="us-gaap_ProductionCosts_lbl_da106b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductionCosts_lbl_da106b" xml:lang="en-US">Product development</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="us-gaap_ProfessionalFees" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalFees" xlink:to="us-gaap_ProfessionalFees_lbl_6b30b8" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfessionalFees_lbl_6b30b8" xml:lang="en-US">Professional Fees</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl_9bd87b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl_9bd87b" xml:lang="en-US">General and administrative</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl_f7b304" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl_f7b304" xml:lang="en-US">Total Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl_11" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_lbl_11" xml:lang="en-US">[Operating Expenses]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl_cdee15" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl_cdee15" xml:lang="en-US">Income (loss) From Operations</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl_12" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_lbl_12" xml:lang="en-US">[Operating Income (Loss)]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_OtherIncomeAndExpensesAbstract_lbl_a89e4b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract_lbl_a89e4b" xml:lang="en-US">Other Income (expense)</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_AwardIncome" xlink:label="scwo_AwardIncome" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_AwardIncome" xlink:to="scwo_AwardIncome_lbl_0e4a36" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_AwardIncome_lbl_0e4a36" xml:lang="en-US">Award income</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeOperating" xlink:label="us-gaap_InterestIncomeOperating" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeOperating" xlink:to="us-gaap_InterestIncomeOperating_lbl_18c788" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestIncomeOperating_lbl_18c788" xml:lang="en-US">Interest income</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncome" xlink:label="us-gaap_OtherIncome" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncome" xlink:to="us-gaap_OtherIncome_lbl_ec852f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIncome_lbl_ec852f" xml:lang="en-US">Other income</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl_7b13b7" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl_7b13b7" xml:lang="en-US">Total Other Income (expense)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl_17" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl_17" xml:lang="en-US">[Nonoperating Income (Expense)]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl_786b80" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl_786b80" xml:lang="en-US">Net Income (Loss) before Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl_18" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl_18" xml:lang="en-US">[Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl_80d811" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl_80d811" xml:lang="en-US">Provision for Income Taxes</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl_164b40" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl_164b40" xml:lang="en-US">Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl_20" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl_20" xml:lang="en-US">[Net Income (Loss) Attributable to Parent]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_NetLossPerShareBasicAndDiluted" xlink:label="scwo_NetLossPerShareBasicAndDiluted" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_NetLossPerShareBasicAndDiluted" xlink:to="scwo_NetLossPerShareBasicAndDiluted_lbl_f6483c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_NetLossPerShareBasicAndDiluted_lbl_f6483c" xml:lang="en-US">Net Loss Per Share - Basic And Diluted</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_WeightedAverageCommonSharesOutstandingBasicAndDiluted" xlink:label="scwo_WeightedAverageCommonSharesOutstandingBasicAndDiluted" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_WeightedAverageCommonSharesOutstandingBasicAndDiluted" xlink:to="scwo_WeightedAverageCommonSharesOutstandingBasicAndDiluted_lbl_608f4f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_WeightedAverageCommonSharesOutstandingBasicAndDiluted_lbl_608f4f" xml:lang="en-US">Weighted Average Common Shares Outstanding - Basic And Diluted</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl_6cb1bf" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl_6cb1bf" xml:lang="en-US">Condensed Consolidated Changes in Stockholders' Deficit</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl_1f42d7" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl_1f42d7" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl_2221ab" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl_2221ab" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl_690af1" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl_690af1" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl_72f670" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl_72f670" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl_0e96a3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl_0e96a3" xml:lang="en-US">Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl_49dc4f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl_49dc4f" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl_03f2c4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl_03f2c4" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl_5a13b8" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesIssued_lbl_5a13b8" xml:lang="en-US">Balance, shares</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued" xlink:label="us-gaap_SharesIssued" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssued_lbl_2" xml:lang="en-US">[Shares, Issued]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl_f29d59" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_lbl_f29d59" xml:lang="en-US">Balance, amount</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl_d0f704" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl_d0f704" xml:lang="en-US">Issuance of common stock for services</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_AccretionOfStockBasedCompensation" xlink:label="scwo_AccretionOfStockBasedCompensation" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_AccretionOfStockBasedCompensation" xlink:to="scwo_AccretionOfStockBasedCompensation_lbl_53b81f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_AccretionOfStockBasedCompensation_lbl_53b81f" xml:lang="en-US">Accretion of stock-based</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl_d6a10c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProfitLoss_lbl_d6a10c" xml:lang="en-US">Net Loss</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl_6" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_lbl_6" xml:lang="en-US">[Net Income (Loss), Including Portion Attributable to Noncontrolling Interest]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionExpense" xlink:label="us-gaap_AccretionExpense" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccretionExpense" xlink:to="us-gaap_AccretionExpense_lbl_0a7260" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccretionExpense_lbl_0a7260" xml:lang="en-US">Accretion Of Stock-based Compensation</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl_665fa1" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_lbl_665fa1" xml:lang="en-US">Net Loss</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_IssuanceOfStockWarrantsForDevelopmentOfProduct" xlink:label="scwo_IssuanceOfStockWarrantsForDevelopmentOfProduct" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_IssuanceOfStockWarrantsForDevelopmentOfProduct" xlink:to="scwo_IssuanceOfStockWarrantsForDevelopmentOfProduct_lbl_b3b409" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_IssuanceOfStockWarrantsForDevelopmentOfProduct_lbl_b3b409" xml:lang="en-US">Issuance of stock warrants for development of product</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_RecapitalizationOfTheCompanyShares" xlink:label="scwo_RecapitalizationOfTheCompanyShares" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_RecapitalizationOfTheCompanyShares" xlink:to="scwo_RecapitalizationOfTheCompanyShares_lbl_c783d5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_RecapitalizationOfTheCompanyShares_lbl_c783d5" xml:lang="en-US">Recapitalization of the Company, shares</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_RecapitalizationOfTheCompanyAmount" xlink:label="scwo_RecapitalizationOfTheCompanyAmount" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_RecapitalizationOfTheCompanyAmount" xlink:to="scwo_RecapitalizationOfTheCompanyAmount_lbl_05548e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_RecapitalizationOfTheCompanyAmount_lbl_05548e" xml:lang="en-US">Recapitalization of the Company, amount</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_SeriesDPreferredStockIssuedForCashShares" xlink:label="scwo_SeriesDPreferredStockIssuedForCashShares" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_SeriesDPreferredStockIssuedForCashShares" xlink:to="scwo_SeriesDPreferredStockIssuedForCashShares_lbl_4c7157" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_SeriesDPreferredStockIssuedForCashShares_lbl_4c7157" xml:lang="en-US">Series D Preferred Stock issued for cash, shares</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_SeriesDPreferredStockIssuedForCashAmount" xlink:label="scwo_SeriesDPreferredStockIssuedForCashAmount" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_SeriesDPreferredStockIssuedForCashAmount" xlink:to="scwo_SeriesDPreferredStockIssuedForCashAmount_lbl_3bc1ab" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_SeriesDPreferredStockIssuedForCashAmount_lbl_3bc1ab" xml:lang="en-US">Series D Preferred Stock issued for cash, amount</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_ExercisedOptionAndWarrantsShares" xlink:label="scwo_ExercisedOptionAndWarrantsShares" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_ExercisedOptionAndWarrantsShares" xlink:to="scwo_ExercisedOptionAndWarrantsShares_lbl_f002d5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_ExercisedOptionAndWarrantsShares_lbl_f002d5" xml:lang="en-US">Exercised. Option and Warrants, shares</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_ExercisedOptionAndWarrantsAmount" xlink:label="scwo_ExercisedOptionAndWarrantsAmount" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_ExercisedOptionAndWarrantsAmount" xlink:to="scwo_ExercisedOptionAndWarrantsAmount_lbl_331407" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_ExercisedOptionAndWarrantsAmount_lbl_331407" xml:lang="en-US">Exercised. Option and Warrants, amount</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_IssuanceOfCommonStockForLicenseRightsShares" xlink:label="scwo_IssuanceOfCommonStockForLicenseRightsShares" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_IssuanceOfCommonStockForLicenseRightsShares" xlink:to="scwo_IssuanceOfCommonStockForLicenseRightsShares_lbl_d86fdc" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_IssuanceOfCommonStockForLicenseRightsShares_lbl_d86fdc" xml:lang="en-US">Issuance of common stock for license rights, shares</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_IssuanceOfCommonStockForLicenseRightsAmount" xlink:label="scwo_IssuanceOfCommonStockForLicenseRightsAmount" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_IssuanceOfCommonStockForLicenseRightsAmount" xlink:to="scwo_IssuanceOfCommonStockForLicenseRightsAmount_lbl_80ada6" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_IssuanceOfCommonStockForLicenseRightsAmount_lbl_80ada6" xml:lang="en-US">Issuance of common stock for license rights, amount</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_ConversionOfConvertiblePreferredSharesIntoCommonStockShares" xlink:label="scwo_ConversionOfConvertiblePreferredSharesIntoCommonStockShares" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_ConversionOfConvertiblePreferredSharesIntoCommonStockShares" xlink:to="scwo_ConversionOfConvertiblePreferredSharesIntoCommonStockShares_lbl_51b168" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_ConversionOfConvertiblePreferredSharesIntoCommonStockShares_lbl_51b168" xml:lang="en-US">Conversion of convertible preferred shares into common stock, shares</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_ConversionOfConvertiblePreferredSharesIntoCommonStockAmount" xlink:label="scwo_ConversionOfConvertiblePreferredSharesIntoCommonStockAmount" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_ConversionOfConvertiblePreferredSharesIntoCommonStockAmount" xlink:to="scwo_ConversionOfConvertiblePreferredSharesIntoCommonStockAmount_lbl_aee2be" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_ConversionOfConvertiblePreferredSharesIntoCommonStockAmount_lbl_aee2be" xml:lang="en-US">Conversion of convertible preferred shares into common stock, amount</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl_2a4e11" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl_2a4e11" xml:lang="en-US">Issuance of common stock, shares</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl_ae0bd0" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl_ae0bd0" xml:lang="en-US">Issuance of common stock, amount</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="us-gaap_ConversionOfStockSharesIssued1" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesIssued1" xlink:to="us-gaap_ConversionOfStockSharesIssued1_lbl_d89b39" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockSharesIssued1_lbl_d89b39" xml:lang="en-US">Conversion Of Preferred Shares To Common Shares, Shares</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockAmountIssued1" xlink:label="us-gaap_ConversionOfStockAmountIssued1" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockAmountIssued1" xlink:to="us-gaap_ConversionOfStockAmountIssued1_lbl_7055b2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockAmountIssued1_lbl_7055b2" xml:lang="en-US">Conversion Of Preferred Shares To Common Shares, Amount</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl_cdabf0" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesIssued_lbl_cdabf0" xml:lang="en-US">Balance, Shares</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl_e9f0f5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_lbl_e9f0f5" xml:lang="en-US">Balance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl_59af56" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl_59af56" xml:lang="en-US">Condensed Consolidated Statements of Cash Flows (Unaudited)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl_f64852" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl_f64852" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl_30f2fe" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLoss_lbl_30f2fe" xml:lang="en-US">Net Income (loss)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl_10da0f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl_10da0f" xml:lang="en-US">Adjustments To Reconcile Net Income (loss) To Net Cash Provided By (used In) Operating Activities:</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl_7c8d18" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationAndAmortization_lbl_7c8d18" xml:lang="en-US">Depreciation and amortization expense</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl_871257" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl_871257" xml:lang="en-US">Stock-based compensation</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_AdjustmentForCommonStockIssuedForServices" xlink:label="scwo_AdjustmentForCommonStockIssuedForServices" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_AdjustmentForCommonStockIssuedForServices" xlink:to="scwo_AdjustmentForCommonStockIssuedForServices_lbl_fb3e2c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_AdjustmentForCommonStockIssuedForServices_lbl_fb3e2c" xml:lang="en-US">Common stock issued for services</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_WarrantIssuedForProductDevelopmentAgreement" xlink:label="scwo_WarrantIssuedForProductDevelopmentAgreement" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_WarrantIssuedForProductDevelopmentAgreement" xlink:to="scwo_WarrantIssuedForProductDevelopmentAgreement_lbl_833a0d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_WarrantIssuedForProductDevelopmentAgreement_lbl_833a0d" xml:lang="en-US">Warrant issued for product development agreement</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl_fbc739" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl_fbc739" xml:lang="en-US">Changes in operating assets and liabilities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl_c13aa7" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl_c13aa7" xml:lang="en-US">Accounts receivable</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl_10" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl_10" xml:lang="en-US">[Increase (Decrease) in Accounts Receivable]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl_0efbbd" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl_0efbbd" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl_7f47d3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl_7f47d3" xml:lang="en-US">Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl_12" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl_12" xml:lang="en-US">[Increase (Decrease) in Deferred Revenue]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl_08a353" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl_08a353" xml:lang="en-US">Prepaid expense and other assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl_13" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl_13" xml:lang="en-US">[Increase (Decrease) in Prepaid Expense and Other Assets]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_lbl_79c192" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_lbl_79c192" xml:lang="en-US">Other liabilities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl_dc4c26" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl_dc4c26" xml:lang="en-US">Net cash (used in) provided by operating activities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl_15" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl_15" xml:lang="en-US">[Net Cash Provided by (Used in) Operating Activities]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl_048050" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl_048050" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl_91377b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl_91377b" xml:lang="en-US">Purchase of property and equipment</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl_17" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl_17" xml:lang="en-US">[Payments to Acquire Property, Plant, and Equipment]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_ProceedsFromReverseAcquisition" xlink:label="scwo_ProceedsFromReverseAcquisition" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_ProceedsFromReverseAcquisition" xlink:to="scwo_ProceedsFromReverseAcquisition_lbl_8fa3cf" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_ProceedsFromReverseAcquisition_lbl_8fa3cf" xml:lang="en-US">Proceeds from reverse acquisition</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentAssets_lbl_4e2610" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets_lbl_4e2610" xml:lang="en-US">Increase in other assets acquisition</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentAssets_lbl_19" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets_lbl_19" xml:lang="en-US">[Increase (Decrease) in Other Current Assets]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfCapitalDistribution" xlink:to="us-gaap_PaymentsOfCapitalDistribution_lbl_899e3c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfCapitalDistribution_lbl_899e3c" xml:lang="en-US">Recapitalization of the Company</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfCapitalDistribution" xlink:label="us-gaap_PaymentsOfCapitalDistribution" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfCapitalDistribution" xlink:to="us-gaap_PaymentsOfCapitalDistribution_lbl_20" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfCapitalDistribution_lbl_20" xml:lang="en-US">[Payments of Capital Distribution]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl_2fc17e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl_2fc17e" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl_21" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl_21" xml:lang="en-US">[Net Cash Provided by (Used in) Investing Activities]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl_20f968" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl_20f968" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_lbl_d5b004" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_lbl_d5b004" xml:lang="en-US">Advances from Stockholders</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_lbl_fbe072" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_lbl_fbe072" xml:lang="en-US">Proceeds from Series D Preferred Shares</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl_137541" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl_137541" xml:lang="en-US">Proceeds from Common Stock Offering</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl_ac5949" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl_ac5949" xml:lang="en-US">Proceeds from exercise of Options</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="us-gaap_ProceedsFromWarrantExercises" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromWarrantExercises" xlink:to="us-gaap_ProceedsFromWarrantExercises_lbl_7c9b6c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromWarrantExercises_lbl_7c9b6c" xml:lang="en-US">Proceeds from exercise of warrant</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl_23d484" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl_23d484" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl_28" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl_28" xml:lang="en-US">[Net Cash Provided by (Used in) Financing Activities]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl_1ba934" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl_1ba934" xml:lang="en-US">Net Increase in Cash</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl_29" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl_29" xml:lang="en-US">[Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl_7f6e39" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl_7f6e39" xml:lang="en-US">Cash - Beginning Of The Period</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl_30" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl_30" xml:lang="en-US">[Cash and Cash Equivalents, at Carrying Value]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl_6f39db" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl_6f39db" xml:lang="en-US">Cash - End Of The Period</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl_1e2c5b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl_1e2c5b" xml:lang="en-US">SUPPLEMENTAL CASH FLOW DISCLOSURES:</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl_551500" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl_551500" xml:lang="en-US">Cash paid for interest</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:label="us-gaap_RepaymentsOfDebt" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfDebt" xlink:to="us-gaap_RepaymentsOfDebt_lbl_9ca7b5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfDebt_lbl_9ca7b5" xml:lang="en-US">Cash paid for taxes</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl_90d2b9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl_90d2b9" xml:lang="en-US">NON-CASH INVESTING AND FINANCING ACTIVITIES:</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_ConversionOfStockAmountIssued" xlink:label="scwo_ConversionOfStockAmountIssued" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_ConversionOfStockAmountIssued" xlink:to="scwo_ConversionOfStockAmountIssued_lbl_5d415a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_ConversionOfStockAmountIssued_lbl_5d415a" xml:lang="en-US">Conversion Of Preferred Stock To Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_IssuanceOfCommonStockForLicenseRights" xlink:label="scwo_IssuanceOfCommonStockForLicenseRights" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_IssuanceOfCommonStockForLicenseRights" xlink:to="scwo_IssuanceOfCommonStockForLicenseRights_lbl_6be5cf" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_IssuanceOfCommonStockForLicenseRights_lbl_6be5cf" xml:lang="en-US">Issuance of common stock for license rights</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_AccountsPayableSettledWithStockOption" xlink:label="scwo_AccountsPayableSettledWithStockOption" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_AccountsPayableSettledWithStockOption" xlink:to="scwo_AccountsPayableSettledWithStockOption_lbl_daa9d3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_AccountsPayableSettledWithStockOption_lbl_daa9d3" xml:lang="en-US">Accounts payable settled with Series D Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_NetLiabilitiesAssumedInReverseAcquisitionAbstract" xlink:label="scwo_NetLiabilitiesAssumedInReverseAcquisitionAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_NetLiabilitiesAssumedInReverseAcquisitionAbstract" xlink:to="scwo_NetLiabilitiesAssumedInReverseAcquisitionAbstract_lbl_137995" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_NetLiabilitiesAssumedInReverseAcquisitionAbstract_lbl_137995" xml:lang="en-US">Net Liabilities Assumed in Reverse Acquisition:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_NetLiabilitiesAssumedInReverseAcquisitioncash" xlink:to="scwo_NetLiabilitiesAssumedInReverseAcquisitioncash_lbl_975de3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="scwo_NetLiabilitiesAssumedInReverseAcquisitioncash_lbl_975de3" xml:lang="en-US">Cash</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_NetLiabilitiesAssumedInReverseAcquisitioncash" xlink:label="scwo_NetLiabilitiesAssumedInReverseAcquisitioncash" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_NetLiabilitiesAssumedInReverseAcquisitioncash" xlink:to="scwo_NetLiabilitiesAssumedInReverseAcquisitioncash_lbl_40" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_NetLiabilitiesAssumedInReverseAcquisitioncash_lbl_40" xml:lang="en-US">[Cash]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl_adda25" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl_adda25" xml:lang="en-US">Prepaid expense</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableSale" xlink:to="us-gaap_AccountsReceivableSale_lbl_74a2eb" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsReceivableSale_lbl_74a2eb" xml:lang="en-US">Accounts receivable</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableSale" xlink:label="us-gaap_AccountsReceivableSale" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableSale" xlink:to="us-gaap_AccountsReceivableSale_lbl_42" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableSale_lbl_42" xml:lang="en-US">[Accounts Receivable, Sale]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl_9ec650" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl_9ec650" xml:lang="en-US">Accounts payable</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl_7b088c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl_7b088c" xml:lang="en-US">Accrued expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_NetLiabilityAssumed" xlink:label="scwo_NetLiabilityAssumed" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_NetLiabilityAssumed" xlink:to="scwo_NetLiabilityAssumed_lbl_a2ac3f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_NetLiabilityAssumed_lbl_a2ac3f" xml:lang="en-US">Net liability assumed</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl_6e48de" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl_6e48de" xml:lang="en-US">Nature of Business and Presentation of Financial Statements</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl_231867" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl_231867" xml:lang="en-US">Nature Of Business And Presentation Of Financial Statements</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl_c858d0" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl_c858d0" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl_9abf4a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl_9abf4a" xml:lang="en-US">Summary Of Significant Accounting Policies</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:to="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock_lbl_cc9bbd" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock_lbl_cc9bbd" xml:lang="en-US">Liquidity, Capital Resources</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="us-gaap_BusinessCombinationsAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="us-gaap_BusinessCombinationsAbstract_lbl_05cb5b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationsAbstract_lbl_05cb5b" xml:lang="en-US">Acquisition of 374Water Inc fka PowerVerde Inc</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock_lbl_50cfb8" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl_50cfb8" xml:lang="en-US">Acquisition of 374Water, Inc. f/k/a PowerVerde Inc.</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl_6d6f07" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl_6d6f07" xml:lang="en-US">Intangible Assets</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl_98263e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl_98263e" xml:lang="en-US">Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl_2" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl_cc6b5e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl_cc6b5e" xml:lang="en-US">Stockholder Equity</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl_f03169" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl_f03169" xml:lang="en-US">Stockholder Equity</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl_2" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl_5fd794" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl_5fd794" xml:lang="en-US">Related Party Transactions</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl_dcc656" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl_dcc656" xml:lang="en-US">Related Party Transactions</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl_2" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl_2182a9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl_2182a9" xml:lang="en-US">Commitments And Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl_dc4afd" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl_dc4afd" xml:lang="en-US">Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl_a43d47" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl_a43d47" xml:lang="en-US">Income taxes</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueAbstract" xlink:label="us-gaap_DeferredRevenueAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueAbstract" xlink:to="us-gaap_DeferredRevenueAbstract_lbl_adefb4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueAbstract_lbl_adefb4" xml:lang="en-US">Deferred Revenue</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueDisclosureTextBlock" xlink:to="us-gaap_DeferredRevenueDisclosureTextBlock_lbl_e427d0" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredRevenueDisclosureTextBlock_lbl_e427d0" xml:lang="en-US">Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueDisclosureTextBlock" xlink:label="us-gaap_DeferredRevenueDisclosureTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueDisclosureTextBlock" xlink:to="us-gaap_DeferredRevenueDisclosureTextBlock_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueDisclosureTextBlock_lbl_2" xml:lang="en-US">Deferred Revenue Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl_04359f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl_04359f" xml:lang="en-US">Subsequent Events</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl_dc5cec" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl_dc5cec" xml:lang="en-US">Subsequents Events</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl_9afc13" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl_9afc13" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl_66aa78" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl_66aa78" xml:lang="en-US">Concentration of Credit Risk</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="us-gaap_ReceivablesPolicyTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesPolicyTextBlock" xlink:to="us-gaap_ReceivablesPolicyTextBlock_lbl_dbdaf4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivablesPolicyTextBlock_lbl_dbdaf4" xml:lang="en-US">Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_EquipmentPolicy" xlink:label="scwo_EquipmentPolicy" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_EquipmentPolicy" xlink:to="scwo_EquipmentPolicy_lbl_8dc879" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_EquipmentPolicy_lbl_8dc879" xml:lang="en-US">Equipment</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl_9c66d2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl_9c66d2" xml:lang="en-US">Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl_6" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl_6" xml:lang="en-US">Intangible Assets, Finite-Lived, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_LongLivedAssetsPolicy" xlink:label="scwo_LongLivedAssetsPolicy" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_LongLivedAssetsPolicy" xlink:to="scwo_LongLivedAssetsPolicy_lbl_f2579f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_LongLivedAssetsPolicy_lbl_f2579f" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_RevenueRecognitionAndConcentrationPolicy" xlink:label="scwo_RevenueRecognitionAndConcentrationPolicy" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_RevenueRecognitionAndConcentrationPolicy" xlink:to="scwo_RevenueRecognitionAndConcentrationPolicy_lbl_3d3b47" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_RevenueRecognitionAndConcentrationPolicy_lbl_3d3b47" xml:lang="en-US">Revenue Recognition and Concentration</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl_2244bd" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl_2244bd" xml:lang="en-US">Stock-based Compensation</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxUncertaintiesPolicy" xlink:label="us-gaap_IncomeTaxUncertaintiesPolicy" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxUncertaintiesPolicy" xlink:to="us-gaap_IncomeTaxUncertaintiesPolicy_lbl_5cb50b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxUncertaintiesPolicy_lbl_5cb50b" xml:lang="en-US">Accounting for Uncertainty in Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl_771627" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl_771627" xml:lang="en-US">Income Tax Policy</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl_071919" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl_071919" xml:lang="en-US">Research and Development Costs</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl_2f57f6" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl_2f57f6" xml:lang="en-US">Earnings (Loss) Per Share</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl_7b7cba" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl_7b7cba" xml:lang="en-US">Financial Instruments</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl_582eb3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl_582eb3" xml:lang="en-US">Use of Estimates</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl_784adb" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl_784adb" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_lbl_cad7b0" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_lbl_cad7b0" xml:lang="en-US">Schedule Of Assets And Liabilities Were Assumed</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl_8840b2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl_8840b2" xml:lang="en-US">Schedule Of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl_8d583e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl_8d583e" xml:lang="en-US">Schedule Of Future Amortization Expense</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl_53cf69" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialInstrumentAxis_lbl_53cf69" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionMember" xlink:label="us-gaap_StockOptionMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionMember" xlink:to="us-gaap_StockOptionMember_lbl_0371f3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockOptionMember_lbl_0371f3" xml:lang="en-US">Stock Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl_076326" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl_076326" xml:lang="en-US">Schedule Of Stock Option Activity</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl_4f8c7b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl_4f8c7b" xml:lang="en-US">Schedule Of Warrant Activity</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl_ab45e7" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl_ab45e7" xml:lang="en-US">Schedule Of Stock Option Assumptions</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_IncomeTaxesAbstract" xlink:label="scwo_IncomeTaxesAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_IncomeTaxesAbstract" xlink:to="scwo_IncomeTaxesAbstract_lbl_afd81d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_IncomeTaxesAbstract_lbl_afd81d" xml:lang="en-US">Income Taxes (Tables)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl_4c133f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl_4c133f" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl_d4a09c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl_d4a09c" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_SharesIssuedToFormerHolder" xlink:label="scwo_SharesIssuedToFormerHolder" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_SharesIssuedToFormerHolder" xlink:to="scwo_SharesIssuedToFormerHolder_lbl_4cdcf6" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_SharesIssuedToFormerHolder_lbl_4cdcf6" xml:lang="en-US">Shares issued to former holder</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_MergerEffectDescription" xlink:label="scwo_MergerEffectDescription" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_MergerEffectDescription" xlink:to="scwo_MergerEffectDescription_lbl_6ff37b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_MergerEffectDescription_lbl_6ff37b" xml:lang="en-US">Merger effect description</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PolicyTextBlockAbstract" xlink:label="us-gaap_PolicyTextBlockAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PolicyTextBlockAbstract" xlink:to="us-gaap_PolicyTextBlockAbstract_lbl_931f66" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PolicyTextBlockAbstract_lbl_931f66" xml:lang="en-US">Summary of Significant Accounting Policies (Details Narrative)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl_18e894" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl_18e894" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_WarrantsMember" xlink:label="scwo_WarrantsMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_WarrantsMember" xlink:to="scwo_WarrantsMember_lbl_380486" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_WarrantsMember_lbl_380486" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl_6bb72d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl_6bb72d" xml:lang="en-US">Depreciation</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl_7a0895" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl_7a0895" xml:lang="en-US">Research And Development Cost</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl_593cf2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl_593cf2" xml:lang="en-US">Antidilutive Excluded From Computation Of Earnings Per Share, Shares</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl_728ffa" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl_728ffa" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashEquivalentsAtCarryingValue_lbl_fe2a3f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl_fe2a3f" xml:lang="en-US">Cash equivalents</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl_c656aa" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl_c656aa" xml:lang="en-US">Uncertain tax positions</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="us-gaap_GoodwillImpairmentLoss" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillImpairmentLoss" xlink:to="us-gaap_GoodwillImpairmentLoss_lbl_827c57" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillImpairmentLoss_lbl_827c57" xml:lang="en-US">Loss on impairment</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl_7f873d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl_7f873d" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInContinuingOperations" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInContinuingOperations_lbl_a17908" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInContinuingOperations_lbl_a17908" xml:lang="en-US">Net Cash Used In Operations</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_WorkingCapital" xlink:label="scwo_WorkingCapital" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_WorkingCapital" xlink:to="scwo_WorkingCapital_lbl_739f1b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_WorkingCapital_lbl_739f1b" xml:lang="en-US">Working capital</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl_7595c3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl_7595c3" xml:lang="en-US">Proceed from sales of stock</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_NetCashProvidedByUsedInOperatingActivity" xlink:label="scwo_NetCashProvidedByUsedInOperatingActivity" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_NetCashProvidedByUsedInOperatingActivity" xlink:to="scwo_NetCashProvidedByUsedInOperatingActivity_lbl_1bd14f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_NetCashProvidedByUsedInOperatingActivity_lbl_1bd14f" xml:lang="en-US">Net cash used in operations</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl_cbdca3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl_cbdca3" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_ThreeSevenFourWaterMember" xlink:label="scwo_ThreeSevenFourWaterMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_ThreeSevenFourWaterMember" xlink:to="scwo_ThreeSevenFourWaterMember_lbl_d90fb9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_ThreeSevenFourWaterMember_lbl_d90fb9" xml:lang="en-US">374Water, Inc. [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl_fc2dce" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl_fc2dce" xml:lang="en-US">Cash</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl_2" xml:lang="en-US">[Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl_bf4210" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl_bf4210" xml:lang="en-US">Prepaid expense</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl_3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl_3" xml:lang="en-US">[Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl_506fe6" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl_506fe6" xml:lang="en-US">Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl_4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl_4" xml:lang="en-US">[Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_lbl_4a2f6c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_lbl_4a2f6c" xml:lang="en-US">Total assets acquired</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl_e28a59" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl_e28a59" xml:lang="en-US">Accounts payable</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl_6" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl_6" xml:lang="en-US">[Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_lbl_399c81" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_lbl_399c81" xml:lang="en-US">Accrued expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_lbl_7" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_lbl_7" xml:lang="en-US">[Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_lbl_153f3f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_lbl_153f3f" xml:lang="en-US">Total liabilities assumed</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl_74f52a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl_74f52a" xml:lang="en-US">Net liabilities assumed</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl_770022" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl_770022" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl_0e0382" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl_0e0382" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesDPreferredStockMember" xlink:label="us-gaap_SeriesDPreferredStockMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesDPreferredStockMember" xlink:to="us-gaap_SeriesDPreferredStockMember_lbl_abbc1f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesDPreferredStockMember_lbl_abbc1f" xml:lang="en-US">Series D Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="srt_ChiefExecutiveOfficerMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ChiefExecutiveOfficerMember" xlink:to="srt_ChiefExecutiveOfficerMember_lbl_05a80a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ChiefExecutiveOfficerMember_lbl_05a80a" xml:lang="en-US">CEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_MrNagarMember" xlink:label="scwo_MrNagarMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_MrNagarMember" xlink:to="scwo_MrNagarMember_lbl_15bfd3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_MrNagarMember_lbl_15bfd3" xml:lang="en-US">Mr Nagar</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalariesAndWages" xlink:label="us-gaap_SalariesAndWages" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalariesAndWages" xlink:to="us-gaap_SalariesAndWages_lbl_4ef846" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalariesAndWages_lbl_4ef846" xml:lang="en-US">Annual Salary</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_AnnaulSalaryIncreasedAmount" xlink:label="scwo_AnnaulSalaryIncreasedAmount" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_AnnaulSalaryIncreasedAmount" xlink:to="scwo_AnnaulSalaryIncreasedAmount_lbl_91ac4d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_AnnaulSalaryIncreasedAmount_lbl_91ac4d" xml:lang="en-US">Annaul Salary Increased Amount</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_Description" xlink:label="scwo_Description" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_Description" xlink:to="scwo_Description_lbl_c651bc" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_Description_lbl_c651bc" xml:lang="en-US">Description Issuance Of The Preferred Stock</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl_725b7f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl_725b7f" xml:lang="en-US">Preferred Stock, Par Value</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl_f631bd" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl_f631bd" xml:lang="en-US">Gross Proceeds From Private Placement</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PartnersCapitalAccountUnitsSoldInPrivatePlacement" xlink:label="us-gaap_PartnersCapitalAccountUnitsSoldInPrivatePlacement" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PartnersCapitalAccountUnitsSoldInPrivatePlacement" xlink:to="us-gaap_PartnersCapitalAccountUnitsSoldInPrivatePlacement_lbl_3bca99" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PartnersCapitalAccountUnitsSoldInPrivatePlacement_lbl_3bca99" xml:lang="en-US">Shares In Private Placement</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_SettlementOfLiabilityForPreferredStockShares" xlink:label="scwo_SettlementOfLiabilityForPreferredStockShares" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_SettlementOfLiabilityForPreferredStockShares" xlink:to="scwo_SettlementOfLiabilityForPreferredStockShares_lbl_04f40c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_SettlementOfLiabilityForPreferredStockShares_lbl_04f40c" xml:lang="en-US">Settlement Of Liability For Preferred Stock Shares</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl_edd963" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl_edd963" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_LicenseAgreementMember" xlink:label="scwo_LicenseAgreementMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_LicenseAgreementMember" xlink:to="scwo_LicenseAgreementMember_lbl_50d534" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_LicenseAgreementMember_lbl_50d534" xml:lang="en-US">License Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember" xlink:label="us-gaap_PatentsMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PatentsMember" xlink:to="us-gaap_PatentsMember_lbl_96849d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PatentsMember_lbl_96849d" xml:lang="en-US">Patents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl_f5a54a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl_f5a54a" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl_11cf2d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl_11cf2d" xml:lang="en-US">Net Book Value</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_IntangibleAssetsAdditions" xlink:label="scwo_IntangibleAssetsAdditions" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_IntangibleAssetsAdditions" xlink:to="scwo_IntangibleAssetsAdditions_lbl_0a4a38" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_IntangibleAssetsAdditions_lbl_0a4a38" xml:lang="en-US">Intangible Assets Additions</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl_e920bd" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl_e920bd" xml:lang="en-US">Intangible Assets Gross</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl_5d2546" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl_5d2546" xml:lang="en-US">Estimated Life</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_lbl_22b0e9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_lbl_22b0e9" xml:lang="en-US">2022 (remaining 9 Months)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl_238254" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl_238254" xml:lang="en-US">2023</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl_0ea797" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl_0ea797" xml:lang="en-US">2024</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl_35b2c3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl_35b2c3" xml:lang="en-US">2025</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl_6de95a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl_6de95a" xml:lang="en-US">2026</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl_d7fe58" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl_d7fe58" xml:lang="en-US">Thereafter</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl_542348" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl_542348" xml:lang="en-US">Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentForAmortization" xlink:label="us-gaap_AdjustmentForAmortization" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentForAmortization" xlink:to="us-gaap_AdjustmentForAmortization_lbl_aa6e72" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentForAmortization_lbl_aa6e72" xml:lang="en-US">Amortization Of Intangible Assets</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl_f2ca37" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockValue_lbl_f2ca37" xml:lang="en-US">Common Shares Issued, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl_59b97e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl_59b97e" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_OptionsMember" xlink:label="scwo_OptionsMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_OptionsMember" xlink:to="scwo_OptionsMember_lbl_773d18" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_OptionsMember_lbl_773d18" xml:lang="en-US">Options [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_OptionUnvestedMember" xlink:label="scwo_OptionUnvestedMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_OptionUnvestedMember" xlink:to="scwo_OptionUnvestedMember_lbl_fce30f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_OptionUnvestedMember_lbl_fce30f" xml:lang="en-US">Options Unvested</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl_4ebc25" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl_4ebc25" xml:lang="en-US">Options Outstanding, Beginning Balance</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl_2" xml:lang="en-US">[Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl_d5746b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl_d5746b" xml:lang="en-US">Granted</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl_488a09" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl_488a09" xml:lang="en-US">Vested</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl_4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl_4" xml:lang="en-US">[Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl_66b84a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl_66b84a" xml:lang="en-US">Expired/forfeited</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl_5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl_5" xml:lang="en-US">[Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl_9dda32" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl_9dda32" xml:lang="en-US">Options Outstanding, Ending Balance</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="us-gaap_ConversionOfStockSharesConverted1" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_lbl_2f7d59" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl_2f7d59" xml:lang="en-US">Exercised</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl_3289ef" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl_3289ef" xml:lang="en-US">Weighted Average Exercise Price ,Beginning</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl_8" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl_8" xml:lang="en-US">[Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice" xlink:label="scwo_Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice" xlink:to="scwo_Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice_lbl_4a3451" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice_lbl_4a3451" xml:lang="en-US">Weighted Average Exercise Price, Granted</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice" xlink:label="scwo_Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice" xlink:to="scwo_Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice_lbl_7fc999" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice_lbl_7fc999" xml:lang="en-US">Weighted Average Exercise Price, Exercised</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice" xlink:label="scwo_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice" xlink:to="scwo_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice_lbl_e8a379" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice_lbl_e8a379" xml:lang="en-US">Weighted Average Exercise Price, Expired/forfeit</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl_0f410d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl_0f410d" xml:lang="en-US">Weighted Average Exercise Price ,ending</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl_b8b965" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl_b8b965" xml:lang="en-US">Aggregate Intrinsic Value, Beginng</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl_13" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl_13" xml:lang="en-US">[Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl_e18656" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl_e18656" xml:lang="en-US">Aggregate Intrinsic Value ,ending</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl_a1ac47" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl_a1ac47" xml:lang="en-US">Weighted Average Remaining Contractual Life(Years)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl_291751" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl_291751" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_MinimumsMember" xlink:label="scwo_MinimumsMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_MinimumsMember" xlink:to="scwo_MinimumsMember_lbl_530730" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_MinimumsMember_lbl_530730" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_MaximumsMember" xlink:label="scwo_MaximumsMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_MaximumsMember" xlink:to="scwo_MaximumsMember_lbl_5e3123" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_MaximumsMember_lbl_5e3123" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl_352d83" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl_352d83" xml:lang="en-US">Dividend yield</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl_015224" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl_015224" xml:lang="en-US">Expected Life</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl_ab47bc" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl_ab47bc" xml:lang="en-US">Expected volatility</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl_aacee0" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl_aacee0" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_MinimumsMember" xlink:to="scwo_MinimumsMember_lbl_401fef" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="scwo_MinimumsMember_lbl_401fef" xml:lang="en-US">Minimum [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_MaximumsMember" xlink:to="scwo_MaximumsMember_lbl_94af1e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="scwo_MaximumsMember_lbl_94af1e" xml:lang="en-US">Maximum [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl_01ff56" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl_01ff56" xml:lang="en-US">Balance At Beginning</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl_2" xml:lang="en-US">[Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl_0fad74" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl_0fad74" xml:lang="en-US">Shares Issued</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_lbl_23a600" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_lbl_23a600" xml:lang="en-US">Shares Exercised</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_lbl_4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_lbl_4" xml:lang="en-US">[Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl_71332c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl_71332c" xml:lang="en-US">Balance At End</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl_fef79d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl_fef79d" xml:lang="en-US">Weighted Average Remaining Contractual Life(years)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl_95d01f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl_95d01f" xml:lang="en-US">Weighted Average Exercise Price Issued</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_WeightedAverageExercisePriceExercised" xlink:label="scwo_WeightedAverageExercisePriceExercised" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_WeightedAverageExercisePriceExercised" xlink:to="scwo_WeightedAverageExercisePriceExercised_lbl_556888" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_WeightedAverageExercisePriceExercised_lbl_556888" xml:lang="en-US">Weighted Average Exercise Price Exercised</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl_caa6a9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl_caa6a9" xml:lang="en-US">Weighted Average Exercise Price Balance At Ending</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl_12" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl_12" xml:lang="en-US">[Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl_75a59b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl_75a59b" xml:lang="en-US">Dividend yield</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl_fc44c2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl_fc44c2" xml:lang="en-US">Expected Life</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl_5a4a4b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl_5a4a4b" xml:lang="en-US">Expected volatility</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl_47454d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl_47454d" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl_541197" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl_541197" xml:lang="en-US">Weighted Average Remaining Contractual Life(Years)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl_521cdf" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl_521cdf" xml:lang="en-US">Shares Issued</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl_6e518c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl_6e518c" xml:lang="en-US">Weighted Average Exercise Price Issued</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_WeightedAverageExercisePriceExercised" xlink:to="scwo_WeightedAverageExercisePriceExercised_lbl_8c8f65" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="scwo_WeightedAverageExercisePriceExercised_lbl_8c8f65" xml:lang="en-US">Weighted Average Exercise Price Exercised</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl_986c73" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl_986c73" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_WarrantsMember" xlink:to="scwo_WarrantsMember_lbl_2d731d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="scwo_WarrantsMember_lbl_2d731d" xml:lang="en-US">Warrant [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_OptionsMember" xlink:to="scwo_OptionsMember_lbl_7697f7" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="scwo_OptionsMember_lbl_7697f7" xml:lang="en-US">Options [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_ThreeSeverFourWaterFormerStockholdersMember" xlink:label="scwo_ThreeSeverFourWaterFormerStockholdersMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_ThreeSeverFourWaterFormerStockholdersMember" xlink:to="scwo_ThreeSeverFourWaterFormerStockholdersMember_lbl_96cbd0" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_ThreeSeverFourWaterFormerStockholdersMember_lbl_96cbd0" xml:lang="en-US">374Water Former Stockholders [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_ConsultantMember" xlink:label="scwo_ConsultantMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_ConsultantMember" xlink:to="scwo_ConsultantMember_lbl_66f669" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_ConsultantMember_lbl_66f669" xml:lang="en-US">Consultant [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl_6f1866" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl_6f1866" xml:lang="en-US">Intrinsic Value Of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_StockIssuedUponWarrantExercised" xlink:label="scwo_StockIssuedUponWarrantExercised" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_StockIssuedUponWarrantExercised" xlink:to="scwo_StockIssuedUponWarrantExercised_lbl_6c6ef7" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_StockIssuedUponWarrantExercised_lbl_6c6ef7" xml:lang="en-US">Stock Issued Upon Warrant Exercised</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_ProceedsFromStockIssuedUponWarrantsExercisedAmount" xlink:label="scwo_ProceedsFromStockIssuedUponWarrantsExercisedAmount" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_ProceedsFromStockIssuedUponWarrantsExercisedAmount" xlink:to="scwo_ProceedsFromStockIssuedUponWarrantsExercisedAmount_lbl_f354a5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_ProceedsFromStockIssuedUponWarrantsExercisedAmount_lbl_f354a5" xml:lang="en-US">Proceeds From Stock Issued Upon Warrants Exercised</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_WarrantsOutstandingSeriesOneShares" xlink:label="scwo_WarrantsOutstandingSeriesOneShares" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_WarrantsOutstandingSeriesOneShares" xlink:to="scwo_WarrantsOutstandingSeriesOneShares_lbl_064068" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_WarrantsOutstandingSeriesOneShares_lbl_064068" xml:lang="en-US">Warrants Outstanding Series 1</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesIssued1" xlink:to="us-gaap_ConversionOfStockSharesIssued1_lbl_d04743" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ConversionOfStockSharesIssued1_lbl_d04743" xml:lang="en-US">Common Stock Issued On Conversion</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_lbl_13f94a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl_13f94a" xml:lang="en-US">Preferred Stock Converted</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl_3ebb17" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl_3ebb17" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_LiabilityForPreferredStockShares" xlink:label="scwo_LiabilityForPreferredStockShares" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_LiabilityForPreferredStockShares" xlink:to="scwo_LiabilityForPreferredStockShares_lbl_c54293" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_LiabilityForPreferredStockShares_lbl_c54293" xml:lang="en-US">Liability For Preferred Stock Shares</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl_c1a0f8" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl_c1a0f8" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl_6c7a6a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockSharesIssued_lbl_6c7a6a" xml:lang="en-US">Preferred stock, shares issued</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl_1686ec" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl_1686ec" xml:lang="en-US">Gross Process From Private Placement of Stocks</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl_a6aa8d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesIssued_lbl_a6aa8d" xml:lang="en-US">Common stock, shares issued</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl_0314e9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl_0314e9" xml:lang="en-US">Capital Raised through issuance of common stock</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl_f4fa56" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl_f4fa56" xml:lang="en-US">Common Stock shares issues to raise capital</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_CommonStockSharesIssuesForCash" xlink:label="scwo_CommonStockSharesIssuesForCash" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_CommonStockSharesIssuesForCash" xlink:to="scwo_CommonStockSharesIssuesForCash_lbl_14cd70" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_CommonStockSharesIssuesForCash_lbl_14cd70" xml:lang="en-US">Common Stock shares issues for cash</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_NumberOfWarrantPurchase" xlink:label="scwo_NumberOfWarrantPurchase" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_NumberOfWarrantPurchase" xlink:to="scwo_NumberOfWarrantPurchase_lbl_ef8b86" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_NumberOfWarrantPurchase_lbl_ef8b86" xml:lang="en-US">Number of warrant purchase</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantExercisePriceIncrease" xlink:label="us-gaap_WarrantExercisePriceIncrease" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantExercisePriceIncrease" xlink:to="us-gaap_WarrantExercisePriceIncrease_lbl_e8fe55" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantExercisePriceIncrease_lbl_e8fe55" xml:lang="en-US">Exercise price</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl_a746be" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl_a746be" xml:lang="en-US">Weighted Average Exercise Price Issued</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_AggregateFairValueOfWarrant" xlink:label="scwo_AggregateFairValueOfWarrant" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_AggregateFairValueOfWarrant" xlink:to="scwo_AggregateFairValueOfWarrant_lbl_17373d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_AggregateFairValueOfWarrant_lbl_17373d" xml:lang="en-US">Aggregate fair value of warrant</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl_68bb93" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl_68bb93" xml:lang="en-US">Issuance of common stock, exercise of warrants</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromWarrantExercises" xlink:to="us-gaap_ProceedsFromWarrantExercises_lbl_1d4807" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromWarrantExercises_lbl_1d4807" xml:lang="en-US">Gross proceeds on exercise of warrants</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl_89f5cc" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl_89f5cc" xml:lang="en-US">Warrants outstanding</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl_81745e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl_81745e" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockNoParValue" xlink:label="us-gaap_CommonStockNoParValue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockNoParValue" xlink:to="us-gaap_CommonStockNoParValue_lbl_12649e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockNoParValue_lbl_12649e" xml:lang="en-US">common stock price</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl_5e5c98" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl_5e5c98" xml:lang="en-US">Warrants Outstanding</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl_d0f83d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl_d0f83d" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl_4ede39" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl_4ede39" xml:lang="en-US">Common Stock Value Per Share</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl_9b754a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl_9b754a" xml:lang="en-US">Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockConvertibleSharesIssuable" xlink:label="us-gaap_PreferredStockConvertibleSharesIssuable" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockConvertibleSharesIssuable" xlink:to="us-gaap_PreferredStockConvertibleSharesIssuable_lbl_72728b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockConvertibleSharesIssuable_lbl_72728b" xml:lang="en-US">Convertion of preferred stock to common stock</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_Preferredstockparorstatedvaluepershare" xlink:label="scwo_Preferredstockparorstatedvaluepershare" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_Preferredstockparorstatedvaluepershare" xlink:to="scwo_Preferredstockparorstatedvaluepershare_lbl_8ff301" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_Preferredstockparorstatedvaluepershare_lbl_8ff301" xml:lang="en-US">Preferred stock, par value</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl_705312" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl_705312" xml:lang="en-US">Preferred stock, shares Outstanding</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_PreferredStockParValue" xlink:to="scwo_PreferredStockParValue_lbl_8bf983" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="scwo_PreferredStockParValue_lbl_8bf983" xml:lang="en-US">Preferred Stock Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_PreferredStockParValue" xlink:label="scwo_PreferredStockParValue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_PreferredStockParValue" xlink:to="scwo_PreferredStockParValue_lbl_34" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_PreferredStockParValue_lbl_34" xml:lang="en-US">[Preferred Stock Value Per Share]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockLiquidationPreferenceValue" xlink:to="us-gaap_PreferredStockLiquidationPreferenceValue_lbl_6810c2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockLiquidationPreferenceValue_lbl_6810c2" xml:lang="en-US">Liquidation Value of Preferred Stocks</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_PreferredStockStatedValuePerShare" xlink:label="scwo_PreferredStockStatedValuePerShare" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_PreferredStockStatedValuePerShare" xlink:to="scwo_PreferredStockStatedValuePerShare_lbl_eee717" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_PreferredStockStatedValuePerShare_lbl_eee717" xml:lang="en-US">Preferred Stock Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl_e74ff2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl_e74ff2" xml:lang="en-US">Common Stock which were issued to investees as part of the capital raise</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl_a25202" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl_a25202" xml:lang="en-US">Common Stock which were issued in connection with the exercise of warrants</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl_7924dc" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl_7924dc" xml:lang="en-US">Stock-based compensation</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl_c06ea0" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl_c06ea0" xml:lang="en-US">Research and development</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl_864332" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl_864332" xml:lang="en-US">General and administrative</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl_44c602" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl_44c602" xml:lang="en-US">Unrecognized compensation expense, unvested options</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyCosts" xlink:label="us-gaap_RelatedPartyCosts" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyCosts" xlink:to="us-gaap_RelatedPartyCosts_lbl_c68a05" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyCosts_lbl_c68a05" xml:lang="en-US">Related party cost</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_StockInExcessPercentageOfOutstandingShare" xlink:label="scwo_StockInExcessPercentageOfOutstandingShare" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_StockInExcessPercentageOfOutstandingShare" xlink:to="scwo_StockInExcessPercentageOfOutstandingShare_lbl_453d97" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_StockInExcessPercentageOfOutstandingShare_lbl_453d97" xml:lang="en-US">Stock In Excess Percentage Of Outstanding Share</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueFromRelatedParties" xlink:label="us-gaap_DueFromRelatedParties" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueFromRelatedParties" xlink:to="us-gaap_DueFromRelatedParties_lbl_f89fea" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueFromRelatedParties_lbl_f89fea" xml:lang="en-US">Due to related party</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_AdvancesFromStockholders" xlink:to="scwo_AdvancesFromStockholders_lbl_1f3f76" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="scwo_AdvancesFromStockholders_lbl_1f3f76" xml:lang="en-US">Advances from stockholders</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_lbl_c5a873" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_lbl_c5a873" xml:lang="en-US">Advances from Shareholders</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_DeferredIncomeTaxAssetAbstract" xlink:label="scwo_DeferredIncomeTaxAssetAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_DeferredIncomeTaxAssetAbstract" xlink:to="scwo_DeferredIncomeTaxAssetAbstract_lbl_47f0b0" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_DeferredIncomeTaxAssetAbstract_lbl_47f0b0" xml:lang="en-US">Income Taxes (Details)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:label="us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:to="us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_lbl_83c03c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_lbl_83c03c" xml:lang="en-US">Deferred tax assets:</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl_4eb0c2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl_4eb0c2" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_DeferredTaxAssetsStartupCost" xlink:label="scwo_DeferredTaxAssetsStartupCost" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_DeferredTaxAssetsStartupCost" xlink:to="scwo_DeferredTaxAssetsStartupCost_lbl_a2db06" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_DeferredTaxAssetsStartupCost_lbl_a2db06" xml:lang="en-US">Start-up cost</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_OtherIntangibles" xlink:label="scwo_OtherIntangibles" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_OtherIntangibles" xlink:to="scwo_OtherIntangibles_lbl_d6078a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_OtherIntangibles_lbl_d6078a" xml:lang="en-US">Other Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_OtherAccruals" xlink:label="scwo_OtherAccruals" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_OtherAccruals" xlink:to="scwo_OtherAccruals_lbl_b57768" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_OtherAccruals_lbl_b57768" xml:lang="en-US">Other Accruals</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl_6e39f3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl_6e39f3" xml:lang="en-US">Stock based compensation</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl_41037d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl_41037d" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl_8" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl_8" xml:lang="en-US">[Deferred Tax Assets, Operating Loss Carryforwards]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl_e6122c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl_e6122c" xml:lang="en-US">Deferred tax assets</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl_b74463" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl_b74463" xml:lang="en-US">Less valuation allowance</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl_10" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl_10" xml:lang="en-US">[Deferred Tax Assets, Valuation Allowance]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl_d3fe57" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl_d3fe57" xml:lang="en-US">Net deferred tax assets after valuation allowance</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_lbl_08b09d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxLiabilities_lbl_08b09d" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_lbl_12" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilities_lbl_12" xml:lang="en-US">[Deferred Tax Liabilities, Net]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl_c84026" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl_c84026" xml:lang="en-US">Net deferred tax asset (liability)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesOther" xlink:to="us-gaap_DeferredTaxLiabilitiesOther_lbl_6c3384" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesOther_lbl_6c3384" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:label="us-gaap_DeferredTaxLiabilitiesOther" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesOther" xlink:to="us-gaap_DeferredTaxLiabilitiesOther_lbl_14" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesOther_lbl_14" xml:lang="en-US">[Deferred Tax Liabilities, Other]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_RateReconciliationAbstract" xlink:label="scwo_RateReconciliationAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_RateReconciliationAbstract" xlink:to="scwo_RateReconciliationAbstract_lbl_48c0bc" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_RateReconciliationAbstract_lbl_48c0bc" xml:lang="en-US">Income Taxes (Details 1)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl_c9323b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl_c9323b" xml:lang="en-US">Federal income tax at statutory rate</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_IncomeTaxRateReconciliationChangeInStateTax" xlink:label="scwo_IncomeTaxRateReconciliationChangeInStateTax" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_IncomeTaxRateReconciliationChangeInStateTax" xlink:to="scwo_IncomeTaxRateReconciliationChangeInStateTax_lbl_d5b948" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_IncomeTaxRateReconciliationChangeInStateTax_lbl_d5b948" xml:lang="en-US">Change in State Tax</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_IncomeTaxReconciliationChangeInValuationAllowance" xlink:label="scwo_IncomeTaxReconciliationChangeInValuationAllowance" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_IncomeTaxReconciliationChangeInValuationAllowance" xlink:to="scwo_IncomeTaxReconciliationChangeInValuationAllowance_lbl_77612f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_IncomeTaxReconciliationChangeInValuationAllowance_lbl_77612f" xml:lang="en-US">Change in Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_IncomeTaxReconciliationPermanentDifferences" xlink:label="scwo_IncomeTaxReconciliationPermanentDifferences" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_IncomeTaxReconciliationPermanentDifferences" xlink:to="scwo_IncomeTaxReconciliationPermanentDifferences_lbl_e0e6a3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_IncomeTaxReconciliationPermanentDifferences_lbl_e0e6a3" xml:lang="en-US">Permanent Differences</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_IncomeTaxReconciliationStateTaxes" xlink:label="scwo_IncomeTaxReconciliationStateTaxes" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_IncomeTaxReconciliationStateTaxes" xlink:to="scwo_IncomeTaxReconciliationStateTaxes_lbl_d2c874" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_IncomeTaxReconciliationStateTaxes_lbl_d2c874" xml:lang="en-US">State Tax</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_IncomeTaxReconciliationOther" xlink:label="scwo_IncomeTaxReconciliationOther" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_IncomeTaxReconciliationOther" xlink:to="scwo_IncomeTaxReconciliationOther_lbl_4099cb" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_IncomeTaxReconciliationOther_lbl_4099cb" xml:lang="en-US">Other</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl_95615f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl_95615f" xml:lang="en-US">Net operating loss carry forwards for federal income tax purposes</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueCurrent_lbl_1644a5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredRevenueCurrent_lbl_1644a5" xml:lang="en-US">Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueCurrent_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueCurrent_lbl_2" xml:lang="en-US">[Deferred Revenue, Current]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_DeferredRevenuePercentage" xlink:label="scwo_DeferredRevenuePercentage" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_DeferredRevenuePercentage" xlink:to="scwo_DeferredRevenuePercentage_lbl_a5a44a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_DeferredRevenuePercentage_lbl_a5a44a" xml:lang="en-US">Deferred Revenue Percentage</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl_66d9c2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl_66d9c2" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl_330074" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl_330074" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl_f51a9e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl_f51a9e" xml:lang="en-US">Shares Of Common Stock Reserve For Issuance</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>scwo-20220331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 06/17/2022-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2022 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://powerverdeinc.com/role/Cover" xlink:href="scwo-20220331.xsd#Cover" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets" xlink:href="scwo-20220331.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="scwo-20220331.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations" xlink:href="scwo-20220331.xsd#CondensedConsolidatedStatementsOfOperations" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/CondensedConsolidatedChangesInStockholdersDeficit" xlink:href="scwo-20220331.xsd#CondensedConsolidatedChangesInStockholdersDeficit" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:href="scwo-20220331.xsd#CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/NatureOfBusinessAndPresentationOfFinancialStatements" xlink:href="scwo-20220331.xsd#NatureOfBusinessAndPresentationOfFinancialStatements" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="scwo-20220331.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/LiquidityCapitalResourcesAndGoingConcern" xlink:href="scwo-20220331.xsd#LiquidityCapitalResourcesAndGoingConcern" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeInc" xlink:href="scwo-20220331.xsd#AcquisitionOf374WaterIncFkaPowerverdeInc" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/IntangibleAssets" xlink:href="scwo-20220331.xsd#IntangibleAssets" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/StockholderEquity" xlink:href="scwo-20220331.xsd#StockholderEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/RelatedPartyTransactions" xlink:href="scwo-20220331.xsd#RelatedPartyTransactions" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/CommitmentsAndContingencies" xlink:href="scwo-20220331.xsd#CommitmentsAndContingencies" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/IncomeTaxes" xlink:href="scwo-20220331.xsd#IncomeTaxes" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/DeferredRevenue" xlink:href="scwo-20220331.xsd#DeferredRevenue" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/SubsequentEvents" xlink:href="scwo-20220331.xsd#SubsequentEvents" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="scwo-20220331.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncTables" xlink:href="scwo-20220331.xsd#AcquisitionOf374WaterIncFkaPowerverdeIncTables" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/IntangibleAssetsTables" xlink:href="scwo-20220331.xsd#IntangibleAssetsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/StockholderEquityTables" xlink:href="scwo-20220331.xsd#StockholderEquityTables" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/IncomeTaxesTables" xlink:href="scwo-20220331.xsd#IncomeTaxesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/NatureOfBusinessAndPresentationOfFinancialStatementsDetailsNarrative" xlink:href="scwo-20220331.xsd#NatureOfBusinessAndPresentationOfFinancialStatementsDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="scwo-20220331.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/LiquidityCapitalResourcesAndGoingConcernDetailsNarrative" xlink:href="scwo-20220331.xsd#LiquidityCapitalResourcesAndGoingConcernDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetails" xlink:href="scwo-20220331.xsd#AcquisitionOf374WaterIncFkaPowerverdeIncDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetailsNarrative" xlink:href="scwo-20220331.xsd#AcquisitionOf374WaterIncFkaPowerverdeIncDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/IntangibleAssetsDetails" xlink:href="scwo-20220331.xsd#IntangibleAssetsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/IntangibleAssetsDetails1" xlink:href="scwo-20220331.xsd#IntangibleAssetsDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/IntangibleAssetsDetailsNarrative" xlink:href="scwo-20220331.xsd#IntangibleAssetsDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/StockholderEquityDetails" xlink:href="scwo-20220331.xsd#StockholderEquityDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/StockholderEquityDetails1" xlink:href="scwo-20220331.xsd#StockholderEquityDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/StockholderEquityDetails2" xlink:href="scwo-20220331.xsd#StockholderEquityDetails2" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/StockholderEquityDetails3" xlink:href="scwo-20220331.xsd#StockholderEquityDetails3" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/StockholderEquityDetailsNarrative" xlink:href="scwo-20220331.xsd#StockholderEquityDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="scwo-20220331.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/IncomeTaxesDetails" xlink:href="scwo-20220331.xsd#IncomeTaxesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/IncomeTaxesDetails1" xlink:href="scwo-20220331.xsd#IncomeTaxesDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/IncomeTaxesDetailsNarrative" xlink:href="scwo-20220331.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/DeferredRevenueDetailsNarrative" xlink:href="scwo-20220331.xsd#DeferredRevenueDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/SubsequentEventsDetailsNarrative" xlink:href="scwo-20220331.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/Cover" xlink:title="00000001 - Document - Document and Entity Information" />
  <link:calculationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets" xlink:title="000002 - Statement - Condensed Consolidated Balance Sheets">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
    <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
    <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCash" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaapAccountsReceivableNet" />
    <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNet" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets" />
    <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapOtherAssets" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsNet" xlink:label="loc_us-gaapOtherIntangibleAssetsNet" />
    <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapOtherIntangibleAssetsNet" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
    <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
    <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
    <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities" />
    <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherLiabilities" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
    <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="loc_us-gaapDeferredRevenue" />
    <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDeferredRevenue" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_AdvancesFromStockholders" xlink:label="loc_scwoAdvancesFromStockholders" />
    <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_scwoAdvancesFromStockholders" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
    <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
    <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
    <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
    <link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
    <link:calculationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
    <link:calculationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    <link:calculationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:title="000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations" xlink:title="000004 - Statement - Condensed Consolidated Statements of Operations">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
    <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
    <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
    <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees" />
    <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductionCosts" xlink:label="loc_us-gaapProductionCosts" />
    <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapProductionCosts" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
    <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="loc_us-gaapLaborAndRelatedExpense" />
    <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapLaborAndRelatedExpense" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
    <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
    <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncome" xlink:label="loc_us-gaapOtherIncome" />
    <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapOtherIncome" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeOperating" xlink:label="loc_us-gaapInterestIncomeOperating" />
    <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestIncomeOperating" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_AwardIncome" xlink:label="loc_scwoAwardIncome" />
    <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_scwoAwardIncome" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
    <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
    <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
    <link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/CondensedConsolidatedChangesInStockholdersDeficit" xlink:title="000005 - Statement - Condensed Consolidated Changes in Stockholders' Deficit" />
  <link:calculationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:title="000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
    <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
    <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
    <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_WarrantIssuedForProductDevelopmentAgreement" xlink:label="loc_scwoWarrantIssuedForProductDevelopmentAgreement" />
    <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_scwoWarrantIssuedForProductDevelopmentAgreement" xlink:type="arc" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
    <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" />
    <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_AdjustmentForCommonStockIssuedForServices" xlink:label="loc_scwoAdjustmentForCommonStockIssuedForServices" />
    <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_scwoAdjustmentForCommonStockIssuedForServices" xlink:type="arc" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
    <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_ProceedsFromReverseAcquisition" xlink:label="loc_scwoProceedsFromReverseAcquisition" />
    <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_scwoProceedsFromReverseAcquisition" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" />
    <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" xlink:type="arc" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfCapitalDistribution" xlink:label="loc_us-gaapPaymentsOfCapitalDistribution" />
    <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsOfCapitalDistribution" xlink:type="arc" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRepaymentsOfRelatedPartyDebt" />
    <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromRepaymentsOfRelatedPartyDebt" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfPreferredStockAndPreferenceStock" />
    <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
    <link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
    <link:calculationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaapProceedsFromWarrantExercises" />
    <link:calculationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromWarrantExercises" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
    <link:calculationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
    <link:calculationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
    <link:calculationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/NatureOfBusinessAndPresentationOfFinancialStatements" xlink:title="000007 - Disclosure - Nature of Business and Presentation of Financial Statements" />
  <link:calculationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="000008 - Disclosure - Summary of Significant Accounting Policies" />
  <link:calculationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/LiquidityCapitalResourcesAndGoingConcern" xlink:title="000009 - Disclosure - Liquidity Capital Resources and Going Concern" />
  <link:calculationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeInc" xlink:title="000010 - Disclosure - Acquisition of 374Water Inc fka PowerVerde Inc" />
  <link:calculationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/IntangibleAssets" xlink:title="000011 - Disclosure - Intangible Assets" />
  <link:calculationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/StockholderEquity" xlink:title="000012 - Disclosure - Stockholder Equity" />
  <link:calculationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/RelatedPartyTransactions" xlink:title="000013 - Disclosure - Related Party Transactions" />
  <link:calculationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/CommitmentsAndContingencies" xlink:title="000014 - Disclosure - Commitments and Contingencies" />
  <link:calculationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/IncomeTaxes" xlink:title="000015 - Disclosure - Income Taxes" />
  <link:calculationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/DeferredRevenue" xlink:title="000016 - Disclosure - Deferred Revenue" />
  <link:calculationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/SubsequentEvents" xlink:title="000017 - Disclosure - Subsequent Events" />
  <link:calculationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="000018 - Disclosure - Summary of Significant Accounting Policies (Policies)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncTables" xlink:title="000019 - Disclosure - Acquisition of 374Water Inc fka PowerVerde Inc (Tables)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/IntangibleAssetsTables" xlink:title="000020 - Disclosure - Intangible Assets (Tables)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/StockholderEquityTables" xlink:title="000021 - Disclosure - Stockholder Equity (Tables)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/IncomeTaxesTables" xlink:title="000022 - Disclosure - Income Taxes (Tables)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/NatureOfBusinessAndPresentationOfFinancialStatementsDetailsNarrative" xlink:title="000023 - Disclosure - Nature of Business and Presentation of Financial Statements (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="000024 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/LiquidityCapitalResourcesAndGoingConcernDetailsNarrative" xlink:title="000025 - Disclosure - Liquidity Capital Resources and Going Concern (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetails" xlink:title="000026 - Disclosure - Acquisition of 374Water Inc fka PowerVerde Inc (Details)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetailsNarrative" xlink:title="000027 - Disclosure - Acquisition of 374Water Inc fka PowerVerde Inc (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/IntangibleAssetsDetails" xlink:title="000028 - Disclosure - Intangible Assets (Details)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/IntangibleAssetsDetails1" xlink:title="000029 - Disclosure - Intangible Assets (Details 1)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/IntangibleAssetsDetailsNarrative" xlink:title="000030 - Disclosure - Intangible Assets (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/StockholderEquityDetails" xlink:title="000031 - Disclosure - Stockholder Equity (Details)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/StockholderEquityDetails1" xlink:title="000032 - Disclosure - Stockholder Equity (Details 1)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/StockholderEquityDetails2" xlink:title="000033 - Disclosure - Stockholder Equity (Details 2)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/StockholderEquityDetails3" xlink:title="000034 - Disclosure - Stockholder Equity (Details 3)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/StockholderEquityDetailsNarrative" xlink:title="000035 - Disclosure - Stockholder Equity (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="000036 - Disclosure - Related Party Transactions (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/IncomeTaxesDetails" xlink:title="000037 - Disclosure - Income Taxes (Details)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/IncomeTaxesDetails1" xlink:title="000038 - Disclosure - Income Taxes (Details 1)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/IncomeTaxesDetailsNarrative" xlink:title="000039 - Disclosure - Income Taxes (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/DeferredRevenueDetailsNarrative" xlink:title="000040 - Disclosure - Deferred Revenue (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/SubsequentEventsDetailsNarrative" xlink:title="000041 - Disclosure - Subsequent Events (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>scwo-20220331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 06/17/2022-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2022 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://powerverdeinc.com/role/Cover" xlink:href="scwo-20220331.xsd#Cover" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets" xlink:href="scwo-20220331.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="scwo-20220331.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations" xlink:href="scwo-20220331.xsd#CondensedConsolidatedStatementsOfOperations" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/CondensedConsolidatedChangesInStockholdersDeficit" xlink:href="scwo-20220331.xsd#CondensedConsolidatedChangesInStockholdersDeficit" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:href="scwo-20220331.xsd#CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/NatureOfBusinessAndPresentationOfFinancialStatements" xlink:href="scwo-20220331.xsd#NatureOfBusinessAndPresentationOfFinancialStatements" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="scwo-20220331.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/LiquidityCapitalResourcesAndGoingConcern" xlink:href="scwo-20220331.xsd#LiquidityCapitalResourcesAndGoingConcern" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeInc" xlink:href="scwo-20220331.xsd#AcquisitionOf374WaterIncFkaPowerverdeInc" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/IntangibleAssets" xlink:href="scwo-20220331.xsd#IntangibleAssets" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/StockholderEquity" xlink:href="scwo-20220331.xsd#StockholderEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/RelatedPartyTransactions" xlink:href="scwo-20220331.xsd#RelatedPartyTransactions" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/CommitmentsAndContingencies" xlink:href="scwo-20220331.xsd#CommitmentsAndContingencies" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/IncomeTaxes" xlink:href="scwo-20220331.xsd#IncomeTaxes" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/DeferredRevenue" xlink:href="scwo-20220331.xsd#DeferredRevenue" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/SubsequentEvents" xlink:href="scwo-20220331.xsd#SubsequentEvents" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="scwo-20220331.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncTables" xlink:href="scwo-20220331.xsd#AcquisitionOf374WaterIncFkaPowerverdeIncTables" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/IntangibleAssetsTables" xlink:href="scwo-20220331.xsd#IntangibleAssetsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/StockholderEquityTables" xlink:href="scwo-20220331.xsd#StockholderEquityTables" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/IncomeTaxesTables" xlink:href="scwo-20220331.xsd#IncomeTaxesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/NatureOfBusinessAndPresentationOfFinancialStatementsDetailsNarrative" xlink:href="scwo-20220331.xsd#NatureOfBusinessAndPresentationOfFinancialStatementsDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="scwo-20220331.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/LiquidityCapitalResourcesAndGoingConcernDetailsNarrative" xlink:href="scwo-20220331.xsd#LiquidityCapitalResourcesAndGoingConcernDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetails" xlink:href="scwo-20220331.xsd#AcquisitionOf374WaterIncFkaPowerverdeIncDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetailsNarrative" xlink:href="scwo-20220331.xsd#AcquisitionOf374WaterIncFkaPowerverdeIncDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/IntangibleAssetsDetails" xlink:href="scwo-20220331.xsd#IntangibleAssetsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/IntangibleAssetsDetails1" xlink:href="scwo-20220331.xsd#IntangibleAssetsDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/IntangibleAssetsDetailsNarrative" xlink:href="scwo-20220331.xsd#IntangibleAssetsDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/StockholderEquityDetails" xlink:href="scwo-20220331.xsd#StockholderEquityDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/StockholderEquityDetails1" xlink:href="scwo-20220331.xsd#StockholderEquityDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/StockholderEquityDetails2" xlink:href="scwo-20220331.xsd#StockholderEquityDetails2" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/StockholderEquityDetails3" xlink:href="scwo-20220331.xsd#StockholderEquityDetails3" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/StockholderEquityDetailsNarrative" xlink:href="scwo-20220331.xsd#StockholderEquityDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="scwo-20220331.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/IncomeTaxesDetails" xlink:href="scwo-20220331.xsd#IncomeTaxesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/IncomeTaxesDetails1" xlink:href="scwo-20220331.xsd#IncomeTaxesDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/IncomeTaxesDetailsNarrative" xlink:href="scwo-20220331.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/DeferredRevenueDetailsNarrative" xlink:href="scwo-20220331.xsd#DeferredRevenueDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/SubsequentEventsDetailsNarrative" xlink:href="scwo-20220331.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/Cover" xlink:title="00000001 - Document - Cover Page Information">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
    <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets" xlink:title="000002 - Statement - Condensed Consolidated Balance Sheets">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract_689aa9" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash_092f38" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_689aa9" xlink:to="loc_us-gaapCash_092f38" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaapAccountsReceivableNet_e4a338" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_689aa9" xlink:to="loc_us-gaapAccountsReceivableNet_e4a338" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent_d89737" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_689aa9" xlink:to="loc_us-gaapPrepaidExpenseCurrent_d89737" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_d2830f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_689aa9" xlink:to="loc_us-gaapAssetsCurrent_d2830f" order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_f072be" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_689aa9" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_f072be" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsNet" xlink:label="loc_us-gaapOtherIntangibleAssetsNet_349ad3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_689aa9" xlink:to="loc_us-gaapOtherIntangibleAssetsNet_349ad3" order="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets_77382f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_689aa9" xlink:to="loc_us-gaapOtherAssets_77382f" order="7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent_abed4e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_689aa9" xlink:to="loc_us-gaapAssetsNoncurrent_abed4e" order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_01d2ab" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_689aa9" xlink:to="loc_us-gaapAssets_01d2ab" order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract_d190af" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_689aa9" xlink:to="loc_us-gaapAssetsCurrentAbstract_d190af" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent_3b9087" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract_d190af" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent_3b9087" order="11" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_AdvancesFromStockholders" xlink:label="loc_scwoAdvancesFromStockholders_5109ab" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract_d190af" xlink:to="loc_scwoAdvancesFromStockholders_5109ab" order="12" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="loc_us-gaapDeferredRevenue_7b61c4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract_d190af" xlink:to="loc_us-gaapDeferredRevenue_7b61c4" order="13" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities_4e8121" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract_d190af" xlink:to="loc_us-gaapOtherLiabilities_4e8121" order="14" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_e6770b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract_d190af" xlink:to="loc_us-gaapLiabilitiesCurrent_e6770b" order="15" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract_219f8d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract_d190af" xlink:to="loc_us-gaapAssetsAbstract_219f8d" order="16" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaapAssetsNoncurrentAbstract_fbf0f8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract_219f8d" xlink:to="loc_us-gaapAssetsNoncurrentAbstract_fbf0f8" order="17" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities_b90212" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract_fbf0f8" xlink:to="loc_us-gaapLiabilities_b90212" order="18" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract_dd4a3f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract_fbf0f8" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract_dd4a3f" order="19" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract_7959b0" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract_dd4a3f" xlink:to="loc_us-gaapStockholdersEquityAbstract_7959b0" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue_53022b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract_7959b0" xlink:to="loc_us-gaapPreferredStockValue_53022b" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_c7bab5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract_7959b0" xlink:to="loc_us-gaapCommonStockValue_c7bab5" order="22" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital_297dbc" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract_7959b0" xlink:to="loc_us-gaapAdditionalPaidInCapital_297dbc" order="23" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_fcb71e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract_7959b0" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_fcb71e" order="24" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_e2f001" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract_7959b0" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_e2f001" order="25" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract_eaa6ee" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_e2f001" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract_eaa6ee" order="26" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_ccae55" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_eaa6ee" xlink:to="loc_us-gaapStockholdersEquity_ccae55" order="27" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity_33efb4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_eaa6ee" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity_33efb4" order="28" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:title="000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract_c670de" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_4d1da7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_c670de" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_4d1da7" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_091b64" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_c670de" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_091b64" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_8eebb4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_c670de" xlink:to="loc_us-gaapPreferredStockSharesIssued_8eebb4" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockLiquidationPreferenceValue" xlink:label="loc_us-gaapPreferredStockLiquidationPreferenceValue_dac0e3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_c670de" xlink:to="loc_us-gaapPreferredStockLiquidationPreferenceValue_dac0e3" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_1a93dc" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_c670de" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_1a93dc" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_c020e5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_c670de" xlink:to="loc_us-gaapCommonStockSharesAuthorized_c020e5" order="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_a17558" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_c670de" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_a17558" order="7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_ffdf7f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_c670de" xlink:to="loc_us-gaapCommonStockSharesIssued_ffdf7f" order="8" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_62d46e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_c670de" xlink:to="loc_us-gaapCommonStockSharesOutstanding_62d46e" order="9" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations" xlink:title="000004 - Statement - Condensed Consolidated Statements of Operations">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract_2b467f" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_b3ccbb" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract_2b467f" xlink:to="loc_us-gaapRevenues_b3ccbb" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue_d0f86d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract_2b467f" xlink:to="loc_us-gaapCostOfRevenue_d0f86d" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit_d213a7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract_2b467f" xlink:to="loc_us-gaapGrossProfit_d213a7" order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract_ce5362" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract_2b467f" xlink:to="loc_us-gaapOperatingExpensesAbstract_ce5362" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense_c8eb3e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract_ce5362" xlink:to="loc_us-gaapResearchAndDevelopmentExpense_c8eb3e" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="loc_us-gaapLaborAndRelatedExpense_769489" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract_ce5362" xlink:to="loc_us-gaapLaborAndRelatedExpense_769489" order="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductionCosts" xlink:label="loc_us-gaapProductionCosts_5583c1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract_ce5362" xlink:to="loc_us-gaapProductionCosts_5583c1" order="7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees_6e67aa" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract_ce5362" xlink:to="loc_us-gaapProfessionalFees_6e67aa" order="8" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense_e5cb94" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract_ce5362" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense_e5cb94" order="9" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses_ac2628" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract_ce5362" xlink:to="loc_us-gaapOperatingExpenses_ac2628" order="10" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss_9ec030" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract_ce5362" xlink:to="loc_us-gaapOperatingIncomeLoss_9ec030" order="11" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="loc_us-gaapOtherIncomeAndExpensesAbstract_619171" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract_ce5362" xlink:to="loc_us-gaapOtherIncomeAndExpensesAbstract_619171" order="12" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_AwardIncome" xlink:label="loc_scwoAwardIncome_1cb906" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract_619171" xlink:to="loc_scwoAwardIncome_1cb906" order="13" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeOperating" xlink:label="loc_us-gaapInterestIncomeOperating_6ae47a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract_619171" xlink:to="loc_us-gaapInterestIncomeOperating_6ae47a" order="14" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncome" xlink:label="loc_us-gaapOtherIncome_1ee95a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract_619171" xlink:to="loc_us-gaapOtherIncome_1ee95a" order="15" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense_a8b445" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract_619171" xlink:to="loc_us-gaapNonoperatingIncomeExpense_a8b445" order="16" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2a7a34" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract_619171" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2a7a34" order="17" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit_67222a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract_619171" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit_67222a" order="18" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_613f36" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract_619171" xlink:to="loc_us-gaapNetIncomeLoss_613f36" order="19" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_NetLossPerShareBasicAndDiluted" xlink:label="loc_scwoNetLossPerShareBasicAndDiluted_ba8266" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract_619171" xlink:to="loc_scwoNetLossPerShareBasicAndDiluted_ba8266" order="20" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_WeightedAverageCommonSharesOutstandingBasicAndDiluted" xlink:label="loc_scwoWeightedAverageCommonSharesOutstandingBasicAndDiluted_a0878f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract_619171" xlink:to="loc_scwoWeightedAverageCommonSharesOutstandingBasicAndDiluted_a0878f" order="21" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/CondensedConsolidatedChangesInStockholdersDeficit" xlink:title="000005 - Statement - Condensed Consolidated Changes in Stockholders' Deficit">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract_6f23ae" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_6bc6c4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract_6f23ae" xlink:to="loc_us-gaapStatementTable_6bc6c4" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_b93d5e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_6bc6c4" xlink:to="loc_us-gaapStatementLineItems_b93d5e" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis_95ca7a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_6bc6c4" xlink:to="loc_us-gaapStatementEquityComponentsAxis_95ca7a" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_caecd7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis_95ca7a" xlink:to="loc_us-gaapEquityComponentDomain_caecd7" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_33dddf" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain_caecd7" xlink:to="loc_us-gaapCommonStockMember_33dddf" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_ecbc2f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain_caecd7" xlink:to="loc_us-gaapPreferredStockMember_ecbc2f" order="22" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_f0c091" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain_caecd7" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_f0c091" order="23" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_3db828" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain_caecd7" xlink:to="loc_us-gaapRetainedEarningsMember_3db828" order="24" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued_ce09d4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_b93d5e" xlink:to="loc_us-gaapSharesIssued_ce09d4" order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_0b1395" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_b93d5e" xlink:to="loc_us-gaapStockholdersEquity_0b1395" order="2" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_0edd04" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_b93d5e" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_0edd04" order="3" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_AccretionOfStockBasedCompensation" xlink:label="loc_scwoAccretionOfStockBasedCompensation_4bf83b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_b93d5e" xlink:to="loc_scwoAccretionOfStockBasedCompensation_4bf83b" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss_048fb6" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_b93d5e" xlink:to="loc_us-gaapProfitLoss_048fb6" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionExpense" xlink:label="loc_us-gaapAccretionExpense_c656f2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_b93d5e" xlink:to="loc_us-gaapAccretionExpense_c656f2" order="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_522224" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_b93d5e" xlink:to="loc_us-gaapNetIncomeLoss_522224" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_IssuanceOfStockWarrantsForDevelopmentOfProduct" xlink:label="loc_scwoIssuanceOfStockWarrantsForDevelopmentOfProduct_627fce" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_b93d5e" xlink:to="loc_scwoIssuanceOfStockWarrantsForDevelopmentOfProduct_627fce" order="8" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_RecapitalizationOfTheCompanyShares" xlink:label="loc_scwoRecapitalizationOfTheCompanyShares_1acfbc" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_b93d5e" xlink:to="loc_scwoRecapitalizationOfTheCompanyShares_1acfbc" order="9" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_RecapitalizationOfTheCompanyAmount" xlink:label="loc_scwoRecapitalizationOfTheCompanyAmount_e8af75" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_b93d5e" xlink:to="loc_scwoRecapitalizationOfTheCompanyAmount_e8af75" order="10" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_SeriesDPreferredStockIssuedForCashShares" xlink:label="loc_scwoSeriesDPreferredStockIssuedForCashShares_4a7838" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_b93d5e" xlink:to="loc_scwoSeriesDPreferredStockIssuedForCashShares_4a7838" order="11" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_SeriesDPreferredStockIssuedForCashAmount" xlink:label="loc_scwoSeriesDPreferredStockIssuedForCashAmount_c348c1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_b93d5e" xlink:to="loc_scwoSeriesDPreferredStockIssuedForCashAmount_c348c1" order="12" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_ExercisedOptionAndWarrantsShares" xlink:label="loc_scwoExercisedOptionAndWarrantsShares_65206c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_b93d5e" xlink:to="loc_scwoExercisedOptionAndWarrantsShares_65206c" order="13" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_ExercisedOptionAndWarrantsAmount" xlink:label="loc_scwoExercisedOptionAndWarrantsAmount_3b39bb" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_b93d5e" xlink:to="loc_scwoExercisedOptionAndWarrantsAmount_3b39bb" order="14" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_IssuanceOfCommonStockForLicenseRightsShares" xlink:label="loc_scwoIssuanceOfCommonStockForLicenseRightsShares_c2a276" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_b93d5e" xlink:to="loc_scwoIssuanceOfCommonStockForLicenseRightsShares_c2a276" order="15" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_IssuanceOfCommonStockForLicenseRightsAmount" xlink:label="loc_scwoIssuanceOfCommonStockForLicenseRightsAmount_4896e9" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_b93d5e" xlink:to="loc_scwoIssuanceOfCommonStockForLicenseRightsAmount_4896e9" order="16" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_ConversionOfConvertiblePreferredSharesIntoCommonStockShares" xlink:label="loc_scwoConversionOfConvertiblePreferredSharesIntoCommonStockShares_46fa5a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_b93d5e" xlink:to="loc_scwoConversionOfConvertiblePreferredSharesIntoCommonStockShares_46fa5a" order="17" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_ConversionOfConvertiblePreferredSharesIntoCommonStockAmount" xlink:label="loc_scwoConversionOfConvertiblePreferredSharesIntoCommonStockAmount_e2bc37" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_b93d5e" xlink:to="loc_scwoConversionOfConvertiblePreferredSharesIntoCommonStockAmount_e2bc37" order="18" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_c761e5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_b93d5e" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_c761e5" order="19" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_18d481" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_b93d5e" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_18d481" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="loc_us-gaapConversionOfStockSharesIssued1_121db3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_b93d5e" xlink:to="loc_us-gaapConversionOfStockSharesIssued1_121db3" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockAmountIssued1" xlink:label="loc_us-gaapConversionOfStockAmountIssued1_6d6fae" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_b93d5e" xlink:to="loc_us-gaapConversionOfStockAmountIssued1_6d6fae" order="22" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued_9bd8f2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_b93d5e" xlink:to="loc_us-gaapSharesIssued_9bd8f2" order="23" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_017342" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_b93d5e" xlink:to="loc_us-gaapStockholdersEquity_017342" order="24" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:title="000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract_d00aa0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract_932873" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_d00aa0" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract_932873" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_017d7a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract_932873" xlink:to="loc_us-gaapNetIncomeLoss_017d7a" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e17a69" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract_932873" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e17a69" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization_600074" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e17a69" xlink:to="loc_us-gaapDepreciationAndAmortization_600074" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation_5d9ea3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e17a69" xlink:to="loc_us-gaapShareBasedCompensation_5d9ea3" order="5" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_AdjustmentForCommonStockIssuedForServices" xlink:label="loc_scwoAdjustmentForCommonStockIssuedForServices_344f7f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e17a69" xlink:to="loc_scwoAdjustmentForCommonStockIssuedForServices_344f7f" order="6" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_WarrantIssuedForProductDevelopmentAgreement" xlink:label="loc_scwoWarrantIssuedForProductDevelopmentAgreement_44034b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e17a69" xlink:to="loc_scwoWarrantIssuedForProductDevelopmentAgreement_44034b" order="7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_94f851" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e17a69" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_94f851" order="8" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable_b9f4ab" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_94f851" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable_b9f4ab" order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities_43f5fa" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_94f851" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities_43f5fa" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredRevenue_adba6b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_94f851" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredRevenue_adba6b" order="11" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_c304c3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_94f851" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_c304c3" order="12" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities_8c8f6a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_94f851" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities_8c8f6a" order="13" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities_10ad0e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_94f851" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities_10ad0e" order="14" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_a798a3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_94f851" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_a798a3" order="15" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment_cb04aa" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_a798a3" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment_cb04aa" order="16" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_ProceedsFromReverseAcquisition" xlink:label="loc_scwoProceedsFromReverseAcquisition_24aed8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_a798a3" xlink:to="loc_scwoProceedsFromReverseAcquisition_24aed8" order="17" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets_5cb947" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_a798a3" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets_5cb947" order="18" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfCapitalDistribution" xlink:label="loc_us-gaapPaymentsOfCapitalDistribution_0695b3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_a798a3" xlink:to="loc_us-gaapPaymentsOfCapitalDistribution_0695b3" order="19" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities_2ecf59" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_a798a3" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities_2ecf59" order="20" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract_513f19" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_a798a3" xlink:to="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract_513f19" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRepaymentsOfRelatedPartyDebt_897ffe" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract_513f19" xlink:to="loc_us-gaapProceedsFromRepaymentsOfRelatedPartyDebt_897ffe" order="22" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfPreferredStockAndPreferenceStock_b72b62" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract_513f19" xlink:to="loc_us-gaapProceedsFromIssuanceOfPreferredStockAndPreferenceStock_b72b62" order="23" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock_31cb96" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract_513f19" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock_31cb96" order="24" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised_89e303" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract_513f19" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised_89e303" order="25" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaapProceedsFromWarrantExercises_c58dd7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract_513f19" xlink:to="loc_us-gaapProceedsFromWarrantExercises_c58dd7" order="26" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities_784024" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract_513f19" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities_784024" order="27" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_9fd7af" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract_513f19" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_9fd7af" order="28" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_56ef1b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract_513f19" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_56ef1b" order="29" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_186cc7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract_513f19" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_186cc7" order="30" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract_2515ea" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract_513f19" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract_2515ea" order="31" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet_458638" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract_2515ea" xlink:to="loc_us-gaapInterestPaidNet_458638" order="32" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:label="loc_us-gaapRepaymentsOfDebt_f116b2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract_2515ea" xlink:to="loc_us-gaapRepaymentsOfDebt_f116b2" order="33" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_2b46d2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract_2515ea" xlink:to="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_2b46d2" order="34" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_ConversionOfStockAmountIssued" xlink:label="loc_scwoConversionOfStockAmountIssued_6cbeec" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_2b46d2" xlink:to="loc_scwoConversionOfStockAmountIssued_6cbeec" order="35" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_IssuanceOfCommonStockForLicenseRights" xlink:label="loc_scwoIssuanceOfCommonStockForLicenseRights_68968c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_2b46d2" xlink:to="loc_scwoIssuanceOfCommonStockForLicenseRights_68968c" order="36" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_AccountsPayableSettledWithStockOption" xlink:label="loc_scwoAccountsPayableSettledWithStockOption_f8d9cc" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_2b46d2" xlink:to="loc_scwoAccountsPayableSettledWithStockOption_f8d9cc" order="37" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_NetLiabilitiesAssumedInReverseAcquisitionAbstract" xlink:label="loc_scwoNetLiabilitiesAssumedInReverseAcquisitionAbstract_62071d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_2b46d2" xlink:to="loc_scwoNetLiabilitiesAssumedInReverseAcquisitionAbstract_62071d" order="38" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_NetLiabilitiesAssumedInReverseAcquisitioncash" xlink:label="loc_scwoNetLiabilitiesAssumedInReverseAcquisitioncash_7e3e4d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_scwoNetLiabilitiesAssumedInReverseAcquisitionAbstract_62071d" xlink:to="loc_scwoNetLiabilitiesAssumedInReverseAcquisitioncash_7e3e4d" order="39" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense_ff952b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_scwoNetLiabilitiesAssumedInReverseAcquisitionAbstract_62071d" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense_ff952b" order="40" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableSale" xlink:label="loc_us-gaapAccountsReceivableSale_397bcf" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_scwoNetLiabilitiesAssumedInReverseAcquisitionAbstract_62071d" xlink:to="loc_us-gaapAccountsReceivableSale_397bcf" order="41" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable_6286de" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_scwoNetLiabilitiesAssumedInReverseAcquisitionAbstract_62071d" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable_6286de" order="42" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities_74fb84" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_scwoNetLiabilitiesAssumedInReverseAcquisitionAbstract_62071d" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities_74fb84" order="43" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_NetLiabilityAssumed" xlink:label="loc_scwoNetLiabilityAssumed_b797c5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_scwoNetLiabilitiesAssumedInReverseAcquisitionAbstract_62071d" xlink:to="loc_scwoNetLiabilityAssumed_b797c5" order="44" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/NatureOfBusinessAndPresentationOfFinancialStatements" xlink:title="000007 - Disclosure - Nature of Business and Presentation of Financial Statements">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_41736c" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_9c2232" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_41736c" xlink:to="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_9c2232" order="1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="000008 - Disclosure - Summary of Significant Accounting Policies">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract_876a96" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapBasisOfPresentationAndSignificantAccountingPoliciesTextBlock_9c0c00" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_876a96" xlink:to="loc_us-gaapBasisOfPresentationAndSignificantAccountingPoliciesTextBlock_9c0c00" order="1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/LiquidityCapitalResourcesAndGoingConcern" xlink:title="000009 - Disclosure - Liquidity Capital Resources and Going Concern">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d9b725" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock_ab9815" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d9b725" xlink:to="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock_ab9815" order="1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeInc" xlink:title="000010 - Disclosure - Acquisition of 374Water Inc fka PowerVerde Inc">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaapBusinessCombinationsAbstract_d54cce" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="loc_us-gaapBusinessCombinationDisclosureTextBlock_9e3652" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract_d54cce" xlink:to="loc_us-gaapBusinessCombinationDisclosureTextBlock_9e3652" order="1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/IntangibleAssets" xlink:title="000011 - Disclosure - Intangible Assets">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract_155e0d" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaapIntangibleAssetsDisclosureTextBlock_9208f6" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract_155e0d" xlink:to="loc_us-gaapIntangibleAssetsDisclosureTextBlock_9208f6" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/StockholderEquity" xlink:title="000012 - Disclosure - Stockholder Equity">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract_34b083" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock_cd7a88" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_34b083" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock_cd7a88" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/RelatedPartyTransactions" xlink:title="000013 - Disclosure - Related Party Transactions">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract_1de063" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock_1374b4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract_1de063" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock_1374b4" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/CommitmentsAndContingencies" xlink:title="000014 - Disclosure - Commitments and Contingencies">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract_4f70b6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock_127732" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract_4f70b6" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock_127732" order="1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/IncomeTaxes" xlink:title="000015 - Disclosure - Income Taxes">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract_0e268b" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock_551f50" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract_0e268b" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock_551f50" order="1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/DeferredRevenue" xlink:title="000016 - Disclosure - Deferred Revenue">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueAbstract" xlink:label="loc_us-gaapDeferredRevenueAbstract_69b756" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueDisclosureTextBlock" xlink:label="loc_us-gaapDeferredRevenueDisclosureTextBlock_d009bb" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredRevenueAbstract_69b756" xlink:to="loc_us-gaapDeferredRevenueDisclosureTextBlock_d009bb" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/SubsequentEvents" xlink:title="000017 - Disclosure - Subsequent Events">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract_d7a8cd" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock_d2808e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract_d7a8cd" xlink:to="loc_us-gaapSubsequentEventsTextBlock_d2808e" order="1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="000018 - Disclosure - Summary of Significant Accounting Policies (Policies)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract_ddf3ef" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock_5630fb" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_ddf3ef" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock_5630fb" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="loc_us-gaapConcentrationRiskDisclosureTextBlock_5c7056" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_ddf3ef" xlink:to="loc_us-gaapConcentrationRiskDisclosureTextBlock_5c7056" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="loc_us-gaapReceivablesPolicyTextBlock_26028d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_ddf3ef" xlink:to="loc_us-gaapReceivablesPolicyTextBlock_26028d" order="3" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_EquipmentPolicy" xlink:label="loc_scwoEquipmentPolicy_96fe2c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_ddf3ef" xlink:to="loc_scwoEquipmentPolicy_96fe2c" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="loc_us-gaapIntangibleAssetsFiniteLivedPolicy_491f12" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_ddf3ef" xlink:to="loc_us-gaapIntangibleAssetsFiniteLivedPolicy_491f12" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_LongLivedAssetsPolicy" xlink:label="loc_scwoLongLivedAssetsPolicy_7ade5a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_ddf3ef" xlink:to="loc_scwoLongLivedAssetsPolicy_7ade5a" order="6" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_RevenueRecognitionAndConcentrationPolicy" xlink:label="loc_scwoRevenueRecognitionAndConcentrationPolicy_635201" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_ddf3ef" xlink:to="loc_scwoRevenueRecognitionAndConcentrationPolicy_635201" order="7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy_e0d302" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_ddf3ef" xlink:to="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy_e0d302" order="8" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxUncertaintiesPolicy" xlink:label="loc_us-gaapIncomeTaxUncertaintiesPolicy_2580d7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_ddf3ef" xlink:to="loc_us-gaapIncomeTaxUncertaintiesPolicy_2580d7" order="9" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock_9dbf4c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_ddf3ef" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock_9dbf4c" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaapResearchAndDevelopmentExpensePolicy_104345" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_ddf3ef" xlink:to="loc_us-gaapResearchAndDevelopmentExpensePolicy_104345" order="11" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock_651d82" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_ddf3ef" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock_651d82" order="12" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy_d82c1b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_ddf3ef" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy_d82c1b" order="13" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates_68adee" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_ddf3ef" xlink:to="loc_us-gaapUseOfEstimates_68adee" order="14" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock_7eb7e6" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_ddf3ef" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock_7eb7e6" order="15" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncTables" xlink:title="000019 - Disclosure - Acquisition of 374Water Inc fka PowerVerde Inc (Tables)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaapBusinessCombinationsAbstract_c78568" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_e93ef0" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract_c78568" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_e93ef0" order="1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/IntangibleAssetsTables" xlink:title="000020 - Disclosure - Intangible Assets (Tables)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract_64c535" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_2cd3e4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract_64c535" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_2cd3e4" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="loc_us-gaapScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_61223f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract_64c535" xlink:to="loc_us-gaapScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_61223f" order="2" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/StockholderEquityTables" xlink:title="000021 - Disclosure - Stockholder Equity (Tables)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract_95d43e" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_9b669d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_95d43e" xlink:to="loc_us-gaapStatementTable_9b669d" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_dea23d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_9b669d" xlink:to="loc_us-gaapStatementLineItems_dea23d" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis_b5dc42" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_9b669d" xlink:to="loc_us-gaapFinancialInstrumentAxis_b5dc42" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_35d5d4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis_b5dc42" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_35d5d4" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember_e97ea1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_35d5d4" xlink:to="loc_us-gaapStockOptionMember_e97ea1" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_d5d009" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_dea23d" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_d5d009" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_fa55a8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_dea23d" xlink:to="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_fa55a8" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_c200f3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_dea23d" xlink:to="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_c200f3" order="3" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/IncomeTaxesTables" xlink:title="000022 - Disclosure - Income Taxes (Tables)">
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_IncomeTaxesAbstract" xlink:label="loc_scwoIncomeTaxesAbstract_4aae74" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_5a7e93" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_scwoIncomeTaxesAbstract_4aae74" xlink:to="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_5a7e93" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_9f6fe3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_scwoIncomeTaxesAbstract_4aae74" xlink:to="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_9f6fe3" order="2" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/NatureOfBusinessAndPresentationOfFinancialStatementsDetailsNarrative" xlink:title="000023 - Disclosure - Nature of Business and Presentation of Financial Statements (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_34024e" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_SharesIssuedToFormerHolder" xlink:label="loc_scwoSharesIssuedToFormerHolder_734b84" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_34024e" xlink:to="loc_scwoSharesIssuedToFormerHolder_734b84" order="1" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_MergerEffectDescription" xlink:label="loc_scwoMergerEffectDescription_eb759b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_34024e" xlink:to="loc_scwoMergerEffectDescription_eb759b" order="2" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="000024 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PolicyTextBlockAbstract" xlink:label="loc_us-gaapPolicyTextBlockAbstract_245e70" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_016590" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPolicyTextBlockAbstract_245e70" xlink:to="loc_us-gaapStatementTable_016590" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_9dbbc1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_016590" xlink:to="loc_us-gaapStatementLineItems_9dbbc1" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis_9c6071" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_016590" xlink:to="loc_us-gaapAwardTypeAxis_9c6071" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_82cff5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis_9c6071" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_82cff5" order="20" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_WarrantsMember" xlink:label="loc_scwoWarrantsMember_bdbbe7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_82cff5" xlink:to="loc_scwoWarrantsMember_bdbbe7" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation_01123a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_9dbbc1" xlink:to="loc_us-gaapDepreciation_01123a" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense_688395" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_9dbbc1" xlink:to="loc_us-gaapResearchAndDevelopmentExpense_688395" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_a71fe4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_9dbbc1" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_a71fe4" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent_e37a2c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_9dbbc1" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent_e37a2c" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashEquivalentsAtCarryingValue_040dbb" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_9dbbc1" xlink:to="loc_us-gaapCashEquivalentsAtCarryingValue_040dbb" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaapUnrecognizedTaxBenefits_9c95c3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_9dbbc1" xlink:to="loc_us-gaapUnrecognizedTaxBenefits_9c95c3" order="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaapGoodwillImpairmentLoss_d25d37" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_9dbbc1" xlink:to="loc_us-gaapGoodwillImpairmentLoss_d25d37" order="7" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/LiquidityCapitalResourcesAndGoingConcernDetailsNarrative" xlink:title="000025 - Disclosure - Liquidity Capital Resources and Going Concern (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1de155" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_a7da16" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1de155" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_a7da16" order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_c2219c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1de155" xlink:to="loc_us-gaapNetIncomeLoss_c2219c" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInContinuingOperations_0a7295" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1de155" xlink:to="loc_us-gaapNetCashProvidedByUsedInContinuingOperations_0a7295" order="3" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_WorkingCapital" xlink:label="loc_scwoWorkingCapital_df8c99" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1de155" xlink:to="loc_scwoWorkingCapital_df8c99" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity_e183b2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1de155" xlink:to="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity_e183b2" order="5" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_NetCashProvidedByUsedInOperatingActivity" xlink:label="loc_scwoNetCashProvidedByUsedInOperatingActivity_6e9015" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1de155" xlink:to="loc_scwoNetCashProvidedByUsedInOperatingActivity_6e9015" order="6" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetails" xlink:title="000026 - Disclosure - Acquisition of 374Water Inc fka PowerVerde Inc (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaapBusinessCombinationsAbstract_3c5995" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_e457f9" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract_3c5995" xlink:to="loc_us-gaapStatementTable_e457f9" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_3fe29d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_e457f9" xlink:to="loc_us-gaapStatementLineItems_3fe29d" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis_9c5009" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_e457f9" xlink:to="loc_us-gaapBusinessAcquisitionAxis_9c5009" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_812be3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis_9c5009" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_812be3" order="20" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_ThreeSevenFourWaterMember" xlink:label="loc_scwoThreeSevenFourWaterMember_c4543d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain_812be3" xlink:to="loc_scwoThreeSevenFourWaterMember_c4543d" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_4b41ff" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_3fe29d" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_4b41ff" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_e83a65" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_3fe29d" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_e83a65" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_548862" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_3fe29d" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_548862" order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_d188fa" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_3fe29d" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_d188fa" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_1b599b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_3fe29d" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_1b599b" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_5f6a28" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_3fe29d" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_5f6a28" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_d67c70" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_3fe29d" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_d67c70" order="7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_a10ceb" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_3fe29d" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_a10ceb" order="8" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetailsNarrative" xlink:title="000027 - Disclosure - Acquisition of 374Water Inc fka PowerVerde Inc (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaapBusinessCombinationsAbstract_b75d3c" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_239b79" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract_b75d3c" xlink:to="loc_us-gaapStatementTable_239b79" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_35acf1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_239b79" xlink:to="loc_us-gaapStatementLineItems_35acf1" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis_534c26" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_239b79" xlink:to="loc_us-gaapStatementClassOfStockAxis_534c26" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_d5da18" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis_534c26" xlink:to="loc_us-gaapClassOfStockDomain_d5da18" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_555f1b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_239b79" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_555f1b" order="40" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_d8be31" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_555f1b" xlink:to="loc_us-gaapRelatedPartyDomain_d8be31" order="40" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesDPreferredStockMember" xlink:label="loc_us-gaapSeriesDPreferredStockMember_176acc" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain_d5da18" xlink:to="loc_us-gaapSeriesDPreferredStockMember_176acc" order="41" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="loc_srtChiefExecutiveOfficerMember_350db1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain_d8be31" xlink:to="loc_srtChiefExecutiveOfficerMember_350db1" order="42" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_MrNagarMember" xlink:label="loc_scwoMrNagarMember_4a6054" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain_d8be31" xlink:to="loc_scwoMrNagarMember_4a6054" order="43" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalariesAndWages" xlink:label="loc_us-gaapSalariesAndWages_d3a506" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_35acf1" xlink:to="loc_us-gaapSalariesAndWages_d3a506" order="1" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_AnnaulSalaryIncreasedAmount" xlink:label="loc_scwoAnnaulSalaryIncreasedAmount_ab9d11" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_35acf1" xlink:to="loc_scwoAnnaulSalaryIncreasedAmount_ab9d11" order="2" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_Description" xlink:label="loc_scwoDescription_a7520b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_35acf1" xlink:to="loc_scwoDescription_a7520b" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_93e777" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_35acf1" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_93e777" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement_cf0be7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_35acf1" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement_cf0be7" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PartnersCapitalAccountUnitsSoldInPrivatePlacement" xlink:label="loc_us-gaapPartnersCapitalAccountUnitsSoldInPrivatePlacement_1d031f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_35acf1" xlink:to="loc_us-gaapPartnersCapitalAccountUnitsSoldInPrivatePlacement_1d031f" order="6" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_SettlementOfLiabilityForPreferredStockShares" xlink:label="loc_scwoSettlementOfLiabilityForPreferredStockShares_65bb2a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_35acf1" xlink:to="loc_scwoSettlementOfLiabilityForPreferredStockShares_65bb2a" order="7" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/IntangibleAssetsDetails" xlink:title="000028 - Disclosure - Intangible Assets (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract_bf20cf" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_4cc867" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract_bf20cf" xlink:to="loc_us-gaapStatementTable_4cc867" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_d44fb8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_4cc867" xlink:to="loc_us-gaapStatementLineItems_d44fb8" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_1af597" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_4cc867" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_1af597" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_a2422d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_1af597" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_a2422d" order="20" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_LicenseAgreementMember" xlink:label="loc_scwoLicenseAgreementMember_515608" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_a2422d" xlink:to="loc_scwoLicenseAgreementMember_515608" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaapPatentsMember_398212" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_a2422d" xlink:to="loc_us-gaapPatentsMember_398212" order="22" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_994110" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_d44fb8" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_994110" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_25f570" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_d44fb8" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_25f570" order="2" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_IntangibleAssetsAdditions" xlink:label="loc_scwoIntangibleAssetsAdditions_628b0a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_d44fb8" xlink:to="loc_scwoIntangibleAssetsAdditions_628b0a" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross_a5521b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_d44fb8" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross_a5521b" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_c01362" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_d44fb8" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_c01362" order="5" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/IntangibleAssetsDetails1" xlink:title="000029 - Disclosure - Intangible Assets (Details 1)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract_9ca905" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0b571c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract_9ca905" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0b571c" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_d1452c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract_9ca905" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_d1452c" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree_53686e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract_9ca905" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree_53686e" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour_ba3c15" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract_9ca905" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour_ba3c15" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive_d59ecd" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract_9ca905" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive_d59ecd" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_54699b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract_9ca905" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_54699b" order="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet_b2a975" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract_9ca905" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet_b2a975" order="7" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/IntangibleAssetsDetailsNarrative" xlink:title="000030 - Disclosure - Intangible Assets (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract_335a0f" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_769f46" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract_335a0f" xlink:to="loc_us-gaapStatementTable_769f46" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_9177d9" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_769f46" xlink:to="loc_us-gaapStatementLineItems_9177d9" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_c94821" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_769f46" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_c94821" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_3eee13" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_c94821" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_3eee13" order="10" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_LicenseAgreementMember" xlink:label="loc_scwoLicenseAgreementMember_656679" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_3eee13" xlink:to="loc_scwoLicenseAgreementMember_656679" order="11" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentForAmortization" xlink:label="loc_us-gaapAdjustmentForAmortization_cff8d7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_9177d9" xlink:to="loc_us-gaapAdjustmentForAmortization_cff8d7" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_90d535" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_9177d9" xlink:to="loc_us-gaapCommonStockValue_90d535" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/StockholderEquityDetails" xlink:title="000031 - Disclosure - Stockholder Equity (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract_f9efa5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_704214" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_f9efa5" xlink:to="loc_us-gaapStatementTable_704214" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_650ce3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_704214" xlink:to="loc_us-gaapStatementLineItems_650ce3" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_74eefd" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_704214" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_74eefd" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain_d669fa" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_74eefd" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain_d669fa" order="20" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_OptionsMember" xlink:label="loc_scwoOptionsMember_6abfb5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain_d669fa" xlink:to="loc_scwoOptionsMember_6abfb5" order="21" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_OptionUnvestedMember" xlink:label="loc_scwoOptionUnvestedMember_a33f05" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain_d669fa" xlink:to="loc_scwoOptionUnvestedMember_a33f05" order="22" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a12114" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_650ce3" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a12114" order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_4167c1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_650ce3" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_4167c1" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_a767ee" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_650ce3" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_a767ee" order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_3ce89c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_650ce3" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_3ce89c" order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5156b6" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_650ce3" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5156b6" order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaapConversionOfStockSharesConverted1_0cc886" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_650ce3" xlink:to="loc_us-gaapConversionOfStockSharesConverted1_0cc886" order="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_bb0647" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_650ce3" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_bb0647" order="7" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice" xlink:label="loc_scwoSharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice_cf10d4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_650ce3" xlink:to="loc_scwoSharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice_cf10d4" order="8" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice" xlink:label="loc_scwoSharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice_21650e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_650ce3" xlink:to="loc_scwoSharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice_21650e" order="9" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice" xlink:label="loc_scwoSharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice_d3c242" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_650ce3" xlink:to="loc_scwoSharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice_d3c242" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3dcb4c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_650ce3" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3dcb4c" order="11" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_aa68e2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_650ce3" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_aa68e2" order="12" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_ca0321" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_650ce3" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_ca0321" order="13" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_c7c5dd" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_650ce3" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_c7c5dd" order="14" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/StockholderEquityDetails1" xlink:title="000032 - Disclosure - Stockholder Equity (Details 1)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract_f63954" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_934ad8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_f63954" xlink:to="loc_us-gaapStatementTable_934ad8" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_a9a7f9" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_934ad8" xlink:to="loc_us-gaapStatementLineItems_a9a7f9" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_28810f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_934ad8" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_28810f" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain_416ef7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_28810f" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain_416ef7" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis_46c4d9" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_934ad8" xlink:to="loc_us-gaapPlanNameAxis_46c4d9" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_41a1de" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis_46c4d9" xlink:to="loc_us-gaapPlanNameDomain_41a1de" order="30" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_OptionsMember" xlink:label="loc_scwoOptionsMember_a8b00d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain_416ef7" xlink:to="loc_scwoOptionsMember_a8b00d" order="31" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_MinimumsMember" xlink:label="loc_scwoMinimumsMember_cae3a6" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain_41a1de" xlink:to="loc_scwoMinimumsMember_cae3a6" order="32" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_MaximumsMember" xlink:label="loc_scwoMaximumsMember_8749b5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain_41a1de" xlink:to="loc_scwoMaximumsMember_8749b5" order="33" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_5a5fdf" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_a9a7f9" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_5a5fdf" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_49fcd4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_a9a7f9" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_49fcd4" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_378cb1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_a9a7f9" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_378cb1" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_c03ca2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_a9a7f9" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_c03ca2" order="4" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/StockholderEquityDetails2" xlink:title="000033 - Disclosure - Stockholder Equity (Details 2)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract_6638b3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_9c0406" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_6638b3" xlink:to="loc_us-gaapStatementTable_9c0406" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_6395b4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_9c0406" xlink:to="loc_us-gaapStatementLineItems_6395b4" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis_f931ce" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_9c0406" xlink:to="loc_us-gaapAwardTypeAxis_f931ce" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_100ce9" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis_f931ce" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_100ce9" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis_c716dc" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_9c0406" xlink:to="loc_us-gaapPlanNameAxis_c716dc" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_cfb00c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis_c716dc" xlink:to="loc_us-gaapPlanNameDomain_cfb00c" order="20" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_WarrantsMember" xlink:label="loc_scwoWarrantsMember_0a7f83" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_100ce9" xlink:to="loc_scwoWarrantsMember_0a7f83" order="21" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_MinimumsMember" xlink:label="loc_scwoMinimumsMember_c3909d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain_cfb00c" xlink:to="loc_scwoMinimumsMember_c3909d" order="22" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_MaximumsMember" xlink:label="loc_scwoMaximumsMember_018220" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain_cfb00c" xlink:to="loc_scwoMaximumsMember_018220" order="23" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3393c7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_6395b4" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3393c7" order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_bb1ffb" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_6395b4" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_bb1ffb" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_97e608" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_6395b4" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_97e608" order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_aedcef" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_6395b4" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_aedcef" order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_5d5bad" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_6395b4" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_5d5bad" order="5" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_768822" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_6395b4" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_768822" order="6" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_72be2f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_6395b4" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_72be2f" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1cc787" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_6395b4" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1cc787" order="8" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_702a8f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_6395b4" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_702a8f" order="9" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_WeightedAverageExercisePriceExercised" xlink:label="loc_scwoWeightedAverageExercisePriceExercised_733c2d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_6395b4" xlink:to="loc_scwoWeightedAverageExercisePriceExercised_733c2d" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_26b936" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_6395b4" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_26b936" order="11" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c3380c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_6395b4" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c3380c" order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_0b0484" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_6395b4" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_0b0484" order="13" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_a1bdd4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_6395b4" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_a1bdd4" order="14" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_37182c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_6395b4" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_37182c" order="15" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/StockholderEquityDetails3" xlink:title="000034 - Disclosure - Stockholder Equity (Details 3)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract_e253ca" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_eaec8a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_e253ca" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_eaec8a" order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_468d4c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_e253ca" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_468d4c" order="2" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_e5e1ba" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_e253ca" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_e5e1ba" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_8abf1b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_e253ca" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_8abf1b" order="4" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_a04e6d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_e253ca" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_a04e6d" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_234351" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_e253ca" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_234351" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_15abad" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_e253ca" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_15abad" order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_WeightedAverageExercisePriceExercised" xlink:label="loc_scwoWeightedAverageExercisePriceExercised_efa0f8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_e253ca" xlink:to="loc_scwoWeightedAverageExercisePriceExercised_efa0f8" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_88fcd9" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_e253ca" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_88fcd9" order="9" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_7cc8d1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_e253ca" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_7cc8d1" order="10" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3830f7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_e253ca" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3830f7" order="11" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/StockholderEquityDetailsNarrative" xlink:title="000035 - Disclosure - Stockholder Equity (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract_739bf5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_0c1d7d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_739bf5" xlink:to="loc_us-gaapStatementTable_0c1d7d" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_8b913e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_0c1d7d" xlink:to="loc_us-gaapStatementLineItems_8b913e" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis_81f58b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_0c1d7d" xlink:to="loc_us-gaapAwardTypeAxis_81f58b" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_764aab" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis_81f58b" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_764aab" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis_dd944b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_0c1d7d" xlink:to="loc_us-gaapBusinessAcquisitionAxis_dd944b" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_882a42" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis_dd944b" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_882a42" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis_06353a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_0c1d7d" xlink:to="loc_us-gaapStatementClassOfStockAxis_06353a" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_95fb40" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis_06353a" xlink:to="loc_us-gaapClassOfStockDomain_95fb40" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_4a6d6c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_0c1d7d" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_4a6d6c" order="40" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_67069e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_4a6d6c" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_67069e" order="40" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a20748" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_0c1d7d" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a20748" order="50" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain_0f3f26" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a20748" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain_0f3f26" order="50" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis_2fac21" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_0c1d7d" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis_2fac21" order="70" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain_4ce6e8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis_2fac21" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain_4ce6e8" order="70" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis_731ad2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_0c1d7d" xlink:to="loc_us-gaapFinancialInstrumentAxis_731ad2" order="80" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6808ce" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis_731ad2" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6808ce" order="80" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_WarrantsMember" xlink:label="loc_scwoWarrantsMember_7d0193" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_764aab" xlink:to="loc_scwoWarrantsMember_7d0193" order="81" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_ThreeSevenFourWaterMember" xlink:label="loc_scwoThreeSevenFourWaterMember_b37390" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain_882a42" xlink:to="loc_scwoThreeSevenFourWaterMember_b37390" order="82" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesDPreferredStockMember" xlink:label="loc_us-gaapSeriesDPreferredStockMember_afa86b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain_95fb40" xlink:to="loc_us-gaapSeriesDPreferredStockMember_afa86b" order="83" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaapPatentsMember_e265d8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_67069e" xlink:to="loc_us-gaapPatentsMember_e265d8" order="84" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_OptionsMember" xlink:label="loc_scwoOptionsMember_d35c32" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain_0f3f26" xlink:to="loc_scwoOptionsMember_d35c32" order="85" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_ThreeSeverFourWaterFormerStockholdersMember" xlink:label="loc_scwoThreeSeverFourWaterFormerStockholdersMember_272187" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain_4ce6e8" xlink:to="loc_scwoThreeSeverFourWaterFormerStockholdersMember_272187" order="86" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_ConsultantMember" xlink:label="loc_scwoConsultantMember_804350" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6808ce" xlink:to="loc_scwoConsultantMember_804350" order="87" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_f339a7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_8b913e" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_f339a7" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_StockIssuedUponWarrantExercised" xlink:label="loc_scwoStockIssuedUponWarrantExercised_59b598" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_8b913e" xlink:to="loc_scwoStockIssuedUponWarrantExercised_59b598" order="2" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_ProceedsFromStockIssuedUponWarrantsExercisedAmount" xlink:label="loc_scwoProceedsFromStockIssuedUponWarrantsExercisedAmount_6f5a46" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_8b913e" xlink:to="loc_scwoProceedsFromStockIssuedUponWarrantsExercisedAmount_6f5a46" order="3" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_WarrantsOutstandingSeriesOneShares" xlink:label="loc_scwoWarrantsOutstandingSeriesOneShares_08d956" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_8b913e" xlink:to="loc_scwoWarrantsOutstandingSeriesOneShares_08d956" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="loc_us-gaapConversionOfStockSharesIssued1_690811" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_8b913e" xlink:to="loc_us-gaapConversionOfStockSharesIssued1_690811" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaapConversionOfStockSharesConverted1_cc9f34" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_8b913e" xlink:to="loc_us-gaapConversionOfStockSharesConverted1_cc9f34" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_083fe9" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_8b913e" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_083fe9" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_LiabilityForPreferredStockShares" xlink:label="loc_scwoLiabilityForPreferredStockShares_843450" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_8b913e" xlink:to="loc_scwoLiabilityForPreferredStockShares_843450" order="8" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_754c24" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_8b913e" xlink:to="loc_us-gaapCommonStockSharesAuthorized_754c24" order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_5ca061" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_8b913e" xlink:to="loc_us-gaapPreferredStockSharesIssued_5ca061" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement_e07914" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_8b913e" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement_e07914" order="11" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_462590" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_8b913e" xlink:to="loc_us-gaapCommonStockSharesIssued_462590" order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock_c73db9" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_8b913e" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock_c73db9" order="13" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_4263d2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_8b913e" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_4263d2" order="14" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_CommonStockSharesIssuesForCash" xlink:label="loc_scwoCommonStockSharesIssuesForCash_a49538" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_8b913e" xlink:to="loc_scwoCommonStockSharesIssuesForCash_a49538" order="15" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_NumberOfWarrantPurchase" xlink:label="loc_scwoNumberOfWarrantPurchase_5482af" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_8b913e" xlink:to="loc_scwoNumberOfWarrantPurchase_5482af" order="16" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantExercisePriceIncrease" xlink:label="loc_us-gaapWarrantExercisePriceIncrease_99ae3e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_8b913e" xlink:to="loc_us-gaapWarrantExercisePriceIncrease_99ae3e" order="17" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d7e932" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_8b913e" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d7e932" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_AggregateFairValueOfWarrant" xlink:label="loc_scwoAggregateFairValueOfWarrant_f9a822" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_8b913e" xlink:to="loc_scwoAggregateFairValueOfWarrant_f9a822" order="19" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_fd16f8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_8b913e" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_fd16f8" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaapProceedsFromWarrantExercises_154e72" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_8b913e" xlink:to="loc_us-gaapProceedsFromWarrantExercises_154e72" order="21" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7aa8d7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_8b913e" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7aa8d7" order="22" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_b1a7b0" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_8b913e" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_b1a7b0" order="23" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockNoParValue" xlink:label="loc_us-gaapCommonStockNoParValue_32f274" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_8b913e" xlink:to="loc_us-gaapCommonStockNoParValue_32f274" order="24" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7c678f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_8b913e" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7c678f" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_3f99b5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_8b913e" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_3f99b5" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_b37efc" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_8b913e" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_b37efc" order="27" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_7f79ee" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_8b913e" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_7f79ee" order="28" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_4e330f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_8b913e" xlink:to="loc_us-gaapCommonStockSharesOutstanding_4e330f" order="29" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockConvertibleSharesIssuable" xlink:label="loc_us-gaapPreferredStockConvertibleSharesIssuable_9dd947" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_8b913e" xlink:to="loc_us-gaapPreferredStockConvertibleSharesIssuable_9dd947" order="30" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_Preferredstockparorstatedvaluepershare" xlink:label="loc_scwoPreferredstockparorstatedvaluepershare_4979dd" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_8b913e" xlink:to="loc_scwoPreferredstockparorstatedvaluepershare_4979dd" order="31" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_5d70f1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_8b913e" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_5d70f1" order="32" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_PreferredStockParValue" xlink:label="loc_scwoPreferredStockParValue_dfc8e7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_8b913e" xlink:to="loc_scwoPreferredStockParValue_dfc8e7" order="33" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockLiquidationPreferenceValue" xlink:label="loc_us-gaapPreferredStockLiquidationPreferenceValue_a81779" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_8b913e" xlink:to="loc_us-gaapPreferredStockLiquidationPreferenceValue_a81779" order="34" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_PreferredStockStatedValuePerShare" xlink:label="loc_scwoPreferredStockStatedValuePerShare_5f62b9" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_8b913e" xlink:to="loc_scwoPreferredStockStatedValuePerShare_5f62b9" order="35" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_73d2c1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_8b913e" xlink:to="loc_us-gaapCommonStockValue_73d2c1" order="36" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_396d07" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_8b913e" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_396d07" order="37" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther_5b0f31" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_8b913e" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther_5b0f31" order="38" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation_fba58f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_8b913e" xlink:to="loc_us-gaapShareBasedCompensation_fba58f" order="39" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense_483c11" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_8b913e" xlink:to="loc_us-gaapResearchAndDevelopmentExpense_483c11" order="40" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense_91f249" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_8b913e" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense_91f249" order="41" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_961639" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_8b913e" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_961639" order="42" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="000036 - Disclosure - Related Party Transactions (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract_7bfaf4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyCosts" xlink:label="loc_us-gaapRelatedPartyCosts_7ad1ec" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract_7bfaf4" xlink:to="loc_us-gaapRelatedPartyCosts_7ad1ec" order="1" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_StockInExcessPercentageOfOutstandingShare" xlink:label="loc_scwoStockInExcessPercentageOfOutstandingShare_4dbe5a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract_7bfaf4" xlink:to="loc_scwoStockInExcessPercentageOfOutstandingShare_4dbe5a" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueFromRelatedParties" xlink:label="loc_us-gaapDueFromRelatedParties_509df8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract_7bfaf4" xlink:to="loc_us-gaapDueFromRelatedParties_509df8" order="3" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_AdvancesFromStockholders" xlink:label="loc_scwoAdvancesFromStockholders_4f74c4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract_7bfaf4" xlink:to="loc_scwoAdvancesFromStockholders_4f74c4" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRepaymentsOfRelatedPartyDebt_4f4019" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract_7bfaf4" xlink:to="loc_us-gaapProceedsFromRepaymentsOfRelatedPartyDebt_4f4019" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/IncomeTaxesDetails" xlink:title="000037 - Disclosure - Income Taxes (Details)">
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_DeferredIncomeTaxAssetAbstract" xlink:label="loc_scwoDeferredIncomeTaxAssetAbstract_76e074" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:label="loc_us-gaapDeferredTaxAssetsNetOfValuationAllowanceAbstract_3c4344" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_scwoDeferredIncomeTaxAssetAbstract_76e074" xlink:to="loc_us-gaapDeferredTaxAssetsNetOfValuationAllowanceAbstract_3c4344" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:label="loc_us-gaapDeferredTaxAssetsGoodwillAndIntangibleAssets_bf7686" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetOfValuationAllowanceAbstract_3c4344" xlink:to="loc_us-gaapDeferredTaxAssetsGoodwillAndIntangibleAssets_bf7686" order="2" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_DeferredTaxAssetsStartupCost" xlink:label="loc_scwoDeferredTaxAssetsStartupCost_214baa" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetOfValuationAllowanceAbstract_3c4344" xlink:to="loc_scwoDeferredTaxAssetsStartupCost_214baa" order="3" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_OtherIntangibles" xlink:label="loc_scwoOtherIntangibles_9fb974" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetOfValuationAllowanceAbstract_3c4344" xlink:to="loc_scwoOtherIntangibles_9fb974" order="4" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_OtherAccruals" xlink:label="loc_scwoOtherAccruals_6cf567" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetOfValuationAllowanceAbstract_3c4344" xlink:to="loc_scwoOtherAccruals_6cf567" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_ade83a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetOfValuationAllowanceAbstract_3c4344" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_ade83a" order="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards_782951" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetOfValuationAllowanceAbstract_3c4344" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards_782951" order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross_a68e0f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetOfValuationAllowanceAbstract_3c4344" xlink:to="loc_us-gaapDeferredTaxAssetsGross_a68e0f" order="8" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance_aa48c4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetOfValuationAllowanceAbstract_3c4344" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance_aa48c4" order="9" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet_55c9c5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetOfValuationAllowanceAbstract_3c4344" xlink:to="loc_us-gaapDeferredTaxAssetsNet_55c9c5" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaapDeferredTaxLiabilities_201bfe" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetOfValuationAllowanceAbstract_3c4344" xlink:to="loc_us-gaapDeferredTaxLiabilities_201bfe" order="11" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet_ec7d56" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetOfValuationAllowanceAbstract_3c4344" xlink:to="loc_us-gaapDeferredTaxAssetsLiabilitiesNet_ec7d56" order="12" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:label="loc_us-gaapDeferredTaxLiabilitiesOther_abcd18" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetOfValuationAllowanceAbstract_3c4344" xlink:to="loc_us-gaapDeferredTaxLiabilitiesOther_abcd18" order="13" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/IncomeTaxesDetails1" xlink:title="000038 - Disclosure - Income Taxes (Details 1)">
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_RateReconciliationAbstract" xlink:label="loc_scwoRateReconciliationAbstract_6f42df" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_f50562" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_scwoRateReconciliationAbstract_6f42df" xlink:to="loc_us-gaapConcentrationRiskPercentage1_f50562" order="1" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_IncomeTaxRateReconciliationChangeInStateTax" xlink:label="loc_scwoIncomeTaxRateReconciliationChangeInStateTax_5b7f68" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_scwoRateReconciliationAbstract_6f42df" xlink:to="loc_scwoIncomeTaxRateReconciliationChangeInStateTax_5b7f68" order="2" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_IncomeTaxReconciliationChangeInValuationAllowance" xlink:label="loc_scwoIncomeTaxReconciliationChangeInValuationAllowance_3ad039" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_scwoRateReconciliationAbstract_6f42df" xlink:to="loc_scwoIncomeTaxReconciliationChangeInValuationAllowance_3ad039" order="3" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_IncomeTaxReconciliationPermanentDifferences" xlink:label="loc_scwoIncomeTaxReconciliationPermanentDifferences_6ec5ac" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_scwoRateReconciliationAbstract_6f42df" xlink:to="loc_scwoIncomeTaxReconciliationPermanentDifferences_6ec5ac" order="4" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_IncomeTaxReconciliationStateTaxes" xlink:label="loc_scwoIncomeTaxReconciliationStateTaxes_f31667" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_scwoRateReconciliationAbstract_6f42df" xlink:to="loc_scwoIncomeTaxReconciliationStateTaxes_f31667" order="5" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_IncomeTaxReconciliationOther" xlink:label="loc_scwoIncomeTaxReconciliationOther_8ccfc9" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_scwoRateReconciliationAbstract_6f42df" xlink:to="loc_scwoIncomeTaxReconciliationOther_8ccfc9" order="6" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/IncomeTaxesDetailsNarrative" xlink:title="000039 - Disclosure - Income Taxes (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_IncomeTaxesAbstract" xlink:label="loc_scwoIncomeTaxesAbstract_433c74" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards_5af119" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_scwoIncomeTaxesAbstract_433c74" xlink:to="loc_us-gaapOperatingLossCarryforwards_5af119" order="1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/DeferredRevenueDetailsNarrative" xlink:title="000040 - Disclosure - Deferred Revenue (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueAbstract" xlink:label="loc_us-gaapDeferredRevenueAbstract_65c59c" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent_bd2b5a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredRevenueAbstract_65c59c" xlink:to="loc_us-gaapDeferredRevenueCurrent_bd2b5a" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_DeferredRevenuePercentage" xlink:label="loc_scwoDeferredRevenuePercentage_413f52" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredRevenueAbstract_65c59c" xlink:to="loc_scwoDeferredRevenuePercentage_413f52" order="2" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/SubsequentEventsDetailsNarrative" xlink:title="000041 - Disclosure - Subsequent Events (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract_58413c" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_95a28b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract_58413c" xlink:to="loc_us-gaapStatementTable_95a28b" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_5b6b1f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_95a28b" xlink:to="loc_us-gaapStatementLineItems_5b6b1f" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis_bccfe7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_95a28b" xlink:to="loc_us-gaapSubsequentEventTypeAxis_bccfe7" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_144fa5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis_bccfe7" xlink:to="loc_us-gaapSubsequentEventTypeDomain_144fa5" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_58edbc" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain_144fa5" xlink:to="loc_us-gaapSubsequentEventMember_58edbc" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_fbe896" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_5b6b1f" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_fbe896" order="1" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>scwo-20220331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 06/17/2022-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2022 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://powerverdeinc.com/role/Cover" xlink:href="scwo-20220331.xsd#Cover" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets" xlink:href="scwo-20220331.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="scwo-20220331.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations" xlink:href="scwo-20220331.xsd#CondensedConsolidatedStatementsOfOperations" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/CondensedConsolidatedChangesInStockholdersDeficit" xlink:href="scwo-20220331.xsd#CondensedConsolidatedChangesInStockholdersDeficit" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:href="scwo-20220331.xsd#CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/NatureOfBusinessAndPresentationOfFinancialStatements" xlink:href="scwo-20220331.xsd#NatureOfBusinessAndPresentationOfFinancialStatements" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="scwo-20220331.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/LiquidityCapitalResourcesAndGoingConcern" xlink:href="scwo-20220331.xsd#LiquidityCapitalResourcesAndGoingConcern" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeInc" xlink:href="scwo-20220331.xsd#AcquisitionOf374WaterIncFkaPowerverdeInc" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/IntangibleAssets" xlink:href="scwo-20220331.xsd#IntangibleAssets" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/StockholderEquity" xlink:href="scwo-20220331.xsd#StockholderEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/RelatedPartyTransactions" xlink:href="scwo-20220331.xsd#RelatedPartyTransactions" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/CommitmentsAndContingencies" xlink:href="scwo-20220331.xsd#CommitmentsAndContingencies" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/IncomeTaxes" xlink:href="scwo-20220331.xsd#IncomeTaxes" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/DeferredRevenue" xlink:href="scwo-20220331.xsd#DeferredRevenue" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/SubsequentEvents" xlink:href="scwo-20220331.xsd#SubsequentEvents" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="scwo-20220331.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncTables" xlink:href="scwo-20220331.xsd#AcquisitionOf374WaterIncFkaPowerverdeIncTables" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/IntangibleAssetsTables" xlink:href="scwo-20220331.xsd#IntangibleAssetsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/StockholderEquityTables" xlink:href="scwo-20220331.xsd#StockholderEquityTables" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/IncomeTaxesTables" xlink:href="scwo-20220331.xsd#IncomeTaxesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/NatureOfBusinessAndPresentationOfFinancialStatementsDetailsNarrative" xlink:href="scwo-20220331.xsd#NatureOfBusinessAndPresentationOfFinancialStatementsDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="scwo-20220331.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/LiquidityCapitalResourcesAndGoingConcernDetailsNarrative" xlink:href="scwo-20220331.xsd#LiquidityCapitalResourcesAndGoingConcernDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetails" xlink:href="scwo-20220331.xsd#AcquisitionOf374WaterIncFkaPowerverdeIncDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetailsNarrative" xlink:href="scwo-20220331.xsd#AcquisitionOf374WaterIncFkaPowerverdeIncDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/IntangibleAssetsDetails" xlink:href="scwo-20220331.xsd#IntangibleAssetsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/IntangibleAssetsDetails1" xlink:href="scwo-20220331.xsd#IntangibleAssetsDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/IntangibleAssetsDetailsNarrative" xlink:href="scwo-20220331.xsd#IntangibleAssetsDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/StockholderEquityDetails" xlink:href="scwo-20220331.xsd#StockholderEquityDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/StockholderEquityDetails1" xlink:href="scwo-20220331.xsd#StockholderEquityDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/StockholderEquityDetails2" xlink:href="scwo-20220331.xsd#StockholderEquityDetails2" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/StockholderEquityDetails3" xlink:href="scwo-20220331.xsd#StockholderEquityDetails3" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/StockholderEquityDetailsNarrative" xlink:href="scwo-20220331.xsd#StockholderEquityDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="scwo-20220331.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/IncomeTaxesDetails" xlink:href="scwo-20220331.xsd#IncomeTaxesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/IncomeTaxesDetails1" xlink:href="scwo-20220331.xsd#IncomeTaxesDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/IncomeTaxesDetailsNarrative" xlink:href="scwo-20220331.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/DeferredRevenueDetailsNarrative" xlink:href="scwo-20220331.xsd#DeferredRevenueDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://powerverdeinc.com/role/SubsequentEventsDetailsNarrative" xlink:href="scwo-20220331.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <link:definitionLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/Cover" xlink:title="00000001 - Document - Cover Page Information">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_deiCover" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets" xlink:title="000002 - Statement - Condensed Consolidated Balance Sheets" />
  <link:definitionLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:title="000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations" xlink:title="000004 - Statement - Condensed Consolidated Statements of Operations" />
  <link:definitionLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/CondensedConsolidatedChangesInStockholdersDeficit" xlink:title="000005 - Statement - Condensed Consolidated Changes in Stockholders' Deficit">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" order="40" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapPreferredStockMember" order="22" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" order="23" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember" order="24" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssued" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" order="3" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_AccretionOfStockBasedCompensation" xlink:label="loc_scwoAccretionOfStockBasedCompensation" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoAccretionOfStockBasedCompensation" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionExpense" xlink:label="loc_us-gaapAccretionExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccretionExpense" order="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" order="7" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_IssuanceOfStockWarrantsForDevelopmentOfProduct" xlink:label="loc_scwoIssuanceOfStockWarrantsForDevelopmentOfProduct" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoIssuanceOfStockWarrantsForDevelopmentOfProduct" order="8" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_RecapitalizationOfTheCompanyShares" xlink:label="loc_scwoRecapitalizationOfTheCompanyShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoRecapitalizationOfTheCompanyShares" order="9" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_RecapitalizationOfTheCompanyAmount" xlink:label="loc_scwoRecapitalizationOfTheCompanyAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoRecapitalizationOfTheCompanyAmount" order="10" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_SeriesDPreferredStockIssuedForCashShares" xlink:label="loc_scwoSeriesDPreferredStockIssuedForCashShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoSeriesDPreferredStockIssuedForCashShares" order="11" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_SeriesDPreferredStockIssuedForCashAmount" xlink:label="loc_scwoSeriesDPreferredStockIssuedForCashAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoSeriesDPreferredStockIssuedForCashAmount" order="12" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_ExercisedOptionAndWarrantsShares" xlink:label="loc_scwoExercisedOptionAndWarrantsShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoExercisedOptionAndWarrantsShares" order="13" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_ExercisedOptionAndWarrantsAmount" xlink:label="loc_scwoExercisedOptionAndWarrantsAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoExercisedOptionAndWarrantsAmount" order="14" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_IssuanceOfCommonStockForLicenseRightsShares" xlink:label="loc_scwoIssuanceOfCommonStockForLicenseRightsShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoIssuanceOfCommonStockForLicenseRightsShares" order="15" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_IssuanceOfCommonStockForLicenseRightsAmount" xlink:label="loc_scwoIssuanceOfCommonStockForLicenseRightsAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoIssuanceOfCommonStockForLicenseRightsAmount" order="16" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_ConversionOfConvertiblePreferredSharesIntoCommonStockShares" xlink:label="loc_scwoConversionOfConvertiblePreferredSharesIntoCommonStockShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoConversionOfConvertiblePreferredSharesIntoCommonStockShares" order="17" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_ConversionOfConvertiblePreferredSharesIntoCommonStockAmount" xlink:label="loc_scwoConversionOfConvertiblePreferredSharesIntoCommonStockAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoConversionOfConvertiblePreferredSharesIntoCommonStockAmount" order="18" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" order="19" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="loc_us-gaapConversionOfStockSharesIssued1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConversionOfStockSharesIssued1" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockAmountIssued1" xlink:label="loc_us-gaapConversionOfStockAmountIssued1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConversionOfStockAmountIssued1" order="22" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:title="000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/NatureOfBusinessAndPresentationOfFinancialStatements" xlink:title="000007 - Disclosure - Nature of Business and Presentation of Financial Statements" />
  <link:definitionLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="000008 - Disclosure - Summary of Significant Accounting Policies" />
  <link:definitionLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/LiquidityCapitalResourcesAndGoingConcern" xlink:title="000009 - Disclosure - Liquidity Capital Resources and Going Concern" />
  <link:definitionLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeInc" xlink:title="000010 - Disclosure - Acquisition of 374Water Inc fka PowerVerde Inc" />
  <link:definitionLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/IntangibleAssets" xlink:title="000011 - Disclosure - Intangible Assets" />
  <link:definitionLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/StockholderEquity" xlink:title="000012 - Disclosure - Stockholder Equity" />
  <link:definitionLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/RelatedPartyTransactions" xlink:title="000013 - Disclosure - Related Party Transactions" />
  <link:definitionLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/CommitmentsAndContingencies" xlink:title="000014 - Disclosure - Commitments and Contingencies" />
  <link:definitionLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/IncomeTaxes" xlink:title="000015 - Disclosure - Income Taxes" />
  <link:definitionLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/DeferredRevenue" xlink:title="000016 - Disclosure - Deferred Revenue" />
  <link:definitionLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/SubsequentEvents" xlink:title="000017 - Disclosure - Subsequent Events" />
  <link:definitionLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="000018 - Disclosure - Summary of Significant Accounting Policies (Policies)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncTables" xlink:title="000019 - Disclosure - Acquisition of 374Water Inc fka PowerVerde Inc (Tables)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/IntangibleAssetsTables" xlink:title="000020 - Disclosure - Intangible Assets (Tables)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/StockholderEquityTables" xlink:title="000021 - Disclosure - Stockholder Equity (Tables)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" order="40" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_us-gaapStockOptionMember" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="3" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/IncomeTaxesTables" xlink:title="000022 - Disclosure - Income Taxes (Tables)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/NatureOfBusinessAndPresentationOfFinancialStatementsDetailsNarrative" xlink:title="000023 - Disclosure - Nature of Business and Presentation of Financial Statements (Details Narrative)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="000024 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" order="40" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_WarrantsMember" xlink:label="loc_scwoWarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_scwoWarrantsMember" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepreciation" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashEquivalentsAtCarryingValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashEquivalentsAtCarryingValue" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaapUnrecognizedTaxBenefits" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapUnrecognizedTaxBenefits" order="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaapGoodwillImpairmentLoss" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGoodwillImpairmentLoss" order="7" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/LiquidityCapitalResourcesAndGoingConcernDetailsNarrative" xlink:title="000025 - Disclosure - Liquidity Capital Resources and Going Concern (Details Narrative)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetails" xlink:title="000026 - Disclosure - Acquisition of 374Water Inc fka PowerVerde Inc (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" order="40" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_ThreeSevenFourWaterMember" xlink:label="loc_scwoThreeSevenFourWaterMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_scwoThreeSevenFourWaterMember" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" order="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" order="7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" order="8" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetailsNarrative" xlink:title="000027 - Disclosure - Acquisition of 374Water Inc fka PowerVerde Inc (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" order="40" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="40" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="50" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" order="60" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesDPreferredStockMember" xlink:label="loc_us-gaapSeriesDPreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesDPreferredStockMember" order="41" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="loc_srtChiefExecutiveOfficerMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_srtChiefExecutiveOfficerMember" order="42" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_MrNagarMember" xlink:label="loc_scwoMrNagarMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_scwoMrNagarMember" order="43" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalariesAndWages" xlink:label="loc_us-gaapSalariesAndWages" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSalariesAndWages" order="1" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_AnnaulSalaryIncreasedAmount" xlink:label="loc_scwoAnnaulSalaryIncreasedAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoAnnaulSalaryIncreasedAmount" order="2" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_Description" xlink:label="loc_scwoDescription" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoDescription" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PartnersCapitalAccountUnitsSoldInPrivatePlacement" xlink:label="loc_us-gaapPartnersCapitalAccountUnitsSoldInPrivatePlacement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPartnersCapitalAccountUnitsSoldInPrivatePlacement" order="6" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_SettlementOfLiabilityForPreferredStockShares" xlink:label="loc_scwoSettlementOfLiabilityForPreferredStockShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoSettlementOfLiabilityForPreferredStockShares" order="7" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/IntangibleAssetsDetails" xlink:title="000028 - Disclosure - Intangible Assets (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" order="40" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_LicenseAgreementMember" xlink:label="loc_scwoLicenseAgreementMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_scwoLicenseAgreementMember" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaapPatentsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapPatentsMember" order="22" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" order="2" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_IntangibleAssetsAdditions" xlink:label="loc_scwoIntangibleAssetsAdditions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoIntangibleAssetsAdditions" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" order="5" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/IntangibleAssetsDetails1" xlink:title="000029 - Disclosure - Intangible Assets (Details 1)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/IntangibleAssetsDetailsNarrative" xlink:title="000030 - Disclosure - Intangible Assets (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" order="30" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_LicenseAgreementMember" xlink:label="loc_scwoLicenseAgreementMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_scwoLicenseAgreementMember" order="11" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentForAmortization" xlink:label="loc_us-gaapAdjustmentForAmortization" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentForAmortization" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockValue" order="2" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/StockholderEquityDetails" xlink:title="000031 - Disclosure - Stockholder Equity (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" order="40" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_OptionsMember" xlink:label="loc_scwoOptionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_scwoOptionsMember" order="21" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_OptionUnvestedMember" xlink:label="loc_scwoOptionUnvestedMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_scwoOptionUnvestedMember" order="22" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaapConversionOfStockSharesConverted1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConversionOfStockSharesConverted1" order="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="7" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice" xlink:label="loc_scwoSharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoSharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice" order="8" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice" xlink:label="loc_scwoSharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoSharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice" order="9" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice" xlink:label="loc_scwoSharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoSharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="12" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="14" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/StockholderEquityDetails1" xlink:title="000032 - Disclosure - Stockholder Equity (Details 1)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" order="30" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="40" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" order="50" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_OptionsMember" xlink:label="loc_scwoOptionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_scwoOptionsMember" order="31" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_MinimumsMember" xlink:label="loc_scwoMinimumsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_scwoMinimumsMember" order="32" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_MaximumsMember" xlink:label="loc_scwoMaximumsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_scwoMaximumsMember" order="33" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="4" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/StockholderEquityDetails2" xlink:title="000033 - Disclosure - Stockholder Equity (Details 2)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" order="30" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" order="40" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_WarrantsMember" xlink:label="loc_scwoWarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_scwoWarrantsMember" order="21" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_MinimumsMember" xlink:label="loc_scwoMinimumsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_scwoMinimumsMember" order="22" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_MaximumsMember" xlink:label="loc_scwoMaximumsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_scwoMaximumsMember" order="23" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="8" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="9" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_WeightedAverageExercisePriceExercised" xlink:label="loc_scwoWeightedAverageExercisePriceExercised" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoWeightedAverageExercisePriceExercised" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" order="11" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="12" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="13" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="14" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="15" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/StockholderEquityDetails3" xlink:title="000034 - Disclosure - Stockholder Equity (Details 3)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/StockholderEquityDetailsNarrative" xlink:title="000035 - Disclosure - Stockholder Equity (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" order="30" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" order="40" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="40" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" order="50" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="40" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="50" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" order="60" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="50" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain" order="60" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" order="70" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" order="70" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" order="80" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain_10" order="90" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="80" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="90" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" order="100" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_WarrantsMember" xlink:label="loc_scwoWarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_scwoWarrantsMember" order="81" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_ThreeSevenFourWaterMember" xlink:label="loc_scwoThreeSevenFourWaterMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_scwoThreeSevenFourWaterMember" order="82" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesDPreferredStockMember" xlink:label="loc_us-gaapSeriesDPreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesDPreferredStockMember" order="83" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaapPatentsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapPatentsMember" order="84" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_OptionsMember" xlink:label="loc_scwoOptionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_scwoOptionsMember" order="85" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_ThreeSeverFourWaterFormerStockholdersMember" xlink:label="loc_scwoThreeSeverFourWaterFormerStockholdersMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_scwoThreeSeverFourWaterFormerStockholdersMember" order="86" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_ConsultantMember" xlink:label="loc_scwoConsultantMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_scwoConsultantMember" order="87" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="1" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_StockIssuedUponWarrantExercised" xlink:label="loc_scwoStockIssuedUponWarrantExercised" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoStockIssuedUponWarrantExercised" order="2" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_ProceedsFromStockIssuedUponWarrantsExercisedAmount" xlink:label="loc_scwoProceedsFromStockIssuedUponWarrantsExercisedAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoProceedsFromStockIssuedUponWarrantsExercisedAmount" order="3" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_WarrantsOutstandingSeriesOneShares" xlink:label="loc_scwoWarrantsOutstandingSeriesOneShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoWarrantsOutstandingSeriesOneShares" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="loc_us-gaapConversionOfStockSharesIssued1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConversionOfStockSharesIssued1" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaapConversionOfStockSharesConverted1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConversionOfStockSharesConverted1" order="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" order="7" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_LiabilityForPreferredStockShares" xlink:label="loc_scwoLiabilityForPreferredStockShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoLiabilityForPreferredStockShares" order="8" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" order="9" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" order="11" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" order="12" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" order="13" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" order="14" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_CommonStockSharesIssuesForCash" xlink:label="loc_scwoCommonStockSharesIssuesForCash" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoCommonStockSharesIssuesForCash" order="15" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_NumberOfWarrantPurchase" xlink:label="loc_scwoNumberOfWarrantPurchase" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoNumberOfWarrantPurchase" order="16" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantExercisePriceIncrease" xlink:label="loc_us-gaapWarrantExercisePriceIncrease" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantExercisePriceIncrease" order="17" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="18" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_AggregateFairValueOfWarrant" xlink:label="loc_scwoAggregateFairValueOfWarrant" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoAggregateFairValueOfWarrant" order="19" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaapProceedsFromWarrantExercises" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromWarrantExercises" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="22" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" order="23" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockNoParValue" xlink:label="loc_us-gaapCommonStockNoParValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockNoParValue" order="24" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" order="27" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" order="28" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" order="29" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockConvertibleSharesIssuable" xlink:label="loc_us-gaapPreferredStockConvertibleSharesIssuable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockConvertibleSharesIssuable" order="30" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_Preferredstockparorstatedvaluepershare" xlink:label="loc_scwoPreferredstockparorstatedvaluepershare" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoPreferredstockparorstatedvaluepershare" order="31" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" order="32" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_PreferredStockParValue" xlink:label="loc_scwoPreferredStockParValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoPreferredStockParValue" order="33" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockLiquidationPreferenceValue" xlink:label="loc_us-gaapPreferredStockLiquidationPreferenceValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockLiquidationPreferenceValue" order="34" />
    <link:loc xlink:type="locator" xlink:href="scwo-20220331.xsd#scwo_PreferredStockStatedValuePerShare" xlink:label="loc_scwoPreferredStockStatedValuePerShare" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoPreferredStockStatedValuePerShare" order="35" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockValue" order="36" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="37" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther" order="38" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensation" order="39" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" order="40" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" order="41" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="42" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="000036 - Disclosure - Related Party Transactions (Details Narrative)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/IncomeTaxesDetails" xlink:title="000037 - Disclosure - Income Taxes (Details)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/IncomeTaxesDetails1" xlink:title="000038 - Disclosure - Income Taxes (Details 1)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/IncomeTaxesDetailsNarrative" xlink:title="000039 - Disclosure - Income Taxes (Details Narrative)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/DeferredRevenueDetailsNarrative" xlink:title="000040 - Disclosure - Deferred Revenue (Details Narrative)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://powerverdeinc.com/role/SubsequentEventsDetailsNarrative" xlink:title="000041 - Disclosure - Subsequent Events (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" order="40" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" order="1" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>scwo_s1img11.jpg
<TEXT>
begin 644 scwo_s1img11.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" #U 5@# 2(  A$! Q$!_\0
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MG@7_ *!^N_\ @!_]E7RS17)_:M3^4][_ %%P][<[_ ^IO^&GO ?_ $#=<_\
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ME4P-+VU&7-%;]T?1%%%%>P?G@^-=S#TJU4<*XC'O4E !1110 55U+_D%W?\
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M*1K>&0(IC4A3\HQTKFC5AR*,D?05<%B/;2J4Y6N5?M5QB6;S%(A6,[0HRVX
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M\E^9'_?7\Q1YD?\ ?7\Q7UI_PKGX?_\ 0D:'_P" *?X4?\*Y^'W_ $)&B_\
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M/H#3,SOJ*8K!D#8(SV/6GT %5=2_Y!=W_P!<7_\ 035JJNI?\@N[_P"N+_\
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M )!=W_UQ?_T$U:JKJ7_(+N_^N+_^@F@#@_@9_P D \$_]@N+^5>C5YS\#/\
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M,FD37,\]LK"[2?9+'$DP5L =8WSD9 *D9Z$@'H:[BH++@]QUI]%% !574O\
MD%W?_7%__035JJNI?\@N[_ZXO_Z": .#^!G_ "0#P3_V"XOY5Z-7G/P,_P"2
M >"?^P7%_*O1J "BBB@ HHHH \H\%I]@UKQQH)X-EKTMP@Z8CN8TG'_CSO\
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M0 5E>)/^1.UW_L'W/_HIJU:RO$G_ ")VN_\ 8/N?_134GLQG3_"W_DC?@O\
M[ EG_P"B$HH^%O\ R1OP7_V!+/\ ]$)17D&AI^(OM0\*ZO\ 9Y((K@6<WEO<
M[3$K;#@ONPNW/7/&.M>.?"6;PR/%4<6F^$]#T[4Y;9C-<6/B6#4"G"[A'$'8
MHI*C[H P #TKV?6KB.ST'4+R::.".WMY)7EF0O&@"DEF48+*,9('6O(O"NH3
MZI\5M)&JS6=M-90RI&-.T22S26:2!96MY9'D8[TB97,>T#.,G*XH ]WHHHH
MR-4U"QTC3Y]2U*Z2UM($,DDK\!1_GL.36-HOB73_ !=X&'B/2TN([.\AE:-;
ME/+<!2R'*\X^Z?ZUUK*K#D9'%>=^%_"?V'X66VD>)M-MIKRU6[?;(%F"%Y9'
M&#Z[2.E !\"_^2 >"?\ L%Q?RKT?->3_  9T;2;OX)^![^XTVVFNX]+@VS/$
M&=<<C!QV[5Z!'H&BQW<URFEVBSSAEDD$(#.&^\">^>] &QFC-8B^&]!CM)+5
M-%LUMY6#21"%=K$="1CG%))X=\/S6T-O)HMD\,&?+1H%*IGDX&.,T ;E&:QS
MHNCM?IJ#:7;&[3:5G,0WK@8'/7@8%,7P_H4+SM!H]G&UPICF*PJ/,4\D'CG-
M ''>.%%C\3/ 6M?=6:6\T>1N@/G0^8G_ (] /SKI/RKA_B]I7AW1?AO#JC:?
M:V]MIFLZ??-&L("2'[0D9R,?W)&%=//X?T*0112:/9R1VXV0AH5(1<YP..*U
M@SEJ[FC^(H_*J7]D:5_:/]I?V;;?;=V[[1Y8\S.,?>Q44>@:%"D\<.CV<:SK
MME585 D&<X/'//K5G.:7Y4?E6:?#^AM:+9G1[,VZOYBQ&%=H;INQCK2R:%HL
MQ@,VDVDA@4)$6A4^6HY 'IS0&AH_E1^541H^DK?O?KIML+M\[IA&N]L_>YQ^
M'O4<?A_0X;>:WBT>SCAFP)$6%0KX.1GCGV]* T-+\J/RK-;0-#DM8[1]'LVM
MXV+)$85*J3U(&/\ ]=.?0]&DGBN)-*M6EA55C<Q*60+]W'';]* T-#\J/RJA
M'HFCQW4MS'I5JMQ,&6218@&?=][/U_6O/M<N;75KN^\$^ M.L82KA-7U<6ZO
M!IY'/EH,8EN!G@<B/JWI1:^Q25S;\3>+KU=6?PEX-CAO/$6T-<SS M;:1&>D
MDV/O.?X8NK=3@4[P]X>M/#MA+##/->W=U*;B]O[EMTUY,>#(Y_0 8"C '2J?
M@SP]H_A?1[S1]$8M;1WKLY<LTA?:F=['EV[Y]_05TE=<(<JN=2CRA1116HPH
MHHH H7 O/[;TTPR8M0LWGJ&X8[5V<=^_TJ_69=QPMXDTF5K@)*D=SY<14YDR
MJ9Y[8_K[5IU(!1115 %%%% !1110 4444 %97B3_ )$[7?\ L'W/_HIJU:RO
M$G_(G:[_ -@^Y_\ 134GLQG3_"W_ )(WX+_[ EG_ .B$HH^%O_)&_!?_ &!+
M/_T0E%>0:&GXG=(_!^M22:?_ &DBV,[-:#_EX'EM^[]?FZ?C7C'PYN+5O'VC
M?V?9VEUIQ^UQV\\<]S-+)+Y4;7-]NE8[HS)_HZEAN 4 '!(KV;7IKR#PWJLV
MG74-M>1VDSP2SL%CCD"$JS$\  XSG@"O*OAVWBJ3Q7$K6WBNWTV":X:YEUZ3
M>DT+Q1[%5MQWOYP<AD^4+D?Q** /=**** "JNI?\@N[_ .N+_P#H)JU574O^
M07=_]<7_ /030!P?P,_Y(!X)_P"P7%_*O1J\Y^!G_) /!/\ V"XOY5Z-0!EZ
M=JNG:L+K^SKI;C[)</:3%<_)*F RGW%:E?/_ -AOK/4I6\06>LP>%Y/$FK37
MJV4<X:0MM^S.XA'F&(_O,$<;MF:R=5B\92:PNVX\1:>?LMB-!^U6MS=72  ;
M]YBD6'S=V?,\[.5QD\4 ?2U%'.** ."^*6EVVO?#?5-#N(7E_M +;PA&VE96
M8"-OH'VG'>H_">J#7/!&@ZR#DWNGP3-[,8QG]<UTNO23Q6]HT%N+AC>VZL&B
MWA5,@#-[8'.>V,UP'PT1;/PA<:"K$G0]4O=-P>H5)V9/_''2M('/66AD^*M)
MNF^)/A>W@\5>(;*UUJ6[^U06NH&.-?*M]Z[!CY>?SY]:=-XMUB759K+^SA#I
M.G^(;70UNTOF%S<R%H\LR["-F'Y&<L1[UW-UI-A>:KIVJ7$)>[TUI6M7#$!#
M(NQ^,\\?7%5?^$:T,&5I+4[9-3369"9& -RFTB3K_L#CI5&%]CSC6?B-XC;P
M)<ZI-H\&DV^JV>I1Z;=6MVTD\$]O'*RLX*@ ,(F(P3MXSUJW)\6)+77QI,>E
MM>064EK9W;JD[W$DDD<;-(FV,Q[5\P$[F4G#>@SJ:!\+- L-#^R:MYNISR0W
M4+'[5(8$6X9C(8D+8C+*V"1C//K6Y-X&\.S:LNHM!=1ONADD@BNY$@N'B $;
MRQ!@KLH5>3_=&<XIZCO$Z5AM8KU([CI24=_4T4S,*4 DX&2?05SGB/QEH?AF
M6*SO)9;O5;@9M]*L8_/NY_I&#POJS;5'<URUQIOBOQFK?\)9='0-%D'_ " M
M-GS+,OI<W(QD>J1X'J6JE%RV-(P<A^J>(-1\;WEQH7@Z^DL="A<PZEXAA/S2
M$<-;V9[MV:7D)R%RW3H=*TK3=#TFWTG2+..SL;==L<,?0=R?<GJ2<D_C4UK:
MVMC906-C;QVMK @CAAA4*D:C@*!V%35U0@HHZ$K&;I36[2ZKY$;(1?.)"S9W
M/L3+#T'3C_&M*J&FO*\FI^9"L02]=4*IMWKM0[O]KOSWQ[5?JAA1115 %%%%
M &9=-;CQ)I*R1N;@QW/E.&PJC:F[(QR>GT_&M.LZZDD7Q!I<:P*T;QW&Z4QY
M:/"KC![9_7'M6C4@%%%%4 4444 %%%% !1110 5E>)/^1.UW_L'W/_HIJU:R
MO$G_ ")VN_\ 8/N?_134GLQG3_"W_DC?@O\ [ EG_P"B$HH^%O\ R1OP7_V!
M+/\ ]$)17D&A6\>:C=6^CVN@:?I,6J7WB*9]-BAN;@P1!3"[R,[A6( 1&Z*2
M3CZUB?"W0X/[$LM6AU3Q%$;8S6,FF7^K-=PP/%(T+*"0-P!0[3Z8X'2NL\4^
M$=.\606"WUUJ%G-I]P;BWN-/NFMI8W*,APR\X*NPQ[UF^%_AWIGA&_%UIFM>
M()TW2.UM>:I)/"SR,6=RC'!8L2<^I)H [NBBB@ JKJ7_ ""[O_KB_P#Z":M5
M5U+_ )!=W_UQ?_T$T <'\#/^2 >"?^P7%_*O1J\Y^!G_ "0#P3_V"XOY5Z-0
M 4444 %%%% &'K273VMHMC-Y+"]MRY\S9NC$BEESWRN1COTKA]#C73OBEX^T
MC[JW$UIJ\:^HEA\IB/\ @<!_.NV\01V\EG9"ZN/(47]JRG9OW.)E*K[9.!GM
M7'ZY'_9_QVTB\W836M#N+/'J]O*DJ_\ CLDGY&JCN9U%>)Q>O>+M<L?%?BC[
M/XHMXQHM]I\%IH1@C+WJSK'N4DC><EFV[<;2#G(K+NO&VOMH4>I3:Y:7<NK-
MJEI<>'VMXR-/2&&<ANF_Y?*7?OR&\SMD5ZK:^&='M?$.H:_]DCGU"]F2;SIH
MU9H"L:Q_NSC*Y"C/K5]=+TW[;/>)IEH+NY7RYIA;KYDR_P!UFQEA]<UH<EUV
M/(U\3>+H["]UBUUV&VL=%_L6--.2SC\N<7$4'FAFQD#]X=NW&WW[=;\,5N$T
M+7([K69=3ECU[48V\[9OAQ<,-IVCOUYZ9XP*O:]XO\$^'96T_4;NVDOI-O\
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M,!JT445H(**** "BBB@ K*\2?\B=KO\ V#[G_P!%-6K65XD_Y$[7?^P?<_\
MHIJ3V8SI_A;_ ,D;\%_]@2S_ /1"44?"W_DC?@O_ + EG_Z(2BO(-#L:S=5U
M2ST;1KS5KZ;RK.RA>XFD()V(JEB?R%:5<WXRT63Q%X%USP_!,L,VHV4MO'(_
M*HS*0I/MDB@"GX=\80^(+VXL9=)O]'O8((KI;:_5%>2&3.R0;&88RK @X*D<
MCI5*'XB:2WB$V,EC?0V)O)M/CU:5%%K)<Q*S21@[MW&QQN*A24(!X&<K1[?Q
M5-XDN?&&J>&1972Z?:Z3'IZWT;M(/.+S3;QP$ ;Y1]Y@IX!(%9$G@OQ-?,O@
M^ZTZ.#1(=:N]6&KBY5O,BF\YUC$?WA('GP<X7"'!.<4 =!:_%C19+&6^O-+U
M33H6L1J5CY\*EM0MRRHK1*C,=Q9XQL;:W[Q..:OKXTLYM*U :Y;R^&KB+=$(
M=5DCC$OR;@T;J[)(,'G:3@@@XKSC4/AWXR\4>&[#3=4TF#39?#VC)IMN!>@K
MJ4JS6[E@R<QQE;8#)PP,G3Y>>M\&^&[S2;?Q1=3^'X_#NFWI5[/1EF246Y6(
MK)+\A**7./E7/W03RQH C^#.N:/:_!;P/IMUJEE;WLFEP;+:2X59&SPN%)R<
M]O6N^C\1:!)<SVL>NV#SVZLTL:W2%HPOWBPSD8[YZ5R'P.AC;X">"':-2PTN
M+YB.>E>AB&$$D1)D]2%'- &.GBCPW+:RWD?B'39+:)@LDRW<91"?N@G=@$]O
M6FR^*/#<4$-S-KVG1P7&[R96NXPDF.&VG/.._I6S]GA"E?*0*>HV\&E-O"5"
MF%"!T&WI0!D-K^AKJ2::VM62WLFT);FY02-D97"YSR""..:;%XD\/S2W"6^O
M:=,UNC23!+I&\I0<%FP?E [DUM>3%O#^6NX?Q8Y% @A4MB)!NZX7K0!Q6O>*
M/"YTBVO9=4L+NV74K6+S4O45(Y3(I4E@3TZX[@5QGQ@\:>%/#4O@?Q=?:U;F
M*UU;</(<2M+;RPRQ2,H7)8#*GT^7UP*]-UOS8[2T%G9I*6OK<.IA#A4,@#-C
MMA<G/;K7AWQ TO3_ (J:AJ]Q?6)OO#OAV0:?IMNA91<W?FJ+F;*$$JH_= 9Q
MD2&JC%R>@GJCJO\ A8MSK<0;P'X7N]:AD7='J=\?L-B1UW!F'F2#O\J'/K5:
M7P[XFUX'_A,/&$YMV^]IFA!K&W_W6DR9G_[Z7/I750V]O9V\5G:1+#;6Z"&&
M-.%1%& H_#I3Z]&--+<Q44C-T;0-#\.VS6^@Z3:Z=&WW_(C"M)[LW5C]2:TJ
M**TT6Q04444P"BBB@ HHHH S=*>%Y=5\F$QE;]UD);=O?8AW>W;CMCWK2JAI
MK7#2:CY\(C"WCK&1'MWIM4AO?J>>^/:K]2 44450!1110!F73VZ^)=)22$M.
MT5SY<@; 0 )NX[YX^F/>M.L^YDN%U_3(XX0\#1S^9(8\E" FT;NV>?KCVK0J
M0"BBBJ **** "BBB@ HHHH *RO$G_(G:[_V#[G_T4U:M97B3_D3M=_[!]S_Z
M*:D]F,Z?X6_\D;\%_P#8$L__ $0E%'PM_P"2-^"_^P)9_P#HA**\@T.QHHHH
M **** "JNI?\@N[_ .N+_P#H)JU574O^07=_]<7_ /030!P?P,_Y(!X)_P"P
M7%_*O1J\Y^!G_) /!/\ V"XOY5Z-0 4444 %%%<GXP\8Z9X-TM+N^\V[O+B3
MR+'3K8;I[V8CB.-?U)/"CDD"@#G/BYKE_IOA[3]%T'4/L7B+7+Z&ST^3/W#N
MW22'GHD88^Y*CG.*RYM%BT7P)'H.@O\ 9(K.**&!VDV$ 2*2Q;/4\Y]2?>LK
M^Q;VXU"#Q;XVO!+XAN+JWCBCM_G@TV/S59;6+IU(&^3JQ'3  K?\21V\GAJ[
MCO)S! QBW2*F\J?-4CCZX^GX5WTJ?*M2&:[??;' SP.F*2G/_K'SP<]*;722
M%%%% !1110 4444 %%%% %#34E234O-F64->NR /NV*50;?;OQVS[U?K-TI;
M=9=5\B1G)OG:0,NW:^Q,@<\CISWS[5I5(!1115 %%%% &=<I,VOZ8Z3A(5CG
M\R(R8+DA,?+WQ@\]L^]:-9ETMNWB727DE99UBN?+0+E7&$W9.>,<?7/M6G4@
M%%%%4 4444 %%%% !1110 5E>)/^1.UW_L'W/_HIJU:RO$G_ ")VN_\ 8/N?
M_134GLQG3_"W_DC?@O\ [ EG_P"B$HH^%O\ R1OP7_V!+/\ ]$)17D&AV-%'
M:B@ HHHH *JZE_R"[O\ ZXO_ .@FK55=2_Y!=W_UQ?\ ]!- '!_ S_D@'@G_
M +!<7\J]&KSGX&?\D \$_P#8+B_E7HU !15*YNK>RM9+N\N([:WC7=)+*X1$
M [EB< 5YI>?$K4/$'^B_#?2TU"'.UM>U -'8)_US'W[@_P"[A?\ ;IJ+EL!U
M7B[QAI_@[2XY[B.6^U&[D^SV&FVRYGO9NNQ!V'<L>%&237#Z+HFHMK$OBSQ9
M<17WB:YC\O,7,&G0DY^SP9[?WGX+GV %2Z3X<^QZM+K^L:I<:]X@GC\E]0NE
M5?*CSGRX8U^6),]ADMCDG%;U=]*CRZR(;,W6I(8[:R,T'G WULJ@MMVL9  W
MX'G'>H_$DEO%X:NY+NW-Q &BW1A]A;]Z@'/UP??\:L:HUTL%K]CC\QOM<(D
M7=B/S!O/3T[]JCUUKJ/0KAK&'S[@&/:AC\P']XH/&#VS]/PK81J/_K&SR<]?
M6FTK8WMCD9Z]:2J$%%%% !1110 4444 %%%% &;I4D,DNJ^5!Y12_=7(;=O;
M8AW>W;CMCWK2JCI[73/J'VJ/8!>.(3MV[H]JX/OSGG_"KU2 44450!1110!F
M74D*^)=*C:#=,\-R8Y=WW -F1COGCZ8]ZTZH7#70US3UCCW6ICG\Y]F=I^3;
MSCC/S?7\*OU(!1115 %%%% !1110 4444 %97B3_ )$[7?\ L'W/_HIJU:RO
M$G_(G:[_ -@^Y_\ 134I;,9T_P +?^2-^"_^P)9_^B$HH^%O_)&_!?\ V!+/
M_P!$)17D&AV"G*@TM10MQMJ6@ HHHH *JZE_R"[O_KB__H)JU3&574JPRIX(
M/.: /,/@GJFFP? ?P7%-J5K'(NF1 JTR@@X[\TFO?%BRCU.?0?!]O%X@UFW;
MR[AVN%@LK-O2:8Y&?]A S?2M-O@M\)68LWPYT D\Y^PI_A1_PI3X28 _X5UH
M&/\ KR3_  H XI]%A\074>H?$+Q-9^(KA&\R/3UD6+3;8]?EAW'S"/[TA8_[
MO2NI_M#3<!1J-F !@ 7"  ?GTJU_PI/X2?\ 1.= _P# )/\ "E_X4G\(_P#H
MG.@?^ 2?X5TQK*.R)M<J?VAIW_02L_\ P(3_ !H_M#3O^@E9_P#@0G^-6_\
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M)K+*NGG[&F;HE#(-G'/R GZ4?6/(+%S^T=._Z"5G_P"!"?XT?VCIW_02L_\
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MI2,P4<U7=RY]!Z4 (S;F)HIM% !1110 O2I%E8CFBB@"8'BES110 9HS110
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M2JHF"N#E0<YYHHH =H>@Z7H\=]:V<<\AN[@I=37=P]Q+<,(\;G=R6/R@*!G
M XIW@G3FTGPO%H(N6GBTF1[*&1AAC$C8C!YZA=JY[XSQFBB@#%G\ ^$;W5#J
MMQI<C?:+BWO)K,74HM)IV(_>O;[O+9L@')7DC)YYK2\/Z5]AU/Q#KTUQ]HNM
M1O!%]W:(HH?W<:#DYQ\[$]RYHHH ['-&:** #-&:** $+8[5"TK <444 19W
-?,>M%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>scwo_s1img13.jpg
<TEXT>
begin 644 scwo_s1img13.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" $R U(# 2(  A$! Q$!_\0
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M5+10 FU?[H_*C:O]T?E2T4 )M7^Z/RHVK_='Y4M% ";5_NC\J-J_W1^5+10
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M2T4 )M7^Z/RHVK_='Y4M% ";5_NC\J-J_P!T?E2T4 )M7^Z/RHVK_='Y4M%
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M>!<:TB*1'Y*,)(U<XZENWO0!Z)H%UJEQX9L;S6(XH[^: 2S1Q@JJ$C..2>G
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MIX@\.WNBWN5@NH_++)]Y.X8>X/-<[H_A_P 7)FP\0>)+74M)2W>W,,5ILDN
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M4CQVT.-[)&7(R0.@!/4UY=#XL\27'AZWL+?4O+U'5?$-QIL=[(@;[-$K$\#
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M8\MF"\L0.H/!-=9)>>(O&'C2[T6RUJX\.6FF6D$TJP(OG22RKNP=PX"].G-
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 E%%%
M"^E%'I10 5P?Q,TF\UKPQ:6-G:RW+'4;9G6+AE0/\S9ZC [UWE% '%:1X#L=
M,UY]>N=6U+5[P1&"W:^FW_9XSU"\#D^IJU:^#M'L_!/_  B4JR7>FE71A,WS
MMN8L>1CG)XKJZ* .,T/PB^BW\=Q)XFUG44@C,<-O=7 ,:+[@ ;CQU.<4V3P'
MHLGAS4=%DFN6AO;UM0\S>!)%*6#!D('8CC@UVM% '&67@N&WUF/6KW6]2U*^
M2UDM-URRE=C'/"A1@\?C63#\)]'CMK/3GUC6)](MF$ATZ2X!AE8'.6  []AQ
M7I-% &!9^'K6R\3ZCXACDE-U?Q10R(Q&Q0@P,<5BR?#_ $.;PW-H<DMT8WO'
MOH[A9-LT$S-NW(P'&,\>U=S10!PH^']K-HE[INK:UJVJ-=M')]HN;C+PM'RC
M)@ *0?;GO5K3?!L-EXBM]?NM:U'4K^"W>U#73KMV,0>@48/%=A10!Y_:_#?1
M[?1M1T.6^O[K3;N7SHH991_H;[BP:(@ @Y.>_05JZ/X3;3)YYK[Q!JNM>;%Y
M.R^F#($[_*H )]SDUU=% 'F#?"?26L6TS^W=972Q()8;'[2#% 0P;@%>1['I
M7H.H6-OJ6FW.FW2[[>YC:*10<$J1@U>HH \[L/AGI]G+I;S:YJ]ZNDW"S6<<
M]PI2(#@)M"].?KQU%;MMX4L;6T\06R37!77)99;@EAE"Z[3MX]/K73T4 <E8
M^#=-T_4=&O89KAI-'LFL80[*0Z''+<=>/:L^U^']M8V%]8V?B#6+6"XN?M4*
M17 7[(^XL=G'()/(.1_.N]HH Y;P_P"%;?0[^[U*34+O5-3NU5)KN[92Y1?N
MJ H  YI-8\)V^K>(]-UY=1O+"]L1Y8:V8 2QD@E&R#QFNJHH Y)?!>F)X;UC
M05N+G[-JLL\LS;AN0RG+;>,?3(-5YO UJ=3M-1T_5K_3;N&U2RDDMG4>?$OW
M0P*GD>HQ7:T4 <(WPYTO_A$?^$:CU"_CC6\-]'="4>='+NW @X]371_V3#<>
M'VT74II+^&2#[/,\[ O*"N"20!R:V** .#M?A_;V]QI,ESKVK7J:1,LMG%/*
MI1,*5"G"C/!Q6SI7ANQTF+588VDGBU.YDN)TFP1E^"HX''YUT=% '"Z3X!BT
M>]MC:>(M:&G6S^9!IYN?W2?[/3)4>A-=#K&DV.NZ/<:7J$/GVMPNQUR01[@]
MB#S^%;-% '(:'X1ET?4%N)?$VLZFL<9BB@NYPT:*?4 #<>.IS2#P'I(\"W/@
MX75U]AN'9VDW+Y@W2;S@XQU]J["B@#CM8\$6NH:G'JUCJVHZ-J*Q"![BRD"F
M:,=%<$$''8]JF?PA9S0:'%<:A?W#Z-<?:HI9I@[ROR/G)'(Y/I75T4 >9^.M
M-@?Q'9:DND^(#=I 8_M^AR!78;O]2X]#USVS6;H>E:AX=^'>N?;O#=[=2:S=
M2F/2XV$LR(XV@.V?;)/.*]>HH X[X=^&I/"O@6QTVZ&+U@9KHYR3(W)Y]N!^
M%2^(/"-GKE]:ZE'?7FEZE:J5CO;*3:^P]5.005]JZRB@#CKGP3:WGA"7P[?:
MMJ5Y'+,)I+F>8/*S!@W7& ..@%:<_A^SN/%-AXB:6475E;R6T: @(RO@G(QU
MXK>HH XAOA_H<GAN?0VDNFBEO'OTG$@66"9FW;D8#C!/'MZU'_P@-O-H&I:3
MJ6O:OJ7]H>6))[F<,R!#D!1MP/R.:[NB@#C]8\$VNI:NNL6&L:CHNHF(02SV
M,@4SH.@8,"#CL>U/D\)V4B: MQ?7\\FB3_:(99I=[RM@@^8Q'(^;V[>E=;10
M!S3>%]/?7]3UB225I=2M%LYH]PVA!GIQG)R:7PMX;7POI TJ'5+R^@0_N?M;
MAC"N,!%P!P,5TE% '!WGP[L;HZK!'K6IV>GZJSR7-C;R*(R[?>894D9[C.*V
M+7PK8V>NVFLQS3-/:Z>NG(K,-IC!SD\=:Z2B@#BKCP#HMUHVJZ7/)<O'J-\V
MH%Q)M>&8D'<A XQCWJ/1_ MOIGB&TUZ;5M5U/4+6%X!)>3!P5;'&,#&/;]:[
MFB@#G/$WAG3_ !181VMX\\$L$@FM[FV?9+!(.C*>W]:RX_ MC-H6H:1K&J:E
MK(OF5Y)KN?+HR_=,>  I&.WXUV]% '$Z+X#L]+U0ZI>ZQJ>L7RPFWAGOIMS6
M\9X(3 &"?7K45GX!MK?4;*ZOM>U;58=.E\ZSMKR972%^0&SM!;&>,GBN[HH
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M** "BBB@ HHHH **** "BBB@!**** %]**/2B@ HHHH **** "BBB@ HHHH
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MK8Z3-KOB36Y!#IVE0-M:5N,LQP<*,@9]_8D 'J-%> 6/QH\8>'?%FCZ3\7/
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M9^&[>&:.6&8LS21R+MV,6R0!TQGI[5TE !1110 4444 %%%% !1110 4444
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M<NSR;0%V@8'!YKCI-<AUF]&J2+':EX(X_*+[L;1C_(KP*%*7UR3DM#UJL_\
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MRCJ03R>N<=ZO1V,[>*9]2EPL2VRV\6#RWS;F)_0?G0!M4444 %%%% !1110
M5S>H^(FL]=CTB"R\^9D$AWS+%N!.,+N(W&NDKG-;\.OK4@6346CM2 &A\E&Q
M@]58C*GZ4 5[WQ-/;V%Y>1:9YL-G/)!*6F"G*XP1QSDGI47_  E%Q_::6+:>
MD,OEQ22+/=+&R[^< '[Q'2G7/A-YG3R-6E@5+Q[P*8E=2YX&0>N*E;PS<MK
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M *!&K?\ @*?\:/\ A+K7_H$:M_X"G_&NCHH YS_A+K7_ *!&K?\ @*?\:/\
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M/^$NM?\ H$:M_P" I_QH_P"$NM?^@1JW_@*?\:Z.B@#G/^$NM?\ H$:M_P"
MI_QH_P"$NM?^@1JW_@*?\:Z.B@#G/^$NM?\ H$:M_P" I_QH_P"$NM?^@1JW
M_@*?\:Z.B@#E(_&5C)++%'IFILT1VN!;'*D\\\U8_P"$NM?^@1JW_@*?\:70
M_P#D8_$7_7Q'_P"BQ714 <Y_PEUK_P! C5O_  %/^-'_  EUK_T"-6_\!3_C
M71T4 <Y_PEUK_P! C5O_  %/^-'_  EUK_T"-6_\!3_C71T4 <Y_PEUK_P!
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ME;FZ!SQORG7T445)84444 <]X1_Y ]Q_U^3_ /H9KH:Y[PC_ ,@>X_Z_)_\
MT,UT- !1110 4444 %%>=/\ $Q+C7Y]/T7PMJVLV=K<?9;C4+5 8HY,X('/S
M8[D=*]%'2@ HHHH **** "N<T/\ Y&'Q'_U])_Z*%='7.:'_ ,C#XC_Z^D_]
M%"@#HZ*** "BBF,=JENN/3K0 ^BO,8?BM:C5+:/4O#&L:7IEW<?9;?4KJ';&
M\A.!D9RH/O5[QK\2-+\%ZGI^G26L][<7;+N2 @>0A8*&;/J>!]#0!Z!17G_B
M;XC6_A_7'T>QT&_UR[MX!=7B6:@_98CT9L_3H*ZC0]8L/$&B6FM:9)YMI=QB
M2-B,''H1V(Z4 ;%%%% !1110!SFA?\C)XC_Z^(__ $"NCKG-"_Y&3Q'_ -?$
M?_H%='0 4444 %%%>>R?$K2Q\3+?P3!9SW$\CM&]VI BCD"%RGN0,9^HH ]"
MHKRV^^+FFV.KW4:Z+J-QHUG<_9+K6(T!MX9<XQZD GDUVVO>(-.\/>'+K7M0
MDS:6\1ERG)<=@OJ30!N45Q6B>.]-U:]TS3[JWDL-3U"V:[CMI'1]J!L %E.-
MQX./\*[6@ HHHH *YWP__P AGQ%_U_#_ -%K715SOA__ )#/B+_K^'_HM: .
MBHHHH **** "BBB@ HHHH **** &M]ROBW]IS_DJ.F_]<8_YFOM%N]?%W[4'
M_)5--_ZX1_S->QDW^]?(\['?PSRN\OHK%8O,C9C(2!M[5%_:FX#$+_B14.K1
M^9-:I]T%SDGH*$==O2OT?GG=I,^0E""BG;4F_M)\<6_YM70^ ;R23X@Z2K0A
M1NDYST_=M7-[H_[OZ5TGP_93\0M+"CO)_P"BVKEQ3DZ<M>A6'Y54C9'#65Y-
M:M+%Y(;]X><^IK4^WW!'^J05DJV^>3:I8;^HK363C_5D_A489R5-),TQ"BY-
MV.I^']S<2>/;%61 OES9(Z_ZIO>N2T-2MO(IYQ(W2NL^'[D^.[,;"/W<W./^
MF35RVC,&AE9>1YAYK*FO]H^14W_L_P Q\7_(=O?^N,=:?CZ6:'PKX%>%MK"*
MXY(_Z:5EP_\ (<O_ /KC'6I\0%D?PGX%6-2Q\JX.!R?]96&+VA;^9G3AOXC_
M ,*_(P+6ZU"9,M-@@] H%6,WI'-PW\JALX;J.,AK=ADYJYMN,?ZAJ].FI<JO
M<\^HUS.UCI/!:3-;>+%EE9P=#G&"<@=*X&S^T(RP+<2!!T&>E>A>#?,2U\5M
M)&5 T2<Y/U%<+917$Q6XCBRA[],UYM./^T2^1VN7[E%I893]Z9R?<U)]G<_\
MM&/_  (U,L=QC_5?K3_)N/\ GGC_ (%7L1@SS')]RI]E]68_C2QVX29&ZX85
M:\FZQ_JP/QH6"Y#JS+@ YZ\T^7R%S/N7(?\ 57/T'\ZBE_X]9?\ @/\ .I8/
M]7<_[M12?\>DO_ ?YU<_A,8?$76_UT?_ %V3C\*E7[WI\LU0G_6Q_P#7:/\
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MP^)X_&$.HN^FO:,PM'1Y-V_CY<$9SNS7T];^=]DA^T8\[8/,V]-V.?UJQ10
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M\_UO_P!_5_QJA_PBOAO_ * MK_W[H_X17PW_ - 6U_[]T 7_ .TK#_G^M_\
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M#_A%?#?_ $!;7_OW1_PBOAO_ * MK_W[H O_ -I6'_/];_\ ?U?\:/[2L/\
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M / 9JH?:/WJMCC<K8^G%2+<'>>Y^?GZUY-8]F@:,7^OC_P!Y/_0:FA_U\?\
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M_P#A"_#O_/BW_?Y_\:/^$+\._P#/BW_?Y_\ &@#H/,3^^OYT>8G]]?SKG_\
MA"_#O_/BW_?Y_P#&E_X0OP[G_CQ;_O\ /_C0 WPDRC1[C+#_ (_)^_\ TT-=
M#YB?WU_.N%\-^%]#O-+FDN+0LRW4R ^8PX#D#O6U_P (7X=_Y\6_[_/_ (T
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MKX7L[>QO]>M[6/9$EX JEB<?NU/<^YH ZRBBB@ HHHH **** "BBB@ HHHH
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MT;^S_P")HIM+F\+_ &9A+;@W'G[@58$@ 8ZU\_6&BZKK\ZV>C:?/?3L>D29
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M44 %%%% !7.:'_R,/B/_ *^D_P#10KHZYS0_^1A\1_\ 7TG_ **% '1T444
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MC\:[VBB@ HHHH YS0O\ D9/$?_7Q'_Z!6Y)-%$R+)(J-(VU0S8W'T%8>A?\
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M?;4/_ 1_\* .CHKG/^$RTO\ Y]M0_P# 1_\ "C_A,M+_ .?;4/\ P$?_  H
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M9:7_ ,^VH?\ @(_^%'_"9:7_ ,^VH?\ @(_^% '1T5SG_"9:7_S[:A_X"/\
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M-\F'3QLM6M9&A>%>F RG./7-:7_"9:7_ ,^VH?\ @(_^%'_"9:7_ ,^VH?\
M@(_^% %*3P#X5F\'Q^$VTM1I<9#)&K$,KYSOW]=WOUJUX:\(:'X1M);71;5X
M_/?S)I9)#))*W3+,3D\4_P#X3+2_^?;4/_ 1_P#"C_A,M+_Y]M0_\!'_ ,*
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M(B=:<MV.HHHIF04444 %%%% !1110 4444 )1110 OI11Z44 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $Q2T44 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 )1110 VBBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
?**** "BBB@ HHHH **** "BBB@ HHHH ;1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>scwo_s1img10.jpg
<TEXT>
begin 644 scwo_s1img10.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" !B!#\# 2(  A$! Q$!_\0
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M** "BBB@ HHHH **** "BBB@!.U9U]J%CIEO]IU"XCMH2ZQAY&P"S$*H^I)
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M:E9ZI;R6MN2)I2VT1$=0V?NGZUYY\*]:TRW^#6C7NHV=Q NG1[8I)H.9&8D
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MSPVMN]Q<2".)!N9FZ 5@>!X)K7P-I<%Q"\,J1D,CKM(^8]1713?ZA_\ =--
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M3-3?5K.Q,=\\0ADG,SLTBCH&R3NQV)R:Z*BCFEW"R,*^\,Z-J3S&^M7E6?\
MUL?G2".7_>0-M/XBB;PSH\T:1?96@A2,0B.WF>%-@Z+M0@8K=HHYGW"Q2L-.
ML=+L(M/TVUBM+2%=L<,2A54>P%4K/P_I-CI]QI]G:""WN)GGE1'8;G<Y9LYS
MR:VZ*+L+',1^$M!CT0Z*NFQ#3FP?L[%F12#D$ GY2#SD8YJ_9Z+IMA=2W5K;
M$7$RJDDTCM)(RKG"[F).!D\=.:UZ,4<S?4+(6BBBD,*S?[*L?[3_ +4\C_3?
M+\KS=[?=Z[<9QBM*B@##N/#NC7&D3Z1<:;";"X9FEMU&U'+'+$@8SDDDU3D\
M'^'YYA-+IB-)]G^RLV]QOA_N-S\R^@.<5T^**?,UU%9',V?@OPS8RZ?+:Z6L
M;Z:K):-YCDVZGJJY/ ]J=_PAOAC^S;O3?[)B^QWDAEN(=S;97/4L,\FNDHHY
MI=PLNQ2AM;>WLULXX@($78J=0%Z8YK&7P7X:CLWL8],6.R<DM:)(ZP')R?W8
M.W'MC%=-123:V86,*Z\-Z'?/8O=:=$QL#NM0,J(#TRH&,5&OA'P^O]I[=-C_
M .)IDWGS-_I&1CY^>>./I70T4^9]PLCF9/!_AR2"QA_LM8QIRE+1XG9'@4\;
M58$,![9Q3[GPGH5VEJTVGJ9+1F>"8.PEB9OO$2 [N>_/-='11S2[A9&%-X7T
M6XAM8[BQ$RVMP+J(O(Y(E'1R<Y)^N:NWVG6NHQK#=(Q56W*4D9&4^H*D$5HT
M4786.=M?#.BV4UVT6FQL]\H2YDES*\Z@8 =FR2.3P>*;:>%-!L+BUN+;3%$E
MHICMBS,XMU/!$8)(08],5T=%%WW"R,"W\+Z/::K<ZI;V82]NE"33>8Y:51T#
M<\XR<>E3Z9H^FZ1I*Z3IMJ+>R0-MB!) W$D]3GJ36Q12;;ZA9',2>"?"LVC6
M.CRZ/$]A8-NMH2S8B//(YSGDU+IGA'P[H_VG^S-+2S:Z4)*\3L'91G W9R.I
MZ&NBHIWEW"R['.IX5\.K97UFNEQ"*_!6Z/)><=/G?.X_B:%\)Z")8)$T\02V
M\ MHY89'C<1#HA92"1[$FNBHHYGW"R.8O/!/A:_M+.UNM%@D@LE*V\8RHB!Z
MXP1UJN?A_P"#6T^;3SH<#6TTBRR1L6.]E^Z3SGC/%==2_C1S2[BY5V.4M? _
MA73YI)K/1HH99$,9<.^[:>2 <Y'0=*T+7P[I%CJ/]HPV>^]V>6+B:1I9%3.=
MH9R2!["MRDYI7D^H["T444#"H)HDGA:&0$HXP0"1Q]14]% &!I7AW1]'TY]/
MTO3X[6SD+,T"Y*$M][@^N3GUJC;^!O#-JMFEOI?EK8N7M0L\@^SDC!"?-\H(
M/08'M7644^:7<5D<Y)X1\.S1VB3:7&XLYS<P%F8F.4G)<'.<^]6;/1=-L=4O
M=4M;3RKR^*FXE#$F3:,#.3C\JVJ*5WW"R,&^\*Z+J?G?;K5YHYSF:$SR".3_
M 'D#;3^5/N/#^CW4MM-)8HDUJAC@EB)C>)",%59<$+[=*VZ*=WW"R,%/#.BQ
M:/)H\6G)'8N69XDRHD+?>+8.6)[YZTU?#.AQVUA;+IZB'3I5FM4WMB%E& 5Y
M[#MTKH**+ON%D<?+\.?!<]S/<2Z! TMPYDE;<X,C'J3SS5S_ (0_PWYGF1Z5
M' YA6V9H&:(O$HPJ-M(W #C!S72T4<TNX678Y>\\#^%-0ALX;K1;9H[%#';(
M@*"%3U"A2,9IMOX'\+V]JEM!H\,<27*W@ 9O]:HPK$YR2/>NI_&C\:.:7<7*
MNQS]WX2T#4"WVZQ^TQL_F-!+*[1,V<Y,9.WK[5HW>GVE]ILVGW,"R6L\9ADB
M/ 9",$<>U:%%%V.Q4M[:&UM8[6",)#$@1%'\*@8 JGI&CZ?H>GC3]+M4M+4.
MT@C0D@,S%F//J236O11=C,?3]%TO2[S4+NPLU@FU";S[IU))E?&-QS[#M6Q1
M12O< HHHH **** "BBB@ HHHH **** "BBB@#YKU[]IS^Q/$FI:.?"/G?8KF
M2W\S[7C=M8KG&WCI6?\ \-:#_H2__)W_ .PKP'Q]_P E*\2_]A*X_P#1C5S=
M?01PE%I>[^9YCKU+[GU%_P -:#_H2_\ R=_^PH_X:T'_ $)?_D[_ /85\NT5
M7U2C_+^8O;U.Y]1?\-:#_H2__)W_ .PH_P"&M!_T)?\ Y.__ &%?+M%'U2C_
M "_F'MZG<^HO^&M!_P!"7_Y._P#V%'_#6@_Z$O\ \G?_ +"OEVBCZI1_E_,/
M;U.Y]1?\-:#_ *$O_P G?_L*/^&M!_T)?_D[_P#85\NT4?5*/\OYA[>IW/J+
M_AK0?]"7_P"3O_V%'_#6@_Z$O_R=_P#L*^7:*/JE'^7\P]O4[GU%_P -:#_H
M2_\ R=_^PH_X:T'_ $)?_D[_ /85\NT4?5*/\OYA[>IW/J+_ (:T'_0E_P#D
M[_\ 84?\-:#_ *$O_P G?_L*^7:*/JE'^7\P]O4[GU%_PUH/^A+_ /)W_P"P
MH_X:T'_0E_\ D[_]A7R[12^J4?Y?S#V]3N?47_#6@_Z$O_R=_P#L*/\ AK0?
M]"7_ .3O_P!A7R[11]4H_P OYA[>IW/J+_AK0?\ 0E_^3O\ ]A1_PUH/^A+_
M /)W_P"PKY=HH^J4?Y?S#V]3N?47_#6@_P"A+_\ )W_["C_AK0?]"7_Y._\
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M_P"A+_\ )W_["C_AK0?]"7_Y._\ V%?+M%'U2C_+^8>WJ=SZB_X:T'_0E_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KU_]F_\
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>pwvi_s1img6.jpg
<TEXT>
begin 644 pwvi_s1img6.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" #, C<# 2(  A$! Q$!_\0
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M1<SK&T:?9T+E.2S8+;E;@'G:3F@#NJ*X'2_&%]_:\MCJ6GSR6\NKW&GP7J;
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M.+DL\[Q(&82#:-I8'((SZ5?N?%FH6=])/=Z:?MTMC;&&TCNBT)DFG:.,'*@
M]-S>G':@#HK7PO#;SZ=<S7UQ=7%A-),DDFQ=S.A0@A5 P >  *@M_!NG6=O9
MPVM[?0-:6<EE#+'(H=4=U<MG;][*CVQGBJ&L>*M<T>RMA>6.F+J;>:YA6YE9
M6C0 [EVQDC.<98 #UYK-;QYJEM=ZEK%Q9HVB1Z59WL$ ?]Z'F)"@_+W;@\G
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MSTO3-"_X2^R\,V-W;WT::L=+>26780R2#Y@H;=QZ  U]#?\ "3:/_P ]YO\
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M7_7C/_Z+-?G=I+JFF[G8*/,;DG ^\:^KX>^*9X&;_!$TN_2M+P[_ ,C=H_\
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MZG^SO_R.&M_]>Z?^A"EA%:O&YSYDT\/)H^GJ***^H/A@HHHH *KWG_'E<?\
M7-OY58JO>?\ 'E<?]<V_E0!C:+HVD2:!ITDFEVC,UM&2QA4DG:/:M#^Q-%_Z
M!%G_ -^%_P *-#_Y%W3?^O6/_P!!%:- &;_8NB_] FS_ ._"_P"%+_8FB_\
M0)L_^_"_X5B>-/$\GA'PM/KD6FMJ4D4D4:VR/M:0O(J8!P>?FX'>L&S^)%GJ
M.JI;Z?'']D=K/RYY';=*)UD8H$53AU\LC![Y'&*N,)2C=+0S=2,9<K>IW/\
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MK#_KUG_]"CH F_L31?\ H$6?_?A?\*/[$T7_ *!%G_WX7_"M&B@#._L31?\
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M'YT;T_O#\Z ,GQ+_ ,BQ??[@_F*V*QO$C*?#-]A@?D'?W%;- !1110 4444
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M!H?\(SH'_0)M_P#OFC_A&= _Z!-O_P!\UKT4 <EH^@Z)(FH&;38"$O)5!*]
M#TK47PWX>8972[9AZA<US'B.&XN/AMXSAM8Y)9G^U*B1 EF..@ YS7G6BR>(
M-$M-8NO#MC+!;RFQCFN;:PFMXH4^<2E8I0Y,@^7<X##!''% 'MW_  C.@?\
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M:/-\3_\ /GIW_?\ ?_XFMFB@#&\WQ/\ \^>G?]_W_P#B:/-\3_\ /GIW_?\
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M)K9HH YJXM-:U)!:W_V.VM'8&7R69W=0<[1D #..3SQ72T44 %%%% !1110
M4444 <]XA\-:-XJTEM)UZQ6]LV8.8F8CYAT.00:\VO/V:_A;>.K'3[R%%R5C
MBNV"@GOSFO:*3%:4ZU2FN6$FEZF4J4)/FDKL^=[_ /93\'S,3IFNZK9>BN4E
M _0&N8O/V4=9MY?.T/QM&'7[K36[1M^:DXKZPI/^!5U1Q^(2MSW]=3%X2BW?
ME/AS5OV6_B3O=O,TS5AD'<ER48X&!]X#M7.6OP;^*WA'5X]4M/!UY-+ & $;
MK.F""#PI]Z_0>DS6RS.I;EE%/Y">%CNI-?,_,S4?#?BBUU":ZU;PQJ5C(X52
M'MI% P,=Q1;ZS86>@SZ7>6+O-)/YJRL@8I\N,<\]:_3$JK#!7(K*OO#GA_4E
M/]HZ'87>>#YUNC_S%:O,HSARRAIY,Q^JR4N:,M?0_,6-=MIG;'-,J_=*+\Q^
MN*V/!Z6+:Y,VI22Z1MM9"DT<QC^?&-N>ASD\5][W_P &?A?J&[[1X+T]">\"
MF+_T BN0U#]F/X8WX;[/;ZE8,>GD79('X.#70\QHS@X236G9,B.&J0ES:/[_
M /ACXI:-X=1N(;>XN)$0J%D,^\O\H]0?I3U;4/-^6\?_ (%$K?RQ7U7=_LFZ
M.,_V5XNOH/19[=9!^8*URU]^RSXOA!.F^)-.NAV69'B/\C7H8;'X>--0Y]O5
M')6P]:4G+E6OHSP!;B^,@C5H7)[,K#_&K,,EQYQ\Q$( ()C8-@^E>H7/[//Q
M6T^99%T>UOD&>;:[3/Y,17(1_"7XC:'=S27?A74S&=VWR[9I"<GN5R*]&&.I
MN249II^:T.:6&DHOFC;Y/4Y::/S93(VTNH"[=V<?44W=&H"LV?11_A7MOA#]
MG'QEXBD:X\03#P]8.P;#J&N"HZ (#Q]6(^E?1G@OX*_#_P $B.:QT9;R_7_E
M]OOWTF?49X7\ *\W&YG2BVD[OR_S.O#82HTG+1'RAX,^#?C[QDJ3V>E_V9IS
M'_C\O@8U(]57[S?@*^BO!_[-_@S0O+NO$$DOB&]7!Q/\D"GV0=?Q)KV_:**^
M8K8J=5]D>W"/(K(K6=G:V%JEK96L5M;QC"Q1($51[ 5;HHKF+"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
3 "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>pwvi_s1img5.jpg
<TEXT>
begin 644 pwvi_s1img5.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" #' ;D# 2(  A$! Q$!_\0
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M;6;1PVZ^1Y*[49V)QU.6YSVKOM/MYH[BV0QL=C+D[?2NLHH'<6BBB@04444
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M')P1SQT[TV2\\7?O/+L8\CE,@#<,9YZX)],]>/>@#LJ*C3=Y:[L;L#./6I*
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M..,\^O'XTJF)IRV9I"A..YN6NCZ7-:0S2V:,[H&9CGDXJ?\ L'2?^?&/]?\
M&KENJPV\<.\-L4+GUJ?<O]X?G7EO<[T9G]@Z3_SXQ_K_ (T?V#I/_/C'^O\
MC6GN7^\/SHW+_>'YTAG)ZMX/TW5/)V[K41Y_U7\6<=<_2MW2]/CTO38;&)F=
M(EVAFZFK=.7I7+'#TXU74BO>>[-'6J2@J;?NK9#Z***ZC,2HIO\ 4O\ 0U+3
M)%W(R^HQ6=3X1K<\)TFQ;5-<1)%:2/F27N6 [?B<#\:W/&&AQV,QU)KS+7#
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M(]:%[.%^2*39$W4J6]I)M(DHHHI%!1110 4444 %%%% !1110 4444 %%%%
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MK!H>V45QW@>WUZUT IXB:\:]>[NI1]LDC>81-.[1AO*)0'85X7@=!C&*[&@
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MY)&2<8;C)/;L,=*ETGPU<6%Y:7$FIF7[.@0J$VA^'&3[_,/RYSQ@ ZJBBB@
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M^H;LQ']_VKX@^(F\?%'Q*)&#/_:$N2HP#\WIS7HY9_$?H<.8?#'U.;2IUZ5
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M2?$GBG3FO/B4?$4^GR&YMK)K5+;]X%(W< %L DX'\JZSXA1^9H=D!U^V(?\
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M6TC3[>=[I_[9MIIIY""\CM+EG..E<<XMW9Z%.<;I=;G2^+$WQZ/[7B&MZ/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
..HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>pwvi_s1img4.jpg
<TEXT>
begin 644 pwvi_s1img4.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" #U 5@# 2(  A$! Q$!_\0
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M\;W]C<+OAN;?0Y'CE7LRG/(-6_\ A<-O_P!$X\?_ /@@D_QJ;X%_\D \$_\
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M1DO#M/'X>-:I)IMO1>1]+_\ #1_@C_GQUW_P _\ LJ/^&C_!?_0/U[_P _\
MLJ^:**Y?[6J?RH^A_P!4Z7\S_ ^E?^&E/!/_ #X:Y_X _P#V5+_PTEX*_P"@
M?KO_ ( __95\TT4?VM4_E1G_ *JTOYG]Q]+_ /#27@O_ *!VN_\ @#_]E1_P
MTAX-_P"@?K?_ ( ?_95\T44?VM4_E17^J=/N_N/I?_AI+P3_ ,^&N?\ @#_]
ME1_PTEX+_P"@=KO_ ( __95\T44?VM4_E0_]4J?\S^X^PO"/Q:\"^+KE;&SN
MKBSO"?DM[^W:!I/]T_=8^P.?:O2X_P!R/:OSS5F1U=&*LIR&!P0:^B_A#\7+
MB]NK?PKXJN-\K?+9WSG!E/:-_5O1N_0\GGLPN81JRY)JS>Q\UFW#M3"4W6HR
M<HKXD]UYKR/I*BCM17L'PP4444 %%%% !534?^07=_\ 7%__ $$U;JIJ/_(+
MN_\ KB__ *": .#^!?\ R0#P3_V"XOY5Z/7G'P+_ .2 >"?^P7%_*O1Z "BB
MB@#R^X4:?\>]1A"[4UK08;D'^]);S,C?^.3)^5=17.^/%^P_$/X?ZUT22ZNM
M)D;VG@+K_P"/P+^==%6L=CCJJT@HHHJS$**\P^)E]>^&]:L=>TYBL^JZ==:!
M&,\&ZD*O:G'KO\S\ZQO#%JND^,+;P+)/)]C\!&]U+S)69@T,D2_9BQZG'G3_
M /?NE<OETN>T]3@4E?/>J^.?%.J>&]7LI=:DC@O_  W)J\%TUG!;LH66(;HE
M61G$3+(>9<-QGU%=/<>.O%L?C6^M;?RYM/TS5;32V5Q:Q1W2R+%NE9VD$BNW
MF$H$0J=H'.3@N'*SUVBN/^'>H^(-;\+C7M>U2"[-[++Y$$%J(5MT25XP,@DN
M2%!)/0]*["F2] HHHH$%%%% !1110 4444 %%%%!I#<^7OVA/^2K:5_V!1_Z
M/>O*J]5_:$_Y*MI7_8%'_H]Z\J-?%9C_ !I?(_H3@_\ W6'JRM<1K-<1#"NR
MJ3Y3,5#?0COVIL=XVUE *JL+-AOF((;&,]\>OI5B2&*90LB;@#D<#BD:WC8*
MK1H57H-HP/I7*JL.51DCZ^KA*WM93A)*_P".Q!]HF_?-N&(5C.S;\S[E!Z]O
M:B.ZNI(S-Y>%.\*C* %P#R#G)/'(Q3TMX5NFN/+!D;;M]L  ?RI^V/SV^5?-
M*DGCG!X.:TYZ?2)PJA6T<Y6U?7?71_<1+-=81FN(U;RQ+RO!S_#U]N3UJ$37
M4KB1Y$\OSQ&J '_OK.:MM'#(%5D5O0$ X^E/\M?^>8^]NZ=_\:GVL?Y2G0J/
M1S=O5Z^J*T%Q<1Z:)FD\YQ&S ,/^F@'//OFG37$T;"W6X$DC?=*K\^,9Z9Q^
M)/2IUAC&=JC#9S@#OU_/%1_9;?R_]2O!ST[T.K3;NT:_5*SC[L^B6[Z?J0V-
MU+=&.29<;H^0.A(<C.,^U6IF9+>9T8JRQL00<$'::='''&/W:A?H .,YQ^=1
MW'_'I/\ ]<G_ /031":G53BK*YX^/P\Z6%G&;YG9W??0^[/AS>7>I?##PO?W
MT[7%W<Z5:S32N<M([0J68^Y))HJ'X6?\DF\)?]@6S_\ 1*45]G'8_G[$?Q&=
MY1115&04444 %5-1_P"07=_]<7_]!-6ZJ:C_ ,@N[_ZXO_Z": .#^!?_ "0#
MP3_V"XOY5Z/7G'P+_P"2 >"?^P7%_*O1Z "BBB@#SOXQ+]G^'1UQ5S)H>H6>
MIK[".=-__CA>MYL;SM.1G@U+XQTD>(/ NO:'MW&_L)[<#W:,@?J17-^#-6.N
M^ /#VL-]^\T^"5_9]@W?^/ UI YJRV9NT445H<Q#<6MK=B(75K%<"&19H_-0
M-LD7[KC/1AV/44JVMJEW+>);1+<S*L<DP0;Y%7.U6/4@9. >F34M% &/;^%?
M"]G'-':>&]+MTG5TE6.SC42*_#JV!R#@9'0XJ1?#OAY;^TU!=!TY;RRC6*VN
M!:IYD"*,*J-C*@#@8Z=JU**!W(K>VM[2W6WM+>.WA3.V.)0JKDY. /<D_C4M
M%% @HHHH **** "BBL3Q1K__  CFB+>QV37]W/<16=I:*X0SSRL%12QX49Y)
M[ 'K0!MT5R \4:QH,5]=>/\ 3]/TS3;6%9QJNGSR36XW2!/*<,H</EEP0""#
MVQBJ<WQ*TV*^MHTMY+F&[U2UTV(10S+-#YT1DW31L@*GY>%'4$$XYI7*LSNZ
M*X^/XA^'K?2+2\U;484DN%GEVV,<UPJ112F-I6PF50$ %F  .<$XS5]O&OAL
M:PFE+?LUQ)-]F21;>0P-.4WB+SMNS>5Y"[LT7*@F?/\ ^T)_R5;2O^P*/_1[
MUY77=?%K6G\2>(_#/B"2V6V?4?#<=P85;<(RT[\ ]ZX7M7Q69?QI?(_HC@W_
M '6'JQ****\@_3RO=2"%XEDD*1N2&*]2-N<''.,XID:S2;I&DEXA;RVW%68!
MCC/KQVJTT:LZ.W)&2I]">/Y4M=D:RC%)(^>JX252M*I*6G1?(JM<7#707<Z;
M2GRL6Y!QDA<8QR>M-^T72P31K)(TN#DC<"HW#.01QQZ>G2KE%6L1%?9.=X*H
MVWSN[OT[D>GM(T+;VW*"-OWB.G.">?3Z<U)117+.?-+F/:PU#V-)1;O8=_#4
M-Q_QZ3_]<G_]!-3?PU#<?\>D_P#UR?\ ]!-:T?C7J>!FW^[U/1_D?<_PM_Y)
M/X3_ .P/9_\ HE**/A7_ ,DG\)?]@>S_ /1*45]M'8_FO$?Q&=W1116I@%>7
M?\)%XRL?B%I&D:E-IDRZQ-<XTJTC8W%E:QJQ2Y>7=A@2J*054;I  3@Y]1KS
M3PWX#U[P_P"+K_7Y?&1U!=1N&GNXYM-C$LJX(2+SL[E1.-JC@8/J30!D7'Q$
M\66?AKQUJ6I:/9Z=>:'<P16]N9?.$44D<3;Y"I'F.!(6V)UP%!).3M>"?%%]
MXJ\,^()+ZXM[M;"ZFLX;V&!K;[4HB5MS0N2T9!8K@]=NX<$59U3X?VNI#7V_
MM2>WN-5OK7489412;2>W6,1, <AQNB4D-UR126W@6WM++7+[7IHO$&J:DQN)
M[B>U1$4K$(T5(QG: JCN2><GI@ A^!A'_"@?!(SS_9<7\J]%W#U%>4?!;1])
MN_@CX%U"ZTVVFO(]+@V3O$"Z[>F#UXKT!- T..YFN8])M$GG#++((5#.&^\"
M<<Y[T :^Y<?>%&Y?[PK$7PWX?CM)+2/1+);>5E9XA H5B.A(QSBDD\-^'YK:
M&VET2R>"#=Y4;0*53)R<#'&30!N;AG&1FO)?ALJVGAG4-!&!_8>L7VGJ,]$$
M[/'_ ..2+7H+:%HJZ@FH-I5H;Q=NV<Q+O7:,#!QG@5YKHNCZ1I_Q9\?:6NEV
MJ+>)9ZDH\L?-'+&8I%^A>#)'J:N.YC57NG>?B*/Q%9H\/Z$+1K0:/9BW9Q(8
MO)7:6 P&QCKBB30-"FCACFT>SD2!=D2M"I$:YS@<<#/-:G&:5'XBJ7]D:5_:
M/]I?V;;?;<[OM'E#S,XQG=UZ<5%'H&APQS1Q:/9QI.NV55A4"09S@\<C/- &
ME^(H_P"!5FGP_H1M%M#H]F;=7,@B\E=H8C!;&.N*630M$F,!ETBSD-NH2(M"
MI\M0<@#T H T?^!4?B*HC1])6_>_&F6HNWR6G$0WMD8.3UY%1Q^']"AMYK>+
M1[-(9\"2-85"O@Y&1CG!H TOQ%'_  *LUM T)[2.T?1[-K>-BZ1&%=JD]2!C
M@FG/HFC27$-Q)I-HTT(58W,*ED"_= /;':@#0H_$5031='CNI;J/2K59Y@PD
MD$2AG#?>R>^>],3P_H4=K):QZ/9K;RE6DB$*A7(Z$C'.* -+\16'XJT%O$6A
M+9V]]]@OK>YAO;.ZV>8(9XG#(Q7(W+U!&1D$U:D\/Z%+;Q6\FC63PPY\N-H5
M*IGDX&.,UD>)YM)\.P6FMCPRFJ:A+>6]E;K J++YCL$C(9N !QSV J1HR=5\
M*>,/$UE>1>(/$&G0+(MND%EI\4GV=3'<1S/+(7.YG(CVJ. H)ZYJ35O ^HW7
MB:]\06.J6J32ZU8ZM%%.C%0((#"T;$'.6#$@CIQFJ%KXDTJ35I=$TWP")/$\
MDEQ;WFGK)"BHB+&[NTQ^5D<31;>,DMR!@UFQ^,?"SVMQ-8^&7O;&<:<(]+%O
M!'MN)YIH.2?XE>,JV3@ ?+U-&AIJ:>F^ ?$GAR.WF\/:YIJWK6,^GW$EY;NZ
M!'NI)XY8P#RR^:P*M\K<<C%5Y_AMKUUXIM-4O?$%M>K9ZO'J4<\_G><8U&/(
M$880Q@9/S*N3QG')J-=>AU3Q7X;T'_A";.W1+Z]TW4+>X,4AM3#"LH\I@,%2
M) _ !/3 -=]J4/AS28KKQ-JEO9VJV4;7$]\\8W1JJ\MNZ]./TH%=H^3OBE#I
M^@^,O#GA%M6AO+S1O#T5C<-'D!9!([@$'H2I!QZ&N.\R+_GHOYU[SH_PS\.^
M(/&%OX\\2^'[.UO-9::>+19DPD4 C580T>,-*%^=R>A?':N[_P"%<_#U?^9)
MT3_P!C_PKR\1E3Q-1U.:U_(_2<CXAE@,/&BXWLV[WMN?)?F1_P#/1?SH\R/_
M )Z+^=?6W_"NOA[_ -"3HW_@#'_A3?\ A7?P_P#^A)T3_P  8_\ "N;^Q7_-
M^!]+_KL_Y?Q/DOS(_P#GHOYT>9'_ ,]%_.OK7_A7?P__ .A+T7_P!C_PH_X5
MW\/_ /H2]%_\ 8_\*/[%?\WX!_KGY?B?)7F1_P#/1?SH\R/_ )Z+^=?6O_"N
M_ '_ $)6C?\ @#'_ (4[_A7?P_\ ^A*T7_P!C_PH_L5_S?@/_77^[^)\D>9'
M_P ]%_.CS(_^>B_G7UK_ ,*\^'W_ $)6B?\ @#'_ (4?\*\^'W_0E:)_X Q_
MX4?V*_YOP%_KL_Y?Q/DOS(_^>B_G45Q)']DG_>+_ *I^_P#LFOKK_A7/P_\
M^A(T3_P!C_PK+\0?#WP'#X3UF:'P;HL<L=A<.CK9("K")B"#CJ#5QRAQ:ES;
M>1YN*XJ]M3E3M:Z:W[GI'PO_ .23>#O^P+9_^B4HJ;X7G/P<\%D\G^Q+/_T0
ME%>H?FDI<SN=C16'KFJ7^G62-IFBW&L7DK;(X(G6-0<9R[L<(OOR?0&N<C\0
M?$2QD6;6/ MG-9?Q?V3JOGSQCU\N2.,/]%;/H#00=_14:MN4-@C(S@C!J2@
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M6D0FW1VD2X(E.=T6%7..W.><^E:==AL%%%%, HHHH **** "BBB@ K*\2_\
M(G:[_P!@ZY_]%-6K65XE_P"1.UW_ +!US_Z*:D]BCI_A;_R1SP5_V!+/_P!$
M)11\+?\ DCG@K_L"6?\ Z(2BO&+-'Q=*UOX(UZ:.:X@>/3[AEEM>9D(C8[D_
MVAU'OBO-/AGH"VNH:;JC>!].TN62SRVHV_B*2_9BRC.$88;=ZY./>N_\<#6/
M^$)U3^P;S2[*X6WD9YM6C:2W6/8=Q8 CMSDY'!R#7DGPQN]#NOB!IL>G-X;M
M9XK>?=%H_A2YL'GPBA@9IAA0NY3A<$[E[&@#Z'HHHH *J:C_ ,@N[_ZXO_Z"
M:MU4U'_D%W?_ %Q?_P!!- '!_ O_ )(!X)_[!<7\J]'KSCX%_P#) /!/_8+B
M_E7H] !1110 5P7Q=L9+_P"$'B581F>UM3?0XZ^9 1,N/QC%=[56\MX;ZPN+
M*==T-Q&T3CU5A@_H: .<M;N+4+&WU"$YBNHDG0_[+*&'Z&I:X_X87$DWPLT"
M&<DSV,!T^;/7? [0G_T7785T'G-6=@HHHH$%%%% !1110 4444 %%%% !111
M0 52U?5M-T'1;O6M8NEM+"SC,LTK?PCT [DG  ')) %7&955G=E1%!9F8X"@
M=23V%>86\S?$;7K?Q!,I_P"$1TN;?I$#C U*=>/MC@_\LUY$0/7E_P"[51BY
M.R+C'F9:\.6>I:IK%SXY\1VK6FHWL(M["P?EM-L\[A&W_35SAY,=]J_PUU=%
M%=T8J*LCJV*-Q]M_MO3O)+?8]DWV@#&,X79GOUW=*O5F7<<;>(](E:X1'C2Y
M"Q$'=)E4R1VXQSGUK3J@"BBB@ HHHH **** "BBB@ K*\2_\B=KO_8.N?_13
M5JUE>)?^1.UW_L'7/_HIJ3V&=/\ "W_DCG@K_L"6?_HA**/A;_R1SP5_V!+/
M_P!$)17C&A8\62A?#EU;2:'?:O87<;VUW'8[3,D3J5+*A(+=>B\]P#7FVCSZ
M>OC"VU31F\8Z]=Q#S/L%SI+6D9NC L#7$LTL<87,:@%0<9RP4GBO8=5U*WT?
M1;[5[K=]GLH'N)=@RVQ%+' [G KBO#_Q!O-6UVUTG5O#,FDS74\]LC"[2<)+
M'$DP5MH'6-\Y&0"I&>02 >AKNV@L,''(SG%/HHH *J:C_P @N[_ZXO\ ^@FK
M=5-1_P"07=_]<7_]!- '!_ O_D@'@G_L%Q?RKT>O./@7_P D \$_]@N+^5>C
MT %%%% !1110!Y1X+7[!K7CC03Q]BUZ6X0>D=S&EP,>VYW_*NOKEV1=.^/&L
MPC(76M$MKP>AD@E>)O\ QV6.NHK:.QPU%:3"BBBJ,PHHHH **** "BBB@ HH
MHH ***X;QCK^H7.IIX%\*W)@UFZB$M]?H,_V3:'CS/3SGY$:_5CPO)OHBDKN
MQG>(;M_'VN7/A&PD9?#&GR>7KEW&V/MLHY^PQL/X1P92/9.[8ZU$2.-(XXUC
MC10JH@PJ@<  =@!5/2-)T_0=%M='TFW%O96B;(TSD^I+'JS$Y))Y))-7J[H0
MY4=25E8****T&9EV;?\ X232!(LAN#'<^45(V@;4W;AU/;&/>M.LV[D*^(M)
MC^SHX=+@^:5):/"KP#VSGGUQ6E0 4444 %%%% !1110 4444 %97B7_D3M=_
M[!US_P"BFK5K*\2_\B=KO_8.N?\ T4U)[#.G^%O_ "1SP5_V!+/_ -$)11\+
M?^2.>"O^P)9_^B$HKQC0U?$1G'A75S;R01W'V.;RWN IB5MAP7W?+MSUSQCK
M7C7PCG\-IXJBBTWPCH6FZG+:L9KBQ\20:B4.%W".(.6125'W0!@ 'H*]GUBZ
MCLM%U&]FFBACM[:25I9D+QH%4DEE') QR!R17D/A?4IM4^*VE?VK+96L]C!*
MD?\ 9NARV:2S20+*UM+))(Q#I$RR&/ YQSE<4 >\4444 9VI:E8Z1IEQJ6HW
M"6UI;H9)97Z*!_GI6+HOB2P\7>!U\1:6D\=G>0RF);B/9)A2R\KVY4\=:ZH@
M$<\_6O.O"OA/[#\+[;2?$VFVTUY:"[?8X64)OED<$'W5A0 GP+_Y(!X)_P"P
M7%_*O1Z\G^"^CZ3=?!+P+J%UIMO-=QZ7!LG>,%UQR,'KQ7H":!HD=S-<1Z3:
M)/.K+)((5#.&^\"<<Y[T ;&:*PU\-Z#':26D>BV:V\K*SQ"%=K$="1CG%))X
M;T&:VAMI=%LGA@W>5&T*E4R<G QQDT ;M%8S:'HO]H)?MI=J;M-NV<Q+O7:,
M#!Z\"F1>']!A:9H='M(S<(T<I6%1YBGD@\<@T <AXX06/Q+\ ZT?E2:6\T>1
MO7SH?,0'_@5N/SKHZXOXQ:5X=T7X<0ZI_9]K;6VF:SI]\T:0@+(?M"1L" .Z
M.PKI)_#^A2B**71[.1+<%(@T*D(N<X'H,\UK#8Y:RUN:%%4O['TK^T?[2_LV
MV^VYW?:/+&_.,9SUZ<5%'H&APQS1Q:/9QI.NV55A4"09S@^O/-68&E16:?#^
MAFT6S.CV9MU<R"+R5VAB,;L>N*630M$F,!FTFTD-NH2+="I\M0<@#T H$:-%
M41H^DK?O?C3+87;Y+3^4-[9&#D^XJ./P_H4-O-;Q:/9I#-@21K"H5\'(R.^#
M0!I45FMH&AO:1VCZ/9M;QL62(PKM4GJ0/4TY]#T:2>&XDTJT::$*L;F($H%^
MZ >V.U &A15!-$T=+J6YCTJU6XF#+)(L0W.&^\">^>]>?:W<VNK7M]X)\!Z=
M8P['5=7U?[.KP:>1TC1>DMS@\#I'G+<\4*[T125W9&WXF\77JZL_A+P;'#>>
M(MH:YN)ANMM)C;I)-C[SG^&(<MU.%YIWA[P]:>';"6&&>:\N[J4W%[?W+;I[
MR8C!D<_0 !1PH  XJEX,\/:/X7T>\T?1&9K:*]<L7):0N43.]CR[=RWOQTKI
M:[*=/EU>YTQBHA1116Q04444 4+D7G]MZ:87(M0D_GKN W'"[..IP<].E7ZS
M+N.%O$FDRM<!)4CN0D14DR JF2#T&,#ZYK3H **** "BBB@ HHHH **** "L
MKQ+_ ,B=KO\ V#KG_P!%-6K65XE_Y$[7?^P=<_\ HIJ3V&=/\+?^2.>"O^P)
M9_\ HA**/A;_ ,D<\%?]@2S_ /1"45XQH:?BATC\':U))8_VDBV,[-9\_P"D
M#RS^[XY^;I^->+?#>XM7^(&D?8+.TN=./VM+>>.>YFEDE$4;7-]ND8AHVD/V
M=68;L* #C(KVSQ!<7D/AC59M-N(;:\CLY7@FG8+''($)5F)X"@X))XQ7E'PY
M_P"$LF\6Q1_9?%EMIL$MPUS+KTF])H7BC,:J22'<3!R&3Y0NX=& H ]RHHHH
M *J:C_R"[O\ ZXO_ .@FK=5-1_Y!=W_UQ?\ ]!- '!_ O_D@'@G_ +!<7\J]
M'KSCX%_\D \$_P#8+B_E7H] &7INK:=JHNO[.NDN!:7#VDVW/[N5#AD.>XK4
MKY_^PWUKJ<S>(++6H?"\GB35YKU;..<&1F"?9G80_O#$?WF".-VS-96J0^,I
M-9^6?Q%IY-K8C0?M5K=75T@ ^?<8I%A\W=GS!-_"1DXS0!]*T4=N:* .#^*6
ME6VO?#/5-#N87E_M +;Q!&QME9@(V]P'VG'?%1>$]5&N>!]!UD')O;""9O\
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M444 %%%% !65XE_Y$[7?^P=<_P#HIJU:RO$O_(G:[_V#KG_T4U)[#.G^%O\
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MD8K&L84AB"A!.X#H1FK3> /#_P!EMXX9-2M;B$S$WUO?/'=3>:09?,D'+[R
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M!  FX$=\\?3'O6G6?<O<+K^FQI"&@:.<R2>7DH0$VC=_#G)^N/:M"@ HHHH
M**** "BBB@ HHHH *RO$O_(G:[_V#KG_ -%-6K65XE_Y$[7?^P=<_P#HIJ3V
M&=/\+?\ DCG@K_L"6?\ Z(2BCX6_\D<\%?\ 8$L__1"45XQH=C1110 4444
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M 3%ND5-Y7]ZF..^3@?C7HT:?)%WW(;N:[8WMC@9I*<^?,;/!R:;702%%%%,
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M._Z"5I_X$)_C1_:&G?\ 02M/_ A/\:M_\*4^$?\ T3G0/_ )/\*/^%*?"/\
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M'PQ^"=KJ]CI$_@GPW'?WX=K>W-I'OE"#+D#'0#J?>M'_ (4I\(_^B<Z!_P"
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M_P#@0G^-']HZ;_T$K/\ \"$_QJW_ ,*4^$?_ $3G0/\ P"3_  H_X4I\(_\
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,0 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>scwo_ex232img3.jpg
<TEXT>
begin 644 scwo_ex232img3.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" !R PP# 2(  A$! Q$!_\0
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MH'C?2-36[9=#0)!J4#'Y%$TACCF]MK[<^S'TJ8KFT0V['HM%>;:/KVJ2>/\
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MC+TSPX# YW ]Z[BBJYI=Q<J['-MX5AFFTR:\U*_NY],G-Q;RRRJ2',;1\X4
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M%TP.&4LWL<G(-=A11S2[BY4<RWA6W;4X=574K]-12$VTETDJAYHBVX(XV[<
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M:4^*'_/]8_\ @&E'_#2GQ0_Y_K'_ , TKQRBCV%+^5![2?<]C_X:4^*'_/\
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M_P"?ZQ_\ TKQRBCV%+^5![2?<]C_ .&E/BA_S_6/_@&E'_#2GQ0_Y_K'_P
MTKQRBCV%+^5![2?<]C_X:4^*'_/]8_\ @&E'_#2GQ0_Y_K'_ , TKQRBCV%+
M^5![2?<]C_X:4^*'_/\ 6/\ X!I1_P -*?%#_G^L?_ -*\<HH]A2_E0>TGW/
M8_\ AI3XH?\ /]8_^ :4?\-*?%#_ )_K'_P#2O'**/84OY4'M)]SV/\ X:4^
M*'_/]8_^ :4?\-*?%#_G^L?_  #2O'**7L*7\J#VD^Y['_PTI\4/^?ZQ_P#
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M (!I1_PTI\4/^?ZQ_P# -*\<HH]A2_E0>TGW/8_^&E/BA_S_ %C_ . :4?\
M#2GQ0_Y_K'_P#2O'**/84OY4'M)]SV/_ (:4^*'_ #_6/_@&E'_#2GQ0_P"?
MZQ_\ TKQRBCV%+^5![2?<]C_ .&E/BA_S_6/_@&E'_#2GQ0_Y_K'_P  TKQR
MBCV%+^5![2?<]C_X:4^*'_/]8_\ @&E'_#2GQ0_Y_K'_ , TKQRBCV%+^5![
M2?<]C_X:4^*'_/\ 6/\ X!I1_P -*?%#_G^L?_ -*\<HH]A2_E0>TGW/8_\
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M=[GS>JE&'&#@!<$=:YR>RT_P_P##WP?JFCVMKJ=UK&IW45Y-/")O,$<BHEN
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MC+F(:L%%%%6(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHI ?HO\,_\ DD_A
M3_L&6_\ Z+%==7(_#/\ Y)/X4_[!EO\ ^BQ775\M+XF>Q'X4+7Q;^U%_R5>S
M_P"P9%_Z')7VE7Q;^U%_R5>S_P"P9%_Z')73@OXIEB/A/"Z***^A/,"BBB@
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M113M;804444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\ Y/\*/^%5_$C_H1]:_\ Y/\*_1*BC^T)]D'U6/<_.W_ (57\2/^A'UK_P
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M\ Y/\*_1*BC^T)]D'U6/<_.W_A5?Q(_Z$?6O_ .3_"C_ (57\2/^A'UK_P
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
..*** "BBB@ HHHI@?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>scwo_ex232img2.jpg
<TEXT>
begin 644 scwo_ex232img2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" !K 0L# 2(  A$! Q$!_\0
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MHEKJEMPDZY*GJC="OX&N1'0:4G^I?_=/\JI:/_R K'_K@G\JNR?ZE_\ =/\
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..%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>scwo_ex232img1.jpg
<TEXT>
begin 644 scwo_ex232img1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1"  Y 5 # 2(  A$! Q$!_\0
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M+!'&(HP@!V*!@#YLYX]<U5T'1+3PYX?M]%M999+:U!56G?<VTDG&<  #/ '
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M=W)PH &?>HNAHN44HZ44#&\YI:6B@!**6B@!**6B@!**6B@!,44M% "44M%
M"44M% "44M% "44M% "44M% "44M% "44M% "44M% "44M% #?FI:6B@!,>U
M%+10 F*KW-O'=VDUI-N\N9&C;:<'!&#@CIUJS10!5L;2'3]/MK"W4K#;1K#&
?#R0JC _059I:* &]:6EHH C'RMU_.G9&ZG45('__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>scwo_s1img7.jpg
<TEXT>
begin 644 scwo_s1img7.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1"  F /(# 2(  A$! Q$!_\0
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M9=3D,A+!96.V%!GH%W$J.PCK[.\?>++/P+\/M9\67FTII]NTB(3CS9#Q&G_
MG*C\: -_[=9&X^SB\A\[.WR_,&[/ICK5ROR4AU;Q-;Z]%\1%,_VO^TS<+J!4
M[6NPPE(STSR"1Z&OU'\&>*+'QIX'T?Q3I^/L^I6RS;<Y\MNCH?=6#*?<4 :K
M:IIJDH^H6RL#@@S*"#^=._M;2_\ H)6O_?Y?\:^0?$G['_B37/%NLZW%XRTZ
M&/4+V:Z6-K>0E \A8 \]LU\^_$[X8WWPS\?0>$;[5+>_GF@BG\^%&50'8J!@
M\\;:8C]0/[6TO_H)6O\ W^7_ !I[7EHML+AKJ(0MTD+C:?QZ5\5_\,3^)_\
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M# ?\L9< $_1U4#_?->._#'XJ?&S0O#.A>'?#.@RW'AV*8I'.ND/,"K3$N?,
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MI/<>'I>/TKR#P_K'B[X9_%?1?&VM:-?:;=&Z-W)%<6K6WVF)F*S!5( P07'
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7+JK8R0&(!(R3@D#Z5NT44%!1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>scwo_s1img8.jpg
<TEXT>
begin 644 scwo_s1img8.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1"  O < # 2(  A$! Q$!_\0
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MKU"VW-;2?-M7=_SQ;_>^7_:HM?81W-%-5MRTZD,**** "BBB@ HHHH ****
M"BBF[MJT .HHHH **** "BBB@ HHHH **** "BBB@ HIOS;OO4Z@ HHQBB@
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M>'M>\7ZGI>O7C"QT^Q:UC1H9&C:YE7YFW!=NY5V_]]5K_#;QMHNJ>!](CO\
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@V]WK=AJC2SQR66]56.0JCJR]&7^*M=6IRM1N^:@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>scwo_s1img9.jpg
<TEXT>
begin 644 scwo_s1img9.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" ![ 74# 2(  A$! Q$!_\0
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M%8^A_>U3_K_D_D* -BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7]1T34&:YNA$+A+[[0T@NHRQ 8KN95/;C'TKNDL;..ZFNH[:))Y@%DD5 &D
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %8^A_>U3_K_D_D*V*SK>..&*[\I0FZ65VQW;UH T:***
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
2**** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>scwo_s1img12.jpg
<TEXT>
begin 644 scwo_s1img12.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" $K I8# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#Z^HHI0,D
M<F@!*D6%FZ\#]:ECC"\GDU)0!&L*#W^M/VJ.@%+10 F%HPM+10 F%HPM+10
MF%HPM+10 F%HPM+10 F%HPM+10 F%HPM+10 F%HPM+10 F%HPM+10 F%HPM+
M10 F%HPM+10 F%HPM+10 F%HPM+10 F%HPM+10 F%HPM+10 F%HPM+10 F%H
MPM+10 F%HPM+10 F%HPM+10 F%HPM+10 F%HPM+10 F%HPM+10 F%HPM+10
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]!10 Y?NBEI%^Z*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1*6\QHX'/(#>6N6!.220!6)F=!JOP3\-ZI=3W5QJE^)6U&?483+';3);//\
MZY%26)E*L=I^8,00,$<TS5/A?X/T^ZM!/XHO=$LM0N;&(V$<UO#!?W5O@P\&
M/[Y$8RL>T-MZ<5MZ]I>L>.OAYH\EGK#Z/=W'V.]E2RDAEA;$D4C .T;[@N"5
M*X#'&<@XK(^)W@6Z\9Z'X2T&X:[U.VM]726^NRT<<R1BWF43?*$ 8.Z'Y0,'
M''% &SXA\(Z'XO\ $37UCXBN]*UW2XS97%QI<L32")\2>3,DB.I'W7 9<C.0
M>:YR?X ^#98K6W6\U.**&".!\F"5IMD[3ABSQ,48R.Q)C*9SC&!7)Z;J7CCX
M9Q^)-4\6S:2=5U35K>WM)[M]JZLL=ND0D&& B)VY9GP$YX.17T>IRH/\J //
M-!^&^E>'?&E_XNCO[RYO[V-X6\U(44(SASGRXT,AR, R%B!P.M>BT44 (U%#
M44 (OW:7M0OW17*>)+ZX^WVVE6\GEF?&<<9R=H%.*N[$MV1U.]<?>'YT;T_O
MC\Z\PUK5O!?AN^&GZ]XRM;&\VA_)D^\ >Y&3CI6=_P )I\,?^B@6GY&FW3_F
M*4:CU43V#>O]\?G2;U_OC\Z\@_X33X8_]% L_P C2?\ ":_#'_HH%E^1I7I_
MS#Y*O\I[!YD?]X?G1N7^^/SKR#_A-/AC_P!% L_R-:&BZMX*\17YT_1?&%I?
M7FTLL,> S =P">:$Z;^T)QJ+7E/4NU+VKDO#M]<#4+G2[A]_DYP<YVX;'Y<U
MUG:B2Y782=Q:***0PHHHH **** "BBB@ HHHH **** "BBB@ HHKSSXJ:IKF
MF_#74H/#=G<7NMZEMTZR2W7++),=F_/1=H+-EB -O)H ]"!!&1R/6@XQS^M?
M-/A'_A-_#=A;_#G2]/UOPK:QZ]%]GFEAANY(M.GAE=EWXDCRLT;<\D;ESUYR
M]8U#XFZEX#BCUZ^U;4!>6-K>R*-*3?:SPZI"F46.,$L8\N5.[....* /JGY0
M<=,]J=7S-+XH^(TD\E]H<-WXECL&U3^Q]0O](6*>X LXF7CRT(Q*9%!4+YFW
M!SBKOAGQ'\4M>.F6/_"07D-E>ZM';R7Z6*O<PQ_9)Y)5;S+6)%'F+%@[#M)*
MDG@4 ?15&<UX%\/-1\8W7Q/T:Y\6:IJX:\T*:'RGLQ';SRPWDJ?-B/",8PC]
M5SNXX(%>M^)M4NM-A@:T95+L0VX9S3C!S:BC.<U"+E(Z*BL/33JE[I\-TVH!
M#(N=OD@@?K5W[+J7_04'_@./\:37*VBHRYDFC1HK/^RZG_T%!_X#C_&C[+J?
M_05'_@./\:"C0HK/^RZG_P!!4?\ @./\:/LNI_\ 05'_ (#C_&@#C?%G_(8E
M_P!U?Y"N#ON]=OXD6:/49%FF\Y]H^8*%[>QKB+[H:]:C\*//J[G,7W1JYB^Z
M&NGONC5S%]WKTZ:1Y\V<W<75U:.9+6YE@<?Q1.5(_(BO3/@/X@U[4/B1>6.H
M:U?7EK_9TDGDSW#2(&$D8!P2>>3_ )->6ZAT->@_L\L%^*EX20!_9DO/_;6*
MLL5"/L9.Q%"4O:K4^M:*9YD?_/1?SH\R/_GHOYU\V?1CZ*9YD?\ ST7\Z/,C
M_P">B_G0!RWCR\N+/X>>(KRSF>"XATZ>2*5"0R,(V((]P17QM#X@UZ^0+?:Y
M?W2GM-<N^?P)-?8OQ&=#\+O%(WJ?^)9<]_\ IFU?$^G=%KVLNBG&3:/&QDFI
MJQUU@2Q!8Y/J:ZO3^U<GI_45UFG]J[ZB1SP;.KT_M76:?U6N4T_M75Z?U6O.
MJ'=3.ZTY=2-C']GEMUBYP'1BW7ZBKNW6O^>UE_W[;_XJJ%C#(]C&RZE+"/[B
MA,#\P3[U=^RS?]!N?\H__B:\B6YZ,=A=NM?\][+_ +]M_P#%4;=:_P">]E_W
M[;_XJD^RS?\ 0;G_ "C_ /B:/LLW_0;G_*/_ .)I%"[=:_Y[V7_?MO\ XJHS
M#J\@*O=6\2_WHHF+?JV/YT_[+-_T&Y_RC_\ B:/LLW_0;G_*/_XF@!W^CZ;8
M\G9#$N<GJ?\ $FH]-CD6T+S+M>:1IF4_P[CD#Z@8JI>?8]/M9=2O)YKO[.-X
MWL&QCT48&?UK+LO'6FWM]#9K',))F"J2G )_&N2IB:5.2A*5FS:%&I.+E%72
M.THH[45UF(4444 %%%% #:IWEE:ZA:26M[;1W,$@PT<JAE8>X-7#6#K'B+3]
M&7==3?O#]V-.6;\*QJ5H48\\W8NG"4Y<L%=GF/B+X'V5W>"X\.ZA]AC=OG@F
M4NJ#_9/7CT/YBNR\(_#GP[X519X+?[7J'\5W.H+#_='11]/S-<Y?>,M<U&Y<
MZ;NM88U+[44,<#N21^G\ZU]#\>1L5M]8Q&__ #U7[I^H[5YL,ZHU)>S<FEWZ
M,]&6"KQI\WX=3T?M15>&:*XC$D,BNC<AE.0:LUZT9*2NCS&K:,****H04444
M %%%% !1110 C44-10 B_=K@_$DNWQYI*>OE?^C#7>+TKS3Q9)Y?Q*T-/7R/
M_1I%7#61GT1\Q?&1K7_A?/B$WXD:#S8]PC^]_J4 _I7GMK:B\N6C1]B#YLGK
MCZ5W7QO_ .2X>)?^NL?_ *)2O/X3()E$+%7)V@@X]J\2JO>9]1A[>SC=!<0F
MWN'A9MQ7N._>HZGO+>:TO9;>X8-*I^8JVX'/-;/ATZ&$N?[5\OS.-OF<\>WO
M7.Y.*ON=L8*4N78PX4C<MYDOE@+D'&<FN\^"_P#R6KPS_P!?#?\ HMJX*;R_
M/D\G(BW'9GKCM7>_!?\ Y+5X8_Z^&_\ 1;5O2UDCBQ"M3D?6_AN;=X\U1/3S
MO_1@KO>QKS+PE-N^)FLQ^GG_ /HT5Z;ZU[=31H^7AU'4445)H%%%% !1110
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M-/!?C;Q==>*+7XD6&FO>JC2PRA9!N"A<CYU(X X(XYKF/^%$>%_^BO:5_P"
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MSN_V/:O3H?\ D.7O_7*+_P!GHA_Y#E[_ -<HO_9Z?M)]Q>QAV///^%'>$O\
MG\U3_O\ )_\ $4@^!WA$$?Z9JA^LR?\ Q%>J44O:2[C]E'L<_H/AW2?#>GBQ
MTFS6WCSEL$LSGU+'D_TK?I**AMMW;-$DM$.HHHH&%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!G3?\
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M+CG'7KF@#L**Y[3_ !%9ZCJLFG1P2QRKYF&8H0VQMK?=8D<^N,UT- !1110
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M#CV]:\=TOX?^.?$&F6^M3^*WA:]7SE62>1FVGD9QQT[=O:M#_A4'C3_H</\
MR-+6[I06CD<_M9O:)ZE_PC.C_(HM^(Y(Y8QN^X4 48_ <^M(/#.DJI7$S(!M
MC1I681KN#84$X R!^'%>)^*? ?BSPKX6OM>NO%3SPV:AFCBFEW-E@O<^]+X7
M\ ^+/%'ABQUZU\5/;Q7B;UCEFE++R1S@^U/V,.7FY] ]O._+RGM \+Z,A7R8
MI(=OW?+D*[3ES^GF-^GI0GA?38X+>%;F[46V?*(FY0$ $#VX%>8_\*?\:_\
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MDB]*D'05&O2I%KAF=],D7I4J]*C6I!7%,]"F2+VJ05&O:I!7#,[Z9ZW\#?\
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MMG_"7J<Z_C?(ZVBBBL3H"BBB@ HIA95 W''UIV1ZT"N+1110,**** "BBB@
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MABNVVU+_ 'H_Y&N\NO\ CSF_W#_*N+^'J;+>_P"WS)_6M8_PY&,OC1RFG_\
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M'^U1_:'^U6OL8]C/VOF=I_;U]_S_ $__ '\/^-']O7W_ #_3_P#?P_XUQ?\
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MPSS)_P!#8/\ P!_^V4H_9]D_Z&I?_ '_ .V5[1]JU;_H$Q_^!(_^)H^U:O\
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M& 3TP/8 4R3]YKT 7_EA"[,?3<0 /T/Y4N>0^5&3_P (HW_/]_Y#_P#KTO\
MPB?_ $_?^0__ *]=111SR#E1@6?AV"TF6>24S2*<KD;0#^M;])2TFV]QI6"J
M=Y90W]N89U)7J"."IJY12V&<N?"?/RWN!Z&//]:3_A%&_P"?[_R'_P#7KJ:*
MKGD1R(Y?_A$_^G[_ ,A__7H_X1/_ *?O_(?_ ->NHHHYY!R(Y;_A%&_Y_O\
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MXX_]!I/M&J?\^,?_ ($?_8UPW_"T;W_H0]>_\!S_ (4?\+1O/^A%U[_P'/\
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M_A2]K'N3[.7;\CN_M&J?] V/_P "/_L:/M&J?] V/_P(_P#L:X3_ (6C>?\
M0AZ]_P" Y_PH_P"%HWG_ $(>O?\ @.?\*/;P'[.78[K[1JG_ $#H_P#P(_\
ML:7[1JG_ $#8_P#P(_\ L:X3_A:-Y_T(>O?^ Y_PH_X6C>?]"'KW_@.?\*/:
MQ[BY)=CN_M&J?] V/_P(_P#L:3[3JG_0-C_\"/\ [&N%_P"%HWG_ $(>O?\
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MM)_\!E_^-4>SCW0O:R_E9[%M7^Z/RHVK_='Y5X[_ ,(S\>_^A^TG_P !E_\
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M(S\>O^A^TG_P&7_XU1[./=![679GL'E1_P!T?E1Y4?\ ='Y5X_\ \(S\>O\
MH?M)_P# 9?\ XU1_PC/QZ_Z'[2?_  &7_P"-4>SCW0>UEV9[#Y<?_/,?E2>7
M'_='Y5X__P (S\>O^A^TG_P&7_XU1_PC/QZ_Z'[2?_ 9?_C5'LX]T'M9=F>P
M>5'_ '1^5'E1_P!T?E7C_P#PC/QZ_P"A^TG_ ,!E_P#C5'_",_'K_H?M)_\
M 9?_ (U1[./=![679GL6Q/[H_*C:O]T?E7CO_",_'O\ Z'[2?_ 9?_C5'_",
M_'O_ *'[2?\ P&7_ .-4>SCW0O:R_E9[%M7^Z/RI:\<_X1GX]_\ 0_:3_P"
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MHHH **** 'J[*>.G<5.LBM['T-5:* +M%5(V;UJR* '44E% "T4E% "T4E%
M"T4E% "T4E% "T4E% "T4E% "T4E% "T4E% "T4E% "T4E% "T4E% "T4E%
M"T4E% "T4E% "T4E% "T4E% "T4E% "T4E% "T4E% "T4E% "T4E% "T4E%
M"T4E% "T4E% "T4E% "T4E% "T4E% "T4E% "T4E% "T4E% "T4E% "T4E%
M"T4E% "T4E% "T4E1%F]: )OY5$TP'W>34+,S=3FFT *6+$D\TE%% !1110!
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140152856126520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">374Water Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000933972<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">S-1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">88-0271109<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address Address Line 1</a></td>
<td class="text">701 W. Main Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address Address Line 2</a></td>
<td class="text">Suite 410<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address City Or Town</a></td>
<td class="text">Durham<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address State Or Province</a></td>
<td class="text">NC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address Postal Zip Code</a></td>
<td class="text">27701<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">919<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">888-8194<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140152855091784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Condensed Consolidated Balance Sheets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">$ 11,243,795<span></span>
</td>
<td class="nump">$ 11,131,175<span></span>
</td>
<td class="nump">$ 71,799<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">31,330<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid Expenses</a></td>
<td class="nump">167,867<span></span>
</td>
<td class="nump">218,466<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">11,411,662<span></span>
</td>
<td class="nump">11,349,641<span></span>
</td>
<td class="nump">103,129<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Equipment, Net</a></td>
<td class="nump">4,015<span></span>
</td>
<td class="nump">959<span></span>
</td>
<td class="nump">403<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIntangibleAssetsNet', window );">Intangible Asset, Net</a></td>
<td class="nump">1,012,327<span></span>
</td>
<td class="nump">1,028,114<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Other Assets</a></td>
<td class="nump">34,306<span></span>
</td>
<td class="nump">34,742<span></span>
</td>
<td class="nump">275<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total Long-term Assets</a></td>
<td class="nump">1,050,648<span></span>
</td>
<td class="nump">1,063,815<span></span>
</td>
<td class="nump">678<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">12,462,310<span></span>
</td>
<td class="nump">12,413,456<span></span>
</td>
<td class="nump">103,807<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts Payable And Accrued Expenses</a></td>
<td class="nump">144,040<span></span>
</td>
<td class="nump">62,981<span></span>
</td>
<td class="nump">76,249<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_AdvancesFromStockholders', window );">Advances from stockholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">15,108<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred Revenue</a></td>
<td class="nump">763,333<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Other Liabilities</a></td>
<td class="nump">3,152<span></span>
</td>
<td class="nump">23,390<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">910,525<span></span>
</td>
<td class="nump">86,371<span></span>
</td>
<td class="nump">92,557<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Long-Term Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">910,525<span></span>
</td>
<td class="nump">86,371<span></span>
</td>
<td class="nump">92,557<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred Stock: 1,000,000 Convertible Series D Preferred Shares Authorized; Par Value $0.0001 Per Share, Nil Issued And Outstanding At March 31, 2022 And 27,272 Issued And Outstanding At December 31, 2021</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock: 200,000,000 Common Shares Authorized, Par Value $0.0001 Per Share, 126,680,895 And 125,317,746 Shares Outstanding At March 31, 2022 And December 31, 2021, Respectively</a></td>
<td class="nump">12,669<span></span>
</td>
<td class="nump">12,531<span></span>
</td>
<td class="nump">6,241<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional Paid-in Capital</a></td>
<td class="nump">15,571,989<span></span>
</td>
<td class="nump">15,474,566<span></span>
</td>
<td class="nump">416<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated (deficit) Earnings</a></td>
<td class="num">(4,032,873)<span></span>
</td>
<td class="num">(3,160,015)<span></span>
</td>
<td class="nump">4,593<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Stockholders' Equity</a></td>
<td class="nump">11,551,785<span></span>
</td>
<td class="nump">12,327,085<span></span>
</td>
<td class="nump">11,250<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities And Stockholders' Equity</a></td>
<td class="nump">$ 12,462,310<span></span>
</td>
<td class="nump">$ 12,413,456<span></span>
</td>
<td class="nump">$ 103,807<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_AdvancesFromStockholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_AdvancesFromStockholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 310<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123366838&amp;loc=d3e3073-115593<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6787-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123349782&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140152855067176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Apr. 16, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Condensed Consolidated Balance Sheets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock Par Value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">27,272<span></span>
</td>
<td class="nump">436,782<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreferenceValue', window );">Preferred Stock, Shares Liquidation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 409,005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 409,005<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">27,272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par Value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares Issued</a></td>
<td class="nump">126,680,895<span></span>
</td>
<td class="nump">125,317,746<span></span>
</td>
<td class="nump">33,203,512<span></span>
</td>
<td class="nump">62,410,452<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares Outstanding</a></td>
<td class="nump">126,680,895<span></span>
</td>
<td class="nump">125,317,746<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,410,452<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockLiquidationPreferenceValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of the difference between preference in liquidation and the par or stated values of the preferred shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockLiquidationPreferenceValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140152854885624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Condensed Consolidated Statements of Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 273,231<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 48,100<span></span>
</td>
<td class="nump">$ 86,570<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost Of Goods Sold</a></td>
<td class="nump">247,986<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">14,241<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross Profit</a></td>
<td class="nump">25,245<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">48,100<span></span>
</td>
<td class="nump">72,329<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">185,653<span></span>
</td>
<td class="nump">29,185<span></span>
</td>
<td class="nump">375,032<span></span>
</td>
<td class="nump">57,718<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LaborAndRelatedExpense', window );">Compensation And Related Expenses</a></td>
<td class="nump">301,235<span></span>
</td>
<td class="nump">18,686<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductionCosts', window );">Product development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,399,833<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Professional Fees</a></td>
<td class="nump">150,658<span></span>
</td>
<td class="nump">8,203<span></span>
</td>
<td class="nump">343,862<span></span>
</td>
<td class="nump">8,791<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">261,403<span></span>
</td>
<td class="nump">10,477<span></span>
</td>
<td class="nump">1,095,381<span></span>
</td>
<td class="nump">17,483<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total Operating Expenses</a></td>
<td class="nump">898,950<span></span>
</td>
<td class="nump">66,551<span></span>
</td>
<td class="nump">3,214,108<span></span>
</td>
<td class="nump">83,992<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) From Operations</a></td>
<td class="num">(873,705)<span></span>
</td>
<td class="num">(66,551)<span></span>
</td>
<td class="num">(3,166,008)<span></span>
</td>
<td class="num">(11,663)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income (expense)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_AwardIncome', window );">Award income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">52,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeOperating', window );">Interest income</a></td>
<td class="nump">840<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,066<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other income</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">334<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total Other Income (expense)</a></td>
<td class="nump">847<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
<td class="nump">52,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net Income (Loss) before Income Taxes</a></td>
<td class="num">(872,858)<span></span>
</td>
<td class="num">(66,551)<span></span>
</td>
<td class="num">(3,164,608)<span></span>
</td>
<td class="nump">40,337<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for Income Taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">$ (872,858)<span></span>
</td>
<td class="num">$ (66,551)<span></span>
</td>
<td class="num">$ (3,164,608)<span></span>
</td>
<td class="nump">$ 40,337<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_NetLossPerShareBasicAndDiluted', window );">Net Loss Per Share - Basic And Diluted</a></td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="nump">$ (0.00)<span></span>
</td>
<td class="num">$ (0.03)<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_WeightedAverageCommonSharesOutstandingBasicAndDiluted', window );">Weighted Average Common Shares Outstanding - Basic And Diluted</a></td>
<td class="nump">126,499,142<span></span>
</td>
<td class="nump">62,410,452<span></span>
</td>
<td class="nump">94,002,888<span></span>
</td>
<td class="nump">62,410,452<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_AwardIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_AwardIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_NetLossPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_NetLossPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_WeightedAverageCommonSharesOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_WeightedAverageCommonSharesOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LaborAndRelatedExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LaborAndRelatedExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The capitalized costs incurred during the period (excluded from amortization) to operate and maintain wells and related equipment and facilities, including depreciation and applicable operating costs of support equipment and facilities and other costs of operating and maintaining those wells and related equipment and facilities. They become part of the cost of oil and gas produced. Examples of production costs (sometimes called lifting costs) are: costs of labor to operate the wells and related equipment and facilities; repairs and maintenance; materials, supplies, and fuel consumed and supplies utilized in operating the wells and related equipment and facilities; property taxes and insurance applicable to proved properties and wells and related equipment and facilities; severance taxes; some support equipment or facilities may serve two or more oil and gas producing activities and may also serve transportation, refining, and marketing activities. To the extent that the support equipment and facilities are used in oil and gas producing activities, their depreciation and applicable operating costs become exploration, development or production costs, as appropriate. Depreciation, depletion, and amortization of capitalized acquisition, exploration, and development costs are not production costs but also become part of the cost of oil and gas produced along with production (lifting) costs identified above.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 932<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-10(c)(7)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=123726172&amp;loc=d3e511914-122862<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.2(a),(b),(c),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433917&amp;loc=SL114874205-224268<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140152850893240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Changes in Stockholders' Deficit - USD ($)<br></strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Preferred Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Retained Earnings (Accumulated Deficit)</div></th>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, shares at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,410,452<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, amount at Dec. 31, 2019</a></td>
<td class="num">$ (35,744)<span></span>
</td>
<td class="nump">$ 6,241<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (6,241)<span></span>
</td>
<td class="num">$ (35,744)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common stock for services</a></td>
<td class="nump">6,329<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,329<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_AccretionOfStockBasedCompensation', window );">Accretion of stock-based</a></td>
<td class="nump">328<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">328<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Loss</a></td>
<td class="nump">40,337<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">40,337<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="nump">40,337<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, Shares at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,410,452<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, Amount at Dec. 31, 2020</a></td>
<td class="nump">11,250<span></span>
</td>
<td class="nump">$ 6,241<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">416<span></span>
</td>
<td class="nump">4,593<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionExpense', window );">Accretion Of Stock-based Compensation</a></td>
<td class="nump">10,433<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,433<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="num">(66,551)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(66,551)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, Shares at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,410,452<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, Amount at Mar. 31, 2021</a></td>
<td class="num">(44,868)<span></span>
</td>
<td class="nump">$ 6,241<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,849<span></span>
</td>
<td class="num">(61,958)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, shares at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,410,452<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, amount at Dec. 31, 2020</a></td>
<td class="nump">11,250<span></span>
</td>
<td class="nump">$ 6,241<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">416<span></span>
</td>
<td class="nump">4,593<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_AccretionOfStockBasedCompensation', window );">Accretion of stock-based</a></td>
<td class="nump">204,217<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">204,217<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="num">(3,164,608)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,164,608)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_IssuanceOfStockWarrantsForDevelopmentOfProduct', window );">Issuance of stock warrants for development of product</a></td>
<td class="nump">1,399,833<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,399,833<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_RecapitalizationOfTheCompanyShares', window );">Recapitalization of the Company, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,203,512<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_RecapitalizationOfTheCompanyAmount', window );">Recapitalization of the Company, amount</a></td>
<td class="num">(84,225)<span></span>
</td>
<td class="nump">$ 3,320<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(87,545)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_SeriesDPreferredStockIssuedForCashShares', window );">Series D Preferred Stock issued for cash, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">440,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_SeriesDPreferredStockIssuedForCashAmount', window );">Series D Preferred Stock issued for cash, amount</a></td>
<td class="nump">6,601,745<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 44<span></span>
</td>
<td class="nump">6,601,701<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_ExercisedOptionAndWarrantsShares', window );">Exercised. Option and Warrants, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,958,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_ExercisedOptionAndWarrantsAmount', window );">Exercised. Option and Warrants, amount</a></td>
<td class="nump">1,285,344<span></span>
</td>
<td class="nump">$ 496<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,284,848<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_IssuanceOfCommonStockForLicenseRightsShares', window );">Issuance of common stock for license rights, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,602,282<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_IssuanceOfCommonStockForLicenseRightsAmount', window );">Issuance of common stock for license rights, amount</a></td>
<td class="nump">1,073,529<span></span>
</td>
<td class="nump">$ 160<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1,073,369<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_ConversionOfConvertiblePreferredSharesIntoCommonStockShares', window );">Conversion of convertible preferred shares into common stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,642,667<span></span>
</td>
<td class="num">(412,853)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_ConversionOfConvertiblePreferredSharesIntoCommonStockAmount', window );">Conversion of convertible preferred shares into common stock, amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 2,064<span></span>
</td>
<td class="num">$ (41)<span></span>
</td>
<td class="num">(2,023)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock, amount</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">$ 250<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">4,999,750<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, Shares at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,317,746<span></span>
</td>
<td class="nump">27,272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, Amount at Dec. 31, 2021</a></td>
<td class="nump">12,327,085<span></span>
</td>
<td class="nump">$ 12,531<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">15,474,566<span></span>
</td>
<td class="num">(3,160,015)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionExpense', window );">Accretion Of Stock-based Compensation</a></td>
<td class="nump">97,558<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">97,558<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="num">$ (872,858)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(872,858)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Conversion Of Preferred Shares To Common Shares, Shares</a></td>
<td class="nump">1,363,149<span></span>
</td>
<td class="nump">1,363,149<span></span>
</td>
<td class="num">(27,272)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountIssued1', window );">Conversion Of Preferred Shares To Common Shares, Amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 136<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">135<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, Shares at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">126,680,895<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, Amount at Mar. 31, 2022</a></td>
<td class="nump">$ 11,551,785<span></span>
</td>
<td class="nump">$ 12,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,571,989<span></span>
</td>
<td class="num">$ (3,884,460)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_AccretionOfStockBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_AccretionOfStockBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_ConversionOfConvertiblePreferredSharesIntoCommonStockAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_ConversionOfConvertiblePreferredSharesIntoCommonStockAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_ConversionOfConvertiblePreferredSharesIntoCommonStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_ConversionOfConvertiblePreferredSharesIntoCommonStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_ExercisedOptionAndWarrantsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_ExercisedOptionAndWarrantsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_ExercisedOptionAndWarrantsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_ExercisedOptionAndWarrantsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_IssuanceOfCommonStockForLicenseRightsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_IssuanceOfCommonStockForLicenseRightsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_IssuanceOfCommonStockForLicenseRightsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_IssuanceOfCommonStockForLicenseRightsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_IssuanceOfStockWarrantsForDevelopmentOfProduct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_IssuanceOfStockWarrantsForDevelopmentOfProduct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_RecapitalizationOfTheCompanyAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_RecapitalizationOfTheCompanyAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_RecapitalizationOfTheCompanyShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_RecapitalizationOfTheCompanyShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_SeriesDPreferredStockIssuedForCashAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_SeriesDPreferredStockIssuedForCashAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_SeriesDPreferredStockIssuedForCashShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_SeriesDPreferredStockIssuedForCashShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6392676&amp;loc=d3e7480-110848<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 35<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6394232&amp;loc=d3e17558-110866<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument issued [noncash or part noncash] in the conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140152854067464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (loss)</a></td>
<td class="num">$ (872,858)<span></span>
</td>
<td class="num">$ (66,551)<span></span>
</td>
<td class="num">$ (3,164,608)<span></span>
</td>
<td class="nump">$ 40,337<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments To Reconcile Net Income (loss) To Net Cash Provided By (used In) Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">16,458<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">46,050<span></span>
</td>
<td class="nump">911<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">97,558<span></span>
</td>
<td class="nump">10,433<span></span>
</td>
<td class="nump">204,217<span></span>
</td>
<td class="nump">328<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_AdjustmentForCommonStockIssuedForServices', window );">Common stock issued for services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,329<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_WarrantIssuedForProductDevelopmentAgreement', window );">Warrant issued for product development agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,399,833<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">24,340<span></span>
</td>
<td class="nump">32,330<span></span>
</td>
<td class="num">(31,330)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">81,059<span></span>
</td>
<td class="nump">28,966<span></span>
</td>
<td class="num">(142,512)<span></span>
</td>
<td class="nump">47,488<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred Revenue</a></td>
<td class="nump">763,333<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expense and other assets</a></td>
<td class="num">(50,599)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(238,450)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities', window );">Other liabilities</a></td>
<td class="num">(20,238)<span></span>
</td>
<td class="num">(1,200)<span></span>
</td>
<td class="nump">22,190<span></span>
</td>
<td class="nump">696<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash (used in) provided by operating activities</a></td>
<td class="nump">115,911<span></span>
</td>
<td class="num">(4,022)<span></span>
</td>
<td class="num">(1,840,950)<span></span>
</td>
<td class="nump">64,759<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(3,291)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,190)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_ProceedsFromReverseAcquisition', window );">Proceeds from reverse acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113,760<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets', window );">Increase in other assets acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(275)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfCapitalDistribution', window );">Recapitalization of the Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(84,225)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(3,291)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">28,345<span></span>
</td>
<td class="num">(275)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt', window );">Advances from Stockholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,108)<span></span>
</td>
<td class="nump">2,052<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Proceeds from Series D Preferred Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,601,745<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from Common Stock Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of Options</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,821<span></span>
</td>
<td class="nump">42,845<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from exercise of warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,242,499<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,821<span></span>
</td>
<td class="nump">12,871,981<span></span>
</td>
<td class="nump">2,052<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net Increase in Cash</a></td>
<td class="nump">112,620<span></span>
</td>
<td class="nump">799<span></span>
</td>
<td class="nump">11,059,376<span></span>
</td>
<td class="nump">66,536<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash - Beginning Of The Period</a></td>
<td class="nump">11,131,175<span></span>
</td>
<td class="nump">71,799<span></span>
</td>
<td class="nump">71,799<span></span>
</td>
<td class="nump">5,263<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash - End Of The Period</a></td>
<td class="nump">11,243,795<span></span>
</td>
<td class="nump">72,598<span></span>
</td>
<td class="nump">11,131,175<span></span>
</td>
<td class="nump">71,799<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>SUPPLEMENTAL CASH FLOW DISCLOSURES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Cash paid for taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>NON-CASH INVESTING AND FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_ConversionOfStockAmountIssued', window );">Conversion Of Preferred Stock To Common Stock</a></td>
<td class="nump">$ 133<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_IssuanceOfCommonStockForLicenseRights', window );">Issuance of common stock for license rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,073,529<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_AccountsPayableSettledWithStockOption', window );">Accounts payable settled with Series D Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_NetLiabilitiesAssumedInReverseAcquisitionAbstract', window );"><strong>Net Liabilities Assumed in Reverse Acquisition:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_NetLiabilitiesAssumedInReverseAcquisitioncash', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,536<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,483<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableSale', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(46,150)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(83,094)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_NetLiabilityAssumed', window );">Net liability assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (84,225)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_AccountsPayableSettledWithStockOption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_AccountsPayableSettledWithStockOption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_AdjustmentForCommonStockIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_AdjustmentForCommonStockIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_ConversionOfStockAmountIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_ConversionOfStockAmountIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_IssuanceOfCommonStockForLicenseRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_IssuanceOfCommonStockForLicenseRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_NetLiabilitiesAssumedInReverseAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_NetLiabilitiesAssumedInReverseAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_NetLiabilitiesAssumedInReverseAcquisitioncash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_NetLiabilitiesAssumedInReverseAcquisitioncash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_NetLiabilityAssumed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_NetLiabilityAssumed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_ProceedsFromReverseAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_ProceedsFromReverseAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_WarrantIssuedForProductDevelopmentAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_WarrantIssuedForProductDevelopmentAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease from sale of accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919244-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfCapitalDistribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash outflow to owners or shareholders, excluding ordinary dividends. Includes special dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfCapitalDistribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140152857188904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Business and Presentation of Financial Statements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Nature of Business and Presentation of Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Nature Of Business And Presentation Of Financial Statements</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><strong>Note 1 &#8211; Nature of Business and Presentation of Financial Statements</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><span style="text-decoration:underline">Description of the Company</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">374Water, Inc., f/k/a PowerVerde, Inc. (the &#8220;Company&#8221;) was a Delaware corporation formed in March 2007. The Company was formed to develop, commercialize, and market a series of unique electric generating power systems designed to produce electrical power with zero emissions or waste byproducts, based on a patented pressure-driven expander motor and related organic rankine cycle technology.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">On April 16, 2021, 374Water Inc. (f/k/a PowerVerde, Inc.) entered into an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;) with 374Water, Inc., a privately held company based in Durham, North Carolina, (&#8220;Private 374Water&#8221;) and 374Water Acquisition Corp., a newly-formed wholly-owned subsidiary of PowerVerde (&#8220;Sub&#8221;). The parties entered into the Agreement pursuant to their Binding Letter of Intent dated September 20, 2020.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">Pursuant to the merger contemplated by the Merger Agreement (the &#8220;Merger&#8221;), on April 16, 2021, Sub merged into Private 374Water, with Private 374Water as the surviving corporation. In connection with the Merger, all Private 374Water shares were cancelled and the Company issued to the former Private 374Water shareholders a total of 62,410,452 shares of the Company common stock. , 374 374 374, . , 374 64.2 53.8 . The Merger was accounted for as a reverse acquisition (See Note 4). On April 16, 2021, as a result of the closing of the Merger Agreement (see Note 4), the equity of the consolidated entity is the historical equity of 374Water, Inc (&#8220;374Water&#8221;) retroactively restated to reflect the number of shares issued by the Company in the reverse recapitalization.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><span style="text-decoration:underline">Nature of Business </span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">With the Merger, the Company&#8217;s current mission is to support a clean and healthy environment to sustain life. The Company plans to use what it believes to be cutting-edge science to recover resources from the waste our society generates and keep drinking water clean. The Company&#8217;s customers will include businesses and local governments that will make the sustainable development goals a reality. On February 1, 2022, the Company sold their first AIRSCWO&#160;system to Orange County Sanitation District of Fountain Valley, California.&#160; Revenues to date have been from sale of the first AIRSCWO system&#160;and from testing, consulting, and advisory services procedures for our customers, which have been performed in collaboration with Duke University.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><span style="text-decoration:underline">Presentation of Financial Statements</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules and regulations of the United States Securities and Exchange Commission (SEC) for interim financial information.&#160; It is management&#8217;s opinion that that the accompanying unaudited condensed consolidated financial statements are prepared in accordance with instructions for Form 10-Q and include all adjustments (consisting only of normal recurring accruals) which are necessary for a fair presentation of the results for the periods presented. Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these condensed consolidated financial statements be read in conjunction with the Annual Report on Form 10-K of 374Water Inc, formerly known as PowerVerde, Inc. (&#8220;374 Water," &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; or the &#8220;Company&#8221;) as of and for the year ended December 31, 2021 filed with the Securities and Exchange Commission (&#8220;SEC&#8221;) on March 1, 2022. The results of operations for the three months ended March 31, 2022, are not necessarily indicative of the results to be expected for the full year or for future periods. The condensed consolidated financial statements include the accounts of 374Water Inc, formerly known as PowerVerde, Inc. (the &#8220;Company&#8221;), and PowerVerde Systems, Inc., 374Water Systems Inc, and 374Water Sustainability Israel LTD,&#160;each a&#160;wholly-owned subsidiary of 374 Water. Intercompany balances and transactions have been eliminated in consolidation. These interim financial statements reflect the acquisition of the Company&#8217;s new wholly-owned subsidiary, 374Water Systems Inc., which was consummated on April 16, 2021, as more fully disclosed in Note 4.</p><span></span>
</td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong>Note 1 &#8211; Nature of Business</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">374Water, Inc., f/k/a PowerVerde, Inc. (the &#8220;Company&#8221;) is a Delaware corporation incorporated on September 8, 2005. The Company was formed to develop, commercialize, and market a series of unique electric generating power systems designed to produce electrical power with zero emissions or waste byproducts, based on a patented pressure-driven expander motor and related organic rankine cycle technology.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">On April 16, 2021, 374Water Inc. (f/k/a PowerVerde, Inc.) entered into an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;) with 374Water, Inc., a privately held company based in Durham, North Carolina, (&#8220;374Water&#8221;) and 374Water Acquisition Corp., a newly-formed wholly-owned subsidiary of PowerVerde (&#8220;Sub&#8221;). The parties entered into the Agreement pursuant to their Binding Letter of Intent dated September 20, 2020.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Pursuant to the merger contemplated by the Merger Agreement (the &#8220;Merger&#8221;), on April 16, 2021, Sub merged into 374Water, with 374Water as the surviving corporation. In connection with the Merger, all 374Water shares were cancelled and 374Water, Inc. issued to the former 374Water shareholders a total of 62,410,452 shares of 374Water, Inc. common stock. Immediately following the Merger, 374Water changed its name to 374Water Systems Inc and PowerVerde changed its name to 374Water, Inc. After the Merger, the former 374Water stockholders own 65.8% of 374Water Inc&#8217;s issued and outstanding common stock and 53.8% of 374Water Inc.&#8217;s issued and outstanding voting stock which includes the Preferred Stock. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">With the Merger, 374Water Inc.&#8217;s current mission is to support a clean and healthy environment to sustain life. The Company plans to use what is believes to be cutting-edge science to recover resources from the waste our society generates and keep drinking water clean. The Company&#8217;s customers will include businesses and local governments that will make the sustainable development goals a reality. No material revenues from this planned principal operation have been generated since inception. Revenues to date have been from manufacturing assembly services and from testing, consulting, and advisory services procedures for multiple customers, which have been performed in collaboration with Duke University.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140152852691416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Summary Of Significant Accounting Policies</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">&#160;<strong>Note 2 &#8211; Summary of Significant Accounting Policies</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><span style="text-decoration:underline">Cash and Cash Equivalents</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. The Company held no cash equivalents as of March 31, 2022, and December 31, 2021.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><span style="text-decoration:underline">Accounts Receivable </span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">Accounts receivables consist of balances due from service revenues. The Company monitors accounts receivable and provides allowances when considered necessary. At March 31, 2022 and December 31, 2021, there were no outstanding accounts receivable. Accordingly, no allowance for doubtful accounts was provided.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><span style="text-decoration:underline">Equipment</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">Equipment is recorded at cost. Depreciation is computed using the straight-line method and an estimated useful live of three years. Expenses for maintenance and repairs are charged to expense as incurred.&#160; The Company&#8217;s depreciation expense in the period is $235.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><span style="text-decoration:underline">Intangible Assets</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">Intangible assets are subject to amortization, and any impairment is determined in accordance with ASC 360, &#8220;Property, Plant, and Equipment.&#8221; Intangible assets are stated at historical cost and amortized over their estimated useful lives. The Company uses a straight-line method of amortization, unless a method that better reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up can be reliably determined.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><span style="text-decoration:underline">Long-Lived Assets</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">The Company reviews long-lived assets, including intangible assets with finite lives, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company uses an estimate of the undiscounted cash flows over the remaining life of its long-lived assets, or related group of assets where applicable, in measuring whether the assets to be held and used will be realizable. Recoverability of assets held and used is measured by a comparison of the carrying amount to the future undiscounted expected net cash flows to be generated by the asset. As of March 31, 2022, and 2021, there were no events or changes in circumstances requiring an impairment analysis.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><span style="text-decoration:underline">Revenue Recognition and Concentration</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">The Company follows the revenue standards of Financial Accounting Standards Board Update No. 2014-09: &#8220;Revenue from Contracts with Customers (Topic 606).&#8221; The core principle of this Topic is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Revenue is recognized in accordance with that core principle by applying the following five steps: 1) identify the contracts with a customer; 2) identify the performance obligations in the contract; 3) determine the transaction price; 4) allocate the transaction price to the performance obligations; and 5) recognize revenue when (or as) we satisfy a performance obligation.&#160; Deferred revenue primarily consists of billings or payments received in advance of revenue recognition from the completion of the equipment build for each customer as the outputs are measured against the cost to build the product.&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">The Company&#8217;s performance obligations will be satisfied overtime as the specialized equipment is built for the customer.&#160; Based on the Company&#8217;s contracts, the Company will have a single performance obligation (build and install of the product). The Company will primarily receive fixed consideration for sales of product. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">Revenues for the three months ended March 31, 2022 were generated from the sale of the first AIRSCWO system.&#160; &#160;For the three months ended March 31, 2021, the Company did not have any revenues.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><span style="text-decoration:underline">Stock-based Compensation</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">The Company has accounted for stock-based compensation under the provisions of Accounting Standards Codification (ASC) Topic 718 &#8211; &#8220;Stock Compensation&#8221; which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments (stock options and common stock purchase warrants). The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate. Expected volatilities are based on historical volatility of peer companies and other factors estimated over the expected term of the stock options. The expected term of options granted is derived using the &#8220;simplified method&#8221; which computes expected term as the average of the sum of the vesting term plus the contract term. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><span style="text-decoration:underline">Accounting for Uncertainty in Income Taxes</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">The Company&#160;follows the provisions of ASC Topic 740-10, &#8220;Accounting for Uncertainty in Income Taxes&#8221; which clarifies the accounting for uncertainty in income taxes recognized in an enterprise&#8217;s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This topic also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. There were no uncertain tax positions as of March 31, 2022, and December 31, 2021.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><span style="text-decoration:underline">Income Tax Policy</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">The Company accounts for income taxes using the liability method prescribed by ASC 740 - Income Taxes. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets if, based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the period that includes the enactment date.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><span style="text-decoration:underline">Research and Development Costs</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">The Company&#8217;s research and development costs are expensed in the period in which they are incurred. Such expenditures amounted to $185,653 and $29,185 for the three months ended March 31, 2022, and 2021, respectively.&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><span style="text-decoration:underline">Earnings (Loss) Per Share</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">Earnings (loss) per share is computed in accordance with FASB ASC Topic 260, &#8220;Earnings per Share&#8221;. Diluted earnings per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities outstanding during the period. Certain common stock equivalents were not included in the earnings (loss) per share calculation as their effect would be anti-dilutive. As of March 31, 2022, there were the following potentially dilutive securities that were excluded from diluted net loss per share because their effect would be antidilutive: options for 12,660,000 shares of common stock.&#160; There were no dilutive shares as of March 31, 2022.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><span style="text-decoration:underline">Financial Instruments</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">The Company carries cash, accounts receivable, accounts payable and accrued expenses, at historical costs. The respective estimated fair values of these assets and liabilities approximate carrying values / useful lives of equipment and intangible assets due to their current nature.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><span style="text-decoration:underline">Use of Estimates</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates in the accompanying financial statements include the fair value of equity-based compensation, useful lives of intangible assets, and valuation allowance against deferred tax assets.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><span style="text-decoration:underline">Recent Accounting Pronouncements</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">All other newly issued but not yet effective accounting pronouncements have been deemed to be not applicable or immaterial to the Company.&#160;</p><span></span>
</td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong>Note 2 &#8211; Summary of Significant Accounting Policies&#160; </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><span style="text-decoration:underline">Cash and Cash Equivalents</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p>The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. The Company held no cash equivalents as of December 31, 2021 and 2020.<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><span style="text-decoration:underline">Concentration of Credit Risk </span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Financial instruments that potentially subject the Company to credit risk consist of cash and cash equivalents. Deposits with financial institutions are insured, up to certain limits, by the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;). The Company&#8217;s cash deposits often exceed the FDIC insurance limit; however, all deposits are maintained with high credit quality institutions and the Company has not experienced any losses in such accounts. The financial condition of financial institutions is periodically reassessed, and the Company believes the risk of any loss is minimal. The Company believes the risk of any loss on cash due to credit risk is minimal.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><span style="text-decoration:underline">Accounts Receivable </span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p>Accounts receivables consist of balances due from service revenues. The Company monitors accounts receivable and provides allowances when considered necessary. At December 31, 2021 and 2020, accounts receivable were considered to be fully collectible. Accordingly, no allowance for doubtful accounts was provided and there was no bad debt expense as of December 31, 2021 and 2020. <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><span style="text-decoration:underline">Equipment</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Equipment is recorded at cost. Depreciation is computed using the straight-line method and an estimated useful life of three years. Expenses for maintenance and repairs are charged to expense as incurred.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><span style="text-decoration:underline">Intangible Assets</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Intangible assets are subject to amortization, and any impairment is determined in accordance with ASC 360, &#8220;Property, Plant, and Equipment.&#8221; Intangible assets are stated at historical cost and amortized over their estimated useful lives. The Company uses a straight-line method of amortization, unless a method that better reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up can be reliably determined.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><span style="text-decoration:underline">Long-Lived Assets</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p>The Company reviews long-lived assets, including intangible assets with finite lives, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company uses an estimate of the undiscounted cash flows over the remaining life of its long-lived assets, or related group of assets where applicable, in measuring whether the assets to be held and used will be realizable. Recoverability of assets held and used is measured by a comparison of the carrying amount to the future undiscounted expected net cash flows to be generated by the asset. As of December 31, 2021 and 2020, there were no impairments.<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><span style="text-decoration:underline">Revenue Recognition and Concentration</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">The Company follows the revenue standards of Financial Accounting Standards Board Update No. 2014-09: &#8220;Revenue from Contracts with Customers (Topic 606).&#8221; The core principle of this Topic is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Revenue is recognized in accordance with that core principle by applying the following five steps: 1) identify the contracts with a customer; 2) identify the performance obligations in the contract; 3) determine the transaction price; 4) allocate the transaction price to the performance obligations; and 5) recognize revenue when (or as) we satisfy a performance obligation.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">The Company&#8217;s performance obligations will be satisfied at the point in time when products are shipped or delivered to the customer, which is when the customer has title and the significant risks and rewards of ownership. Therefore, the Company&#8217;s contracts will have a single performance obligation (shipment or delivery of product). The Company will primarily receive fixed consideration for sales of product. Manufacturing assembly services are recognized as revenue when the assembled product is delivered to the customer and the Company has completed its performance obligations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Revenues for the year ended December 31, 2021 were generated from consulting and advisory service agreements, which were recognized when the Company completed its performance obligations under the relevant service agreements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">During the year ended December 31, 2020, 100% of the Company&#8217;s revenues were earned from consulting and advisory services, which were recognized when the Company performed the service pursuant to its agreement with its clients which was the point in time when the Company completed its performance obligations under the agreements. One customer accounted for approximately 88% of revenues in 2020 and 92% of accounts receivable at December 31, 2020. Revenues generated in 2020 were not from the Company&#8217;s planned operations. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><span style="text-decoration:underline">Stock-based Compensation</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">The Company has accounted for stock-based compensation under the provisions of Accounting Standards Codification (ASC) Topic 718 &#8211; &#8220;Stock Compensation&#8221; which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments (stock options and common stock purchase warrants). The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate. Expected volatilities are based on historical volatility of peer companies and other factors estimated over the expected term of the stock options. The expected term of options granted is derived using the &#8220;simplified method&#8221; which computes expected term as the average of the sum of the vesting term plus the contract term. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><span style="text-decoration:underline">Accounting for Uncertainty in Income Taxes</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p>The Company follows the provisions of ASC Topic 740-10, &#8220;Accounting for Uncertainty in Income Taxes&#8221; which clarifies the accounting for uncertainty in income taxes recognized in an enterprise&#8217;s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This topic also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. There were no uncertain tax positions as of December 31, 2021 and 2020.<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><span style="text-decoration:underline">Income Tax Policy</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><span style="text-decoration:underline"/>&#160;</p>The Company accounts for income taxes using the liability method prescribed by ASC 740 - Income Taxes. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets if, based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the period that includes the enactment date.<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><span style="text-decoration:underline">Research and Development Costs</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p>The Company&#8217;s research and development costs are expensed in the period in which they are incurred. Such expenditures amounted to $375,032 and $57,718 for the years ended December 31, 2021 and 2020, respectively. <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><span style="text-decoration:underline">Earnings (Loss) Per Share</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p>Earnings (loss) per share is computed in accordance with FASB ASC Topic 260, &#8220;Earnings per Share&#8221;. Diluted earnings per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities outstanding during the period. Certain common stock equivalents were not included in the earnings (loss) per share calculation as their effect would be anti-dilutive. As of December 31, 2021, there were the following potentially dilutive securities that were excluded from diluted net loss per share because their effect would be antidilutive: options for 12,596,000 shares of common stock and 1,363,350 common stock shares issuable upon conversion of the Series D Preferred Stock. There were no dilutive shares as of December 31, 2020.<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><span style="text-decoration:underline">Financial Instruments</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">The Company carries cash, accounts receivable, accounts payable and accrued expenses, at historical costs. The respective estimated fair values of these assets and liabilities approximate carrying values / useful lives of equipment and intangible assets due to their current nature.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><span style="text-decoration:underline">Use of Estimates</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates in the accompanying financial statements include the fair value of equity-based compensation, fair value of intangible assets, useful lives of intangible assets, capital raise transactions, and valuation allowance against deferred tax assets.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><span style="text-decoration:underline">Recent Accounting Pronouncements</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">In August 2020, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2020-06, Debt &#8212; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#8212; Contracts in Entity&#8217;s Own Equity (Subtopic 815-40) (&#8220;ASU 2020-06&#8221;) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity&#8217;s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity&#8217;s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company notes that there will be no effect on the current financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">There are several other new accounting pronouncements issued or proposed by the FASB. Each of these pronouncements, as applicable, has been or will be adopted by the Company. Management does not believe any of these accounting pronouncements has had or will have a material impact on the Company&#8217;s condensed consolidated financial position, operating results, or cash flows.&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140152852774680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Liquidity Capital Resources and Going Concern<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Nature of Business and Presentation of Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock', window );">Liquidity, Capital Resources</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><strong>Note 3 &#8211; Liquidity, Capital Resources and Going Concern</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">As of March 31, 2022, the Company had working capital of $10,501,137 compared to working capital of $11,263,270 at December 31, 2021.&#160; As of March 31, 2022, the Company has an accumulated deficit of $4032873. For the three months ended March 31, 2022, the Company had a net loss of (872,858) and $115,911 of net cash provided by operations for the period.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">The Company believes they have sufficient cash-on-hand&#160;for the Company to meet its financial obligations for at least the next 12 months from the date of the report as they come due. </p><span></span>
</td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong>Note 3 &#8211; Liquidity, Capital Resources</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">As of December 31, 2021, the Company had working capital of $11,263,270 compared to working capital of $10,572 at December 31, 2020. This significant increase in working capital is due primarily to the increase in cash over the twelve-month period is based on the Company&#8217;s sale and issuance of Series D Convertible Preferred Stock (&#8220;Preferred Stock&#8221;) and the proceeds for the exercise of warrants (see Note 4 and Note 6). During the second quarter of 2021, in connection with the Merger (described in Note 4 below), the Company received gross proceeds of $6,551,745 from the sale of Series D Convertible Preferred Stock. During the fourth quarter of 2021, the Company received gross proceeds of $5,000,000 from the sale of Common Stock (see Note 6). As of December 31, 2021, the Company has an accumulated deficit of $3,160,015. For the year ended December 31, 2021, the Company had a net loss of $3,164,608 and $1,840,950 of net cash used in operations for the period.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">The Company believes that the capital raised from the sale of Common and Preferred Stock and proceeds from conversion of warrants will provide sufficient cash flow for the Company to meet its financial obligations as they come due for at least the next 12 months. </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 40<br> -URI http://asc.fasb.org/subtopic&amp;trid=51888271<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubstantialDoubtAboutGoingConcernTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140152936379112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisition of 374Water Inc fka PowerVerde Inc<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Acquisition of 374Water Inc fka PowerVerde Inc</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Acquisition of 374Water, Inc. f/k/a PowerVerde Inc.</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><strong>Note 4 &#8211; Acquisition of 374Water, Inc. f/k/a PowerVerde Inc. </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><span style="text-decoration:underline">Agreement and Plan of Merger</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">In connection with the Merger,&#160;(see Note 1), the Company closed on a private placement of&#160;436,783&#160;shares of Series D Convertible Preferred Stock (the &#8220;Preferred Stock&#8221;) with a par value of $0.0001, yielding gross proceeds of $6,551,745&#160;(the &#8220;Private Placement&#8221;) and the settlement of a $50,000&#160;liability for Preferred Stock shares. The Private Placement proceeds will be used for working capital, primarily for development, manufacture and commercialization of the Company&#8217;s Air SCWO systems. The Preferred Stock has a stated value of $15 per share, is convertible into common stock at $.30 per share and has voting rights based on the underlying shares of common stock. Upon liquidation of the Company, the Preferred Stockholders have liquidation preference before any assets can be distributed to common stockholders. All of the Preferred Stock was sold pursuant to an exemption from registration requirements under Regulation D and/or Section 4(2) of the Securities Act of 1933, as amended.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">As a result of the Merger, the issuance of the Preferred Stock, the former Private 374Water shareholders own 65.8% of the Company&#8217;s issued and outstanding common stock and 53.8% of the Company&#8217;s issued and outstanding voting stock (which includes the Preferred Stock on an as converted basis).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">Also as a result of the Merger, the Company entered into two-year employment agreements with&#160;the Company &#160;founders Yaacov (Kobe) Nagar and Marc Deshusses, Ph. D. Mr. Nagar will serve as the Company&#8217;s CEO, replacing Richard H. Davis, who resigned as CEO upon closing of the Merger. Mr. Nagar&#160;initially receive an annual salary of $200,000&#160;which was increased to $250,000 effective January 26, 2022. Dr. Deshusses will serve as the Company&#8217;s Head of Technology on a part-time basis at a salary of $60,000 per year.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">Pursuant to the Merger, Messrs. Nagar and Deshusses were appointed to the Company&#8217;s Board of Directors, joining Mr. Davis, who remains as a Director.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">The patented technology underlying 374Water&#8217;s supercritical water oxidation (SCWO) units, which was developed principally through the efforts of Messrs. Nagar and Deshusses at the facilities of Duke University, Durham, North Carolina (&#8220;Duke&#8221;), where Dr. Deshusses is a professor, is licensed to 374Water pursuant to a worldwide license agreement with Duke executed on April 16, 2021 (the &#8220;License Agreement&#8221;) simultaneous with the merger. In connection with the License Agreement, 374Water also executed an equity transfer Agreement with Duke pursuant to which Duke received a small block of shares of common stock (see Note 5).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">As a result of the Merger Agreement, for financial statement reporting purposes, the business combination between 374Water Inc. and 374Water was treated as a reverse acquisition and recapitalization for accounting purposes with 374Water deemed the accounting acquirer and 374Water Inc. deemed the accounting acquiree under the acquisition method of accounting in accordance with FASB Accounting Standards Codification (&#8220;ASC&#8221;) Section 805-10-55.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><span style="text-decoration:underline">The following assets and liabilities were assumed in the transaction:</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Cash</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">29,536</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Prepaid expense</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">14,483</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Accounts Receivable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Total assets acquired</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">45,019</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Accounts payable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(46,150 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Accrued expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(83,094 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Total liabilities assumed</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(129,244 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Net liabilities assumed</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(84,225 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr></tbody></table><span></span>
</td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong>Note 4 &#8211; Acquisition of 374Water, Inc. f/k/a PowerVerde Inc. </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">In connection with the Merger,&#160;374Water&#160;closed on a private placement of 436,783 shares of Series D Convertible Preferred Stock (the &#8220;Preferred Stock&#8221;) with a par value of $0.0001, yielding gross proceeds of $6,551,745 (the &#8220;Private Placement&#8221;) and the settlement of a $50,000 liability for Preferred Stock shares. The Private Placement proceeds will be used for working capital, primarily for development, manufacture and commercialization of 374Water Inc.&#8217;s Air SCWO Nix systems. The Preferred Stock has a stated value of $15 per share, is convertible into common stock at $.30 per share and has voting rights based on the underlying shares of common stock. Upon liquidation of the Company, the Preferred Stockholders have liquidation preference before any assets can be distributed to common stockholders. All of the Preferred Stock was sold pursuant to an exemption from registration requirements under Regulation D and/or Section 4(2) of the Securities Act of 1933, as amended.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">As a result of the Merger, the issuance of the Preferred Stock, the former 374Water shareholders own 65.8% of 374Water Inc&#8217;s issued and outstanding common stock and 53.8% of 374Water Inc.&#8217;s issued and outstanding voting stock (which includes the Preferred Stock on an as converted basis).</p><p style="font-size:10pt;font-family:times new roman;margin:0px">Also as a result of the Merger, 374Water Inc. entered into two-year employment agreements with 374Water founders Yaacov (Kobe) Nagar and Marc Deshusses, Ph. D. Mr. Nagar will serve as the Company&#8217;s CEO, replacing Richard H. Davis, who resigned upon closing of the Merger. Mr. Nagar will receive an annual salary of $200,000. Dr. Deshusses will serve as the Company&#8217;s Head of Technology on a part-time basis at a salary of $60,000 per year. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Pursuant to the Merger, Messrs. Nagar and Deshusses were appointed to the Company&#8217;s Board of Directors, joining Mr. Davis, who remains as a Director.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">The patented technology underlying 374Water&#8217;s supercritical water oxidation (SCWO) units, which was developed principally through the efforts of Messrs. Nagar and Deshusses at the facilities of Duke University, Durham, North Carolina (&#8220;Duke&#8221;), where Dr. Deshusses is a professor, is licensed to 374Water pursuant to a worldwide license agreement with Duke executed on April 16, 2021 (the &#8220;License Agreement&#8221;) simultaneous with the merger. In connection with the License Agreement, 374Water also executed an equity transfer Agreement with Duke pursuant to which Duke received a small block of shares of common stock (see Note 5).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">As a result of the Merger Agreement, for financial statement reporting purposes, the business combination between 374Water Inc. and PowerVerde, Inc. was treated as a reverse acquisition and recapitalization for accounting purposes with 374Water, Inc. deemed the accounting acquirer and PowerVerde, Inc. deemed the accounting acquiree under the acquisition method of accounting in accordance with FASB Accounting Standards Codification (&#8220;ASC&#8221;) Section 805-10-55.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><span style="text-decoration:underline">The following assets and liabilities were assumed in the transaction:</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">29,536</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Prepaid expense</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">14,483</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accounts Receivable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total assets acquired</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">45,019</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accounts payable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(46,150</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accrued expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(83,094</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total liabilities assumed</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(129,244</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net liabilities assumed</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(84,225</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr></tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140152852708072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><strong>Note 5 &#8211; Intangible Assets</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">Intangible assets are recorded at cost and consist of the license agreement with Duke University. The Company issued Duke University a small block of shares of common stock estimated to have a fair value of $1,073,529 as consideration for granting the Company the license based on the Company&#8217;s common stock market price on the date the license agreement was executed (see Note 8). Intangible assets are comprised of the following as of March 31, 2022 and December 31, 2021:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Name</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Estimated Life</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Balance at December 31, 2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Additions</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Amortization</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Balance at March 31, 2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">License agreement</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">17 Years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,028,114</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">15,787</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,012,327</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Patents</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">20 Years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">34,742</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">436</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">34,306</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Total</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,062,856</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">16,223</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,046,633</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">Depreciation and Amortization expense for the three months ended March 31, 2022, was $16,458.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">Estimated future amortization expense as of March 31, 2022:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">2022 (Remaining 9 months)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">48,663</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">64,884</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">64,884</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">2025</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">64,884</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">2026</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">64,884</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Thereafter</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">738,434</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Intangible assets, Net</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,046,633</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong>Note 5 &#8211; Intangible Assets</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Intangible assets are recorded at cost and consist of the license agreement with Duke University. The Company issued Duke University a small block of shares of common stock estimated to have a fair value of $1,073,529 as consideration for granting the Company the license based on the Company&#8217;s common stock market price on the date the license agreement was executed (see Note 8). Intangible assets are comprised of the following as of December 31, 2021 and 2020:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Name</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Estimated Life</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Balance at</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, 2020</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Additions</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Amortization</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Balance at</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, 2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">License agreement</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">17 Years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,073,529</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">45,415</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,028,114</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Patents</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">20 Years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">34,741</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">34,741</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Total</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,108,270</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">45,415</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,062,855</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Amortization expense for the year ended December 31, 2021 was $45,415. There is no amortization expense associated with the patent expenses. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Estimated future amortization expense as of December 31, 2021:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2022 </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">63,149</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">63,149</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">63,149</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2025</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">63,149</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2026</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">63,149</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Thereafter</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">712,369</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Intangible assets, Net</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,028,114</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140152852644584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholder Equity<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Stockholder Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholder Equity</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><strong>Note 6 &#8211; Stockholder&#8217; Equity</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">The Company is authorized to issue 1,000,000 preferred stock shares and 200,000,000 common stock shares both with a par value of $0.0001.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><strong>Preferred Stock</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">On October 30, 2020, the Company designated 1,000,000 shares as Series D Convertible Preferred Stock with a par value of $0.0001.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">On April 16, 2021, the Company closed on a private placement of 440,125 shares of Series D Convertible Preferred Stock (the &#8220;Preferred Stock&#8221;) with a par value of $0.0001, yielding gross proceeds of $6,551,691 (the &#8220;Private Placement&#8221;) and settlement of a $50,000 liability for Preferred Stock shares. The Private Placement proceeds will be used for working capital, primarily for the development, manufacturing and commercialization of 374Water&#8217;s Air SCWO systems. The Preferred Stock has a stated value of $15 per share, is convertible into common stock at $0.30 per share and has voting rights based on the underlying shares of common stock. Upon liquidation of the Company, the Preferred Stockholders have a liquidation preference before any assets can be distributed to common stockholders. All of the Preferred Stock were sold pursuant to an exemption from registration requirements under Regulation D and/or Section 4(2) of the Securities Act of 1933, as amended. On September 29, 2021, 412,853 shares of Series D Preferred stock were converted into 20,642,667 shares of common stock.&#160; On January 12, 2022, the Company converted the remaining 27,272 shares of Series D Preferred stock to 1,363,149 shares of common stock.&#160; As of March 31, 2022, there were no shares of Series D Preferred stock issued and outstanding.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><strong>Common Stock</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">The holders of common stock are entitled to one vote per share on all matters submitted to a vote of shareholders, including the directors&#8217; election. There is no right to cumulate votes in the election of directors. The holders of common stock are entitled to any dividends that may be declared by the board of directors out of funds legally available for payment of dividends subject to the prior rights of holders of preferred stock and any contractual restrictions the Company has against the payment of dividends on common stock. In the event of our liquidation or dissolution, holders of common stock are entitled to share ratably in all assets remaining after payment of liabilities and the liquidation preferences of any outstanding shares of preferred stock. Holders of common stock have no preemptive rights and have no right to convert their common stock into any other securities. As of March 31, 2022, there were 126,680,895 shares of common stock issued and outstanding.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">On April 16, 2021, as a result of the closing of the Merger Agreement (see Note 4), the equity of the consolidated entity is the historical equity of 374Water, Inc (&#8220;Private 374Water&#8221;) retroactively restated to reflect the number of shares issued by the Company in the reverse recapitalization. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">Pursuant to the Merger, all Private 374Water shares were cancelled and&#160;the Company &#160;issued to the former Private 374Water stockholders a total of 62,410,452 shares of&#160;the Company&#8217;s common stock.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">On April 16, 2021, the Company issued a small block of shares of common stock estimated to have a fair value of $1,073,369 as consideration for the grant of a license to the Company (see Notes 5 and 8).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">During the three months ended March 31, 2022, the Company issued 1,363,149 shares of common stock from the conversion of 27,272 Preferred Stock shares.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><span style="text-decoration:underline">Stock-based compensation</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">During the three months ended March 31, 2022, and 2021, the Company recorded stock-based compensation of $97,558 and $10,433, respectively, related to common stock issued or vested options to employees and various consultants of the Company.&#160; For the three months ended March 31, 2022, $93,868 was charged as general and administrative expenses and $3,690 as research and development expenses in the accompanying condensed consolidated statements of operations.&#160; For the three months ended March 31, 2021, $6,518 was charged as general and administrative expenses and $3,915 as research and development expenses in the accompanying condensed consolidated statements of operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><strong>Stock Options</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">Stock option activity for the three months ended March 31, 2022, is summarized as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Weighted Average Exercise Price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Aggregate Intrinsic Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Weighted Average Remaining Contractual Life (Years)</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Options outstanding at December 31, 2021</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">12,300,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.37</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4,521,310</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5.62</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Granted </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">360,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.33</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Expired/forfeit</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Options outstanding at March 31, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">12,660,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.45</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">5,719,310</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">5.39</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">Total unrecognized compensation associated with these unvested options is approximately $501,471 which will be recognized over a period of four years.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">The fair value of these options granted were estimated on the date of grant, using the Black-Scholes option-pricing model with the following assumptions:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>March 31, 2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Dividend yield</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">0.00%</p></td><td style="width:1%;white-space: nowrap;"/></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Expected life</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">5.65 &#8211; 5.75 Years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Expected volatility</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">37.73 &#8211; 39.18%</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Risk-free interest rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">1.44 &#8211; 2.12%</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><strong>Stock Warrants</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">In April 2021, pursuant to the binding Memorandum of Understanding dated as of March 30, 2021, between 374Water and MB Holding Inc. (the &#8220;MOU&#8221;), a warrant for the purchase of&#160;3,783,333&#160;shares of common stock at an exercise price of $0.30&#160;per share was issued to MB Holding Inc. as consideration for executing the MOU and was considered fully vested upon the execution of the MOU. These warrants were to expire in March 2022. Those warrants were estimated to have a grant-date fair value of $0.37&#160;per warrant or aggregate fair value of $1,399,833&#160;which has been presented as product development expense on the condensed statements of operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">During the year ended December 31, 2021, the warrants were exercised resulting in the issuance of 3,783,333 shares of common stock and proceeds of $1,134,499. Terry Merrell, a member of the Company&#8217;s Board of Directors, has sole voting and dispositive power over the securities held by MB Holdings Inc. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">As of March 31, 2022, there were&#160;1,250,000&#160;warrants outstanding which relate to the Series 1 offering executed in December 2021, where investors were offered a warrant for every two common shares purchased during the offering at an exercise price of $2.50&#160;per share. The intrinsic value of all outstanding warrants as of March 31, 2022 was $437,500&#160;based on the market price of our common stock of $2.85&#160;per share.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">During the three months ended March 31, 2022, no warrants were issued or exercised. As of March 31, 2022, there are 1,250,000 outstanding warrants.&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">&#160;A summary of warrant activity during the three months ended March 31, 2022, is as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Shares</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Weighted Average Exercise Price</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Aggregate Intrinsic Value</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Weighted Average Remaining Contractual Life (Years)</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Balance at December 31, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,250,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2.50</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">437,500</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2.96</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Issued</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">&#8212;&#8212;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Balance at March 31, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,250,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">2.50</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">437,500</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">2.72</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong>Note 6 &#8211; Stockholder&#8217; Equity</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">The Company is authorized to issue 1,000,000 preferred stock shares and 200,000,000 common stock shares both with a par value of $0.0001.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong>Preferred Stock</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">On October 30, 2020, the Company designated 1,000,000 shares as Series D Convertible Preferred Stock with a par value of $0.0001.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">On April 16, 2021, the Company closed on a private placement of 436,782 shares of Series D Convertible Preferred Stock (the &#8220;Preferred Stock&#8221;) with a par value of $.0001, yielding gross proceeds of $6,551,691 (the &#8220;Private Placement&#8221;) and settlement of a $50,000 liability for Preferred Stock shares. The Private Placement proceeds will be used for working capital, primarily for the development, manufacturing and commercialization of 374Water&#8217;s Air SCWO Nix systems. The Preferred Stock has a stated value of $15 per share, is convertible into common stock at $0.30 per share and has voting rights based on the underlying shares of common stock. Upon liquidation of the Company, the Preferred Stockholders have a liquidation preference before any assets can be distributed to common stockholders. The current liquidation value is $409,005. All of the Preferred Stock were sold pursuant to an exemption from registration requirements under Regulation D and/or Section 4(2) of the Securities Act of 1933, as amended. On September 30, 2021, 412,853 shares of Series D Preferred stock were converted into 20,642,667 shares of common stock. As of December 31, 2021, there were 27,272 shares of Series D Preferred stock issued and outstanding.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong>Common Stock</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">The holders of common stock are entitled to one vote per share on all matters submitted to a vote of shareholders, including the directors&#8217; election. There is no right to cumulate votes in the election of directors. The holders of common stock are entitled to any dividends that may be declared by the board of directors out of funds legally available for payment of dividends subject to the prior rights of holders of preferred stock and any contractual restrictions the Company has against the payment of dividends on common stock. In the event of our liquidation or dissolution, holders of common stock are entitled to share ratably in all assets remaining after payment of liabilities and the liquidation preferences of any outstanding shares of preferred stock. Holders of common stock have no preemptive rights and have no right to convert their common stock into any other securities. As of December 31, 2021, there were 125,317,746 shares of common stock issued and outstanding.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">On April 16, 2021, as a result of the closing of the Merger Agreement (see Note 4), the equity of the consolidated entity is the historical equity of 374Water, Inc (&#8220;374Water&#8221;) retroactively restated to reflect the number of shares issued by the Company in the reverse recapitalization.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">In connection with the Merger, 33,203,512 shares of common stock were issued to 374Water, Inc. (f/k/a PowerVerde, Inc.) stockholders.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Pursuant to the Merger, all 374Water shares were cancelled and 374Water, Inc. issued to the former 374Water stockholders a total of 62,410,452 shares of 374Water, Inc. common stock. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">On April 16, 2021, the Company issued&#160;Common Stock estimated to have a fair value of $1,073,369 as consideration for the grant of a license to the Company (see Notes 5 and 8).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">In December 2021, the Company raised $5,000,000 through a private placement and sale of 2,500,000 shares of Common Stock which were issued to investees as part of the capital raise. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">During the year ended December 31, 2021, the Company issued 4,958,833 shares of common stock, in connection with the exercise of warrants and options and received cash proceeds of $1,284,848.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><span style="text-decoration:underline">Stock-based compensation</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">During the year ended December 31, 2021 and 2020, the Company recorded stock-based compensation of $204,217 and $6,657, respectively, related to common stock issued or vested options to employees and various consultants of the Company, of which $190,136 and $328 was charged as general and administrative expenses and $14,081 and $6,329 as research and development expenses in the accompanying consolidated statements of operations during the years ended December 31, 2021 and 2020, respectively</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong>Stock Options</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Stock option activity for the year ended December 31, 2021, is summarized as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise Price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Aggregate</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Intrinsic Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Remaining</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Contractual</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Life (Years)</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Options outstanding at December 31, 2019</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">12,180,500</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.20</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4,750,395</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5.59</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Granted </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#8212;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#8212;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expired/forfeit</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#8212;</p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Options outstanding at December 31, 2020</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">12,180,500</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.20</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4,750,395</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4.59</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Granted </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,885,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.20</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(225,500</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.19</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expired/forfeit</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(2,540,000</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.17</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Options outstanding at December 31, 2021</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">12,300,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.37</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">4,521,310</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">5.62</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Stock option unvested activity for the year ended December 31, 2021, is summarized as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Options</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Options Unvested at December 31, 2019</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Granted </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Vested</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expired/forfeit</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Options Unvested at December 31, 2020</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Granted </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,885,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Vested </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(379,817</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expired/forfeit</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(40,000</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Options Unvested at December 31, 2021</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">2,465,183</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Total unrecognized compensation associated with these unvested options is approximately $1,136,921 which will be recognized over a period of four years. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">The fair value of these options granted were estimated on the date of grant, using the Black-Scholes option-pricing model with the following assumptions:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>For the years ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2020</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Dividend yield</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.00</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"/></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected life</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">5.49 &#8211; 6.25 Years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#8212;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected volatility</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">38.39- 38.67</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"/></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Risk-free interest rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.87&#8211; 1.07</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"/></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong>Stock Warrants</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">In April 2021, pursuant to the binding Memorandum of Understanding dated as of March 30, 2021, between 374Water and MB Holding Inc. (the &#8220;MOU&#8221;), a warrant for the purchase of 3,783,333 shares of common stock at an exercise price of $0.30 per share was issued to MB Holding Inc. as consideration for executing the MOU and was considered fully vested upon the execution of the MOU. These warrants expire in March 2022. Those warrants were estimated to have a grant-date fair value of $0.37 per warrant or aggregate fair value of $1,399,833 which has been presented as product development expense on the condensed statements of operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">During the year ended December 31, 2021, the warrants were exercised resulting in the issuance of 3,783,333 shares of common stock and proceeds of $1,134,499. As of December 31, 2021, there were 1,250,000 warrants outstanding which relate to the Series 1 offering executed in December 2021, where investors were offered a warrant for every two common shares purchased during the offering at an exercise price of $2.50 per share. The intrinsic value of all outstanding warrants as of December 31, 2021 was $437,500 based on the market price of our common stock of $2.85 per share.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">The fair value of those warrants granted were estimated on the date of grant, using the Black-Scholes option-pricing model with the following assumptions:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>For the years ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2020</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Dividend yield</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.00</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected life</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1 - 3 Years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected volatility</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">42.39% - 45.24%</p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Risk-free interest rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.600% - 0.795%</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><table cellpadding="0" style="border-spacing:0;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td class="hpbhr"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">F-14</td></tr><tr style="height:15px"><td><p style="page-break-after: always"/></td></tr><tr style="height:15px"><td><em><a href="#TOCFS">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">A summary of warrant activity during the year ended December 31, 2021, is as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise Price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Aggregate</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Intrinsic Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Remaining</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Contractual</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Life (Years)</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance at December 31, 2019</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">950,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.11</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">690,500</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.44</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Issued</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance at December 31, 2020</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">950,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.11</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">690,500</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.44</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Issued</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,033,333</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.85</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#8212;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(4,733,333</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.26</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance at December 31, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,250,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">2.50</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">437,500</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">2.96</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140152852669048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Note 7 - Related Party Transactions</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">In 2021, the Company entered into an agreement to fabricate and manufacture the AIRSCWO systems&#160;with Merrell Bros. Holding Company. As part of the agreement, the Company&#160;appointed Terry Merrell to its board of directors. As of March 31, 2022, Merrell Bros. or their affiliates own stock in excess of 5% of the outstanding common stock.&#160; As of March 31, 2022, the Company had $50,000 in related party expenses related to the manufacturing of the AIRSCWO systems.&#160;</p><span></span>
</td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong>Note 7 - Related Party Transactions</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At December 31, 2021 and 2020, the Company has due $0 and 15,108, respectively, of advances received from stockholders of the Company for working capital. There is no formal agreement, these advances are non-interest bearing and due on demand. During the years ended December 31, 2021 and 2020, stockholders advanced $0 and 2,053 respectively, for working capital needs. Advancements were fully paid in fiscal year 2021. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our previous CFO John L Hofmann is a member of the accounting firm Kabat, Schertzer, De La Torre, Taraboulos &amp; Co, LLC (&#8220;KSDT&#8221;). The Company paid $43,205 and $0 to KSDT for its services in the year ended December 31, 2021 and 2020, respectively, and $0 of services rendered remain unpaid as of December 31, 2021. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Additionally, the Company entered into an agreement to fabricate and manufacture the units with Merrell Bros. Holding Company. As part of the agreement, the Company provided Terry Merrell a board of director position. As of December 31, 2021, Merrell Bros. own stock in excess of 5% of the outstanding common stock.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140152852604072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and contingencies (Note 8)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments And Contingencies</a></td>
<td class="text"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Note 8 &#8211; Commitments and Contingencies </strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px">The patented technology underlying 374Water&#8217;s supercritical water oxidation (SCWO) units, which was developed principally through the efforts of Messrs. Nagar and Deshusses at the facilities of Duke University, Durham, North Carolina (&#8220;Duke&#8221;), where Dr. Deshusses is a professor, is licensed to 374Water pursuant to a worldwide license agreement with Duke executed on April 16, 2021 (the &#8220;License Agreement&#8221;). In connection with the License Agreement, 374Water also executed an equity transfer Agreement with Duke pursuant to which Duke received a small block of common stock in the Company (See Notes 4 and 6). Under the terms of the License Agreement, the Company is required to make royalty payments based on a percentage of licensed product sales, as defined in the License Agreement which is triggered by the sale of licensed products. Further, the Company is also required to pay royalties on a percentage of sublicensing fees. The Company will reimburse Duke for any ongoing patent expenses incurred. During the three month period ending March 31, 2022, the Company has not incurred any expenses in connection with this License Agreement. The Company may terminate the license agreement anytime by providing Duke 60 days&#8217; written notice.</p><span></span>
</td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong>Note 8 &#8211; Commitments and Contingencies </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">The patented technology underlying 374Water&#8217;s supercritical water oxidation (SCWO) units, which was developed principally through the efforts of Messrs. Nagar and Deshusses at the facilities of Duke University, Durham, North Carolina (&#8220;Duke&#8221;), where Dr. Deshusses is a professor, is licensed to 374Water pursuant to a worldwide license agreement with Duke executed on April 16, 2021 (the &#8220;License Agreement&#8221;). In connection with the License Agreement, 374Water also executed an equity transfer Agreement with Duke pursuant to which Duke received a small block of common stock in the Company (See Notes 4 and 6). Under the terms of the License Agreement, the Company is required to make royalty payments based on a percentage of licensed product sales, as defined in the License Agreement which is triggered by the sale of licensed products. Further, the Company is also required to pay royalties on a percentage of sublicensing fees. The Company will reimburse Duke for any ongoing patent expenses incurred. During the year ended December 31, 2021, the Company has incurred $19,075 in connection with this License Agreement. The Company may terminate the license agreement anytime by providing Duke 60 days&#8217; notice.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140152852560632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income taxes</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong>Note 9 &#8211; Income Taxes </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Deferred income taxes are provided based on the provisions of ASC Topic 740, &#8220;Accounting for Income Taxes&#8221;, to reflect the tax consequences in future years of differences between the tax basis of assets and liabilities and their financial reporting amounts based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Significant components of the Company&#8217;s net deferred income taxes are as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2020</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Deferred tax assets:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Goodwill </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">208,742</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Capitalized Start-Up Costs</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">83,710</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Other Intangibles</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">10,339</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Other Accruals</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,875</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Stock Compensation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">17,423</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,764</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Operating Loss</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">381,112</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Deferred tax assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">703,211</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,764</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Less valuation allowance</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(703,083 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(1,764 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net deferred tax assets after valuation allowance</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">128</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2020</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Deferred tax liabilities:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Depreciation </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(128 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Deferred tax liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(128 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,764</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net deferred tax asset (liability) </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">A reconciliation of the U.S. statutory federal income tax rate to the effective income tax rate (benefit) follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong>Rate Reconciliation</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2020</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Rate Reconciliation</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Federal income tax at statutory rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">21.00</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">21.00</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Change in State Tax</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Change in Valuation Allowance</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-22.16</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">19.11</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Permanent Differences</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-12.26</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">State Taxes </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.98</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5.50</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Other</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">11.44</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-45.61</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">At December 31, 2021, the Company had U.S. federal net operating loss carryforwards of approximately $1.7 million, which will carry forward indefinitely.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">NOLs that were acquired with the acquisition of businesses are excluded from the amount of available NOLs to the extent their use is limited by the provisions of Section 382 of the Internal Revenue Code. Under the provisions of the Internal Revenue Code, certain substantial changes in the Company&#8217;s ownership may result in further limitation on the amount of net operating loss carryforwards which can be utilized in future years.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">In evaluating the amount of the valuation allowance against its deferred tax assets as of December 31, 2021 and 2020, the Company considered all available positive and negative evidence and concluded that it is more likely than not that a portion of its deferred tax assets would not be realized. Accordingly, the Company has recorded a valuation allowance against its net deferred tax assets due to the uncertainty surrounding the realization of such assets.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">The Company had no unrecognized tax benefits as of December 31, 2021 and 2020. The Company does not anticipate a significant change in total unrecognized tax benefits within the next 12 months. Tax years 2018-2020 remain open to examination by the major taxing jurisdictions to which the Company is subject.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140152852729496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Revenue<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueAbstract', window );"><strong>Deferred Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueDisclosureTextBlock', window );">Deferred Revenue</a></td>
<td class="text"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Note 9 &#8211; Deferred Revenue</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">As of March&#160;31, 2022 and March 31, 2021, the Company had total deferred revenue of $763,333 and $0, respectively. As of March&#160;31, 2022, the Company expects&#160;100% of total deferred revenue to be realized in less than a year.&#160; </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for deferred revenues at the end of the reporting period, and description and amounts of significant changes that occurred during the reporting period. Deferred revenue is a liability as of the balance sheet date related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 430<br> -URI http://asc.fasb.org/topic&amp;trid=2122452<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140152852710152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequents Events</a></td>
<td class="text"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Note 10 &#8211; Subsequent Events </strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">Effective April 13, 2022, in accordance with Section 228 of the Delaware Corporation Law, shareholders of the Company holding a majority of the voting power of the Company (the &#8220;Consenting Shareholders&#8221;) approved the adoption of the Company&#8217;s 2021 Equity Incentive Plan, reserving up to 10,000,000 shares of Common Stock for issuance in connection with awards thereunder (the &#8220;Equity Plan Adoption&#8221;).&#160; </p><span></span>
</td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong>Note 10 &#8211; Subsequent Events </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">On Feb 17, 2022, the Company opened 374Water Sustainability Israel LTD in Israel as a subsidiary of the Company.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Effective February 7, 2022, Israel Abitbol was promoted to CFO of the Company and the prior CFO, John Hofmann, moved to a senior vice president role. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">On February 2, 2022, the Company signed a MOU with Environmental Services Company Ltd. An Israeli based company, in order to produce and sell the second AirSCWO unit. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">On February 1, 2022, the Company sold its first AirSCWO unit to the Orange County Sanitation District of Fountain Valley, California. </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140152856007832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. The Company held no cash equivalents as of March 31, 2022, and December 31, 2021.</p><span></span>
</td>
<td class="text">The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. The Company held no cash equivalents as of December 31, 2021 and 2020.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">Concentration of Credit Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Financial instruments that potentially subject the Company to credit risk consist of cash and cash equivalents. Deposits with financial institutions are insured, up to certain limits, by the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;). The Company&#8217;s cash deposits often exceed the FDIC insurance limit; however, all deposits are maintained with high credit quality institutions and the Company has not experienced any losses in such accounts. The financial condition of financial institutions is periodically reassessed, and the Company believes the risk of any loss is minimal. The Company believes the risk of any loss on cash due to credit risk is minimal.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivable</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">Accounts receivables consist of balances due from service revenues. The Company monitors accounts receivable and provides allowances when considered necessary. At March 31, 2022 and December 31, 2021, there were no outstanding accounts receivable. Accordingly, no allowance for doubtful accounts was provided.</p><span></span>
</td>
<td class="text">Accounts receivables consist of balances due from service revenues. The Company monitors accounts receivable and provides allowances when considered necessary. At December 31, 2021 and 2020, accounts receivable were considered to be fully collectible. Accordingly, no allowance for doubtful accounts was provided and there was no bad debt expense as of December 31, 2021 and 2020. <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_EquipmentPolicy', window );">Equipment</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">Equipment is recorded at cost. Depreciation is computed using the straight-line method and an estimated useful live of three years. Expenses for maintenance and repairs are charged to expense as incurred.&#160; The Company&#8217;s depreciation expense in the period is $235.</p><span></span>
</td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Equipment is recorded at cost. Depreciation is computed using the straight-line method and an estimated useful life of three years. Expenses for maintenance and repairs are charged to expense as incurred.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsFiniteLivedPolicy', window );">Intangible Assets</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">Intangible assets are subject to amortization, and any impairment is determined in accordance with ASC 360, &#8220;Property, Plant, and Equipment.&#8221; Intangible assets are stated at historical cost and amortized over their estimated useful lives. The Company uses a straight-line method of amortization, unless a method that better reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up can be reliably determined.</p><span></span>
</td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Intangible assets are subject to amortization, and any impairment is determined in accordance with ASC 360, &#8220;Property, Plant, and Equipment.&#8221; Intangible assets are stated at historical cost and amortized over their estimated useful lives. The Company uses a straight-line method of amortization, unless a method that better reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up can be reliably determined.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_LongLivedAssetsPolicy', window );">Long-Lived Assets</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">The Company reviews long-lived assets, including intangible assets with finite lives, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company uses an estimate of the undiscounted cash flows over the remaining life of its long-lived assets, or related group of assets where applicable, in measuring whether the assets to be held and used will be realizable. Recoverability of assets held and used is measured by a comparison of the carrying amount to the future undiscounted expected net cash flows to be generated by the asset. As of March 31, 2022, and 2021, there were no events or changes in circumstances requiring an impairment analysis.</p><span></span>
</td>
<td class="text">The Company reviews long-lived assets, including intangible assets with finite lives, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company uses an estimate of the undiscounted cash flows over the remaining life of its long-lived assets, or related group of assets where applicable, in measuring whether the assets to be held and used will be realizable. Recoverability of assets held and used is measured by a comparison of the carrying amount to the future undiscounted expected net cash flows to be generated by the asset. As of December 31, 2021 and 2020, there were no impairments.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_RevenueRecognitionAndConcentrationPolicy', window );">Revenue Recognition and Concentration</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">The Company follows the revenue standards of Financial Accounting Standards Board Update No. 2014-09: &#8220;Revenue from Contracts with Customers (Topic 606).&#8221; The core principle of this Topic is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Revenue is recognized in accordance with that core principle by applying the following five steps: 1) identify the contracts with a customer; 2) identify the performance obligations in the contract; 3) determine the transaction price; 4) allocate the transaction price to the performance obligations; and 5) recognize revenue when (or as) we satisfy a performance obligation.&#160; Deferred revenue primarily consists of billings or payments received in advance of revenue recognition from the completion of the equipment build for each customer as the outputs are measured against the cost to build the product.&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">The Company&#8217;s performance obligations will be satisfied overtime as the specialized equipment is built for the customer.&#160; Based on the Company&#8217;s contracts, the Company will have a single performance obligation (build and install of the product). The Company will primarily receive fixed consideration for sales of product. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">Revenues for the three months ended March 31, 2022 were generated from the sale of the first AIRSCWO system.&#160; &#160;For the three months ended March 31, 2021, the Company did not have any revenues.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">&#160;</p><span></span>
</td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">The Company follows the revenue standards of Financial Accounting Standards Board Update No. 2014-09: &#8220;Revenue from Contracts with Customers (Topic 606).&#8221; The core principle of this Topic is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Revenue is recognized in accordance with that core principle by applying the following five steps: 1) identify the contracts with a customer; 2) identify the performance obligations in the contract; 3) determine the transaction price; 4) allocate the transaction price to the performance obligations; and 5) recognize revenue when (or as) we satisfy a performance obligation.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">The Company&#8217;s performance obligations will be satisfied at the point in time when products are shipped or delivered to the customer, which is when the customer has title and the significant risks and rewards of ownership. Therefore, the Company&#8217;s contracts will have a single performance obligation (shipment or delivery of product). The Company will primarily receive fixed consideration for sales of product. Manufacturing assembly services are recognized as revenue when the assembled product is delivered to the customer and the Company has completed its performance obligations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Revenues for the year ended December 31, 2021 were generated from consulting and advisory service agreements, which were recognized when the Company completed its performance obligations under the relevant service agreements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">During the year ended December 31, 2020, 100% of the Company&#8217;s revenues were earned from consulting and advisory services, which were recognized when the Company performed the service pursuant to its agreement with its clients which was the point in time when the Company completed its performance obligations under the agreements. One customer accounted for approximately 88% of revenues in 2020 and 92% of accounts receivable at December 31, 2020. Revenues generated in 2020 were not from the Company&#8217;s planned operations. </p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-based Compensation</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">The Company has accounted for stock-based compensation under the provisions of Accounting Standards Codification (ASC) Topic 718 &#8211; &#8220;Stock Compensation&#8221; which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments (stock options and common stock purchase warrants). The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate. Expected volatilities are based on historical volatility of peer companies and other factors estimated over the expected term of the stock options. The expected term of options granted is derived using the &#8220;simplified method&#8221; which computes expected term as the average of the sum of the vesting term plus the contract term. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term.</p><span></span>
</td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">The Company has accounted for stock-based compensation under the provisions of Accounting Standards Codification (ASC) Topic 718 &#8211; &#8220;Stock Compensation&#8221; which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments (stock options and common stock purchase warrants). The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate. Expected volatilities are based on historical volatility of peer companies and other factors estimated over the expected term of the stock options. The expected term of options granted is derived using the &#8220;simplified method&#8221; which computes expected term as the average of the sum of the vesting term plus the contract term. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxUncertaintiesPolicy', window );">Accounting for Uncertainty in Income Taxes</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">The Company&#160;follows the provisions of ASC Topic 740-10, &#8220;Accounting for Uncertainty in Income Taxes&#8221; which clarifies the accounting for uncertainty in income taxes recognized in an enterprise&#8217;s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This topic also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. There were no uncertain tax positions as of March 31, 2022, and December 31, 2021.</p><span></span>
</td>
<td class="text">The Company follows the provisions of ASC Topic 740-10, &#8220;Accounting for Uncertainty in Income Taxes&#8221; which clarifies the accounting for uncertainty in income taxes recognized in an enterprise&#8217;s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This topic also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. There were no uncertain tax positions as of December 31, 2021 and 2020.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Tax Policy</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">The Company accounts for income taxes using the liability method prescribed by ASC 740 - Income Taxes. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets if, based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the period that includes the enactment date.</p><span></span>
</td>
<td class="text">The Company accounts for income taxes using the liability method prescribed by ASC 740 - Income Taxes. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets if, based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the period that includes the enactment date.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Costs</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">The Company&#8217;s research and development costs are expensed in the period in which they are incurred. Such expenditures amounted to $185,653 and $29,185 for the three months ended March 31, 2022, and 2021, respectively.&#160; </p><span></span>
</td>
<td class="text">The Company&#8217;s research and development costs are expensed in the period in which they are incurred. Such expenditures amounted to $375,032 and $57,718 for the years ended December 31, 2021 and 2020, respectively. <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings (Loss) Per Share</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">Earnings (loss) per share is computed in accordance with FASB ASC Topic 260, &#8220;Earnings per Share&#8221;. Diluted earnings per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities outstanding during the period. Certain common stock equivalents were not included in the earnings (loss) per share calculation as their effect would be anti-dilutive. As of March 31, 2022, there were the following potentially dilutive securities that were excluded from diluted net loss per share because their effect would be antidilutive: options for 12,660,000 shares of common stock.&#160; There were no dilutive shares as of March 31, 2022.</p><span></span>
</td>
<td class="text">Earnings (loss) per share is computed in accordance with FASB ASC Topic 260, &#8220;Earnings per Share&#8221;. Diluted earnings per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities outstanding during the period. Certain common stock equivalents were not included in the earnings (loss) per share calculation as their effect would be anti-dilutive. As of December 31, 2021, there were the following potentially dilutive securities that were excluded from diluted net loss per share because their effect would be antidilutive: options for 12,596,000 shares of common stock and 1,363,350 common stock shares issuable upon conversion of the Series D Preferred Stock. There were no dilutive shares as of December 31, 2020.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Financial Instruments</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">The Company carries cash, accounts receivable, accounts payable and accrued expenses, at historical costs. The respective estimated fair values of these assets and liabilities approximate carrying values / useful lives of equipment and intangible assets due to their current nature.</p><span></span>
</td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">The Company carries cash, accounts receivable, accounts payable and accrued expenses, at historical costs. The respective estimated fair values of these assets and liabilities approximate carrying values / useful lives of equipment and intangible assets due to their current nature.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates in the accompanying financial statements include the fair value of equity-based compensation, useful lives of intangible assets, and valuation allowance against deferred tax assets.</p><span></span>
</td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates in the accompanying financial statements include the fair value of equity-based compensation, fair value of intangible assets, useful lives of intangible assets, capital raise transactions, and valuation allowance against deferred tax assets.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">All other newly issued but not yet effective accounting pronouncements have been deemed to be not applicable or immaterial to the Company.&#160;</p><span></span>
</td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">In August 2020, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2020-06, Debt &#8212; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#8212; Contracts in Entity&#8217;s Own Equity (Subtopic 815-40) (&#8220;ASU 2020-06&#8221;) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity&#8217;s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity&#8217;s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company notes that there will be no effect on the current financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">There are several other new accounting pronouncements issued or proposed by the FASB. Each of these pronouncements, as applicable, has been or will be adopted by the Company. Management does not believe any of these accounting pronouncements has had or will have a material impact on the Company&#8217;s condensed consolidated financial position, operating results, or cash flows.&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_EquipmentPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_EquipmentPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_LongLivedAssetsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_LongLivedAssetsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_RevenueRecognitionAndConcentrationPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_RevenueRecognitionAndConcentrationPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxUncertaintiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for tax positions taken in the tax return filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other types of contingencies related to income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxUncertaintiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsFiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155638-234783<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155628-234783<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155628-234783<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsFiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140152852705144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisition of 374Water Inc fka PowerVerde Inc (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Acquisition of 374Water Inc fka PowerVerde Inc</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule Of Assets And Liabilities Were Assumed</a></td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Cash</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">29,536</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Prepaid expense</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">14,483</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Accounts Receivable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Total assets acquired</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">45,019</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Accounts payable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(46,150 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Accrued expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(83,094 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Total liabilities assumed</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(129,244 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Net liabilities assumed</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(84,225 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr></tbody></table><span></span>
</td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">29,536</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Prepaid expense</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">14,483</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accounts Receivable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total assets acquired</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">45,019</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accounts payable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(46,150</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accrued expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(83,094</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total liabilities assumed</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(129,244</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net liabilities assumed</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(84,225</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr></tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1486-128463<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140152854946984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule Of Intangible Assets</a></td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Name</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Estimated Life</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Balance at December 31, 2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Additions</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Amortization</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Balance at March 31, 2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">License agreement</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">17 Years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,028,114</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">15,787</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,012,327</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Patents</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">20 Years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">34,742</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">436</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">34,306</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Total</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,062,856</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">16,223</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,046,633</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Name</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Estimated Life</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Balance at</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, 2020</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Additions</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Amortization</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Balance at</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, 2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">License agreement</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">17 Years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,073,529</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">45,415</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,028,114</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Patents</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">20 Years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">34,741</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">34,741</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Total</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,108,270</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">45,415</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,062,855</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule Of Future Amortization Expense</a></td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">2022 (Remaining 9 months)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">48,663</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">64,884</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">64,884</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">2025</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">64,884</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">2026</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">64,884</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Thereafter</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">738,434</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Intangible assets, Net</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,046,633</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2022 </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">63,149</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">63,149</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">63,149</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2025</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">63,149</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2026</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">63,149</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Thereafter</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">712,369</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Intangible assets, Net</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,028,114</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140152852827352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholder Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule Of Stock Option Activity</a></td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Weighted Average Exercise Price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Aggregate Intrinsic Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Weighted Average Remaining Contractual Life (Years)</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Options outstanding at December 31, 2021</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">12,300,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.37</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4,521,310</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5.62</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Granted </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">360,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.33</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Expired/forfeit</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Options outstanding at March 31, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">12,660,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.45</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">5,719,310</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">5.39</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise Price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Aggregate</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Intrinsic Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Remaining</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Contractual</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Life (Years)</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Options outstanding at December 31, 2019</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">12,180,500</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.20</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4,750,395</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5.59</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Granted </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#8212;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#8212;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expired/forfeit</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#8212;</p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Options outstanding at December 31, 2020</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">12,180,500</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.20</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4,750,395</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4.59</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Granted </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,885,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.20</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(225,500</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.19</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expired/forfeit</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(2,540,000</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.17</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Options outstanding at December 31, 2021</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">12,300,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.37</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">4,521,310</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">5.62</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule Of Warrant Activity</a></td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Shares</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Weighted Average Exercise Price</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Aggregate Intrinsic Value</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Weighted Average Remaining Contractual Life (Years)</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Balance at December 31, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,250,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2.50</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">437,500</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2.96</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Issued</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">&#8212;&#8212;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Balance at March 31, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,250,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">2.50</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">437,500</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">2.72</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Options</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Options Unvested at December 31, 2019</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Granted </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Vested</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expired/forfeit</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Options Unvested at December 31, 2020</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Granted </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,885,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Vested </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(379,817</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expired/forfeit</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(40,000</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Options Unvested at December 31, 2021</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">2,465,183</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_StockOptionMember', window );">Stock Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule Of Stock Option Assumptions</a></td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>March 31, 2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Dividend yield</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">0.00%</p></td><td style="width:1%;white-space: nowrap;"/></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Expected life</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">5.65 &#8211; 5.75 Years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Expected volatility</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">37.73 &#8211; 39.18%</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Risk-free interest rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">1.44 &#8211; 2.12%</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>For the years ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2020</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Dividend yield</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.00</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"/></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected life</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">5.49 &#8211; 6.25 Years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#8212;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected volatility</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">38.39- 38.67</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"/></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Risk-free interest rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.87&#8211; 1.07</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"/></tr></tbody></table><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>For the years ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2020</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Dividend yield</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.00</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected life</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1 - 3 Years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected volatility</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">42.39% - 45.24%</p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Risk-free interest rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.600% - 0.795%</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise Price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Aggregate</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Intrinsic Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Remaining</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Contractual</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Life (Years)</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance at December 31, 2019</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">950,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.11</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">690,500</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.44</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Issued</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance at December 31, 2020</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">950,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.11</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">690,500</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.44</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Issued</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,033,333</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.85</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#8212;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(4,733,333</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.26</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance at December 31, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,250,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">2.50</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">437,500</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">2.96</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6784392&amp;loc=d3e188667-122775<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140152852574152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_IncomeTaxesAbstract', window );"><strong>Income Taxes (Tables)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Significant components of the Company&#8217;s net deferred income taxes are as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2020</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Deferred tax assets:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Goodwill </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">208,742</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Capitalized Start-Up Costs</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">83,710</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Other Intangibles</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">10,339</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Other Accruals</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,875</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Stock Compensation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">17,423</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,764</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net Operating Loss</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">381,112</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Deferred tax assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">703,211</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,764</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Less valuation allowance</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(703,083 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(1,764 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net deferred tax assets after valuation allowance</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">128</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2020</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Deferred tax liabilities:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Depreciation </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(128 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Deferred tax liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(128 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,764</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net deferred tax asset (liability) </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation</a></td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2020</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Rate Reconciliation</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Federal income tax at statutory rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">21.00</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">21.00</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Change in State Tax</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Change in Valuation Allowance</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-22.16</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">19.11</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Permanent Differences</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-12.26</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">State Taxes </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.98</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5.50</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Other</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">11.44</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-45.61</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr></tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_IncomeTaxesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_IncomeTaxesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140152852744936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Business and Presentation of Financial Statements (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr><th class="th">
<div>Apr. 16, 2021 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Nature of Business and Presentation of Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_SharesIssuedToFormerHolder', window );">Shares issued to former holder</a></td>
<td class="nump">62,410,452<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_MergerEffectDescription', window );">Merger effect description</a></td>
<td class="text">Immediately following the Merger, 374Water changed its name to 374Water Systems Inc and PowerVerde changed its name to 374Water, Inc. After the Merger, the former 374Water stockholders own 65.8% of 374Water Inc&#8217;s issued and outstanding common stock and 53.8% of 374Water Inc.&#8217;s issued and outstanding voting stock which includes the Preferred Stock.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_MergerEffectDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_MergerEffectDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_SharesIssuedToFormerHolder">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_SharesIssuedToFormerHolder</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140152854834920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">$ 235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research And Development Cost</a></td>
<td class="nump">$ 185,653<span></span>
</td>
<td class="nump">$ 29,185<span></span>
</td>
<td class="nump">$ 375,032<span></span>
</td>
<td class="nump">$ 57,718<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Excluded From Computation Of Earnings Per Share, Shares</a></td>
<td class="nump">12,660,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Uncertain tax positions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Loss on impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=scwo_WarrantsMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Excluded From Computation Of Earnings Per Share, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,596,000<span></span>
</td>
<td class="nump">1,363,350<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=scwo_WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=scwo_WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140152852866552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Liquidity Capital Resources and Going Concern (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Nature of Business and Presentation of Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated Deficit</a></td>
<td class="nump">$ 4,032,873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,160,015<span></span>
</td>
<td class="num">$ (4,593)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (loss)</a></td>
<td class="num">(872,858)<span></span>
</td>
<td class="num">$ (66,551)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,164,608)<span></span>
</td>
<td class="nump">40,337<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInContinuingOperations', window );">Net Cash Used In Operations</a></td>
<td class="nump">115,911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_WorkingCapital', window );">Working capital</a></td>
<td class="nump">$ 10,501,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,263,270<span></span>
</td>
<td class="nump">$ 10,572<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Proceed from sales of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="nump">6,551,745<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_NetCashProvidedByUsedInOperatingActivity', window );">Net cash used in operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,840,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_NetCashProvidedByUsedInOperatingActivity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_NetCashProvidedByUsedInOperatingActivity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_WorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_WorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in cash associated with the entity's continuing operating, investing, and financing activities. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140152850851096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisition of 374Water Inc fka PowerVerde Inc (Details) - 374Water, Inc. [Member] - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="nump">$ 29,536<span></span>
</td>
<td class="nump">$ 29,536<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expense</a></td>
<td class="nump">14,483<span></span>
</td>
<td class="nump">14,483<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts Receivable</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets acquired</a></td>
<td class="nump">45,019<span></span>
</td>
<td class="nump">45,019<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">46,150<span></span>
</td>
<td class="nump">46,150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability', window );">Accrued expenses</a></td>
<td class="num">(83,094)<span></span>
</td>
<td class="nump">83,094<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities assumed</a></td>
<td class="nump">129,244<span></span>
</td>
<td class="nump">129,244<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net liabilities assumed</a></td>
<td class="num">$ (84,225)<span></span>
</td>
<td class="nump">$ 84,225<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liability arising from an inherited contingency (as defined) which has been recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=scwo_ThreeSevenFourWaterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=scwo_ThreeSevenFourWaterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140152851053656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisition of 374Water Inc fka PowerVerde Inc (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 16, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Gross Proceeds From Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,551,691<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ChiefExecutiveOfficerMember', window );">CEO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalariesAndWages', window );">Annual Salary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=scwo_MrNagarMember', window );">Mr Nagar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalariesAndWages', window );">Annual Salary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_AnnaulSalaryIncreasedAmount', window );">Annaul Salary Increased Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember', window );">Series D Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_Description', window );">Description Issuance Of The Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">the former Private 374Water shareholders own 65.8% of the Company&#8217;s issued and outstanding common stock and 53.8% of the Company&#8217;s issued and outstanding voting stock<span></span>
</td>
<td class="text">the former 374Water shareholders own 65.8% of 374Water Inc&#8217;s issued and outstanding common stock and 53.8% of 374Water Inc.&#8217;s issued and outstanding voting stock<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Gross Proceeds From Private Placement</a></td>
<td class="nump">$ 6,551,691<span></span>
</td>
<td class="nump">$ 6,551,745<span></span>
</td>
<td class="nump">$ 6,551,745<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PartnersCapitalAccountUnitsSoldInPrivatePlacement', window );">Shares In Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">436,783<span></span>
</td>
<td class="nump">436,783<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_SettlementOfLiabilityForPreferredStockShares', window );">Settlement Of Liability For Preferred Stock Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_AnnaulSalaryIncreasedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_AnnaulSalaryIncreasedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_Description">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_Description</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_SettlementOfLiabilityForPreferredStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_SettlementOfLiabilityForPreferredStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PartnersCapitalAccountUnitsSoldInPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of units sold in a private placement of each class of partners' capital account. Units represent shares of ownership of the general, limited, and preferred partners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 4.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187171-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PartnersCapitalAccountUnitsSoldInPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalariesAndWages">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary and wage arising from service rendered by nonofficer employee. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalariesAndWages</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=scwo_MrNagarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=scwo_MrNagarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140152851015944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">$ 16,223<span></span>
</td>
<td class="nump">$ 45,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Book Value</a></td>
<td class="nump">1,046,633<span></span>
</td>
<td class="nump">1,062,855<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=scwo_LicenseAgreementMember', window );">License Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">15,787<span></span>
</td>
<td class="nump">45,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Book Value</a></td>
<td class="nump">1,012,327<span></span>
</td>
<td class="nump">1,028,114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_IntangibleAssetsAdditions', window );">Intangible Assets Additions</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1,073,529<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible Assets Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,062,856<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated Life</a></td>
<td class="text">17 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">$ 436<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Book Value</a></td>
<td class="nump">34,306<span></span>
</td>
<td class="nump">34,741<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_IntangibleAssetsAdditions', window );">Intangible Assets Additions</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">34,741<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible Assets Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,742<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated Life</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_IntangibleAssetsAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_IntangibleAssetsAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=scwo_LicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=scwo_LicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140152850744968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets (Details 1) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">2022 (remaining 9 Months)</a></td>
<td class="nump">$ 48,663<span></span>
</td>
<td class="nump">$ 63,149<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2023</a></td>
<td class="nump">64,884<span></span>
</td>
<td class="nump">63,149<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2024</a></td>
<td class="nump">64,884<span></span>
</td>
<td class="nump">63,149<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2025</a></td>
<td class="nump">64,884<span></span>
</td>
<td class="nump">63,149<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2026</a></td>
<td class="nump">64,884<span></span>
</td>
<td class="nump">63,149<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">738,434<span></span>
</td>
<td class="nump">712,369<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible Assets, Net</a></td>
<td class="nump">$ 1,046,633<span></span>
</td>
<td class="nump">$ 1,028,114<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140152856501928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization Of Intangible Assets</a></td>
<td class="nump">$ 16,458<span></span>
</td>
<td class="nump">$ 45,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Shares Issued, Fair Value</a></td>
<td class="nump">12,669<span></span>
</td>
<td class="nump">12,531<span></span>
</td>
<td class="nump">$ 6,241<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=scwo_LicenseAgreementMember', window );">License Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Shares Issued, Fair Value</a></td>
<td class="nump">$ 1,073,529<span></span>
</td>
<td class="nump">$ 1,073,529<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=scwo_LicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=scwo_LicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140152849055544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholder Equity (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,033,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Exercised</a></td>
<td class="nump">27,272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price ,Beginning</a></td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="nump">$ 0.11<span></span>
</td>
<td class="nump">$ 0.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price ,ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="nump">$ 0.11<span></span>
</td>
<td class="nump">$ 0.11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Beginng</a></td>
<td class="nump">$ 437,500<span></span>
</td>
<td class="nump">$ 690,500<span></span>
</td>
<td class="nump">$ 690,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value ,ending</a></td>
<td class="nump">$ 437,500<span></span>
</td>
<td class="nump">$ 437,500<span></span>
</td>
<td class="nump">$ 690,500<span></span>
</td>
<td class="nump">$ 690,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Life(Years)</a></td>
<td class="text">2 years 8 months 19 days<span></span>
</td>
<td class="text">2 years 11 months 15 days<span></span>
</td>
<td class="text">1 year 5 months 8 days<span></span>
</td>
<td class="text">5 months 8 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=scwo_OptionsMember', window );">Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options Outstanding, Beginning Balance</a></td>
<td class="nump">12,300,000<span></span>
</td>
<td class="nump">12,180,500<span></span>
</td>
<td class="nump">12,180,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted</a></td>
<td class="nump">360,000<span></span>
</td>
<td class="nump">2,885,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Expired/forfeited</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,540,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options Outstanding, Ending Balance</a></td>
<td class="nump">12,660,000<span></span>
</td>
<td class="nump">12,300,000<span></span>
</td>
<td class="nump">12,180,500<span></span>
</td>
<td class="nump">12,180,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(225,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price ,Beginning</a></td>
<td class="nump">$ 0.37<span></span>
</td>
<td class="nump">$ 0.20<span></span>
</td>
<td class="nump">$ 0.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice', window );">Weighted Average Exercise Price, Granted</a></td>
<td class="nump">3.33<span></span>
</td>
<td class="nump">1.20<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice', window );">Weighted Average Exercise Price, Exercised</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0.19<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice', window );">Weighted Average Exercise Price, Expired/forfeit</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0.17<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price ,ending</a></td>
<td class="nump">$ 0.45<span></span>
</td>
<td class="nump">$ 0.37<span></span>
</td>
<td class="nump">$ 0.20<span></span>
</td>
<td class="nump">$ 0.20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Beginng</a></td>
<td class="nump">$ 4,521,310<span></span>
</td>
<td class="nump">$ 4,750,395<span></span>
</td>
<td class="nump">$ 4,750,395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value ,ending</a></td>
<td class="nump">$ 5,719,310<span></span>
</td>
<td class="nump">$ 4,521,310<span></span>
</td>
<td class="nump">$ 4,750,395<span></span>
</td>
<td class="nump">$ 4,750,395<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Life(Years)</a></td>
<td class="text">5 years 4 months 20 days<span></span>
</td>
<td class="text">5 years 7 months 13 days<span></span>
</td>
<td class="text">4 years 7 months 2 days<span></span>
</td>
<td class="text">5 years 7 months 2 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=scwo_OptionUnvestedMember', window );">Options Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options Outstanding, Beginning Balance</a></td>
<td class="nump">2,465,183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,885,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(379,817)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Expired/forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(40,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options Outstanding, Ending Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,465,183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=scwo_OptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=scwo_OptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=scwo_OptionUnvestedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=scwo_OptionUnvestedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140152853787512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholder Equity (Details 1) - Options [Member]<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=scwo_OptionsMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected Life</a></td>
<td class="text">5 years 7 months 24 days<span></span>
</td>
<td class="text">5 years 5 months 26 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">37.73%<span></span>
</td>
<td class="nump">38.39%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">1.44%<span></span>
</td>
<td class="nump">0.87%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=scwo_OptionsMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected Life</a></td>
<td class="text">5 years 9 months<span></span>
</td>
<td class="text">6 years 3 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">39.18%<span></span>
</td>
<td class="nump">38.67%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">2.12%<span></span>
</td>
<td class="nump">1.07%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=scwo_OptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=scwo_OptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=scwo_MinimumsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=scwo_MinimumsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=scwo_MaximumsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=scwo_MaximumsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140152850907752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholder Equity (Details 2) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Balance At Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250,000<span></span>
</td>
<td class="nump">950,000<span></span>
</td>
<td class="nump">950,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Shares Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,033,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised', window );">Shares Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,733,333)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Balance At End</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250,000<span></span>
</td>
<td class="nump">1,250,000<span></span>
</td>
<td class="nump">950,000<span></span>
</td>
<td class="nump">950,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Beginng</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 437,500<span></span>
</td>
<td class="nump">$ 690,500<span></span>
</td>
<td class="nump">$ 690,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value ,ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 437,500<span></span>
</td>
<td class="nump">$ 437,500<span></span>
</td>
<td class="nump">$ 690,500<span></span>
</td>
<td class="nump">$ 690,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Life(years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 8 months 19 days<span></span>
</td>
<td class="text">2 years 11 months 15 days<span></span>
</td>
<td class="text">1 year 5 months 8 days<span></span>
</td>
<td class="text">5 months 8 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price ,Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="nump">$ 0.11<span></span>
</td>
<td class="nump">$ 0.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Exercise Price Issued</a></td>
<td class="nump">$ 0.37<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_WeightedAverageExercisePriceExercised', window );">Weighted Average Exercise Price Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Exercise Price Balance At Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="nump">$ 0.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=scwo_WarrantsMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=scwo_WarrantsMember', window );">Warrant [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42.39%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=scwo_WarrantsMember', window );">Warrant [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45.24%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.795%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_WeightedAverageExercisePriceExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_WeightedAverageExercisePriceExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-option equity instruments exercised by participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=scwo_WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=scwo_WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=scwo_MinimumsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=scwo_MinimumsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=scwo_MaximumsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=scwo_MaximumsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140152850816360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholder Equity (Details 3) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Stockholder Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Balance At Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250,000<span></span>
</td>
<td class="nump">950,000<span></span>
</td>
<td class="nump">950,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Beginng</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 437,500<span></span>
</td>
<td class="nump">$ 690,500<span></span>
</td>
<td class="nump">$ 690,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Life(Years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 8 months 19 days<span></span>
</td>
<td class="text">2 years 11 months 15 days<span></span>
</td>
<td class="text">1 year 5 months 8 days<span></span>
</td>
<td class="text">5 months 8 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price ,Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="nump">$ 0.11<span></span>
</td>
<td class="nump">$ 0.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Shares Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,033,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Exercise Price Issued</a></td>
<td class="nump">$ 0.37<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised', window );">Shares Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,733,333)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_WeightedAverageExercisePriceExercised', window );">Weighted Average Exercise Price Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value ,ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 437,500<span></span>
</td>
<td class="nump">$ 437,500<span></span>
</td>
<td class="nump">$ 690,500<span></span>
</td>
<td class="nump">$ 690,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Exercise Price Balance At Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="nump">$ 0.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Balance At End</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250,000<span></span>
</td>
<td class="nump">1,250,000<span></span>
</td>
<td class="nump">950,000<span></span>
</td>
<td class="nump">950,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_WeightedAverageExercisePriceExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_WeightedAverageExercisePriceExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-option equity instruments exercised by participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140152844712152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholder Equity (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2021</div></th>
<th class="th"><div>Apr. 16, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jan. 12, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 29, 2021</div></th>
<th class="th"><div>Oct. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Intrinsic Value Of Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 437,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 437,500<span></span>
</td>
<td class="nump">$ 690,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 690,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_StockIssuedUponWarrantExercised', window );">Stock Issued Upon Warrant Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,783,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_ProceedsFromStockIssuedUponWarrantsExercisedAmount', window );">Proceeds From Stock Issued Upon Warrants Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,134,499<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_WarrantsOutstandingSeriesOneShares', window );">Warrants Outstanding Series 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Common Stock Issued On Conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,363,149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Preferred Stock Converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_LiabilityForPreferredStockShares', window );">Liability For Preferred Stock Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">436,782<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,272<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Gross Process From Private Placement of Stocks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,551,691<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,203,512<span></span>
</td>
<td class="nump">126,680,895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,317,746<span></span>
</td>
<td class="nump">62,410,452<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Capital Raised through issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Common Stock shares issues to raise capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_CommonStockSharesIssuesForCash', window );">Common Stock shares issues for cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,958,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_NumberOfWarrantPurchase', window );">Number of warrant purchase</a></td>
<td class="nump">3,783,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantExercisePriceIncrease', window );">Exercise price</a></td>
<td class="nump">$ 0.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Exercise Price Issued</a></td>
<td class="nump">$ 0.37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_AggregateFairValueOfWarrant', window );">Aggregate fair value of warrant</a></td>
<td class="nump">$ 1,399,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock, exercise of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,783,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Gross proceeds on exercise of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,242,499<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250,000<span></span>
</td>
<td class="nump">950,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">950,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Exercise Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="nump">$ 0.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockNoParValue', window );">common stock price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Warrants Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250,000<span></span>
</td>
<td class="nump">950,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">950,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Exercise Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="nump">$ 0.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0001<span></span>
</td>
<td class="nump">0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">126,680,895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,317,746<span></span>
</td>
<td class="nump">62,410,452<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,272<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreferenceValue', window );">Liquidation Value of Preferred Stocks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 409,005<span></span>
</td>
<td class="nump">$ 409,005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Shares Issued, Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,669<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,531<span></span>
</td>
<td class="nump">6,241<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97,558<span></span>
</td>
<td class="nump">$ 10,433<span></span>
</td>
<td class="nump">204,217<span></span>
</td>
<td class="nump">328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">185,653<span></span>
</td>
<td class="nump">29,185<span></span>
</td>
<td class="nump">375,032<span></span>
</td>
<td class="nump">57,718<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">261,403<span></span>
</td>
<td class="nump">10,477<span></span>
</td>
<td class="nump">1,095,381<span></span>
</td>
<td class="nump">17,483<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=scwo_ConsultantMember', window );">Consultant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97,558<span></span>
</td>
<td class="nump">10,433<span></span>
</td>
<td class="nump">204,217<span></span>
</td>
<td class="nump">6,657<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,690<span></span>
</td>
<td class="nump">3,915<span></span>
</td>
<td class="nump">14,081<span></span>
</td>
<td class="nump">6,329<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,868<span></span>
</td>
<td class="nump">$ 6,518<span></span>
</td>
<td class="nump">190,136<span></span>
</td>
<td class="nump">328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=scwo_ThreeSeverFourWaterFormerStockholdersMember', window );">374Water Former Stockholders [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,410,452<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=scwo_OptionsMember', window );">Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Intrinsic Value Of Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,719,310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,521,310<span></span>
</td>
<td class="nump">$ 4,750,395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,750,395<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Preferred Stock Converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(225,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation expense, unvested options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">501,471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,136,921<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,602,282<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Shares Issued, Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,073,369<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Common Stock which were issued to investees as part of the capital raise</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Common Stock which were issued in connection with the exercise of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,958,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember', window );">Series D Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,272<span></span>
</td>
<td class="nump">412,853<span></span>
</td>
<td class="nump">412,853<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Gross Process From Private Placement of Stocks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,551,691<span></span>
</td>
<td class="nump">$ 6,551,745<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,551,745<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleSharesIssuable', window );">Convertion of preferred stock to common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,363,149<span></span>
</td>
<td class="nump">20,642,667<span></span>
</td>
<td class="nump">20,642,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_Preferredstockparorstatedvaluepershare', window );">Preferred stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_PreferredStockParValue', window );">Preferred Stock Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=scwo_ThreeSevenFourWaterMember', window );">374Water, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,317,746<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,317,746<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreferenceValue', window );">Liquidation Value of Preferred Stocks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 409,005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_PreferredStockStatedValuePerShare', window );">Preferred Stock Stated Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=scwo_WarrantsMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,284,848<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_AggregateFairValueOfWarrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_AggregateFairValueOfWarrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_CommonStockSharesIssuesForCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_CommonStockSharesIssuesForCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_LiabilityForPreferredStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_LiabilityForPreferredStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_NumberOfWarrantPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_NumberOfWarrantPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_PreferredStockParValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_PreferredStockParValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_PreferredStockStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_PreferredStockStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_Preferredstockparorstatedvaluepershare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_Preferredstockparorstatedvaluepershare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_ProceedsFromStockIssuedUponWarrantsExercisedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_ProceedsFromStockIssuedUponWarrantsExercisedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_StockIssuedUponWarrantExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_StockIssuedUponWarrantExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_WarrantsOutstandingSeriesOneShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_WarrantsOutstandingSeriesOneShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockNoParValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount per share of no-par value common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockNoParValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockConvertibleSharesIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common shares issuable upon conversion of preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockConvertibleSharesIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockLiquidationPreferenceValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of the difference between preference in liquidation and the par or stated values of the preferred shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockLiquidationPreferenceValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantExercisePriceIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantExercisePriceIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=scwo_ConsultantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=scwo_ConsultantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=scwo_ThreeSeverFourWaterFormerStockholdersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=scwo_ThreeSeverFourWaterFormerStockholdersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=scwo_OptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=scwo_OptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=scwo_ThreeSevenFourWaterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=scwo_ThreeSevenFourWaterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=scwo_WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=scwo_WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140152856244712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyCosts', window );">Related party cost</a></td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 43,205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_StockInExcessPercentageOfOutstandingShare', window );">Stock In Excess Percentage Of Outstanding Share</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueFromRelatedParties', window );">Due to related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_AdvancesFromStockholders', window );">Advances from stockholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 15,108<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt', window );">Advances from Shareholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (15,108)<span></span>
</td>
<td class="nump">$ 2,052<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_AdvancesFromStockholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_AdvancesFromStockholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_StockInExcessPercentageOfOutstandingShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_StockInExcessPercentageOfOutstandingShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an unclassified balance sheet, amounts due from related parties including affiliates, employees, joint ventures, officers and stockholders, immediate families thereof, and pension funds.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Direct costs arising from transactions with related parties who are not affiliates or joint Ventures. These costs are categorized as cost of goods sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140152848922504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets', window );">Goodwill</a></td>
<td class="nump">$ 208,742<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_DeferredTaxAssetsStartupCost', window );">Start-up cost</a></td>
<td class="nump">83,710<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_OtherIntangibles', window );">Other Intangibles</a></td>
<td class="nump">10,339<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_OtherAccruals', window );">Other Accruals</a></td>
<td class="nump">1,875<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock based compensation</a></td>
<td class="nump">17,423<span></span>
</td>
<td class="nump">1,764<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="num">(381,112)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Deferred tax assets</a></td>
<td class="nump">703,211<span></span>
</td>
<td class="nump">1,764<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less valuation allowance</a></td>
<td class="num">(703,083)<span></span>
</td>
<td class="num">(1,764)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax assets after valuation allowance</a></td>
<td class="nump">128<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="num">(128)<span></span>
</td>
<td class="num">(1,764)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax asset (liability)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Depreciation</a></td>
<td class="num">$ (128)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_DeferredTaxAssetsStartupCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_DeferredTaxAssetsStartupCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_OtherAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_OtherAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_OtherIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_OtherIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140152853721976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details 1)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_RateReconciliationAbstract', window );"><strong>Income Taxes (Details 1)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Federal income tax at statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_IncomeTaxRateReconciliationChangeInStateTax', window );">Change in State Tax</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_IncomeTaxReconciliationChangeInValuationAllowance', window );">Change in Valuation Allowance</a></td>
<td class="num">(22.16%)<span></span>
</td>
<td class="nump">19.11%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_IncomeTaxReconciliationPermanentDifferences', window );">Permanent Differences</a></td>
<td class="num">(12.26%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_IncomeTaxReconciliationStateTaxes', window );">State Tax</a></td>
<td class="nump">1.98%<span></span>
</td>
<td class="nump">5.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_IncomeTaxReconciliationOther', window );">Other</a></td>
<td class="nump">11.44%<span></span>
</td>
<td class="num">(45.61%)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_IncomeTaxRateReconciliationChangeInStateTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_IncomeTaxRateReconciliationChangeInStateTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_IncomeTaxReconciliationChangeInValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_IncomeTaxReconciliationChangeInValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_IncomeTaxReconciliationOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_IncomeTaxReconciliationOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_IncomeTaxReconciliationPermanentDifferences">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_IncomeTaxReconciliationPermanentDifferences</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_IncomeTaxReconciliationStateTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_IncomeTaxReconciliationStateTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_RateReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_RateReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140152852697672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes (Details Narrative)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_IncomeTaxesAbstract', window );"><strong>Income Taxes (Tables)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carry forwards for federal income tax purposes</a></td>
<td class="nump">$ 1.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_IncomeTaxesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_IncomeTaxesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140152857274552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Deferred Revenue (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueAbstract', window );"><strong>Deferred Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred Revenue</a></td>
<td class="nump">$ 763,333<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_scwo_DeferredRevenuePercentage', window );">Deferred Revenue Percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_DeferredRevenuePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_DeferredRevenuePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140152852657304">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events (Details Narrative)<br></strong></div></th>
<th class="th">
<div>Apr. 13, 2022 </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares Of Common Stock Reserve For Issuance</a></td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>scwo_s1_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:scwo="http://powerverdeinc.com/20220331"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="scwo-20220331.xsd" xlink:type="simple"/>
    <context id="From2022-01-01to2022-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-04-13_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-13</instant>
        </period>
    </context>
    <context id="From2020-01-01to2020-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-03-31_scwo_ConsultantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">scwo:ConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-01to2022-03-31_scwo_ConsultantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">scwo:ConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-04-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="From2021-04-01to2021-04-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="From2020-01-01to2020-12-31_scwo_ConsultantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">scwo:ConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-12-31_scwo_ConsultantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">scwo:ConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-12-31_us-gaap_PatentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-04-16_us-gaap_PatentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-16</instant>
        </period>
    </context>
    <context id="AsOf2021-04-16_scwo_ThreeSeverFourWaterFormerStockholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">scwo:ThreeSeverFourWaterFormerStockholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-16</instant>
        </period>
    </context>
    <context id="AsOf2021-04-16_scwo_ThreeSevenFourWaterMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">scwo:ThreeSevenFourWaterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-16</instant>
        </period>
    </context>
    <context id="AsOf2020-10-30_us-gaap_SeriesDPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-29_us-gaap_SeriesDPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-29</instant>
        </period>
    </context>
    <context id="AsOf2022-01-12_us-gaap_SeriesDPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-12</instant>
        </period>
    </context>
    <context id="From2021-04-01to2021-04-16_us-gaap_SeriesDPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-16</endDate>
        </period>
    </context>
    <context id="From2019-01-01to2019-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-12-31_scwo_WarrantsMember_scwo_MaximumsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">scwo:WarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">scwo:MaximumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-12-31_scwo_WarrantsMember_scwo_MinimumsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">scwo:WarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">scwo:MinimumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-01to2022-03-31_scwo_OptionsMember_scwo_MaximumsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">scwo:OptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">scwo:MaximumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-01to2022-03-31_scwo_OptionsMember_scwo_MinimumsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">scwo:OptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">scwo:MinimumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-12-31_scwo_OptionsMember_scwo_MaximumsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">scwo:OptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">scwo:MaximumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-12-31_scwo_OptionsMember_scwo_MinimumsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">scwo:OptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">scwo:MinimumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-01to2019-12-31_scwo_OptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">scwo:OptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-03-31_scwo_OptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">scwo:OptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="From2021-01-01to2021-12-31_scwo_OptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">scwo:OptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-01to2022-03-31_scwo_OptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">scwo:OptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2020-01-01to2020-12-31_scwo_OptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">scwo:OptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2019-12-31_scwo_OptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">scwo:OptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_scwo_OptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">scwo:OptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_scwo_OptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">scwo:OptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_scwo_OptionUnvestedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">scwo:OptionUnvestedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-01to2021-12-31_scwo_OptionUnvestedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">scwo:OptionUnvestedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_PatentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_scwo_LicenseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">scwo:LicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-01to2022-03-31_us-gaap_PatentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-01to2022-03-31_scwo_LicenseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">scwo:LicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_PatentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_scwo_LicenseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">scwo:LicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_PatentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_scwo_LicenseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">scwo:LicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="From2021-01-01to2021-12-31_srt_ChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-12-31_us-gaap_SeriesDPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_SeriesDPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_SeriesDPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="From2021-01-01to2021-12-31_scwo_MrNagarMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">scwo:MrNagarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_SeriesDPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="From2022-01-01to2022-03-31_us-gaap_SeriesDPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-01to2022-03-31_srt_ChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-01to2022-03-31_scwo_MrNagarMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">scwo:MrNagarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-03-31_scwo_ThreeSevenFourWaterMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">scwo:ThreeSevenFourWaterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_scwo_ThreeSevenFourWaterMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">scwo:ThreeSevenFourWaterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-01to2021-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2020-01-01to2020-12-31_scwo_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">scwo:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-12-31_scwo_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">scwo:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-04-01to2021-04-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-16</endDate>
        </period>
    </context>
    <context id="AsOf2021-04-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
        </entity>
        <period>
            <instant>2021-04-16</instant>
        </period>
    </context>
    <context id="From2021-01-01to2021-12-31_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-01to2022-03-31_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="From2022-01-01to2022-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-01to2022-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-01to2022-03-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-01to2022-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-01to2021-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-12-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="From2021-01-01to2021-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-03-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-01to2020-12-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-01to2020-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2019-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-01to2020-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-01to2021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-01-01to2022-03-31">0000933972</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-01-01to2022-03-31">false</dei:AmendmentFlag>
    <us-gaap:DeferredRevenue contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">0</us-gaap:DeferredRevenue>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2020-12-31" decimals="0" unitRef="Shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2020-12-31"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2022-03-31" decimals="0" unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2020-12-31" decimals="0" unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockLiquidationPreferenceValue contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">409005</us-gaap:PreferredStockLiquidationPreferenceValue>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2021-12-31" decimals="0" unitRef="Shares">27272</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2020-12-31" decimals="0" unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2022-03-31" decimals="0" unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2020-12-31" decimals="0" unitRef="Shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2020-12-31"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2021-12-31" decimals="0" unitRef="Shares">125317746</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2020-12-31" decimals="0" unitRef="Shares">62410452</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">0</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:UnrecognizedTaxBenefits contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      unitRef="USD">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2021-09-30_us-gaap_SeriesDPreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <scwo:IntangibleAssetsAdditions
      contextRef="AsOf2022-03-31_scwo_LicenseAgreementMember"
      decimals="0"
      unitRef="USD">0</scwo:IntangibleAssetsAdditions>
    <scwo:IntangibleAssetsAdditions
      contextRef="AsOf2022-03-31_us-gaap_PatentsMember"
      decimals="0"
      unitRef="USD">0</scwo:IntangibleAssetsAdditions>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2022-01-01to2022-03-31_scwo_LicenseAgreementMember">P17Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2022-01-01to2022-03-31_us-gaap_PatentsMember">P20Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2021-01-01to2021-12-31_scwo_OptionUnvestedMember"
      decimals="0"
      unitRef="Shares">2885000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="From2022-01-01to2022-03-31_scwo_OptionsMember"
      decimals="0"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <scwo:Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice
      contextRef="From2022-01-01to2022-03-31_scwo_OptionsMember"
      decimals="INF"
      unitRef="USDPShares">0</scwo:Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice>
    <scwo:Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice
      contextRef="From2022-01-01to2022-03-31_scwo_OptionsMember"
      decimals="INF"
      unitRef="USDPShares">0</scwo:Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2022-01-01to2022-03-31"
      decimals="INF"
      unitRef="USDPShares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <scwo:WeightedAverageExercisePriceExercised
      contextRef="From2022-01-01to2022-03-31"
      decimals="INF"
      unitRef="USDPShares">0</scwo:WeightedAverageExercisePriceExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2019-12-31"
      decimals="INF"
      unitRef="USDPShares">0.11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="Shares">5033333</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <scwo:WarrantsOutstandingSeriesOneShares contextRef="AsOf2022-03-31" decimals="0" unitRef="Shares">1250000</scwo:WarrantsOutstandingSeriesOneShares>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="From2021-04-01to2021-04-16_us-gaap_SeriesDPreferredStockMember"
      decimals="0"
      unitRef="USD">6551691</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2022-01-12_us-gaap_SeriesDPreferredStockMember"
      decimals="0"
      unitRef="Shares">27272</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2021-09-29_us-gaap_SeriesDPreferredStockMember"
      decimals="0"
      unitRef="Shares">412853</us-gaap:PreferredStockSharesAuthorized>
    <scwo:LiabilityForPreferredStockShares
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      unitRef="USD">50000</scwo:LiabilityForPreferredStockShares>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2021-12-31_scwo_ThreeSevenFourWaterMember"
      decimals="0"
      unitRef="Shares">125317746</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2021-04-16_us-gaap_PatentsMember"
      decimals="0"
      unitRef="Shares">1602282</us-gaap:CommonStockSharesIssued>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="From2021-01-01to2021-12-31_us-gaap_PatentsMember"
      decimals="0"
      unitRef="Shares">2500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="From2021-01-01to2021-12-31_us-gaap_PatentsMember"
      decimals="0"
      unitRef="Shares">4958833</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2021-12-31_us-gaap_SeriesDPreferredStockMember"
      decimals="0"
      unitRef="Shares">27272</us-gaap:PreferredStockSharesOutstanding>
    <scwo:PreferredStockParValue
      contextRef="AsOf2020-10-30_us-gaap_SeriesDPreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</scwo:PreferredStockParValue>
    <us-gaap:PreferredStockConvertibleSharesIssuable
      contextRef="AsOf2021-09-29_us-gaap_SeriesDPreferredStockMember"
      decimals="0"
      unitRef="Shares">20642667</us-gaap:PreferredStockConvertibleSharesIssuable>
    <us-gaap:PreferredStockConvertibleSharesIssuable
      contextRef="AsOf2022-01-12_us-gaap_SeriesDPreferredStockMember"
      decimals="0"
      unitRef="Shares">1363149</us-gaap:PreferredStockConvertibleSharesIssuable>
    <scwo:PreferredStockStatedValuePerShare
      contextRef="AsOf2021-04-16_scwo_ThreeSevenFourWaterMember"
      decimals="INF"
      unitRef="USDPShares">15</scwo:PreferredStockStatedValuePerShare>
    <dei:DocumentType contextRef="From2022-01-01to2022-03-31">S-1</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="From2022-01-01to2022-03-31">374Water Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-01-01to2022-03-31">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-01-01to2022-03-31">88-0271109</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-01-01to2022-03-31">701 W. Main Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2022-01-01to2022-03-31">Suite 410</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2022-01-01to2022-03-31">Durham</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-01-01to2022-03-31">NC</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-01-01to2022-03-31">27701</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-01-01to2022-03-31">919</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-01-01to2022-03-31">888-8194</dei:LocalPhoneNumber>
    <dei:EntityFilerCategory contextRef="From2022-01-01to2022-03-31">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2022-01-01to2022-03-31">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-01-01to2022-03-31">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2022-01-01to2022-03-31">false</dei:EntityExTransitionPeriod>
    <us-gaap:Cash
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_2"
      unitRef="USD">11131175</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="AsOf2020-12-31"
      decimals="0"
      id="fid_3"
      unitRef="USD">71799</us-gaap:Cash>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_4"
      unitRef="USD">0</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2020-12-31"
      decimals="0"
      id="fid_5"
      unitRef="USD">31330</us-gaap:AccountsReceivableNet>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_6"
      unitRef="USD">218466</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2020-12-31"
      decimals="0"
      id="fid_7"
      unitRef="USD">0</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_8"
      unitRef="USD">11349641</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2020-12-31"
      decimals="0"
      id="fid_9"
      unitRef="USD">103129</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_11"
      unitRef="USD">959</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2020-12-31"
      decimals="0"
      id="fid_12"
      unitRef="USD">403</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OtherIntangibleAssetsNet
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_13"
      unitRef="USD">1028114</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:OtherIntangibleAssetsNet
      contextRef="AsOf2020-12-31"
      decimals="0"
      id="fid_14"
      unitRef="USD">0</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:OtherAssets
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_15"
      unitRef="USD">34742</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="AsOf2020-12-31"
      decimals="0"
      id="fid_16"
      unitRef="USD">275</us-gaap:OtherAssets>
    <us-gaap:AssetsNoncurrent
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_17"
      unitRef="USD">1063815</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="AsOf2020-12-31"
      decimals="0"
      id="fid_18"
      unitRef="USD">678</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_19"
      unitRef="USD">12413456</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2020-12-31"
      decimals="0"
      id="fid_20"
      unitRef="USD">103807</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_23"
      unitRef="USD">62981</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="AsOf2020-12-31"
      decimals="0"
      id="fid_24"
      unitRef="USD">76249</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <scwo:AdvancesFromStockholders
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_25"
      unitRef="USD">0</scwo:AdvancesFromStockholders>
    <scwo:AdvancesFromStockholders
      contextRef="AsOf2020-12-31"
      decimals="0"
      id="fid_26"
      unitRef="USD">15108</scwo:AdvancesFromStockholders>
    <us-gaap:OtherLiabilities
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_27"
      unitRef="USD">23390</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities
      contextRef="AsOf2020-12-31"
      decimals="0"
      id="fid_28"
      unitRef="USD">1200</us-gaap:OtherLiabilities>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_29"
      unitRef="USD">86371</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2020-12-31"
      decimals="0"
      id="fid_30"
      unitRef="USD">92557</us-gaap:LiabilitiesCurrent>
    <us-gaap:Liabilities
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_31"
      unitRef="USD">86371</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2020-12-31"
      decimals="0"
      id="fid_32"
      unitRef="USD">92557</us-gaap:Liabilities>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_801"
      unitRef="Shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2021-12-31"
      decimals="INF"
      id="fid_803"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_806"
      unitRef="Shares">27272</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockLiquidationPreferenceValue
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_827"
      unitRef="USD">409005</us-gaap:PreferredStockLiquidationPreferenceValue>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_35"
      unitRef="USD">3</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2020-12-31"
      decimals="0"
      id="fid_36"
      unitRef="USD">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_810"
      unitRef="Shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2021-12-31"
      decimals="INF"
      id="fid_812"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_815"
      unitRef="Shares">125317746</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2020-12-31"
      decimals="0"
      id="fid_822"
      unitRef="Shares">62410452</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_37"
      unitRef="USD">12531</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2020-12-31"
      decimals="0"
      id="fid_38"
      unitRef="USD">6241</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_39"
      unitRef="USD">15474566</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2020-12-31"
      decimals="0"
      id="fid_40"
      unitRef="USD">416</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_41"
      unitRef="USD">-3160015</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2020-12-31"
      decimals="0"
      id="fid_42"
      unitRef="USD">4593</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_43"
      unitRef="USD">12327085</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31"
      decimals="0"
      id="fid_44"
      unitRef="USD">11250</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_45"
      unitRef="USD">12413456</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2020-12-31"
      decimals="0"
      id="fid_46"
      unitRef="USD">103807</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_64"
      unitRef="USD">48100</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_65"
      unitRef="USD">86570</us-gaap:Revenues>
    <us-gaap:CostOfRevenue
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_66"
      unitRef="USD">0</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_96"
      unitRef="USD">14241</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_67"
      unitRef="USD">48100</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_97"
      unitRef="USD">72329</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_69"
      unitRef="USD">375032</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_70"
      unitRef="USD">57718</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ProductionCosts
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_71"
      unitRef="USD">1399833</us-gaap:ProductionCosts>
    <us-gaap:ProductionCosts
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_72"
      unitRef="USD">0</us-gaap:ProductionCosts>
    <us-gaap:ProfessionalFees
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_73"
      unitRef="USD">343862</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_74"
      unitRef="USD">8791</us-gaap:ProfessionalFees>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_75"
      unitRef="USD">1095381</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_76"
      unitRef="USD">17483</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_77"
      unitRef="USD">3214108</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_78"
      unitRef="USD">83992</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_79"
      unitRef="USD">-3166008</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_80"
      unitRef="USD">-11663</us-gaap:OperatingIncomeLoss>
    <scwo:AwardIncome
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_82"
      unitRef="USD">0</scwo:AwardIncome>
    <scwo:AwardIncome
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_83"
      unitRef="USD">52000</scwo:AwardIncome>
    <us-gaap:InterestIncomeOperating
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_84"
      unitRef="USD">1066</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestIncomeOperating
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_85"
      unitRef="USD">0</us-gaap:InterestIncomeOperating>
    <us-gaap:OtherIncome
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_94"
      unitRef="USD">334</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_95"
      unitRef="USD">0</us-gaap:OtherIncome>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_86"
      unitRef="USD">1400</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_87"
      unitRef="USD">52000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_88"
      unitRef="USD">-3164608</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_89"
      unitRef="USD">40337</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_90"
      unitRef="USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_91"
      unitRef="USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_92"
      unitRef="USD">-3164608</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_93"
      unitRef="USD">40337</us-gaap:NetIncomeLoss>
    <scwo:NetLossPerShareBasicAndDiluted
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      id="fid_754"
      unitRef="USDPShares">-0.03</scwo:NetLossPerShareBasicAndDiluted>
    <scwo:NetLossPerShareBasicAndDiluted
      contextRef="From2020-01-01to2020-12-31"
      decimals="INF"
      id="fid_755"
      unitRef="USDPShares">0.00</scwo:NetLossPerShareBasicAndDiluted>
    <scwo:WeightedAverageCommonSharesOutstandingBasicAndDiluted
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_756"
      unitRef="Shares">94002888</scwo:WeightedAverageCommonSharesOutstandingBasicAndDiluted>
    <scwo:WeightedAverageCommonSharesOutstandingBasicAndDiluted
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_757"
      unitRef="Shares">62410452</scwo:WeightedAverageCommonSharesOutstandingBasicAndDiluted>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-12-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="fid_103"
      unitRef="USD">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="AsOf2019-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_759"
      unitRef="Shares">62410452</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_758"
      unitRef="USD">6241</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_104"
      unitRef="USD">-6241</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_105"
      unitRef="USD">-35744</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-12-31"
      decimals="0"
      id="fid_106"
      unitRef="USD">-35744</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2020-01-01to2020-12-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="fid_762"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_107"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_108"
      unitRef="USD">6329</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_109"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_110"
      unitRef="USD">6329</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <scwo:AccretionOfStockBasedCompensation
      contextRef="From2020-01-01to2020-12-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="fid_111"
      unitRef="USD">0</scwo:AccretionOfStockBasedCompensation>
    <scwo:AccretionOfStockBasedCompensation
      contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_760"
      unitRef="USD">0</scwo:AccretionOfStockBasedCompensation>
    <scwo:AccretionOfStockBasedCompensation
      contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_112"
      unitRef="USD">328</scwo:AccretionOfStockBasedCompensation>
    <scwo:AccretionOfStockBasedCompensation
      contextRef="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_113"
      unitRef="USD">0</scwo:AccretionOfStockBasedCompensation>
    <scwo:AccretionOfStockBasedCompensation
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_114"
      unitRef="USD">328</scwo:AccretionOfStockBasedCompensation>
    <us-gaap:ProfitLoss
      contextRef="From2020-01-01to2020-12-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="fid_115"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_761"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_116"
      unitRef="USD">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_117"
      unitRef="USD">40337</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_118"
      unitRef="USD">40337</us-gaap:ProfitLoss>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="fid_120"
      unitRef="USD">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_559"
      unitRef="Shares">62410452</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_560"
      unitRef="USD">6241</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_121"
      unitRef="USD">416</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_122"
      unitRef="USD">4593</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31"
      decimals="0"
      id="fid_123"
      unitRef="USD">11250</us-gaap:StockholdersEquity>
    <scwo:AccretionOfStockBasedCompensation
      contextRef="From2021-01-01to2021-12-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="fid_124"
      unitRef="USD">0</scwo:AccretionOfStockBasedCompensation>
    <scwo:AccretionOfStockBasedCompensation
      contextRef="From2021-01-01to2021-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_763"
      unitRef="USD">0</scwo:AccretionOfStockBasedCompensation>
    <scwo:AccretionOfStockBasedCompensation
      contextRef="From2021-01-01to2021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_125"
      unitRef="USD">204217</scwo:AccretionOfStockBasedCompensation>
    <scwo:AccretionOfStockBasedCompensation
      contextRef="From2021-01-01to2021-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_126"
      unitRef="USD">0</scwo:AccretionOfStockBasedCompensation>
    <scwo:AccretionOfStockBasedCompensation
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_127"
      unitRef="USD">204217</scwo:AccretionOfStockBasedCompensation>
    <scwo:IssuanceOfStockWarrantsForDevelopmentOfProduct
      contextRef="From2021-01-01to2021-12-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="fid_128"
      unitRef="USD">0</scwo:IssuanceOfStockWarrantsForDevelopmentOfProduct>
    <scwo:IssuanceOfStockWarrantsForDevelopmentOfProduct
      contextRef="From2021-01-01to2021-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_764"
      unitRef="USD">0</scwo:IssuanceOfStockWarrantsForDevelopmentOfProduct>
    <scwo:IssuanceOfStockWarrantsForDevelopmentOfProduct
      contextRef="From2021-01-01to2021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_129"
      unitRef="USD">1399833</scwo:IssuanceOfStockWarrantsForDevelopmentOfProduct>
    <scwo:IssuanceOfStockWarrantsForDevelopmentOfProduct
      contextRef="From2021-01-01to2021-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_130"
      unitRef="USD">0</scwo:IssuanceOfStockWarrantsForDevelopmentOfProduct>
    <scwo:IssuanceOfStockWarrantsForDevelopmentOfProduct
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_131"
      unitRef="USD">1399833</scwo:IssuanceOfStockWarrantsForDevelopmentOfProduct>
    <scwo:RecapitalizationOfTheCompanyAmount
      contextRef="From2021-01-01to2021-12-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="fid_765"
      unitRef="USD">0</scwo:RecapitalizationOfTheCompanyAmount>
    <scwo:RecapitalizationOfTheCompanyShares
      contextRef="From2021-01-01to2021-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_132"
      unitRef="Shares">33203512</scwo:RecapitalizationOfTheCompanyShares>
    <scwo:RecapitalizationOfTheCompanyAmount
      contextRef="From2021-01-01to2021-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_133"
      unitRef="USD">3320</scwo:RecapitalizationOfTheCompanyAmount>
    <scwo:RecapitalizationOfTheCompanyAmount
      contextRef="From2021-01-01to2021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_134"
      unitRef="USD">-87545</scwo:RecapitalizationOfTheCompanyAmount>
    <scwo:RecapitalizationOfTheCompanyAmount
      contextRef="From2021-01-01to2021-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_135"
      unitRef="USD">0</scwo:RecapitalizationOfTheCompanyAmount>
    <scwo:RecapitalizationOfTheCompanyAmount
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_136"
      unitRef="USD">-84225</scwo:RecapitalizationOfTheCompanyAmount>
    <scwo:SeriesDPreferredStockIssuedForCashShares
      contextRef="From2021-01-01to2021-12-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="fid_137"
      unitRef="Shares">440125</scwo:SeriesDPreferredStockIssuedForCashShares>
    <scwo:SeriesDPreferredStockIssuedForCashAmount
      contextRef="From2021-01-01to2021-12-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="fid_138"
      unitRef="USD">44</scwo:SeriesDPreferredStockIssuedForCashAmount>
    <scwo:SeriesDPreferredStockIssuedForCashAmount
      contextRef="From2021-01-01to2021-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_766"
      unitRef="USD">0</scwo:SeriesDPreferredStockIssuedForCashAmount>
    <scwo:SeriesDPreferredStockIssuedForCashAmount
      contextRef="From2021-01-01to2021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_139"
      unitRef="USD">6601701</scwo:SeriesDPreferredStockIssuedForCashAmount>
    <scwo:SeriesDPreferredStockIssuedForCashAmount
      contextRef="From2021-01-01to2021-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_772"
      unitRef="USD">0</scwo:SeriesDPreferredStockIssuedForCashAmount>
    <scwo:SeriesDPreferredStockIssuedForCashAmount
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_140"
      unitRef="USD">6601745</scwo:SeriesDPreferredStockIssuedForCashAmount>
    <scwo:ExercisedOptionAndWarrantsAmount
      contextRef="From2021-01-01to2021-12-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="fid_767"
      unitRef="USD">0</scwo:ExercisedOptionAndWarrantsAmount>
    <scwo:ExercisedOptionAndWarrantsShares
      contextRef="From2021-01-01to2021-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_141"
      unitRef="Shares">4958833</scwo:ExercisedOptionAndWarrantsShares>
    <scwo:ExercisedOptionAndWarrantsAmount
      contextRef="From2021-01-01to2021-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_142"
      unitRef="USD">496</scwo:ExercisedOptionAndWarrantsAmount>
    <scwo:ExercisedOptionAndWarrantsAmount
      contextRef="From2021-01-01to2021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_143"
      unitRef="USD">1284848</scwo:ExercisedOptionAndWarrantsAmount>
    <scwo:ExercisedOptionAndWarrantsAmount
      contextRef="From2021-01-01to2021-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_144"
      unitRef="USD">0</scwo:ExercisedOptionAndWarrantsAmount>
    <scwo:ExercisedOptionAndWarrantsAmount
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_145"
      unitRef="USD">1285344</scwo:ExercisedOptionAndWarrantsAmount>
    <scwo:IssuanceOfCommonStockForLicenseRightsAmount
      contextRef="From2021-01-01to2021-12-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="fid_768"
      unitRef="USD">0</scwo:IssuanceOfCommonStockForLicenseRightsAmount>
    <scwo:IssuanceOfCommonStockForLicenseRightsShares
      contextRef="From2021-01-01to2021-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_146"
      unitRef="Shares">1602282</scwo:IssuanceOfCommonStockForLicenseRightsShares>
    <scwo:IssuanceOfCommonStockForLicenseRightsAmount
      contextRef="From2021-01-01to2021-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_147"
      unitRef="USD">160</scwo:IssuanceOfCommonStockForLicenseRightsAmount>
    <scwo:IssuanceOfCommonStockForLicenseRightsAmount
      contextRef="From2021-01-01to2021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_148"
      unitRef="USD">1073369</scwo:IssuanceOfCommonStockForLicenseRightsAmount>
    <scwo:IssuanceOfCommonStockForLicenseRightsAmount
      contextRef="From2021-01-01to2021-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_149"
      unitRef="USD">0</scwo:IssuanceOfCommonStockForLicenseRightsAmount>
    <scwo:IssuanceOfCommonStockForLicenseRightsAmount
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_150"
      unitRef="USD">1073529</scwo:IssuanceOfCommonStockForLicenseRightsAmount>
    <scwo:ConversionOfConvertiblePreferredSharesIntoCommonStockShares
      contextRef="From2021-01-01to2021-12-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="fid_151"
      unitRef="Shares">-412853</scwo:ConversionOfConvertiblePreferredSharesIntoCommonStockShares>
    <scwo:ConversionOfConvertiblePreferredSharesIntoCommonStockAmount
      contextRef="From2021-01-01to2021-12-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="fid_152"
      unitRef="USD">-41</scwo:ConversionOfConvertiblePreferredSharesIntoCommonStockAmount>
    <scwo:ConversionOfConvertiblePreferredSharesIntoCommonStockShares
      contextRef="From2021-01-01to2021-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_769"
      unitRef="Shares">20642667</scwo:ConversionOfConvertiblePreferredSharesIntoCommonStockShares>
    <scwo:ConversionOfConvertiblePreferredSharesIntoCommonStockAmount
      contextRef="From2021-01-01to2021-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_770"
      unitRef="USD">2064</scwo:ConversionOfConvertiblePreferredSharesIntoCommonStockAmount>
    <scwo:ConversionOfConvertiblePreferredSharesIntoCommonStockAmount
      contextRef="From2021-01-01to2021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_153"
      unitRef="USD">-2023</scwo:ConversionOfConvertiblePreferredSharesIntoCommonStockAmount>
    <scwo:ConversionOfConvertiblePreferredSharesIntoCommonStockAmount
      contextRef="From2021-01-01to2021-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_771"
      unitRef="USD">0</scwo:ConversionOfConvertiblePreferredSharesIntoCommonStockAmount>
    <scwo:ConversionOfConvertiblePreferredSharesIntoCommonStockAmount
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_154"
      unitRef="USD">0</scwo:ConversionOfConvertiblePreferredSharesIntoCommonStockAmount>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-01-01to2021-12-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="fid_773"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2021-01-01to2021-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_155"
      unitRef="Shares">2500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-01-01to2021-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_156"
      unitRef="USD">250</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-01-01to2021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_157"
      unitRef="USD">4999750</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-01-01to2021-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_774"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_158"
      unitRef="USD">5000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-01to2021-12-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="fid_776"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-01to2021-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_775"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-01to2021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_777"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-01to2021-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_159"
      unitRef="USD">-3164608</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_160"
      unitRef="USD">-3164608</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="AsOf2021-12-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="fid_161"
      unitRef="Shares">27272</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="fid_162"
      unitRef="USD">3</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_778"
      unitRef="Shares">125317746</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_779"
      unitRef="USD">12531</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_163"
      unitRef="USD">15474566</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_164"
      unitRef="USD">-3160015</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_165"
      unitRef="USD">12327085</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_167"
      unitRef="USD">-3164608</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_168"
      unitRef="USD">40337</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_170"
      unitRef="USD">46050</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_171"
      unitRef="USD">911</us-gaap:DepreciationAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_172"
      unitRef="USD">204217</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_173"
      unitRef="USD">328</us-gaap:ShareBasedCompensation>
    <scwo:AdjustmentForCommonStockIssuedForServices
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_174"
      unitRef="USD">0</scwo:AdjustmentForCommonStockIssuedForServices>
    <scwo:AdjustmentForCommonStockIssuedForServices
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_175"
      unitRef="USD">6329</scwo:AdjustmentForCommonStockIssuedForServices>
    <scwo:WarrantIssuedForProductDevelopmentAgreement
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_176"
      unitRef="USD">1399833</scwo:WarrantIssuedForProductDevelopmentAgreement>
    <scwo:WarrantIssuedForProductDevelopmentAgreement
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_177"
      unitRef="USD">0</scwo:WarrantIssuedForProductDevelopmentAgreement>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_179"
      unitRef="USD">32330</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_180"
      unitRef="USD">-31330</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_181"
      unitRef="USD">-142512</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_182"
      unitRef="USD">47488</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_183"
      unitRef="USD">238450</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_241"
      unitRef="USD">-0</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_184"
      unitRef="USD">22190</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_185"
      unitRef="USD">696</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_188"
      unitRef="USD">-1840950</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_189"
      unitRef="USD">64759</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_191"
      unitRef="USD">1190</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_192"
      unitRef="USD">0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <scwo:ProceedsFromReverseAcquisition
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_193"
      unitRef="USD">113760</scwo:ProceedsFromReverseAcquisition>
    <scwo:ProceedsFromReverseAcquisition
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_194"
      unitRef="USD">0</scwo:ProceedsFromReverseAcquisition>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_195"
      unitRef="USD">0</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_240"
      unitRef="USD">275</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:PaymentsOfCapitalDistribution
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_186"
      unitRef="USD">84225</us-gaap:PaymentsOfCapitalDistribution>
    <us-gaap:PaymentsOfCapitalDistribution
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_187"
      unitRef="USD">0</us-gaap:PaymentsOfCapitalDistribution>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_196"
      unitRef="USD">28345</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_197"
      unitRef="USD">-275</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_199"
      unitRef="USD">-15108</us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt>
    <us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_200"
      unitRef="USD">2052</us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_201"
      unitRef="USD">6601745</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_202"
      unitRef="USD">0</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_203"
      unitRef="USD">5000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_204"
      unitRef="USD">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_205"
      unitRef="USD">42845</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_206"
      unitRef="USD">0</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_238"
      unitRef="USD">1242499</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_239"
      unitRef="USD">0</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_207"
      unitRef="USD">12871981</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_208"
      unitRef="USD">2052</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_209"
      unitRef="USD">11059376</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_210"
      unitRef="USD">66536</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2020-12-31"
      decimals="0"
      id="fid_607"
      unitRef="USD">71799</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2019-12-31"
      decimals="0"
      id="fid_783"
      unitRef="USD">5263</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_784"
      unitRef="USD">11131175</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2020-12-31"
      decimals="0"
      id="fid_785"
      unitRef="USD">71799</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:InterestPaidNet
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_216"
      unitRef="USD">0</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_217"
      unitRef="USD">0</us-gaap:InterestPaidNet>
    <us-gaap:RepaymentsOfDebt
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_218"
      unitRef="USD">0</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_219"
      unitRef="USD">0</us-gaap:RepaymentsOfDebt>
    <scwo:IssuanceOfCommonStockForLicenseRights
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_221"
      unitRef="USD">1073529</scwo:IssuanceOfCommonStockForLicenseRights>
    <scwo:IssuanceOfCommonStockForLicenseRights
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_222"
      unitRef="USD">0</scwo:IssuanceOfCommonStockForLicenseRights>
    <scwo:AccountsPayableSettledWithStockOption
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_223"
      unitRef="USD">50000</scwo:AccountsPayableSettledWithStockOption>
    <scwo:AccountsPayableSettledWithStockOption
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_224"
      unitRef="USD">0</scwo:AccountsPayableSettledWithStockOption>
    <scwo:NetLiabilitiesAssumedInReverseAcquisitioncash
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_226"
      unitRef="USD">29536</scwo:NetLiabilitiesAssumedInReverseAcquisitioncash>
    <scwo:NetLiabilitiesAssumedInReverseAcquisitioncash
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_227"
      unitRef="USD">0</scwo:NetLiabilitiesAssumedInReverseAcquisitioncash>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_228"
      unitRef="USD">14483</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_229"
      unitRef="USD">0</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:AccountsReceivableSale
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_230"
      unitRef="USD">1000</us-gaap:AccountsReceivableSale>
    <us-gaap:AccountsReceivableSale
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_231"
      unitRef="USD">0</us-gaap:AccountsReceivableSale>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_232"
      unitRef="USD">-46150</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_233"
      unitRef="USD">0</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_234"
      unitRef="USD">-83094</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_235"
      unitRef="USD">0</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <scwo:NetLiabilityAssumed
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_236"
      unitRef="USD">-84225</scwo:NetLiabilityAssumed>
    <scwo:NetLiabilityAssumed
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_237"
      unitRef="USD">0</scwo:NetLiabilityAssumed>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="From2021-01-01to2021-12-31" id="fid_242">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&lt;strong&gt;Note 1 &#x2013; Nature of Business&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;374Water, Inc., f/k/a PowerVerde, Inc. (the &#x201c;Company&#x201d;) is a Delaware corporation incorporated on September 8, 2005. The Company was formed to develop, commercialize, and market a series of unique electric generating power systems designed to produce electrical power with zero emissions or waste byproducts, based on a patented pressure-driven expander motor and related organic rankine cycle technology.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;On April 16, 2021, 374Water Inc. (f/k/a PowerVerde, Inc.) entered into an Agreement and Plan of Merger (the &#x201c;Merger Agreement&#x201d;) with 374Water, Inc., a privately held company based in Durham, North Carolina, (&#x201c;374Water&#x201d;) and 374Water Acquisition Corp., a newly-formed wholly-owned subsidiary of PowerVerde (&#x201c;Sub&#x201d;). The parties entered into the Agreement pursuant to their Binding Letter of Intent dated September 20, 2020.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;Pursuant to the merger contemplated by the Merger Agreement (the &#x201c;Merger&#x201d;), on April 16, 2021, Sub merged into 374Water, with 374Water as the surviving corporation. In connection with the Merger, all 374Water shares were cancelled and 374Water, Inc. issued to the former 374Water shareholders a total of 62,410,452 shares of 374Water, Inc. common stock. Immediately following the Merger, 374Water changed its name to 374Water Systems Inc and PowerVerde changed its name to 374Water, Inc. After the Merger, the former 374Water stockholders own 65.8% of 374Water Inc&#x2019;s issued and outstanding common stock and 53.8% of 374Water Inc.&#x2019;s issued and outstanding voting stock which includes the Preferred Stock. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;With the Merger, 374Water Inc.&#x2019;s current mission is to support a clean and healthy environment to sustain life. The Company plans to use what is believes to be cutting-edge science to recover resources from the waste our society generates and keep drinking water clean. The Company&#x2019;s customers will include businesses and local governments that will make the sustainable development goals a reality. No material revenues from this planned principal operation have been generated since inception. Revenues to date have been from manufacturing assembly services and from testing, consulting, and advisory services procedures for multiple customers, which have been performed in collaboration with Duke University.&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <scwo:SharesIssuedToFormerHolder
      contextRef="AsOf2021-04-16"
      decimals="0"
      id="fid_275"
      unitRef="Shares">62410452</scwo:SharesIssuedToFormerHolder>
    <scwo:MergerEffectDescription contextRef="From2021-04-01to2021-04-16" id="fid_276">Immediately following the Merger, 374Water changed its name to 374Water Systems Inc and PowerVerde changed its name to 374Water, Inc. After the Merger, the former 374Water stockholders own 65.8% of 374Water Inc&#x2019;s issued and outstanding common stock and 53.8% of 374Water Inc.&#x2019;s issued and outstanding voting stock which includes the Preferred Stock.</scwo:MergerEffectDescription>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock contextRef="From2021-01-01to2021-12-31" id="fid_243">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&lt;strong&gt;Note 2 &#x2013; Summary of Significant Accounting Policies&#160; &lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&lt;span style="text-decoration:underline"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. The Company held no cash equivalents as of December 31, 2021 and 2020.&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&lt;span style="text-decoration:underline"&gt;Concentration of Credit Risk &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;Financial instruments that potentially subject the Company to credit risk consist of cash and cash equivalents. Deposits with financial institutions are insured, up to certain limits, by the Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;). The Company&#x2019;s cash deposits often exceed the FDIC insurance limit; however, all deposits are maintained with high credit quality institutions and the Company has not experienced any losses in such accounts. The financial condition of financial institutions is periodically reassessed, and the Company believes the risk of any loss is minimal. The Company believes the risk of any loss on cash due to credit risk is minimal.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&lt;span style="text-decoration:underline"&gt;Accounts Receivable &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;Accounts receivables consist of balances due from service revenues. The Company monitors accounts receivable and provides allowances when considered necessary. At December 31, 2021 and 2020, accounts receivable were considered to be fully collectible. Accordingly, no allowance for doubtful accounts was provided and there was no bad debt expense as of December 31, 2021 and 2020. &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&lt;span style="text-decoration:underline"&gt;Equipment&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;Equipment is recorded at cost. Depreciation is computed using the straight-line method and an estimated useful life of three years. Expenses for maintenance and repairs are charged to expense as incurred.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&lt;span style="text-decoration:underline"&gt;Intangible Assets&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;Intangible assets are subject to amortization, and any impairment is determined in accordance with ASC 360, &#x201c;Property, Plant, and Equipment.&#x201d; Intangible assets are stated at historical cost and amortized over their estimated useful lives. The Company uses a straight-line method of amortization, unless a method that better reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up can be reliably determined.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&lt;span style="text-decoration:underline"&gt;Long-Lived Assets&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;The Company reviews long-lived assets, including intangible assets with finite lives, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company uses an estimate of the undiscounted cash flows over the remaining life of its long-lived assets, or related group of assets where applicable, in measuring whether the assets to be held and used will be realizable. Recoverability of assets held and used is measured by a comparison of the carrying amount to the future undiscounted expected net cash flows to be generated by the asset. As of December 31, 2021 and 2020, there were no impairments.&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&lt;span style="text-decoration:underline"&gt;Revenue Recognition and Concentration&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;The Company follows the revenue standards of Financial Accounting Standards Board Update No. 2014-09: &#x201c;Revenue from Contracts with Customers (Topic 606).&#x201d; The core principle of this Topic is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Revenue is recognized in accordance with that core principle by applying the following five steps: 1) identify the contracts with a customer; 2) identify the performance obligations in the contract; 3) determine the transaction price; 4) allocate the transaction price to the performance obligations; and 5) recognize revenue when (or as) we satisfy a performance obligation.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;The Company&#x2019;s performance obligations will be satisfied at the point in time when products are shipped or delivered to the customer, which is when the customer has title and the significant risks and rewards of ownership. Therefore, the Company&#x2019;s contracts will have a single performance obligation (shipment or delivery of product). The Company will primarily receive fixed consideration for sales of product. Manufacturing assembly services are recognized as revenue when the assembled product is delivered to the customer and the Company has completed its performance obligations.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;Revenues for the year ended December 31, 2021 were generated from consulting and advisory service agreements, which were recognized when the Company completed its performance obligations under the relevant service agreements.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;During the year ended December 31, 2020, 100% of the Company&#x2019;s revenues were earned from consulting and advisory services, which were recognized when the Company performed the service pursuant to its agreement with its clients which was the point in time when the Company completed its performance obligations under the agreements. One customer accounted for approximately 88% of revenues in 2020 and 92% of accounts receivable at December 31, 2020. Revenues generated in 2020 were not from the Company&#x2019;s planned operations. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&lt;span style="text-decoration:underline"&gt;Stock-based Compensation&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;The Company has accounted for stock-based compensation under the provisions of Accounting Standards Codification (ASC) Topic 718 &#x2013; &#x201c;Stock Compensation&#x201d; which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments (stock options and common stock purchase warrants). The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate. Expected volatilities are based on historical volatility of peer companies and other factors estimated over the expected term of the stock options. The expected term of options granted is derived using the &#x201c;simplified method&#x201d; which computes expected term as the average of the sum of the vesting term plus the contract term. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&lt;span style="text-decoration:underline"&gt;Accounting for Uncertainty in Income Taxes&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;The Company follows the provisions of ASC Topic 740-10, &#x201c;Accounting for Uncertainty in Income Taxes&#x201d; which clarifies the accounting for uncertainty in income taxes recognized in an enterprise&#x2019;s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This topic also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. There were no uncertain tax positions as of December 31, 2021 and 2020.&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&lt;span style="text-decoration:underline"&gt;Income Tax Policy&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&lt;span style="text-decoration:underline"/&gt;&#160;&lt;/p&gt;The Company accounts for income taxes using the liability method prescribed by ASC 740 - Income Taxes. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets if, based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the period that includes the enactment date.&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&lt;span style="text-decoration:underline"&gt;Research and Development Costs&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;The Company&#x2019;s research and development costs are expensed in the period in which they are incurred. Such expenditures amounted to $375,032 and $57,718 for the years ended December 31, 2021 and 2020, respectively. &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&lt;span style="text-decoration:underline"&gt;Earnings (Loss) Per Share&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;Earnings (loss) per share is computed in accordance with FASB ASC Topic 260, &#x201c;Earnings per Share&#x201d;. Diluted earnings per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities outstanding during the period. Certain common stock equivalents were not included in the earnings (loss) per share calculation as their effect would be anti-dilutive. As of December 31, 2021, there were the following potentially dilutive securities that were excluded from diluted net loss per share because their effect would be antidilutive: options for 12,596,000 shares of common stock and 1,363,350 common stock shares issuable upon conversion of the Series D Preferred Stock. There were no dilutive shares as of December 31, 2020.&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&lt;span style="text-decoration:underline"&gt;Financial Instruments&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;The Company carries cash, accounts receivable, accounts payable and accrued expenses, at historical costs. The respective estimated fair values of these assets and liabilities approximate carrying values / useful lives of equipment and intangible assets due to their current nature.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&lt;span style="text-decoration:underline"&gt;Use of Estimates&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates in the accompanying financial statements include the fair value of equity-based compensation, fair value of intangible assets, useful lives of intangible assets, capital raise transactions, and valuation allowance against deferred tax assets.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&lt;span style="text-decoration:underline"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;In August 2020, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2020-06, Debt &#x2014; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#x2014; Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40) (&#x201c;ASU 2020-06&#x201d;) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity&#x2019;s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity&#x2019;s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company notes that there will be no effect on the current financial statements.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;There are several other new accounting pronouncements issued or proposed by the FASB. Each of these pronouncements, as applicable, has been or will be adopted by the Company. Management does not believe any of these accounting pronouncements has had or will have a material impact on the Company&#x2019;s condensed consolidated financial position, operating results, or cash flows.&#160;&lt;/p&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2021-01-01to2021-12-31" id="fid_252">The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. The Company held no cash equivalents as of December 31, 2021 and 2020.</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_285"
      unitRef="USD">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="From2021-01-01to2021-12-31" id="fid_253">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;Financial instruments that potentially subject the Company to credit risk consist of cash and cash equivalents. Deposits with financial institutions are insured, up to certain limits, by the Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;). The Company&#x2019;s cash deposits often exceed the FDIC insurance limit; however, all deposits are maintained with high credit quality institutions and the Company has not experienced any losses in such accounts. The financial condition of financial institutions is periodically reassessed, and the Company believes the risk of any loss is minimal. The Company believes the risk of any loss on cash due to credit risk is minimal.&lt;/p&gt;</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <us-gaap:ReceivablesPolicyTextBlock contextRef="From2021-01-01to2021-12-31" id="fid_254">Accounts receivables consist of balances due from service revenues. The Company monitors accounts receivable and provides allowances when considered necessary. At December 31, 2021 and 2020, accounts receivable were considered to be fully collectible. Accordingly, no allowance for doubtful accounts was provided and there was no bad debt expense as of December 31, 2021 and 2020. </us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_277"
      unitRef="USD">0</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <scwo:EquipmentPolicy contextRef="From2021-01-01to2021-12-31" id="fid_255">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;Equipment is recorded at cost. Depreciation is computed using the straight-line method and an estimated useful life of three years. Expenses for maintenance and repairs are charged to expense as incurred.&lt;/p&gt;</scwo:EquipmentPolicy>
    <us-gaap:IntangibleAssetsFiniteLivedPolicy contextRef="From2021-01-01to2021-12-31" id="fid_256">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;Intangible assets are subject to amortization, and any impairment is determined in accordance with ASC 360, &#x201c;Property, Plant, and Equipment.&#x201d; Intangible assets are stated at historical cost and amortized over their estimated useful lives. The Company uses a straight-line method of amortization, unless a method that better reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up can be reliably determined.&lt;/p&gt;</us-gaap:IntangibleAssetsFiniteLivedPolicy>
    <scwo:LongLivedAssetsPolicy contextRef="From2021-01-01to2021-12-31" id="fid_257">The Company reviews long-lived assets, including intangible assets with finite lives, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company uses an estimate of the undiscounted cash flows over the remaining life of its long-lived assets, or related group of assets where applicable, in measuring whether the assets to be held and used will be realizable. Recoverability of assets held and used is measured by a comparison of the carrying amount to the future undiscounted expected net cash flows to be generated by the asset. As of December 31, 2021 and 2020, there were no impairments.</scwo:LongLivedAssetsPolicy>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_278"
      unitRef="USD">0</us-gaap:GoodwillImpairmentLoss>
    <scwo:RevenueRecognitionAndConcentrationPolicy contextRef="From2021-01-01to2021-12-31" id="fid_258">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;The Company follows the revenue standards of Financial Accounting Standards Board Update No. 2014-09: &#x201c;Revenue from Contracts with Customers (Topic 606).&#x201d; The core principle of this Topic is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Revenue is recognized in accordance with that core principle by applying the following five steps: 1) identify the contracts with a customer; 2) identify the performance obligations in the contract; 3) determine the transaction price; 4) allocate the transaction price to the performance obligations; and 5) recognize revenue when (or as) we satisfy a performance obligation.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;The Company&#x2019;s performance obligations will be satisfied at the point in time when products are shipped or delivered to the customer, which is when the customer has title and the significant risks and rewards of ownership. Therefore, the Company&#x2019;s contracts will have a single performance obligation (shipment or delivery of product). The Company will primarily receive fixed consideration for sales of product. Manufacturing assembly services are recognized as revenue when the assembled product is delivered to the customer and the Company has completed its performance obligations.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;Revenues for the year ended December 31, 2021 were generated from consulting and advisory service agreements, which were recognized when the Company completed its performance obligations under the relevant service agreements.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;During the year ended December 31, 2020, 100% of the Company&#x2019;s revenues were earned from consulting and advisory services, which were recognized when the Company performed the service pursuant to its agreement with its clients which was the point in time when the Company completed its performance obligations under the agreements. One customer accounted for approximately 88% of revenues in 2020 and 92% of accounts receivable at December 31, 2020. Revenues generated in 2020 were not from the Company&#x2019;s planned operations. &lt;/p&gt;</scwo:RevenueRecognitionAndConcentrationPolicy>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="From2021-01-01to2021-12-31" id="fid_259">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;The Company has accounted for stock-based compensation under the provisions of Accounting Standards Codification (ASC) Topic 718 &#x2013; &#x201c;Stock Compensation&#x201d; which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments (stock options and common stock purchase warrants). The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate. Expected volatilities are based on historical volatility of peer companies and other factors estimated over the expected term of the stock options. The expected term of options granted is derived using the &#x201c;simplified method&#x201d; which computes expected term as the average of the sum of the vesting term plus the contract term. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term.&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:IncomeTaxUncertaintiesPolicy contextRef="From2021-01-01to2021-12-31" id="fid_260">The Company follows the provisions of ASC Topic 740-10, &#x201c;Accounting for Uncertainty in Income Taxes&#x201d; which clarifies the accounting for uncertainty in income taxes recognized in an enterprise&#x2019;s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This topic also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. There were no uncertain tax positions as of December 31, 2021 and 2020.</us-gaap:IncomeTaxUncertaintiesPolicy>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_280"
      unitRef="USD">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2021-01-01to2021-12-31" id="fid_261">The Company accounts for income taxes using the liability method prescribed by ASC 740 - Income Taxes. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets if, based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the period that includes the enactment date.</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="From2021-01-01to2021-12-31" id="fid_262">The Company&#x2019;s research and development costs are expensed in the period in which they are incurred. Such expenditures amounted to $375,032 and $57,718 for the years ended December 31, 2021 and 2020, respectively. </us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_281"
      unitRef="USD">375032</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2020-01-01to2020-12-31"
      decimals="0"
      id="fid_282"
      unitRef="USD">57718</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2021-01-01to2021-12-31" id="fid_263">Earnings (loss) per share is computed in accordance with FASB ASC Topic 260, &#x201c;Earnings per Share&#x201d;. Diluted earnings per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities outstanding during the period. Certain common stock equivalents were not included in the earnings (loss) per share calculation as their effect would be anti-dilutive. As of December 31, 2021, there were the following potentially dilutive securities that were excluded from diluted net loss per share because their effect would be antidilutive: options for 12,596,000 shares of common stock and 1,363,350 common stock shares issuable upon conversion of the Series D Preferred Stock. There were no dilutive shares as of December 31, 2020.</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2021-01-01to2021-12-31_scwo_WarrantsMember"
      decimals="0"
      id="fid_283"
      unitRef="Shares">12596000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2020-01-01to2020-12-31_scwo_WarrantsMember"
      decimals="0"
      id="fid_284"
      unitRef="Shares">1363350</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2021-01-01to2021-12-31" id="fid_264">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;The Company carries cash, accounts receivable, accounts payable and accrued expenses, at historical costs. The respective estimated fair values of these assets and liabilities approximate carrying values / useful lives of equipment and intangible assets due to their current nature.&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:UseOfEstimates contextRef="From2021-01-01to2021-12-31" id="fid_265">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates in the accompanying financial statements include the fair value of equity-based compensation, fair value of intangible assets, useful lives of intangible assets, capital raise transactions, and valuation allowance against deferred tax assets.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2021-01-01to2021-12-31" id="fid_266">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;In August 2020, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2020-06, Debt &#x2014; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#x2014; Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40) (&#x201c;ASU 2020-06&#x201d;) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity&#x2019;s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity&#x2019;s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company notes that there will be no effect on the current financial statements.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;There are several other new accounting pronouncements issued or proposed by the FASB. Each of these pronouncements, as applicable, has been or will be adopted by the Company. Management does not believe any of these accounting pronouncements has had or will have a material impact on the Company&#x2019;s condensed consolidated financial position, operating results, or cash flows.&#160;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:SubstantialDoubtAboutGoingConcernTextBlock contextRef="From2021-01-01to2021-12-31" id="fid_244">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&lt;strong&gt;Note 3 &#x2013; Liquidity, Capital Resources&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;As of December 31, 2021, the Company had working capital of $11,263,270 compared to working capital of $10,572 at December 31, 2020. This significant increase in working capital is due primarily to the increase in cash over the twelve-month period is based on the Company&#x2019;s sale and issuance of Series D Convertible Preferred Stock (&#x201c;Preferred Stock&#x201d;) and the proceeds for the exercise of warrants (see Note 4 and Note 6). During the second quarter of 2021, in connection with the Merger (described in Note 4 below), the Company received gross proceeds of $6,551,745 from the sale of Series D Convertible Preferred Stock. During the fourth quarter of 2021, the Company received gross proceeds of $5,000,000 from the sale of Common Stock (see Note 6). As of December 31, 2021, the Company has an accumulated deficit of $3,160,015. For the year ended December 31, 2021, the Company had a net loss of $3,164,608 and $1,840,950 of net cash used in operations for the period.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;The Company believes that the capital raised from the sale of Common and Preferred Stock and proceeds from conversion of warrants will provide sufficient cash flow for the Company to meet its financial obligations as they come due for at least the next 12 months. &lt;/p&gt;</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>
    <scwo:WorkingCapital
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_289"
      unitRef="USD">11263270</scwo:WorkingCapital>
    <scwo:WorkingCapital
      contextRef="AsOf2020-12-31"
      decimals="0"
      id="fid_290"
      unitRef="USD">10572</scwo:WorkingCapital>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_291"
      unitRef="USD">6551745</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="From2021-01-01to2021-06-30"
      decimals="0"
      id="fid_292"
      unitRef="USD">5000000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_293"
      unitRef="USD">-3160015</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_797"
      unitRef="USD">-3164608</us-gaap:NetIncomeLoss>
    <scwo:NetCashProvidedByUsedInOperatingActivity
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_295"
      unitRef="USD">1840950</scwo:NetCashProvidedByUsedInOperatingActivity>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="From2021-01-01to2021-12-31" id="fid_245">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&lt;strong&gt;Note 4 &#x2013; Acquisition of 374Water, Inc. f/k/a PowerVerde Inc. &lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;In connection with the Merger,&#160;374Water&#160;closed on a private placement of 436,783 shares of Series D Convertible Preferred Stock (the &#x201c;Preferred Stock&#x201d;) with a par value of $0.0001, yielding gross proceeds of $6,551,745 (the &#x201c;Private Placement&#x201d;) and the settlement of a $50,000 liability for Preferred Stock shares. The Private Placement proceeds will be used for working capital, primarily for development, manufacture and commercialization of 374Water Inc.&#x2019;s Air SCWO Nix systems. The Preferred Stock has a stated value of $15 per share, is convertible into common stock at $.30 per share and has voting rights based on the underlying shares of common stock. Upon liquidation of the Company, the Preferred Stockholders have liquidation preference before any assets can be distributed to common stockholders. All of the Preferred Stock was sold pursuant to an exemption from registration requirements under Regulation D and/or Section 4(2) of the Securities Act of 1933, as amended.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;As a result of the Merger, the issuance of the Preferred Stock, the former 374Water shareholders own 65.8% of 374Water Inc&#x2019;s issued and outstanding common stock and 53.8% of 374Water Inc.&#x2019;s issued and outstanding voting stock (which includes the Preferred Stock on an as converted basis).&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Also as a result of the Merger, 374Water Inc. entered into two-year employment agreements with 374Water founders Yaacov (Kobe) Nagar and Marc Deshusses, Ph. D. Mr. Nagar will serve as the Company&#x2019;s CEO, replacing Richard H. Davis, who resigned upon closing of the Merger. Mr. Nagar will receive an annual salary of $200,000. Dr. Deshusses will serve as the Company&#x2019;s Head of Technology on a part-time basis at a salary of $60,000 per year. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;Pursuant to the Merger, Messrs. Nagar and Deshusses were appointed to the Company&#x2019;s Board of Directors, joining Mr. Davis, who remains as a Director.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;The patented technology underlying 374Water&#x2019;s supercritical water oxidation (SCWO) units, which was developed principally through the efforts of Messrs. Nagar and Deshusses at the facilities of Duke University, Durham, North Carolina (&#x201c;Duke&#x201d;), where Dr. Deshusses is a professor, is licensed to 374Water pursuant to a worldwide license agreement with Duke executed on April 16, 2021 (the &#x201c;License Agreement&#x201d;) simultaneous with the merger. In connection with the License Agreement, 374Water also executed an equity transfer Agreement with Duke pursuant to which Duke received a small block of shares of common stock (see Note 5).&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;As a result of the Merger Agreement, for financial statement reporting purposes, the business combination between 374Water Inc. and PowerVerde, Inc. was treated as a reverse acquisition and recapitalization for accounting purposes with 374Water, Inc. deemed the accounting acquirer and PowerVerde, Inc. deemed the accounting acquiree under the acquisition method of accounting in accordance with FASB Accounting Standards Codification (&#x201c;ASC&#x201d;) Section 805-10-55.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&lt;span style="text-decoration:underline"&gt;The following assets and liabilities were assumed in the transaction:&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Cash&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;29,536&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Prepaid expense&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;14,483&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Accounts Receivable&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1,000&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Total assets acquired&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;45,019&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Accounts payable&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;(46,150&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Accrued expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(83,094&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Total liabilities assumed&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(129,244&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Net liabilities assumed&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(84,225&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:PartnersCapitalAccountUnitsSoldInPrivatePlacement
      contextRef="From2021-01-01to2021-12-31_us-gaap_SeriesDPreferredStockMember"
      decimals="0"
      id="fid_308"
      unitRef="Shares">436783</us-gaap:PartnersCapitalAccountUnitsSoldInPrivatePlacement>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2021-12-31_us-gaap_SeriesDPreferredStockMember"
      decimals="INF"
      id="fid_306"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="From2021-01-01to2021-12-31_us-gaap_SeriesDPreferredStockMember"
      decimals="0"
      id="fid_307"
      unitRef="USD">6551745</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <scwo:SettlementOfLiabilityForPreferredStockShares
      contextRef="From2021-01-01to2021-12-31_us-gaap_SeriesDPreferredStockMember"
      decimals="0"
      id="fid_309"
      unitRef="USD">50000</scwo:SettlementOfLiabilityForPreferredStockShares>
    <scwo:Description
      contextRef="From2021-01-01to2021-12-31_us-gaap_SeriesDPreferredStockMember"
      id="fid_311">the former 374Water shareholders own 65.8% of 374Water Inc&#x2019;s issued and outstanding common stock and 53.8% of 374Water Inc.&#x2019;s issued and outstanding voting stock</scwo:Description>
    <us-gaap:SalariesAndWages
      contextRef="From2021-01-01to2021-12-31_scwo_MrNagarMember"
      decimals="0"
      id="fid_312"
      unitRef="USD">200000</us-gaap:SalariesAndWages>
    <us-gaap:SalariesAndWages
      contextRef="From2021-01-01to2021-12-31_srt_ChiefExecutiveOfficerMember"
      decimals="0"
      id="fid_310"
      unitRef="USD">60000</us-gaap:SalariesAndWages>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock contextRef="From2021-01-01to2021-12-31" id="fid_267">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Cash&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;29,536&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Prepaid expense&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;14,483&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Accounts Receivable&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1,000&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Total assets acquired&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;45,019&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Accounts payable&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;(46,150&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Accrued expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(83,094&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Total liabilities assumed&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(129,244&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Net liabilities assumed&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(84,225&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="AsOf2021-12-31_scwo_ThreeSevenFourWaterMember"
      decimals="0"
      id="fid_298"
      unitRef="USD">29536</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="AsOf2021-12-31_scwo_ThreeSevenFourWaterMember"
      decimals="0"
      id="fid_297"
      unitRef="USD">14483</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="AsOf2021-12-31_scwo_ThreeSevenFourWaterMember"
      decimals="0"
      id="fid_299"
      unitRef="USD">1000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="AsOf2021-12-31_scwo_ThreeSevenFourWaterMember"
      decimals="0"
      id="fid_300"
      unitRef="USD">45019</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="AsOf2021-12-31_scwo_ThreeSevenFourWaterMember"
      decimals="0"
      id="fid_301"
      unitRef="USD">46150</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability
      contextRef="AsOf2021-12-31_scwo_ThreeSevenFourWaterMember"
      decimals="0"
      id="fid_302"
      unitRef="USD">83094</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="AsOf2021-12-31_scwo_ThreeSevenFourWaterMember"
      decimals="0"
      id="fid_303"
      unitRef="USD">129244</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="AsOf2021-12-31_scwo_ThreeSevenFourWaterMember"
      decimals="0"
      id="fid_304"
      unitRef="USD">84225</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="From2021-01-01to2021-12-31" id="fid_246">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&lt;strong&gt;Note 5 &#x2013; Intangible Assets&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;Intangible assets are recorded at cost and consist of the license agreement with Duke University. The Company issued Duke University a small block of shares of common stock estimated to have a fair value of $1,073,529 as consideration for granting the Company the license based on the Company&#x2019;s common stock market price on the date the license agreement was executed (see Note 8). Intangible assets are comprised of the following as of December 31, 2021 and 2020:&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Name&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Estimated Life&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Balance at&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;December 31, 2020&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Additions&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Amortization&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Balance at&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;December 31, 2021&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;License agreement&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;17 Years&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1,073,529&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;45,415&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1,028,114&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Patents&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;20 Years&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;34,741&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;34,741&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Total&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1,108,270&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;45,415&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1,062,855&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;Amortization expense for the year ended December 31, 2021 was $45,415. There is no amortization expense associated with the patent expenses. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;Estimated future amortization expense as of December 31, 2021:&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;December 31,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2021&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;2022 &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;63,149&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;2023&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;63,149&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;2024&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;63,149&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;2025&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;63,149&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;2026&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;63,149&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Thereafter&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;712,369&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Intangible assets, Net&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1,028,114&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:CommonStockValue
      contextRef="AsOf2021-12-31_scwo_LicenseAgreementMember"
      decimals="0"
      id="fid_331"
      unitRef="USD">1073529</us-gaap:CommonStockValue>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="From2021-01-01to2021-12-31" id="fid_268">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Name&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Estimated Life&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Balance at&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;December 31, 2020&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Additions&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Amortization&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Balance at&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;December 31, 2021&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;License agreement&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;17 Years&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1,073,529&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;45,415&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1,028,114&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Patents&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;20 Years&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;34,741&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;34,741&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Total&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1,108,270&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;45,415&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1,062,855&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2020-12-31_scwo_LicenseAgreementMember"
      decimals="0"
      id="fid_320"
      unitRef="USD">0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <scwo:IntangibleAssetsAdditions
      contextRef="AsOf2021-12-31_scwo_LicenseAgreementMember"
      decimals="0"
      id="fid_313"
      unitRef="USD">1073529</scwo:IntangibleAssetsAdditions>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2021-12-31_scwo_LicenseAgreementMember"
      decimals="0"
      id="fid_314"
      unitRef="USD">45415</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2021-12-31_scwo_LicenseAgreementMember"
      decimals="0"
      id="fid_316"
      unitRef="USD">1028114</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2020-12-31_us-gaap_PatentsMember"
      decimals="0"
      id="fid_321"
      unitRef="USD">0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <scwo:IntangibleAssetsAdditions
      contextRef="AsOf2021-12-31_us-gaap_PatentsMember"
      decimals="0"
      id="fid_318"
      unitRef="USD">34741</scwo:IntangibleAssetsAdditions>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2021-12-31_us-gaap_PatentsMember"
      decimals="0"
      id="fid_317"
      unitRef="USD">34741</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_314-0f08b8"
      unitRef="USD">45415</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_315"
      unitRef="USD">1062855</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AdjustmentForAmortization
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_332"
      unitRef="USD">45415</us-gaap:AdjustmentForAmortization>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="From2021-01-01to2021-12-31" id="fid_786">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;December 31,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2021&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;2022 &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;63,149&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;2023&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;63,149&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;2024&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;63,149&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;2025&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;63,149&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;2026&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;63,149&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Thereafter&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;712,369&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Intangible assets, Net&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1,028,114&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_324"
      unitRef="USD">63149</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_325"
      unitRef="USD">63149</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_326"
      unitRef="USD">63149</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_327"
      unitRef="USD">63149</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_328"
      unitRef="USD">63149</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_329"
      unitRef="USD">712369</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_330"
      unitRef="USD">1028114</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2021-01-01to2021-12-31" id="fid_247">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&lt;strong&gt;Note 6 &#x2013; Stockholder&#x2019; Equity&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;The Company is authorized to issue 1,000,000 preferred stock shares and 200,000,000 common stock shares both with a par value of $0.0001.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&lt;strong&gt;Preferred Stock&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;On October 30, 2020, the Company designated 1,000,000 shares as Series D Convertible Preferred Stock with a par value of $0.0001.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;On April 16, 2021, the Company closed on a private placement of 436,782 shares of Series D Convertible Preferred Stock (the &#x201c;Preferred Stock&#x201d;) with a par value of $.0001, yielding gross proceeds of $6,551,691 (the &#x201c;Private Placement&#x201d;) and settlement of a $50,000 liability for Preferred Stock shares. The Private Placement proceeds will be used for working capital, primarily for the development, manufacturing and commercialization of 374Water&#x2019;s Air SCWO Nix systems. The Preferred Stock has a stated value of $15 per share, is convertible into common stock at $0.30 per share and has voting rights based on the underlying shares of common stock. Upon liquidation of the Company, the Preferred Stockholders have a liquidation preference before any assets can be distributed to common stockholders. The current liquidation value is $409,005. All of the Preferred Stock were sold pursuant to an exemption from registration requirements under Regulation D and/or Section 4(2) of the Securities Act of 1933, as amended. On September 30, 2021, 412,853 shares of Series D Preferred stock were converted into 20,642,667 shares of common stock. As of December 31, 2021, there were 27,272 shares of Series D Preferred stock issued and outstanding.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&lt;strong&gt;Common Stock&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;The holders of common stock are entitled to one vote per share on all matters submitted to a vote of shareholders, including the directors&#x2019; election. There is no right to cumulate votes in the election of directors. The holders of common stock are entitled to any dividends that may be declared by the board of directors out of funds legally available for payment of dividends subject to the prior rights of holders of preferred stock and any contractual restrictions the Company has against the payment of dividends on common stock. In the event of our liquidation or dissolution, holders of common stock are entitled to share ratably in all assets remaining after payment of liabilities and the liquidation preferences of any outstanding shares of preferred stock. Holders of common stock have no preemptive rights and have no right to convert their common stock into any other securities. As of December 31, 2021, there were 125,317,746 shares of common stock issued and outstanding.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;On April 16, 2021, as a result of the closing of the Merger Agreement (see Note 4), the equity of the consolidated entity is the historical equity of 374Water, Inc (&#x201c;374Water&#x201d;) retroactively restated to reflect the number of shares issued by the Company in the reverse recapitalization.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;In connection with the Merger, 33,203,512 shares of common stock were issued to 374Water, Inc. (f/k/a PowerVerde, Inc.) stockholders.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;Pursuant to the Merger, all 374Water shares were cancelled and 374Water, Inc. issued to the former 374Water stockholders a total of 62,410,452 shares of 374Water, Inc. common stock. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;On April 16, 2021, the Company issued&#160;Common Stock estimated to have a fair value of $1,073,369 as consideration for the grant of a license to the Company (see Notes 5 and 8).&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;In December 2021, the Company raised $5,000,000 through a private placement and sale of 2,500,000 shares of Common Stock which were issued to investees as part of the capital raise. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;During the year ended December 31, 2021, the Company issued 4,958,833 shares of common stock, in connection with the exercise of warrants and options and received cash proceeds of $1,284,848.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&lt;span style="text-decoration:underline"&gt;Stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;During the year ended December 31, 2021 and 2020, the Company recorded stock-based compensation of $204,217 and $6,657, respectively, related to common stock issued or vested options to employees and various consultants of the Company, of which $190,136 and $328 was charged as general and administrative expenses and $14,081 and $6,329 as research and development expenses in the accompanying consolidated statements of operations during the years ended December 31, 2021 and 2020, respectively&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&lt;strong&gt;Stock Options&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;Stock option activity for the year ended December 31, 2021, is summarized as follows:&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Shares&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Weighted&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Average&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Exercise Price&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Aggregate&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Intrinsic Value&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Weighted&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Average&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Remaining&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Contractual&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Life (Years)&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Options outstanding at December 31, 2019&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;12,180,500&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.20&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;4,750,395&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;5.59&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Granted &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Exercised&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Expired/forfeit&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Options outstanding at December 31, 2020&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;12,180,500&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.20&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;4,750,395&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;4.59&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Granted &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;2,885,000&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;1.20&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Exercised&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;(225,500&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.19&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Expired/forfeit&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(2,540,000&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.17&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Options outstanding at December 31, 2021&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;12,300,000&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.37&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;4,521,310&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;5.62&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;Stock option unvested activity for the year ended December 31, 2021, is summarized as follows:&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Options&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Options Unvested at December 31, 2019&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Granted &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Vested&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Expired/forfeit&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Options Unvested at December 31, 2020&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Granted &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;2,885,000&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Vested &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;(379,817&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Expired/forfeit&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(40,000&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Options Unvested at December 31, 2021&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;2,465,183&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;Total unrecognized compensation associated with these unvested options is approximately $1,136,921 which will be recognized over a period of four years. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;The fair value of these options granted were estimated on the date of grant, using the Black-Scholes option-pricing model with the following assumptions:&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;For the years ended&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td style="BORDER-BOTTOM: 1px solid;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2021&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2020&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Dividend yield&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.00&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"/&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Expected life&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"&gt;5.49 &#x2013; 6.25 Years&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Expected volatility&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"&gt;38.39- 38.67&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"/&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Risk-free interest rate&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"&gt;0.87&#x2013; 1.07&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"/&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&lt;strong&gt;Stock Warrants&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;In April 2021, pursuant to the binding Memorandum of Understanding dated as of March 30, 2021, between 374Water and MB Holding Inc. (the &#x201c;MOU&#x201d;), a warrant for the purchase of 3,783,333 shares of common stock at an exercise price of $0.30 per share was issued to MB Holding Inc. as consideration for executing the MOU and was considered fully vested upon the execution of the MOU. These warrants expire in March 2022. Those warrants were estimated to have a grant-date fair value of $0.37 per warrant or aggregate fair value of $1,399,833 which has been presented as product development expense on the condensed statements of operations.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;During the year ended December 31, 2021, the warrants were exercised resulting in the issuance of 3,783,333 shares of common stock and proceeds of $1,134,499. As of December 31, 2021, there were 1,250,000 warrants outstanding which relate to the Series 1 offering executed in December 2021, where investors were offered a warrant for every two common shares purchased during the offering at an exercise price of $2.50 per share. The intrinsic value of all outstanding warrants as of December 31, 2021 was $437,500 based on the market price of our common stock of $2.85 per share.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;The fair value of those warrants granted were estimated on the date of grant, using the Black-Scholes option-pricing model with the following assumptions:&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;For the years ended&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td style="BORDER-BOTTOM: #000000 1px solid;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2021&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2020&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Dividend yield&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.00&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Expected life&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"&gt;1 - 3 Years&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Expected volatility&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"&gt;42.39% - 45.24%&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Risk-free interest rate&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"&gt;0.600% - 0.795%&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;table cellpadding="0" style="border-spacing:0;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td class="hpbhr"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;"&gt;F-14&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="page-break-after: always"/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;em&gt;&lt;a href="#TOCFS"&gt;Table of Contents&lt;/a&gt;&lt;/em&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;A summary of warrant activity during the year ended December 31, 2021, is as follows:&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Shares&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Weighted&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Average&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Exercise Price&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Aggregate&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Intrinsic Value&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Weighted&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Average&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Remaining&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Contractual&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Life (Years)&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Balance at December 31, 2019&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;950,000&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.11&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;690,500&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;1.44&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Issued&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Exercised&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Balance at December 31, 2020&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;950,000&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.11&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;690,500&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.44&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Issued&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;5,033,333&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.85&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Exercised&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(4,733,333&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.26&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Balance at December 31, 2021&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1,250,000&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;2.50&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;437,500&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;2.96&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_385"
      unitRef="Shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_386"
      unitRef="Shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2020-10-30_us-gaap_SeriesDPreferredStockMember"
      decimals="0"
      id="fid_387"
      unitRef="Shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <scwo:Preferredstockparorstatedvaluepershare
      contextRef="AsOf2020-10-30_us-gaap_SeriesDPreferredStockMember"
      decimals="INF"
      id="fid_427"
      unitRef="USDPShares">0.0001</scwo:Preferredstockparorstatedvaluepershare>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2021-04-16"
      decimals="0"
      id="fid_388"
      unitRef="Shares">436782</us-gaap:PreferredStockSharesIssued>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_389"
      unitRef="USD">6551691</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <scwo:LiabilityForPreferredStockShares
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_390"
      unitRef="USD">50000</scwo:LiabilityForPreferredStockShares>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2021-04-16_scwo_ThreeSevenFourWaterMember"
      decimals="INF"
      id="fid_391"
      unitRef="USDPShares">15</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2021-04-16_scwo_ThreeSevenFourWaterMember"
      decimals="INF"
      id="fid_392"
      unitRef="USDPShares">0.30</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockLiquidationPreferenceValue
      contextRef="AsOf2021-04-16_scwo_ThreeSevenFourWaterMember"
      decimals="0"
      id="fid_393"
      unitRef="USD">409005</us-gaap:PreferredStockLiquidationPreferenceValue>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2021-09-30_us-gaap_SeriesDPreferredStockMember"
      decimals="0"
      id="fid_409"
      unitRef="Shares">412853</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockConvertibleSharesIssuable
      contextRef="AsOf2021-09-30_us-gaap_SeriesDPreferredStockMember"
      decimals="0"
      id="fid_394"
      unitRef="Shares">20642667</us-gaap:PreferredStockConvertibleSharesIssuable>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2021-12-31_us-gaap_SeriesDPreferredStockMember"
      decimals="0"
      id="fid_408"
      unitRef="Shares">27272</us-gaap:PreferredStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2021-12-31_scwo_ThreeSevenFourWaterMember"
      decimals="0"
      id="fid_396"
      unitRef="Shares">125317746</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2021-04-16"
      decimals="0"
      id="fid_397"
      unitRef="Shares">33203512</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2021-04-16_scwo_ThreeSeverFourWaterFormerStockholdersMember"
      decimals="0"
      id="fid_398"
      unitRef="Shares">62410452</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="AsOf2021-04-16_us-gaap_PatentsMember"
      decimals="0"
      id="fid_400"
      unitRef="USD">1073369</us-gaap:CommonStockValue>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_403"
      unitRef="USD">5000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_404"
      unitRef="Shares">2500000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <scwo:CommonStockSharesIssuesForCash
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_405"
      unitRef="Shares">4958833</scwo:CommonStockSharesIssuesForCash>
    <us-gaap:ShareBasedCompensation
      contextRef="From2021-01-01to2021-12-31_scwo_WarrantsMember"
      decimals="0"
      id="fid_406"
      unitRef="USD">1284848</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2021-01-01to2021-12-31_scwo_ConsultantMember"
      decimals="0"
      id="fid_414"
      unitRef="USD">204217</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2020-01-01to2020-12-31_scwo_ConsultantMember"
      decimals="0"
      id="fid_415"
      unitRef="USD">6657</us-gaap:ShareBasedCompensation>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2021-01-01to2021-12-31_scwo_ConsultantMember"
      decimals="0"
      id="fid_410"
      unitRef="USD">190136</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2020-01-01to2020-12-31_scwo_ConsultantMember"
      decimals="0"
      id="fid_411"
      unitRef="USD">328</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2021-01-01to2021-12-31_scwo_ConsultantMember"
      decimals="0"
      id="fid_412"
      unitRef="USD">14081</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2020-01-01to2020-12-31_scwo_ConsultantMember"
      decimals="0"
      id="fid_413"
      unitRef="USD">6329</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2021-01-01to2021-12-31" id="fid_270">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Shares&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Weighted&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Average&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Exercise Price&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Aggregate&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Intrinsic Value&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Weighted&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Average&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Remaining&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Contractual&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Life (Years)&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Options outstanding at December 31, 2019&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;12,180,500&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.20&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;4,750,395&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;5.59&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Granted &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Exercised&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Expired/forfeit&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Options outstanding at December 31, 2020&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;12,180,500&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.20&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;4,750,395&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;4.59&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Granted &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;2,885,000&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;1.20&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Exercised&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;(225,500&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.19&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Expired/forfeit&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(2,540,000&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.17&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Options outstanding at December 31, 2021&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;12,300,000&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.37&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;4,521,310&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;5.62&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2020-12-31_scwo_OptionsMember"
      decimals="0"
      id="fid_342"
      unitRef="Shares">12180500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2020-12-31_scwo_OptionsMember"
      decimals="INF"
      id="fid_350"
      unitRef="USDPShares">0.20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2020-12-31_scwo_OptionsMember"
      decimals="0"
      id="fid_339"
      unitRef="USD">4750395</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="From2019-01-01to2019-12-31_scwo_OptionsMember"
      id="fid_347">P5Y7M2D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <scwo:Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice
      contextRef="From2020-01-01to2020-12-31_scwo_OptionsMember"
      decimals="INF"
      id="fid_853"
      unitRef="USDPShares">0</scwo:Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice>
    <scwo:Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice
      contextRef="From2020-01-01to2020-12-31_scwo_OptionsMember"
      decimals="INF"
      id="fid_854"
      unitRef="USDPShares">0</scwo:Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice>
    <scwo:Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice
      contextRef="From2020-01-01to2020-12-31_scwo_OptionsMember"
      decimals="INF"
      id="fid_855"
      unitRef="USDPShares">0</scwo:Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2019-12-31_scwo_OptionsMember"
      decimals="0"
      id="fid_344"
      unitRef="Shares">12180500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2019-12-31_scwo_OptionsMember"
      decimals="INF"
      id="fid_352"
      unitRef="USDPShares">0.20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2019-12-31_scwo_OptionsMember"
      decimals="0"
      id="fid_348"
      unitRef="USD">4750395</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="From2020-01-01to2020-12-31_scwo_OptionsMember"
      id="fid_346">P4Y7M2D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2021-01-01to2021-12-31_scwo_OptionsMember"
      decimals="0"
      id="fid_336"
      unitRef="Shares">2885000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <scwo:Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice
      contextRef="From2021-01-01to2021-12-31_scwo_OptionsMember"
      decimals="INF"
      id="fid_334"
      unitRef="USDPShares">1.20</scwo:Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2021-01-01to2021-12-31_scwo_OptionsMember"
      decimals="0"
      id="fid_337"
      unitRef="Shares">-225500</us-gaap:ConversionOfStockSharesConverted1>
    <scwo:Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice
      contextRef="From2021-01-01to2021-12-31_scwo_OptionsMember"
      decimals="INF"
      id="fid_333"
      unitRef="USDPShares">0.19</scwo:Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="From2021-01-01to2021-12-31_scwo_OptionsMember"
      decimals="0"
      id="fid_338"
      unitRef="Shares">2540000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <scwo:Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice
      contextRef="From2021-01-01to2021-12-31_scwo_OptionsMember"
      decimals="INF"
      id="fid_335"
      unitRef="USDPShares">0.17</scwo:Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2021-12-31_scwo_OptionsMember"
      decimals="0"
      id="fid_343"
      unitRef="Shares">12300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2021-12-31_scwo_OptionsMember"
      decimals="INF"
      id="fid_351"
      unitRef="USDPShares">0.37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2021-12-31_scwo_OptionsMember"
      decimals="0"
      id="fid_340"
      unitRef="USD">4521310</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="From2021-01-01to2021-12-31_scwo_OptionsMember"
      id="fid_341">P5Y7M13D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2021-01-01to2021-12-31" id="fid_271">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Options&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Options Unvested at December 31, 2019&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Granted &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Vested&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Expired/forfeit&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Options Unvested at December 31, 2020&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Granted &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;2,885,000&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Vested &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;(379,817&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Expired/forfeit&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(40,000&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Options Unvested at December 31, 2021&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;2,465,183&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2021-01-01to2021-12-31_scwo_OptionsMember"
      decimals="0"
      id="fid_336-1970bd"
      unitRef="Shares">2885000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="From2021-01-01to2021-12-31_scwo_OptionUnvestedMember"
      decimals="0"
      id="fid_851"
      unitRef="Shares">379817</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="From2021-01-01to2021-12-31_scwo_OptionUnvestedMember"
      decimals="0"
      id="fid_852"
      unitRef="Shares">40000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2021-12-31_scwo_OptionUnvestedMember"
      decimals="0"
      id="fid_842"
      unitRef="Shares">2465183</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="AsOf2021-12-31_scwo_OptionsMember"
      decimals="0"
      id="fid_416"
      unitRef="USD">1136921</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="From2021-01-01to2021-12-31_us-gaap_StockOptionMember"
      id="fid_272">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;For the years ended&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td style="BORDER-BOTTOM: 1px solid;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2021&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2020&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Dividend yield&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.00&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"/&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Expected life&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"&gt;5.49 &#x2013; 6.25 Years&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Expected volatility&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"&gt;38.39- 38.67&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"/&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Risk-free interest rate&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"&gt;0.87&#x2013; 1.07&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"/&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;For the years ended&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td style="BORDER-BOTTOM: #000000 1px solid;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2021&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2020&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Dividend yield&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.00&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Expected life&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"&gt;1 - 3 Years&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Expected volatility&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"&gt;42.39% - 45.24%&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Risk-free interest rate&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"&gt;0.600% - 0.795%&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Shares&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Weighted&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Average&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Exercise Price&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Aggregate&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Intrinsic Value&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Weighted&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Average&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Remaining&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Contractual&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Life (Years)&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Balance at December 31, 2019&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;950,000&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.11&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;690,500&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;1.44&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Issued&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Exercised&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Balance at December 31, 2020&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;950,000&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.11&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;690,500&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.44&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Issued&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;5,033,333&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.85&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Exercised&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(4,733,333&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.26&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Balance at December 31, 2021&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1,250,000&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;2.50&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;437,500&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;2.96&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2021-01-01to2021-12-31_scwo_OptionsMember"
      decimals="INF"
      id="fid_354"
      unitRef="Pure">0.0000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2021-01-01to2021-12-31_scwo_OptionsMember_scwo_MinimumsMember"
      id="fid_355">P5Y5M26D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2021-01-01to2021-12-31_scwo_OptionsMember_scwo_MaximumsMember"
      id="fid_356">P6Y3M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2021-01-01to2021-12-31_scwo_OptionsMember_scwo_MinimumsMember"
      decimals="INF"
      id="fid_357"
      unitRef="Pure">0.3839</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2021-01-01to2021-12-31_scwo_OptionsMember_scwo_MaximumsMember"
      decimals="INF"
      id="fid_358"
      unitRef="Pure">0.3867</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2021-01-01to2021-12-31_scwo_OptionsMember_scwo_MinimumsMember"
      decimals="INF"
      id="fid_359"
      unitRef="Pure">0.0087</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2021-01-01to2021-12-31_scwo_OptionsMember_scwo_MaximumsMember"
      decimals="INF"
      id="fid_360"
      unitRef="Pure">0.0107</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <scwo:NumberOfWarrantPurchase
      contextRef="From2021-04-01to2021-04-30"
      decimals="0"
      id="fid_417"
      unitRef="Shares">3783333</scwo:NumberOfWarrantPurchase>
    <us-gaap:WarrantExercisePriceIncrease
      contextRef="From2021-04-01to2021-04-30"
      decimals="INF"
      id="fid_418"
      unitRef="USDPShares">0.30</us-gaap:WarrantExercisePriceIncrease>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2021-04-01to2021-04-30"
      decimals="INF"
      id="fid_419"
      unitRef="USDPShares">0.37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <scwo:AggregateFairValueOfWarrant
      contextRef="AsOf2021-04-30"
      decimals="0"
      id="fid_420"
      unitRef="USD">1399833</scwo:AggregateFairValueOfWarrant>
    <scwo:StockIssuedUponWarrantExercised
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_736"
      unitRef="Shares">3783333</scwo:StockIssuedUponWarrantExercised>
    <scwo:ProceedsFromStockIssuedUponWarrantsExercisedAmount
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_737"
      unitRef="USD">1134499</scwo:ProceedsFromStockIssuedUponWarrantsExercisedAmount>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_423"
      unitRef="Shares">1250000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2021-12-31"
      decimals="INF"
      id="fid_425"
      unitRef="USDPShares">2.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_424"
      unitRef="USD">437500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:CommonStockNoParValue
      contextRef="AsOf2021-12-31"
      decimals="INF"
      id="fid_426"
      unitRef="USDPShares">2.85</us-gaap:CommonStockNoParValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2021-01-01to2021-12-31_scwo_WarrantsMember"
      decimals="INF"
      id="fid_361"
      unitRef="Pure">0.0000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2021-01-01to2021-12-31_scwo_WarrantsMember_scwo_MinimumsMember"
      id="fid_362">P1Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2021-01-01to2021-12-31_scwo_WarrantsMember_scwo_MaximumsMember"
      id="fid_363">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2021-01-01to2021-12-31_scwo_WarrantsMember_scwo_MinimumsMember"
      decimals="INF"
      id="fid_364"
      unitRef="Pure">0.4239</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2021-01-01to2021-12-31_scwo_WarrantsMember_scwo_MaximumsMember"
      decimals="INF"
      id="fid_365"
      unitRef="Pure">0.4524</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2021-01-01to2021-12-31_scwo_WarrantsMember_scwo_MinimumsMember"
      decimals="INF"
      id="fid_366"
      unitRef="Pure">0.00600</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2021-01-01to2021-12-31_scwo_WarrantsMember_scwo_MaximumsMember"
      decimals="INF"
      id="fid_367"
      unitRef="Pure">0.00795</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="AsOf2019-12-31"
      decimals="0"
      id="fid_368"
      unitRef="Shares">950000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2020-12-31"
      decimals="INF"
      id="fid_371"
      unitRef="USDPShares">0.11</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2020-12-31"
      decimals="0"
      id="fid_377"
      unitRef="USD">690500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2020-01-01to2020-12-31" id="fid_380">P1Y5M8D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="AsOf2020-12-31"
      decimals="0"
      id="fid_382"
      unitRef="Shares">950000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2020-12-31"
      decimals="INF"
      id="fid_383"
      unitRef="USDPShares">0.11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2019-12-31"
      decimals="0"
      id="fid_378"
      unitRef="USD">690500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2019-01-01to2019-12-31" id="fid_381">P0Y5M8D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      id="fid_373"
      unitRef="USDPShares">0.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_370"
      unitRef="Shares">4733333</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised>
    <scwo:WeightedAverageExercisePriceExercised
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      id="fid_374"
      unitRef="USDPShares">0.26</scwo:WeightedAverageExercisePriceExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_375"
      unitRef="Shares">1250000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2021-12-31"
      decimals="INF"
      id="fid_372"
      unitRef="USDPShares">2.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_376"
      unitRef="USD">437500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2021-01-01to2021-12-31" id="fid_379">P2Y11M15D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2021-01-01to2021-12-31" id="fid_248">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&lt;strong&gt;Note 7 - Related Party Transactions&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;At December 31, 2021 and 2020, the Company has due $0 and 15,108, respectively, of advances received from stockholders of the Company for working capital. There is no formal agreement, these advances are non-interest bearing and due on demand. During the years ended December 31, 2021 and 2020, stockholders advanced $0 and 2,053 respectively, for working capital needs. Advancements were fully paid in fiscal year 2021. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Our previous CFO John L Hofmann is a member of the accounting firm Kabat, Schertzer, De La Torre, Taraboulos &amp;amp; Co, LLC (&#x201c;KSDT&#x201d;). The Company paid $43,205 and $0 to KSDT for its services in the year ended December 31, 2021 and 2020, respectively, and $0 of services rendered remain unpaid as of December 31, 2021. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;Additionally, the Company entered into an agreement to fabricate and manufacture the units with Merrell Bros. Holding Company. As part of the agreement, the Company provided Terry Merrell a board of director position. As of December 31, 2021, Merrell Bros. own stock in excess of 5% of the outstanding common stock.&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <scwo:AdvancesFromStockholders
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_431"
      unitRef="USD">0</scwo:AdvancesFromStockholders>
    <scwo:AdvancesFromStockholders
      contextRef="AsOf2020-12-31"
      decimals="0"
      id="fid_432"
      unitRef="USD">15108</scwo:AdvancesFromStockholders>
    <us-gaap:RelatedPartyCosts
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_428"
      unitRef="USD">43205</us-gaap:RelatedPartyCosts>
    <us-gaap:RelatedPartyCosts
      contextRef="From2020-01-01to2020-09-30"
      decimals="0"
      id="fid_429"
      unitRef="USD">0</us-gaap:RelatedPartyCosts>
    <us-gaap:DueFromRelatedParties
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_430"
      unitRef="USD">0</us-gaap:DueFromRelatedParties>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2021-01-01to2021-12-31" id="fid_249">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&lt;strong&gt;Note 8 &#x2013; Commitments and Contingencies &lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;The patented technology underlying 374Water&#x2019;s supercritical water oxidation (SCWO) units, which was developed principally through the efforts of Messrs. Nagar and Deshusses at the facilities of Duke University, Durham, North Carolina (&#x201c;Duke&#x201d;), where Dr. Deshusses is a professor, is licensed to 374Water pursuant to a worldwide license agreement with Duke executed on April 16, 2021 (the &#x201c;License Agreement&#x201d;). In connection with the License Agreement, 374Water also executed an equity transfer Agreement with Duke pursuant to which Duke received a small block of common stock in the Company (See Notes 4 and 6). Under the terms of the License Agreement, the Company is required to make royalty payments based on a percentage of licensed product sales, as defined in the License Agreement which is triggered by the sale of licensed products. Further, the Company is also required to pay royalties on a percentage of sublicensing fees. The Company will reimburse Duke for any ongoing patent expenses incurred. During the year ended December 31, 2021, the Company has incurred $19,075 in connection with this License Agreement. The Company may terminate the license agreement anytime by providing Duke 60 days&#x2019; notice.&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2021-01-01to2021-12-31" id="fid_250">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&lt;strong&gt;Note 9 &#x2013; Income Taxes &lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;Deferred income taxes are provided based on the provisions of ASC Topic 740, &#x201c;Accounting for Income Taxes&#x201d;, to reflect the tax consequences in future years of differences between the tax basis of assets and liabilities and their financial reporting amounts based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;Significant components of the Company&#x2019;s net deferred income taxes are as follows:&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;December 31,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2021&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2020&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Deferred tax assets:&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" colspan="2" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" colspan="2" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" colspan="2" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" colspan="2" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Goodwill &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;208,742&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Capitalized Start-Up Costs&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;83,710&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Other Intangibles&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;10,339&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Other Accruals&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;1,875&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Stock Compensation&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;17,423&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;1,764&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Net Operating Loss&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;381,112&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Deferred tax assets&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;703,211&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;1,764&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Less valuation allowance&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(703,083 &lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(1,764 &lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Net deferred tax assets after valuation allowance&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;128&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;December 31,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2021&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2020&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Deferred tax liabilities:&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" colspan="2" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" colspan="2" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" colspan="2" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" colspan="2" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Depreciation &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;(128 &lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Deferred tax liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;(128 &lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;1,764&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Net deferred tax asset (liability) &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;A reconciliation of the U.S. statutory federal income tax rate to the effective income tax rate (benefit) follows:&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&lt;strong&gt;Rate Reconciliation&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;December 31,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2021&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2020&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Rate Reconciliation&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" colspan="2" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" colspan="2" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Federal income tax at statutory rate&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;21.00&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;21.00&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Change in State Tax&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Change in Valuation Allowance&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;-22.16&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;19.11&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Permanent Differences&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;-12.26&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;State Taxes &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;1.98&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;5.50&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Other&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;11.44&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;-45.61&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;At December 31, 2021, the Company had U.S. federal net operating loss carryforwards of approximately $1.7 million, which will carry forward indefinitely.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;NOLs that were acquired with the acquisition of businesses are excluded from the amount of available NOLs to the extent their use is limited by the provisions of Section 382 of the Internal Revenue Code. Under the provisions of the Internal Revenue Code, certain substantial changes in the Company&#x2019;s ownership may result in further limitation on the amount of net operating loss carryforwards which can be utilized in future years.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;In evaluating the amount of the valuation allowance against its deferred tax assets as of December 31, 2021 and 2020, the Company considered all available positive and negative evidence and concluded that it is more likely than not that a portion of its deferred tax assets would not be realized. Accordingly, the Company has recorded a valuation allowance against its net deferred tax assets due to the uncertainty surrounding the realization of such assets.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;The Company had no unrecognized tax benefits as of December 31, 2021 and 2020. The Company does not anticipate a significant change in total unrecognized tax benefits within the next 12 months. Tax years 2018-2020 remain open to examination by the major taxing jurisdictions to which the Company is subject.&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2021-01-01to2021-12-31" id="fid_273">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;Significant components of the Company&#x2019;s net deferred income taxes are as follows:&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;December 31,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2021&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2020&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Deferred tax assets:&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" colspan="2" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" colspan="2" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" colspan="2" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" colspan="2" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Goodwill &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;208,742&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Capitalized Start-Up Costs&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;83,710&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Other Intangibles&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;10,339&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Other Accruals&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;1,875&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Stock Compensation&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;17,423&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;1,764&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Net Operating Loss&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;381,112&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Deferred tax assets&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;703,211&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;1,764&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Less valuation allowance&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(703,083 &lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(1,764 &lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Net deferred tax assets after valuation allowance&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;128&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;December 31,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2021&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2020&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Deferred tax liabilities:&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" colspan="2" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" colspan="2" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" colspan="2" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" colspan="2" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Depreciation &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;(128 &lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Deferred tax liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;(128 &lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;1,764&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Net deferred tax asset (liability) &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_441"
      unitRef="USD">208742</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets
      contextRef="AsOf2020-12-31"
      decimals="0"
      id="fid_440"
      unitRef="USD">0</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <scwo:DeferredTaxAssetsStartupCost
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_439"
      unitRef="USD">83710</scwo:DeferredTaxAssetsStartupCost>
    <scwo:DeferredTaxAssetsStartupCost
      contextRef="AsOf2020-12-31"
      decimals="0"
      id="fid_438"
      unitRef="USD">0</scwo:DeferredTaxAssetsStartupCost>
    <scwo:OtherIntangibles
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_450"
      unitRef="USD">10339</scwo:OtherIntangibles>
    <scwo:OtherIntangibles
      contextRef="AsOf2020-12-31"
      decimals="0"
      id="fid_452"
      unitRef="USD">0</scwo:OtherIntangibles>
    <scwo:OtherAccruals
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_451"
      unitRef="USD">1875</scwo:OtherAccruals>
    <scwo:OtherAccruals
      contextRef="AsOf2020-12-31"
      decimals="0"
      id="fid_453"
      unitRef="USD">0</scwo:OtherAccruals>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_443"
      unitRef="USD">17423</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="AsOf2020-12-31"
      decimals="0"
      id="fid_442"
      unitRef="USD">1764</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_437"
      unitRef="USD">381112</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_445"
      unitRef="USD">703211</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="AsOf2020-12-31"
      decimals="0"
      id="fid_444"
      unitRef="USD">1764</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_447"
      unitRef="USD">703083</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2020-12-31"
      decimals="0"
      id="fid_446"
      unitRef="USD">1764</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_449"
      unitRef="USD">128</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2020-12-31"
      decimals="0"
      id="fid_448"
      unitRef="USD">0</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_458"
      unitRef="USD">-128</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="AsOf2020-12-31"
      decimals="0"
      id="fid_459"
      unitRef="USD">0</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilities
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_454"
      unitRef="USD">128</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="AsOf2020-12-31"
      decimals="0"
      id="fid_455"
      unitRef="USD">1764</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_456"
      unitRef="USD">0</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="AsOf2020-12-31"
      decimals="0"
      id="fid_457"
      unitRef="USD">0</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2021-01-01to2021-12-31" id="fid_274">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="6" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;December 31,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2021&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2020&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Rate Reconciliation&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" colspan="2" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" colspan="2" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Federal income tax at statutory rate&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;21.00&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;21.00&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Change in State Tax&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Change in Valuation Allowance&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;-22.16&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;19.11&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Permanent Differences&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;-12.26&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;State Taxes &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;1.98&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;5.50&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Other&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;11.44&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;-45.61&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-01to2020-12-31"
      decimals="INF"
      id="fid_460"
      unitRef="Pure">0.2100</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2019-01-01to2019-12-31"
      decimals="INF"
      id="fid_461"
      unitRef="Pure">0.2100</us-gaap:ConcentrationRiskPercentage1>
    <scwo:IncomeTaxRateReconciliationChangeInStateTax
      contextRef="From2020-01-01to2020-12-31"
      decimals="INF"
      id="fid_470"
      unitRef="Pure">0</scwo:IncomeTaxRateReconciliationChangeInStateTax>
    <scwo:IncomeTaxRateReconciliationChangeInStateTax
      contextRef="From2019-01-01to2019-12-31"
      decimals="INF"
      id="fid_471"
      unitRef="Pure">0</scwo:IncomeTaxRateReconciliationChangeInStateTax>
    <scwo:IncomeTaxReconciliationChangeInValuationAllowance
      contextRef="From2020-01-01to2020-12-31"
      decimals="INF"
      id="fid_468"
      unitRef="Pure">-0.2216</scwo:IncomeTaxReconciliationChangeInValuationAllowance>
    <scwo:IncomeTaxReconciliationChangeInValuationAllowance
      contextRef="From2019-01-01to2019-12-31"
      decimals="INF"
      id="fid_469"
      unitRef="Pure">0.1911</scwo:IncomeTaxReconciliationChangeInValuationAllowance>
    <scwo:IncomeTaxReconciliationPermanentDifferences
      contextRef="From2020-01-01to2020-12-31"
      decimals="INF"
      id="fid_464"
      unitRef="Pure">-0.1226</scwo:IncomeTaxReconciliationPermanentDifferences>
    <scwo:IncomeTaxReconciliationPermanentDifferences
      contextRef="From2019-01-01to2019-12-31"
      decimals="INF"
      id="fid_465"
      unitRef="Pure">0</scwo:IncomeTaxReconciliationPermanentDifferences>
    <scwo:IncomeTaxReconciliationStateTaxes
      contextRef="From2020-01-01to2020-12-31"
      decimals="INF"
      id="fid_462"
      unitRef="Pure">0.0198</scwo:IncomeTaxReconciliationStateTaxes>
    <scwo:IncomeTaxReconciliationStateTaxes
      contextRef="From2019-01-01to2019-12-31"
      decimals="INF"
      id="fid_463"
      unitRef="Pure">0.0550</scwo:IncomeTaxReconciliationStateTaxes>
    <scwo:IncomeTaxReconciliationOther
      contextRef="From2020-01-01to2020-12-31"
      decimals="INF"
      id="fid_466"
      unitRef="Pure">0.1144</scwo:IncomeTaxReconciliationOther>
    <scwo:IncomeTaxReconciliationOther
      contextRef="From2019-01-01to2019-12-31"
      decimals="INF"
      id="fid_467"
      unitRef="Pure">-0.4561</scwo:IncomeTaxReconciliationOther>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2021-12-31"
      decimals="-5"
      id="fid_472"
      unitRef="USD">1700000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2021-01-01to2021-12-31" id="fid_251">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&lt;strong&gt;Note 10 &#x2013; Subsequent Events &lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;On Feb 17, 2022, the Company opened 374Water Sustainability Israel LTD in Israel as a subsidiary of the Company.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;Effective February 7, 2022, Israel Abitbol was promoted to CFO of the Company and the prior CFO, John Hofmann, moved to a senior vice president role. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;On February 2, 2022, the Company signed a MOU with Environmental Services Company Ltd. An Israeli based company, in order to produce and sell the second AirSCWO unit. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;On February 1, 2022, the Company sold its first AirSCWO unit to the Orange County Sanitation District of Fountain Valley, California. &lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:Cash
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="fid_473"
      unitRef="USD">11243795</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_2-52a6fe"
      unitRef="USD">11131175</us-gaap:Cash>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="fid_474"
      unitRef="USD">167867</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_6-573195"
      unitRef="USD">218466</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="fid_475"
      unitRef="USD">11411662</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_8-4100c0"
      unitRef="USD">11349641</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="fid_476"
      unitRef="USD">4015</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_11-782875"
      unitRef="USD">959</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OtherIntangibleAssetsNet
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="fid_477"
      unitRef="USD">1012327</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:OtherIntangibleAssetsNet
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_13-9907dd"
      unitRef="USD">1028114</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:OtherAssets
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="fid_478"
      unitRef="USD">34306</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_15-b2c315"
      unitRef="USD">34742</us-gaap:OtherAssets>
    <us-gaap:AssetsNoncurrent
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="fid_479"
      unitRef="USD">1050648</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_17-cc0fd0"
      unitRef="USD">1063815</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="fid_480"
      unitRef="USD">12462310</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_19-bab962"
      unitRef="USD">12413456</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="fid_481"
      unitRef="USD">144040</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_23-dc08a9"
      unitRef="USD">62981</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:DeferredRevenue
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="fid_483"
      unitRef="USD">763333</us-gaap:DeferredRevenue>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_4-f1132b"
      unitRef="USD">0</us-gaap:AccountsReceivableNet>
    <us-gaap:OtherLiabilities
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="fid_484"
      unitRef="USD">3152</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_27-932f96"
      unitRef="USD">23390</us-gaap:OtherLiabilities>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="fid_485"
      unitRef="USD">910525</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_29-8a6862"
      unitRef="USD">86371</us-gaap:LiabilitiesCurrent>
    <us-gaap:Liabilities
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="fid_486"
      unitRef="USD">910525</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_31-669953"
      unitRef="USD">86371</us-gaap:Liabilities>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="fid_802"
      unitRef="Shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2022-03-31"
      decimals="INF"
      id="fid_804"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="fid_487"
      unitRef="USD">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_35-6c5647"
      unitRef="USD">3</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="fid_811"
      unitRef="Shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-03-31"
      decimals="INF"
      id="fid_813"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="fid_814"
      unitRef="Shares">126680895</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="fid_488"
      unitRef="USD">12669</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_37-9c46a7"
      unitRef="USD">12531</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="fid_489"
      unitRef="USD">15571989</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_39-446a4f"
      unitRef="USD">15474566</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="fid_490"
      unitRef="USD">-4032873</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_41-57e764"
      unitRef="USD">-3160015</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="fid_491"
      unitRef="USD">11551785</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_43-71a9f2"
      unitRef="USD">12327085</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="fid_492"
      unitRef="USD">12462310</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_45-5ce6af"
      unitRef="USD">12413456</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      id="fid_501"
      unitRef="USD">273231</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-01-01to2021-03-31"
      decimals="0"
      id="fid_502"
      unitRef="USD">0</us-gaap:Revenues>
    <us-gaap:CostOfRevenue
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      id="fid_503"
      unitRef="USD">247986</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2021-01-01to2021-03-31"
      decimals="0"
      id="fid_504"
      unitRef="USD">0</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      id="fid_752"
      unitRef="USD">25245</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2021-01-01to2021-03-31"
      decimals="0"
      id="fid_753"
      unitRef="USD">0</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      id="fid_507"
      unitRef="USD">185653</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2021-01-01to2021-03-31"
      decimals="0"
      id="fid_508"
      unitRef="USD">29185</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:LaborAndRelatedExpense
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      id="fid_533"
      unitRef="USD">301235</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense
      contextRef="From2021-01-01to2021-03-31"
      decimals="0"
      id="fid_534"
      unitRef="USD">18686</us-gaap:LaborAndRelatedExpense>
    <us-gaap:ProfessionalFees
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      id="fid_509"
      unitRef="USD">150658</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="From2021-01-01to2021-03-31"
      decimals="0"
      id="fid_510"
      unitRef="USD">8203</us-gaap:ProfessionalFees>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      id="fid_511"
      unitRef="USD">261403</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2021-01-01to2021-03-31"
      decimals="0"
      id="fid_512"
      unitRef="USD">10477</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      id="fid_513"
      unitRef="USD">898950</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2021-01-01to2021-03-31"
      decimals="0"
      id="fid_514"
      unitRef="USD">66551</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      id="fid_515"
      unitRef="USD">-873705</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2021-01-01to2021-03-31"
      decimals="0"
      id="fid_516"
      unitRef="USD">-66551</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeOperating
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      id="fid_517"
      unitRef="USD">840</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestIncomeOperating
      contextRef="From2021-01-01to2021-03-31"
      decimals="0"
      id="fid_518"
      unitRef="USD">0</us-gaap:InterestIncomeOperating>
    <us-gaap:OtherIncome
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      id="fid_519"
      unitRef="USD">7</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="From2021-01-01to2021-03-31"
      decimals="0"
      id="fid_520"
      unitRef="USD">0</us-gaap:OtherIncome>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      id="fid_521"
      unitRef="USD">847</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2021-01-01to2021-03-31"
      decimals="0"
      id="fid_522"
      unitRef="USD">0</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      id="fid_523"
      unitRef="USD">-872858</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2021-01-01to2021-03-31"
      decimals="0"
      id="fid_524"
      unitRef="USD">-66551</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      id="fid_525"
      unitRef="USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-01-01to2021-03-31"
      decimals="0"
      id="fid_526"
      unitRef="USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      id="fid_527"
      unitRef="USD">-872858</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-01to2021-03-31"
      decimals="0"
      id="fid_528"
      unitRef="USD">-66551</us-gaap:NetIncomeLoss>
    <scwo:NetLossPerShareBasicAndDiluted
      contextRef="From2022-01-01to2022-03-31"
      decimals="INF"
      id="fid_529"
      unitRef="USDPShares">-0.01</scwo:NetLossPerShareBasicAndDiluted>
    <scwo:NetLossPerShareBasicAndDiluted
      contextRef="From2021-01-01to2021-03-31"
      decimals="INF"
      id="fid_530"
      unitRef="USDPShares">-0.00</scwo:NetLossPerShareBasicAndDiluted>
    <scwo:WeightedAverageCommonSharesOutstandingBasicAndDiluted
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      id="fid_531"
      unitRef="Shares">126499142</scwo:WeightedAverageCommonSharesOutstandingBasicAndDiluted>
    <scwo:WeightedAverageCommonSharesOutstandingBasicAndDiluted
      contextRef="From2021-01-01to2021-03-31"
      decimals="0"
      id="fid_532"
      unitRef="Shares">62410452</scwo:WeightedAverageCommonSharesOutstandingBasicAndDiluted>
    <us-gaap:SharesIssued
      contextRef="AsOf2021-12-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="fid_161-0d54c2"
      unitRef="Shares">27272</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="fid_162-42db7a"
      unitRef="USD">3</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_163-e5b1ce"
      unitRef="USD">15474566</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_164-ecbb44"
      unitRef="USD">-3160015</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_165-e328b2"
      unitRef="USD">12327085</us-gaap:StockholdersEquity>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="From2022-01-01to2022-03-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="fid_537"
      unitRef="Shares">-27272</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:ConversionOfStockAmountIssued1
      contextRef="From2022-01-01to2022-03-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="fid_539"
      unitRef="USD">3</us-gaap:ConversionOfStockAmountIssued1>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="From2022-01-01to2022-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_538"
      unitRef="Shares">1363149</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:ConversionOfStockAmountIssued1
      contextRef="From2022-01-01to2022-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_578"
      unitRef="USD">136</us-gaap:ConversionOfStockAmountIssued1>
    <us-gaap:ConversionOfStockAmountIssued1
      contextRef="From2022-01-01to2022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_579"
      unitRef="USD">135</us-gaap:ConversionOfStockAmountIssued1>
    <us-gaap:ConversionOfStockAmountIssued1
      contextRef="From2022-01-01to2022-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_540"
      unitRef="USD">0</us-gaap:ConversionOfStockAmountIssued1>
    <us-gaap:ConversionOfStockAmountIssued1
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      id="fid_541"
      unitRef="USD">0</us-gaap:ConversionOfStockAmountIssued1>
    <us-gaap:AccretionExpense
      contextRef="From2022-01-01to2022-03-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="fid_542"
      unitRef="USD">0</us-gaap:AccretionExpense>
    <us-gaap:AccretionExpense
      contextRef="From2022-01-01to2022-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_543"
      unitRef="USD">0</us-gaap:AccretionExpense>
    <us-gaap:AccretionExpense
      contextRef="From2022-01-01to2022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_544"
      unitRef="USD">97558</us-gaap:AccretionExpense>
    <us-gaap:AccretionExpense
      contextRef="From2022-01-01to2022-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_545"
      unitRef="USD">0</us-gaap:AccretionExpense>
    <us-gaap:AccretionExpense
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      id="fid_546"
      unitRef="USD">97558</us-gaap:AccretionExpense>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-01to2022-03-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="fid_547"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-01to2022-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_548"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-01to2022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_549"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-01to2022-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_550"
      unitRef="USD">-872858</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      id="fid_551"
      unitRef="USD">-872858</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="AsOf2022-03-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="fid_552"
      unitRef="Shares">0</us-gaap:SharesIssued>
    <us-gaap:SharesIssued
      contextRef="AsOf2022-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_553"
      unitRef="Shares">126680895</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_555"
      unitRef="USD">12667</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_556"
      unitRef="USD">15571989</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_557"
      unitRef="USD">-3884460</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="fid_558"
      unitRef="USD">11551785</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_121-64188c"
      unitRef="USD">416</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_122-4ea4fb"
      unitRef="USD">4593</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31"
      decimals="0"
      id="fid_123-b05836"
      unitRef="USD">11250</us-gaap:StockholdersEquity>
    <us-gaap:AccretionExpense
      contextRef="From2021-01-01to2021-03-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="fid_561"
      unitRef="USD">0</us-gaap:AccretionExpense>
    <us-gaap:AccretionExpense
      contextRef="From2021-01-01to2021-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_562"
      unitRef="USD">0</us-gaap:AccretionExpense>
    <us-gaap:AccretionExpense
      contextRef="From2021-01-01to2021-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_563"
      unitRef="USD">10433</us-gaap:AccretionExpense>
    <us-gaap:AccretionExpense
      contextRef="From2021-01-01to2021-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_564"
      unitRef="USD">0</us-gaap:AccretionExpense>
    <us-gaap:AccretionExpense
      contextRef="From2021-01-01to2021-03-31"
      decimals="0"
      id="fid_565"
      unitRef="USD">10433</us-gaap:AccretionExpense>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-01to2021-03-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="fid_566"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-01to2021-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_567"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-01to2021-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_568"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-01to2021-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_569"
      unitRef="USD">-66551</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-01to2021-03-31"
      decimals="0"
      id="fid_570"
      unitRef="USD">-66551</us-gaap:NetIncomeLoss>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-03-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="fid_573"
      unitRef="USD">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="AsOf2021-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_572"
      unitRef="Shares">62410452</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_574"
      unitRef="USD">6241</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_575"
      unitRef="USD">10849</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_576"
      unitRef="USD">-61958</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-03-31"
      decimals="0"
      id="fid_577"
      unitRef="USD">-44868</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      id="fid_580"
      unitRef="USD">-872858</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-01to2021-03-31"
      decimals="0"
      id="fid_581"
      unitRef="USD">-66551</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      id="fid_582"
      unitRef="USD">16458</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2021-01-01to2021-03-31"
      decimals="0"
      id="fid_583"
      unitRef="USD">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      id="fid_584"
      unitRef="USD">97558</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2021-01-01to2021-03-31"
      decimals="0"
      id="fid_585"
      unitRef="USD">10433</us-gaap:ShareBasedCompensation>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      id="fid_586"
      unitRef="USD">0</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2021-01-01to2021-03-31"
      decimals="0"
      id="fid_587"
      unitRef="USD">24340</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      id="fid_588"
      unitRef="USD">81059</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2021-01-01to2021-03-31"
      decimals="0"
      id="fid_589"
      unitRef="USD">28966</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      id="fid_612"
      unitRef="USD">763333</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="From2021-01-01to2021-03-31"
      decimals="0"
      id="fid_613"
      unitRef="USD">0</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      id="fid_781"
      unitRef="USD">50599</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2021-01-01to2021-03-31"
      decimals="0"
      id="fid_782"
      unitRef="USD">-0</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      id="fid_592"
      unitRef="USD">-20238</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="From2021-01-01to2021-03-31"
      decimals="0"
      id="fid_593"
      unitRef="USD">-1200</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      id="fid_594"
      unitRef="USD">115911</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2021-01-01to2021-03-31"
      decimals="0"
      id="fid_595"
      unitRef="USD">-4022</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      id="fid_596"
      unitRef="USD">3291</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2021-01-01to2021-03-31"
      decimals="0"
      id="fid_597"
      unitRef="USD">0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      id="fid_598"
      unitRef="USD">-3291</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2021-01-01to2021-03-31"
      decimals="0"
      id="fid_599"
      unitRef="USD">0</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      id="fid_600"
      unitRef="USD">0</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2021-01-01to2021-03-31"
      decimals="0"
      id="fid_601"
      unitRef="USD">4821</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      id="fid_602"
      unitRef="USD">0</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2021-01-01to2021-03-31"
      decimals="0"
      id="fid_603"
      unitRef="USD">4821</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      id="fid_604"
      unitRef="USD">112620</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2021-01-01to2021-03-31"
      decimals="0"
      id="fid_605"
      unitRef="USD">799</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_606"
      unitRef="USD">11131175</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2020-12-31"
      decimals="0"
      id="fid_607-61051f"
      unitRef="USD">71799</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="fid_608"
      unitRef="USD">11243795</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2021-03-31"
      decimals="0"
      id="fid_609"
      unitRef="USD">72598</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <scwo:ConversionOfStockAmountIssued
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      id="fid_610"
      unitRef="USD">133</scwo:ConversionOfStockAmountIssued>
    <scwo:ConversionOfStockAmountIssued
      contextRef="From2021-01-01to2021-03-31"
      decimals="0"
      id="fid_611"
      unitRef="USD">0</scwo:ConversionOfStockAmountIssued>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="From2022-01-01to2022-03-31" id="fid_614">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;&lt;strong&gt;Note 1 &#x2013; Nature of Business and Presentation of Financial Statements&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;&lt;span style="text-decoration:underline"&gt;Description of the Company&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;374Water, Inc., f/k/a PowerVerde, Inc. (the &#x201c;Company&#x201d;) was a Delaware corporation formed in March 2007. The Company was formed to develop, commercialize, and market a series of unique electric generating power systems designed to produce electrical power with zero emissions or waste byproducts, based on a patented pressure-driven expander motor and related organic rankine cycle technology.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;On April 16, 2021, 374Water Inc. (f/k/a PowerVerde, Inc.) entered into an Agreement and Plan of Merger (the &#x201c;Merger Agreement&#x201d;) with 374Water, Inc., a privately held company based in Durham, North Carolina, (&#x201c;Private 374Water&#x201d;) and 374Water Acquisition Corp., a newly-formed wholly-owned subsidiary of PowerVerde (&#x201c;Sub&#x201d;). The parties entered into the Agreement pursuant to their Binding Letter of Intent dated September 20, 2020.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Pursuant to the merger contemplated by the Merger Agreement (the &#x201c;Merger&#x201d;), on April 16, 2021, Sub merged into Private 374Water, with Private 374Water as the surviving corporation. In connection with the Merger, all Private 374Water shares were cancelled and the Company issued to the former Private 374Water shareholders a total of 62,410,452 shares of the Company common stock. , 374 374 374, . , 374 64.2 53.8 . The Merger was accounted for as a reverse acquisition (See Note 4). On April 16, 2021, as a result of the closing of the Merger Agreement (see Note 4), the equity of the consolidated entity is the historical equity of 374Water, Inc (&#x201c;374Water&#x201d;) retroactively restated to reflect the number of shares issued by the Company in the reverse recapitalization.&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;&lt;span style="text-decoration:underline"&gt;Nature of Business &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;With the Merger, the Company&#x2019;s current mission is to support a clean and healthy environment to sustain life. The Company plans to use what it believes to be cutting-edge science to recover resources from the waste our society generates and keep drinking water clean. The Company&#x2019;s customers will include businesses and local governments that will make the sustainable development goals a reality. On February 1, 2022, the Company sold their first AIRSCWO&#160;system to Orange County Sanitation District of Fountain Valley, California.&#160; Revenues to date have been from sale of the first AIRSCWO system&#160;and from testing, consulting, and advisory services procedures for our customers, which have been performed in collaboration with Duke University.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;&lt;span style="text-decoration:underline"&gt;Presentation of Financial Statements&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules and regulations of the United States Securities and Exchange Commission (SEC) for interim financial information.&#160; It is management&#x2019;s opinion that that the accompanying unaudited condensed consolidated financial statements are prepared in accordance with instructions for Form 10-Q and include all adjustments (consisting only of normal recurring accruals) which are necessary for a fair presentation of the results for the periods presented. Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these condensed consolidated financial statements be read in conjunction with the Annual Report on Form 10-K of 374Water Inc, formerly known as PowerVerde, Inc. (&#x201c;374 Water," &#x201c;we,&#x201d; &#x201c;us,&#x201d; &#x201c;our,&#x201d; or the &#x201c;Company&#x201d;) as of and for the year ended December 31, 2021 filed with the Securities and Exchange Commission (&#x201c;SEC&#x201d;) on March 1, 2022. The results of operations for the three months ended March 31, 2022, are not necessarily indicative of the results to be expected for the full year or for future periods. The condensed consolidated financial statements include the accounts of 374Water Inc, formerly known as PowerVerde, Inc. (the &#x201c;Company&#x201d;), and PowerVerde Systems, Inc., 374Water Systems Inc, and 374Water Sustainability Israel LTD,&#160;each a&#160;wholly-owned subsidiary of 374 Water. Intercompany balances and transactions have been eliminated in consolidation. These interim financial statements reflect the acquisition of the Company&#x2019;s new wholly-owned subsidiary, 374Water Systems Inc., which was consummated on April 16, 2021, as more fully disclosed in Note 4.&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock contextRef="From2022-01-01to2022-03-31" id="fid_615">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;&#160;&lt;strong&gt;Note 2 &#x2013; Summary of Significant Accounting Policies&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;&lt;span style="text-decoration:underline"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. The Company held no cash equivalents as of March 31, 2022, and December 31, 2021.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;&lt;span style="text-decoration:underline"&gt;Accounts Receivable &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;Accounts receivables consist of balances due from service revenues. The Company monitors accounts receivable and provides allowances when considered necessary. At March 31, 2022 and December 31, 2021, there were no outstanding accounts receivable. Accordingly, no allowance for doubtful accounts was provided.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;&lt;span style="text-decoration:underline"&gt;Equipment&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;Equipment is recorded at cost. Depreciation is computed using the straight-line method and an estimated useful live of three years. Expenses for maintenance and repairs are charged to expense as incurred.&#160; The Company&#x2019;s depreciation expense in the period is $235.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;&lt;span style="text-decoration:underline"&gt;Intangible Assets&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;Intangible assets are subject to amortization, and any impairment is determined in accordance with ASC 360, &#x201c;Property, Plant, and Equipment.&#x201d; Intangible assets are stated at historical cost and amortized over their estimated useful lives. The Company uses a straight-line method of amortization, unless a method that better reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up can be reliably determined.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;&lt;span style="text-decoration:underline"&gt;Long-Lived Assets&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;The Company reviews long-lived assets, including intangible assets with finite lives, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company uses an estimate of the undiscounted cash flows over the remaining life of its long-lived assets, or related group of assets where applicable, in measuring whether the assets to be held and used will be realizable. Recoverability of assets held and used is measured by a comparison of the carrying amount to the future undiscounted expected net cash flows to be generated by the asset. As of March 31, 2022, and 2021, there were no events or changes in circumstances requiring an impairment analysis.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;&lt;span style="text-decoration:underline"&gt;Revenue Recognition and Concentration&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;The Company follows the revenue standards of Financial Accounting Standards Board Update No. 2014-09: &#x201c;Revenue from Contracts with Customers (Topic 606).&#x201d; The core principle of this Topic is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Revenue is recognized in accordance with that core principle by applying the following five steps: 1) identify the contracts with a customer; 2) identify the performance obligations in the contract; 3) determine the transaction price; 4) allocate the transaction price to the performance obligations; and 5) recognize revenue when (or as) we satisfy a performance obligation.&#160; Deferred revenue primarily consists of billings or payments received in advance of revenue recognition from the completion of the equipment build for each customer as the outputs are measured against the cost to build the product.&#160; &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;The Company&#x2019;s performance obligations will be satisfied overtime as the specialized equipment is built for the customer.&#160; Based on the Company&#x2019;s contracts, the Company will have a single performance obligation (build and install of the product). The Company will primarily receive fixed consideration for sales of product. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;Revenues for the three months ended March 31, 2022 were generated from the sale of the first AIRSCWO system.&#160; &#160;For the three months ended March 31, 2021, the Company did not have any revenues.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;&lt;span style="text-decoration:underline"&gt;Stock-based Compensation&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;The Company has accounted for stock-based compensation under the provisions of Accounting Standards Codification (ASC) Topic 718 &#x2013; &#x201c;Stock Compensation&#x201d; which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments (stock options and common stock purchase warrants). The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate. Expected volatilities are based on historical volatility of peer companies and other factors estimated over the expected term of the stock options. The expected term of options granted is derived using the &#x201c;simplified method&#x201d; which computes expected term as the average of the sum of the vesting term plus the contract term. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;&lt;span style="text-decoration:underline"&gt;Accounting for Uncertainty in Income Taxes&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;The Company&#160;follows the provisions of ASC Topic 740-10, &#x201c;Accounting for Uncertainty in Income Taxes&#x201d; which clarifies the accounting for uncertainty in income taxes recognized in an enterprise&#x2019;s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This topic also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. There were no uncertain tax positions as of March 31, 2022, and December 31, 2021.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;&lt;span style="text-decoration:underline"&gt;Income Tax Policy&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;The Company accounts for income taxes using the liability method prescribed by ASC 740 - Income Taxes. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets if, based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the period that includes the enactment date.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;&lt;span style="text-decoration:underline"&gt;Research and Development Costs&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;The Company&#x2019;s research and development costs are expensed in the period in which they are incurred. Such expenditures amounted to $185,653 and $29,185 for the three months ended March 31, 2022, and 2021, respectively.&#160; &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;&lt;span style="text-decoration:underline"&gt;Earnings (Loss) Per Share&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;Earnings (loss) per share is computed in accordance with FASB ASC Topic 260, &#x201c;Earnings per Share&#x201d;. Diluted earnings per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities outstanding during the period. Certain common stock equivalents were not included in the earnings (loss) per share calculation as their effect would be anti-dilutive. As of March 31, 2022, there were the following potentially dilutive securities that were excluded from diluted net loss per share because their effect would be antidilutive: options for 12,660,000 shares of common stock.&#160; There were no dilutive shares as of March 31, 2022.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;&lt;span style="text-decoration:underline"&gt;Financial Instruments&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;The Company carries cash, accounts receivable, accounts payable and accrued expenses, at historical costs. The respective estimated fair values of these assets and liabilities approximate carrying values / useful lives of equipment and intangible assets due to their current nature.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;&lt;span style="text-decoration:underline"&gt;Use of Estimates&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates in the accompanying financial statements include the fair value of equity-based compensation, useful lives of intangible assets, and valuation allowance against deferred tax assets.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;&lt;span style="text-decoration:underline"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;All other newly issued but not yet effective accounting pronouncements have been deemed to be not applicable or immaterial to the Company.&#160;&lt;/p&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2022-01-01to2022-03-31" id="fid_624">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. The Company held no cash equivalents as of March 31, 2022, and December 31, 2021.&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:ReceivablesPolicyTextBlock contextRef="From2022-01-01to2022-03-31" id="fid_625">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;Accounts receivables consist of balances due from service revenues. The Company monitors accounts receivable and provides allowances when considered necessary. At March 31, 2022 and December 31, 2021, there were no outstanding accounts receivable. Accordingly, no allowance for doubtful accounts was provided.&lt;/p&gt;</us-gaap:ReceivablesPolicyTextBlock>
    <scwo:EquipmentPolicy contextRef="From2022-01-01to2022-03-31" id="fid_626">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;Equipment is recorded at cost. Depreciation is computed using the straight-line method and an estimated useful live of three years. Expenses for maintenance and repairs are charged to expense as incurred.&#160; The Company&#x2019;s depreciation expense in the period is $235.&lt;/p&gt;</scwo:EquipmentPolicy>
    <us-gaap:Depreciation
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      id="fid_647"
      unitRef="USD">235</us-gaap:Depreciation>
    <us-gaap:IntangibleAssetsFiniteLivedPolicy contextRef="From2022-01-01to2022-03-31" id="fid_748">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;Intangible assets are subject to amortization, and any impairment is determined in accordance with ASC 360, &#x201c;Property, Plant, and Equipment.&#x201d; Intangible assets are stated at historical cost and amortized over their estimated useful lives. The Company uses a straight-line method of amortization, unless a method that better reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up can be reliably determined.&lt;/p&gt;</us-gaap:IntangibleAssetsFiniteLivedPolicy>
    <scwo:LongLivedAssetsPolicy contextRef="From2022-01-01to2022-03-31" id="fid_628">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;The Company reviews long-lived assets, including intangible assets with finite lives, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company uses an estimate of the undiscounted cash flows over the remaining life of its long-lived assets, or related group of assets where applicable, in measuring whether the assets to be held and used will be realizable. Recoverability of assets held and used is measured by a comparison of the carrying amount to the future undiscounted expected net cash flows to be generated by the asset. As of March 31, 2022, and 2021, there were no events or changes in circumstances requiring an impairment analysis.&lt;/p&gt;</scwo:LongLivedAssetsPolicy>
    <scwo:RevenueRecognitionAndConcentrationPolicy contextRef="From2022-01-01to2022-03-31" id="fid_629">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;The Company follows the revenue standards of Financial Accounting Standards Board Update No. 2014-09: &#x201c;Revenue from Contracts with Customers (Topic 606).&#x201d; The core principle of this Topic is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Revenue is recognized in accordance with that core principle by applying the following five steps: 1) identify the contracts with a customer; 2) identify the performance obligations in the contract; 3) determine the transaction price; 4) allocate the transaction price to the performance obligations; and 5) recognize revenue when (or as) we satisfy a performance obligation.&#160; Deferred revenue primarily consists of billings or payments received in advance of revenue recognition from the completion of the equipment build for each customer as the outputs are measured against the cost to build the product.&#160; &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;The Company&#x2019;s performance obligations will be satisfied overtime as the specialized equipment is built for the customer.&#160; Based on the Company&#x2019;s contracts, the Company will have a single performance obligation (build and install of the product). The Company will primarily receive fixed consideration for sales of product. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;Revenues for the three months ended March 31, 2022 were generated from the sale of the first AIRSCWO system.&#160; &#160;For the three months ended March 31, 2021, the Company did not have any revenues.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;&#160;&lt;/p&gt;</scwo:RevenueRecognitionAndConcentrationPolicy>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="From2022-01-01to2022-03-31" id="fid_749">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;The Company has accounted for stock-based compensation under the provisions of Accounting Standards Codification (ASC) Topic 718 &#x2013; &#x201c;Stock Compensation&#x201d; which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments (stock options and common stock purchase warrants). The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate. Expected volatilities are based on historical volatility of peer companies and other factors estimated over the expected term of the stock options. The expected term of options granted is derived using the &#x201c;simplified method&#x201d; which computes expected term as the average of the sum of the vesting term plus the contract term. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term.&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:IncomeTaxUncertaintiesPolicy contextRef="From2022-01-01to2022-03-31" id="fid_631">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;The Company&#160;follows the provisions of ASC Topic 740-10, &#x201c;Accounting for Uncertainty in Income Taxes&#x201d; which clarifies the accounting for uncertainty in income taxes recognized in an enterprise&#x2019;s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This topic also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. There were no uncertain tax positions as of March 31, 2022, and December 31, 2021.&lt;/p&gt;</us-gaap:IncomeTaxUncertaintiesPolicy>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2022-01-01to2022-03-31" id="fid_632">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;The Company accounts for income taxes using the liability method prescribed by ASC 740 - Income Taxes. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets if, based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the period that includes the enactment date.&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="From2022-01-01to2022-03-31" id="fid_633">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;The Company&#x2019;s research and development costs are expensed in the period in which they are incurred. Such expenditures amounted to $185,653 and $29,185 for the three months ended March 31, 2022, and 2021, respectively.&#160; &lt;/p&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      id="fid_644"
      unitRef="USD">185653</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2021-01-01to2021-03-31"
      decimals="0"
      id="fid_645"
      unitRef="USD">29185</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2022-01-01to2022-03-31" id="fid_750">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;Earnings (loss) per share is computed in accordance with FASB ASC Topic 260, &#x201c;Earnings per Share&#x201d;. Diluted earnings per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities outstanding during the period. Certain common stock equivalents were not included in the earnings (loss) per share calculation as their effect would be anti-dilutive. As of March 31, 2022, there were the following potentially dilutive securities that were excluded from diluted net loss per share because their effect would be antidilutive: options for 12,660,000 shares of common stock.&#160; There were no dilutive shares as of March 31, 2022.&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      id="fid_646"
      unitRef="Shares">12660000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2022-01-01to2022-03-31" id="fid_635">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;The Company carries cash, accounts receivable, accounts payable and accrued expenses, at historical costs. The respective estimated fair values of these assets and liabilities approximate carrying values / useful lives of equipment and intangible assets due to their current nature.&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:UseOfEstimates contextRef="From2022-01-01to2022-03-31" id="fid_636">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates in the accompanying financial statements include the fair value of equity-based compensation, useful lives of intangible assets, and valuation allowance against deferred tax assets.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2022-01-01to2022-03-31" id="fid_751">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;All other newly issued but not yet effective accounting pronouncements have been deemed to be not applicable or immaterial to the Company.&#160;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:SubstantialDoubtAboutGoingConcernTextBlock contextRef="From2022-01-01to2022-03-31" id="fid_616">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;&lt;strong&gt;Note 3 &#x2013; Liquidity, Capital Resources and Going Concern&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;As of March 31, 2022, the Company had working capital of $10,501,137 compared to working capital of $11,263,270 at December 31, 2021.&#160; As of March 31, 2022, the Company has an accumulated deficit of $4032873. For the three months ended March 31, 2022, the Company had a net loss of (872,858) and $115,911 of net cash provided by operations for the period.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;The Company believes they have sufficient cash-on-hand&#160;for the Company to meet its financial obligations for at least the next 12 months from the date of the report as they come due. &lt;/p&gt;</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>
    <scwo:WorkingCapital
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="fid_798"
      unitRef="USD">10501137</scwo:WorkingCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="fid_648"
      unitRef="USD">-4032873</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      id="fid_649"
      unitRef="USD">-872858</us-gaap:NetIncomeLoss>
    <us-gaap:NetCashProvidedByUsedInContinuingOperations
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      id="fid_650"
      unitRef="USD">115911</us-gaap:NetCashProvidedByUsedInContinuingOperations>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="From2022-01-01to2022-03-31" id="fid_746">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;&lt;strong&gt;Note 4 &#x2013; Acquisition of 374Water, Inc. f/k/a PowerVerde Inc. &lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;&lt;span style="text-decoration:underline"&gt;Agreement and Plan of Merger&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;In connection with the Merger,&#160;(see Note 1), the Company closed on a private placement of&#160;436,783&#160;shares of Series D Convertible Preferred Stock (the &#x201c;Preferred Stock&#x201d;) with a par value of $0.0001, yielding gross proceeds of $6,551,745&#160;(the &#x201c;Private Placement&#x201d;) and the settlement of a $50,000&#160;liability for Preferred Stock shares. The Private Placement proceeds will be used for working capital, primarily for development, manufacture and commercialization of the Company&#x2019;s Air SCWO systems. The Preferred Stock has a stated value of $15 per share, is convertible into common stock at $.30 per share and has voting rights based on the underlying shares of common stock. Upon liquidation of the Company, the Preferred Stockholders have liquidation preference before any assets can be distributed to common stockholders. All of the Preferred Stock was sold pursuant to an exemption from registration requirements under Regulation D and/or Section 4(2) of the Securities Act of 1933, as amended.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;As a result of the Merger, the issuance of the Preferred Stock, the former Private 374Water shareholders own 65.8% of the Company&#x2019;s issued and outstanding common stock and 53.8% of the Company&#x2019;s issued and outstanding voting stock (which includes the Preferred Stock on an as converted basis).&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;Also as a result of the Merger, the Company entered into two-year employment agreements with&#160;the Company &#160;founders Yaacov (Kobe) Nagar and Marc Deshusses, Ph. D. Mr. Nagar will serve as the Company&#x2019;s CEO, replacing Richard H. Davis, who resigned as CEO upon closing of the Merger. Mr. Nagar&#160;initially receive an annual salary of $200,000&#160;which was increased to $250,000 effective January 26, 2022. Dr. Deshusses will serve as the Company&#x2019;s Head of Technology on a part-time basis at a salary of $60,000 per year.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;Pursuant to the Merger, Messrs. Nagar and Deshusses were appointed to the Company&#x2019;s Board of Directors, joining Mr. Davis, who remains as a Director.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;The patented technology underlying 374Water&#x2019;s supercritical water oxidation (SCWO) units, which was developed principally through the efforts of Messrs. Nagar and Deshusses at the facilities of Duke University, Durham, North Carolina (&#x201c;Duke&#x201d;), where Dr. Deshusses is a professor, is licensed to 374Water pursuant to a worldwide license agreement with Duke executed on April 16, 2021 (the &#x201c;License Agreement&#x201d;) simultaneous with the merger. In connection with the License Agreement, 374Water also executed an equity transfer Agreement with Duke pursuant to which Duke received a small block of shares of common stock (see Note 5).&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;As a result of the Merger Agreement, for financial statement reporting purposes, the business combination between 374Water Inc. and 374Water was treated as a reverse acquisition and recapitalization for accounting purposes with 374Water deemed the accounting acquirer and 374Water Inc. deemed the accounting acquiree under the acquisition method of accounting in accordance with FASB Accounting Standards Codification (&#x201c;ASC&#x201d;) Section 805-10-55.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;&lt;span style="text-decoration:underline"&gt;The following assets and liabilities were assumed in the transaction:&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;Cash&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;29,536&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;Prepaid expense&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;14,483&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;Accounts Receivable&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1,000&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;Total assets acquired&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;45,019&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;Accounts payable&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;(46,150 &lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;Accrued expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(83,094 &lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;Total liabilities assumed&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(129,244 &lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;Net liabilities assumed&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(84,225 &lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:PartnersCapitalAccountUnitsSoldInPrivatePlacement
      contextRef="From2022-01-01to2022-03-31_us-gaap_SeriesDPreferredStockMember"
      decimals="0"
      id="fid_658"
      unitRef="Shares">436783</us-gaap:PartnersCapitalAccountUnitsSoldInPrivatePlacement>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2022-03-31_us-gaap_SeriesDPreferredStockMember"
      decimals="INF"
      id="fid_656"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="From2022-01-01to2022-03-31_us-gaap_SeriesDPreferredStockMember"
      decimals="0"
      id="fid_657"
      unitRef="USD">6551745</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <scwo:SettlementOfLiabilityForPreferredStockShares
      contextRef="From2022-01-01to2022-03-31_us-gaap_SeriesDPreferredStockMember"
      decimals="0"
      id="fid_659"
      unitRef="USD">50000</scwo:SettlementOfLiabilityForPreferredStockShares>
    <scwo:Description
      contextRef="From2022-01-01to2022-03-31_us-gaap_SeriesDPreferredStockMember"
      id="fid_655">the former Private 374Water shareholders own 65.8% of the Company&#x2019;s issued and outstanding common stock and 53.8% of the Company&#x2019;s issued and outstanding voting stock</scwo:Description>
    <us-gaap:SalariesAndWages
      contextRef="From2022-01-01to2022-03-31_scwo_MrNagarMember"
      decimals="0"
      id="fid_653"
      unitRef="USD">200000</us-gaap:SalariesAndWages>
    <scwo:AnnaulSalaryIncreasedAmount
      contextRef="From2022-01-01to2022-03-31_scwo_MrNagarMember"
      decimals="0"
      id="fid_660"
      unitRef="USD">250000</scwo:AnnaulSalaryIncreasedAmount>
    <us-gaap:SalariesAndWages
      contextRef="From2022-01-01to2022-03-31_srt_ChiefExecutiveOfficerMember"
      decimals="0"
      id="fid_654"
      unitRef="USD">60000</us-gaap:SalariesAndWages>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock contextRef="From2022-01-01to2022-03-31" id="fid_638">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;Cash&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;29,536&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;Prepaid expense&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;14,483&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;Accounts Receivable&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1,000&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;Total assets acquired&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;45,019&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;Accounts payable&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;(46,150 &lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;Accrued expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(83,094 &lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;Total liabilities assumed&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(129,244 &lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;Net liabilities assumed&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(84,225 &lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="AsOf2022-03-31_scwo_ThreeSevenFourWaterMember"
      decimals="0"
      id="fid_788"
      unitRef="USD">29536</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="AsOf2022-03-31_scwo_ThreeSevenFourWaterMember"
      decimals="0"
      id="fid_789"
      unitRef="USD">14483</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="AsOf2022-03-31_scwo_ThreeSevenFourWaterMember"
      decimals="0"
      id="fid_790"
      unitRef="USD">1000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="AsOf2022-03-31_scwo_ThreeSevenFourWaterMember"
      decimals="0"
      id="fid_791"
      unitRef="USD">45019</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="AsOf2022-03-31_scwo_ThreeSevenFourWaterMember"
      decimals="0"
      id="fid_792"
      unitRef="USD">46150</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability
      contextRef="AsOf2022-03-31_scwo_ThreeSevenFourWaterMember"
      decimals="0"
      id="fid_793"
      unitRef="USD">-83094</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="AsOf2022-03-31_scwo_ThreeSevenFourWaterMember"
      decimals="0"
      id="fid_794"
      unitRef="USD">129244</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="AsOf2022-03-31_scwo_ThreeSevenFourWaterMember"
      decimals="0"
      id="fid_795"
      unitRef="USD">-84225</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="From2022-01-01to2022-03-31" id="fid_747">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;&lt;strong&gt;Note 5 &#x2013; Intangible Assets&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;Intangible assets are recorded at cost and consist of the license agreement with Duke University. The Company issued Duke University a small block of shares of common stock estimated to have a fair value of $1,073,529 as consideration for granting the Company the license based on the Company&#x2019;s common stock market price on the date the license agreement was executed (see Note 8). Intangible assets are comprised of the following as of March 31, 2022 and December 31, 2021:&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"&gt;&lt;strong&gt;Name&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"&gt;&lt;strong&gt;Estimated Life&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"&gt;&lt;strong&gt;Balance at December 31, 2021&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"&gt;&lt;strong&gt;Additions&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"&gt;&lt;strong&gt;Amortization&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"&gt;&lt;strong&gt;Balance at March 31, 2022&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;License agreement&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"&gt;17 Years&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1,028,114&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;15,787&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1,012,327&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;Patents&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;20 Years&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;34,742&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;436&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;34,306&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;&lt;strong&gt;Total&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1,062,856&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;16,223&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1,046,633&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;Depreciation and Amortization expense for the three months ended March 31, 2022, was $16,458.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;Estimated future amortization expense as of March 31, 2022:&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"&gt;&lt;strong&gt;March 31,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"&gt;&lt;strong&gt;2022&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;2022 (Remaining 9 months)&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;48,663&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;2023&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;64,884&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;2024&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;64,884&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;2025&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;64,884&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;2026&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;64,884&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;Thereafter&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;738,434&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;Intangible assets, Net&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1,046,633&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:CommonStockValue
      contextRef="AsOf2022-03-31_scwo_LicenseAgreementMember"
      decimals="0"
      id="fid_680"
      unitRef="USD">1073529</us-gaap:CommonStockValue>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="From2022-01-01to2022-03-31" id="fid_640">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"&gt;&lt;strong&gt;Name&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"&gt;&lt;strong&gt;Estimated Life&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"&gt;&lt;strong&gt;Balance at December 31, 2021&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"&gt;&lt;strong&gt;Additions&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"&gt;&lt;strong&gt;Amortization&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"&gt;&lt;strong&gt;Balance at March 31, 2022&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;License agreement&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"&gt;17 Years&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1,028,114&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;15,787&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1,012,327&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;Patents&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;20 Years&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;34,742&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;436&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;34,306&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;&lt;strong&gt;Total&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1,062,856&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;16,223&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1,046,633&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2021-12-31_scwo_LicenseAgreementMember"
      decimals="0"
      id="fid_316-a7e9c3"
      unitRef="USD">1028114</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2021-12-31_us-gaap_PatentsMember"
      decimals="0"
      id="fid_319"
      unitRef="USD">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2022-03-31_scwo_LicenseAgreementMember"
      decimals="0"
      id="fid_664"
      unitRef="USD">15787</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2022-03-31_scwo_LicenseAgreementMember"
      decimals="0"
      id="fid_670"
      unitRef="USD">1012327</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2021-12-31_us-gaap_PatentsMember"
      decimals="0"
      id="fid_668"
      unitRef="USD">34742</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2022-03-31_us-gaap_PatentsMember"
      decimals="0"
      id="fid_665"
      unitRef="USD">436</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2022-03-31_us-gaap_PatentsMember"
      decimals="0"
      id="fid_671"
      unitRef="USD">34306</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2021-12-31_scwo_LicenseAgreementMember"
      decimals="0"
      id="fid_669"
      unitRef="USD">1062856</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="fid_796"
      unitRef="USD">16223</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="fid_663"
      unitRef="USD">1046633</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AdjustmentForAmortization
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      id="fid_679"
      unitRef="USD">16458</us-gaap:AdjustmentForAmortization>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="From2022-01-01to2022-03-31" id="fid_639">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"&gt;&lt;strong&gt;March 31,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"&gt;&lt;strong&gt;2022&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;2022 (Remaining 9 months)&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;48,663&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;2023&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;64,884&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;2024&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;64,884&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;2025&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;64,884&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;2026&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;64,884&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;Thereafter&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;738,434&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;Intangible assets, Net&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1,046,633&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="fid_672"
      unitRef="USD">48663</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="fid_673"
      unitRef="USD">64884</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="fid_674"
      unitRef="USD">64884</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="fid_675"
      unitRef="USD">64884</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="fid_676"
      unitRef="USD">64884</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="fid_677"
      unitRef="USD">738434</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="fid_678"
      unitRef="USD">1046633</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2022-01-01to2022-03-31" id="fid_619">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;&lt;strong&gt;Note 6 &#x2013; Stockholder&#x2019; Equity&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;The Company is authorized to issue 1,000,000 preferred stock shares and 200,000,000 common stock shares both with a par value of $0.0001.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;&lt;strong&gt;Preferred Stock&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;On October 30, 2020, the Company designated 1,000,000 shares as Series D Convertible Preferred Stock with a par value of $0.0001.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;On April 16, 2021, the Company closed on a private placement of 440,125 shares of Series D Convertible Preferred Stock (the &#x201c;Preferred Stock&#x201d;) with a par value of $0.0001, yielding gross proceeds of $6,551,691 (the &#x201c;Private Placement&#x201d;) and settlement of a $50,000 liability for Preferred Stock shares. The Private Placement proceeds will be used for working capital, primarily for the development, manufacturing and commercialization of 374Water&#x2019;s Air SCWO systems. The Preferred Stock has a stated value of $15 per share, is convertible into common stock at $0.30 per share and has voting rights based on the underlying shares of common stock. Upon liquidation of the Company, the Preferred Stockholders have a liquidation preference before any assets can be distributed to common stockholders. All of the Preferred Stock were sold pursuant to an exemption from registration requirements under Regulation D and/or Section 4(2) of the Securities Act of 1933, as amended. On September 29, 2021, 412,853 shares of Series D Preferred stock were converted into 20,642,667 shares of common stock.&#160; On January 12, 2022, the Company converted the remaining 27,272 shares of Series D Preferred stock to 1,363,149 shares of common stock.&#160; As of March 31, 2022, there were no shares of Series D Preferred stock issued and outstanding.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;&lt;strong&gt;Common Stock&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;The holders of common stock are entitled to one vote per share on all matters submitted to a vote of shareholders, including the directors&#x2019; election. There is no right to cumulate votes in the election of directors. The holders of common stock are entitled to any dividends that may be declared by the board of directors out of funds legally available for payment of dividends subject to the prior rights of holders of preferred stock and any contractual restrictions the Company has against the payment of dividends on common stock. In the event of our liquidation or dissolution, holders of common stock are entitled to share ratably in all assets remaining after payment of liabilities and the liquidation preferences of any outstanding shares of preferred stock. Holders of common stock have no preemptive rights and have no right to convert their common stock into any other securities. As of March 31, 2022, there were 126,680,895 shares of common stock issued and outstanding.&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;On April 16, 2021, as a result of the closing of the Merger Agreement (see Note 4), the equity of the consolidated entity is the historical equity of 374Water, Inc (&#x201c;Private 374Water&#x201d;) retroactively restated to reflect the number of shares issued by the Company in the reverse recapitalization. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;Pursuant to the Merger, all Private 374Water shares were cancelled and&#160;the Company &#160;issued to the former Private 374Water stockholders a total of 62,410,452 shares of&#160;the Company&#x2019;s common stock.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;On April 16, 2021, the Company issued a small block of shares of common stock estimated to have a fair value of $1,073,369 as consideration for the grant of a license to the Company (see Notes 5 and 8).&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;During the three months ended March 31, 2022, the Company issued 1,363,149 shares of common stock from the conversion of 27,272 Preferred Stock shares.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;&lt;span style="text-decoration:underline"&gt;Stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;During the three months ended March 31, 2022, and 2021, the Company recorded stock-based compensation of $97,558 and $10,433, respectively, related to common stock issued or vested options to employees and various consultants of the Company.&#160; For the three months ended March 31, 2022, $93,868 was charged as general and administrative expenses and $3,690 as research and development expenses in the accompanying condensed consolidated statements of operations.&#160; For the three months ended March 31, 2021, $6,518 was charged as general and administrative expenses and $3,915 as research and development expenses in the accompanying condensed consolidated statements of operations.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;&lt;strong&gt;Stock Options&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;Stock option activity for the three months ended March 31, 2022, is summarized as follows:&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"&gt;&lt;strong&gt;Shares&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"&gt;&lt;strong&gt;Weighted Average Exercise Price&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"&gt;&lt;strong&gt;Aggregate Intrinsic Value&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"&gt;&lt;strong&gt;Weighted Average Remaining Contractual Life (Years)&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;&lt;strong&gt;Options outstanding at December 31, 2021&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;12,300,000&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.37&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;4,521,310&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;5.62&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;Granted &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;360,000&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;3.33&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;Exercised&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;Expired/forfeit&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;&lt;strong&gt;Options outstanding at March 31, 2022&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;12,660,000&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.45&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;5,719,310&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;5.39&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;Total unrecognized compensation associated with these unvested options is approximately $501,471 which will be recognized over a period of four years.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;The fair value of these options granted were estimated on the date of grant, using the Black-Scholes option-pricing model with the following assumptions:&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"&gt;&lt;strong&gt;March 31, 2022&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;Dividend yield&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;0.00%&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"/&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;Expected life&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"&gt;5.65 &#x2013; 5.75 Years&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;Expected volatility&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"&gt;37.73 &#x2013; 39.18%&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;Risk-free interest rate&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"&gt;1.44 &#x2013; 2.12%&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;&lt;strong&gt;Stock Warrants&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;In April 2021, pursuant to the binding Memorandum of Understanding dated as of March 30, 2021, between 374Water and MB Holding Inc. (the &#x201c;MOU&#x201d;), a warrant for the purchase of&#160;3,783,333&#160;shares of common stock at an exercise price of $0.30&#160;per share was issued to MB Holding Inc. as consideration for executing the MOU and was considered fully vested upon the execution of the MOU. These warrants were to expire in March 2022. Those warrants were estimated to have a grant-date fair value of $0.37&#160;per warrant or aggregate fair value of $1,399,833&#160;which has been presented as product development expense on the condensed statements of operations.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;During the year ended December 31, 2021, the warrants were exercised resulting in the issuance of 3,783,333 shares of common stock and proceeds of $1,134,499. Terry Merrell, a member of the Company&#x2019;s Board of Directors, has sole voting and dispositive power over the securities held by MB Holdings Inc. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;As of March 31, 2022, there were&#160;1,250,000&#160;warrants outstanding which relate to the Series 1 offering executed in December 2021, where investors were offered a warrant for every two common shares purchased during the offering at an exercise price of $2.50&#160;per share. The intrinsic value of all outstanding warrants as of March 31, 2022 was $437,500&#160;based on the market price of our common stock of $2.85&#160;per share.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;During the three months ended March 31, 2022, no warrants were issued or exercised. As of March 31, 2022, there are 1,250,000 outstanding warrants.&#160; &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;&#160;A summary of warrant activity during the three months ended March 31, 2022, is as follows:&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"&gt;&lt;strong&gt;Shares&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"&gt;&lt;strong&gt;Weighted Average Exercise Price&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"&gt;&lt;strong&gt;Aggregate Intrinsic Value&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"&gt;&lt;strong&gt;Weighted Average Remaining Contractual Life (Years)&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;Balance at December 31, 2021&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;1,250,000&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;2.50&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;437,500&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;2.96&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;Issued&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;"&gt;&#x2014;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;Exercised&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;Balance at March 31, 2022&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1,250,000&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;2.50&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;437,500&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;2.72&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="fid_710"
      unitRef="Shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="fid_800"
      unitRef="Shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2022-03-31"
      decimals="INF"
      id="fid_721"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="fid_724"
      unitRef="Shares">126680895</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      id="fid_733"
      unitRef="Shares">1363149</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      id="fid_734"
      unitRef="Shares">27272</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ShareBasedCompensation
      contextRef="From2022-01-01to2022-03-31_scwo_ConsultantMember"
      decimals="0"
      id="fid_719"
      unitRef="USD">97558</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2021-01-01to2021-03-31_scwo_ConsultantMember"
      decimals="0"
      id="fid_720"
      unitRef="USD">10433</us-gaap:ShareBasedCompensation>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2022-01-01to2022-03-31_scwo_ConsultantMember"
      decimals="0"
      id="fid_728"
      unitRef="USD">93868</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2022-01-01to2022-03-31_scwo_ConsultantMember"
      decimals="0"
      id="fid_726"
      unitRef="USD">3690</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2021-01-01to2021-03-31_scwo_ConsultantMember"
      decimals="0"
      id="fid_729"
      unitRef="USD">6518</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2021-01-01to2021-03-31_scwo_ConsultantMember"
      decimals="0"
      id="fid_727"
      unitRef="USD">3915</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2022-01-01to2022-03-31" id="fid_641">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"&gt;&lt;strong&gt;Shares&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"&gt;&lt;strong&gt;Weighted Average Exercise Price&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"&gt;&lt;strong&gt;Aggregate Intrinsic Value&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"&gt;&lt;strong&gt;Weighted Average Remaining Contractual Life (Years)&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;&lt;strong&gt;Options outstanding at December 31, 2021&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;12,300,000&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.37&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;4,521,310&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;5.62&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;Granted &lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;360,000&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;3.33&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;Exercised&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;Expired/forfeit&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;&lt;strong&gt;Options outstanding at March 31, 2022&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;12,660,000&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.45&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;5,719,310&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;5.39&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2021-12-31_scwo_OptionsMember"
      decimals="0"
      id="fid_343-ded48a"
      unitRef="Shares">12300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2021-12-31_scwo_OptionsMember"
      decimals="INF"
      id="fid_351-c44ca4"
      unitRef="USDPShares">0.37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2021-12-31_scwo_OptionsMember"
      decimals="0"
      id="fid_340-482c35"
      unitRef="USD">4521310</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="From2021-01-01to2021-12-31_scwo_OptionsMember"
      id="fid_341-3d2fcb">P5Y7M13D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2022-01-01to2022-03-31_scwo_OptionsMember"
      decimals="0"
      id="fid_681"
      unitRef="Shares">360000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <scwo:Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice
      contextRef="From2022-01-01to2022-03-31_scwo_OptionsMember"
      decimals="INF"
      id="fid_685"
      unitRef="USDPShares">3.33</scwo:Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2022-03-31_scwo_OptionsMember"
      decimals="0"
      id="fid_688"
      unitRef="Shares">12660000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2022-03-31_scwo_OptionsMember"
      decimals="INF"
      id="fid_689"
      unitRef="USDPShares">0.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2022-03-31_scwo_OptionsMember"
      decimals="0"
      id="fid_690"
      unitRef="USD">5719310</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="From2022-01-01to2022-03-31_scwo_OptionsMember"
      id="fid_684">P5Y4M20D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="AsOf2022-03-31_scwo_OptionsMember"
      decimals="0"
      id="fid_725"
      unitRef="USD">501471</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="From2022-01-01to2022-03-31_us-gaap_StockOptionMember"
      id="fid_643">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"&gt;&lt;strong&gt;March 31, 2022&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;Dividend yield&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;0.00%&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"/&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;Expected life&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"&gt;5.65 &#x2013; 5.75 Years&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;Expected volatility&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"&gt;37.73 &#x2013; 39.18%&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;Risk-free interest rate&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"&gt;1.44 &#x2013; 2.12%&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2022-01-01to2022-03-31_scwo_OptionsMember"
      decimals="INF"
      id="fid_691"
      unitRef="Pure">0.0000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2022-01-01to2022-03-31_scwo_OptionsMember_scwo_MinimumsMember"
      id="fid_692">P5Y7M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2022-01-01to2022-03-31_scwo_OptionsMember_scwo_MaximumsMember"
      id="fid_693">P5Y9M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2022-01-01to2022-03-31_scwo_OptionsMember_scwo_MinimumsMember"
      decimals="INF"
      id="fid_694"
      unitRef="Pure">0.3773</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2022-01-01to2022-03-31_scwo_OptionsMember_scwo_MaximumsMember"
      decimals="INF"
      id="fid_695"
      unitRef="Pure">0.3918</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2022-01-01to2022-03-31_scwo_OptionsMember_scwo_MinimumsMember"
      decimals="INF"
      id="fid_696"
      unitRef="Pure">0.0144</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2022-01-01to2022-03-31_scwo_OptionsMember_scwo_MaximumsMember"
      decimals="INF"
      id="fid_697"
      unitRef="Pure">0.0212</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="fid_421"
      unitRef="Shares">3783333</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2022-03-31"
      decimals="INF"
      id="fid_716"
      unitRef="USDPShares">2.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="fid_735"
      unitRef="USD">437500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:CommonStockNoParValue
      contextRef="AsOf2022-03-31"
      decimals="INF"
      id="fid_715"
      unitRef="USDPShares">2.85</us-gaap:CommonStockNoParValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="fid_714"
      unitRef="Shares">1250000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2022-01-01to2022-03-31" id="fid_642">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"&gt;&lt;strong&gt;Shares&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"&gt;&lt;strong&gt;Weighted Average Exercise Price&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"&gt;&lt;strong&gt;Aggregate Intrinsic Value&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"&gt;&lt;strong&gt;Weighted Average Remaining Contractual Life (Years)&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;Balance at December 31, 2021&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;1,250,000&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;2.50&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;437,500&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;2.96&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;Issued&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;"&gt;&#x2014;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;Exercised&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"&gt;Balance at March 31, 2022&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1,250,000&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;2.50&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;437,500&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;2.72&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_698"
      unitRef="Shares">1250000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2021-12-31"
      decimals="INF"
      id="fid_706"
      unitRef="USDPShares">2.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="fid_699"
      unitRef="USD">437500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2021-01-01to2021-12-31" id="fid_709">P2Y11M15D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="fid_705"
      unitRef="Shares">1250000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2022-03-31"
      decimals="INF"
      id="fid_707"
      unitRef="USDPShares">2.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="fid_708"
      unitRef="USD">437500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2022-01-01to2022-03-31" id="fid_700">P2Y8M19D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2022-01-01to2022-03-31" id="fid_620">&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Note 7 - Related Party Transactions&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"&gt;In 2021, the Company entered into an agreement to fabricate and manufacture the AIRSCWO systems&#160;with Merrell Bros. Holding Company. As part of the agreement, the Company&#160;appointed Terry Merrell to its board of directors. As of March 31, 2022, Merrell Bros. or their affiliates own stock in excess of 5% of the outstanding common stock.&#160; As of March 31, 2022, the Company had $50,000 in related party expenses related to the manufacturing of the AIRSCWO systems.&#160;&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <scwo:StockInExcessPercentageOfOutstandingShare
      contextRef="From2022-01-01to2022-03-31"
      decimals="INF"
      id="fid_741"
      unitRef="Pure">0.05</scwo:StockInExcessPercentageOfOutstandingShare>
    <us-gaap:RelatedPartyCosts
      contextRef="From2022-01-01to2022-03-31"
      decimals="0"
      id="fid_740"
      unitRef="USD">50000</us-gaap:RelatedPartyCosts>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2022-01-01to2022-03-31" id="fid_621">&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Note 8 &#x2013; Commitments and Contingencies &lt;/strong&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;The patented technology underlying 374Water&#x2019;s supercritical water oxidation (SCWO) units, which was developed principally through the efforts of Messrs. Nagar and Deshusses at the facilities of Duke University, Durham, North Carolina (&#x201c;Duke&#x201d;), where Dr. Deshusses is a professor, is licensed to 374Water pursuant to a worldwide license agreement with Duke executed on April 16, 2021 (the &#x201c;License Agreement&#x201d;). In connection with the License Agreement, 374Water also executed an equity transfer Agreement with Duke pursuant to which Duke received a small block of common stock in the Company (See Notes 4 and 6). Under the terms of the License Agreement, the Company is required to make royalty payments based on a percentage of licensed product sales, as defined in the License Agreement which is triggered by the sale of licensed products. Further, the Company is also required to pay royalties on a percentage of sublicensing fees. The Company will reimburse Duke for any ongoing patent expenses incurred. During the three month period ending March 31, 2022, the Company has not incurred any expenses in connection with this License Agreement. The Company may terminate the license agreement anytime by providing Duke 60 days&#x2019; written notice.&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:DeferredRevenueDisclosureTextBlock contextRef="From2022-01-01to2022-03-31" id="fid_622">&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Note 9 &#x2013; Deferred Revenue&lt;/strong&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;As of March&#160;31, 2022 and March 31, 2021, the Company had total deferred revenue of $763,333 and $0, respectively. As of March&#160;31, 2022, the Company expects&#160;100% of total deferred revenue to be realized in less than a year.&#160; &lt;/p&gt;</us-gaap:DeferredRevenueDisclosureTextBlock>
    <us-gaap:DeferredRevenueCurrent
      contextRef="AsOf2022-03-31"
      decimals="0"
      id="fid_742"
      unitRef="USD">763333</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="AsOf2021-03-31"
      decimals="0"
      id="fid_743"
      unitRef="USD">0</us-gaap:DeferredRevenueCurrent>
    <scwo:DeferredRevenuePercentage
      contextRef="AsOf2022-03-31"
      decimals="INF"
      id="fid_744"
      unitRef="Pure">1</scwo:DeferredRevenuePercentage>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2022-01-01to2022-03-31" id="fid_623">&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Note 10 &#x2013; Subsequent Events &lt;/strong&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Effective April 13, 2022, in accordance with Section 228 of the Delaware Corporation Law, shareholders of the Company holding a majority of the voting power of the Company (the &#x201c;Consenting Shareholders&#x201d;) approved the adoption of the Company&#x2019;s 2021 Equity Incentive Plan, reserving up to 10,000,000 shares of Common Stock for issuance in connection with awards thereunder (the &#x201c;Equity Plan Adoption&#x201d;).&#160; &lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="AsOf2022-04-13_us-gaap_SubsequentEventMember"
      decimals="0"
      id="fid_745"
      unitRef="Shares">10000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>65
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MHO!1=CJ9/H*]G,$+-L877FRN)!6Y@TKKZ#3( 0S]6&-C!89>K*^^A06H<L8
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MBQ\&F$J N+XAA+\OY,:P_JDQ_PM02P,$%     @ -HG15! 3ED6@!0  N!<
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MK;H'?:-"T%(];DB:$58#Y/]7E(KC2SU =UD_^0]02P,$%     @ -HG15*,
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MO]SQ(.)Y)2 _WPI1'B^J!YY.S]Q=_P=02P,$%     @ -HG15*:&B!#("
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MW_BV-RD(1'BL??B#H9BG)\LTWK'C-1&S$T3<Z?C[86.+IDJG1<H$$VWA.T&
M71;7_,G,_%E5RZ9B6X4Q+.PS*J:)'\N4Z1 L90@A,\^E X^V8Z CNZL#KUF9
MFUFY/)FKF%D=R&$><YUB*64.:[N-X-QV/L=H9[#A 272\AI!.H[-.Y0[KZF=
MFZF].'>\(+?R+8QCE>_9BCP#M<^AKB38B?TMUQF;@G:BU+7;(="1+D6"<!9L
M@L!LYO". -1B@9O%0AF "6CETZ[K= VY%]P=:*[K2)?9 Z_M.M8A%LL)UN%1
MD([=;SP!,$N%Q<M\?C]YF#P^#^])I1O(>+H8W<\6+T^3A>FHF==*@9N50A'F
MXD! G>B%<2Z!:M%BR$]N[B=&R+&!M3K@9G5P;&#N?^!*@)L(OK3N; W :PW
M'6.:'F>/%T5V&CO(QS$J[(SYJ@F<FPE\E,1J(Z7$/BR+AD8J=,=S<J1#T+7B
M:@]6J';PA("Z0E4S,#<S\#3+=DJ4*LX-FL?>*J]1&!2G4:EZL(PG&.%BR^4V
MT^K1V5S,:R[F9B[6#C=A7YA'$/;W,%^CDK4C_&.NLZ2-:#\$UN&$J)E4F(_
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M%OXK*F_M%E09WW(A-814A01J4CM %C/P+'?+MB;=4B.I8SR_?K]SI&ZW'2?
M3G:>>)C@5DOG^IV;>DY7UMWXI5)!?"T+XU_VEB%4OPR'/ENJ4OJ!K93!F[EU
MI0QX=(NAKYR2.1\JB^%D-#H>EE*;WMDIKUV[LU-;AT(;=>V$K\M2NO4K5=C5
MR]ZXURQ\T(MEH(7AV6DE%VJJPN_5M</3L*62ZU(9KZT13LU?]L['OUP<TG[>
M\$FKE>_\%J3)S-H;>KC*7_9&)) J5!:(@L0_M^I"%041@AA?$LU>RY(.=G\W
MU-^P[M!E)KVZL,5GG8?ER]Y)3^1J+NLB?+"K7U72YXCH9;;P_%>LXM[C44]D
MM0^V3(<A0:E-_%=^37;H'#BY[\ D'9A\[X&#=." %8V2L5J7,LBS4V=7PM%N
M4*,?;!L^#6VT(2].@\-;C7/A[)T,M5/"SL6KVN.=]T*:7%P[Y94)DDV-EV^T
MD2;3LA!3+"JX,?C388  1&:8)6:O(K/)/<P.Q%MKPM*+UR97^9[S%P^?'T\>
M(#"$YJWZDT;]5Y,'*;Z5;B .QGTQ&4TF^P1Z^/BERMKCXP?$.6B]<<#T#O[?
MWMCB?MAR/V3NAP]S?]_A?K[+_?WW8^$;S&Q08BS^]8^3R7C\0OP%S<6E\IG3
M5;,G+)6XL&4ES5H</#_\C'VN+ZY,-NB+^?!F*,6U72GW2;E<Q77QA,Z0*)/1
MBW24G\8OGHJ5A"C@4<B5A(29=95U42!*HBH7V@C@*%L"!:/G _&QPY\.IUW!
M(KW<(FU6?1 I2^5(#_TG9"!-D4-OD+2E\,IIY4F1VN@OM1*<\IS.Q$(919S-
M0E2D@?!K#QMXT/5Z82*/RMF\SC:G8*JX>:7#4ORIG!6JU)ZR,)@XDA".F*WC
MN>#[G!5S02E65+"="7A"A? >#GJ6.V1=(]17J)>#:FD#B) "#A:BK:@HTD!:
M)\T-'"FR=58H$52V-+:PB_5 O#?BO'*Z$./C&#G]UD_)'?O=]%20,(XM#DTE
MR"R<8A!$L!22 ?!6N05(=9V:EMK]&^^25791 L6A)E:*M5BJ(B=_L3NC:>#O
MR]HM9=D7[ZS#^0OI+/ M^^))XG<=S[>46WXD9ZOL>?:EUEXSEBZ *V9MU*I8
M/TN@62UM@2>[(N_Z>N9UKE%L2<N-=5JNTWK6,(HPK*0+!*8MNY%9-H:K:N=K
MB1_QC7;BE38Y8>PW%4A(L+HR! .1LW^GJ@+H9G@S&;'[1@-QO4U$E-'<&9*U
M*JN(B]F:7^UZ8H^;&AWZ!,)=I$#'2#YILVOI?G3I[K) (!(C@/A6WY)ZG4 >
M0$,2UJ3>@BELA(57BN(N1;]$/O "7@#(D970BD H<G W R'4ZAB9M,IN=??0
M@J\14I1M@@V(6UC^>-(_'(_ZAT>3AMU.@J-, HG1)V0W \&!U/S7%\W"\>%@
M(HX.!B<BPB+Y@#-;EMF:0WQNV4@2@7P+*11>;=#Y9*J4X)1]^'1O *>3'MU3
M(V)66$^&3H]W'>\W-/N\18%A6+?GD:$05A%U.$"O=/3B4D/AF-PV9[:BN(V)
M.Q'H5' V=H\(;X@<F $<A :2DB9S,#5#'&23W9,?$XI;[QI^;$SF5"8K'2BM
M)V#MJ6N?=]'5(<CE\/D+C];/.3)22M6LN 5Z*V"6J@1R*I(=@6VI9!&6:UCH
M5CMKV+2\%8I!O$+/U79-0CP:IE9#XM52!J&#F*E"0PE>G\'V=: Z\TSE"\1,
MIA7@'4V46:A*9K.UR[!_[FS)&L1"@E7A+0[ )ZE>J5C*;Y2J!,H'584%=A/L
M68LMZ3H&H-Z7PF&E$7W:9$6-5#=+5DQ$"TL86)!,)C8#@13B(Z6\42GFV11R
MACJ42C!;:6%E$6$+AX58F-ZHF:LIPZ:><,L[T*S(4Y:<:^>#.+_Z,+WX_#Y5
M8K+0>]2]!9U 5*W%%*4P=2^7P"P@R^'QAMZ2=SXALZAU'Q4$?K+.:#D0'R"B
MJ:,K"/QB*6^AN$+996-[6:@F1O9*08:);@&X8>P^AQ(BDW_36YG?:F^A)9J-
M6TUN1/G/5%X3TBD1D!M;#R"E+C7:FXT<E7*;W@<C2"%G34_$N?.RANE_-YJB
M@BW[77T<P8#R$=N:0%(;6>>:HA,*Y!@=XZ]-5IBW9/R&3$=,IU !HY1$V.64
MIJ.(*?%Q,P509KHJH'N$+$HNO:="ES<A#FVX^@4&-%0XAVF0@=J$[^HB@=*I
M15VPJFVZWCX]50AOS969]K_^FBT3:,HFWI],7U\\95=HJMVZ[.BJ39S>8^4*
ME!M*:3!S-YT-!Y"MM"%*'!#ISZ/8E[K@ARRK#8!>9U%_TH#F;3$>/?L/:]M$
M,M54F?\!D$6R3XBS9L"B[A><T@WI65#603JD%^"%\"S\TP1)D@55&PF!8I9+
MF)A+A&>U [B8I2D(HDST#!1KF_MFK\H'XD(YCLN.B6,X61L,E:I<>ZIK'"A1
MNF+=J-1BY=LV_%N0N0F$C7LIMDL=6-D('5\O%L@35 (32+SZ(3S,R+(RI0+S
M1VUVFJAS8^ RI#4N77C3X.'?W:I-1;N?^B,H>6/0\U)7<7=6VQ1V$>M]KVD?
M5ZJ?RGRS4OO=%62V=BGAX)[!3[(QH_?CQK62#G66/(W)/S;!S?0/VU#[UVK]
M/3'>M.VO+UJFMIDE4_V)Q;%!+N2QE7)R$UO$*BS14F$2XYN1*%ZD<= 6,8X3
M&]I8T8S:'"BA/F@W0&(/@!D/W9#:J#^O$;)L RS0XKSFYB;%413U1Y#3I((F
M,=4FZOCCF+C?C;'@=8:E:1R:FUFOY976(\^M,6W:] ^:V@1QY9U4A?CMXV5?
M*$E)Z*$QK87I@,<HMQDE"PKYB(Z IL'+E#(W88N>K 3?T-39QIZ<^#]RH-ZM
M#AW[=AO:;C>_/4.T%</0I>M^3?;;:=!T!C1)<(]1EO$.8.^ 4%H70;1NTFA4
M+,X @WW7;W_U#ND1[G_TO=<_@&]ZBBIO)N,3TGIT]/,NZ.==T)X)].<=T"/?
M >W<_3S>G<]WW/5LXV7_=<__=LVS0WG[IN<*20,P8%C.@0^[(OVZ\K=,8^,!
M4Z$B&%GR'+\OF^\6RH?.)9G.YT1C]R[CCM8D<J,UE?#CH\')/W<+?5N&D@E)
M&EL'E+,(Q:[^_)(NM.Y0&7R+S*WEI!G)Q.J5VI (%DRJ<^4<-]1LZ3O7-?O9
M_;T7-O[GA0U=*[RS@AH.IWE(3-<F24'8B QGN&+Q&$6QUG3/G2ZKT1K)59/5
MZ$\54\2WKF(P=M=S]&UU'$ZA93DK.K<JCW 34])N3("/>1VS[UOAL/,-F7,K
M?5JGK@Y->?R<W*ZV7^_/^:/U<+,]?OK'\+'00&RAYC@Z&CP_Z@D7/Z?'AV K
M_B(]LP$J\4\$!=(#;<![FK:;!V+0_C\-9_\%4$L#!!0    ( #:)T50_;Y4O
M[1(  -%$   8    >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL[5S[;QRYD?Y7
M"-WF8 &CUTCV>OT"9*V-^+ ;&]8Z^9G3S9GAN:?9V^S6>/+7WU=5))L]#ZV2
M["(!3D"REGJ:9+WKJRIJ7JU=^]4OC>G4MU55^]='RZYK7IR=^6)I5MJ?NL;4
M^&3NVI7N\&N[./--:W3)BU;5V?3\_-G92MOZZ,TK?O:I??/*]5UE:_.I5;Y?
MK72[>6LJMWY]='$4'WRVBV5'#\[>O&KTPMR:[DOSJ<5O9VF7TJY,[:VK56OF
MKX^N+U[<7-'[_,)?K5G[[&=%G,R<^TJ_?"A?'YT30:8R14<[:/QS9VY,5=%&
M(./7L.=1.I(6YC_'W=\S[^!EIKVY<=7?;-DM7Q\]/U*EF>N^ZCZ[]9]-X.<I
M[5>XRO-_U5K>O;H\4D7O.[<*BT'!RM;RK_X6Y) M>'Y^8,$T+)@^=,%E6'#)
MC IES-:/NM-O7K5NK5IZ&[O1#RP;7@UN;$U:O.U:?&JQKGMS*]I3;JYN[:*V
M<UOHNE/71>'ZNK/U0GURE2VL\:_..IQ'J\Z*L/=;V7MZ8.]+];.KNZ57[^K2
ME'O6W]R__F)ZSP9G8#1Q.XW<OIW>N^//NCU5EQ<3-3V?3O<1=/_R'TV1EE_<
M0\YE$OXE[W?Y.PM_=-A5.NR*#[OZC<,^_E.:OG=O"C4O?*,+\_H(L<2;]LX<
MO5%_<9U14_7?__5\>G'Q4CV<6W6C_5+INI0?WOW:VSM=F;KSZI>E43=NU>AZ
MHPJ'8%*:UBM=56H)AZTVJK)XNU2VOC.^6_&:IF^+)5R]A&]UM*]RK5W86E?P
MI*YO;<=$=<O6&+42BW.MJHSWJG-J9E1!9)B!C-,1'4M3E:IV.V\I[6E?&%VQ
M3%8W8;Y@268U,VVRIM,H!Z\^XS-L,:O,\*Q-S[RP[3O:>J8K71=X5O9&S5NW
M4B1[6Q@LN#-U;[8H!7.V<R2PW8V9KJ9U=Q I2]2M9>_UTM1)UA!BC27>0Y.@
MN=OB;C]S$\@62]6:_@-!(9OX#F^2SO=0(K)HZ>-J,Z$%B1J%O*5*U\^Z>5\-
M:]>0=""]/&5[:4CUV4^6#\"F8$!W8,=WIR 4UEI8S0G%DF173=_AC=X3:2!:
M^:[5E E.R.35RG1+5S*3L"(8F(4!\?N&Z*F0D09+VAC=0O[OOB'C>LB12*>\
MVIF:6:%=6M-H2_J 8&"C[0*;P>2,K"$#LG71MRVQE2F27>K[E]![SD%<96LF
MO3&M!;'@Z[OIY=-3]:&&S!>6[<I[ [%E3[0\(3I\/_M?)%FB0Z]<V]F_\_:3
MP/9&V141'<5:FLZTR$R&G(Y5TI;,'SO;]>V-NGQV/N$H,#U_^:D% &D[J/43
M3+>339.:3ODMQ(H#E'4L;>AO"0> $Q=P85*ED";$X@5W!^.#"&R[7T=;7M&3
M=O1^54.;8R'T-<<%'5_HEB!G9CH(@5 -P1,OXM?TK":AK)<6/D(/88*U6]D"
M*VHSMYT7<R&=C1D6BX#3]2MBJ%6.7&AMH=Z>(EG?(-S4%)M:4UEXS293Q*GZ
MR=6+DY_ :AEUG3.,X$!P2%7T5L5OB90G9&Y5SXZY39$7A<XM0H@1,4[8IC-S
MH%!A2/@4?3J.HK#J>F'(CE5AVZ)?D><7_*"$_K 52Y!D4.BVW7!,6)%;L^SK
M((Z5WB 0=,)P00J62+&KQ\$OHVQ[G.0Y4H!1#M)SA!.?S 0[DE_2R96=\S+2
MS![I.-)QQ>:T:!UT0"0&X7"$TTV#%$:DD2AA(]HCOV!C?$P*Y./""DDMG#S(
M?'M)4,ADS*.N8'+,XN?(KZU"I@H;C)?"%>4X_#S;P$ IFNG6>D2&((AM 8,"
M>CSOD02WQ$2QI.@XVG>YS(3H!=3<LAAP4F()<?M@PMN7!AY@)"VE4Q8@])H9
MFD;RWB +DG0XT;&4 "JD-B#DX+!!#9?F)[F9S%TEK"Q3FE2<CG1;,OWO+05H
MB]B289/;],9;AW_4EZ8D$_N+.P5O%U<GYS^\B#$NDL0)&72 B"*ZSPU#>L(L
M3WYQ#0+!L_-GQRGL$9F(GP@>X+FP315L&+J5MZT7=R$K!UW=AKT!?/^=A27G
M0D?("[80K\+IM9_#]+ 3<N3*DK$LG"M9\@$OL&*+1!L%\CI9"1TX"FT1#(AL
ML3(+<$*5F$\T%WY828(PWT39'#H001'0=H@9M!K2-C.X-[\P<5LB(^N''VYB
M#A>%TV]S2M"^,XU_H2Z.%7@ 9?--9"I7E$[B>*FF6Z\B@W']3%2X6647+ @?
M$V_<Z:6Z/!ZB\J ,+14L""[,2W5US/ FA,(]KT0W/7#J2S;WI\>#H)(A,')[
M L%J?PRO4QXK_)QBP_Z]"!'!4BB"Q"U  4"[K381=K*'(!0A22Y8:8W>",P6
M !?45-[)WO.T4YLY*'N&B&H%C?&S$*-,@FRSWB*^D9D8#>N*ZB!01"\"1 *L
M"3!(@4\O$,A]2"<$#,@ >1^68.O*ONCV0ZE#2HTA681G [Q AC&1$M\0!*O8
M1$V...GD+ABZ20R<JK=<C#BQEFTZDAU.\H^%C*6&_0*I$#(^9!#JB3!,5D&R
MH-HHR#;P?SQ.F[SSH.>@1OC*-TJ7(U<G5KRF(D2"B4@S.*M/G(XJ*4.U^W:9
MP"E@R"+)'FCS2.T<P!CEX8?/MS=_^ZC\!GZ[.E7O'WC&Q5A\I2T9/X@$!0.%
M NFV<\77DQGKA%X'AMY-&J@?8[EAQ"A]MJS(ER&/AD3/)8EG*P)/>Y/)C2NY
M$!;- 2T?ATC__<7S5#F'O,*$CDB,>4/BKR1+(T8)3) $B:QY@IH43BCD1NCJ
MLN@T8H'X([L!7J!8+?XM?,E1!F[K-H;Q5BG8- 4 Y5'(B(FPC"A($&5("V2/
M;2_;/0D?-N)FM ]H@$+#JEBUH[@C*CH?S):X4<(-3N#0D.^D])K2,[QO@/[!
MT\J "1>T75;CO:TT-'E;+!U9-FTM4EBYTE22801:>J#Q0"Z'I8B1[APP(:.S
MR?"PM%2.UJ7/GI&P!0\Q^+#^Z\F<S)B*0H@,:18D2LDXWIB:(A3H9C%R9 70
M<#I[I8&2&/K5-E</Y%9PZ9^))>+?$7W1:D;J$='OO!>5QQ(5# H;X20PB#=8
MKP=\ [RVR?[&QAMJ;[]U2 BQF@#P(EDT]!!_I#8/GT1O-U6?$ H'47XLQ _2
M)B%S>,[#\)?36[S7<B+9J(TE;(W*^X[+:3.?4T4<ZA2._<F.8M +Y79,8SD7
MI[GOT_M?$++;CGH!Y!.H=L&]4;_H;\8?A*I;P01U=0@45^<G%T.!_?"3MN1?
M(?S/;8@>>KQ+/][%RBX=T[N%SQB8FA;YQ)N4T^8)47,)+P% ^DW&%ZV=<0&>
M(P0*[QX.*7DLY'?.JY #]9^8KCW[CG;97DNU$Y&M&N?#.?JKJ57NS )9Y3DQ
MQ.^W!B52389$")SEKBOOAG[9HK>"2K$GM<D2#1.2K/<IR$\&9V<!&%0RY-Z3
M7.8L8[QE5\&L\#$59Y4C5D($(9QH!;;],JJKDK9&K/Z#[<C!4J0MNQD99NJ\
M<0,@-X?![ZDM(6$IY)ND;"X;R8)AN^ID9)2GL%A)GUS/TKH)C64$E1(_L1\$
MLN,),3IFK:B1;R/%8@-#ZIF9;FU,'0!&M)[6--3CX3)33J'U/JNUMX\3-J$\
ML1DR$=V94)U%R#A$CE 94$MPW! :2!,6<C,DB-+ZK2:'=#')789$-;1'L<K-
MY]0PV2<S.Y^,!;/F*1>S>:=MQ6U@PVFKH 8&@]@5BJN3RGXUU>8$W-4G!*.8
M34]:8\&160MDF,0 N.]\EDOJX@AB#IE%Q,3.,ZP+&@CM 14,6@0]K@RE44KT
M4./>^52+A:C,]$IO*T0X5AT'A9)S[F?C#7N&^,.=J9S@^!OGQ^VS%-7:?$F9
M+2EX251G[24TYCW9S 0V_.+0YKWM"5_1NM)27\:'.EQLXKN+YT\GSYY>\IG?
M37^8X/>'X^Z\%X.=R=20K*L-((=N:Z[HGOP$Z1VK3_#!6\)QV2<5?P(6!.&-
M.N9[2O/WU[=OLSPUS;K :<\F'A.2$2I06_&&)G]E][S91@ 6>2&UJ(+V XVA
M*R7F;<J3"!_JGJ,<(=.$47/0.1E#T-$L)P&IQG74"X"Q$PV@EC&O*6B01*$A
MGVZ4TOT;5'^J;D)L/GA2"./)7I/QF(.:  PL^BH$ Q];W^)3:]<CB\ZHZNGL
M223X4*\NZ]"-6R>_Q;4$/L,V'\CFJJX,^B0EL6,.5,],H:E,.4QN/.A%0IID
MZA?3R3,8T_GY^0$U;B?$@5YY?5\B/,W:?A^R,F4T<$0E0KQ2/W2R;W*5/6ST
M)DW5\+#M0U.51D&3/2., +$'K\R ^E#RQ'F!-P?S8 -,\DWZWZG?&]:>C88@
M7#ZE=H6T"[9;_F4?VT^@@",47JUI: H+^B(EYKM I\BJH9%6:!?@P[W(CZV_
MIMX%H0-IMPW@)S7R?.@0D,GA<]-T@R]\H2E$285T)YQ<KPP)<RB"5[K64KH2
M!RO@N211D5I>SDE352Q0P( I0]R]#P5PX$^X3,R0F6")'EC3C8K1,1#9@L?2
MHMXE)T0[>B7:5!YJ!C@3@\YUT?6,<WQ?=11&R<D$>\3F"W5BDX!.1R/Z06Y!
M^J0M=@EIJNY5,0>!U'_(*G9N!>QIG$QVK'/''B5_[0,^L?&W!W;P!,5LW31H
M7>T()PNUU]0CX^!>FS6LS<(T*,GT'0?B#6*7A"?RRY&ICK;AYM*,X&5IS"K5
M$K3%,!A2/#(C<;8DL]#<#2'F5.V[E?)/7+[X(^Y>C$<JV.H&@@9(_(S*.HN>
M>9.'_2I/'6FXG(55&CW(3E2CY_<;BDC+[@6,'PT7-L-4,CL=N"E4/(RLN#4\
MH9$IG132;V41?&!0 2J\-]3DK.*VE +ZEBWKQK7PIM"@"_CE_8\?;@)B.=[?
M36:"RTBCFT,"E!B-$:>F#80R/H.)>:F6;DV0?\*]M[28&]Q4>VNN;)A?NNP2
MA?8K/#LVUP;.0_3(^Y=DAQ0ND,-PJ,SR*26+7WO"G3%]A59;DBIT4MK=F#XZ
MTOH0;BBG<2.9_ __*R<[Y,Q,9<U=@.*L=1[V;@)V]W35#2&G&M<^]Z\"<2)U
MR5FY2>4;[KMG\V^\,3+_ V^,/-[X^/]\X^-Q,OXX&7^<C/]>D_%_;60<0'_C
M;"W-0!HA,!%ABAK"W=(VC7A_:2ANM1+=\_'Q)-B4#3<S\\\XS;-%I8SK,[A'
MN="'++*./NW6J+'HX% U@R,SFIWN3J;_D6$T[2R]]\33)IL>_]ZSZ)]UW=.D
M2XHA"JPKBI3)F4G*X[[AR"2Z<)<)BTP9=Y6<=T =>Y%6N-9 CMD=-),]@W/N
M#TOC;J<EOW=FSOFB2IUK7=Y9[]K$+\JBUDAQ$LV&=\DDD-@>;E4_@/9LR(UL
M9.[(NG;/!%X:BM)[> -8N#@__U/,C+M]UB F:2_IMGX@^P]G.K 9T'GDI.E;
MWVMI(# 2CYQ)(*1'!1 I-^WDG#"NW./G_XJ(<XE^K'/;&]U(R%H_,/GGS_^4
M7;_A$$RB9D'],.7/]MX"[W;5DUGJ8']QO]2N3)<X=L(D<!^IC'!@-/W'2Q>/
MERX>+UT\7KKX#[ETL3OM_HUYX.%YV>,8X7&,\#A&^'>.$<8O[ADB/&#.4.C&
M=L2JI@9,5GG^83.(#[6Z[A= =@$1<YOX(?V6U)2^OGT;F])Q@K%W66C0Q'77
MMU_2,CKZY/S9!!%OU@D4FKZ47Z1)XVJZDQ);21\YR7T,UO_DMI_)W:BK[\]/
MIN?'(78B-^F.94V__]F4"Z(G;CZT@6 5[[A)DI#CQW7-K4*X][#Y\XNG)U?8
M/*,_TIWX@*N&U+?9OLL6!P#S?0,+F/BPFS+4EZ_#O1Z3 A=#%!^[/QPG4#+D
MX4IZ?;%SGDN,.]39L[G1<LDCUC-\MYPL,8=MM#*E<A_NUT2Q*E\ 6?-T0<!8
MNHO6"*OLSR["P?%UM!ALD@92_RPIP4$)LE9R2VW6J2LHM^#@/UPIDX9+F1.
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M1[-!&(3;+TY7_A?CN79.%_YC3FT0#1^@]PM-M[3YP@:Z_W-P]CM02P,$%
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MZ?$0'<2(29R2DQ"6 F^%,N%"GU*Y QQ:U< R5S NO2M,W<@%DEV:WRB39Z\
M]_-&VQ190V;UI@OVQ"MCX2/$/8T#9S08B6MR$VAR3FY8B;G*X"ZIKFO3)6J
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M%9 YS92SB).B _%B,CH3^?@X/CL4ENR8;E!^SV8T+(&J78"*=7U9%SK!4)1
MV2XJ5-7.U\H$V50R"8L4<X'7PJ0RQRSAQ[@ DTB4GSBI)>*(UQ7"4=#XN*E;
M.A#?6I)_M1!7:X@UXP%]-E*/IIVP$5D4MS3ZST15X>VS966(?]8(%06GC%]
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M=B* \X5%1[0+,=#=NB__!5!+ P04    "  VB=%4M5<P%($&  "D#P  &0
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MK:EV9R&CNY.J# ,X.FFI=.\YMW'G:!SJXD#Y2O'<G*T/;(BW[:EO-,TVY,4
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M-!Y-+AB8;F@[P>DV#,I:.QJ[L*SIG4/C'<A>:3J?7O )AI<S_PU02P,$%
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M3N-AP!O^-XU?89YUF&<!\^P?,=V)Q)W$X OBTE4BPW%$-X!#N\5H\IOQ",D
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M/Z^0C 4D05V$L%72@NB\95HYHCA9=E41!Q"*5;74EJT^Q!YVQ<Q,Z*NKK+7
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M#Y]UC_-;G#]("^+D1*&6L'1Z^N3B2%A^,3+_ 9:;WBV\,$UC2OJX5A)L&#X
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M:. -F@?7Z72F] -G?#@74[Q!]65^)6GEM%:2-,>B2LL")$Z.!L?>P6FHY8W
M;8I/56<.&LE]63[HQ45R-'"U0YAAK+0%0<,CGF*6:4/DQM>ES4&[I5;LSAOK
M/QKLA.5>5'A:9G=IHF9'@^$ $IR(1::NRZ>?<8DGT/;B,JO,+SS5LCP:0+RH
M5)DOE<F#/"WJ43POX]!1&+H;%-A2@6VKP)<*W "M/3.PSH02XT-9/H'4TF1-
M3TQLC#:A20N=Q1LEZ6U*>FI\H\KX859F"4HX_[I(U0OL_BKN,ZSV#AU%&V@Q
M)UX:.ZF-L0W&.%R6A9I5<%XDF*S1/^W7]UB/ 8>0M?!8 ^^$]5J\%-(&[EG
M7,;6.=2O?H9QJ^[UN,/;:'-CS]\4;2K"9)$A?)Z B3Q\GALV'VLV4_#7Q;S7
MI*[R@VHN8CP:4!E7*!]Q,(:;F: %W!D68P+'CRBI*.'\&66<5@A7,HT1CJ=3
MB5.A$"X*)5.JS1AN1;; 5<UKU#TA+:9P2BF25'X+D<$OZ01A]S<4LMI;8JF
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MP8!69X-A."+.8Y<7'4R/&O72STA#GY6UM.T@Z7:[,7S93I\]O)WA7YA><FE
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M#,"U0,TO&9/?'7TFV5^0R7]02P,$%     @ -HG15,MURD,E!   80\  !D
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MG*X2]85O_H#2D!$8\42:7[(I8L/0(M%**IZ68%20LJSXIS_*1.P!D*<>X)4
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MDB\XP3=,DE6^RJB"% US+A3[0TT9M 6Z8@I+)E/%3P,<$>+WW*==]X^M@C#
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M[0RI+;0ELV5-B2)E(?@6":/6::9A]\:Z=36T,?_BLQ)ZEFJ?*N\;19H5G3%
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MWDS@Y'3AP=_N6'I!62[V>$L>"7O:WU-^II0LGA^2*/'C"%"RN9G<PFL'66E
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M<8V<]#(G79J3\TZHZR?BK/1.FVC._\0M&F6+AK3%[]EMA'C@]HU0?EL$IQ3
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M_^&)IK9I.HJ7=7FPX$H7&W4SU_4@B&J"?K_D7!TZU0*FPIS\!5!+ P04
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M0K XO]P "8%G ?+[%6/B>),-4)U%3OX#4$L#!!0    ( #:)T51N,+1NVP,
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MN"VVK#8@WP"JWK/P^2:#6U]EI NCA;:WF+9 WP TW7=6S;C,M%5*2Q)@6YU
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M-!<O8I5MU*X+:#>P#1TRSORNX4##'&&C+@'(U*&&;T2@2<>" />9K@L8WU[
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M62GLNA7,@--9VPD-TV# [&#0W!*Y-@[P'5R=Z43/[(G^35<A/C*S-0,ZZEN
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MYR)7!/+OSUE6[KZH ?8O\5W\%U!+ P04    "  VB=%4WMD27N<"  #Z"
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MYC-T]>EZY"J]BK%UX\KC0^G1;_$X@_@6!?@S\CT?6^33R^7>>[FK8ZL#].L
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MW#ZXMQ_%ZWTJWOP3./H-4$L#!!0    ( #:)T527BKL<P    !,"   +
M7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_
MK]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8ECVG.D4*NU"P>-8?2
M0$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^ KSI,<4)I2$LS#O#-
MTG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE?QW']I#3Z:]C(K1Z
M6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ -HG15"434V&C P
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MZ^)]5MZ(2(FC2"R..*]LA"/G)8G=00X">Q]B00FD2"P0NEOS&)-22)%8(>1
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M<',O87!P+GAM;%!+ 0(4 Q0    ( #:)T52QQ.,N[@   "L"   1
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M965T,BYX;6Q02P$"% ,4    "  VB=%4.&('V# #  !V#   &
M    @('S$0  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @
M-HG15! 3ED6@!0  N!<  !@              ("!614  'AL+W=O<FMS:&5E
M=',O<VAE970T+GAM;%!+ 0(4 Q0    ( #:)T52C +FQK0<  '\G   8
M          " @2\;  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4
M    "  VB=%4IH:($,@(  #/)0  &               @($2(P  >&PO=V]R
M:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ -HG15&R7RK7Y"0  WR
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M:&5E=#$Q+GAM;%!+ 0(4 Q0    ( #:)T53I__/1@ X  'Q    9
M      " @75;  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%
M  @ -HG15-E*S2AI!   A0L  !D              ("!+&H  'AL+W=O<FMS
M:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    "  VB=%4!'NR4(H$  "!#P
M&0              @(',;@  >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+
M 0(4 Q0    ( #:)T52U5S 4@08  *0/   9              " @8US  !X
M;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ -HG15$<1? A+
M @  104  !D              ("!17H  'AL+W=O<FMS:&5E=',O<VAE970Q
M-BYX;6Q02P$"% ,4    "  VB=%4_5E=!/<#  !I"0  &0
M@(''?   >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( #:)
MT52@X?S<IA0  *I:   9              " @?6   !X;"]W;W)K<VAE971S
M+W-H965T,3@N>&UL4$L! A0#%     @ -HG15 ) +I*= @  , <  !D
M         ("!TI4  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4
M    "  VB=%4V]\))%@#  !E"0  &0              @(&FF   >&PO=V]R
M:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( #:)T52YP5:XM00  %(1
M   9              " @36<  !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL
M4$L! A0#%     @ -HG15%V/0WFS P  J @  !D              ("!(:$
M 'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    "  VB=%4N3_D
M0M$"  "=!@  &0              @($+I0  >&PO=V]R:W-H965T<R]S:&5E
M=#(S+GAM;%!+ 0(4 Q0    ( #:)T53',1V+>@,  !4+   9
M  " @1.H  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @
M-HG15).0 <*  P  Q H  !D              ("!Q*L  'AL+W=O<FMS:&5E
M=',O<VAE970R-2YX;6Q02P$"% ,4    "  VB=%4TN?G"<H"  "."   &0
M            @(%[KP  >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4
M Q0    ( #:)T53+=<I#)00  &$/   9              " @7RR  !X;"]W
M;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ -HG15'?6V:1; P
MCPP  !D              ("!V+8  'AL+W=O<FMS:&5E=',O<VAE970R."YX
M;6Q02P$"% ,4    "  VB=%4(I3F)'@"  #@!P  &0              @(%J
MN@  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( #:)T51P
MC=5QE@(  "T'   9              " @1F]  !X;"]W;W)K<VAE971S+W-H
M965T,S N>&UL4$L! A0#%     @ -HG15*NOV?A1!0  +AH  !D
M     ("!YK\  'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( #:)T53>V1)>YP(  /H(   9              "
M@2?<  !X;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @ -HG1
M5#&1@XXZ P  - L  !D              ("!1=\  'AL+W=O<FMS:&5E=',O
M<VAE970S-RYX;6Q02P$"% ,4    "  VB=%4 P*;;*\"  #O"   &0
M        @(&VX@  >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0
M   ( #:)T51QAY5K^ $  /,#   9              " @9SE  !X;"]W;W)K
M<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ -HG15%=3N2CY 0  X00
M !D              ("!R^<  'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q0
M2P$"% ,4    "  VB=%4 LH.5.8!  #; P  &0              @('[Z0
M>&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( #:)T5033W'K
M-@,  !84   -              "  1CL  !X;"]S='EL97,N>&UL4$L! A0#
M%     @ -HG15)>*NQS     $P(   L              ( !>>\  %]R96QS
M+RYR96QS4$L! A0#%     @ -HG15"434V&C P  J1L   \
M ( !8O   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( #:)T50I78B@DP$
M .(8   :              "  3+T  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN
M<F5L<U!+ 0(4 Q0    ( #:)T52(C*DWI0$  "\9   3              "
M ?WU  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     Q #$ 3@T  -/W
!  $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>104</ContextCount>
  <ElementCount>256</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>19</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="scwo_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://powerverdeinc.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="scwo_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>000002 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="scwo_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="scwo_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>000004 - Statement - Condensed Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations</Role>
      <ShortName>Condensed Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="scwo_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>000005 - Statement - Condensed Consolidated Changes in Stockholders' Deficit</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://powerverdeinc.com/role/CondensedConsolidatedChangesInStockholdersDeficit</Role>
      <ShortName>Condensed Consolidated Changes in Stockholders' Deficit</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="scwo_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="scwo_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>000007 - Disclosure - Nature of Business and Presentation of Financial Statements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://powerverdeinc.com/role/NatureOfBusinessAndPresentationOfFinancialStatements</Role>
      <ShortName>Nature of Business and Presentation of Financial Statements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="scwo_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>000008 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://powerverdeinc.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="scwo_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>000009 - Disclosure - Liquidity Capital Resources and Going Concern</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://powerverdeinc.com/role/LiquidityCapitalResourcesAndGoingConcern</Role>
      <ShortName>Liquidity Capital Resources and Going Concern</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="scwo_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>000010 - Disclosure - Acquisition of 374Water Inc fka PowerVerde Inc</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeInc</Role>
      <ShortName>Acquisition of 374Water Inc fka PowerVerde Inc</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="scwo_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>000011 - Disclosure - Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://powerverdeinc.com/role/IntangibleAssets</Role>
      <ShortName>Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="scwo_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>000012 - Disclosure - Stockholder Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://powerverdeinc.com/role/StockholderEquity</Role>
      <ShortName>Stockholder Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="scwo_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>000013 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://powerverdeinc.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="scwo_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>000014 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://powerverdeinc.com/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="scwo_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>000015 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://powerverdeinc.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="scwo_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>000016 - Disclosure - Deferred Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://powerverdeinc.com/role/DeferredRevenue</Role>
      <ShortName>Deferred Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="scwo_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>000017 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://powerverdeinc.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="scwo_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>000018 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://powerverdeinc.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="scwo_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>000019 - Disclosure - Acquisition of 374Water Inc fka PowerVerde Inc (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncTables</Role>
      <ShortName>Acquisition of 374Water Inc fka PowerVerde Inc (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeInc</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="scwo_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>000020 - Disclosure - Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://powerverdeinc.com/role/IntangibleAssetsTables</Role>
      <ShortName>Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://powerverdeinc.com/role/IntangibleAssets</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="scwo_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>000021 - Disclosure - Stockholder Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://powerverdeinc.com/role/StockholderEquityTables</Role>
      <ShortName>Stockholder Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://powerverdeinc.com/role/StockholderEquity</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="scwo_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>000022 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://powerverdeinc.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://powerverdeinc.com/role/IncomeTaxes</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="scwo_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>000023 - Disclosure - Nature of Business and Presentation of Financial Statements (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://powerverdeinc.com/role/NatureOfBusinessAndPresentationOfFinancialStatementsDetailsNarrative</Role>
      <ShortName>Nature of Business and Presentation of Financial Statements (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://powerverdeinc.com/role/NatureOfBusinessAndPresentationOfFinancialStatements</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="scwo_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>000024 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>Summary of Significant Accounting Policies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="scwo_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>000025 - Disclosure - Liquidity Capital Resources and Going Concern (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://powerverdeinc.com/role/LiquidityCapitalResourcesAndGoingConcernDetailsNarrative</Role>
      <ShortName>Liquidity Capital Resources and Going Concern (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://powerverdeinc.com/role/LiquidityCapitalResourcesAndGoingConcern</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="scwo_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>000026 - Disclosure - Acquisition of 374Water Inc fka PowerVerde Inc (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetails</Role>
      <ShortName>Acquisition of 374Water Inc fka PowerVerde Inc (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncTables</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="scwo_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>000027 - Disclosure - Acquisition of 374Water Inc fka PowerVerde Inc (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetailsNarrative</Role>
      <ShortName>Acquisition of 374Water Inc fka PowerVerde Inc (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncTables</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="scwo_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>000028 - Disclosure - Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://powerverdeinc.com/role/IntangibleAssetsDetails</Role>
      <ShortName>Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://powerverdeinc.com/role/IntangibleAssetsTables</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="scwo_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>000029 - Disclosure - Intangible Assets (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://powerverdeinc.com/role/IntangibleAssetsDetails1</Role>
      <ShortName>Intangible Assets (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://powerverdeinc.com/role/IntangibleAssetsTables</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="scwo_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>000030 - Disclosure - Intangible Assets (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://powerverdeinc.com/role/IntangibleAssetsDetailsNarrative</Role>
      <ShortName>Intangible Assets (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://powerverdeinc.com/role/IntangibleAssetsTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="scwo_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>000031 - Disclosure - Stockholder Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://powerverdeinc.com/role/StockholderEquityDetails</Role>
      <ShortName>Stockholder Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://powerverdeinc.com/role/StockholderEquityTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="scwo_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>000032 - Disclosure - Stockholder Equity (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://powerverdeinc.com/role/StockholderEquityDetails1</Role>
      <ShortName>Stockholder Equity (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://powerverdeinc.com/role/StockholderEquityTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="scwo_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>000033 - Disclosure - Stockholder Equity (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://powerverdeinc.com/role/StockholderEquityDetails2</Role>
      <ShortName>Stockholder Equity (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://powerverdeinc.com/role/StockholderEquityTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="scwo_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>000034 - Disclosure - Stockholder Equity (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://powerverdeinc.com/role/StockholderEquityDetails3</Role>
      <ShortName>Stockholder Equity (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://powerverdeinc.com/role/StockholderEquityTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="scwo_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>000035 - Disclosure - Stockholder Equity (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://powerverdeinc.com/role/StockholderEquityDetailsNarrative</Role>
      <ShortName>Stockholder Equity (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://powerverdeinc.com/role/StockholderEquityTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="scwo_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>000036 - Disclosure - Related Party Transactions (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://powerverdeinc.com/role/RelatedPartyTransactionsDetailsNarrative</Role>
      <ShortName>Related Party Transactions (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://powerverdeinc.com/role/RelatedPartyTransactions</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="scwo_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>000037 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://powerverdeinc.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://powerverdeinc.com/role/IncomeTaxesTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="scwo_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>000038 - Disclosure - Income Taxes (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://powerverdeinc.com/role/IncomeTaxesDetails1</Role>
      <ShortName>Income Taxes (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://powerverdeinc.com/role/IncomeTaxesTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="scwo_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>000039 - Disclosure - Income Taxes (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://powerverdeinc.com/role/IncomeTaxesDetailsNarrative</Role>
      <ShortName>Income Taxes (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://powerverdeinc.com/role/IncomeTaxesTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="scwo_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>000040 - Disclosure - Deferred Revenue (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://powerverdeinc.com/role/DeferredRevenueDetailsNarrative</Role>
      <ShortName>Deferred Revenue (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://powerverdeinc.com/role/DeferredRevenue</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="scwo_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>000041 - Disclosure - Subsequent Events (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://powerverdeinc.com/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>Subsequent Events (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://powerverdeinc.com/role/SubsequentEvents</ParentRole>
      <Position>41</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="S-1" original="scwo_s1.htm">scwo_s1.htm</File>
    <File>scwo-20220331.xsd</File>
    <File>scwo-20220331_cal.xml</File>
    <File>scwo-20220331_def.xml</File>
    <File>scwo-20220331_lab.xml</File>
    <File>scwo-20220331_pre.xml</File>
    <File>scwo_ex107.htm</File>
    <File>scwo_ex231.htm</File>
    <File>scwo_ex232.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>pwvi_s1img4.jpg</File>
    <File>pwvi_s1img5.jpg</File>
    <File>pwvi_s1img6.jpg</File>
    <File>scwo_s1img10.jpg</File>
    <File>scwo_s1img11.jpg</File>
    <File>scwo_s1img12.jpg</File>
    <File>scwo_s1img13.jpg</File>
    <File>scwo_s1img7.jpg</File>
    <File>scwo_s1img8.jpg</File>
    <File>scwo_s1img9.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="643">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="17">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>71
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "scwo_s1.htm": {
   "axisCustom": 0,
   "axisStandard": 11,
   "contextCount": 104,
   "dts": {
    "calculationLink": {
     "local": [
      "scwo-20220331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "scwo-20220331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "scwo_s1.htm"
     ]
    },
    "labelLink": {
     "local": [
      "scwo-20220331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "scwo-20220331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "scwo-20220331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd",
      "https://xbrl.sec.gov/exch/2021/exch-2021.xsd",
      "https://xbrl.sec.gov/naics/2021/naics-2021.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd",
      "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"
     ]
    }
   },
   "elementCount": 335,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 37,
    "http://powerverdeinc.com/20220331": 9,
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 48
   },
   "keyCustom": 59,
   "keyStandard": 197,
   "memberCustom": 10,
   "memberStandard": 9,
   "nsprefix": "scwo",
   "nsuri": "http://powerverdeinc.com/20220331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "strong",
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000001 - Document - Cover",
     "role": "http://powerverdeinc.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "strong",
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "000010 - Disclosure - Acquisition of 374Water Inc fka PowerVerde Inc",
     "role": "http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeInc",
     "shortName": "Acquisition of 374Water Inc fka PowerVerde Inc",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "000011 - Disclosure - Intangible Assets",
     "role": "http://powerverdeinc.com/role/IntangibleAssets",
     "shortName": "Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "000012 - Disclosure - Stockholder Equity",
     "role": "http://powerverdeinc.com/role/StockholderEquity",
     "shortName": "Stockholder Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "000013 - Disclosure - Related Party Transactions",
     "role": "http://powerverdeinc.com/role/RelatedPartyTransactions",
     "shortName": "Related Party Transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "000014 - Disclosure - Commitments and Contingencies",
     "role": "http://powerverdeinc.com/role/CommitmentsAndContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "000015 - Disclosure - Income Taxes",
     "role": "http://powerverdeinc.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredRevenueDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "000016 - Disclosure - Deferred Revenue",
     "role": "http://powerverdeinc.com/role/DeferredRevenue",
     "shortName": "Deferred Revenue",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredRevenueDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "000017 - Disclosure - Subsequent Events",
     "role": "http://powerverdeinc.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "000018 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "000019 - Disclosure - Acquisition of 374Water Inc fka PowerVerde Inc (Tables)",
     "role": "http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncTables",
     "shortName": "Acquisition of 374Water Inc fka PowerVerde Inc (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Cash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "000002 - Statement - Condensed Consolidated Balance Sheets",
     "role": "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Cash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "000020 - Disclosure - Intangible Assets (Tables)",
     "role": "http://powerverdeinc.com/role/IntangibleAssetsTables",
     "shortName": "Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "000021 - Disclosure - Stockholder Equity (Tables)",
     "role": "http://powerverdeinc.com/role/StockholderEquityTables",
     "shortName": "Stockholder Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "000022 - Disclosure - Income Taxes (Tables)",
     "role": "http://powerverdeinc.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "AsOf2021-04-16",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "scwo:SharesIssuedToFormerHolder",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "000023 - Disclosure - Nature of Business and Presentation of Financial Statements (Details Narrative)",
     "role": "http://powerverdeinc.com/role/NatureOfBusinessAndPresentationOfFinancialStatementsDetailsNarrative",
     "shortName": "Nature of Business and Presentation of Financial Statements (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "AsOf2021-04-16",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "scwo:SharesIssuedToFormerHolder",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "scwo:EquipmentPolicy",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "000024 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)",
     "role": "http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
     "shortName": "Summary of Significant Accounting Policies (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "scwo:EquipmentPolicy",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:RetainedEarningsAccumulatedDeficit",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "000025 - Disclosure - Liquidity Capital Resources and Going Concern (Details Narrative)",
     "role": "http://powerverdeinc.com/role/LiquidityCapitalResourcesAndGoingConcernDetailsNarrative",
     "shortName": "Liquidity Capital Resources and Going Concern (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:NetCashProvidedByUsedInContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "AsOf2022-03-31_scwo_ThreeSevenFourWaterMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "000026 - Disclosure - Acquisition of 374Water Inc fka PowerVerde Inc (Details)",
     "role": "http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetails",
     "shortName": "Acquisition of 374Water Inc fka PowerVerde Inc (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "AsOf2022-03-31_scwo_ThreeSevenFourWaterMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "000027 - Disclosure - Acquisition of 374Water Inc fka PowerVerde Inc (Details Narrative)",
     "role": "http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetailsNarrative",
     "shortName": "Acquisition of 374Water Inc fka PowerVerde Inc (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31_srt_ChiefExecutiveOfficerMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:SalariesAndWages",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "000028 - Disclosure - Intangible Assets (Details)",
     "role": "http://powerverdeinc.com/role/IntangibleAssetsDetails",
     "shortName": "Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "000029 - Disclosure - Intangible Assets (Details 1)",
     "role": "http://powerverdeinc.com/role/IntangibleAssetsDetails1",
     "shortName": "Intangible Assets (Details 1)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "role": "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AdjustmentForAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "000030 - Disclosure - Intangible Assets (Details Narrative)",
     "role": "http://powerverdeinc.com/role/IntangibleAssetsDetailsNarrative",
     "shortName": "Intangible Assets (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AdjustmentForAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ConversionOfStockSharesConverted1",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "000031 - Disclosure - Stockholder Equity (Details)",
     "role": "http://powerverdeinc.com/role/StockholderEquityDetails",
     "shortName": "Stockholder Equity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31_scwo_OptionsMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31_scwo_OptionsMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "000032 - Disclosure - Stockholder Equity (Details 1)",
     "role": "http://powerverdeinc.com/role/StockholderEquityDetails1",
     "shortName": "Stockholder Equity (Details 1)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31_scwo_OptionsMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "000033 - Disclosure - Stockholder Equity (Details 2)",
     "role": "http://powerverdeinc.com/role/StockholderEquityDetails2",
     "shortName": "Stockholder Equity (Details 2)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2021-01-01to2021-12-31_scwo_WarrantsMember",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "000034 - Disclosure - Stockholder Equity (Details 3)",
     "role": "http://powerverdeinc.com/role/StockholderEquityDetails3",
     "shortName": "Stockholder Equity (Details 3)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "000035 - Disclosure - Stockholder Equity (Details Narrative)",
     "role": "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative",
     "shortName": "Stockholder Equity (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "lang": null,
      "name": "scwo:StockIssuedUponWarrantExercised",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:RelatedPartyCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "000036 - Disclosure - Related Party Transactions (Details Narrative)",
     "role": "http://powerverdeinc.com/role/RelatedPartyTransactionsDetailsNarrative",
     "shortName": "Related Party Transactions (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:RelatedPartyCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "000037 - Disclosure - Income Taxes (Details)",
     "role": "http://powerverdeinc.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "000038 - Disclosure - Income Taxes (Details 1)",
     "role": "http://powerverdeinc.com/role/IncomeTaxesDetails1",
     "shortName": "Income Taxes (Details 1)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2020-01-01to2020-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "000039 - Disclosure - Income Taxes (Details Narrative)",
     "role": "http://powerverdeinc.com/role/IncomeTaxesDetailsNarrative",
     "shortName": "Income Taxes (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "000004 - Statement - Condensed Consolidated Statements of Operations",
     "role": "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations",
     "shortName": "Condensed Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:DeferredRevenueDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredRevenueCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "000040 - Disclosure - Deferred Revenue (Details Narrative)",
     "role": "http://powerverdeinc.com/role/DeferredRevenueDetailsNarrative",
     "shortName": "Deferred Revenue (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:DeferredRevenueDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredRevenueCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "AsOf2022-04-13_us-gaap_SubsequentEventMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "000041 - Disclosure - Subsequent Events (Details Narrative)",
     "role": "http://powerverdeinc.com/role/SubsequentEventsDetailsNarrative",
     "shortName": "Subsequent Events (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "AsOf2022-04-13_us-gaap_SubsequentEventMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "AsOf2019-12-31_us-gaap_CommonStockMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "000005 - Statement - Condensed Consolidated Changes in Stockholders' Deficit",
     "role": "http://powerverdeinc.com/role/CondensedConsolidatedChangesInStockholdersDeficit",
     "shortName": "Condensed Consolidated Changes in Stockholders' Deficit",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "AsOf2019-12-31_us-gaap_CommonStockMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "role": "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited",
     "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:DepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "000007 - Disclosure - Nature of Business and Presentation of Financial Statements",
     "role": "http://powerverdeinc.com/role/NatureOfBusinessAndPresentationOfFinancialStatements",
     "shortName": "Nature of Business and Presentation of Financial Statements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "000008 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://powerverdeinc.com/role/SummaryOfSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "000009 - Disclosure - Liquidity Capital Resources and Going Concern",
     "role": "http://powerverdeinc.com/role/LiquidityCapitalResourcesAndGoingConcern",
     "shortName": "Liquidity Capital Resources and Going Concern",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "scwo_s1.htm",
      "contextRef": "From2022-01-01to2022-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 19,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://powerverdeinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://powerverdeinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://powerverdeinc.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address Address Line 1"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://powerverdeinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address Address Line 2"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://powerverdeinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address City Or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://powerverdeinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://powerverdeinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address State Or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://powerverdeinc.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://powerverdeinc.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://powerverdeinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://powerverdeinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://powerverdeinc.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://powerverdeinc.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://powerverdeinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://powerverdeinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://powerverdeinc.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://powerverdeinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "scwo_AccountsPayableSettledWithStockOption": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable settled with Series D Preferred Stock"
       }
      }
     },
     "localname": "AccountsPayableSettledWithStockOption",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "scwo_AccretionOfStockBasedCompensation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accretion of stock-based"
       }
      }
     },
     "localname": "AccretionOfStockBasedCompensation",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedChangesInStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "scwo_AdjustmentForCommonStockIssuedForServices": {
     "auth_ref": [],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock issued for services"
       }
      }
     },
     "localname": "AdjustmentForCommonStockIssuedForServices",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "scwo_AdvancesFromStockholders": {
     "auth_ref": [],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 13.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Advances from stockholders",
        "verboseLabel": "Advances from stockholders"
       }
      }
     },
     "localname": "AdvancesFromStockholders",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets",
      "http://powerverdeinc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "scwo_AggregateFairValueOfWarrant": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate fair value of warrant"
       }
      }
     },
     "localname": "AggregateFairValueOfWarrant",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "scwo_AnnaulSalaryIncreasedAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Annaul Salary Increased Amount"
       }
      }
     },
     "localname": "AnnaulSalaryIncreasedAmount",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "scwo_AwardIncome": {
     "auth_ref": [],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 13.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award income"
       }
      }
     },
     "localname": "AwardIncome",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "scwo_CommonStockSharesIssuesForCash": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock shares issues for cash"
       }
      }
     },
     "localname": "CommonStockSharesIssuesForCash",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "scwo_ConsultantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consultant [Member]"
       }
      }
     },
     "localname": "ConsultantMember",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "scwo_ConversionOfConvertiblePreferredSharesIntoCommonStockAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of convertible preferred shares into common stock, amount"
       }
      }
     },
     "localname": "ConversionOfConvertiblePreferredSharesIntoCommonStockAmount",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedChangesInStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "scwo_ConversionOfConvertiblePreferredSharesIntoCommonStockShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of convertible preferred shares into common stock, shares"
       }
      }
     },
     "localname": "ConversionOfConvertiblePreferredSharesIntoCommonStockShares",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedChangesInStockholdersDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "scwo_ConversionOfStockAmountIssued": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion Of Preferred Stock To Common Stock"
       }
      }
     },
     "localname": "ConversionOfStockAmountIssued",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "scwo_DeferredIncomeTaxAssetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes (Details)"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetAbstract",
     "nsuri": "http://powerverdeinc.com/20220331",
     "xbrltype": "stringItemType"
    },
    "scwo_DeferredRevenuePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Revenue Percentage"
       }
      }
     },
     "localname": "DeferredRevenuePercentage",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/DeferredRevenueDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "scwo_DeferredTaxAssetsStartupCost": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Start-up cost"
       }
      }
     },
     "localname": "DeferredTaxAssetsStartupCost",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "scwo_Description": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description Issuance Of The Preferred Stock"
       }
      }
     },
     "localname": "Description",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "scwo_EquipmentPolicy": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equipment"
       }
      }
     },
     "localname": "EquipmentPolicy",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "scwo_ExercisedOptionAndWarrantsAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercised. Option and Warrants, amount"
       }
      }
     },
     "localname": "ExercisedOptionAndWarrantsAmount",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedChangesInStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "scwo_ExercisedOptionAndWarrantsShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercised. Option and Warrants, shares"
       }
      }
     },
     "localname": "ExercisedOptionAndWarrantsShares",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedChangesInStockholdersDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "scwo_IncomeTaxRateReconciliationChangeInStateTax": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in State Tax"
       }
      }
     },
     "localname": "IncomeTaxRateReconciliationChangeInStateTax",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/IncomeTaxesDetails1"
     ],
     "xbrltype": "percentItemType"
    },
    "scwo_IncomeTaxReconciliationChangeInValuationAllowance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Valuation Allowance"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInValuationAllowance",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/IncomeTaxesDetails1"
     ],
     "xbrltype": "percentItemType"
    },
    "scwo_IncomeTaxReconciliationOther": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOther",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/IncomeTaxesDetails1"
     ],
     "xbrltype": "percentItemType"
    },
    "scwo_IncomeTaxReconciliationPermanentDifferences": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Permanent Differences"
       }
      }
     },
     "localname": "IncomeTaxReconciliationPermanentDifferences",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/IncomeTaxesDetails1"
     ],
     "xbrltype": "percentItemType"
    },
    "scwo_IncomeTaxReconciliationStateTaxes": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "State Tax"
       }
      }
     },
     "localname": "IncomeTaxReconciliationStateTaxes",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/IncomeTaxesDetails1"
     ],
     "xbrltype": "percentItemType"
    },
    "scwo_IncomeTaxesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes (Tables)"
       }
      }
     },
     "localname": "IncomeTaxesAbstract",
     "nsuri": "http://powerverdeinc.com/20220331",
     "xbrltype": "stringItemType"
    },
    "scwo_IntangibleAssetsAdditions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets Additions"
       }
      }
     },
     "localname": "IntangibleAssetsAdditions",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/IntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "scwo_IssuanceOfCommonStockForLicenseRights": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock for license rights"
       }
      }
     },
     "localname": "IssuanceOfCommonStockForLicenseRights",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "scwo_IssuanceOfCommonStockForLicenseRightsAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock for license rights, amount"
       }
      }
     },
     "localname": "IssuanceOfCommonStockForLicenseRightsAmount",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedChangesInStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "scwo_IssuanceOfCommonStockForLicenseRightsShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock for license rights, shares"
       }
      }
     },
     "localname": "IssuanceOfCommonStockForLicenseRightsShares",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedChangesInStockholdersDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "scwo_IssuanceOfStockWarrantsForDevelopmentOfProduct": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of stock warrants for development of product"
       }
      }
     },
     "localname": "IssuanceOfStockWarrantsForDevelopmentOfProduct",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedChangesInStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "scwo_LiabilityForPreferredStockShares": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability For Preferred Stock Shares"
       }
      }
     },
     "localname": "LiabilityForPreferredStockShares",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "scwo_LicenseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "License Agreement [Member]"
       }
      }
     },
     "localname": "LicenseAgreementMember",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/IntangibleAssetsDetails",
      "http://powerverdeinc.com/role/IntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "scwo_LongLivedAssetsPolicy": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Assets"
       }
      }
     },
     "localname": "LongLivedAssetsPolicy",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "scwo_MaximumsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "verboseLabel": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumsMember",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetails1",
      "http://powerverdeinc.com/role/StockholderEquityDetails2"
     ],
     "xbrltype": "domainItemType"
    },
    "scwo_MergerEffectDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Merger effect description"
       }
      }
     },
     "localname": "MergerEffectDescription",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/NatureOfBusinessAndPresentationOfFinancialStatementsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "scwo_MinimumsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "verboseLabel": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumsMember",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetails1",
      "http://powerverdeinc.com/role/StockholderEquityDetails2"
     ],
     "xbrltype": "domainItemType"
    },
    "scwo_MrNagarMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mr Nagar"
       }
      }
     },
     "localname": "MrNagarMember",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "scwo_NetCashProvidedByUsedInOperatingActivity": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Net cash used in operations"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivity",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/LiquidityCapitalResourcesAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "scwo_NetLiabilitiesAssumedInReverseAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Liabilities Assumed in Reverse Acquisition:"
       }
      }
     },
     "localname": "NetLiabilitiesAssumedInReverseAcquisitionAbstract",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "scwo_NetLiabilitiesAssumedInReverseAcquisitioncash": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "[Cash]",
        "verboseLabel": "Cash"
       }
      }
     },
     "localname": "NetLiabilitiesAssumedInReverseAcquisitioncash",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "scwo_NetLiabilityAssumed": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Net liability assumed"
       }
      }
     },
     "localname": "NetLiabilityAssumed",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "scwo_NetLossPerShareBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Loss Per Share - Basic And Diluted"
       }
      }
     },
     "localname": "NetLossPerShareBasicAndDiluted",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "scwo_NumberOfWarrantPurchase": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of warrant purchase"
       }
      }
     },
     "localname": "NumberOfWarrantPurchase",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "scwo_OptionUnvestedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options Unvested"
       }
      }
     },
     "localname": "OptionUnvestedMember",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "scwo_OptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options [Member]",
        "verboseLabel": "Options [Member]"
       }
      }
     },
     "localname": "OptionsMember",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetails",
      "http://powerverdeinc.com/role/StockholderEquityDetails1",
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "scwo_OtherAccruals": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Accruals"
       }
      }
     },
     "localname": "OtherAccruals",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "scwo_OtherIntangibles": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Intangibles"
       }
      }
     },
     "localname": "OtherIntangibles",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "scwo_PreferredStockParValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "[Preferred Stock Value Per Share]",
        "verboseLabel": "Preferred Stock Value Per Share"
       }
      }
     },
     "localname": "PreferredStockParValue",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "scwo_PreferredStockStatedValuePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Stated Value Per Share"
       }
      }
     },
     "localname": "PreferredStockStatedValuePerShare",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "scwo_Preferredstockparorstatedvaluepershare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, par value"
       }
      }
     },
     "localname": "Preferredstockparorstatedvaluepershare",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "scwo_ProceedsFromReverseAcquisition": {
     "auth_ref": [],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from reverse acquisition"
       }
      }
     },
     "localname": "ProceedsFromReverseAcquisition",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "scwo_ProceedsFromStockIssuedUponWarrantsExercisedAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds From Stock Issued Upon Warrants Exercised"
       }
      }
     },
     "localname": "ProceedsFromStockIssuedUponWarrantsExercisedAmount",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "scwo_RateReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes (Details 1)"
       }
      }
     },
     "localname": "RateReconciliationAbstract",
     "nsuri": "http://powerverdeinc.com/20220331",
     "xbrltype": "stringItemType"
    },
    "scwo_RecapitalizationOfTheCompanyAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recapitalization of the Company, amount"
       }
      }
     },
     "localname": "RecapitalizationOfTheCompanyAmount",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedChangesInStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "scwo_RecapitalizationOfTheCompanyShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recapitalization of the Company, shares"
       }
      }
     },
     "localname": "RecapitalizationOfTheCompanyShares",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedChangesInStockholdersDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "scwo_RevenueRecognitionAndConcentrationPolicy": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Recognition and Concentration"
       }
      }
     },
     "localname": "RevenueRecognitionAndConcentrationPolicy",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "scwo_SeriesDPreferredStockIssuedForCashAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Series D Preferred Stock issued for cash, amount"
       }
      }
     },
     "localname": "SeriesDPreferredStockIssuedForCashAmount",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedChangesInStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "scwo_SeriesDPreferredStockIssuedForCashShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series D Preferred Stock issued for cash, shares"
       }
      }
     },
     "localname": "SeriesDPreferredStockIssuedForCashShares",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedChangesInStockholdersDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "scwo_SettlementOfLiabilityForPreferredStockShares": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Settlement Of Liability For Preferred Stock Shares"
       }
      }
     },
     "localname": "SettlementOfLiabilityForPreferredStockShares",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "scwo_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price, Expired/forfeit"
       }
      }
     },
     "localname": "Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "scwo_Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price, Exercised"
       }
      }
     },
     "localname": "Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "scwo_Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price, Granted"
       }
      }
     },
     "localname": "Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "scwo_SharesIssuedToFormerHolder": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued to former holder"
       }
      }
     },
     "localname": "SharesIssuedToFormerHolder",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/NatureOfBusinessAndPresentationOfFinancialStatementsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "scwo_StockInExcessPercentageOfOutstandingShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock In Excess Percentage Of Outstanding Share"
       }
      }
     },
     "localname": "StockInExcessPercentageOfOutstandingShare",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "scwo_StockIssuedUponWarrantExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued Upon Warrant Exercised"
       }
      }
     },
     "localname": "StockIssuedUponWarrantExercised",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "scwo_ThreeSevenFourWaterMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "374Water, Inc. [Member]"
       }
      }
     },
     "localname": "ThreeSevenFourWaterMember",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetails",
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "scwo_ThreeSeverFourWaterFormerStockholdersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "374Water Former Stockholders [Member]"
       }
      }
     },
     "localname": "ThreeSeverFourWaterFormerStockholdersMember",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "scwo_WarrantIssuedForProductDevelopmentAgreement": {
     "auth_ref": [],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant issued for product development agreement"
       }
      }
     },
     "localname": "WarrantIssuedForProductDevelopmentAgreement",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "scwo_WarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant [Member]",
        "verboseLabel": "Warrant [Member]"
       }
      }
     },
     "localname": "WarrantsMember",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetails2",
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative",
      "http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "scwo_WarrantsOutstandingSeriesOneShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Outstanding Series 1"
       }
      }
     },
     "localname": "WarrantsOutstandingSeriesOneShares",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "scwo_WeightedAverageCommonSharesOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Common Shares Outstanding - Basic And Diluted"
       }
      }
     },
     "localname": "WeightedAverageCommonSharesOutstandingBasicAndDiluted",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    },
    "scwo_WeightedAverageExercisePriceExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price Exercised",
        "verboseLabel": "Weighted Average Exercise Price Exercised"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceExercised",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetails2",
      "http://powerverdeinc.com/role/StockholderEquityDetails3"
     ],
     "xbrltype": "perShareItemType"
    },
    "scwo_WorkingCapital": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Working capital"
       }
      }
     },
     "localname": "WorkingCapital",
     "nsuri": "http://powerverdeinc.com/20220331",
     "presentation": [
      "http://powerverdeinc.com/role/LiquidityCapitalResourcesAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "srt_ChiefExecutiveOfficerMember": {
     "auth_ref": [
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CEO [Member]"
       }
      }
     },
     "localname": "ChiefExecutiveOfficerMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r30"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 11.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts Payable And Accrued Expenses"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNet": {
     "auth_ref": [
      "r21",
      "r379",
      "r399"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.",
        "label": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableSale": {
     "auth_ref": [
      "r144"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease from sale of accounts receivable.",
        "label": "[Accounts Receivable, Sale]",
        "verboseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableSale",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionExpense": {
     "auth_ref": [
      "r171",
      "r172",
      "r173"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations.",
        "label": "Accretion Of Stock-based Compensation"
       }
      }
     },
     "localname": "AccretionExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedChangesInStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r22",
      "r243",
      "r315"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 16.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r78",
      "r79",
      "r80",
      "r240",
      "r241",
      "r242",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedChangesInStockholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r62",
      "r165"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization Of Intangible Assets"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/IntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments To Reconcile Net Income (loss) To Net Cash Provided By (used In) Operating Activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r27",
      "r131",
      "r143"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Excluded From Computation Of Earnings Per Share, Shares"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetails",
      "http://powerverdeinc.com/role/StockholderEquityDetails1",
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetails",
      "http://powerverdeinc.com/role/StockholderEquityDetails1",
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r73",
      "r115",
      "r118",
      "r124",
      "r141",
      "r179",
      "r180",
      "r181",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r190",
      "r191",
      "r281",
      "r285",
      "r297",
      "r313",
      "r315",
      "r371",
      "r381"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "[Assets]",
        "totalLabel": "Total Assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r6",
      "r8",
      "r35",
      "r73",
      "r141",
      "r179",
      "r180",
      "r181",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r190",
      "r191",
      "r281",
      "r285",
      "r297",
      "r313",
      "r315"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "[Assets, Current]",
        "totalLabel": "Total Current Assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsNoncurrent": {
     "auth_ref": [
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r73",
      "r141",
      "r179",
      "r180",
      "r181",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r190",
      "r191",
      "r281",
      "r285",
      "r297",
      "r313"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 9.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.",
        "label": "[Assets, Noncurrent]",
        "totalLabel": "Total Long-term Assets"
       }
      }
     },
     "localname": "AssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Assets:"
       }
      }
     },
     "localname": "AssetsNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r218",
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetails2",
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative",
      "http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r77"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Summary Of Significant Accounting Policies"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/SummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r215",
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetails",
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r215",
      "r216",
      "r274",
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetails",
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Acquisition of 374Water, Inc. f/k/a PowerVerde Inc."
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeInc"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": {
     "auth_ref": [
      "r277"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets acquired at the acquisition date.",
        "label": "Total assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r277"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "[Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents]",
        "verboseLabel": "Cash"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability": {
     "auth_ref": [
      "r276",
      "r277"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of liability arising from an inherited contingency (as defined) which has been recognized as of the acquisition date.",
        "label": "[Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability]",
        "verboseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "auth_ref": [
      "r277"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "[Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets]",
        "verboseLabel": "Prepaid expense"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r277"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "[Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables]",
        "verboseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r277"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "[Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable]",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r277"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Total liabilities assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r276",
      "r277"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Net liabilities assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquisition of 374Water Inc fka PowerVerde Inc"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_Cash": {
     "auth_ref": [
      "r29",
      "r315",
      "r395",
      "r396"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash"
       }
      }
     },
     "localname": "Cash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r4",
      "r29",
      "r64"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "[Cash and Cash Equivalents, at Carrying Value]",
        "periodEndLabel": "Cash - End Of The Period",
        "periodStartLabel": "Cash - Beginning Of The Period"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r9",
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "auth_ref": [
      "r58",
      "r298"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "[Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect]",
        "totalLabel": "Net Increase in Cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r29"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash equivalents"
       }
      }
     },
     "localname": "CashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NON-CASH INVESTING AND FINANCING ACTIVITIES:"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r71",
      "r73",
      "r90",
      "r91",
      "r92",
      "r94",
      "r95",
      "r99",
      "r100",
      "r101",
      "r141",
      "r179",
      "r184",
      "r185",
      "r186",
      "r190",
      "r191",
      "r193",
      "r194",
      "r197",
      "r201",
      "r297",
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetailsNarrative",
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "auth_ref": [
      "r212",
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of warrant or right issued.",
        "label": "Class of Warrant or Right [Axis]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "localname": "ClassOfWarrantOrRightDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and contingencies (Note 8)"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r175",
      "r176",
      "r177",
      "r178",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments And Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r33"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Shares Of Common Stock Reserve For Issuance"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r78",
      "r79",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedChangesInStockholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockNoParValue": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount per share of no-par value common stock.",
        "label": "common stock price"
       }
      }
     },
     "localname": "CommonStockNoParValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par Value",
        "verboseLabel": "Common Stock Value Per Share"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "verboseLabel": "Common Stock, Shares Authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares Issued",
        "verboseLabel": "Common stock, shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r20",
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares Outstanding",
        "verboseLabel": "Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r20",
      "r315"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 17.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock: 200,000,000 Common Shares Authorized, Par Value $0.0001 Per Share, 126,680,895 And 125,317,746 Shares Outstanding At March 31, 2022 And December 31, 2021, Respectively",
        "verboseLabel": "Common Shares Issued, Fair Value"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets",
      "http://powerverdeinc.com/role/IntangibleAssetsDetailsNarrative",
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskDisclosureTextBlock": {
     "auth_ref": [
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.",
        "label": "Concentration of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r106",
      "r107",
      "r128",
      "r295",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Federal income tax at statutory rate"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/IncomeTaxesDetails1"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConversionOfStockAmountIssued1": {
     "auth_ref": [
      "r67",
      "r68",
      "r69"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of the financial instrument issued [noncash or part noncash] in the conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion Of Preferred Shares To Common Shares, Amount"
       }
      }
     },
     "localname": "ConversionOfStockAmountIssued1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedChangesInStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConversionOfStockSharesConverted1": {
     "auth_ref": [
      "r67",
      "r68",
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Exercised",
        "verboseLabel": "Preferred Stock Converted"
       }
      }
     },
     "localname": "ConversionOfStockSharesConverted1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetails",
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ConversionOfStockSharesIssued1": {
     "auth_ref": [
      "r67",
      "r68",
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion Of Preferred Shares To Common Shares, Shares",
        "verboseLabel": "Common Stock Issued On Conversion"
       }
      }
     },
     "localname": "ConversionOfStockSharesIssued1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedChangesInStockholdersDeficit",
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r49",
      "r73",
      "r141",
      "r179",
      "r180",
      "r181",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r190",
      "r191",
      "r297"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost Of Goods Sold"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenue": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 12.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "[Deferred Revenue]",
        "verboseLabel": "Deferred Revenue"
       }
      }
     },
     "localname": "DeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Revenue"
       }
      }
     },
     "localname": "DeferredRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r28"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "[Deferred Revenue, Current]",
        "verboseLabel": "Deferred Revenue"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/DeferredRevenueDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueDisclosureTextBlock": {
     "auth_ref": [
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for deferred revenues at the end of the reporting period, and description and amounts of significant changes that occurred during the reporting period. Deferred revenue is a liability as of the balance sheet date related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.",
        "label": "Deferred Revenue Disclosure [Text Block]",
        "verboseLabel": "Deferred Revenue"
       }
      }
     },
     "localname": "DeferredRevenueDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/DeferredRevenue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.",
        "label": "Goodwill"
       }
      }
     },
     "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r256"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r258"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Net deferred tax asset (liability)"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r258"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Net deferred tax assets after valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax assets:"
       }
      }
     },
     "localname": "DeferredTaxAssetsNetOfValuationAllowanceAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r262",
      "r263"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "[Deferred Tax Assets, Operating Loss Carryforwards]",
        "negatedLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r262",
      "r263"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Stock based compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r257"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "[Deferred Tax Assets, Valuation Allowance]",
        "negatedLabel": "Less valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r249",
      "r258"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "[Deferred Tax Liabilities, Net]",
        "negatedLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r262",
      "r263"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "[Deferred Tax Liabilities, Other]",
        "verboseLabel": "Depreciation"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r62",
      "r169"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r62",
      "r169"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation and amortization expense"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DueFromRelatedParties": {
     "auth_ref": [
      "r76",
      "r182",
      "r184",
      "r185",
      "r189",
      "r190",
      "r191",
      "r309",
      "r373",
      "r385"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an unclassified balance sheet, amounts due from related parties including affiliates, employees, joint ventures, officers and stockholders, immediate families thereof, and pension funds.",
        "label": "Due to related party"
       }
      }
     },
     "localname": "DueFromRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r96",
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings (Loss) Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r237"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Unrecognized compensation expense, unvested options"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholder Equity"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r39",
      "r40",
      "r41",
      "r78",
      "r79",
      "r80",
      "r82",
      "r87",
      "r89",
      "r98",
      "r142",
      "r208",
      "r210",
      "r240",
      "r241",
      "r242",
      "r265",
      "r266",
      "r291",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r390",
      "r391",
      "r392",
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedChangesInStockholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r293",
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r136",
      "r137",
      "r138",
      "r139",
      "r140",
      "r145",
      "r146",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r192",
      "r206",
      "r290",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative",
      "http://powerverdeinc.com/role/StockholderEquityTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Estimated Life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/IntangibleAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r164"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/IntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/IntangibleAssetsDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "2022 (remaining 9 Months)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/IntangibleAssetsDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r166"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/IntangibleAssetsDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r166"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/IntangibleAssetsDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r166"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/IntangibleAssetsDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r166"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/IntangibleAssetsDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r160",
      "r161",
      "r164",
      "r167",
      "r354",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/IntangibleAssetsDetails",
      "http://powerverdeinc.com/role/IntangibleAssetsDetailsNarrative",
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r164",
      "r355"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Intangible Assets Gross"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/IntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r160",
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/IntangibleAssetsDetails",
      "http://powerverdeinc.com/role/IntangibleAssetsDetailsNarrative",
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r164",
      "r354"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Intangible Assets, Net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/IntangibleAssetsDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and administrative",
        "verboseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r62",
      "r156",
      "r157",
      "r158"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Loss on impairment"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r48",
      "r73",
      "r115",
      "r117",
      "r120",
      "r123",
      "r125",
      "r141",
      "r179",
      "r180",
      "r181",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r190",
      "r191",
      "r297"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 10.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "[Gross Profit]",
        "totalLabel": "Gross Profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r43",
      "r115",
      "r117",
      "r120",
      "r123",
      "r125",
      "r369",
      "r375",
      "r377",
      "r387"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 17.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "[Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest]",
        "totalLabel": "Net Income (Loss) before Income Taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Consolidated Statements of Operations"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r74",
      "r252",
      "r254",
      "r260",
      "r267",
      "r269",
      "r271",
      "r272",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r75",
      "r88",
      "r89",
      "r114",
      "r250",
      "r268",
      "r270",
      "r388"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 16.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Provision for Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r38",
      "r247",
      "r248",
      "r254",
      "r255",
      "r259",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax Policy"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxUncertaintiesPolicy": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for tax positions taken in the tax return filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other types of contingencies related to income taxes.",
        "label": "Accounting for Uncertainty in Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxUncertaintiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r61"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "[Increase (Decrease) in Accounts Receivable]",
        "verboseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r61"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r61"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "[Increase (Decrease) in Deferred Revenue]",
        "verboseLabel": "Deferred Revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in operating assets and liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentAssets": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in current assets classified as other.",
        "label": "[Increase (Decrease) in Other Current Assets]",
        "negatedLabel": "Increase in other assets acquisition"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in current liabilities classified as other.",
        "label": "Other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "[Increase (Decrease) in Prepaid Expense and Other Assets]",
        "negatedLabel": "Prepaid expense and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "auth_ref": [
      "r61"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.",
        "label": "Prepaid expense"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "Intangible Assets Disclosure [Text Block]",
        "verboseLabel": "Intangible Assets"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/IntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsFiniteLivedPolicy": {
     "auth_ref": [
      "r70",
      "r163",
      "r350",
      "r351",
      "r352",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.",
        "label": "Intangible Assets, Finite-Lived, Policy [Policy Text Block]",
        "verboseLabel": "Intangible Assets"
       }
      }
     },
     "localname": "IntangibleAssetsFiniteLivedPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r159",
      "r162"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Net Book Value"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/IntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeOperating": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 12.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities.",
        "label": "Interest income"
       }
      }
     },
     "localname": "InterestIncomeOperating",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r56",
      "r59",
      "r66"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LaborAndRelatedExpense": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 8.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.",
        "label": "Compensation And Related Expenses"
       }
      }
     },
     "localname": "LaborAndRelatedExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r31",
      "r73",
      "r119",
      "r141",
      "r179",
      "r180",
      "r181",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r190",
      "r191",
      "r282",
      "r285",
      "r286",
      "r297",
      "r313",
      "r314"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 20.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "[Liabilities]",
        "totalLabel": "Total Liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r26",
      "r73",
      "r141",
      "r297",
      "r315",
      "r372",
      "r383"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "[Liabilities and Equity]",
        "totalLabel": "Total Liabilities And Stockholders' Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Stockholders' Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r32",
      "r73",
      "r141",
      "r179",
      "r180",
      "r181",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r190",
      "r191",
      "r282",
      "r285",
      "r286",
      "r297",
      "r313",
      "r314",
      "r315"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 14.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "[Liabilities, Current]",
        "totalLabel": "Total Current Liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInContinuingOperations": {
     "auth_ref": [
      "r58"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in cash associated with the entity's continuing operating, investing, and financing activities. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label.",
        "label": "Net Cash Used In Operations"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/LiquidityCapitalResourcesAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 22.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "[Net Cash Provided by (Used in) Financing Activities]",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 21.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "[Net Cash Provided by (Used in) Investing Activities]",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r58",
      "r60",
      "r63"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 20.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "[Net Cash Provided by (Used in) Operating Activities]",
        "totalLabel": "Net cash (used in) provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r1",
      "r36",
      "r37",
      "r41",
      "r44",
      "r63",
      "r73",
      "r81",
      "r83",
      "r84",
      "r85",
      "r86",
      "r88",
      "r89",
      "r93",
      "r115",
      "r117",
      "r120",
      "r123",
      "r125",
      "r141",
      "r179",
      "r180",
      "r181",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r190",
      "r191",
      "r292",
      "r297",
      "r376",
      "r386"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "[Net Income (Loss) Attributable to Parent]",
        "terseLabel": "Net Income (loss)",
        "totalLabel": "Net Income (Loss)",
        "verboseLabel": "Net Loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedChangesInStockholdersDeficit",
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited",
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://powerverdeinc.com/role/LiquidityCapitalResourcesAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 14.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "[Nonoperating Income (Expense)]",
        "totalLabel": "Total Other Income (expense)"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 9.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "[Operating Expenses]",
        "totalLabel": "Total Operating Expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r115",
      "r117",
      "r120",
      "r123",
      "r125"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 15.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "[Operating Income (Loss)]",
        "totalLabel": "Income (loss) From Operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r261"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Net operating loss carry forwards for federal income tax purposes"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nature of Business and Presentation of Financial Statements"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r3",
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Nature Of Business And Presentation Of Financial Statements"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/NatureOfBusinessAndPresentationOfFinancialStatements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssets": {
     "auth_ref": [
      "r17",
      "r370",
      "r380"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets classified as other.",
        "label": "Other Assets"
       }
      }
     },
     "localname": "OtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIncome": {
     "auth_ref": [
      "r389"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 11.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue and income classified as other.",
        "label": "Other income"
       }
      }
     },
     "localname": "OtherIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIncomeAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income (expense)"
       }
      }
     },
     "localname": "OtherIncomeAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherIntangibleAssetsNet": {
     "auth_ref": [],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.",
        "label": "Intangible Asset, Net"
       }
      }
     },
     "localname": "OtherIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilities": {
     "auth_ref": [
      "r374"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 10.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other.",
        "label": "Other Liabilities"
       }
      }
     },
     "localname": "OtherLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PartnersCapitalAccountUnitsSoldInPrivatePlacement": {
     "auth_ref": [
      "r210",
      "r211"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of units sold in a private placement of each class of partners' capital account. Units represent shares of ownership of the general, limited, and preferred partners.",
        "label": "Shares In Private Placement"
       }
      }
     },
     "localname": "PartnersCapitalAccountUnitsSoldInPrivatePlacement",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PatentsMember": {
     "auth_ref": [
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.",
        "label": "Patents [Member]"
       }
      }
     },
     "localname": "PatentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/IntangibleAssetsDetails",
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsOfCapitalDistribution": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow to owners or shareholders, excluding ordinary dividends. Includes special dividends.",
        "label": "[Payments of Capital Distribution]",
        "negatedLabel": "Recapitalization of the Company"
       }
      }
     },
     "localname": "PaymentsOfCapitalDistribution",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "[Payments to Acquire Property, Plant, and Equipment]",
        "negatedLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r218",
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetails1",
      "http://powerverdeinc.com/role/StockholderEquityDetails2"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetails1",
      "http://powerverdeinc.com/role/StockholderEquityDetails2"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PolicyTextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies (Details Narrative)"
       }
      }
     },
     "localname": "PolicyTextBlockAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PreferredStockConvertibleSharesIssuable": {
     "auth_ref": [
      "r195"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common shares issuable upon conversion of preferred stock.",
        "label": "Convertion of preferred stock to common stock"
       }
      }
     },
     "localname": "PreferredStockConvertibleSharesIssuable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockLiquidationPreferenceValue": {
     "auth_ref": [
      "r71",
      "r197"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of the difference between preference in liquidation and the par or stated values of the preferred shares.",
        "label": "Preferred Stock, Shares Liquidation",
        "verboseLabel": "Liquidation Value of Preferred Stocks"
       }
      }
     },
     "localname": "PreferredStockLiquidationPreferenceValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.",
        "label": "Preferred Stock"
       }
      }
     },
     "localname": "PreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedChangesInStockholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r19",
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock Par Value",
        "verboseLabel": "Preferred Stock, Par Value"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetailsNarrative",
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "verboseLabel": "Preferred Stock, Shares Authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r19",
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "verboseLabel": "Preferred stock, shares issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "verboseLabel": "Preferred stock, shares Outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r19",
      "r315"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 18.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock: 1,000,000 Convertible Series D Preferred Shares Authorized; Par Value $0.0001 Per Share, Nil Issued And Outstanding At March 31, 2022 And 27,272 Issued And Outstanding At December 31, 2021"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r5",
      "r7",
      "r154",
      "r155"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expenses"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Common Stock Offering",
        "verboseLabel": "Capital Raised through issuance of common stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited",
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.",
        "label": "Proceeds from Series D Preferred Shares"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfPreferredStockAndPreferenceStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": {
     "auth_ref": [
      "r53"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.",
        "label": "Gross Proceeds From Private Placement",
        "verboseLabel": "Gross Process From Private Placement of Stocks"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfPrivatePlacement",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetailsNarrative",
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": {
     "auth_ref": [
      "r53"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.",
        "label": "Proceed from sales of stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOrSaleOfEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/LiquidityCapitalResourcesAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt": {
     "auth_ref": [],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts.",
        "label": "Advances from Stockholders",
        "verboseLabel": "Advances from Shareholders"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfRelatedPartyDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited",
      "http://powerverdeinc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r53",
      "r239"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from exercise of Options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromWarrantExercises": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 19.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.",
        "label": "Proceeds from exercise of warrant",
        "verboseLabel": "Gross proceeds on exercise of warrants"
       }
      }
     },
     "localname": "ProceedsFromWarrantExercises",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited",
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductionCosts": {
     "auth_ref": [
      "r356"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 6.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The capitalized costs incurred during the period (excluded from amortization) to operate and maintain wells and related equipment and facilities, including depreciation and applicable operating costs of support equipment and facilities and other costs of operating and maintaining those wells and related equipment and facilities. They become part of the cost of oil and gas produced. Examples of production costs (sometimes called lifting costs) are: costs of labor to operate the wells and related equipment and facilities; repairs and maintenance; materials, supplies, and fuel consumed and supplies utilized in operating the wells and related equipment and facilities; property taxes and insurance applicable to proved properties and wells and related equipment and facilities; severance taxes; some support equipment or facilities may serve two or more oil and gas producing activities and may also serve transportation, refining, and marketing activities. To the extent that the support equipment and facilities are used in oil and gas producing activities, their depreciation and applicable operating costs become exploration, development or production costs, as appropriate. Depreciation, depletion, and amortization of capitalized acquisition, exploration, and development costs are not production costs but also become part of the cost of oil and gas produced along with production (lifting) costs identified above.",
        "label": "Product development"
       }
      }
     },
     "localname": "ProductionCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfessionalFees": {
     "auth_ref": [
      "r397",
      "r398"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.",
        "label": "Professional Fees"
       }
      }
     },
     "localname": "ProfessionalFees",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r1",
      "r36",
      "r37",
      "r41",
      "r57",
      "r73",
      "r81",
      "r88",
      "r89",
      "r115",
      "r117",
      "r120",
      "r123",
      "r125",
      "r141",
      "r179",
      "r180",
      "r181",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r190",
      "r191",
      "r280",
      "r283",
      "r284",
      "r287",
      "r288",
      "r292",
      "r297",
      "r377"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "[Net Income (Loss), Including Portion Attributable to Noncontrolling Interest]",
        "verboseLabel": "Net Loss"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedChangesInStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r13",
      "r14",
      "r170",
      "r315",
      "r378",
      "r384"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r130",
      "r133",
      "r134",
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Accounts Receivable"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RelatedPartyCosts": {
     "auth_ref": [
      "r49",
      "r76",
      "r182",
      "r184",
      "r185",
      "r189",
      "r190",
      "r191"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Direct costs arising from transactions with related parties who are not affiliates or joint Ventures. These costs are categorized as cost of goods sold.",
        "label": "Related party cost"
       }
      }
     },
     "localname": "RelatedPartyCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r214",
      "r308",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r214",
      "r308",
      "r310",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r306",
      "r307",
      "r309",
      "r311",
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "verboseLabel": "Related Party Transactions"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/RelatedPartyTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r55"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Cash paid for taxes"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r245",
      "r349",
      "r401"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 7.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and development",
        "terseLabel": "Research and development",
        "verboseLabel": "Research And Development Cost"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative",
      "http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Costs"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r23",
      "r210",
      "r243",
      "r315",
      "r382",
      "r393",
      "r394"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 15.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Accumulated (deficit) Earnings",
        "negatedLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets",
      "http://powerverdeinc.com/role/LiquidityCapitalResourcesAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r78",
      "r79",
      "r80",
      "r82",
      "r87",
      "r89",
      "r142",
      "r240",
      "r241",
      "r242",
      "r265",
      "r266",
      "r291",
      "r390",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedChangesInStockholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r42",
      "r73",
      "r112",
      "r113",
      "r116",
      "r121",
      "r122",
      "r126",
      "r127",
      "r128",
      "r141",
      "r179",
      "r180",
      "r181",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r190",
      "r191",
      "r297",
      "r377"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenue"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalariesAndWages": {
     "auth_ref": [
      "r45"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for salary and wage arising from service rendered by nonofficer employee. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.",
        "label": "Annual Salary"
       }
      }
     },
     "localname": "SalariesAndWages",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Common Stock shares issues to raise capital"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "auth_ref": [
      "r274",
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.",
        "label": "Schedule Of Assets And Liabilities Were Assumed"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r160",
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule Of Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/IntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r221",
      "r228",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Schedule Of Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule Of Stock Option Assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "auth_ref": [
      "r212",
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.",
        "label": "Schedule Of Warrant Activity"
       }
      }
     },
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule Of Future Amortization Expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/IntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SeriesDPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series D preferred stock or outstanding series D preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series D Preferred Stock [Member]"
       }
      }
     },
     "localname": "SeriesDPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetailsNarrative",
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Stock-based compensation",
        "verboseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited",
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "[Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number]",
        "periodEndLabel": "Balance At End",
        "periodStartLabel": "Balance At Beginning",
        "terseLabel": "Warrants Outstanding",
        "verboseLabel": "Warrants outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetails2",
      "http://powerverdeinc.com/role/StockholderEquityDetails3",
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Common Stock which were issued to investees as part of the capital raise"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Dividend yield",
        "verboseLabel": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetails1",
      "http://powerverdeinc.com/role/StockholderEquityDetails2"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Expected volatility",
        "verboseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetails1",
      "http://powerverdeinc.com/role/StockholderEquityDetails2"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Risk-free interest rate",
        "verboseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetails1",
      "http://powerverdeinc.com/role/StockholderEquityDetails2"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of non-option equity instruments exercised by participants.",
        "label": "[Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised]",
        "negatedLabel": "Shares Exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetails2",
      "http://powerverdeinc.com/role/StockholderEquityDetails3"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "[Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period]",
        "negatedLabel": "Expired/forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Granted",
        "terseLabel": "Shares Issued",
        "verboseLabel": "Shares Issued"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetails",
      "http://powerverdeinc.com/role/StockholderEquityDetails2",
      "http://powerverdeinc.com/role/StockholderEquityDetails3"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Weighted Average Exercise Price Issued",
        "terseLabel": "Weighted Average Exercise Price Issued",
        "verboseLabel": "Weighted Average Exercise Price Issued"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetails2",
      "http://powerverdeinc.com/role/StockholderEquityDetails3",
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r238"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "[Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value]",
        "periodEndLabel": "Aggregate Intrinsic Value ,ending",
        "periodStartLabel": "Aggregate Intrinsic Value, Beginng",
        "verboseLabel": "Intrinsic Value Of Warrants"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetails",
      "http://powerverdeinc.com/role/StockholderEquityDetails2",
      "http://powerverdeinc.com/role/StockholderEquityDetails3",
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r223",
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "[Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number]",
        "periodEndLabel": "Options Outstanding, Ending Balance",
        "periodStartLabel": "Options Outstanding, Beginning Balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "[Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price]",
        "periodEndLabel": "Weighted Average Exercise Price ,ending",
        "periodStartLabel": "Weighted Average Exercise Price ,Beginning"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetails",
      "http://powerverdeinc.com/role/StockholderEquityDetails2",
      "http://powerverdeinc.com/role/StockholderEquityDetails3"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r217",
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetails2",
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative",
      "http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r218",
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Stock-based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r233",
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Expected Life",
        "verboseLabel": "Expected Life"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetails1",
      "http://powerverdeinc.com/role/StockholderEquityDetails2"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant-date fair value of non-vested options outstanding.",
        "label": "[Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price]",
        "periodEndLabel": "Weighted Average Exercise Price Balance At Ending",
        "terseLabel": "Weighted Average Exercise Price",
        "verboseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetails2",
      "http://powerverdeinc.com/role/StockholderEquityDetails3",
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Weighted Average Remaining Contractual Life(Years)",
        "terseLabel": "Weighted Average Remaining Contractual Life(Years)",
        "verboseLabel": "Weighted Average Remaining Contractual Life(years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetails",
      "http://powerverdeinc.com/role/StockholderEquityDetails2",
      "http://powerverdeinc.com/role/StockholderEquityDetails3"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options vested.",
        "label": "[Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares]",
        "negatedLabel": "Vested"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "[Shares, Issued]",
        "periodEndLabel": "Balance, Shares",
        "periodStartLabel": "Balance, shares"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedChangesInStockholdersDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r18",
      "r19",
      "r20",
      "r71",
      "r73",
      "r90",
      "r91",
      "r92",
      "r94",
      "r95",
      "r99",
      "r100",
      "r101",
      "r141",
      "r179",
      "r184",
      "r185",
      "r186",
      "r190",
      "r191",
      "r193",
      "r194",
      "r197",
      "r201",
      "r208",
      "r297",
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetailsNarrative",
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r34",
      "r39",
      "r40",
      "r41",
      "r78",
      "r79",
      "r80",
      "r82",
      "r87",
      "r89",
      "r98",
      "r142",
      "r208",
      "r210",
      "r240",
      "r241",
      "r242",
      "r265",
      "r266",
      "r291",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r390",
      "r391",
      "r392",
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedChangesInStockholdersDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetails",
      "http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetailsNarrative",
      "http://powerverdeinc.com/role/CondensedConsolidatedChangesInStockholdersDeficit",
      "http://powerverdeinc.com/role/IntangibleAssetsDetails",
      "http://powerverdeinc.com/role/IntangibleAssetsDetailsNarrative",
      "http://powerverdeinc.com/role/StockholderEquityDetails",
      "http://powerverdeinc.com/role/StockholderEquityDetails1",
      "http://powerverdeinc.com/role/StockholderEquityDetails2",
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative",
      "http://powerverdeinc.com/role/StockholderEquityTables",
      "http://powerverdeinc.com/role/SubsequentEventsDetailsNarrative",
      "http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Consolidated Statements of Cash Flows (Unaudited)"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Consolidated Balance Sheets"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Consolidated Changes in Stockholders' Deficit"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r78",
      "r79",
      "r80",
      "r98",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetails",
      "http://powerverdeinc.com/role/AcquisitionOf374WaterIncFkaPowerverdeIncDetailsNarrative",
      "http://powerverdeinc.com/role/CondensedConsolidatedChangesInStockholdersDeficit",
      "http://powerverdeinc.com/role/IntangibleAssetsDetails",
      "http://powerverdeinc.com/role/IntangibleAssetsDetailsNarrative",
      "http://powerverdeinc.com/role/StockholderEquityDetails",
      "http://powerverdeinc.com/role/StockholderEquityDetails1",
      "http://powerverdeinc.com/role/StockholderEquityDetails2",
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative",
      "http://powerverdeinc.com/role/StockholderEquityTables",
      "http://powerverdeinc.com/role/SubsequentEventsDetailsNarrative",
      "http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r19",
      "r20",
      "r208",
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Issuance of common stock, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedChangesInStockholdersDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesOther": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued attributable to transactions classified as other.",
        "label": "Common Stock which were issued in connection with the exercise of warrants"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r19",
      "r20",
      "r208",
      "r210",
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Issuance of common stock, exercise of warrants"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.",
        "label": "Issuance of common stock for services"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueIssuedForServices",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedChangesInStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r19",
      "r20",
      "r208",
      "r210"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Issuance of common stock, amount"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedChangesInStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).",
        "label": "Stock Option [Member]"
       }
      }
     },
     "localname": "StockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r20",
      "r24",
      "r25",
      "r73",
      "r132",
      "r141",
      "r297",
      "r315"
     ],
     "calculation": {
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 19.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "[Stockholders' Equity Attributable to Parent]",
        "periodEndLabel": "Balance, Amount",
        "periodStartLabel": "Balance, amount",
        "totalLabel": "Total Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets",
      "http://powerverdeinc.com/role/CondensedConsolidatedChangesInStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r72",
      "r194",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r207",
      "r210",
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "verboseLabel": "Stockholder Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r305",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r305",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r305",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r316",
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequents Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.",
        "label": "Liquidity, Capital Resources"
       }
      }
     },
     "localname": "SubstantialDoubtAboutGoingConcernTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/LiquidityCapitalResourcesAndGoingConcern"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUPPLEMENTAL CASH FLOW DISCLOSURES:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r136",
      "r137",
      "r138",
      "r139",
      "r140",
      "r192",
      "r206",
      "r290",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative",
      "http://powerverdeinc.com/role/StockholderEquityTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r246",
      "r253"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Uncertain tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r102",
      "r103",
      "r104",
      "r105",
      "r108",
      "r109",
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WarrantExercisePriceIncrease": {
     "auth_ref": [
      "r209"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision.",
        "label": "Exercise price"
       }
      }
     },
     "localname": "WarrantExercisePriceIncrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://powerverdeinc.com/role/StockholderEquityDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    }
   },
   "unitCount": 4
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(11))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "410",
   "URI": "http://asc.fasb.org/extlink&oid=6392676&loc=d3e7480-110848"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394232&loc=d3e17558-110866"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "430",
   "URI": "http://asc.fasb.org/topic&trid=2122452"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "40",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=51888271"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.F)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187171-122770"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "50",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)-(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(a)",
   "Topic": "920",
   "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(b)",
   "Topic": "920",
   "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(a)",
   "Topic": "920",
   "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155638-234783"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-10(c)(7)(ii))",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123726172&loc=d3e511914-122862"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10(3))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(5))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.3)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.4)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Subparagraph": "(k)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07.2(a),(b),(c),(d))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123366838&loc=d3e3073-115593"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r402": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r403": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r404": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r405": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r406": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r407": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r408": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r409": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r410": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1(e))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>72
<FILENAME>0001654954-22-008496-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001654954-22-008496-xbrl.zip
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M+A9"1',K/KNRDYA37!].^]A]A(2.2V+I!N(7:W]P]E]C+/3_BK-_,?9OOF
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M;:PQFEXM\O+:/AMD,4(7D?O;J+R$9R(ZRRSPY?FSJ37(DJ<)9$0)L8XFLL4
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M _T&L"(+7=>;A4#S,,!Q/P8XNG:'N]!0ID0@4TF90L[$M-?EP_3<R?!Y]=+
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MI%6D <(ZX@B$NO5\=T2DPG/NUOSB%X[:FUU5<7PO.O6Y*#KPCCHD%QSNHSS
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M=V2S2LDI-;OKG7PB/F=A\=C /CZJMS*<XQ6OJOR+#76',5_<;@SPI#Z645+
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M0";OE;J8_&WCK*LM/(OV->=]-;O:1HWT8]](U;C. MVUI4Y3T*:UG42,OAC
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M!/HR4!Z%_<<!*1)Z*JSY_\G7T$"8Z?\%4$L#!!0    ( #:)T51;Q-CT<S0
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M-ZL*9;3 ICB351ZN7W/9[O5I?[-&8/!.U,\XCD,9);,F\_?RJSE@W7V3!1O
M @O.: H-Z,*S=8LC*,H$"^#%QWJ?Q9E68(Q.J;% :_&^7.OG;_G3)JILC8T-
M#@1'&RL15V[6+Z#BW )AC:]N<U-3&N7;?]Y@]I +*!G^3G8MU"%EUI>%._[Q
M=))EPO0X! N0TMS% EF@K#D4:^+7_"UQ+3]'9XGJ<2ISY363_A=3<>-,^.Q+
MN*_+*NXG>R)Y8XK@_+DWL^'\P#_'IQO7X*OT879C:E-%G[LE%7PV4(F+G]!/
M2QZK+A26>IPYY50.,3OX.B[9F$3LK-BF.1#B=P^14=91'?>R7"E>[VNZ^':1
M/U?P\U/N0;QM;!;"4;!M+-5I0NVP '(PV*6=N6-N1M2A3:]>N*'E.8_:>5(?
MY9O4Y%&R:V4BK2W<$)=,ZL[/K\04V?0T1'L0P^]3K.,C9-3RA32\YLOESNAX
MXL7WAJ#'(RJ/KHE#.5PO\EG=&!X_+.0_J';K(M>@68OR5"BH$G91)$#:E"_6
M2JI7.0I+Y <C4ED\;6]0FSS*N_5&8(UBMPXRPP5$I8?<']V5O)>85:%,53W<
M]$S\3-@J>](Y6XXU/O[-3-J1H;:X+A;(> 3=.\,"B_R'DI"SXQ ,> 7#^:K'
MS('&8LQZR#(T.]3Z4-K6M5,T%HF B.O\:X)@$M+=5()^S@XN@\%(J9DH*(3:
M:_%)I-!XO;'K35LTFG#C&3RUK.^/O4PJE.YTI)B&Y=E[=\,VTKL@Q22+GA:+
MI0R&&('CK-=YPH.K_51Z"MJ.L4LU04A,LJNO+18P<^R!K1,4#^TX<=17AFW.
MG':("47,S>J)4:Y8X&]>,C>M[(_$@4N!(\=_"PNPNYQB@?QG=>7O'PWHNFXZ
MO&[7*/E@/3"=G7-HB072WX"U27>U"PLH,&#.RV2.*&P[S"7 FA[BN+,VOL<\
MX\2::\)I3WI5+'!=!NV0!"[II04FB&.E7'3+=@_))^CI,-ZY$<N%NEQUQ@*B
MA.62TSS\,K$,,GB.>/GK!9O<.T-U\^V#XF<%)*6D5@&RD(X Q?G8+QO29)2^
M;$9G-E6.#8X\L_*-"I9$%T-.F%<-=]4QS$?"D.R1D;;AF.XAN@+AB4V=3?HO
M2K$\/_FW,Q/%*,@U3WI$SM A& PELNAAF9LP)RE;(0NAM-KMC;F50G1/V=F:
M-1: :6,!&G/+Z2,JZ2FAYK4#R@L4M#-U,C1"'Y-\Y83B"C14==4,UG]+Y.(<
MADJ5G_KL$_,3<KX)GM\5W+$[*O:,TQ!-$J\\AC00T7U*_+G)7!63(B'^?+P[
M+?(@7N)99DSNDJS\A2<B[5:M"()Z<])9C(EPY055'&I,H$I:6DO=77CT^.*-
M2SP\[4%_V5T5.#\B@L2!W\-:@;A##@X@$0SJ8XITU=D'DZ9;]?BH..L*IM1?
M46L>5C'$F[<Q5*F]:1WI0JC$@MX<E.7=!*W@U?;Z-Z9B15T9]6ILVBY7SHWR
MMM(%R@>_Q?X\+-@AL^5#'I4T\G6>^\>>W-JRV)YP3R3:=>^7)_/LE_<;ER@?
M>:J?I&<Z%][_<S>4)":C4K?Y^-?POG;H>*LB0[C:A=&DZ2UU[C2O5[WK($<7
M]]Y?TZVM:1P>-Q[N2-ND+#9AJNP7\ZAUR*N;XCH+4F<_GC00B$]341G0SB\N
MSK3F>'= O&S06%R0EC&[ZWJKQLL7"X2CQ1<=:2RDR8M-M*T_F6H'%.:*$EN*
MBPEP=C"1_0"4-'T;/GQLEB8;:6+9D$M^W1^Z^K4^OE-+^T+%N5*+^^?$AQ^Z
MC],$QW&"N[F\^7@;J>'XH- 0D)9I7_F1ZCC6?%F<DVLD5OFE2*ABNM?CD$&
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M$R\YTQXG\P.&N&5_MT ]0AF,X?K%L/,<Y*.+XI6JVBJD2!1O?4T\\:XDL-\
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MI&"-%ON6&<RR-12 Q93IC?5'M:+Q1QGS[CX8%RX]SP]O1*[?86FS22O_?@2
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M7".:B=\?\/? INL4#<HR-#(/+NU> (*$9N@8]<S*T,^NA#\VMFKS99K,#06
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M.G+3CT3UT1->#_M^HSQL*=7E(AJ8>@^'D%B*"+DQ6S4]:QXW[QSSF'RW\'=
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MYK9B;H2*6F+>]^\F^]-,/RXKM&)G1(L*=JA]EVP*RK@2E;$=%B/.4PX+&/?
MU 8F-R9:J6Q 3>I$>/KAK4VP)S.^E99: :H5[NE'N,:XC*N!L8]QDQJ7/_I!
MKA4V1]78'-FQ,4(V5=@<]=C4QV92C<W$CHT91ZG 9M)C4Q^;?"#,2F;%RHA\
M5&'5KP]:7'HKAJXVM15!(Z!1?BFN1[+I"5)N#VN\MZ)CA!ZR9TC]NJX!"N,R
M&&JLY0K"" 4X]*NX>D@8N]1R BLR!9&$(F3Z$:O^;<9BE&Q$-J3>&J&$_&W'
M'JU6-R#+3CDM5%:\S,A"_H;D_RE@\I_,>/2 9D!E2CJ6^6Y.!PPO5Y[,:Z3>
M+52J+9F39ACE@/E;F'NP67H1B91?D2E)H9UOH;#B2 2DCB'%R.0DA/@K1#E&
M;!0I/P"C5S/+@\]-S1(LR.NJ/<*WFMJ3<\<N6B4<OZE5V;[R^D:=C-+9C\2G
M;':D$V&33SD@1IZEJK1B.C/>C>\H014L\M,PXAO*5\/QT7 R/M@P-]*QB0J)
M?<U4B/@:JU"<*ZUFY1&#K/5=@_J*DZ@55<JJ6*(/TC^;F%N2@;!>_6F>^%-;
M#=)YU&I5GS#(QZ%^;.%LQ1G6ZL">YKS5C!+^#]+IQN]W4J6=&BUU*$O^6 N&
MF%X]-4#?3 L8#H&C&73X$&U6'B20^W1[)3[7:PJ/THR4RT3(;L@4Y*NLJT^:
MZ_64:- @$<=N?I'.OEG+,1(&_=AV8$CREM:J-B*7#PVJM"2!K*S:R+TX0AYG
MB:1A(JF%,F8*S+;**$F-E;$GUBS3Q\:I/K,V+I$D:JWG$Q&]>FKC%0%K[13I
M#)L:BTA8>[\H3&^[@SKM/*,TYVA;!]VE/8PLICLTA\J[7*),F,I4107DCN#O
MJ;N6*UYV1?UE.H'90"E\.J@HQYXGO[9P.N!4?NM5Y?H]?M89#$\'#D6N3,^F
M7XME/_;=)[4[T:ML4:0W*YI@Z8LQ'M+M-4=+229:('AF''.5 OL/Z@>KB!0+
MD@J#7B!U==POMB'SJJW:;J#3]GTGO6\1O_$9NT?T<0$I.H-B!I@2]P)[@9JP
MM2E6JD+KJLP0RRY9KL3M;,1G)/.3(W>Z1A3.D?S>OD^4:'87<)7;'9-YB6UM
MF1N;K"F8DKR[OSG"9?1%4]4_5(IYH?L*$1;6&GIA#<*.^N8U8X%4(=3\LPSP
M$<ZN?'J!ULCS5Y+\;G9/?3>0BUUM<&.NCEK_@!Q]<1__-_RFT--">N<*DJUV
MS\CB6I3[==<J%:=+N0VO8TQ,60V9BY[W@MBCJ JQBWL:'BHH_Y/NB%SA?3)Y
M8Q:W!O3[1<^N:!;#!O0=[7R7&T0=+"/R*\DI!OYH',E"6(-NO]"5*YB%K 9=
M-SM=,MR',[?T->%E-]B1^53U+Y=D06O&LE_\:NF:A;(92T<[X+E/PE_MD6;(
M9RXO?"=#BFY>POV4D5F8=Q.Q7]A;Z9YU@]U$=-0MINY_ L;#G\5(Z1U/+F+J
M60L_3VTDZS-TU.9P((XU#E>NJ=7L=$Z18HKW-(U8.FJW4-I!R%4Q 'D]@S*4
M^M9;9*J5JIO35KIWIGJ>1JRH"Q<1=12X6A-0H]FJN[:&WZ1G]W KU7M$G'O(
M_8SY0AFB5U.IO7@MXH[:*J- &#YC#\NS]*D ;HG<:V+VNJD03V&R)6_#F&L#
M&)8TGH\YQ63^XTQWQ.:FL=DA4S='JI05V]"& @-311WU7OE5 #7UJ8P7VWCC
M8[QN'LM4/T5VS-&&GWER;;&KJC<^F=_@-7+UUQNS"I<5[E_M\ [E W+\N;ZR
MHY.PBH&<ZZJSEC2@W[]QX7)93;U/OOQ1-D3_5(<2<=2CBL)J0.'QQ"OM)CXB
M.D?T<C9#<@W('(HSTU)Y<=M-T.L,NI]]^E7F1-'QP'AMFW_;S0,A,3;*0)=8
MGJZQB]RS[2<F!__P9YC(?.IPO%:)O>.QM"Y]-^>)*2$P\!Z%&D(8D3]H*PS(
M;DFK2;II5D%_Z5(?T6M(?:01S\5JQY>.O>;CSHUX.CJ?YQ,+3%U7S2')SJ*"
MH)MCAFIR>0W3=5('=&HO/]>YV9ZW+*99P:U\!^4QLZ^\D<U5Q!83K?)+>+()
M]<DF"D.\*XH=E)FT?EB5^STFWMG6R)P?V\)-:^UX(UNLG?ETAK!,7L@@<=%F
MA<.?+7S5-O_.2G3J.D1TM',OE8O/>4JN/Y02[]FKDICMIY5/POBF88R=;*_K
M\'2LLEA5%NN:73FUXNSF)!?IF[I<H\^+[PC*KE-J4>X5T+HKKIU76?L+4^=.
MQI3?L? 4/XE36ZCV>YAV&RR?$;V;A?YT'U!GH;XC$^Z\2HOW?,5K/J?J!OP5
MQ/0OZ 4HUC'>4%62=+/_Q_[/I+^L(/4ID[F'W;747^BAFB\9^&I2-QT'7G5Z
MRO;I>ZBQ,&S(EW9(9Y7^V56*1;<\B]4O)MRK)7I"))<;!ZD[JC)^*)8R=[/T
MQ)&VJ E#VW6/E/D*P0?=\D]PH_>PHO4I#U;G/HO'  M-RWGE^XX!=WPA$Z-&
M^_-XGBQXWUW]Y<W: 'I9Y5,O.ZEYG.CB071C&7DGCEB8* ?6ORDN?[=<% F*
M)([2A&6O_251M5!-.6JI%U//\U_T5W7S-M9G[**E8C!;0B(H+_!,# N(I*["
M-&/IHG61FUEMRA!VT1(U5EB,B&@Z,0.%9W7)9)F??HH(6JX*7K?A$<M?1R@N
MZM:%@ZA98UW5W)ZWQ$K5+:/,"21O4"5%)XS)AB8^(KEW')C1C:B@]<FUZR\A
M)KMI^;2@"#W*CGGE!U0EB#<4KJ#9J^X?Z2V<0U/?W/N]ZAC>48OO4AK*EA'L
M56M]S<QTW=S[_:*/"5X&2U/)?,%^M82;$BUS!=T8!6C<P_7EE/07:\O'A3I<
M>[7O7#AMX,EUA&&$6=2!GO>)K!'CR"WI@/GB'ZGQR4A_ ?RW_P%02P,$%
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M*J#2(M#>I>(T"H&WK+SA(MNW^*_@AEQT.\/+'KH4$ :Y!>V'7^HJ&U\^>"U
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MQ0]:#"7+:2U$S>YDENYI;AYC1/?^/-4[L>MZ6**[2OOG)-1YF?683N'(,PW
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M"DL6N\->(1T.-]M83KW92M?6HF]8LE5X85BRG)OKYZV<2&A2,N"]N\V"T.1
M.+8BIM-#YJZAR:(QM=#D@.-+A"3_1U*37N$6T4( Y$S'39%''S@.O>H?2I3L
MU8_Z,?3E-W>[\[!R^!^T$LD=3-$E]D?YH3^]$C"'VH'KJ37VTF0'""K0%@DK
MY&M6F%<S.#4Z4EH?Y?C_T0Q,;-ARF=*[L62=TQ?HZ:)5^L(9V'^<_4@26>M_
MJS PH0 GO>@,%**!7#9 A -,.G-+(.[D6M=NL!<0QV]85/JJE0BRK8Q9*8H%
MTE9BC+V_<9_".&U;=CI*WSBW(F/_'GQ$CT$8DD&]\<'#$\H08,VZH3RX?7I(
MMY4>&*E3&S*4.HK+-6743C6-$R1^.6L%T&:^6YNS\*=K;_ K0EW>_.DAN\#B
M7))Z =;9FOO=R\N6U@:%V_SMF>O0C^)G5MR[Y6D@56Z-A;"[*52IC*W&RG8C
M:.+.=2%59G=Z"=VHG?WE]O;3Y:^7GQ\VGT"1V0$NKN_//]W<?[F[O+?C(8#K
M,$6X ]-;&'AXVR?HD@:5SB1^KH#5?/T*"7O?:3Z>CVQ8Q:3"<0T;K8E""@\'
M&:L50"GGB$B2>YID^J B$K&,E3H-NXCJPJ5C0T4 N71RM*3PFR5!\-QHRO+B
M]A'/BR!QMU&RBU'+TGAXLWI]]&-T0=WI.Z1-!J:1-W%LB7@<3YM&!//F\WNZ
MZI8* WR^X*94'K@."V[A2E^ K76)"H.F.[A*8A=7<*74;*7S9N,Y- BWKG(J
MO\9+\VM*C_&2_QX$2=R,H*LH_A2XI&K:7?#XU+B1V851$[(ZJ5$@3(F+;18=
M-#=_U[N'O(V;PED3)'?!+3^(0A;Y+6L'Q+2A81[BJ59'OD=IND7>[T'Z5,H%
MXNFNR*CK 9XN:NP?WU'A8BG1$*ZU54,6XJV'O*VUK!/6"/B*6^&FN YFZO#^
MJ%2&;X,GPC,Y=&\631!XBGT;T03)WNH5\.S<0IXYNEZ;W-X<0W;>&76I/9 U
M2(ZKLR9!J4V)DV=\M(G[VW^D"3?SA9=S#UE0GOU0\7F[7+/6ICQ O96TS\H<
M"7<SDU&V0V3F'AC9<3546($Y*Y4LC#6VL5E03KNF@E+A[(R'Y9U['IS8$*SK
M)FU+"7@CYX_-1W_N(?]Y(SXERPN8P0G2=6ZC\"R(BJBG\K"6?("4%-?Z\/DQ
M\#2SX>Y@FWR-M8/S]M49(#RV+BBUG:.RC6OP6?2NE=J:4F-BWB=R%U84RNTH
M;MMFWE[P'?#8FFU/J_5]2(WWY-C2&:U6-ES%ZBXQ!XN*[Z$=9Q/WEGG^+5N$
M/9G^#5E=1-ZV*Z=A[N,$NE/C4>U6Z7C!F?R%C#=2Z9*P6&&+;N)'&&:U\LZC
M,(FV@<?2>F@E@(1D_:3TH"@[A83;>_P7F@[45I#G2&WKLV9'[8RRN3M*P^R8
M!,U6GJY::S)[.(!*C5D#TUU,SWT^[I(@1 E[J+G<.OFQ:!_L/W#Z<VM_PO^
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M?S&W/IETE)'*EU%\9RMGZ?UBK3.@]%V6V3A:^$C7'0.3ZZ)0\<%?B+9]*>1
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MA*LHKJXF3"J>S]"-7]?#A3V4VC]EV(&9!4AF_FQDW'GK+W8S5IBW1'RZHBV
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M18U69_B.J]BMX3['5JNULU[J>HE4:OET*=J\![OG WO&(3.,;^BE3'YV*(]
M4^(*5ZPB6:7R:U;9:>J-C2>H2.2J#W5&.FP]#/:1+^$K2E+DM8UQG4[K4/.%
MK(UXE2A[RQ=-1R8K[2B*)QK_G,>(5\3,%;EJ3PP:WJM2B[:)8RPIS63_^+8G
MN85OY$^;KS#V,NEO=FF"O3N2H?=Y)ZR5=.R/9+4F''<RUS3N+R@.(N\^A7$J
M\\T&UE0$H1+;&?B('H.0GE5_A%MR8]8*%V\PH T] EJKPISN;+1AOSJ<9HWJ
MWK2=]PZM45+^&"A]C=P2*]-E7P3TDV<@^^A9=?:R#]MQ/>30_OP%$Z;)=7A+
MC:<LDW60+YW.O)5TU#%G+N<S+!@]7\X6SG<P@5L5;!:'P PF72^G75E'H.QO
MU&MD]N+&;]Y,'_([S"U9K>!H\"3 -8--B!Y)JFJK\S6HHG7X_-;BN.NVU0.A
M24,_:[?6)SWQ;#'50RDWJ+O%OIQ[6K3D-_VZF4>[#EWRKJ+81T&ZBVDEQLMO
M+T%,6RA6P2$<B=:/LK2.A;,:_N9KQ_5!G]:-ZQ:$ 7D??-:,3>N&#OSI'HQ3
M\O\MGL2Z FQ#;@O4-1UTX2F)0=_W*@D"@A P44YS%3(8>%I['ISJBCZQ,/!E
M..@ZTZ*G4A#XDOZO51'@\RA\17%"#TQ+A<78G_%R.!9TIP*?/DNOK$0UK:2%
MB<49_:6G[>UNF;GM*&[3ST&Q&R2G?Z#U.PH>GTA)%*PV?$2Y7K=QX'*SAS1]
MFET&F*S62->AI_[#+W7]Z^C+.4'&"G)>0)G!67$\9H51U Q7,R-V2J[XB<Q_
M&]*/=>NK[Q"NQ8@,DZJS#Y>Y)5W@7I7$>4L*FA>F!R1J1$R)1WKZ$83,7'_-
M=(!,!91I\,(Q!_H_KZNHK_XNW=<$UO=M%C>%T]E\;- LF-6ZHQ]P!EJ/_DQ.
MY5Q1<[.YHP2G,J%[=>SQYG2GS[/T4=]=&RU:;USQSC-;80,ZY-QNZ0E_'P7$
M[@;:QP 'F^K#"F3+S-?1[>J&8$AI6*&Y%9PN[;<+^OJAAYFHG,?]9[1JN-W;
MR)^-1[IJ..J.T:MKWSE6A>@'3AV9UV$:!WA*N\)[EX-]C/:_LW+6B^_WHH!,
MX\;ULL?'F"9*@(*+70/-KPU\=U%1/OATC<:)1CY-S]BQ#:6:-*BH+Z)9F^XG
MGV5@&J%HO%K,=94!UNW1R/157E':O9<3RHX6NWMW>678\PCK#]UT![</*'Z>
MR(9)MR2GDUM]0$<?,_6ZAQBL)@IYW]J&$IK&.Z!UKU.T TH-T4KD[TBE+$L*
M+-]B)3[#9R0I)5(ET?AP%D>TRKM9I=]9QLYZO#1Z0M0N6>/5+/Q?@) .60#C
M5PS#Y]VSI )&G4)3S),O6!&$K/[,<EBGH^5T9#HJ*!.L/L(9[;!5,'Z%W]I&
MN$:A:X2Y@NU'N/(SZT@T'4],;H]:!6N,,*.UZ^6[WMXRJ9Q%_=M-DNR>V6))
MJCRZ>&V["%X##WN]=]@=/K:7KO[=$X@X=.W$H^SK5#^:%5N>>*N3CD+T4[<^
M>7-*\!:@K44WEOJXMK(>(1ZL* %]R ^>P,Y,N=N.L@%K_1H[4AG/)Y.3O@;;
M44_.94)*:L_338,8JM^B+6Z&/"6O>TVM?_G$5U5^1PZ^KE8_RR($SFSIN+9,
M79T*"^?P:\'T_<WDNR#Y\RI&Z#I,$1[!5-<\YG_W1&>QK!,'F\.\CV:%GUV$
M3 89#*E;G[^$X[V/64"0\8 8,VD]6NL9)YJ-QKZVZV.2FM:M\O4/%]D3LEG/
MH#_65=6XM;,E\O6/W-AH2"__VN$5]3I,TGA'4Y1OTB<4/SS!,#OC^!QEE5<'
MN++>]>.9M^_[F@^5ATM4.JP'ZE#,+K*#30J^DPN<?>%I:GQ.PGDZO3E_TG53
M>VL\1.(3$P:4I %4')!B>?9I485("K56;82X'25#1S[TEKH"< J/H@RN9QVQ
MM+7\09730A"> 4SKQO0M;DX=%4H*W\M>)H:+T>#[2@WUXCHK+ #7D2ZRF?9T
M.N!-XPB<A#]CZU2UYNAE:"6'<%3P]]\S 3@^2^GZZHDY)J?G>R_'T^E$UU'$
ML$G<A^DOV6UC@4^R.OJ))Q+[R%^N==V85/6O3?;#(?G$;_;D$Q]WGU+K2OKC
M!79KB_,-+;LE!2E.P-4ZK(.'VW.WBL!B^'-O-#;Y")H5RG>]8-VV>S\@Y5AV
M*URT[>G"J"E!N9,:Q2&8$A?+&IXO5BOCKS;VD+<KU"RHBGK \EUXC_T-HI:O
MTS%R(5Q 7:51U-UZ QW0%:15O]^J(S:MX#4V?">1$'R*-F%LS3F;9IV'*S%0
M.4KK7S'5QKV _?=3EG,X7^MZLF_(\[=^6O>]IF*C.;7Q?H7OSF:N+I,Y9/BI
MH[H]KUF<F@VSYS; ',[@['NW8S*]#[H4<"JXLRM_?;:<S6>VQ=;U:6UC&OM_
MGOHPJS ;C]>ZRL?@L;;SS*?HA2%KR-AH.NU([9M/QJZGZRA!#81#:OD=)?:=
M]A'6 LW'*UW9&-I32COVP;%/LD[U?&CEKGQMM7O;[D[U$'N 8R*=3S9N89+<
M^+_3@N[I37Q'A)>40I/0:WRBL4WHRM.,(F)VL+Q:N$L;JL HBEE'&V4C+YQG
MC""* 65M+:<VF+U@@HAN3U9_9DG2WG(ZMF"WUBI?8ZIG?6[NJFJV$ GZNO(K
M"Z\NUDM?U_:CK:LEXHE>P!VTAMP#_A7=(RSV%=;U=[QTXW_$SRBF3Z0^15L/
MN[+B G.=V#4E=_10J4!/!UYFHQ:NXQFO3-A;ZCKDILL9Y0:,'93YA\4AWNDF
MNRW>5Z=BL#5I-"%*)%P!FSH!\WH7_F)A_"T;N6B-I;6@/M'K\?;55%_XX]5"
MU_5W#1M 16WKR*K74;\IW+=DF ?-B.EB^\<O+U&8?4N:H]C*HNM1,#71]\]V
MR>G9N+@+I,T)$AJC3I(V0EB$.0L) ,)>^/_#/HUW&T<N0EYRA4>(K\#^AM7F
M.=J%*4_U/JUHPEM_!0L(=F^"G5!/YS.H*PXB1.6APC?*>V?M =(@$,+V:#=A
M1;G:V6=*!OL>Q0%*;D+$PL&RO:",2U>6MK("C9VVF(7=?U_,1@OS^=D=A15L
MQ9/RFSB M0#&1MRV<Y(Z%R?83;CQ*>Z9&@S\W(P?.0?5WQO-EC-=X2H%!ZJ+
MR$W_^OD96X"*3;@)P;Y)FX:-_3GM-G)[INQ!*'\]@]8/GDCJIFE'/HIC/&IL
M" L^(^-62%/29+-+GZ(X^ ?_"KV<@Q7-1HXSMB!<UD?DEN$Z ]DQZ)Y_D)7W
M4P =FN-T%<4\\7F+03N/IE575?ABS6UC8)<WYK/)VO@##]U$K:.IX";A,5 W
M!:P%0_:;K"K*1D!"SCI@#$>^+N](R68KRBM;;3O-?<TVFSD"JO::46=[Y25<
M6+2ZJHHKMM,)&ZN$C55@+EVEO"DD*I ;9#?^;1R\PA3=;J%+8V7\,5/A9'[&
M8K5 %B6']!&]/I8T&0G0EI)L"YPU (H6R.$MA8@E]E(\ 06DK(3R L*5!6>X
MG605V$C+YUU)-?4I5V)B&^GI>(9T'<CTGFU"J1LC!U^"%&[!'20A)) ^Q='N
M\8F.';WNBN>86QI<*U)O[N$691LO5K$'_T<)JM?A0PS#!+KDI$%T?M&I"8T7
M3WNH5CF%ZL#/XH\S'VJKJRQ+X^DON30\4K9%"4@C$!.@ Y?!?J!3:)X%3;"[
M?PZ3)_[QJIQ#VPFUBN"E\VH9.5O?9ZZW-)[9T$70#F#R\?[-Q0T, J)\#F3A
MV5O<&4\PJ=_"EY-J@DV+J 5>!'3L#6U_Y:Q,FB%U">L(84QDH?R:G22^9'Q6
M+):UXU&:2GL=NC%JHDF-1=]BJ")Z>?&3T;,Q7/EH;O*DL+NDS3N064[T"^$Y
MR;2:$[V# 9>SA:/KJ1+-=W\Z]H!%M<0VCX\Q+5==B%J8;YZ%EY)K6B\51"[6
M3 DM\UN6T^545_1 N&XJ2UD'3L$(?,P)7FE2UWXEM6(!+25S7.SB('QD4X9Y
MDO3'F_Q*>TO%[AX-:=QY]E:S8I@[M\)BNBO',7JP<RSY&PF+@CC*&4"YB=S#
MW4P<LQQ JODEW&M!,GHVV[W9:F35V:^JP/PH]$N>B84'SYI1Z[W^GUXI\M7:
MG[L6G6\8TEZ8N!7M$[=.LC#%217+6XV7L[D%#Q::5K_C%L *3ZX4!_P<W4)I
M74L!K<:KNC)A!8>+>\*LR.%BMM:%59E7I2!B'4]E9^D48QVGM\S.T=Q=ZTK8
M&2Z^<9CN*MG1_[G(#KW*>"-_I2VJ,7BMI[[*'VV)U;-*8;M^$]^GY.4XJ@S>
M.=-N:5FS1&RL,!ORT-2B9(O.<DN/$]D=QEMR19IPFAY %N0H&3JE5*82/;L6
M[BSG=N7JJPJLE/BIM YH]&FKR9+938+ V:+]23?$_Z64:BGAUN?W=E1(G.<J
M9&4%,R;+R4I7<569;]Q+:,Z->\J&X1KYV%VN),*2K)?CY7 )[[=FWZ2?>(%Q
M%"?4.-*8_@M>8\MK0?GP0)53VSW6+HJ4[JZJL+$]M.]/1V.#T.LM<&O&-6Z&
M'>)8DQ7?LIRUL+!9-YI/M;V1T#,_7BBS:I*\J?U-%8NY9]78B$C(&$0=?[VR
MX'JGLIQM=P*5?<-CV&QNM[=KI-\F]\;'U.2KO$K"-1XC:4&$F9(Z52T^!7_M
M H]NA]D/"#<@#"*H\F8GJN.13:\L]!.^>?FOX,O&$[MKM8$>II)-;=$0;]/%
MF.4R&;$ +5$&-0Z69X?04ML]947;T"IKV]K!&CCN$F+ZC=?6L.YO-,26)[1I
MCRK7/W\"K[KV[%(])Q35;S/\+V>^;\U;9=JUEH82OSX%[A/XBA>B[-H=V?0'
M+.Z,O7N8D*T9O3&)OYC??F%W8>RP"[*\*]I+?1*V,D9+DN@J:B@GS5$NEGX[
MF>/>LP'_'>7MB-P@!+BK0T2O>H&O0?I$06MYZI6Z>60;]/5DYEF?U%05E5M+
M+WL&T2UQ&1F5.Y0@3/ZT";T+](JVT0NQL.3)J)!_6T3*P$I"C!8(ZKJ]UGH,
MV4'>QC-&&2N H0>\/;.1@?H%A2B&6ZS&QGL.P@ OAA@UKT@R5"TL++*RF$VG
M%FT8.\G<2#QES'2\8(7=BM7Z\OEE&[V1:M'Q:^ BONTHCKVIZY,\1-CC*/]^
M'B7IYRC]=Y3>(3=Z#$DQE7*&M:!?-7U;G\^@M3/+LTK+A]EQ^,Q=6.&Y&%"Y
M/K6_A''!55DUL8-#+<,9V&7?!Q%KT(HY?X>V)*IPB[<1;Z0'1/.30Z=O+@F%
MK"[\-2*V>"Y6<&3#W= 6\9IK.R6G^[LW#*CDP%M3TDK8X>4W4I '^_LN=A_@
M([KQRW5'17'$#LQ:JV-W4*=6)UN!DYF!^=33]FJA,+[84V9![>P0L(; OB52
MB+U2/]::@./%#I%[/Z5)%31*)[;0ZC-?4F'+)HQ+R*JBK-8^TI5^)3-C"B(V
M7BK?(5JAI6S1]!]&;[Q7<F-O7\@[>[JD80E$A"RQW9_Z2PL>;.@@:>-R;L8%
M2.>P=(&,S_@]Q3OTPL*JR8U?7B\OD--:34_&FY7NA"MM+YMUO+^H+KQ\-*F!
M;AW- _R%B^Q(ZCK$/BYZ@-\V28+2C9/0IVAY(&WCT.09J E>& $Y>?:ZM#]R
MC!=!ZB)H\]D5P@,P$\;/NPN4PF K>T!8Y_J>J94KE'Q&Z8U/CC[9H<QV&WTE
MN!<@KW\S&KV"GBI6'(:.;;#PU-0=377%J*6^Q$'2-]R,_+0\A=\ I.W];">6
M?XDB[VNP)4'$:^QGAX\D+YC]I-I3TB8,8EA!-2E^)?S9#0Q'7_Y0)^PJ2]X(
M"F>,@Z[7A9CW*?8K=B\D B%;3OCTFM=JF="-E9I'G)U7>L[(> TZ=3&;VW-,
M^'[W,EP0B)[M[D'+?8*@2:,)#"+A]H^ZU@C8;;O%:+DRN5]6$*WQIBNA!B7R
MX09[X[KQ#F[%([TGT#G,=;&J8YS_2GO1F2^7YE]IDLC%']V<UD['!/\C_UMV
MGEG)A J]CRA$?H"-%_>$A;.H#/LI@X[.$;M*ZA =X3LL=QE-U[X-I;B&UY ?
MW[8DGZ6A_LT+(BD X>.G*$G.81R_^5%,3RB5\"%F9U[G>#1=#G[E?LV&/:0U
M_SQ9T*NW_(WRO"@%4<X+MJ2@EUOFMM/ M@]V__XR:@Z'1;')=?X0F1N7?XH8
M!6X%L&;.0-$0("V!2E,'/J@^6 2#5-!3WADS8I-1B;*X\O@#H60)VHOQ9&)E
ME(PCHT(LS([5KAG<4QJ6)AMSMI>SV6)PI^: U:U-[L9%,G+^_IHS 9ASV6D%
MQ(/9O5^,VH?CHG)L\E"HE[!JZU31 BB:L'1YPLYAAR,'TX<^J@<[+'HT]='<
M9.:1NH0\E]UK+DP ^BF*NUD]/2.4O^DIRM;A4K)WN5;.:&WGMDLHJM2'V.ZY
M;)ORG%%2TM[0M.\/*FW%2A2G/5<^^5)28CD#V!Y8NGZ4Q.RPE-2Y#*XJ? 6D
M"TR5A24=K6:CB0V/R'425FW9 >]RD_8FR7C1;A*$ETDEY-GSN=/I2E<U%(7L
M-F5YF\O.2XS<H"5":WRID5U>EG*87G1Z(VQLLM9.)R$[K$&4\\!52'#0>H>=
M,G*3*'3QU]C.2Y(F*:/6= 3;+G!Q'BLF95'[E3MR3,;..@FIE!8)QG8D1IZ3
M00SIK=$HO N2/_>W-<:".2-GT5GZOEWT:DU:,3U;\M?3R=2&8I_JDM:Q=H4\
M>B,X8)BC[DD*2,7&'4;0&\!-#E,DKL@7;LZ2\R=2\.0ZI/6&, 5O;G5BUV2_
M>JA4&+0.O"S(,7?6,^/I)[VE;I3NH-2D1 >E)[9O8-1QA6T-*/=M1#L".ZK'
MP:%B"ZR4QW(QGOCVH+&7[&),<@+/.M&)C?DS#+$YOPC\K"8@-W&N$[M91,I4
M:L,BCY>=1H[0 II,,3I,ZD;YO9P#E%ATXBXWW9W05F8RB[&F^&W(VG.PU6KB
MKI;&"[QVE)63O:U_/>4%)Q3HS>*E$9AH)6;;N-%Z[9K<!'04DYL7;,76LG-R
MFAVY:-U2SUJRMM;SQ7ANTI/J*J=J7B3(V<D_@-_<=K[LXI<HD:UP&D*5=^@5
MA3MTOL/_$4K/+:J4+/:WF,V@KE(O'4+@,E&%AZX9DQ6&03XZ2EJ;B'L?!":;
MSEH%XHG#W!G#&<A8A@EPU\3;Q[QX"Z2$6/.M0J&XC2N%#4IV46\.9]I>PA(Z
M'(HRMMF74K$?*TS-_<Y)T%\[4@$3RY<^X ]NO@4B!T1(K;$TL%S@2ME8/BD[
M#EUX:RON-2L)V=CD%$R <@'"!OX@C'9D>-2T^A65WV:5]T!.:PQ256$E@&*$
M[.F1Z6AD=.O<0<16,/W!N.Q 4NG=P7-6;IW5QR:U>.-7Y%U%\=4NW<6(OO F
M3HGNT8Z11ZJ[*2EX4E*M$59%;#Z&MCUNW4?\!JJS][A\4"F3GK4&<&L@;ZB!
M\_(?/N%_X3_F?\+_'[G8^"__#U!+ P04    "  VB=%4^YT&C_0^  #BG@,
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M]4$>I0&4C?DTZW4/*(1TF]UI5C7S2UI7?Z!L4QQDT!6/@$),-#JG:/\!_%6
MO<W?@<+M2BAO5D7YJFF<=%43E$ASHR/2L6^&8,R.IUB[76@AI.,T[-KJ)R=)
M)T0T0Z- +L:'LU(%*82\G,8\AQ^8%#HCK+NV#200Y:AL[44,(;^G)89]YR1!
M!Q1%8>0""5LXP>K<0[E-^@'$.J4-4]8+.49H.4",QB=@8A?4;?(/+&M2S\/'
M#4N2I69)V@[(WVMO##F9 %<O+VSFU6\V$G1 1F Y;=US7J=K&6LO"?:K6Z#
M)"0 $E/21U"!]W0/"033SF6:,T71F^JQTPR%6N0Y0"*51[&B&PX$$\S/69KG
MMUD:R<(-&HU0:.@F%*/H*%YT@=D:4N;HZUKO$<G]NBJ+0BJ L LBU#8=( '.
MH_C;#PV"(>6.T9/1XN$B":^86EBF9:F.]91ENY.D&R(>#4P@Q\)^-@@V+16
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MSN:(8$I"( &*:K3O9)L<' AV->+V?Z&"YUC7;5M-D6F&80CD3"FG=2=[Q(!
MU.K;34#LXTY7:T1)0*"\VS2"05),D$OV]3%+V@U%&M%\(.[=$5Q3 P>R?E\?
MW[K;(S,,/"@1-B,8UH,*1%D^M83)G?Q!0C4_A':-:I^WNP]\74"VN3_#[(Q/
M-(M3GN26%9-;_0\LV*8%NND#\4P.YJD8SC:+:.:<K23V:I4Q/7);3JY,QZY^
M_2'-/M/L.2:R^,5!PR"-AJ$VUS4^"NE!]6)$ 5&$9)03:VWD>8=+ ^4CM\N6
M1!2%2?7U0U80>2:0!$QE_@R#!B$3J4J%D[ODMFV09GE1 ,2=,W35=,#89A+-
M\ZVMC:SUANSLMT3$L9T(2*;?4$X*P4!(-AKEY[8-]I^9[D;=2+;Y16=>6H*=
MBN^+O$;G6BO_AK,,)T7.-LI&IN%-M$Z7$FQ;PP9!CN%&!)J-7V4/&XGSH,0E
M =_N**FL /&_<+6K?GG@[MLGG+Q4=QT!K_H[(AV3",YK!P/X,P#;04E((WAR
M\<A?@!W!DZHCHAZ.W+G=TP9B.^QM8P%3V'F?/Q*T:_G<W 8N<?X@72ZJW9&%
M7<\$8K(:Q*#!"$_R,G'_+*0K2+4[(J;E04E=/C*;]A">)-/G_3>:D9C=W&Z>
M2EHE8;T)2E=17S?DV(;FS''+449V6'+08'9(5TM?-V0&I@^ES-.1V+&'[+"L
MG][#=,,3RE;GQYCP^]@=C[63+Y0!(R!B8,.=F]%A+,C#<H(.X9=T)0T8 5F>
M[U @14V.SZ\]D(>]."S@UV6:L'MP7IXBJY^+.%C2[9Y8.7F2(FU53Q3P[X 1
MD>5$&$H*WB!^'@/T80\5'Y._TO5YP(B(&@$QH<5,G8R_>Z!!Y,8('#K5_#_1
MK^6?AKN^]OHCXCHZN-K<BE;&@1#AO%,L\-.-Y^IN=Z1[H>7-[:(W"B&0L,>M
MSFE5GM;%S)3W0[JAAP&TURT4N:@(#41H9&NNU78PG'T[_9 3LN/"W"S]PZ"!
MB)H<$<SE!Z$W5T=G)Y!&_..8F)_W23BYW_K06"[=-:VYLE0,IQ$N>0S&0LE1
M;-;(Y^;;#\OT:_YK@E=AW$A5;68I.F-JY?.A%^78BQ\WH\-X>W&#>E""8JL7
M"C4-XTE//Y]HP:=UFZ7/,9.-=R^_,JY<)YMB0Q>DB)^KAT5[H0X?"_FFX;G0
M3DDR3G6J@ . 0RCB/RK A>FX$$K^W 'T%_&S ^G8R-R";0P (LO"?Z[RHE2N
M7[AK.TU(O*0[2+^D1U,%I_@:HKJ+'2!FZ&.+W$D)!N%AR2O*&$5BO'9NL2M)
M5JP#*\1B).F$'':N<(%$V)V4>YWRHD(9".'(=7V5WB#RY@6I'6%MAS[%0,X)
MYV=V#U$.>CY!E >P <EC-+;&=I7TC3)H7K4_,BT+S MV9V3M."(=% \M*DA4
MQ1EL/KH. FT$AE[<9[0\&0N8/6 $9%F::0$)T#@SN\>0"<*K#HP:&67:YXI6
M_]_ OT[H57I#3G$,Y%N19P/Q?YQ?UX\@%(3G)=K3OB"$6YUS1C4:/\NK'JGT
M1H$?61B(YAC!)45N2X!O([_GF=PD!GN+7SA2?I E)&/:\6.,@WA9+ILQ4B,;
M#UEF9$= +!>GER,E4AP6OWXR\;A:2WGO^Y*]71$. ^R\>N4A0CWZ[0RXJN,V
MHT\X#FO$Z\1!)N9E1<F+/*>R=\'&C8>(J5D$R#7T=%(TB!2-8'U%T?(KT4KH
M/7?Z !2M$N;E*LM*)^"HC4@P!/*(%SFO?N_I0P_BN1%U"^XQ/%Y(UW"H 0DH
M.1;G1\!O9"_,L5*] /%U\DSS([E+)6,A[/H>%#/HB85(A0P@GEMA!^RU?>""
M_+&*,\J0,$(4+[=+G!2\J#7[[9/ >K8>1'T,1 +-@O).Y@&LZQ2%$608_FK+
ML8X? FLJFS*A-"P?^^#'\(R=G#B8/)94SY%W0H:%:0@D0_=H/!^ ^["4C;.<
M$X=?.-J]4?G,*)"\C6.O[4$$:.1PS/-246LR'DI4[H57_%'9.%C)O9_2;DAS
M?!M*2/FI5+\<^?#W58#)A3K9CG%N1 8ED0T[8F:TQ(P@0R/?9):7CS0A#/$6
M81)^B!.<$/XD& ]45KASJ Z!;-V,VLE6KT1T!E,!1*K+[FGI::,Q[^B2*[=;
MS$[*5S20W3,41T">[T81$&O%<&YU[S!#L8/(CVG.>IO-OEM+A1&D^@5E?RQ_
MHR8!ZN.AP#4"!TB"Q@GD800E0!0M[\;0B"0:*@B-KLCDKT,#J=)Q4IYW@091
MZ;PYW7)Z56V8?%,K1HV]G5V9FJ.F!N4V<7SVRD'7[)W6<MB8[CHVK)ZIO'BO
ML!<BMA=">2WG!$P5XJWY.76AV*YCZ@;T 9>[CC&0ZUD:E!*S1^+U"/0UYV?Z
M]#&'R__++=O/>$G+R"]N^2#\,4A>&R\)=W_1:%D55]BWK+W_1I8K_O@E^Z%\
M]O&.G6_?LR.M[&)XWGD@/PI=#"3H^TBR.Q$%:_E7-Y6"DW]&F#UR7# UD&4O
M#'E9.40NMKW=D>W02 <2_'5$:5,'7@O)X-!12*^*G$54=,\AY'4=H(8!KW,%
M!]M( 16C6#T]+<LT"KRL,[FODRC-'BL&]N?LJPV #%NW*11?_'&$92CT6EPF
M-8Q>)P5E1"_X(W/L""GSPNXT1);M.6!*7P^DO,#+V@VP9M.DMLRFU55NI]YO
MB2)==P(@]L>C,$J(L.;4I';%&I9,J6SO8E=Q3I9IOLIHOVH]=&1D!)83OB9)
M.!I%:LDY:F%H:2TQ0323M ]R2$ ID(+I1Z-].[1)C0@US\Y?'%K .Z6^R/%\
MQWO]/!Q&C)J71TW.WDOC^DR+8DG#W^+BH6'@%O!2J2^*O- GKY^7PXA1\_*H
M1:+9@:R1#7'!A.N16S?;@8^2;90/-'@<Y!B:JX>OGL?C"5/S^Z@O72E/A]/A
M4%[S,9!+36I-S>?#.'$ 5W=(4'/T%65+K_/R>I^&[.N)HLBWC:GMH<<4DZ'
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MN93$]6QGTLOE9_) P]6R6>!GRY?\W4OC7RH1 "-&0]1GBP9(V)L2M[JM#(=
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M?WJ[+:^YC75H%S4AQ3L9)4$%@D-WM,S]N,59\5)6XF=:.R[?^&O^1;Z\U,=
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MX37+D3ZU/;BF7<A@QC0MI&2G:?ZED@C^1;O^+V=C\S\6_0502P,$%     @
M-HG15/[7IV'  @  *@D   X   !S8W=O7V5X,C,R+FAT;<U6VV[:0!#]E2F5
M^A0;,)72@F.)BZ&NN F(DO:E6MN#V=;>M7;7"N[7=VQHTJ#DI255'D!X=F;.
MS)FS8]R=R5+/W2&+/==PDZ*GHSOY#?=.Q['IT&T>K.X;RQK)J,A0&(@4,H,Q
M%)J+!/S1I+^:,6U069;G-@_)0AF7H$V9XE5CX]]NK/XTF,R[D.+6]&"\F&^Z
MT&[E!@S/4(/ .U R8Z+AN?GON,K+6@=?_8/K(<P:]V?!]$OW-+ 'L_YJ$A!$
M*]_WP.#>6"SEB>@JGNQ,CQ)KHZ1(//_V4S (-N!T;,=M'HUN,_?@[-!UMPWO
MG0AUWH,3C*T4QM+\)W9KB/IQRS*>EMU3@(RIA(LNI:<V>): 5M%5XV%49'+L
M[WG2..WC+S$.!;\,)Q%)"-4?\Q@NYFM_OH'%&(+YR%_Z]$6/*W\2K#?^RA_!
M\GHP#8;0'PX7U_--,)_ .%C-GIO=/_5\EB'!_8>3H#N7[V_HOJ@+"$1DGTD%
M3T[H#,7>(.Q085A")(6N;KN18'8(7$12Y5(QPZ4 .E>X)4<154?DP36L,.$T
MDH/'VE#/];J06SBA@(['4F6PMMI5^A!ARU-:*&27"E@H"P.?"X'0OKP I^4X
M50Y9*,*D"@S$]?J9,17MP/E8N[3K8')A1<R?P'SW]H/3ONQI0A),1)RE1-JQ
M0@U,5Q$CC# +44&G7>=L 1,Q;*FDBH 26?U# (H88QL6#P41.6D1$\&,3O=Y
MR@0S4I60,\42Q?+=L:DJ#^Z)I)HW@JP,N@BI%&&JFF)9A*:B/D(EJNU:.0QE
MEC-1WK? 0IYR4U;4D:?AHL"J P:)K$*.T>=1VF-UO)3JGMEI[<-.>W57IN&-
M;!@H*7_H6B)]K25)RI#[<-G7%["T^_9Y@)8LS6" C)0^82I&0=G'T_/D?G3%
M7A_'_^<E]+3R.@]OT_JOC/<+4$L#!!0    ( #:)T532!P;92'D" #.7&@ +
M    <V-W;U]S,2YH=&WLO8ESV\JQ+_ROS.<D-U(519/4+I_C5[(D.[JQ)5U1
MSLFYKUZEAL"01 P"/!A %//7?[W,8.&BS1()4DB]=X]%@IBE>WJ;[E__\G_N
M!KZX59'VPN#7=\UZXYU0@1.Z7M#[]5T2=[<.WOV?C[_T8W@*G@STD7?WZ[M^
M' ^/WK\?C4;UNT[DU\.H][[5:&Z_]P+?"]0_/UU_?9<^'L]^/GOT?1S)0'?#
M:"!CF 6^:7>KT=IJ[>5>LJ654W@1_%WOA;</ON=@:[MIW^,D402K&Z<OHMG8
M-]EOX8<M^Y/"D*-MFGGS\/#P_1UNB7WOG?9F/=AJ-)KO__GM:]OIJX'<\@(=
MR\!1Z:]@XC_F#X#?VD>GGLQM>V/[/7[=D3I[,WSKW?/\U$S@6S<N[HIY>/<]
M?UEXU)OYZ!X_ZME'7>7-WFCX@O;XCQW[:) ,9D_7C:/W\7BHWL,3*O*<] =A
M\(C?A,'6Q.\BU9V[+WOOX=N4Y72XTVKNW[>)_(3]0:*WHM!7&<=TI>[0T_8;
M6O-6HYEGR# )XF@>/_*7>78\2N)H[I0.W\.W]D$=Q5NX"3/FDWXU8T*P=Q,_
MF[VU\,L&_C*;&;QUYE S!H$-Z4DYG+E3^,6,GVAG%*;/#\.1BD!F 1\%3MT)
M!_B#5F,;'@=1I:3[\9?8BWWU$7_U+]VLPUG]Y3U_],O_M[5U&CK %4$L3B(E
M8^6*SEB@ /DF=:RBK:V/OPQ4+ 6.MJ7^2+S;7]^=A$$,O]BZ@<6_$P[_]>N[
M6-W%[UD2O/_XRWL>NQ.Z8Z'CL:_X@2WI>[W@Z-^)CKWN^$,7?GS4; QC$7L#
MI46@1B(*!S* R;O>K?GE7UU/#WTY1DY7'Y[RF@]_%9[[ZU]Q0:?G__CKQU^\
MNR.<F(KXGY[KJH#^":^^X.,A CF V<*&'IT%L%'C$UA>)/WSP%5W?U=CL^2[
M^!K/SV<8!W<<2=1HQB'_>QO)];$!_SO<WC[<;_WROC#$_!&/@18NTN.S+WN/
M'DFPH/_U'2B'HTX(!TP&7>F#$/Q(_YDS_.=(.J@=S/B&XXY.55>!]'>OU:T*
M$E6<Q;&^[!)+-ELT<A)X_,7W]ND[X2K'&\"(O[YKP/+ML':<!\:]BLS [3AT
M?K3[,E+Z.(G[8>3]1[DSI]&8F@;_;&(FS0;][Z?F<R6CRZ@=XQGYA_03=:4B
M&NN1\X+MN9J>V_G%9]BG.LRM^0*;=:YU,F>C4DZY?Z->@F3WS.*1Y/JY67SU
M0$RY9/;P%V#'*"+9XTDU,:&=QB%H_Q?8F\LD1FL#+<I''JN9&]3:;V4RY16G
MLQ!Z/6XJK\3 )^%@$ 8O+G!:C<:S1$YN.J\K;YXJ;J;VZ84XN=G:W6[N[^_L
MO?9\'DFXO=9.L[&S^]3#=>S[X0B]B,]A=!HFG;B;^,<.&:WZ6CG*NY4=7YV0
M4Q4_6PP]E9N^!Y%RPEZ W'PC[SZI0'6]6"]L_!.I^V=H,TH?EJV/XQ,916.@
MT,])XZ=.XTL8NB//]\\'0^E%:%Q]#;6>:5PU<L;5:TSE)TP*F-?AUG;C7^95
M_VJ#):?T:?&-W]2@HZ+'B8&G6!WH/!R=!W# >AXP\K'6"NCINAX^,YNAC,#^
M%_D=7SU'!5H=]R*ED "SYOG,K?V)J=FMO)+HP>B?F531DK?D_NS!J]17[U:Y
M$S/\KA6(B*]>5SW6R+]W(S]>-?=_?Y23\2I3F[V1'Z]:C7F3FG,^B%4_2:U<
M$/!#6"F9<<=1!!.D]7X:9X]<R3%^=#R2D7LY)')_@0=C?1[ 2?)"]TLT[YPW
M<XLPFHKWE]_S/;A5X/ZZ4QPQ6]D?'.P^7=7_[%)!TW25%R=HLP3NV=W0B^@-
MZ>J?QECFK8];\9/.)KT!(W*NDUNHS!:J.V.=/C/DE4I<:<AS4G<J<CRMM!<,
M:64CY?7Z0!YYJR+94_;[(?#7$X_3O%7?9SV]Z-H?6'HW([+$\$-*Y)7:BD6?
M[IDADI?U&YZ]E(LPX-6@812/SP,=1Q2 TV>&=H\^N*59TTSR_&8X\Y@YD[X\
M!?WP&6RP&?;?HY;Y4L=R8FYVYZ_PU/P,&4IT5G+^T'VKG64?-0^?YDTVG^I,
M+E'+/W1F=AO;^+\G,1.)\SB_XVR;7P;*CO'\@ 8XR,\*78:.4J[&C<!X'+JF
MEUV@^"V<P"M?.K3-\S9M)]LT^'=S[^D^QZ17O;O;W#M\B1#G ^$9.I[-UA,G
M_*HQM@=F3&Y=Z_ E9KS3;!WL/HEUOWJRX_F@AL"8G#7WYXG J2/U4W&P!X/*
M!?O]I@^.41LO+CZ'2?0;<'OTN,U[L4#4O3,M'J=Y?N?L">[!=A\\E2.?+6JG
MS)/+N*^BF[XTYHO^!WE(]SH;L[RL9ZV=9>"352@2A<EQFD0@EGFJ)EZ(RWG=
M6>\<[AX</%J7O,"UP:+%'LF0J9#6O<&]QHN&L%[@YNPD!%\_BC'ZD9U?#-:^
MMK1N-?9V6GM[^PN<_0MJQ^;VWG9SY_#YC/*$L"?)S$=+]WO8I3GC"N]],0T@
MO3#4'W_!3*(C3?E*\&9!24A'F/'QZU^U-QCZZJ_FLSYFTOP59[AEDR_J=]K]
M*[R]^ X>+C\&_:EA,?07Y2H=F5W S(5[TPO,XXJ2%.Q?GHM_=ST5"1I6S4P4
M.SG_>S$]8?+''^U'Q;=ST,'^!3(I(I_N8S9%^[OLNW2:;NY17$$V!']C_[:#
MO"]LQZS=R?@:>&0[X^NDH]4?"4S][#87(WW=_3++5CW4EORG"X/=#7W/\<P<
MA.O!MYQ>F&JIXF0QJ>;XSM/O/LYY@-_TR_N9 Z2;EL[C$63D#+CX8[:3Z?K,
M-T^GS,S[%+K *!O?-A[/MV8%/\^W,RV-7"P.Q+I.?-SZ<O/N9R\ S]+#W"AK
M)S+ODL"?7,5+\FR!A,W'D[#Y4J+GH7!J1<)5T1YD891"+N4$L9G4BPGBJ:A.
M*18\>8IW'G^*=UY2$,^X]J].\3-.\9-T*6WS*^G2BH0+T:6O3\(YF06E)>&<
MG K]:?Q-_CN,3GRI==&\+ZQLK<CZJ*AG1<IG& ;-O9\W#.Z-KT1I?.5S& U4
M1"&;?NB[*BHYX8@LEUUS*7<97>/=9TZ0/F&)*TW!J0A92>GU*=%>H. D.7\D
MGJ:DO5G4FES.BM#F*1'ODA*( K7X&W.R:,H3$:KYJWHE.IE]?<DS].BX?D6G
M)YTGW-<7H]-3;C J.CV>3F9?7R_<\,@DDHIFKQDQR13;S_IJS</,5TO3Q<H5
M3[)3?,3NV!6\?C#"YHHQ!_!GW^2=-T@&);>K*2DDNYPJ9+X]P.:/'N/*E\&%
M'.2'*&[.6KG'S^(5<$LK7IG'*X7-64=>>5SR_DJ)%7B#Z_E)[-V"G^<D$7B
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M")ZA+PU>Y+ OP=-S5&(J(<DS)G1EK$-DY"Y3S[!Q=75RI4WPD[*/<7(!0V^
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MJ%(^RJ-:SBD881EB>:BGPEXDAWTRRKJADV3;< &OZXMCF"9\2?Q[]NWL6&S
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M&L,NO5D"B_1[0(_C54S@8C)N/I_2 ,=BQ U;/F1?F!M3+(&B)CR9.3"=2R9
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M?IDO15$*IW]']1B+?N#^V\Y@:::#]Q.(.)^=P35+H%K5(.M4QH"MVK%QM--
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MBYGN\ZK J7<5@WXA$YYPKE%57>AZS=1JE!-0U@@M5AU!ZK@0N@6G[>U#\IF
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M@'XE#H)R+C1C27;^UBIB>3%7AX<S$>:2'N@UYFIMPU?GSDOAUZT7>OD/W\(
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M;D'RYDC(4WM5522]6D?YT*V]>(1K/1X4KNW@+\../3F6_X6?F%6X\]K=>K1
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M ]%:R$6N#='AS6^J?I8_7IGV;^JR_1LP>/97.9?3Y"_'$%V#KI8_;I*Y@O,
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MUF^XJ"?@VVB9F0_ V7>L ./J;UP<_WDFM23RVTGR-.\*]T/8$>[145+@1\'
M'+S9>[\=X ]!:KAOOI3D%WE($\Y=BMMT%4E#%2:"RL:S3*CJN,'-L7 X@_\-
M?_][#CXT_,\Q5U#V=H-?HV*3JP2DP:Q+ U$*\;V!"P6>V)!3ZV4T,(%Z3RPL
M_2CS<GG&I<"V@Y.2>'_0+V1-WWQ+NYAX*AOK'0VS'+:ISS@'8;VG30 !OHQP
MCZ;2)#%)S?<0-O(_$/$A*!&_05A(^QO_RICY@P@4-0SF_":(A, FCD0RH&,P
M40C^T/0?']@$T6;P<J5-T&O;42D6 *'!!8,7L.0%?P%S_@G>(:"]0A6E:^ I
M,]CW<I0,+*E<BN-%^M&$&9%8R1%/5T.Y.95&&X!4/1 [(K=HZ"',$(D X2/[
M6.#-4J:/EG(C9BZELI^8K&]^@4O! TK?4A;_0@5L>/)>5,!"%^4FK!FXML,\
MQR TPA47I8[//$SS'F;4/QY=(-H";-_S]6- 8_1KL/ZXF>0W$ H7[4,]0 :S
M0A(;U/\CLBT#['C@V!!$&NNJF39!FN"/BQ M* 04:?!KD9?;H7BQ=+AH/SGC
MT7=U9D("J\V &Q31)(D1N0B;LP5RW7R@RSS%5G@^2TB\!^<?Y5X>$?,%A'IQ
M:9C83-)\RMZXQ=_$U*&FD1L^0YHP@!B6!2548>=>NAI/T51XO^QZQ:WG&TM5
M$8[V '8(#A)HL+S05\5Z@0HSID] AA,X-0*:1G>P>3EO:>":0Y,/87E&>#5.
M[#,N%*7!")8_BN$-.5P8%OF5H*_H/7FXX7.59X*R>SH8!2-->%&L)FQKO-"Z
M& 46,D"7C+VR,%91<XBI%*J.LC-ARQFELJ-4CB%KB#X)D:=J]-?(\Q5Y/1Q-
MZLI*?)\ +1?R)1LR@K=-KI$\*>AW4Q6*^:5C-V5_"<Q%SX.8Q2#5Z'R2'/--
M1E&6P;OH&>5GAN>H$-;.0%R2/)9R;/[ H^.?"A7?*95[RGQ,11O\^C4&4#"V
MQ!4-5J!GJ"K,?G)*F 9\(JI1!;TBC_ H$*2.&@JC_C=P$A:I=E]VB>;MND3S
MY"GA+PZ[?F:QZZN:'KZF!0.Q*Y]@>T=E<$*]9^W1Q: ;*$]2L-J^Z1N[JXC<
MORWQ]T6"@$K\KPEW.%Q)B.>%_ PVIHA/"N^F%&K2N)&IMF:""%HH:)9 R.:H
M.=>LF6HT-ZS/(7RC)R$H1)IKO:O1D:%9$[]%$!ZV9._=>V#O8><_HU\&(#Q0
M,Q3D*#%OA:7N<<&#D[> >_Z\]WH_W-MGC-W/Q*FLEM[BE'3$-7<4%A M')U^
MH9B5KQFVG#($2HQ[X&")Q6='@"Z'OAWZ&K(%40R>))A/]TFOW65JHJ(,3/=!
M8$3@+O6U2%=F.F7/0"#_<H-QDB66N]AR(!.0\.>]5[OAP<[^;(_-O+N6 D;C
MXX=3Z@]>OU8WF"C$Y?NP6OQXDR(9<Z=1S_2CFK'LRH4KT1HA@S$* []A$DV+
M'*(#^Z02OXT2)G$>H[-N9$GGEFSUV[P@$,(/#"6(8%4&AD \^@#T&H<[X:O#
M-_=>AC?A'BSB#ZQ":H;Z9+1I#KY/OZ/Z"SU9WG6LK(N*P/N:,;LM#"&O Z;%
MZ%4X['$GK246NV\.83WN+Q9[;T.XQ-T7A"&9CB;9C]7M(WH#KF>78N6B\;G&
M\%^P4V+29O# ,W805^*:+^RLO!F\-D>__'9PB<W?P9L0(A2V?F]>A8>O9TW@
MHQDW42==\BV ][9Y(\@)?E5VF>N+541YUQF;02F3;)@3(G">[HOPXB[79 8X
M1J,4)+E7R??27'3^KC"'A9,WO >89VUAS; "5&F+V&V4]6VL>,N,A3MO#\/]
M-WMW6.>V07\='KRYQI3MK(9!WS_8#]^\^H%U>!.^?KO[(\MP1XO^2(9\__5A
MN+/_ ^MP^#I\O?OF[@MQ#TNN!ESV%VLNU_HHX?[;M^&;_?W;OYS_9ADFAF$!
MO:,T[Q5%ZXB>F+H1#])#HLRW%N/G,P-&\W/A)=91X^"O&G[-3&;<Z^/27XT3
MH&6TAC8..8LIY2I)%6)#6S/SIC4L,%&>ML*F*[!3I* *#Y_'%1890Z/U*%@M
MK-[AK(SI?(P3"J]UR7QM"5=@@ %1K6@9#78!^WI)7ZQ:WOG:A,WO#2:38TD/
M?U$FDW7JYF6G;DX52<:*B=OV,^.1%_E>XQ4V="4TD*C)'_]J^U4P3M*4U$,[
M67'!8,,/P;E%\5Q8>) #\$1IJHTC,R1[3(XD]JNH&<!FD!>0-$(G>Q\H\,PI
M7_ GY!W]CH_NMSGL?I>2<[ZN]WK5%,5MA>*(WK1];,3-O<J+;U+O(U6"))J[
M.^'ASFZXN_^Z8=HZ/KJ[&^Z]V@_WP+F/JEG3^%Q7M$&4P,U:R/U49W')'4MH
M6LO!E,Q6>]FP8NI:0S.X?E"!SW^)%4!46D+JT&7*YMP-^5/KP0#I&!A/QI0)
M'%I,! 3JN&EF L!&#,*T('";*T=VJ;::SA=U:"O3S]2GW>1'(D"8NSQ1 45E
MSH@P@O7A+1"#DBX27_^BBVW[.^MBVSKKM@JJ=>W!K#V8N1A3L6N<R_ ,6MG,
MU"K[%!D? < T!("VD))R3+SB2)^W@Z-NJHSK'2;G!MW@,)%O]7JORUO2?("?
MWIBY0I^0<]1]X1\3HBWA#)A+FX@F&180BC-(%AT/?(A7X>'A;OCZX/":LW'L
MB7SKG CW)#Q_,JGXK<!9/ C?OGV+/]E;V8O[=%.1IC'<>->.)Z2+A6]?>T\H
MW2CHT/0M3XI=1$IQJ%.E+_-LSL8-<$J/M6OMA][+#UWA\MZ/4FYKW>BGO__Z
MQ\7IYY.+BX50:C^!$]9NA/5><,4=JOW][=>'>('KVV%I $%Y?5=0!2>\Q%ZR
MDAR@*R,M,27GM6DD_!5.(2S3.AZ:,.@E.84B2,V-X';Z]"UZ"5C_(W<ATH[T
M1V;,K0 ;9GNX'1(4?I,;&ZDIFRA$/*H3C[ZY-^52IV!*I8.GI"8'_J;],.D[
M*F2&4G_EQ\#^IP+N;MN;)J!*%,WOMS?QQ=N]3((%)W1LNYOI5AU,%7% GK@.
MA3"XH-XN?KS?\*U9EVZ<7/RVR2U./]+*1,SKTAY%;$\OI[7I9OT J_75'HN7
MHB6N;^3ZX=XM*K]I;SA+G+MZJZSTL!U;\QNV*/)N<*6?IFE=*NQ]-]@@4FSI
M/.NZB[3.EZVG(_!^% PC@>I3U>96[6':^0$*&"_D*[P1-6YI^YAKO[^F@0QA
M_WAM4D7XV.E4:W:H^^O2T!+P_*/VZ^^YU_^3V,W2AG_6W#.Z3E(YKK29/@'D
M#U&/GS".TK>W'?RJ]5VX>DL29+V8%M);-&*=9]6*G/@9$<\1[WR#_19\OR&W
M,2,]?E9NW]A 9URSW9QF.IN$\%IDL#*-!X3-Q0^VUE6CNEQ8?UWK"( QJ>G=
M:>>7MOGNCKUWVSCE0+ON*)+'T\*=D-1RIXP%\*9;?'#R=#I(Z[P ._MMFBH8
M!^35<290V=F7%T\4\; @R2BK Q1>N8/X.\K!;=V>;8B\C7#P<Y)T]UWP11$!
M#,\!53DDZC?<W(4V"+[LY/GN.GG^9'Y9TR"_$_?"L[;DI\*AJ>98Z 1!4>!F
MF_C=0H+P9#P,RJ+_?WZ:7%TF_U^Y"S\?;/][ D$X^-(=O_WEL5W*IDU_US9^
ME>?H+GIA#CL7YO!1%\8^T,+#BG/UUU!DI?VR?$'1A60IPWGNE^W2]GJRQ8-H
MN0_$.X/(.4H<S^VQ);^5<H>.6$MLJ$U:,%$2^ !;:10;21XH&/+A&W/YRNZS
MVB!]FP9;6,M\+&#.)VZQU8DCKM/6Q.K2V'Y;?FXN1! E(?:.Y[HA\+I$IHI.
MOUM%1C%7.J1SHMWSMG$W<U^-M?5>[DA]O*N6C+C;$2H1&][:&DIT@8Q2TDDJ
MF#1^JX X3->((U@W:)7*5/U*4S^#J%<0^3 NI,WN3W6[R9GF 26$ET>7?S+!
M,4G@EU?HRL?2SZ[CEW ?;2B;5UB0T_TSWQ-ND<"*0&43;AXEA!W_&Y3)]V#C
MU29E(2N,<9 \ 9F\O;9VV]+N24.$_ 1(O+^QOW.W;^,!S&1V*U?QZ/V](@7E
M"?9V]O:W@Z.@NLJ#49W%&*-L[.W<_69\ \O&QY<^V-H[W&X&X_L2&XS 34S1
M5>3Q-@IH'B??UUB:!84#>^MP8#G"@?T99]9QL1AE ),C]V[%[,)M7>A7G2[T
MJX=WH>]FJ$B'H^HSQHWN48YB3&%UY/IL&DX[.,H%;MK-*FVK!.5/>NU']9C\
MGJ]R\+?WZK#*\U7Y!#?;OG;KYO3C(!HGZ?1=^YW!O1LFV;L=O-.N-[#>W?1Q
M[G4\XP[KIK<TW).HHR?;V_V_/<3B>F_2VDR^R^%C25"T0 DZ9X9R=("P%8C3
M-GU#TR9Z-.$.A  G.*'/1"5J B010M V "D)47Z5R; 6M@<0%A6X3]MWL+>/
MMVN/LX"]!6Z6C+%E%YV7&'5ZI'$FLYPE>8P$%@0ZPE"Z(VCVN\L&:"J4IY[K
M 20)$Y4,3R*TCG33?@<O6OT\FFG96Z"L_6XB+""]Z(U<C!W9?PYV1#V1E""T
M.N7QUZDJ(JMA)"Q'G S5+>GS/$W-TRSP<9F8"@JID$R(]"%[^0920$EE%4\@
M$YQPBMO,*+"U_?G1>PE7&<ZGHFW;"HXR;TI<E2.RP=DFFFLU:YQH9^ NV\'1
MS&[EK3O,"$:<X]/E9'L\:0B#7EU15LQ$,3%Q\-4H7D4&:8V%? &2V50(D- 4
M-L]9P1QT51?^#?CEVH+TLM3AH]FU_07*\"S_9K!Q<51N(IIQQJ$E-121BX2.
MUBBZ%+Q%HM,X",Q ;-&,<BC=Q&R/%K1/^7,J9+"D8N85I1B1"YSO?!?\6B=I
MO'5VE6WQ.3/!QJ]G9YNA_H%_N?55O'#\Z]=-%-:9+S8^@Q]BC&9$)1)F\K;#
M6!F1;5_^RM#)\AU$.J+J.E+1(@K@LISM"957 'E=$#>"LHEKQ:E5HC3HX?/1
MO]SQYB),0AESQ;#(2?/X'_0IK>[@?+KL#E4T8(L"1/<T_%G*=-SB7J&\M=4J
MLDF:7^=\E^+E&<BIG!]V);X^[$IL7/?^F]*]H9%8(Q:0QA-EA)U1KG;/W7#0
M!UM)G3=QGY7$";HH45^UY%<*F*LQT]-;:/,=.XYLO00EUA18&VFY"/1:U!Q&
M]:VZ[&! :ZU-V(YQDM+^C1%:>0_4D18INNP*#K&JY<.D ^*@GJ 9,@3NGMF6
MV QHV+R,E,5,-378,:*0!WYDE_ 6-G3S&BK$4$5<]_#?9"ELU1.D0&G3F2D<
M[%UX._IAW/8^?!%!L2Y,)@%+/ YQGD6QQ0@VYL1)%:AO 8L$8RNK+67\UUH1
M_[VC2NRA"5N(N:15(,Z#L3%51Z&8L+8!8VWYF;R!W&#ADFVS'0IX%[$Z6,_'
MMZYR=-IC.(]Y>DE52.XH,%5_>Y-G$<GKTH)(_;F7I]56GFGEV1L$@4-ZZ9Z\
M6 ;A@WY[$=X<,;;<GH3>H5LJSE_R?L2>3C/9*%(>-I=HH.EQ[*_)V_6CHH>4
M:PE2I1E!Q(H*P3G??]5&2QBA;3S08\;] O5D6$2QM$C(:H'&4'YY B3C;&-Y
M2OJ8+(85*=>4Y1#=O:D<3>XVA<>!WQ""NDTF)/-.<)",84@"#[^V DLMAZX4
M#]]/,C9%THC5&L::4#<M^@*L600#X7P3&I7(I$/81 B/48:LY UW/K#&P>&J
M3:(TYTS,^E3KHNB"BJ+[ZZ+H4O2N_*.&+UEB*"*)JE.<(O%\@&:WGBW"%(!(
ML(G99TPF;^%M6M2 TO0J')/$KT:MHY1\S@O21/P]"E$8P24W00WY;R8G8%P-
M*$W;OXWJ#YMN0;'U>?0.WZGK01CWL:</E%73:SZVO\KMJHV]0J,'(8EPO4G6
M V$M)J?V!@:YC#'I!A8]+W![9  ZMA=0\YS.,'$FS,W_&LK8[@A'@$5V0IH%
M'6E/=)7CJ%MT]T=T?EQOH47F<2\R6C%JG:.AEMP'3PF_/I^R$/-%,0<!8 #!
MQF65URT8^GX'MC/B;<6PT4JPX80/E=2BT:"695]@RNU/\N"7=,R=A^.;7.DM
M+%L&GE<'HJ2TL=8]DX'_7W&_/<&TA$U!^$\+:K58:7C==8H##S4UD:)<T"A6
M[HYDZ='EGFF$C(OH"H64?>$>AGA)QIC&AI*)",^ 'R)7$L[V($DE@3/)*R,T
MKYCMD+%"_DXB$+;"6)>V4L2[,"\/*;& *LCCX3$V%Y=</*HDB8"CKW$+0U4E
MHFQ(F!!+N"4*B;0@JRN!56,+$YV%YURUV%O@IGSP=L _Y6BD$/4\\&S'<U[S
M_06N^0EGIUHT[9R#\<6?B:79ACM(25E%@T$C52!=MK)]B#]A&X[_DOQ +-G)
MC-(''FKZ.>_IP0+W]".X@U30(W^Q5%9OV3R?])ZZ89-J&G(6N"2>Y9 2!S1Z
M,=0D64+]E;S=)AN*M_:<-^SP*12?I/G4[462LPAK/3PA6M)HE*7BK2""$![9
M2%VU/GT&LF'U_LUGZUF;J%<+W*ES2?BA\Y^2,]!'Y-T_OH1-:OSV. DF"K'D
M!)4_Q,%Y$W9"!;O8%+58]6P5I6.(LL5X;]N?:37AIM $PL.B3H2 PVL6LR0<
MZNAQ-#L17PZWS<0Y=J531N0RB5S_368JC&M*<0FQC.<&4VH/#E'%5ZP?"S.N
M[7 223TK^P2UK!'S6E2 BI5H$C/X3+''73F]/(,(J\2N=T-4>U?87D<C50K4
M":%,Q.QX60J](1"E# EVD6'Y9))&E>4JXE ?(3C8[\LD^?RQJ(XY>L7\-)5+
MQF,3X]P,&;$:6I8Q HXTQJRV,P*#A,IC6<PY:'+?0FUX8FYEI*2+.Y()@SIC
M(DNB-?(B/$I(4*:;1ZDR]3X]?5!$V= P%PC%B?1U-R"=:T-2Y&3-BLLPX]Q(
M>Q85.V<9)>!T#PL^WM(V41CL7W+G'-:.14QJ$/A$<P((K3ND2?:-ZR]"\D]R
MDT99IC7<ED]6V9FW6RYQIE>C18VY1TJ#Z_E:B67L>4]1IF&SIJ+#C*1---\C
MBRF3185FF7&#.Z!CA62*, B"*^ C825N6T>2P[K"2%HQQ0'6(R;6RA,\3D18
M*0V=E_DW7XMWY;"PP ?>66G9_[3 Q" I%<JI,.50M=*7X<(@;5OIW&\J:'FO
M$$=59"5=R&/*:.7[0F\A!W PI($3S2H=%=S+#^H"TZJ<LA>,K$P?_J]H/'E_
MNDGMHYF77=4:M6R;9E?5O58ZU=BD"94K:3I-EE\R18FOF;1"6* 4D*49Y1.T
M")BJ9/0#TJ#R@R#C"A)'HEN /'.HAZB\AP*L8":;$*,DI6\F)ICN('^#YRO1
MIWH&@5)Y\8L#C@R*:&SH60AW@B54O:^KU_=4TBS<1:B3_#'>7*:-:<EQ"@^I
M71PE]5P%[5-.J7:QU&CYG,$2:6A[^,YXDPXAAW^"<!KJ(;:<>9RG5B/0<O*C
M9*RZ K:2+):DPFTNG@,XD!@9;63M PV_Z8]05ZD:LUE9+C;0+F:8=$'-Z2LT
M^NTP]P1 A,++MK=&V42<=?-3;,X5D]'LW#E!TB0D>O3MJVCZ;#74$?-HHQ9I
M.D0-;>$89#W=_LU,&P8@R4C+Y0Q/&.<9$AA(&MV:'@XQL/I#&?.LI (-N5S#
M:-*D2Q-^"8/CDI+^-SL*CKU-AQHA$C:4M^8+-'@;XFA"RJ"E)!2GQJJ9TTYP
M8!"BL$8G+ B=<+!&)RP%.N$34Y>),Q)C*S>:WN>#3;B&Q!YAKA":(C4U:2""
M"RC9KH)!A=O-8^1CV@<*EI)^I07),:9EBKP'5Y=Z@K,E-J^&8;*/"/3KT.PS
M%M1-I]Z4%J )A4U?E*@A1\05_X9=*?K%D$AI71]?WB?60T7#%FP<48670F7;
M9/$A]D9AIK0) R'$&++"A <9L]O!=Z\GC*IHD_"" U'@?"/D)Y12_H3H>[B>
M7AABNH17G/93C3T5<,< 9*KG%][6V+PC?3Z6%@ZQ8SX!XDUP^DD^J05V+)4>
M<CJ*GO5R0L6,X*W^JI%_I)K^(M210B_9XHB$UT 63.(!0ORD8 YU.<O0LU'P
MMS[EO<%)!=.*7[/B(D1+1(I4ACRN@L;+@;?5-Z62).N$! XC*E1TG$DHS%!>
MK@PV?DOS'NRK'FPB@X6G9OSBA73WLPH(+NKB$B3CBT%C'S9Y_(5O=2Y1&5I;
M''-@?(:HB@"1WXBTANZ@.RI<D=QBT_?0VHH$Y1BT]%".H?+CZ/MO&:6U#R5O
M@;:E$#X8AXD41U 1MX3R=0D<X99:9?UVG9]W_9XYQDTE*6V(M.:)XP0SC^PO
M6_O@,V69H1!I>7,/6D?2VU'A#F9G'Z,/#14<G$=+L42-I.=<G@;!_\C0*FI9
MZDBQ]%!4,V=]F?RY)VN^>G@/@@8:^)4-*664TW$O3VE=WNR_MV,+[EPM>? G
M_LUEVUCTR,2RP/>F:GHT;V='@6^TV)^1\7DS5+YZGZ?^_:W=T*=:@M7;-"Y^
ML7]%-%M3.Z+=:7^?.*T9P-LN/$YD3#PUXS05:D%-EM39! D-8NY24/)@\3+&
MF,!J^$LIA<)E4E:4\,I3,#J(5@4;90<FA,%N>!!\2/+O46:PN0#4V 1"L(I<
M@LDH@CBZ;VHAA::LBJ9I^S3U0"DJ-\[/C\]+Z?*RO-H99^+:M-K!QO')<;FY
MELF'?^*OBD&460[BN;!G1TYVS_%.4]TG G],.D(X,XYY79(J'OC#KB_L,GX:
MDQ#9*,>B%W+5;_SVC]\V87NY+:XD+L?UIC[X$Y\-!EJV&1O0$)EQ:X[FP2=
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M%K[Y44>P8N7]0M5"WB%@\;"3-*&Z,2J?:=D-BX<K?859S1G,I+&Y)(Z%E4$
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M)VPW1++S["F5-X"UI!(/BW^> ;;^ 9J?E$?*7 S3D2T5GNHQ%T82R,/MRXV
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M:/_%VKP*.]V-P@FJ'O##V&VS%_PT>]T_@IX(X$>,T4# [YW_!6[A>V]5#H>
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M5]S@QR+3!?,E_N5]B'(1&:%+?[NSPYH",S]H K=L72Q(S>!,I>&;B_ HR'X
M>8?D$&S:<?(5FYO"QB-TDP;2/A-83/>B^P<[1>1X&^:!#]S/"XF]G *J<CYQ
MEBQ0?\T,^_[RM+.]J?A$L3N-\<LS<E!IWGXC8A ^V" '_8Y\H51PX<C?GM*U
ME'(H=QX362#G:2[41$V5]PO9+5WUI:M4UU['C/AC+)!^^1>/9S5OY.$9T7WK
M"D<*'\%1:&.+!3!6\(>*ICDR U!<L&UL9M$((T60'V%W 60@^'@8#U)ES=85
M08M.QA&3*.A&>7%A/(UN  Z_^%Y?1SK/O0O5_X)@2Y3%50[W7DH0@AL+P3Y
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M;"C&(F71XTF43,>(K"JOB*Z$9+PZ\TI6H2?*&^MQ#Y8$>)84*0C N"7X$(2
MDWF2K@O?)*B:F>4[6:CHZJ-);Y26Z[D%GIGOWYY_.C[YM//V_/+R_.-/7@]@
MXXNW/_GJ94D4!C][ER?_=[ES>G9\<G;))]&DUSY_?D?<_I^)&NJ=7JK5EQTU
M@$%^\E1TK:;9__S[#I1"C__]3^6-4CWXU[/_ DG[V;\OZ18 .([@P&%UV3]_
M5# 0/OC(\/%PD_PSR],D'O[[I,2QSC#5>LS[EU\?>!'WO=,*V#U_<>/F$18:
MB)&/Y(WN?]>S1X$4AW[U,ABL@4*9T_.NPWSD4BM4T:I$=M>[A)\!@,<>"5#P
MIC?5*LU\?GF2(!BB4 *K!T4 B&QF2& YCX@E$P4L _0 [SV,A3JA$3'@XP\'
M>Q3DXDV %.(,N][IP(.7<%J8'H0?DN5 C.FK(M,H_'B!'H1Q2>KMA+X'C\$7
MD58HTN!OSOZK0A+N&0\(&< 5T 3D$[[GG.%(158\,@M&C;>G8Y@^Q^%APR.%
MY%PL&\4$2;RKS9HMP.#-&\/33(J<-X?+'R11E%RC[@0< GD6'C+PNWAXT][+
MM5^'LTN'.TR*X6C>ZF!L>"<CO3XAG3Z3(X"3S+UP#/)F"*]%? C.>8RTBO)1
M'U5_>S2T ,/WZ/(.GGMC^#S*=IUUJBA+> <!'ISR\FL=P9+I22].XAW4*W6N
M?\2_D7+WP]PL%U?!<*Z JP*,X:8NT@3@6.>XN-,8^3RKJ/CT:7R%,(L[ZU11
M83ZBC$#40'$;)LK,W1H PO^'0(ZC"/@U"LZ@>0 4YU.XHRL=P=\!RA*C<.P%
M18HW6IUG=_EDY4')V>'A[JL7., \.>Y7%9,"=\!$YH!.<PNUE8.]GT\& SA&
M!-ACN$CZ<O_G[8J6Y!%?)M@G:'D7I@":'3C+@&X+OFQB%MX6CB'3,.#9=\P\
M# <E9.+X^ S(+FFN -?Z*AN1E<-:/>"V0;HC<!+*TCAY%6("9X[*;AHH<'>B
M^^$ 9>UHZCN6LNI)\0G5MH6F6!!"T!YCY[-:H:AY+B$F5=F28EC.#P<OZ&]0
M%$%NP_WR*LK5 RB#\.QIN.80A1-XR5"<RC'!NIFD93]Y6^$V7%L2ZQT$*^^'
MPT.:KY?$168(FKZ:.;4^Z,%7!(6TL63,)"6_3LC4I/L%G<8@S/I(*U4$IP K
M_ N #4XXXX>1#P$Q30)!:B3],3,UCT0U>N0T#HFK710](#:H<6O"W H(P3).
M>1EO<>46AO!ZM\+:'E^^HCT2_,S9*+"0%.1&$'I!7X')  [Z<W5ZF!?(HZ'4
M\";1(?<<F%LS#94M"_TA,RPA#6T[*WJ9_JL0U%FT?7@*:#6R)_VU#]2:SVY4
MQ $",.Y[$ Z \,%T?<*X_1=[_]CF0Z?-('<'=@(\0AFJ>N/FX(: Y =&K+C-
MU5RF"K4,8 ,X:>5V=N&C2#WU"Z0-X \-KP,/G@)?\^"\B.L.X!)IF%1G(U@=
MV[P%1 ,ZH9 LI(T3"2#>:IXDCJ9TS ((SI1P,F;&7>^=@>XB!7U76S)1(PE,
M)^2<YIREG!5HIBK.'$DAOL.5A3PTK#T*,R.ZY;)AXL0@BX2L]](R.]WCSO]Z
M[%'XJ-(O6I9Z!CSGCR3](C^=?#5"$/WX1_<$]P8'J&(2^TBDHY-G@08-68 1
M:8BB)X(MO7V//'?5&*RK,L Y]KUC )<B XCPK6'S4O='<1(EPVF3\F!?6"L%
MXN6JZ0_.,:ZE#E&N?_7UB'*MK2[Q!.C:C,?'G^<D8?IFR5O%YR'^%0#!(,$U
M)@8%O6M@%T"-&B^0J8_QS=2ID'A*2C*T9A>R\.COB@D;89W;VWT1Q@L<X0D#
M&C T:[%G2L)2R!<]%3#2FB5,<8LK#(HA>+,DYU;GZRJT(L9=G)YVJAJL2U.(
MMY"6&E!P3LD*D)^R,F 8Q4_+NZDG[XE_@,-]\_+5FY4(5$'$"$N*@  <@%J.
M>BJ*X6,5:.1C 'MC1RD-TXJ<E7H%Z<$&D$'O20I0+(TDT=/"1IG5MQ%CZP 9
MH Y,69Y#?HNR3@I*IT:ZU(>'$DSF3'5$A"\;A9/,-5J0'@&"I@,EDPB49E?&
MRXP9IQ1&26)D"%(92,\M=*P'=(AT+IRTY*(U#:P%D*<*(*+*E3)/#SF&SI8/
M(FU0QM*#,EZT01F/KA'6C!X?-6C%@)MOTR3;W7CM#UV9160"4??],KRL.\UR
M/<XDS$RT-/-KZ=-4Y'H)@U#B+&OA:8ZAWK&VDY)7\X!^5'$Q4/V<J1Q*VUV=
M7J%3H=G[>8OG:QY1]V*]=ZJ'!G<VFGWX<&2W6'G,CC ITJQ0[%UBZU=U."+G
M8[LD[<.Q3";&,F@6%J;=H\_G^)-.^VC.1R??-1U7\C4,K#,V*/HY^_K,<>YZ
MW:+W)ZCFN #CR'5).V7D9>Q1N,U1AIEP ^/E,/XUXCK6Q$UOB^T4@0W?R8H^
M*# 9&E+1-TC^-WZ9[,Q G :TXM_B0)Q'MUB0WW2@H!VY$$=.&OVU#ZR.K+AX
MPB%Y#<LS%B-!RG<.ZM9$#HT=>'*T8BW^#;8.$-C-80;>ZI&*5: VRN)U+":=
M2J+#1A"VQ<;68X8V)FO7&I3W@ 0N@1#V-:,K&QV=?Q5A/JUZ^S&2H4C)W&[$
M]M(\9ASQH.X;R(-7Y@2_>I\U6\EP^JG.O4 SZI+%K!J)$2D6TW"HZ@BH9\9D
M)3 [J#QC !XE.^+FE7%GEDLX@-OWQ<,!T/\CSLN.CG7#@-M&#1&_B[6W?V@R
M+RJNB\DDP6,.@!AE68KT'Y=YH3''X2*)% <(_*Z0LHV(S% <C'GP),NU]8>\
M-8!P;*\('\9CAP/&E\NKT:I/ 0YP=V5L"R_&A -Q9F$=MJKKIX0S6#T-!X]]
MSRX #AD6".**M#]"-P&[] [83TE1$!FG23F><Y4#5)=1$OHK,+LPTV4LR ^'
MNWM[OO#1:TE(^8:(D9F[+"S'J;^(5, [82P'R02->H"/%X!MLFGR\<J&Z1@S
M\?+A!14IAXV8.!S@Z[RW,,YR%444QVL&6@IQ;YKD&ZW AD^<PN&-8XK2HE.8
M@5QQ1VU&P/(-$7YPXT=H%J#3('#$X)=TD@C2*@H#\PK"]E!.;DH4>0(X0=ZV
MF'SU8XH/X9,3([)[J&P78M2/=>2IH4*@\J)0]<*((S[P.<DQQAB=D/"$XMRJ
M'$BHQ*"((@1=BD;(<>PQN@+)ZWJL(TQ7U1[\PW$-/'5F-Q&22,[9S[@=#'0S
M6R)_/.VHW$22.NXC#AF+IS(JH#B)RZCAXQIAV2&'S0A^]Q6J^K1)T$91  SX
M0%%!QP@ G!T'H5P3BI_"-:48Z@4[I-P3LQ3?K,,GIU!,?X@W"G_-4[A>#9*Y
MX>:@O QE5UD(: )B[*"(^Q1QP\J,BOEZ8-.@1,?X9)  B('@[CG08"=$8Z_O
M_8EDVT/' 2D"-&\YJXD(8%:/I\>60=2&*._4-\%WU:.,$Q,C@:O0Z#-0<JE;
M\(VKH*@B'R4IDCK#$'K3[3G"B8DW0LJ*4*)9A,?[,1D^=[NRC.XL20D60&WA
M$3& B1"GIR,,M03ZFT?PIBA='^#\<R$[L?=!8'\J7L,;Z-+)5Q,N:"B4"?Y"
MUCHH4CK@T'%&BJ@6UD?N 1E@J[V1_FZ-S$L4F)ZVR>QE:S);LDIIS]Y("MV3
MH]\^G5[^X9U_/COYU'U_>N&=O_..3CY==D[/O+<G9R?O3H]..Q_D=Z]S=@R#
MGW5^.?D(=[M<\>'>Q;$[2!&7;EB")VBKV;(#NII+D50/H]Z8-5#L3W(M_,0D
M559%;)*ZC=B[5<01.0R0T%VCJ!UCUCBE?P(QYA,@G8#>QL!;$I,I7H\X/TDY
MI)M,.(QV /0W'DI0']%OY\URF1C6>PW4<@P,$I\%81GIL(V=?O&/;<LWG/6S
MH."L:XZX7Q658C6FH@P.^24NR>.@-[TF6MDG44S VKZ378R]U1.2'&JGY;M*
MF GX)6[EFSAH%5$,,Z94##5]0SHW)[]:?TU-C6,)G/0%X[ZA1/I1 LP2#]2'
M2X#_",/!-%Y@C!C=F&$Z_%62&YL9!B-DK ].,,>WT<0E.IFL/P:PM,:OZKKP
M-%>*:=U[J$R-WY2<IKF\V8/Z_ SI/(-3%WB- _DC".#&,JI.X5+&!RP9\*TG
M!$@<P:7%_WIV\ "G-<-GS@I$+%Y^,N!_!;X?EHG,K,2E>$N>&AE!L#3(>,+0
M=L%,"[.7EGW%@T> *1(NEHY&J$DO_W@Y)6C)TU+1D2>(MAN.JDN?T2H"2YZ8
MPX<>"5<-."X%?VYIOUAVG)@YDQ?_<+6OS-M*)"L3U*UFC6>)DF0SCUYIPM:>
MPU,?\X'; -T[)3A+8KU^ISSWO!Y.4G#JDJ_?:34-OMKG\H\E'O.23N*>I_G'
M-Q*= ?UO)<2/XT818ZU5FZ<]YMHM^*F.N6YBBE3WHVHMZW?:CRBN'+[R7^WM
M^:]>'*SCL6W451R\V7WU\MM6LKI"U$,(?.LFSE3K"+4X<1><./!?'NSYSU_L
MK^.Q;=15[+_:?=V2I_LF3RL@.UWJ-)W:'*BMP^T6+>Z %J_\_?W7_N'AX3J>
MVD;=Q(O=EP>;1I\>ZJP> A366$*K]\*87YAH?UDM#I<PRYMY[38?4M_TW[P^
M\%^_>;V<S6\];VR_TM[EO=SE[MZ+A?M>#N5=SG$ODQ8OW-&*N E60'"=J6/9
MBDMW$9=>O?%?[S^(V6_K1:M#W.4J]G:?/P'->D4(UPJ(F\=:Q;'R/NE8>Y3R
MWF++70Q1!_Z+O;UU/+(E8,7>[MX]FTJ?,JU8 2'G;1$$H?9^3;2W]?;7;0]K
M::PC[#\:N6@#LC8E(&MER<0*B!1_A'^/U%_>UFG^=_AEFVOMK"/@/YY4P6V[
MUO',EB-6O&[IQ0:)%;\J?.7C;J46U];+5F^_$\WP]U^U5&,1U7ASS_:EITPU
M5D#*V.K<IM2%]\:4]FK)R9U""0[]@]?/_5=58^"]&65?M;=Q)_OXR]W]PV];
M24O<+'%;T<K^*]T<Z?_S;@%V=5K_C7-]P.I-E,^[_]A7YRW][IS,V>H]'BZ_
M_105X7%NW:[M\-EC<?NR8)6MT\5%?Z5N4+7LE!3)DOKF?(W8ZN_'Q*FDCO>,
MY?E][]7>OO=YU_N(U>2[>:JQ86VW"'/M/=_?V_6.BW2DQMX9E2L[4FD2A;'R
M#E[!:[?O+]-TP4N_UX.5N]?3F"IT%[FI"A93M2.\3JEQ5"^SQL4^E;EIT^EY
M4A;#J!2-XYYY]*SOE&JNUV+#_@VFL8#I<IJDWK5*N0KR2$<!]SFSP_'?6$6V
M;#\I59ZY*&)JRO=3OVCW)RQ9!K#V<L\+U-2TJ#%U['#$ -L!@$!;Y%D..X3#
M\:6"K%/=#!^,D[SA82KYZ;:/+L]XWCF5W99Y=\TUXASDHW8#Y:$I[$+0-R77
MQT6,A4MMS]-(74N1;E-HMP%#N87B7<N]47?:^?=:7IP>[WJ=<I6-!R'=B .L
MC;I_\-)_^7K/?_WFQ:()W&-W"Q)R76&J(8R]D*M;5;WD2IMCE\'E&AO@W38U
MQ9+I>9@7.=;M!](W#K-,BL'.*YJ8CY+,0,R:4:O#E:-6J'+:(&L7#?F>N.DQ
MP]O'M][[) JH?"0U@:F&MF/%R3JH!V$&"!M2#5^&=>RR:.H&F\;G<R? AKAF
M>.PG+Q493>7,IHX,ZP4/SU<.'HZPA4&6$]8?<"SIW'8 :)^8V*K*MI7 (>4\
M+N@C8+F,E-_\-A9CR=)Z7?F+E;[RPS<'_JO]E[>[<A8X[;WOOW[E[[V9^^X]
MW_J:4?Z7C9'2CT'MK5E],;7O@#@2>[^',/R'BUV//1JN.^/[Z7UM"J3V[@0;
M2?%?K33ZES;2>5AL[HXJ5TN?^:K)6MNJ_67["!B%F\(<^J^%2O1Y6E*+6.IL
M8"5S%L%C/1PMF6N;^7Y;X=.N\?_J5G.6!][6^+_W0HS_1'ICX$&!LF@)#Q+O
M2$U_ KTN"F/]S N#?SV3EH1 )J0+P*>3#YW+T_,S[ [ '0#HFY/CG8O.I\L_
MO,M/G;-NYX@>^>>/.-F_GT!?H5/478/0M-42E;ILTT9&ER$U1)2&;M4>;_,(
M)S?L84L2:KW8J![K'%@[@[1? ;)9Z;OR4<5JZ/;*I!GDQ[*OBMLYT#=/YI7N
M!L2% YWUTW!BVK100?T<=I0I;OZ2P3HUR AQH=(I7\,^DM;]-[PS?+XT*:$-
M)<$]N$.$,9/UGY8')*OBR'C(/3;F/#U?O@&>R8[+1H5O9M-Q+XEHS:\/?[84
MX_%E9=/;L:<UM7-"<0-0NZ?14JMP+2$L-;]]N=GEWOCFSK92Q_Q8T+E^^(2V
M8S5."NQ1'%\E$;9]TU_[6@?<^HS_YIZ1V/6&M;X?]J4G)394BYT.-/ME!QK
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M%L/XVS0DMFI7+M2O'">'O^(I4CJY$(%*_,*XH$B*BG%0P0!_@C";FV ;<\X
M IDFKXIQA< *>N0C_3K%T#U\=JRUS2]S[]S<-XTG%)47N@O;8E<7YA!AO+HY
M9O< [VEKDPA4P,C9F\"#I+_=\W[QLO7ZF;EO)*,?0@"[@*#PJ1!1@5%]Y3@\
MHO(8?'2  NDL#&9>ATP5BXE#GR;$LN_"^9FH L(#4YX:#TJL<Q,PV\"XV1F;
MIV&O, DNU9BE02Y.GHF:CF4[B%PF,%#WQ*'%Y3BB4)$+.'0</YB#D@V415,4
M>9S3< 0E;XCU2W@S'--G-]\H)Y4TO<9Q-@Z)6 BA([THY<JG@D_O%R"!8=L3
M#,F9(-OVT9!R!<\3J@'_<!*<4H%39NF^@5$;70@01*/PLUD84W0>RK>NV; J
MPM>7Q$XV,X.K!B@:!N1RP,2R0,M-*%[6K?$EC(GUB #WB.*7&@PX/*$GL5$\
M=\/X)<)0*1>=AO-U=(X T31=H#.X$10LA*H,"HRB:IV 2W("OFF=@(]NMKFP
M^+'6EILJP.V^".,%WIYO\',8XW;FAD;:^(X&90=CJC($E3 ;D;:'BB;F$)3D
MJ<[=O=]B"F5I4%'AK[-.][CSOU)PK[2USQ46K-I9E8O0/$E141@@BJ:/09$2
M[Q!)!F::)D4E\'?1-C$@N5P,QJ:&7YNL+WJ0B&V4)J]6F7-6SKMAW8:]:JP>
M$F$O0-V6XS-2F"'AQ!1)@VE@3JS$8DBIR8+,*7*0"SB@ EMGH-:T)-/\50 <
M$7!P@%04@I:N;(DZC.U)0Y/73!K/@(]0#J=4MFYQIO7J:F1F<#=/-RNGX]N+
MI#69 'Z)?'(FQ@L8)K1O/CBT:X2Q<N57C+=A*;B24OUT,IS;Y./O29:<J1M9
ME<@:<!;!&S4UN+4"":5C>L!1')AGFE+YF4"5T):?J>?F/<5:PRT ?P\ NY:P
M&A<PL:@$DY7G2)O!/!8DGT2$F64YT-M"9@N9WP>9C@9?:NP.A%94=P?RJ@59
M:N.$?1)+Z0\C=&$J5@NN+;A^1QD2H90-GEJCDCC.*("_.(G++T0Z-7[V5-2Q
M"DA;00)^-.:G4N(G65JF1L](2X=;P+X_.FQMD*YP6DS$K7>51$6<8^H8)4*5
M'RNN$<[VIY=0/*ZX*DPN)OLV\%%':VSAMX7?[X/?)N%A4J1HEB%;0YE)V*R&
M4:E]\D/DE**#^<F^%,,98<$X8VCR:SH@*VID>,;'Z0]-?U8>**UC;@K6H@$&
M7K7&AAF'BK=._7HEANIHU5 "_I)\CX[M)R4N8W^VAI,XE^!5XY5QCZ$BD:%!
M*$]:Y&V1]QZ83XFW).GW.,^-;+N<,FUKT;+IQ18Q_D9$:,&V!=O[YSE(]*N.
MZ+DJ;%-ULQ8(6R"\8\DO]N]HHV7.<07Y)?E#_PME<C5XE1+C*B(I88%WR)_G
M'EH)LKKTM RL&^-$:[,D-2]>^Y;N,FJ"Q#Y<$L P9M&I-PR?G)BT\E,FX:>F
M51,^:_V31NI=\P"L.V9!&M&@GQ11P(DL2*7G.:PYEH8>]N$R)YK#UT05MF'3
M7/19C)'CB0ZT%$N17$2JU]+_JPBY=I"'\:WC25XBHEOZ@:;,DK%F>=_&Z5HY
MO[D FX6?2AC2&%$8(#$*]96V3F=\+TSA;ZK7P(4;,M;G'?7H[O.8# :%YS@.
MB[$!.YBL/'FWJQ5VHL!:3F.5?M$YVVFQBEJ]:)0+MO4[0ERKQU35HJGNLI7>
MM*1F<-<50]M-+V. :%1VF6L*.UXX-X:N%<AWR6LMH[@AE]4 L45C48$J+&N3
M%9&)9<UT"7(8UTD1US<=+Z,*U\")S4$CF"N,H^<S<:_O=HMSD1$K8U#\/K>N
MP%)'9*L7]*P$O,U$E*R2XWZ#(]E>[+61;(\>R693WCN@M^Y<JB^:".@'=2T!
MQM^=D$]/+DAQ;X/GON74T()&%0R,P>WXEZ,/YLNLHCV6I=)LF08KYY4E'$"T
M5\-4349$OZ6'%W)R6@$&5,4C&X46A5^ _X^2)!!C'G"6 L.F1*R4TF\R"28P
M2(W#VP=T$3W/="74NK8B=96$V%LIPVX3N0'='HA"$8I-0-$+66]]NJLBPD@O
M628EC8U@&&Q3*I9(V5::1)*A4V[>O';[V#288*R^@G[SM_:<E I)J ^I4$8L
MN4L4QX8,JHB1F/8I,(+J]M$Z^Q3EZ$Z,F6W7((JEOO!CY\10CK%L%A'<GI)F
MF<;$D = !J8^*Q?LW>:$%:R;F@[Y.U?<K)G%>EB463&14![=4,J+]DERP[PG
M/$Z4#DL)U:S%R*X,=I438B'0%E"#HT+1KB)ESG9/D?%,JJW(D22T(,)82=(V
M+</=*KA4*D7BB!U&PZDV45TH;IG&697<PS6C;#<G=,]E&D\E"^6SKJ5C>%W&
M7U[3P=ZA@19[5E(;","G)/+(9DT)823@90GAF>'*JGR 3J.PAW@ H%ST@$:4
MD[@<A,P#.AZJ(37X0<@W!3^*+(PQ:!I MR?1K+:P)M,?\ZC!,B,=,TB;AZG6
M'"8YALP)<A"KN(JQFRX6"(/+ZQ4)7=50,B5[NH_N*Q5[S3/[0!<QWOOI1-?>
M8U>Z;S2&?N/$#V[R_,9U5<KDSH%-UF&;ZAZ81MJ.I&82A:5+(;W9@&%>,EN4
MD^&?F9/3[<OA@-3?D!.%YZ#$-W77N#=@6H\Q'^%@'A:(5Q6Y4-EI!E/3?#;W
M(HV=>>@*IK6JY:^=LN5BZA(SUBS>52H-L7F.C>$U'$/Y#!T0 38L,9(B<JY)
MD6*#.@Y^$[.ZL9#-1N4[LVV%V_9KVA0F]TMAZ>M10J)!K8)#E"6>;9*"WVR%
M#8. V!HE4RT40,Q6EDW:7YV^9)D7)%Z<Y"SF6Q,EI0@83P'*SP.T..8A"1 V
M*IMG)Y'5D62(&V-M<!-XR/*\I!19Z=X)VR!)_V?XJJ5$+25:%4IT'HOM.]-_
M%=(#XF:.W\2WPZQ2#*24# BSRT0^Q57TX[C@[#CC"S6E/FHE:7RICY;CH+:^
M.] 0:B8A$V'!;2JG>:5M71M+0E^^] Y %']U\.+GPW^8/;F$JD)"F8A0;GM>
MDIQ\+L'>T,9&SU_,G7=&Z0KT ,$!VW8T 08Z%#BA\.FH(S,MS<LNZ_>IM7P'
M5;E[__=O7"-&2)3F,<1<]'X(S: .$D::J!MVYR/=Y@GSY7T</H VV[+3QH-^
M>,#/5(1I)\A R<P[B70P=)S!6 [=&/VKR#!//1B@:.ET_MQ#54#R_^L!_G6L
M:M&F19N51QNG(*BF\H'LGZ-R5O5H'38)V<9P931%:G'.2&\5G5ARQ^?IS"(#
MM[RG1:+-1J+Y\I>$\#>VWN*PN!U6CE!U#(.0\M)F,8FU*8PSPE_8G>K+J-'4
M'3?B.#O0%%+0VLR20)^$L2@D+==E#51K_C6H;'-W3#1@DKKY"?6THML,T&!*
MLPE%'$)>[MPJC;=0&#?2 M22D(TC(5P:H*_#2;X8H VJ]'2L!V%N"U8FBDB.
M] ?VO6&AJ%@E_LURL)/Z-K -:F48$T,M+;70*90FQ7!4Q\H-M;_<6"Y5/-W^
MK _<FF/FN<(P3EX:P5*$3EJZE?'H^VS_!E+&C7\'N:YH'"]F-8ZYUK1F*MHX
MN=,TC_N1L[4 @XLBSJ,H/SN5&^OC2,,VG8Z-<QYILO7% XWNI8D*HJF<4^#8
MIVAALAR4+WVG#7HTY7)855 $&;36C\]N@X ;F$K2IT\^=LU$\Z9X/V%+\%W]
MQ+.2,]&&#>>T[@HWM$D>,XX**G?@!&#C7FU7>!A>?X4K##-$"U]Z$>)^R_:_
MF#B.7]NK-)GD=,[\-EWYM4I3SE%-);NEQ&2JOMVT<E.R62#C-@NP1U#I4CRS
M3+J6D@(1%:%+KXH*)DY)'%I$I^@T::81=S#V#?PF5CEGF[0=IRWAN:3 Y_TV
M\'G%V Z+!$["&>C=L^R'/:V8<TE!HP[MEUA#<L)2&7KT-H<FDR%&C'7K]M>'
M]IF^42[-?<24824!HAVFSYFK*K%([[J-E5$2!E4>1WL"6AN%F13,5QZ[/K!/
M5:F$E([@2D<K)$M_%4DNW)%/XTQE@?J+ZZ9Z'SG:$FDA.J%A?I#+@!I00&F2
M2EO: VY;5>GF</[-H>@2/RW[Q];7TLND?MKK%K;YS5XN3L>A$&"._>7X0O%M
M.**LC=A%@85OG(.7.4[:A-W62W%R"VX0$_I]RD,:HL1!4<=..IN-V2TE 7@/
MHY QJA=E$E)-547+QT$X-GJFC0,);Q-4L8M8@KPS8!B2.B85M7.*!L907VYX
MNR 8>-V@X<8@WELBRE.)Z+VO3!<A+S:HOI:V6>FW7!JI*)LSE[B!29)SK(Z#
M9%P-GA&M@GWX VP<QAY3W( 3#%^=2N@^69ILKQ,284OI=E&V)4<+^=8"K?H.
MXR/T6S0R]C%?G"Q*ZDU*)8\;,AF81C7F9-H4P=GB^YT&Q>1[K_;IN/K;R./[
MCCS&>+Q\7J<GFYY:3/#OIH:=,\VTYM<CMWDK-MK(9A;=HAT%J[C3:L.'F;*8
M5G7GZ*AZ3KJ5&V9DA<WS-+6FX?7%2E;,F)%1E$&IPI1AP"6>2B$.!FK4BJ*I
M9/B7M0H;FJ'E"7;W+0=T9G&JV,]8O+"OTU?0OPASKU0?;<G:^H516 V3(D..
MV##>*)QDWA8^*!;#ST -M/<6B8_)-6IQL<7%U<1%+%5O(=YE/O N #RZ4_,Z
MM)-BZ8N]H]HX<:;G(1: "\7D/C_8MH+(#K?&!F0H?U-0O\^::H@=4;.,S18*
MC1]I,6X1K$6PE4&P8S9[B3&2U+MY34Z)<;!"AJC(90+R:A6?N3T_DUH[UYD6
ME]*>IK%G)P5W1)2?7C96*7^U[A%<O1F JN21S)J-2%?,$F#129+IEL.U"+@Z
M"%CA<+4,$6MZJII21-Y4Q*J,N#DG/U5QB2FW.K%R15,5))-\7K]>1SHDF_PB
M/&]PC#?UPD4ZH"8ABKX5O[FIS=U0IK)%SQ8]'PT]NSI'ML(U$"3"!SDFFAB!
M:?9U4*3:>#B&B"@2<Q<GIB^8;PV.*I8('U$L&4V%VS5;@7S&&, K[M/@LC@4
M9ZMII;5UV"0E-K3V*)8C-WWD5"41S:$PFQ-HM+#455>(;=>)%_HHA'?CBU!U
MJ_F]<[O"HDS&#5WG5\CS&_E6M8EZA6<)N[H AD!IR-2<L:'B4X>M'))!::'U
M%IF4Q!7)06AQP+9-2>*@Z$NA4U-)"&W_&07@]# $K(8I-)!MT)XALL!8Y"JG
MQS%V5Z?(AZOOD;>?7[M'=^&M[[B-KY'XFH,VON;1J>T1)S)38(5+&4#O^Q#J
M K\7XMO27H?V+B"Z1!I9$+"F+ X.'6/N>"!<'X,T2@]0 U'F!XAB4@!$4* Q
MC2EUG?16Z>QFQ$"8(F9AEA'%R"3"U?MD+Z8SF:0JS!07_[M04_2M;SR<_D:!
MJ[D4DUP00=94!:\":<1[.;3,GJ2 ?5.UP[E9U%5E<=>[<-3:<IW5J4=)R9\1
M3W3&90[A&RYY>(L5B0#0O*AR<Q4GJ(F=F#"TF+4/5&@*/?(W-I2"Q/FRFKM@
MK(WM.P(%@48YHM*3Z72CL,_E"0;_CH'V7;$ALL/!)4\.Y:BY3'.9R5E2GI:1
M0U).K^F]6'&# -1>"U(#_RR"(8'HG#<&Z@H#2*EFT9<XN2;%$_A$>3VF9(J-
M:;6^TTKI,ER@,1J;1694:]7-KIG9J&"'4]*IH7A@I>V698N124_@/+9JQ<+R
M&-FQRA4* XU!6)*, T3"4A[ PXU"N0^VP0;&XGX(31U;)(ZG (?CV+;CP.T?
M5RP-)U]UOZ"[/Y<J5AN!FXMC K\MR)CX W4S(1N/U6\-F8M"I_ PL8@"9"^L
MB/8UIV+U5J#C3!++$1 @*Y\,_DD07J5*H?)FUD2EADRE3<K+P:5PYSEOG,2:
MFRZJL1J*Y0E5(L CR[@&(:C2E!<:%!3Y[5JDK-=U0"V=99-MN%P;+O>-ZWHG
M"74E%"H+;9:> R 2RXR2J8H8ISC>?"8DO'4#MGZ&E8-MQ34(DC%HHTBHD4:#
M6#;$TOJ@.IBL3,S#H6!Q"OVB\'!*PAEC9#G9-[FS#XIKY)$+D\@59%K8;V%_
M96"?E1Y)0_+V7SV_?:WT(H8G0%YRM6RGG1*V*@LPCT@@GU6)[8TL3-$BP-HB
MP'<(-LELJMOFN&_O4B?BEA0#[0WCLF.,B9&VRI&U'9@,"HV:F[1*(ST&=#%;
MLT<T)T>%J_KN*2@TIP8YS@,5+5"<B3UM9V(S/DVD@QMUPKJ9<,[&??);)F;S
MZV;(N ,D-"K$OM4 %O50(JUXX@9D76OZDG*WC>4["_/"]"4-Q4XRK5TJS>:6
M]T8#G?,P@Y;4[Y;'.6%GB'Y!_S;73NH_EEXTXX8Z,#4]$,S17&?"+'TWC=QL
MI-)A%2V"AH<BVPS'O2+-M&&J6*H*0!T5:OUUHN.,<PY,1(PQ;H>(#6ZI1_F!
M0F5T<+^.\%6#O,^F'14W> JE(=>LQ<>%#O-=&&=%2F<YP39/TTK('ELV%X$8
MM<*"$1"RA]CR*W=H#D7URJ7;-$WR^MG<R[Y"P\B,#:<RRZ[W69>-/L7"6TW+
ME 34[TJ5I2K:IO38S+'@3F/=UUF&9B>DX7F>*FE=E6K:H[02MNBP:$^;"XZ7
MQ'=*&^^@A A;K(K0&\\CK!E\JW>**'SW.ZVE]%<<%M2,R#H$%!*SK AS"[SE
M;=UH=YPVM89#XF>[G945^9B4X<NV\ZG;N<YQ:< QA4.!S9DUN1#D-Q0EB*U'
M)*0>R BN0,K]F31H4TG,\7OP=>15!\\N'*VGI&>M[TT1R<(8M/^<;E \^?5T
MZ%)\$/[A3@/4/I.251E[N3.-G?(L2+#AUT-F"KK4XD.H4"NF"O,AJJTKM*2X
MI\,V[FG%:/)IG"4#177IZOCA>DF(#:<A5>0JK$NX6U;8Z6!Q4<'Z2L!/)7!8
M<+,L)V?XH:U%E$S"V!'3NB='ON&[U=6%)060'G.&'V>SW>*K"V6"EGEE]E 1
MZQC^Z&N\Z77CP M]JITRZ;97Y-YO,67P!UZ7#$\;X2)=%+Y0T;V"!(=,<A.=
M5HD%X!(!H"P,Q/;A]@=W4I?98E?M:4KUIR@OC0=&CD4,[*S3/>[\KZEH=<TE
M0J@Z5SC@5K2)%R4<P]L4:5#)4*O4N3(C+]P*1NJ+E&UV \B!PBAB)C=(8B7(
MRZ]AS=.RU.3!7MGGBHP&\]-ITMD'9IM3#>J%3VR[>_,(]T)E"E(XN"O!WO*+
M@"_W=;P"DJ39A%&:2TS3+#<?5\800D$%F;C6"H9%*91[5+D>DPY$-23+GE;8
M)!C43*Y\NL06[,M%F,L&*&S(XL+;*!M^<E40)QY4+CVF8J 9QF[V,8/3< 0C
M@?MN32_3SW>VOW$U#,=T*00T,T#>A#IER:%=[R/0^,0B:_U)5261A2&1<ZN:
MV,A]A76X;("" %F)::;V22-N(O9SS2"$]QR8[-_?#-<6H!?!,P'[ "3-"!4P
M[19"8='90KK1 :B[V[IQP]L6F3N/K9&(-3$;\$S5++10?@L->$)%# "A4XS%
MJE!FAM\*B)A09K1X$80T0=ZB&CN&*B;69#  H(@#J>Q8P%RD9Y6%M4PE=&%;
M#%PI-\.C6H5!B (8=IFNEOQ"[=!TN :VT".&,0?YJHVT.0+5KS74;FZGC>JE
M;YH+I;I'?8)S4R/+:=%^(T)SM&R296&/:@EC6:#F ZYH^&CHMO7V0CY;M^+>
M[7MH*RFYEWDCT#5,)MV<NGQKAT$+Y<E+T]NC,S0W\4D/ 6%2E6Z$-'FS"<NV
M-U'V"%)S!$3 ZV7>4'+C8$7OTK8C^O#A:*, @Q4*[P1^#@U'?,?LJ:LB_31@
M@]B_(<Y FV(@_QF:#\)LA,9?EC^%.C2!RJXY,^Q>Q3:PHH=B-55;5..D$,UB
M%L:DWI([A6]D)1%4K,./@X_YQG 9.-N<$1;4-72I7..:'(I(YE4*E49[7$@=
MU(T % *I#?DLG,!3EF.,,&[JOMMS0;TGGSI%?C<*FSX5D>8)]Y\_?P*XXW95
M8/M2Y03(65RB%6;[2#\;91R,6[8- :789%:"0NU?#8>8A X*R+8K/BNG]8%/
MB3FS30&D+IFIO8T"G@4YT]F 9"'[('7-@='[I0B!#Z%$B,8'(W+@"DNS%.!U
M&#D^?$G]K:Z&\A@TUSRU/5:S\"O&1N<C4Z"4#*6^VPVA,C5J)5+;!I!*ZQUZ
M&:<-DP#K9]=U=\FMRJQL-*2Z5OC(3]AIFF\IB9TNV?L+C =SZN]0%C.F<DC\
MP#C)<DI9BO$?/%/*FD#5A61 (E-$54V'%!2;TY]M[VI>%E,_37+NM=9?*.<*
M1\.S3)68,Z)B3/2/Z6)Y*T&1&K_, ,G3!!=$[X!*"S(O,'P<=.UHSQTPLTL$
MMP$G*1T%278)9Z07DZ>K6B:^4KB><F#H5!-3>1YAC;HU2AT+TX&TSK:,UB,L
M*D2;[5A<8CW4M(LRMJ&G2Y\3I9(:#E)0JER?8EEZ:?+%<7F[98,W^$HOA$PB
M2<"RQS8SU[U*((923V"&!MV&),XA461A(<>"K4*'A&.J54JWUD@<ZVE<-X*!
MJ["&EH1;:XUO%LD:,^NSW'1&>@"8%MP,E=?:*:U0ZT-?DONZ[1=_/3%]!]#K
M4#F2-WLPR51B"X!#F3U)O$+U11*AL/P$Y8,UM0JZ[968P^8JTW$2[]38A(Z'
MBBOA%K&)^$KUCB..5BADZSE=DN?T>>LY73$J*@JO9%4'#>R0&CBYS9O$6EBV
M;:(G,&A":AE(&!ZI-CN ]%_0\,CA#L+3!-&=;ERSB)ZJLKS3(L*P:UZ0AXX6
M#:I27:=]&2;NBO#DA.ZA*'<;>H2L@(*G4#(M1Y9N4$8@=<GJNO'D)DPV&AZ'
M?@MU4;D:VIZ"&*T8J>E/0(0!!/0S+PS@2YWUDP$<XK-_'Y]TCSZ=7ER>GI]Y
MY^_01?[;I]/+TY.N]_G$ZWPZ@2_?G7PZ/?O%AHVOI_IX0_46TATH2W]=-WBW
M2$[E.'H<):K9$(3]4.59[LHW1HT-;4CLD>-J^O6&(E6%##T& '5IV+.9OF2I
M5YR](BA^3(_8A)8CL=?0Q=C.?[(DF)%Z[A3KC,D-QAJ-X2: X!2H9UT&GZ55
MWQ, SPL4:E%DMPR*4JBN4TI-H!,Y^/F&8ZIH#@)Y$S=DV[8^-/(X]24,2I>9
ML*7"3*W3&63PZSP,C321=J<I\>8SAY9++^>8QZ-ZI;(4IS-B&-N&4C).VKQ=
MNXN&JBZTH,CI>^BB\=**,&0;4_/J1IIJ*@!%(<,1QM>4]6UGC51T&?"H.# '
MW&J(&W;&1&>E>YPA@](_KJ2>G-AEL*1[]/E<X'[7.TNP9ZD$E_>Q-*?VAB&'
M\DH'(Q-G1$ON.Y43>MKT.%F[3)I[%)(,DWOV[X^=2Q"!.A^\WW:[N]Z[$]#
MX,/IV='Y1Y"1SHZ]D^XE/.)==O[/.SH_ZY[B RA1===<:+JC+W.0F+KI5/<F
M*\9CIYV\%1KH% <ZH$2N, :<P"IM7VVU2C5KVF-74MH?*73[4T]8['_ @=S5
M?)Q9OY&\%\S0;U(:0G9:B<.@8O\Q03)2/0[G,D%_]%-JFE@J0_G1VJBB:19R
M2$,D1GC;X6SA-I$.Y E*6/"Z.3SL<TR+MPU\JY(6?G.*@([!.9\P[*E <U5
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M!")5[E/3-/2:P24J!3-OF3;&T17R)P7&F1A 6JB@[5STH-269<:K_T[G^CW
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MQH4?]:G0G+YN6Z.TH>%@,L+DN:ZX]P&NR;F*KO-*SB MZDT$IRJ?135 U-/
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M[0]%4RF']#7% $J-'T*D2YTUDZ^#UD5%'.CN$1JD6$N6;LQ\L)^J3F2BV:+
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M35^"BR6V>B(Q(G.6Y1T>(//TY+-RA"TZK34<6Y69[K[ Q,"+LSG_P@3!:"L
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M6#O4W:$_QIJ>#$/MQ\$S(VDKWCMI*B%>)NEJ7UT6><H44D7\%%%Z9)F$H(O
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M? A %3.<?14=_?H+/+N4W1<>$9%#+M0)PAX+"1'P0I]J1'(B?FX5 :):[2^
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M3#@HN<1:7N1"Y>['A*>)JDXTL*Z]X#5:\YZN@Q!ECS5A3AA9S._!UG(A$#I
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M'Y;*?[.X(S]Z4'TB/F8+7)2IQ]CU0?2.%5UF%* 9#[]"36#<^1<8+*352-X
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M0U=IA$\!,:868/*1@QE3S]XL %G[^&32.]-WF@AI@>]],%5Z@ \&8 Y!*:*
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M*\JDT5CDQ?-Y,X;8GH6GEMR;=V<*+/PNGI5[N')8X1HWXZ9IU%IUH]8NOC$
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M;"*4B"PY!.[0BWP>\Q.<DQW%\)0%KQ$C0VK[Y!F#/7%M D Q;IZD!^Z%^8P
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M>TI58>K97#4O_L=+F&"B7NP2#7EU@:,A9G"@+WUZ\MG3.AM8J\XP>B]^0;+
MA.D7A-JMM[I<7%V]VS4Z1=PMXNI RH  !.DW@3UAKI22$]^SHD$([WIFCC=!
M$B+T@-@L#C*#N5KX.QZWL!S>*@EWPIM(?@C.#_O4N8S\F(^7UQ'#;\SQ7MP]
MCL"F1@Z7![;8-I0GU!TL/1S::=];T6( Q>X-%T3?0%K,R4YK68CF;@\&$'6
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MBYPJ;-2J^1 1#KXE$\_I0JM-?+8,2+5;J5>W*-]"CR I.(/8P  !\Y]MY&!
M_FN%PS,,.<MMRS>BGKMCO8P8+C:S'S;;E8 '?"=K]G&A/BS5Y[HDO(F#D7(!
MF5O^P0J"N'B\9=FX!]1!FF7E/Z_NR%#Z 3RHF\IYA,N0]D%] T)Q,L- T1"5
M;9";^ K<?!"C=C@BOS$0!8Y#/OL>B-E_@+1&Z2'' +D; *O[82)@9LZ25!KX
M'K;;M0BH\OXT>2<E?0^, GS8LN%@"P&^$R_@Z^&O+B*8,3<E[\45)PF"G?T
M!/#GFG^-Y^2EQ@: <3SVY/?/A<8]9P_L58?."1?8P+$=\E.MYUH77-M_8NX
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MQ#>(Y^[P!8A#&#_,3AWWEL6]OE$=@S_A+M ?_#6"#N>\28C052DV(4N=B"Q
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MLRL18#]3>\*U/C.7#6VP#PL+LI3EG##;1J/V>EW6DX++,0,U5]=J9T#=M-:
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M^2S@4U2KA"SEXM@.43*./6!ZQ_Z.)RI\[(*F$HJ_4WBG'TOE1;-_\2+'XL^
M. $0<G%RCEUO@75ADYSI_+D?\,0M'Z=!7]TP=T%Y:RM*4K@B5XK8< I"UN<V
M;DP=,:$D/RR(0/2)-QSXH?HXITJY'NP#[NN3R^4Y;I5,8'L=8><D^SK+PYD
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M+3:T!W9X1ACU75"]%8O,/V#^>;]08'=SA4*_LI#:+K.N)!$R)+H4!"I!=I,
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M](E5^CZCWRMT"*_Y0*CS0J?!WSZMHE7)M['QIU\H&?G(_W]YO+NX?@!X<4H
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MF/F-._#&C+S_X@7!&1G"HYGZ%3HB;>O.0;FA"VN!-\WFPN-;T HI5;+FF98
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M5!3J/N^RXF$TZ8_\=#[+M:9W2V1=WP&-*B-/YH@*.U%$T>N*V5UIU)08?YN
M\*CT?4:_5^@07O.!4.>%3H._?5I%\Y-O8^-/OU R\E$J_.7Q[N+Z >#%*0'
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MU=< +T;4?8)OVF[6LQ@$+ RX5>_8M&\[VLMX<M ]T9%/B<0'X&7L#0;8 SC
M2Q-F/V.HG H[IS)$MV DY-)D;MR!S\!&N&3BOS=N3)BO"5W>9JD>M(/G1$<N
M'X"Y5)HW W"+-FNM8=0;NI_0)E)\0J<\VIG?%PT&?L2L^*I(L5J[1\E6N5)L
MB]GJ7E *G?B"3E]20Z!LGV3'-*I-G9:KR,CEPS)72FV+L-RF_.\8W99Z'2X/
M0(N_E-5S0(M_9FZD5?BR>:IEYL("\CP54^6K($K94KW=JAMU!7W^)SIR^1#,
M10>\#8(Z1F#/VON]SR;4MG1,UZZBM]OYZ.T\ZTBJQ!PD.\J 8G07CIC?XQ[\
MLD5ZLVHTNVLHZH<>[7]X&%L,L144A#=#;"LB.TTB. K9O1_-FU,J>XFG"+[E
M"P^^1/-VLG6Z*S CI^1%!(SHAKOSQ:1,6*L:M?KK@6*ZD/CQHG0%A7X=E):1
M;V8:M>KK+GI52HP?F=*BK+IT;,L]Q9%/B<1**Y;YVAOWV435;YA+<..>'409
MCE,\X),B60O/^5QJPBT+D= QG3]/D<APV,<43@E<>H:9V32Z9E%">0*L-8[Z
M4Y";IPSQ);IL+@]B0XR7H<PV#%[R:RM07T>KC;?O;&XHK>9J'>@T-EJ36*NY
MRTK,W;C/+#@,W59C^'@W6I-8.3&UIROZR!^,:,!KB[/_1O8$BTVIL'<G:H L
M,3QRN17W=,I+@SUZO0&0SF=@@H#1$4[O'>J&/=>ZB@E:MG%=-VK=UVNUZ1N>
M P?G8FSFTBXVQ.9N0[=4</7H @):,3F-C=8D5DZ>[+5Y]9*;H .RED]+$7C=
M39[+&%O@)D](O+.KH-1-ODAMW9>;7.-8&84VEUFV(7RU0JL56B6XYSBUG1,=
M^91(?& *+=[YB"N?:]'$\Q"46 WAX]UH36+EI-1^,GNN808HC;AP8C^8/[#%
M_<^ 3NR0]QKV!M]5V$QME<PF1E=SS9K ' $,60%:&;PD]]T$'PFN)%DM!6IK
MJ6",: PK@^%<AO+;,+S%\BP-HU/;\/92Q=-%QU%J54:/K$E\J-KJ\DNB [*J
M]<'/#_Y<JOH"EWI"V4UOA+06J\%<;L9;JYK+;-\0U#M0:Q7.=]/ZK59^3F.C
M-8F5DR=[U6^QCWU<% 5;JN 9HJ@ZJQYFMWB>YS+8D1#X#\8K/U.'\<+Q\!I[
M$#(+_]!SK=D/,M^\9[[M6?/%;JY^#)P(7?#P V^B\Y6&[&HX9(/2 _5-LV:T
M:D5U;I0+1#JID7<'\%SZN@( WZ+2VRZL*JD(N-4/84#R&N0S@S^ZZ%OQAB0<
M,2+(K BOG*0ANI"?<UEADF7G&+4'5JGO3X&F_Z3.?+WD7G WY*QGUC8Z6PRS
M#O^TF]J9HC&\#H;;E999;9K#[4&YNAF4VZ91?)"H!V/U31QQIERYUF&?)NL$
M^/^D E?E,C#>SDX;6QU&K5$'EM(GPPGC,9=2L8FFLIF14#.:W0TK$JLHWH_>
M(WX,^E*I&Z0"9#50-%".1'6]O;NM7/0>_D&N;VY[MQ>P8:1W\7CSSYO'FZL'
MC7B->"T:-5#V+AKW4SGLPG-AE !U?+#K)W[<J9%GCY#0 [U]/(8_ZFR2=$H_
M*>)Q,Y-$DF#PXGU(27DWY!'XO3'V3+T)@NBM&21K. =6Z.RH DMJX*H 7'-#
MX)YH'8:?P[YG3?&_V 0Y,\CUW>UCY>'F_ZY@<C@*X1]<]WZ[^?+O#V1^'/);
M[^NO-[<?\!CX2#*$&S#8:?_CS.A;&".KC1>/]SABV _>&T^HBSXCV,@07D=]
M;!5/;/C6DT\=,J%^*-W/ 0/*TLB"S;<0(1:VIN,_<;12_'@HHC5Y+B1\P"O9
MG6]K43,+^2,*0GLXG=TY3J1XH+[G6\SG.('U?:AR('!(Y$:1T*I6_PK8!]:<
M4 MOX3ED?Y$(*%0JWF79>C3IC_QT/LO5D7=+Q%/? 54E(P?(X]6_'BLWMY=7
MMX]B)XHH>EW!J-451DV)\;<)?6*5OL_H]PH=PFL^$.J\T&GPMT^KJ%3R;6S\
MZ1=*1CZR_%\>[RZN'P!>G!( G L4)8""7WZF\"K\ZNZ8JQ C.^&N7P!U;HP+
M&M*G1-A;=C!QZ/0#L)ACN^P=%]&W=X\/9B8(A3\M'^"O!R'J85,$S_T ^BOS
M^:.?ZNW&[\!E/@; G0/;6N0AZ@>V95-_^LO/^)(TA"/> ?EI"1RY-U&6A )R
M"08*]+=$3%TD8NHB*Z:N$S'UD(BIV:#!76R.. -OHS'S[4'FJ,Z%TMWY3]2U
M_^3T3]<!O_1<Z]X'P>R&_->[8;*P=%V7=C!PO"#RV2-,Y[,#A_WJFBD+!G2"
M(/0C]JY<<CIL&,X1DYB$*PSF1W)+0U@!"I3/40#@#P*.]^SJ\8^[)ZR<]HXP
MGVS2:@+B$NCGVY-X=_ .^4*<^&4*@KUL22P+#2X,#3+\^?O/E-Q[+\S_)P-%
M0'Q.WN,>(*AJU8]R*_AOYL<S\D(!5.22.?0%U2#8T(G<4Z[H@MRP7?(;]0<C
M4JM6V^?D,=U/_K#\%D@@BSTSQYL8W);';&R8ZY\P!\0LZ)S?60@C!<#WL%X@
M#&C,_XT880X;8+@@>6)NW,EK@BL@P30 - ?P7JS!)\:8@+X=#=*G4%OC7WZQ
MPQ%!=9RPL1V@D@^#^#A#8*G^5#P7!@;I4Y2,L#P*>AZ>TO#;!#@*A47%\NUG
MYF(+<HJ (F,OA)?@ GS8(?RJQ\72@/C4_0YP(X/I ,[\D U&KN=X3].M*7ZO
MT;X(:6\T NY<TIOXMD/,ED'0U#'(["G[OAA89X0+>(X1H UP9^_)9UP "4'E
M4,Z"OS'_"5Z5A:'\*/E^BD>DXSRN@51 &/C$F9(1<U#_%@ 4Q 2$7D;^B(X-
M<NOY\/P%]>&X<*E!WLOQ[L7SR9N3\7">R6)Y]>G YNB_ $[@0\.>.=.*A/G+
MR'/@-^\%\1@DB@>N,MV=9%303.*!!..@98'PG]DWW)9TXR:1'T04?A!_L7WR
MV18E6+ZP$"<)0]UP]9*(<_V!38!-^O"76I63KUJ.\;%]W-W/+I6,!2CX.3V>
M"'[K3_F?YO%2 *9XIPUD[GD\ R7$Z^6>S^/!$,";_YB @,.!0#@\V\](A(R
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MY+,1ATY@:-7WR3*S6R ?4.'[I7*BU4N3.4S.SDFE$378S.2X@'WX<Z/3U!)
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MT.BP5B.;0B7$\\DFB/X\GSIB\N$'Z%[<\%<,MHD7GNNB_%"TIU!>5 '<:.M
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M:F%<7W;&6B0RNNUB  3ODOL(<8<3AL'@1"0]U)T4O:Z*._,2) QS<-HQ.R5
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M=D*D,& 87 A]'8\&F)7QTCT[?4>"+TT)'3S$' S44YP1@H#>-D*H2IHWE13
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M*^+U9J6";W7 ;]W"S>*ZBL6#QZ)W&&[%%X%OQAQ-ZL>A2CZ*1?< S?BVL7N
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M&SV_Y/ 3'Q\O6L^O0X]7\%:XG0=BT@)57J[I.;X )F[YZ-+C>9*J3QZ-G:&
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M%70@C7"9-X_\*S_I/KWGN;&=-0'5WP-J[P%0L9B31>Z?QQ[U\]OU%#WL;R,
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M6:_Y[UIIYCI2R@JP0(6/OU@:5BHX(25=_>R'N2P:4I=2MU;++8R3!VVQUS>
M=G9#(C_.ML4BL8]&0QETKJ-#BF9:]7P2!IMI\P[-82*3)8=3:C4UE:"K[I_8
MY+%!BD>!B>8=M*<U!^7=8J^0 107DCI)BRJ'ACWI9]Z^([R[NLXNI;<HPL8_
M6]ZO-\3%Y3<DS@ P!U<2KVC'>ZSB(ONZY]*3S..!Y;;7+$M]TY!R1WNJ>$^?
M[EG^I(*SSP+G[X+-CQP'?YII4X60ISNMHZ%DZ>VU^)TY$?KR'>"TD=3$K\&
MT/BQO04TKE^&-/G):L/ZZ;2GJW"#>8-@<D$-%>*]R^I7NU<68S)@L,/@Y#G1
MC\&7[QRUF19)\P)!$IUK;S=.%B.(](:6V@$7KO)G,<2;5V8P?^(UU_E :N7H
M[QB.$Q,W%H'JS8?W -BU)V@U%=.AS+FX$9O>M+W(&4,B\;?/5X&#7G](L]CZ
M%-^^@,/Z<')T5HO388EF&<B]':E=VWIS#Y!9\)4ARW&[-ITQJ.7M=R++<1SM
M(U_1^813*<Z3OC(5?[$UJV0<UL88K8!#OT7<]*CA\;M0-!\MC!0!R+IBUOD0
MTZO&@1J>4_/48HW5NF9VXA<0+%D2K:Y_,PWU/PB_ED^M 6</4B9^QO0>8 2_
M!VS4Z&C?D;3BOKBQ6?H?M@'73(F'K@E(XVLL@X"-GG)':$QGF$\PB9HF?6[$
M<\!_=*LPODU[4.IU.@%3M?> *XZI6.V*N^& (WT.R>W9@%LR^R</FC$YIT#R
M,[5DC.1*_D7"7:<VW17/MZS9]GFZ1!*MN NUM/F0B;N-F^)_NO/^ \AX+^;G
MYV^WHY=JL@ J[>N\HSR[>X"KOZ;::_2_ZZB* @UHDF03J#B77Y4E ?SGJ/\<
M]9^C_K%1%?JWZ0]9#-U</-U_$,2Y0R3:X@%+ [^: B@E[V?^"U!+ P04
M"  VB=%4/YLG+D\W  !'/@  $    '-C=V]?<S%I;6<Q,2YJ<&>UNP=4DTV[
M+OP@TD$$Z2T@($B5+A((B'0146FA*BA-2N@]@%(%(B"@B(2FU(!T:8+TWGOO
M'>D])">^[_[VUO<[9ZW_G'_OAS6L=3]E9NZYVW7- '84.PM<55=64P;P\/
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M;EOK1.$ @L;3VBD0OO;NXIG?0&++V@=Z6@WAAAPAEN$-;Q#W*2Y0?>$B*A]
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MR0O]O&WN^&V=;XSE_7GF^S]7SI0IR=:[2E6<C4J;/\[7,N;"ZPU<7"CH%+
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MR5;(-,B>6+X_.CTSI=WVXHCQQK<*UP)&CVK:OJ<??XPS8X&.BTGU\<AZ+##
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MLM7XBIBYXP:S;S_33[+,9'M75DM?K2"$E)9CC3)LEGPQ&.!\F6B+GH3RW;:
MNON7G;&'/X*]GOGS&G8.SU"-S',-2^V>0.W45Y6QP--W1?'%Y:%&G@KN06[A
M2A3EWV09]%+10@,%XK7!B<_S4RVYWW5Q-]651;N5B+3!N$+S9*Y&I41-R>A)
M9Z#O[EH>=:'*2M/6"L<I7*ME88*E \4?T,77V\,?4KRO?_O .78BJ6\W5G<
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MX1SME\4]599+'BFDXY()*!,?F9W,@.6OU>$-CX;RE0[VZG9EFY$L,5V53[&
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MUF&;T?+*ZJEB[<4QZA=1QHP1/!>^[!-89 -58H!27@S GUV' 3Z?A5P[)V(
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MBL8SL(ZW<73M%(X!+#-!OXF-L;["VGKNY3?FV[5O,G,R@E1;),, Z4,:: S
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M7>MFW\U#9X3I T60Z>(EUBR,5CD$'U_4'7RXJ ,*:$,L4KN  @H^VL" 2D4
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MXE < @2WXA+<&;Z_G;_,GMG=V3DSNR_G)N?DR;V?^^Z[]C#SL QX\5Y!60&
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M&/DA"0Q\ZM_A:E-.RB*_L%'/PNB#,DCPU9AD.+H(<<>H"5%VQ%4N>8E--L:
MLVXV#'$U1.I]NY65#B^#'9*#ZJZC&NWMZYR <S]S=<U"XJK5]!]#KFT;GEG-
M9+.FP/77(5"9(J/0D;T(3)'I)[[75<,MZY/6*A31KDIFU\7KQ:<<;@W+5;#Y
M;M^Y9$KP4#JF4=2]P!+!Y8EF0C=9(QFTQ,8[NS5",03\9N:*[_4!;SWC^=;"
M'=M0;*=V[$I7!FG;9-1%M1%U79OVYO!"HB^1ZQ? )M1V2XH>19J1,P'20WZH
MXE 04*&5>/NG-WIOEM$Y PL3X.IMW47P@B70H=D,JC\#_=IC7A="9L9X0BGT
M1+E/YVS'Y^;CJ708U1<4<UK!+K @J*B[^$!'3#L*B)!IJJMG/*"@6.@5A%LO
M4SP 5O1B,7;T,FPZ _)^-[V'I[3HHV>$TB>*RQX=AI7!*-81,#SF'03% +AV
MXIW6!W6TE&KG& @0L-HLNTI  4E;Z6DKY\SX11YJ':*_$A@9F4#!Y/MGT]&\
MAWURY0$01R2MOO?XFU,:F+RR%+YV=%^X8BS=-2JW<A/(DD!3U_0WC'=AXV A
MND'2^XY]G*@CN7.WX"JRWM"+&M7CL3\$@&R&^,JN$>#=<H_"EJJVCR]=D(P&
M69BM$QM)<W^M17;\#_ \G"^1*M059')E'*P"84GGL[D87N<'*6IWGGBP:(+.
M3&+AD-I#G"5(SE,):1SU6D:/?*L?6 L;(?,*\VM+NSJWEOG;BTR7*=DV0(MQ
MRF53=KT8IE=D4QY]19L4ZU^P$5\D<3N%@?D/@!"WW7T[D>RV^C 5#N<GI/Q]
M- FCYJ@*!A1V6H5=*R/J+*]]:*6I*'M"6WI)WY#?SS6>?<[Q=7V"6GU(C\[7
MY:[!YU$-VO:?:'ST,'-O:8^BRV,=P:4& 3:FF-(VC41]&: ,%3!>-\!D2G!0
MI8WPDFQU\??X#J=F?KSH7]7QMQ)92Z_VO#K*_*1U4/#H6CQ_W(!*?9DV4!4\
M!=>K@JU*1WHORLGG)(/M//+H : Q0=ZI.52FZ$P6Z.PT=K\5 LFCT-F=]+Z
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MN3X@VH-?KN8,)#$0)/.;#K00D=O=H?U[NEV5_"UOU1YH ;4DV3%[F D[7_5
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MDLW"_QIQXJ=H-)4]VHSN3'L:SISM Z:=>&YE:=/_"7+@QXYO*V%8VKUFN!M
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M5![AZ(Y;BBMGW];89:;@D7"KF'JR8+W&TH4+_5!FP@CYS/MJSB&LA,"_)\(
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MTC!A<<@AW1)[*W.+YPOSK2!4S)^.V]?L_5CL$-HVKL>?=3GW^YXYUB.\'+@
MOSTA"*4_(@XR%KF>3F$=X!JBW2ZL(8M@S=/XIXO\WZ,?C[DV=SZ)MZ8,)LD_
MI#?21B1M\[25]M9FW)?8/:>#*]&M4MG9?[PRGC1N()Z<HCV+(*NHXLGE+&I'
M/=B?:<Q-DD41/N5PL'9R(#'['L><$R:&O^FYSEYVF8W2D@Y%>,M#8Q*$FE95
M'63Q?^7+S %UUSAZL9_Q8?G=A0/H<N4AF+$]L100S^Y4J024:SMH)<W8P?'U
MR,>Z)N*W\1GAS/PQG:*'Z>;,,'\F7VU4:/ ]TY8_YE' MWT)V2([A(M1SHCK
M>F:"AX*WFY8-.K*H@OQ(O8?SHPYJ[-)O;01G:(6>N/]I?6UT ;&<1Q#CGO,2
MX/I4LH>=7/^R \6WMMH;=HN[' #0![7-F'Q4YIAN52%UQR!.QR^$YP/\,.4A
MFV&MS)#IC@? $T$"6DCF;Z$DL;/TDK;9K[N^/E0Z,G,]/D*@20'#OU,2TH5V
M6@H,H":;38N/W_-_"$D# 1./?@E0DBQ<YV$']70GK7<@&5B1O=U9<%EDCO3(
MSS7J+Q@L,I1E;+5W[OR[]B:P%_%%V.08(>Y>'[_*&%Q)IN!$LEDH=5IM;/BN
M1]2!08%BH.:+@AJFUWRJ4)47F"Z-+FKP\_&01]UX?]4G#'"T:U ?8YVX=K+0
M=?<DGJ=S_CPE C%FH4FG(N&Z4;7;/K(F0WMC F0;&')_H:_&R-3SXIK^O6'D
MH*'2-[@>H4SHEW$>C0!BHQ](EYV,UY6M*N*E(/;TEG6^WDKQ[ONRR@> *#H2
MNIMTXRMG761LZ[*3] :]>T.1XGOW*]$%>*LBW5(TP WL;I>A>Q,V^<&C-PG=
MZY2N%C')H;MG %M_O?P &.3F<;QMG,8NM;TNR'H5JSJ*7%SLF79O=NE[T<T+
MGJ485L*-\N@O5@OW*K,#AF2[X@+?WK_; "[Q\^H\UZ&.HHGRS,+?<.!<3])?
M2Z%3JG?7I52[O=8FW 'ZANW3[N%7?2_7E7F;D7ZME]E; $FP/PZP2O,Z WGI
MVNH:U1VK%!Q@+?*U[-Q-E>EYTXS9MI+55]6_"Q'R"-:H8]32 VQ430N@S=":
M*\^;WT_ YOF>70W&Q;3L]-5_&Z@*_]XWV*+-TV]JFN^:=,U9A7* ,J8:F5HE
M+3+I\0(H?JV@>NN'N(-/4SA43Z<_6Z58@6Q,_',6I);IYC.A /=_JXQ)WZ]I
M5M8X)2=7&E91/C%X$B]-K ?ZAI*$#D(*</._>H3N99BFT$8LX,V=1-']0)N^
MJY[DB#TOJGOGT>1((;?E)Q81>:.N=C+4-@>]74GO_<NU$N-M52^I^ Y!ZEXZ
M1VU@N.\9R/RE7**O]6TUZQFV=$6^JJ,E)+6NI,+:Z7GUO$# UK.!]F+TBQ:%
M@!$@X""[M:I1P<>PSTKGID<4'?,V6HA343T%O=,/(\)T$-/BXTF Y^Z^B1=V
MJ'N@F0085!>P=TDF\)7[C:5J>[.#Z\5E[W@MV-YRDEHGVBW!\O-HR+>['[)L
M X5LV"SB?I L_!7F$&7&&%$=)'^HCGVBI-=IJ>#(I=4P2!(?JUZ7'(X^TF"+
M19GOH!:0)/ZY\=F_QT^V5)/9?K?SJH6WTT\O<O0PDW?$)L=+:]6*YO2+GRV&
M(NHYI=7C[/54C;% ?EHB&Q^+^ #9?0P!*9EI'OXY7\1MSG I,[1#CBFIN,\B
MJI]\W-V6,S7@4.9?Z*IJ/-#E U"X]Y4_XY2R;:M9J3PZO79#Z!Y#_T!?F/+S
M)L[@2$L98N4_^K/W(UJC8!:8;2T,[B7MW12%/[:2:W\^HMZE@0VB*R[HIXE7
M+#(4>R<LSE'REL ?4MCO94OU5Z5HE(0+5P1043%>;[KG,S7V>0+LQM.S<Z]7
MKX7Q?K0TZ9DA-@ 5 \/=ONY"&NG"J>Q7#0W9FXP ^CQ7'@ ?5&\K'L";>!&H
MT)37&*XPPL_43AW0,IVO=S\][IO+?9Y8D43M\/@&G?#YH_[6XPX1Z(>P1Y+"
MDOXB)'GCIWX?F#6,-===4(B<7^LD%"XM=IO3ME0,)UO^7+ M?<9],%<2=$+@
M/Z^!G:/(Z-)3K= Q%B+WID_Z?5)#V[/9?NN5)HA5C+X5QQ"C"]="E"$CV@3E
M]KXQT_]E;T9QUY3DU@,%CQ)PC/ $ZB:4F\[-TJ;$4.JS7BD"K%IG*B(";&VH
M52\SK24C:U7]B"B;OGKK01,5^*"#7+WX?+?AN8&F%)"Z);TYT"I8#:F@\6=L
MOIXE%NK92-ZC'I;*=<AO#%9]MO_4._#\9AT0('9<='HWX37"V'0GYV+7>^[+
M>#O^X0%@@,]^T)JMD'-17.";7J45VRD4:]!XN8]ZYN1</&=(<&W]),K?*^]H
MI/N06'55[JYMM3]U(=NO*%_!E.83*^F&].RYWX=7L4W$=Z#*2U#^]@D$EJI"
MD<?[V\"3RR,CW9^T,ZI]+%]-C4=I[FGXK_=5:N"?UR-=0W+ EK>M'*T9C+JZ
M'_FC:)> @PD&Q.B-!ZO+F<9#F<,%"(Y]CK-2FWWPYT 3[+@Z+F'AGUX%,?(4
M-();!= +TJBR1$6?-"ELA$.9K\90P3;QXB ' 3T[[&/KW]LJH[+&NF(_+YID
M($=2^8M@/5\LZL;IW%O!^I E@[;XU957Z@R'2G.* =[K@OT,:7J5\:):VC>4
M5W%PM)O?H"3M *2]6X_*SE^J'?*$A2&K))M8HJ_=Z\.NQA7A>[X0)%W(A!V9
M<R"8.^4%/9L"><R"LY%JVVWHH8]ON$GV:@69#6>!K4<.JE/96L*FAQEY"'=
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M(%/\F.V89)[UL%W=RIZ*^(>HSV82"2T24)[M*Y]K^<)XUV.<@9DG>*;7VP^
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M?>10M""<"$A3@A$!_KEX4M;PMAI%"+A203B5BBV*# 4L@OXU!XP1 J2*_VW
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M)99QG]EHG%Z_HE"=?D'H"_\JT!1 <2\E;LF<>OL2JMF>TU*^GUL2I&TJ\,&
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MP&.GL(-ACW_/+YX!_XP+1$"RQ^7(W+ZGC82GI"AL!H(9DP+#VZG=IC\" YI
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MX'.^ZJV/PV&R7*$8>]IF<[Y27#($O8_-1H0RGLXUK#"Y<VKD!;@6-K3=(DF
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M[!LS.JGVKH@S\(I' .5U[2JRU3=C$@4?R*;=,;B$QG)S48Q]16#QKCCVS-#
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MV7;'9TW<P\/301S$F?X74$L#!!0    ( #:)T50CL^:V/P\  !\0   /
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MU+K2E7%KTZ9'(:JWR0!:1/"^*_/G>V6V3M\:XV)FGL9WIAV'+JZ,SUXY*U2
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M-Y((.1WJBDUXJ?3G+5Z3226%"9GR1U$ZU'<H$.W-E;QB-351&"HZ3ATV3D\
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MXR0U-##_Z_H-#>=AX,H]I>03I*'UJS7S/#M[9D0!]A>V_->S._SQSZY,<)H
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M,_%3^;W8:'&,6MC>3U57'6NJ])Z6?XLJ%&N)RP\&B6B>8@K^]QK;,R=#+4Z
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M   /              "  0    !P=W9I7W,Q:6UG-"YJ<&=02P$"% ,4
M"  VB=%46\38]',T  ").0  #P              @ &D-P  <'=V:5]S,6EM
M9S4N:G!G4$L! A0#%     @ -HG15+4NAU925   U5L   \
M ( !1&P  '!W=FE?<S%I;6<V+FIP9U!+ 0(4 Q0    ( #:)T50 2?N#^@X
M #B9   1              "  </   !S8W=O+3(P,C(P,S,Q+GAS9%!+ 0(4
M Q0    ( #:)T52"NATLO@T  $RC   5              "  >S/  !S8W=O
M+3(P,C(P,S,Q7V-A;"YX;6Q02P$"% ,4    "  VB=%4G>A6*>L<  ")Z@$
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M>#$P-RYH=&U02P$"% ,4    "  VB=%4MQZ]SG\"   G!P  #@
M    @ $ACP$ <V-W;U]E>#(S,2YH=&U02P$"% ,4    "  VB=%4_M>G8< "
M   J"0  #@              @ ',D0$ <V-W;U]E>#(S,BYH=&U02P$"% ,4
M    "  VB=%4T@<&V4AY @ SEQH "P              @ &XE $ <V-W;U]S
M,2YH=&U02P$"% ,4    "  VB=%4D+>.=10O   ;/P  $
M@ $I#@0 <V-W;U]S,6EM9S$P+FIP9U!+ 0(4 Q0    ( #:)T50_FR<N3S<
M $<^   0              "  6L]! !S8W=O7W,Q:6UG,3$N:G!G4$L! A0#
M%     @ -HG15,$[2$O)70  /&L  !               ( !Z'0$ '-C=V]?
M<S%I;6<Q,BYJ<&=02P$"% ,4    "  VB=%4));#V8*(  !3G@  $
M        @ '?T@0 <V-W;U]S,6EM9S$S+FIP9U!+ 0(4 Q0    ( #:)T523
MG.1WAA$  #(2   /              "  8];!0!S8W=O7W,Q:6UG-RYJ<&=0
M2P$"% ,4    "  VB=%4([/FMC\/   ?$   #P              @ %";04
M<V-W;U]S,6EM9S@N:G!G4$L! A0#%     @ -HG15#!D+&IY'@  ER    \
M             ( !KGP% '-C=V]?<S%I;6<Y+FIP9U!+!08     $P 3 )X$
(  !4FP4    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
